<SEC-DOCUMENT>0001295947-21-000009.txt : 20210204
<SEC-HEADER>0001295947-21-000009.hdr.sgml : 20210204
<ACCEPTANCE-DATETIME>20210204062142
ACCESSION NUMBER:		0001295947-21-000009
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210204
DATE AS OF CHANGE:		20210204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prestige Consumer Healthcare Inc.
		CENTRAL INDEX KEY:			0001295947
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				201297589
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32433
		FILM NUMBER:		21588765

	BUSINESS ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591
		BUSINESS PHONE:		(914) 524-6800

	MAIL ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Brands Holdings, Inc.
		DATE OF NAME CHANGE:	20040727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Household Brands, Inc.
		DATE OF NAME CHANGE:	20040630
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pbh-20201231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e,d:877786c68c0b4e62bc2be287a69c3d84--><html xmlns:pbh="http://www.prestigebrandsinc.com/20201231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pbh-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV8zLTEtMS0xLTA_142bee87-9bba-4414-bef9-72bb8716e80e">0001295947</ix:nonNumeric><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV80LTItMS0xLTA_ad8471e2-09c3-4cb1-ba29-b7925bacaefc">--03-31</ix:nonNumeric><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV81LTEtMS0xLTA_d5fe1d25-d4dd-4f26-8287-407b100a040f">2021</ix:nonNumeric><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV82LTEtMS0xLTA_ec9e7b40-1376-4b5b-88b2-f86001b68a1f">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV83LTEtMS0xLTA_e14e1ffb-8e4e-4aff-9b05-ceb0ff700476">FALSE</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231" decimals="INF" format="ixt:zerodash" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81Mi9mcmFnOmI3NTEyZTQ4Mzc3YzRkYmNiNWE4MDliNTZiODRmODY5L3RhYmxlOjcxZGMyNzU5MWYyYzRhNjc4MzcwMzZlMDQ0MmI2YTNkL3RhYmxlcmFuZ2U6NzFkYzI3NTkxZjJjNGE2NzgzNzAzNmUwNDQyYjZhM2RfMTAtMS0xLTEtMA_49c6dcd1-c5c4-44f1-8d5a-a7e6a1693d27">&#8212;</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pbh-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8d954142956a41f08ae4450c1ea47581_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifcbae86d41084c1b9bf384e98fee23c6_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i770a1ceeef2b4323aed9a7f2952570b0_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ce9dea78194c07bc2f1b60510b73eb_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a0f5641ebb4c7f9fd27977e8172092_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ccdab8819b486492b15139e175675c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8446af5a29e740a9b3b8a4f709825b08_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4436ee22a94d41a44d64367ead5b9c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00cb6b7127748e28d119cdb054cd965_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8a14a79783154ed0b8aa034b4889e75d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e9c2b24c2343449c5f786157e9131b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645bab1208e440d6bba1b2b50e83f8f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifabce0a4ec3648aba15ce1da427edc94_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0388c23a904078a68ee55997708edc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib79098f710394f8bad4b6249ed402365_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i206f386ef65e4efcbd26b97188566221_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92b5649f7cd473c927b77aec8349b02_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf491c304bf462bbe422c10205da933_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86c6bf5384d2448ab19ea3c25d18c047_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87378b869354db2bcff3f2e742011c8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3ce94650fa9445f823db6a5338d8dbc_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff48eb475ee34d5f9e4435434ac71fab_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b39e4d0e2104f938f396d07693f6bb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232a04fb585849d7b62b28529e631e02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id285b7d072c846c49d7bfc6c90dbb60c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68a428b3ad4d41caa61dc1bda82e2223_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6597d0aa1a884ca6aa3023579166d059_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f3e3881699a45b699f355c9807a956f_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3870a17f657247418f8246de8f8e95d8_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ac3f4783ca6476bb7e3eedcfcdd97ac_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8182d3e7d5ab4ed39c4c86631d2af0a0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7998bc70e21a48d585baf03e6e7fb122_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i895d5defc18447a5924a8b792118d974_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552ef8c73a164d62926cecf57d47ab48_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c33b8ad9e0d4cd78038bc3e069d0540_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6ea02b421b48a483d6068027b2b09e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02378009299044fcbaadf8c1f71fbbc3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic85eaea3b41443acbf6c4b736e319a28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f65082bbe1549b9984db1760459d732_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a5377f8b470400fbb8f9121777eccba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae9f252e2294b9992531339cd343ab0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d5db478bde46f3bf4070353ddfd2d0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1a6f3463264049a9bc9dc455379e33_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie98e17addbc24768a91973f19003abe5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia194dc098eda4f59bfcb88c060c36e3d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cd8e3092d1646ac9ed4f22b175be42f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i894492e356c24389904183d445eebdf6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c7980a5567149ff9eb9001647b782d7_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec46f6b9a8249da93011c913c7e73b9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25e9032e71334883b53310db29ee9dcf_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb539dc22d348d2a949a23eec4d43ac_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919b953b16b64c2594759f09f5b6ad4a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec6216b1c544040948237d6bac14880_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe19bca84d574046993a13ff28023c51_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifefd508b4186429aa4691a4a839c0b30_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b246cfd86a4d3abc3d648d4bf23971_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic19a2270b9564c688d8a49573152aa2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca4dcc6702e4728b7857d76f6eef369_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89f0f45b3414ccab552e76bdf9df478_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia11c055523a04b699e5d7a78fc046593_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i302701c033d5435ebe15ac3c6d5c337f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c0818a176a94086a756b654b26eedb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6867e4a90c294f1fa8dddbeab438a6bc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103b63c927b0400b8db4ba9ce800eedf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a1fb9b631a4bfe88b529e766619c4c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i664da185858d4792aa10a4f8624f5074_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4abf53f8afa1439081a520747b145a31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba357660d1fc4f7787eef1e9535f4bee_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0609d20d39b84155990b8eeece18a13b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i354ed91ee4f3409bab9d6df5ad7c5aa6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if14edde8dc2a46079acba1cc1a731adf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81b414e215924c7b993b038bd3c3eee3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98a0c2ab86804016a4351c2ce5ed98f0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1236a922afd44780b720fd4a3fbba105_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie859ec3583f54138ba3370f6e120dd0b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10121816139428c94900de4ab354727_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc1556813bf44cc90d54deefa6cec4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72f4d7a1b6a4434993fb587f62cd9893_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7242718fff7f4c5d99567a954c71eac2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i038c52e6304749fab109d118081f602b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b28d9ff4d0544048ff592fc0fc0bb1f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2d78644d694801a7c8a37b269dd418_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ebb997344d403486b3f9420c112504_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0552db00f3c641ff80440074b49f730b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd599e3926042aa8b5dbaf89e6bd1cf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice64251d737d426195b9e1a793e60792_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1f1631ffca449e3b2162aa6eb96cc1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5032d30a5899473b981a782119c9d2ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06e52662eda44a78e9e8f9e560ad93f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06feca35d8b343e0a416ad3c87b1d890_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95cbb5a18397486680722f549c6889b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253eee16ff674e2a93a5287e7684fe79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d826a5505c6474db66c7f96cda89129_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7947344d11f749088f4c537fcf966dc3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe6c5d8a5f604fcea4fcd52e68353712_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221c06058a05456781dfa7d93133ca01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362a9c07939d4608b90d4ad15e3b6f16_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24c56ca1f7f41289fa51152754d0628_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12d98be53e544b7bec5cb41aded6489_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae35f6c71da48feb7c77cf3d5184356_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e3326065cf04377b74b6fbe21644c1a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd335d49025d49c487e470de1e7c354f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>pbh:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i92532672091247fb97202d4dd7b0cdcd_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80c1300a1c4f4cad9a29affc4c223aff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ded30b7f28349f78fd6ee06e33334cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3a6736b7e4455c835f368bcb184e94_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669fc4f1f78246bb8b0554fa4c73e813_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4fd7098c3ad41be8df870dde9d83eee_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i254eb380c9514d3b9a242c7b4084efd0_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2ce8e70024f47edbefd0232eb83236a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fd07a49514b46baa2e379f44d08a7e5_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84aca9e12e964a7cb990719431110348_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdae78c641ce4019acb0ab445a097687_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>pbh:vote</xbrli:measure></xbrli:unit><xbrli:context id="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39df23d267604e6189a005f399da0bd9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i242bdd6173d64a318c041525df6090be_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a1431127e184ca5b894517035890a0d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89df545b4177486fb38f4b91b5bfbd05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cf4c1b6e7914984877022bbf9681434_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88373d93eefe43dfaf99307d1663985c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib640d457ba2b4aacae15563b70a4f618_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ceed395390459d9e3572680ae73075_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7ab2765fd5461eb0fcfe3149ec29af_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a87d78fa10e452580fd3a8922dd6800_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30fb3c6cba044feb86d6e4d785c34a76_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00213381c2a14b5fb3a527097c5723e7_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594c5314ab0a48398a297ebae00548bc_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ebd4afe08246cfb5c144ac9fd55615_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63281ab682614b949d3bfa93e92d8a4d_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03dbfb445d744e408d4f455fbf1b0147_I20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e33b766bd5b4b77b3a15f8f572127a5_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-05-31</xbrli:startDate><xbrli:endDate>2014-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3ea26f332a940caa0e1a0c9c84992cb_I20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1a9cb50b5b44418cfc024476a41782_D20200504-20200504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-04</xbrli:startDate><xbrli:endDate>2020-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1cdfb4a0aef433a8562a57ce988186a_D20200504-20200504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-04</xbrli:startDate><xbrli:endDate>2020-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-04</xbrli:startDate><xbrli:endDate>2020-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i573a83e08488462c9f111c2bdfd78f3d_D20200504-20200504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-04</xbrli:startDate><xbrli:endDate>2020-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-04</xbrli:startDate><xbrli:endDate>2020-08-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44304ca391ad4b1694746195e1122111_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id062323b9871449988cd3af690123a42_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c40fb8e1f0479081115a63e83ad551_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09345f1e737c46baa82ce81fda75550b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e9892fc40644c89bbe3123ab2c9d39_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b72b1eb3c7c438ca17d1bd5b4bcebab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5fa425e6fa455fa7fd4d3c4eb57f48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c31348066374fe7ba878c4902bff844_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52df2ac531a04db9891c78e2953258fb_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500b594756b84b84a2b9d22008165363_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda365d016dc42ae9860c7df30b2f158_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9ae14e79e641269492a1e0e4ee76c3_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62cb921e0c1343f998a11bcd1f9d95cb_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f1844d37745467a92c46cb8d2c20da4_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008c0e348a60478bb9f7213b666b06e6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="manufacturer"><xbrli:measure>pbh:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6dcd2ebbac947c5b6cee797817560d4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i501a3213c11d461591927d286d9b027c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f6fb1bf2a34c35a01cae3374745b5b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68e63de10454e24894bd16a7a088bcf_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565b9bce16444927976c88402045c3d4_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8407d623fa84556b0397c38088abbf6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d198cc6856d470c8ec71c81c8103522_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46feb4fd7be74db89bc3151dc91f92e2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f81090cc714b74b8d03f28025f19b1_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96855186767b4db9a00fb69b716c41f6_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c7a94528d9490fb08b81ebf1d7a00b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9dde9deb0240549add526728474f42_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d09d2b366144f2aff1fd2e7f593171_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0694c66689742c5b90557d956ca3f32_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d320cc345b49a2a8fbdada2529df4e_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e950986bcf4e108adee0564716cb37_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3f00e6b81ef4c3482182a197d4a4e32_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4244f86df364e5ebcde26a945e3142b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia738781a6462445a9d482d900ef06acb_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5a85023eca74a8fac623c88ab9c8e78_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80964bb76f874e5281347932224ff34a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41001c9e538a41ed8464330160dc13e6_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28bad73d72f456e8b79877569af8a18_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81550b7b21bc4feea06a01fcc70f411f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8db11a316bb0453ba064a9b94c08d6e7_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7739148e504bf886e60a2197004803_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43dc6fc89aff41f88710ff54c5a7ed8f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice70e5b8d1064b52aebc31f31f0a7884_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id657b6e10bb145bd9e3b992a5952b584_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d12927a6dbe43b78aef3d34a6229cfd_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23c3e9b79a94d9789d9b7517a275164_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e73ad0358e14775a2e9849dd271ff14_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd9073a48464bd7b51b74613aafa24f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49b14bc7d42b468ba1f64dd1c0abaea3_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0a7cd80cd5a4b1bad14f4a51c7ada4e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97460044a83f440fa7584652350076da_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie688265c2fe64317a2d953ab3115c665_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2746c8904701432ab60720e86c50447b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8993e25574f54284bfbbbd9dd41772f5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ae8a85f75464471a53bd0ba32db5176_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3cc2559678948b9aef06ac76f4e1522_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173fab1b453f4560849f0dc00c3452a5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19fe27a1e60e4cbeb166294c0bede61e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic014bbc1359641b1a2b5b3a0a76876d2_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7877fc9a7f02493996cb66d50ec3afe5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5d5430fb96e440aae81e6b0952da7b6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4ec554d2bc4d29b952a1b545f2b547_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic58ac387c2ff481c9484454d90ef155c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6d6045fb4442a2895c9ec699f1811e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i965dae78c4ba4d53871050f36805d7c2_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6593e8a130e4e3f9f3cdf45d175d28f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac53dedfbbed4030a17b1545923bc589_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85a3d3deecd14f63bd429eb4e3e8430e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39009ec2cf5647779e9d225f923247c3_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6166e5bdf88b40a8992f759071b12983_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d710e027cd54fd8aee0485eba0c6cf5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87392d270c0486a93ceaf137e98399d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7e602fc5d9444ebdd4c853c09b50d5_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a79924f9ce947458d38df1406320d6d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03ee54ef632d4869892e5474c4128689_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd84840900f7404d8225e673a8394f3c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b5fa469fe0648758a18c8204ec783a2_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8e154d8fdb4c5ca334f3b074e96118_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eaa79a619a94571be5a3e33b1b9b727_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75cc8b1bbf84638bba89e388838032b_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38d019c5be754bedb9da5cb867242c80_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a054fe50c8445ffbe95cd9a6dae0e73_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07318d3f13404727be431e43ee6a10a9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c0956b5a03a4aac9860d3e814a7a613_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4a0ae5763540aebd26fc7b0246574f_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc317e3286f405d8d099420e0ffdce4_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb8aa6b9b0b4441b011f07d5309b81a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i404178ff281443bf9ced03a0238bf1f6_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3395ce8af8e428c9ad73baa0b989bc5_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a647598543421a924f09921ad19ce3_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic726fc7d1df344b5831a872a1ef09b6f_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac032030eede416e8cce85237744c04c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd0d5b78dd6488a90023e73337561c2_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b5ea8663fe460eb915122aa37bb218_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic326287529e8474aa6d710df42ce383a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b582ceef6b94530a0a15643c10b9bdd_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dfa30afe9ba4d0ab14d9df91c38845b_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cf96e727a648328bd0ddbaf8c22e9f_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1aa98178171483c8a80105d8260faf3_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74206d6c1ef94f85a77a706a302a2921_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e224bfc0f2f4f9bbd343fcf36f723d5_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b281d13ce44cac9f9e545ad208695f_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24eb7719094a43d584a2034ea978272d_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb01bf909b914824bd367b98c9aaf43e_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31318cf15ae24534bba25f86a4dd84c1_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc78679f204d4b82b27f94f4ab6bf2c6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19de88ae5c20400eb8842116fc3aece9_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fffc560ee1744808937bcbe9f0620d4_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b490d84f1fb4012b05a6af473ef1a5b_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed85d9a18a4444b8d4767cd042125e2_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a173370c5b48a196971ab3b9d7d458_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b30c22a1b5488eb65d429328bcc1a7_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376458bf47654387b6b570f09075e008_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ec6dd84935741f89edaadd7dc45c6c8_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia561de999a564dc38eed19fc55917452_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i607b8d0fdd5346f9a3cabe2c53ee8951_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib64ffd54f7d44b71837a1ffd999561dd_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec031e57d3cb43a2833a47073eb677ec_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f1a28867e44d3f9deec4c5458df1e8_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879386f7739b4709a9a498c439de1dd0_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5c3472bd6f439b818e26dba211fba1_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i726c3b7978984c9c89776dace3512cd6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7b3334441a4b4ebd90c904bf63af74_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbf0d2f0f0b45de8dbc05c513975980_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia047992a234e4a6e93507979ba924334_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ac168c392241e985f758d09dfff28a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ffb79e853904250bd4a61db331e3d55_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb23c99f72dd4b83a90f3c672526d24d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b9c1ebb674451b8abea4c22d7a9b9d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bfd9152348e4e888243321c3a99add2_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7cb897e70f478cb92e199f2d901a81_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i877786c68c0b4e62bc2be287a69c3d84_1"></div><div style="min-height:9pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                                                                                                                                               <br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      UNITED STATES SECURITIES AND EXCHANGE COMMISSION &#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-indent:396pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV85Mw_9a5511a0-37e3-4070-a554-bed65acf5148">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One)                                    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:16pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6NDE1NjA1ZWViNzQ5NDU4MzgwMmQ4N2JmYThjN2E5NzIvdGFibGVyYW5nZTo0MTU2MDVlZWI3NDk0NTgzODAyZDg3YmZhOGM3YTk3Ml8wLTAtMS0xLTA_6c49300e-3b4d-47e2-890c-d6dbb8a66719">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xODY_542eb93e-825d-4e2e-bdb0-3d9dd9a618f7">December 31, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OR</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:16pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6NDgzYTg2MGY5MGM1NDZmYzgxNmJlZTU0ZjQ4YjdmMDUvdGFibGVyYW5nZTo0ODNhODYwZjkwYzU0NmZjODE2YmVlNTRmNDhiN2YwNV8wLTAtMS0xLTA_26e68692-12e7-427f-b54d-a85aec5c7e26">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the transition period from ____ to _____</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yMjM_d3e60962-a5e8-4136-9b05-5cc7e48c6d47">001-32433</ix:nonNumeric></span></div><div style="text-align:center"><img src="pbh-20201231_g1.jpg" alt="pbh-20201231_g1.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yMzA_023324d0-7359-482e-af42-be9380910b1b">PRESTIGE CONSUMER HEALTHCARE INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZWFkNmM5MDJmOGI3NGE2YWI2NTEzZDU4MmFiNDk1ODIvdGFibGVyYW5nZTplYWQ2YzkwMmY4Yjc0YTZhYjY1MTNkNTgyYWI0OTU4Ml8wLTAtMS0xLTA_66b7bd0b-4e7f-4a3a-9ea2-c07d06bb6984">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZWFkNmM5MDJmOGI3NGE2YWI2NTEzZDU4MmFiNDk1ODIvdGFibGVyYW5nZTplYWQ2YzkwMmY4Yjc0YTZhYjY1MTNkNTgyYWI0OTU4Ml8wLTItMS0xLTA_9eb0978f-22c7-44f3-9a6e-f386c0c9160b">20-1297589</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTE_9151a7d5-2f7b-4da6-8ae6-951b20d9b8c2">660 White Plains Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTU_70ba391c-f837-4b9a-a825-2342c981e743">Tarrytown</ix:nonNumeric>, <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTk_97497426-84ac-4e26-b366-4a08b8b80d91">New York</ix:nonNumeric> <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zMDI_78fc5879-e234-4a5e-918f-03a4ea20de7d">10591</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zNTk_d06fcbea-e043-4c9d-9e4d-d4ea0041b9ca">914</ix:nonNumeric>) <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zNjM_5ecd5449-0599-4edd-bfd3-9eab6ff85e19">524-6800</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant's Telephone Number, Including Area Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTAtMS0xLTA_699bd20f-deee-462a-b22c-654cdaa2af75">Common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTEtMS0xLTA_d76fa12e-9db0-4b26-a4e6-ce566df32947">PBH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTItMS0xLTA_5bbb48a3-a45b-4a17-81a4-2a048abe8a16">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV83MTk_9c08b852-b3fe-4ab1-9434-55263997f461">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xMDQw_e4336e15-556b-49ac-8944-4006acddedaf">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.731%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8wLTAtMS0xLTA_dc05ec32-3a84-4333-bb98-8fd8467c5509">Large Accelerated Filer</ix:nonNumeric>   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated Filer   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Accelerated Filer   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8xLTUtMS0xLTA_98bd8ada-7245-4cc2-a75c-0526c099fbfe">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8yLTUtMS0xLTA_f17eb4ed-97fd-42fd-a794-327af12e71e5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xNzgw_7d213cfb-7cc4-4d5c-bd06-746dfe5a9647">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 29, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i8d954142956a41f08ae4450c1ea47581_I20210129" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xODIz_c50fbb3e-e8d5-41dc-b26a-2e274d56d8a6">49,864,752</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Income and Comprehensive Income for the three and nine months ended December 31, 2020 and 2019 (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_16">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets as of December 31, 2020 and March 31, 2020 (unaudited) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_19">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended December 31, 2020 and 2019 (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_22">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2020 and 2019 (unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_28">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_91">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_109">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_112">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_118">38</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuer Purchases of Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_121">38</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_124">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_127">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks and Trade Names</span></div><div style="padding-left:72pt;padding-right:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade names used in this Quarterly Report on Form 10-Q are the property of Prestige Consumer Healthcare Inc. or its subsidiaries, as the case may be.&#160;&#160;We have italicized our trademarks or trade names when they appear in this Quarterly Report on Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_13"></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income and Comprehensive Income </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbae86d41084c1b9bf384e98fee23c6_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy0xLTEtMS0w_36e2e4fd-113f-45ab-8143-4aa483a829fe">238,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770a1ceeef2b4323aed9a7f2952570b0_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy0zLTEtMS0w_ea084f83-47cb-4224-b973-084af6203ac4">241,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ce9dea78194c07bc2f1b60510b73eb_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy01LTEtMS0w_a3656c30-9d6b-41dc-8536-ab0a89e8f796">705,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a0f5641ebb4c7f9fd27977e8172092_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy03LTEtMS0w_6ac5ddac-3fd0-4331-a5f0-c8eeda187949">711,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ccdab8819b486492b15139e175675c_D20201001-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC0xLTEtMS0w_c520ab41-89b6-4229-b9ba-344127395a49">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8446af5a29e740a9b3b8a4f709825b08_D20191001-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC0zLTEtMS0w_50ba96ab-2fbd-4b46-ac64-1ba237543a23">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4436ee22a94d41a44d64367ead5b9c_D20200401-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC01LTEtMS0w_e3b62855-23cd-451d-8b07-d99118dfda25">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00cb6b7127748e28d119cdb054cd965_D20190401-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC03LTEtMS0w_7823e575-6943-4521-a985-9284341b6069">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS0xLTEtMS0w_0a969594-c740-40ee-8815-3bd049ec769b">238,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS0zLTEtMS0w_8c90ca22-4c39-4465-ad9f-beb52468b08b">241,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS01LTEtMS0w_c983c7a1-c8ad-45f8-89ce-c1bf2b06d356">705,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS03LTEtMS0w_8bff6665-55d6-45f7-b8b6-26169387fba6">711,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales excluding depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:CostOfSalesExclusiveOfDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC0xLTEtMS0w_b795d968-c017-473e-b754-d72e25de8ae4">98,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:CostOfSalesExclusiveOfDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC0zLTEtMS0w_6bde64f0-3580-4cd7-9b21-c568a48014e6">102,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:CostOfSalesExclusiveOfDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC01LTEtMS0w_833efd98-c908-41e2-ba3e-63496cc11420">290,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:CostOfSalesExclusiveOfDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC03LTEtMS0w_f17bb9c1-aac9-496e-baf0-011708f47e06">300,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS0xLTEtMS0w_9f14063f-e063-4af7-a340-7d91949476e1">1,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS0zLTEtMS0w_b3dbedf5-68a0-4d56-bed2-a9939692b304">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS01LTEtMS0w_60a88cd8-7a95-4d50-a134-e9da918f7dca">4,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS03LTEtMS0w_537b5fa6-deb4-4193-b06f-68121e0d49e2">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtMS0xLTEtMA_f057f329-2464-47d9-b494-785e3f41539c">99,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtMy0xLTEtMA_1ef22bd3-ca4e-4514-8e96-58823eda6ea0">104,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtNS0xLTEtMA_97c3a282-ade5-4b60-8587-4af61d9b3110">295,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtNy0xLTEtMA_e1f34066-78e2-4a15-8213-8bfd152fcbf6">303,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtMS0xLTEtMA_51da1e14-059d-4804-89da-7e0ecf5bcc7f">138,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtMy0xLTEtMA_2e7c7734-7f36-4da1-856b-014785cdffd4">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtNS0xLTEtMA_b49bf149-c564-4aff-ba23-b9fbb5b9d15e">410,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtNy0xLTEtMA_e6dd74e0-79ee-4a8b-bb9c-687b2da01be7">408,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtMS0xLTEtMA_ba05df2b-dd65-4c84-a50e-29551905f4bd">38,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtMy0xLTEtMA_36fdae6c-cb52-4786-8a46-49dd7a33f58e">33,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtNS0xLTEtMA_ccc8bc36-7b5c-4529-9730-f6fc73fa1d1d">104,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtNy0xLTEtMA_3258245f-8c73-4045-adb5-0fd8e776138b">107,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtMS0xLTEtMA_5da4943c-c959-4d00-8791-51ebc98be7e9">21,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtMy0xLTEtMA_4cb5e2ad-3394-49b8-b34d-498295b51dcb">21,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtNS0xLTEtMA_3316bcb4-af25-4319-8aa5-b886d13d5278">61,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtNy0xLTEtMA_e4cab816-09a0-4e8a-8f75-94433538e5c8">65,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtMS0xLTEtMA_a83f23d4-c710-4134-95e1-bc4e13c1966f">5,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtMy0xLTEtMA_6293ab5d-218d-4299-849c-9628d92482de">6,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtNS0xLTEtMA_8de705b0-5d38-484e-b21b-1193887fa930">18,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtNy0xLTEtMA_ebeba9f6-72bc-4202-9595-b5d612a40988">18,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktMS0xLTEtMA_f91030a1-52d2-4371-ab64-18d53df601b9">65,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktMy0xLTEtMA_f8360b0f-44bd-4e3e-a2c8-e293260fe3cb">61,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktNS0xLTEtMA_74d26096-f3dd-48ae-b1b7-e05a0582a73a">183,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktNy0xLTEtMA_a3218925-6b9e-4ced-9c5c-cb18da298d4d">191,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtMS0xLTEtMA_442d3c3f-7654-45d2-85e6-c79e85c18b22">73,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtMy0xLTEtMA_d9d507cf-7486-4df6-a4b7-a16276e7b485">76,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtNS0xLTEtMA_3041792b-eefb-48ee-bec9-64e647c99883">226,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtNy0xLTEtMA_a254b0d5-9c13-49bd-9b6a-75a3ecf9f315">217,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtMS0xLTEtMA_50b093e3-b2d7-4ad5-bb5d-6c0884109a24">20,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtMy0xLTEtMA_5bf6c801-d91a-4d85-80bd-984f8be4c0aa">24,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtNS0xLTEtMA_f7db40b5-5193-4dc4-99b1-461856d24d4a">63,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtNy0xLTEtMA_7e8d9514-44f8-4b06-b38e-2d4b88bc2ba0">73,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtMS0xLTEtNTc_d16ba6bb-e83b-4726-afce-94898e4b9279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtMy0xLTEtNTc_bf238f27-88fc-43b8-b7f3-67bdc93e9823">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtNS0xLTEtMA_acda17f5-c3ae-4c6b-b2e9-ee943caffe28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtNy0xLTEtMA_04bdf43a-d8ef-4bd1-b70e-cd460c22de31">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctMS0xLTEtMA_5fa642f3-659d-466c-8654-abb670575444">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctMy0xLTEtMA_f03a8713-cd8e-48e7-88b8-ca22cd491c22">580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctNS0xLTEtMA_e6e1f65b-5928-416f-94d0-33e0dde1a17a">620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctNy0xLTEtMA_fe3a419c-46f0-43c8-bc71-57810a3641ad">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:TotalOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtMS0xLTEtMA_01897424-6d83-42c4-8bf3-f3664afc1042">19,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:TotalOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtMy0xLTEtMA_e3f98c16-e808-4d68-be3d-dce4fdc9dba2">25,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:TotalOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtNS0xLTEtMA_404ce3c3-d74a-4fda-ab0e-6e3175ead8a0">62,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:TotalOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtNy0xLTEtMA_a6da66ca-46be-419a-aa6f-4a9356b63103">76,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktMS0xLTEtMA_350ee5df-c603-4ab5-95f8-184ee0699fab">53,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktMy0xLTEtMA_971804ef-1741-4413-8a35-d11390f05b26">50,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktNS0xLTEtMA_ceea4856-8e18-4c10-9afd-451cf524cbb0">163,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktNy0xLTEtMA_1efbd8cb-9306-431b-8d73-a85c422ad6bd">140,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtMS0xLTEtMA_c9952761-f01f-414b-a1a9-33822af437b0">12,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtMy0xLTEtMA_ecdb6e37-6f9c-488e-b14a-a2edd7ac9b1b">12,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtNS0xLTEtMA_52ee9b7f-5564-4e33-a0fb-3c7081a28fda">34,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtNy0xLTEtMA_0014201b-dcb4-4fb7-bb40-25000801748a">35,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtMS0xLTEtMA_c4bd849c-de17-489f-968e-fe413c165963">40,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtMy0xLTEtMA_a245e4b0-0488-4224-8c01-a578a0212315">38,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtNS0xLTEtMA_4dcf8d79-2854-4011-8d8e-add11c9684be">129,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtNy0xLTEtMA_f2bce67c-fc6a-4444-a943-1c35ec84d40a">105,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtMS0xLTEtMA_da57acda-2067-460c-bae3-52cab30bfe2b">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtMy0xLTEtMA_6ed6163b-35da-4ef9-90e6-af0fde589d0d">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtNS0xLTEtMA_f4192c87-e665-42fb-bf2a-34c6c956f8aa">2.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtNy0xLTEtMA_f8eaaca2-75d9-4677-ba11-947ecb4de2fe">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktMS0xLTEtMA_89770fef-39d5-4754-8b6c-e81084465790">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktMy0xLTEtMA_2c6837bf-64a2-4a7c-b5f5-625e7da7be02">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktNS0xLTEtMA_6abd2fd7-3931-4468-96d2-b423868e9136">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktNy0xLTEtMA_dc02ff5a-cb99-4c8a-987c-6317fc6f60af">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItMS0xLTEtMA_645fc91d-6375-4b38-97e7-1c9624402cfa">50,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItMy0xLTEtMA_58d697e2-aae8-4a74-861f-66b67a6c62b0">50,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItNS0xLTEtMA_f8e61c46-167c-490e-9d53-93d5eefa4df5">50,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItNy0xLTEtMA_ed899baa-c3af-4afd-a19e-83cd15d5ae2b">50,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtMS0xLTEtMA_c7b85d59-16af-42e1-a6a4-ff9e4f00d2e5">50,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtMy0xLTEtMA_221e7eff-1744-4352-9425-43ad8b7e4ea6">50,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtNS0xLTEtMA_03242e07-5e80-4d99-b6b1-4eb919854e78">50,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtNy0xLTEtMA_44f90425-4b44-4171-b597-c4280faabcde">51,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtMS0xLTEtMA_8afb422e-3a04-468b-b439-99d63f9299f8">8,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtMy0xLTEtMA_c39e9936-1275-4e90-a091-60f84c954bdf">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtNS0xLTEtMA_3b45a6d4-dedb-44ab-9c7e-9f74c095c5ad">22,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtNy0xLTEtMA_95beb3e8-b995-492f-abec-e5665360a8e4">311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctMS0xLTEtMA_8b914188-cc59-4c3c-ae33-be527967307c">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctMy0xLTEtMA_2b9b8539-0bdc-4f42-b4fb-2a2181aced83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctNS0xLTEtMA_87888464-a5a4-4efb-8dd7-3ff492796abf">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctNy0xLTEtMA_2237ea17-0d73-4289-bf2f-8a5e5ee830a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain on pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtMS0xLTEtMA_eee47d6b-e88a-42d4-a64e-bf7c55f90def">2,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtMy0xLTEtMA_5cfcf562-b9e3-47ed-b14f-9076d67873ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtNS0xLTEtMA_9166fdfc-5671-48c9-a8a3-7213eeb09a8c">2,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtNy0xLTEtMA_7279daf3-098c-433e-84b2-1b17c59c69b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on pension distribution reclassified to net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMS0xLTEtMTQ5Ng_8bef9ca6-56db-4486-80a6-017e914d65d3">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMy0xLTEtMTQ5Ng_420f6d42-c52a-478d-9a85-0e1bc5d8314a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNS0xLTEtMTQ5Mg_b4e48534-cc72-4fc3-aa79-13368b9a6fa7">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNy0xLTEtMTQ5Mg_b69d68a7-c1db-475f-ad42-28d9e6a157cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMS0xLTEtMA_b4aa09d6-1f26-4e19-b52f-3455165d6beb">11,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMy0xLTEtMA_b8d2fd09-11f2-4995-88d6-8f719350c096">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNS0xLTEtMA_81a0b9e1-87dc-4cde-9286-607cad5405f5">26,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNy0xLTEtMA_1fc000e8-970a-4659-9ac0-7063a7d42336">311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtMS0xLTEtMA_7ffbdfbf-c628-4aaa-a1f4-146704f40643">52,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtMy0xLTEtMA_4d28e7cd-b83f-4983-9d6a-e424587d0a45">41,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtNS0xLTEtMA_df8f9e06-4734-4152-97c0-0b511b56f7a7">156,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtNy0xLTEtMA_045db7a4-2612-4910-b018-668733114565">104,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">       See accompanying notes.</span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNC0xLTEtMS0w_ff9d013a-2a61-4bc5-af13-ed41b4ecff51">62,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNC0zLTEtMS0w_10c83445-8a5e-4cd3-ac9d-24f31aae8f6c">94,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0wLTEtMS0wL3RleHRyZWdpb246Y2NiYmViOTljN2UyNGZlYmJkMzFmZWIyZjJiZGU2NzhfNDU_89fddc51-7f49-452f-9616-fbbe9724ee08">19,025</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0wLTEtMS0wL3RleHRyZWdpb246Y2NiYmViOTljN2UyNGZlYmJkMzFmZWIyZjJiZGU2NzhfNTI_8a5b8bbf-45dc-4071-9309-b9d1f1a8fb81">20,194</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0xLTEtMS0w_7af17989-9615-409c-8799-b0c18240fcd7">116,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0zLTEtMS0w_a6b4bcf9-047d-4f05-8402-03ed3c28f7dd">150,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNi0xLTEtMS0w_7758d82b-c6fc-4398-b853-ea1e99005a08">117,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNi0zLTEtMS0w_5867d963-40a6-4399-a4de-2ec0e94639ef">116,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfOC0xLTEtMS0w_fe86503a-a9e0-427b-8111-ed0e30736f14">6,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfOC0zLTEtMS0w_da50c044-6a4d-47f9-b17c-7e796d0e5c75">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTAtMS0xLTEtMA_46257b0e-6419-458f-8e12-d09dc468903f">301,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTAtMy0xLTEtMA_40baba8d-9209-477d-ad65-14a9ebeeea19">365,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTItMS0xLTEtMA_f26cbdd8-697f-4037-95e9-97c3fcb8d1d6">68,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTItMy0xLTEtMA_577b25f6-b50b-4c97-b956-4700b86fd8e2">55,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTMtMS0xLTEtMA_0d9b4296-f620-4eaf-8d8b-a9f82ce38006">24,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTMtMy0xLTEtMA_db90cbec-4663-4f0e-8723-1c3c75f3f919">28,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTQtMS0xLTEtMA_a4022529-b038-445d-a277-8af348229cdd">9,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTQtMy0xLTEtMA_87569283-3c4c-434c-ba9f-de26193c80d6">5,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTUtMS0xLTEtMA_3ab14c32-f20b-4156-a33d-730af902062b">579,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTUtMy0xLTEtMA_e7f1d056-fff8-4952-8279-92f317e92c7a">575,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTYtMS0xLTEtMA_d3ae15f7-7f75-412f-baec-2ef807949cbd">2,481,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTYtMy0xLTEtMA_b0192e8a-d00f-4ac0-82da-b9632cfb4d74">2,479,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTctMS0xLTEtMA_c5cfaa06-09df-44d7-a5d0-49043d8816e2">3,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTctMy0xLTEtMA_99767ec2-f6bb-40f3-bf24-cb8ce2360e86">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTktMS0xLTEtMA_19025b31-8bf4-4ee9-b565-8d3a40aadaf2">3,468,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTktMy0xLTEtMA_1c7dcf78-601e-47cd-92ff-7e3b2e51474b">3,513,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjQtMS0xLTEtMA_beae7b64-184d-482f-b6ec-edde7082e94f">29,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjQtMy0xLTEtMA_53b30390-b5c4-41b9-a76d-e8fab9e69379">62,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDividendsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjUtMS0xLTEtMA_02a7d3a3-9765-4c40-9fbf-497c815a7ab3">22,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestAndDividendsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjUtMy0xLTEtMA_c5cc1612-28ad-40a0-9890-a7be7c05e9ac">9,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjYtMS0xLTEtMA_eec47764-609c-4957-95fd-ca7a88588e5d">5,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjYtMy0xLTEtMA_df5a0fae-f6dc-4bdb-97a3-6808cdc2124b">5,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjctMS0xLTEtMA_24549760-223d-4eae-bd63-810789ac7584">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjctMy0xLTEtMA_2034648f-ff34-4e38-9a68-8091e59e0185">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedAndOtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjgtMS0xLTEtMA_d144c77a-05f4-4f8d-a95f-376e5c0fbe9b">66,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedAndOtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjgtMy0xLTEtMA_853ad77c-0de3-4dc2-81fe-13753f06c0bf">70,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzAtMS0xLTEtMA_43ead510-2906-43cf-88c4-ee823630072b">126,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzAtMy0xLTEtMA_e84516b5-d802-4f89-a39c-31c5735863b8">149,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzUtMS0xLTEtMA_b87683c9-043f-492d-b9cf-b0eb3b7bdce3">1,548,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzUtMy0xLTEtMA_1b80f08f-d170-483a-8e2e-5cc628cd76c0">1,730,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzctMS0xLTEtMA_3fd3c8d0-fdb4-44f3-82b4-3038ba9b753b">424,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzctMy0xLTEtMA_b1eb943f-d9a9-4f54-9f16-b7600e27d1d8">407,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzgtMS0xLTEtMA_2305e869-fb19-420b-a5b4-780205a35a36">21,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzgtMy0xLTEtMA_f2411b9e-87ca-481f-b458-0b8d94ee4fd0">24,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzktMS0xLTEtMA_4a3edaae-f26e-4c22-8747-8401f6c8c967">7,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzktMy0xLTEtMA_185e031e-6e0e-4bad-9ead-935ea6b77158">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDAtMS0xLTEtMA_9ab71550-a7d2-4e42-b4dc-c8cc1e950c32">17,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDAtMy0xLTEtMA_70060e06-98ac-43bf-b832-f2c5f8e496fd">25,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDEtMS0xLTEtMA_ec2e08d5-6345-4dc6-9eb7-a6e90b380c69">2,145,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDEtMy0xLTEtMA_b966f8c0-94a2-46a3-bb4f-0c9dac8580fc">2,342,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies &#8212; Note 16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDMtMS0xLTEtMA_145078ba-a6d2-48a2-8ff2-b9f113f60fea"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDMtMy0xLTEtMA_0382286e-3f86-48f9-8362-56530cd3af39"></ix:nonFraction></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOjViOTc4Njk3MWZlYzQyNTdiZjdiNWQ1NmVjMDA4ZjhkXzIy_9e3ac873-2ae2-47f2-b3b1-822e1571602c"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOjViOTc4Njk3MWZlYzQyNTdiZjdiNWQ1NmVjMDA4ZjhkXzIy_b6b39535-0590-49d4-9edd-1dd0e0156da2">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized - <ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDctMC0xLTEtMC90ZXh0cmVnaW9uOjVjZWMwNWMxNjVlNjQ0NmFiYmRmZDUwMGFmNDZhODczXzE3_a9ee0cbc-5066-4a0d-a0c0-eda2841f7790"><ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDctMC0xLTEtMC90ZXh0cmVnaW9uOjVjZWMwNWMxNjVlNjQ0NmFiYmRmZDUwMGFmNDZhODczXzE3_dfd81fd1-cff7-4001-b06d-c1f8fdfa7a39">5,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and outstanding - <ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_2e9898d5-cbb3-48f5-9882-73978fe1598c"><ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_657064db-c406-4c97-b5d9-e3cf7fb67abc"><ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_797e61ad-d954-4be4-81d8-c6801a44aa13"><ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_ec3a92ce-8cc8-4716-b030-b4d37edeaca0">None</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMS0xLTEtMA_a102b09e-3a14-405d-b51c-567f70de3c35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMy0xLTEtMA_0b8b0c0c-09c5-452b-bc2d-f264e6d31c9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDktMC0xLTEtMC90ZXh0cmVnaW9uOjRhZjU5M2QyZmZmNDQxZjJiYTk5NTRmMTc2NGM1ZTNmXzE5_32525059-a593-4256-9a07-42213eca9d5b"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDktMC0xLTEtMC90ZXh0cmVnaW9uOjRhZjU5M2QyZmZmNDQxZjJiYTk5NTRmMTc2NGM1ZTNmXzE5_8284ee06-790f-4665-b8c5-df4cec10c9c9">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized - <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOmFlYWMzYzkxNTUyNzRiZjdhMzBhYTNiNDY5OTkwYjQzXzE3_0ca90044-953d-4d2f-aec2-c2ed027068af"><ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOmFlYWMzYzkxNTUyNzRiZjdhMzBhYTNiNDY5OTkwYjQzXzE3_1533f2a9-4aa9-482c-ba93-82ff5ee110b3">250,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued - <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMC0xLTEtMC90ZXh0cmVnaW9uOjg5N2I4MDgzNDg1MzQ4N2NiMTlmZTg0NzlkM2M0NzczXzEz_603a5975-0ff1-4abe-a4c6-5421ca7decb6">53,945</ix:nonFraction> shares at December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMC0xLTEtMC90ZXh0cmVnaW9uOjg5N2I4MDgzNDg1MzQ4N2NiMTlmZTg0NzlkM2M0NzczXzQ5_44488116-2f27-4d4e-8fcd-92190972eafe">53,805</ix:nonFraction> shares at March 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMS0xLTEtMA_4b392820-f20c-4d1b-9866-90c228f2ad04">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMy0xLTEtMA_44f70277-771b-4d38-9198-2fab50291dc4">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTItMS0xLTEtMA_5c3eccc4-a47d-4232-81e9-cf93a1050444">495,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTItMy0xLTEtMA_463589ac-d97d-4200-8059-76e6f49874a8">488,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMC0xLTEtMC90ZXh0cmVnaW9uOjAwNWZlYmNkMjVhOTQ3M2NiMzZlYmZjNzE4ZmFhMTQ3XzMw_143793cf-2ee0-4c90-a6df-77a88469aa68">4,033</ix:nonFraction> shares at December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMC0xLTEtMC90ZXh0cmVnaW9uOjAwNWZlYmNkMjVhOTQ3M2NiMzZlYmZjNzE4ZmFhMTQ3XzY2_3e3368ca-353a-4795-be9d-0e02e770eebe">3,719</ix:nonFraction> shares at March 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMS0xLTEtMA_032a06fc-bbed-43d5-b18e-bb19c8c46541">128,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMy0xLTEtMA_21d16489-6ee6-41d3-a100-cf2529b8f57b">117,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTQtMS0xLTEtMA_4bdddb89-0315-4508-84ac-bef9574d628a">17,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTQtMy0xLTEtMA_5aa79671-7542-45e6-8cbd-06cd8c1b9890">44,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTUtMS0xLTEtMA_a30b4412-44d4-438c-b613-5a3d44bf5930">973,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTUtMy0xLTEtMA_442a293f-be4f-4c07-83e4-bb71c2106374">844,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stockholders' Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTYtMS0xLTEtMA_5d0095a4-094a-484e-8f87-334a5ab6a6aa">1,323,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTYtMy0xLTEtMA_570b4ccc-b045-4930-9858-1f39ca8b4f6f">1,170,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Stockholders' Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTctMS0xLTEtMA_8032e8f3-2d28-423a-b5a8-27a951173d54">3,468,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTctMy0xLTEtMA_2e6ceb6a-bc39-4008-8a74-de3e5a5d2e57">3,513,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive <br/>Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i645bab1208e440d6bba1b2b50e83f8f7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xLTEtMS0w_fb701717-8143-4dbd-acc8-69910694f923">53,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645bab1208e440d6bba1b2b50e83f8f7_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0zLTEtMS0w_06f45e0f-c32d-471f-bad9-ec9c28ec6ac1">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabce0a4ec3648aba15ce1da427edc94_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy01LTEtMS0w_e908b6e3-ba34-4864-ae52-9f5275cbedb7">493,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e0388c23a904078a68ee55997708edc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy03LTEtMS0w_670bc303-8051-41a2-95ff-1964992efee6">3,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0388c23a904078a68ee55997708edc_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy05LTEtMS0w_b915239b-c8ae-4678-beca-7669cfdf81bf">119,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79098f710394f8bad4b6249ed402365_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xMS0xLTEtMA_b235a443-32f4-4ac2-8c79-b00106deffa2">28,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206f386ef65e4efcbd26b97188566221_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xNS0xLTEtMA_e3e20fc1-ba73-4893-8b73-dfec27a3f30a">932,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92b5649f7cd473c927b77aec8349b02_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xNy0xLTEtMA_043bdd74-6712-402f-930c-16579e249f0f">1,278,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf491c304bf462bbe422c10205da933_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNS01LTEtMS0w_54db2a6c-5247-48df-ba3f-900fe889e9b0">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNS0xNy0xLTEtMA_82d7f9ad-95bf-4675-b6c8-746ffb43114a">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86c6bf5384d2448ab19ea3c25d18c047_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi0xLTEtMS0w_ed7c2b1c-df98-49b8-be02-74af4f25fd49">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf491c304bf462bbe422c10205da933_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi01LTEtMS0w_dafe01a6-97e6-4d8b-a6e8-0dbb6fab062b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi0xNy0xLTEtMA_8a6ad57f-a220-405e-a01b-9f237fc7fe91">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id87378b869354db2bcff3f2e742011c8_D20201001-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS03LTEtMS0w_08b1c59c-3ed1-4cc6-87ba-35f74ace21cf">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id87378b869354db2bcff3f2e742011c8_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS05LTEtMS0w_9381317e-0f78-49f2-9613-5bdaac1b1315">8,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS0xNy0xLTEtMA_8598e237-b8a6-414e-9a34-1f7c7934630b">8,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ce94650fa9445f823db6a5338d8dbc_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTQtMTUtMS0xLTA_e4c22f7c-5986-4d8a-a58b-3426d52a084d">40,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTQtMTctMS0xLTA_c0e73b31-df04-4d72-800f-c1dcc96eaba7">40,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff48eb475ee34d5f9e4435434ac71fab_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTctMTEtMS0xLTA_bd084478-633f-4960-937c-9cd7b82cd433">11,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTctMTctMS0xLTA_0dc64638-0af2-408e-adc1-b22b4c3ca28d">11,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMS0xLTEtMA_fc3dc53b-1b53-4ad9-95ae-37fa9bb3306c">53,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMy0xLTEtMA_11fc2d0b-4488-46f9-a2ee-aea7a9ae4ae3">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232a04fb585849d7b62b28529e631e02_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktNS0xLTEtMA_e3c95f77-b329-478a-b1af-930e9abc23ae">495,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktNy0xLTEtMA_8a7a3502-ac22-45e9-a68c-2e9daa838636">4,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktOS0xLTEtMA_f143905e-17bd-478c-87e9-a5098a6b907d">128,739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTEtMS0xLTA_5a601146-b170-45e2-9f5d-dbc19c2545ba">17,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a428b3ad4d41caa61dc1bda82e2223_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTUtMS0xLTA_e381a8e8-621a-490a-b932-97535d620a5f">973,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTctMS0xLTA_3865158f-947a-47d6-91c9-0ca2f72d6f92">1,323,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive Income  (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6597d0aa1a884ca6aa3023579166d059_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xLTEtMS0w_666d2c1f-16ed-4007-816e-cd432ec7e71d">53,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6597d0aa1a884ca6aa3023579166d059_I20190930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0zLTEtMS0w_13623ed5-0713-4b97-892c-52fa6d3cc05d">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3e3881699a45b699f355c9807a956f_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy01LTEtMS0w_463ba186-9e05-4fa3-bd90-f9e9f0513647">483,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3870a17f657247418f8246de8f8e95d8_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy03LTEtMS0w_aa95260a-66ef-4d60-9fc8-50a07684bbd0">3,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3870a17f657247418f8246de8f8e95d8_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy05LTEtMS0w_5de68607-2008-4be4-8596-4eb56e1f1240">110,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ac3f4783ca6476bb7e3eedcfcdd97ac_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xMS0xLTEtMA_64219522-91d4-4eb6-8a88-1e14131bb5b0">29,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8182d3e7d5ab4ed39c4c86631d2af0a0_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xNS0xLTEtMA_be51d0a6-aacd-46ad-b5b7-cc2c5aabfb1a">768,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7998bc70e21a48d585baf03e6e7fb122_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xNy0xLTEtMA_cf3b5f7d-6788-42e3-ab61-e38babafdc98">1,112,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNi01LTEtMS0w_d3b0a6e0-6d27-4d11-8cd9-5f4437ebaf35">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNi0xNy0xLTEtMA_dd8113e8-e334-493e-8bce-61d97f5c0b17">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy0xLTEtMS0w_b3ececc1-e384-4ad2-973b-545ecb8bb592">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy01LTEtMS0w_4768dd43-5fd8-43ac-b0c1-eec75ce32687">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy0xNy0xLTEtMA_81afbd24-f54f-4f37-aebb-cbd9216a970b">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfOS0xLTEtMS0w_4b92ba29-09c1-411f-aaf9-8041bf1b198e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfOS0xNy0xLTEtMA_d71ed54b-f1ac-4aee-90eb-be0c5f577d0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i895d5defc18447a5924a8b792118d974_D20191001-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtNy0xLTEtMA_a11de9e5-29d3-493b-a633-687fca888e5f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i895d5defc18447a5924a8b792118d974_D20191001-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtOS0xLTEtMA_f75416e9-89bf-4491-89f2-98f1083e3902">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtMTctMS0xLTA_0af8f288-c893-4250-849f-979d15ea5f45">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i552ef8c73a164d62926cecf57d47ab48_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTMtMTUtMS0xLTA_67349240-0372-41a6-a52f-a55ef92c57cf">38,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTMtMTctMS0xLTA_be935af8-6590-4db4-958a-9b0885a0e283">38,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c33b8ad9e0d4cd78038bc3e069d0540_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTYtMTEtMS0xLTA_13dafa90-7db3-4837-bd5b-1da5b7e83578">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTYtMTctMS0xLTA_da954cb9-fc0d-4447-83d7-27fbd870b5f2">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMS0xLTEtMA_667e846c-f11f-4505-9c2b-9e13cef9a61f">53,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMy0xLTEtMA_24a2430d-2ffd-4a2e-b7e2-4129af7d4c85">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02378009299044fcbaadf8c1f71fbbc3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtNS0xLTEtMA_92ff9a10-3156-4d73-bc0f-2e3fbf9d98c4">485,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtNy0xLTEtMA_1ae4d6b8-307c-4e93-bbbd-a40e5e1690a0">3,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtOS0xLTEtMA_e71f4290-a399-42fc-8c14-22f002985ed6">110,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f65082bbe1549b9984db1760459d732_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTEtMS0xLTA_cee8b55f-fc73-45e8-afcd-16ecb1c3303a">26,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTUtMS0xLTA_1e7789bf-e41f-47c7-b4e6-30e4c923afa5">807,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTctMS0xLTA_df76fdc5-4215-4c9d-90b4-cacba9e6c619">1,156,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaae9f252e2294b9992531339cd343ab0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xLTEtMS0w_38855c35-fd3c-4cb4-a92c-4c95bed38a39">53,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae9f252e2294b9992531339cd343ab0_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0zLTEtMS0w_24ec5a75-53ed-4f63-8e17-229d860ae6ad">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d5db478bde46f3bf4070353ddfd2d0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy01LTEtMS0w_76a51638-01df-4275-83fd-26b9dce9c7b7">488,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e1a6f3463264049a9bc9dc455379e33_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy03LTEtMS0w_6a470698-2454-436c-9464-6f6441c0d71f">3,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e1a6f3463264049a9bc9dc455379e33_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy05LTEtMS0w_5e1f7a53-386a-42fc-8899-4fc7f487cbf7">117,623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98e17addbc24768a91973f19003abe5_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xMS0xLTEtMA_5a8d0e1b-7426-4124-9a11-d1147edf5719">44,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia194dc098eda4f59bfcb88c060c36e3d_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xNS0xLTEtMA_e1b67b16-4c5f-46b1-9f29-31e0d5fffe99">844,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xNy0xLTEtMA_b1495f49-bb87-41d0-aba6-e49d51d67003">1,170,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNS01LTEtMS0w_1e8a31dc-c11c-4c8a-bb28-7b317a42a35e">5,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNS0xNy0xLTEtMA_bf855086-1c91-4ed2-8d0f-e5ae235b36a0">5,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi0xLTEtMS0w_52da54fe-ef21-42d6-a349-774766117e7b">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi01LTEtMS0w_d9c60142-cc69-4387-afdc-4ae5aed4d9b3">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi0xNy0xLTEtMA_e6f094e4-2c27-4d77-864f-adef91e8783c">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0xLTEtMS0w_90a37d77-769e-41cc-9af3-af8a672a56f2">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0zLTEtMS0w_24077a98-4e45-4424-bb10-86375275daa1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC01LTEtMS0w_1097187b-7081-40ac-9cbf-e9464392e08a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0xNy0xLTEtMA_33a02550-f6a2-46fd-8ea6-73de30985f92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS03LTEtMS0w_2417f48e-f23a-4492-aef5-d995d03b5778">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS05LTEtMS0w_9a50e554-1f78-401a-a8b3-f6eaadcd1b73">11,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS0xNy0xLTEtMA_909b557d-fa15-4aa6-a628-7128c00b4668">11,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd8e3092d1646ac9ed4f22b175be42f_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTQtMTUtMS0xLTA_fc0cf4a2-f2b8-4824-8798-7d127b11a45b">129,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTQtMTctMS0xLTA_e289a573-69c9-4a15-863e-02ba256c280d">129,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i894492e356c24389904183d445eebdf6_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTctMTEtMS0xLTA_f9b352ea-d33a-45ee-a3f3-e86c51812d4d">26,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTctMTctMS0xLTA_a571597f-f1fa-498c-a13f-79cc5d9d122a">26,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMS0xLTEtMA_dbb265b0-9aa5-4095-bb2b-bbe6ab69d557">53,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMy0xLTEtMA_ef67ccbd-7ffa-4c11-b48e-3a021a7bd786">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232a04fb585849d7b62b28529e631e02_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktNS0xLTEtMA_c6c3b35c-8050-44ac-a6bc-2e95563d444d">495,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktNy0xLTEtMA_a29fac5d-f1c0-406b-85ba-69bf202e44c6">4,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktOS0xLTEtMA_59a89f2c-be14-4f89-bc88-3faf036c217c">128,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTEtMS0xLTA_9df53df7-5b72-422c-b088-a3e151aa0c79">17,231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a428b3ad4d41caa61dc1bda82e2223_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTUtMS0xLTA_2be533e7-637c-4b69-a94c-78b52d2b5201">973,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTctMS0xLTA_80398755-b058-48e6-b616-579a8d2709fb">1,323,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive <br/>Loss </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c7980a5567149ff9eb9001647b782d7_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xLTEtMS0w_5bc57fe9-02a5-4e97-bfb6-35cafcee4992">53,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7980a5567149ff9eb9001647b782d7_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0zLTEtMS0w_e28ecea3-c628-41cb-9e06-9aa0bf48f4b4">536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec46f6b9a8249da93011c913c7e73b9_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy01LTEtMS0w_bdbc13fa-511f-408a-956b-979fc8ede2a6">479,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25e9032e71334883b53310db29ee9dcf_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy03LTEtMS0w_967da122-be7a-4db6-96ac-556857cda1aa">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25e9032e71334883b53310db29ee9dcf_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy05LTEtMS0w_879dba79-5820-43ae-b092-985a6879ff93">59,928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cb539dc22d348d2a949a23eec4d43ac_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xMS0xLTEtMA_00943f4a-ddbc-49ac-b089-d1c0478f1ca2">25,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919b953b16b64c2594759f09f5b6ad4a_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xNS0xLTEtMA_5e4c0c4d-f9be-463c-ab96-6eead45b9bae">701,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec6216b1c544040948237d6bac14880_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xNy0xLTEtMA_5210993e-921c-4e32-8d43-75895132e875">1,095,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNi01LTEtMS0w_c5f5c152-8239-4903-a93a-00ee13052028">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNi0xNy0xLTEtMA_fd1d36e5-d437-4053-b4a9-d54fa1403aa1">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy0xLTEtMS0w_ac0884ee-4d7a-489e-8cb3-1b3eb42b6882">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy01LTEtMS0w_7aaf88cd-fab2-4dad-9bb1-acbe68ceeaa1">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy0xNy0xLTEtMA_9495ba60-e202-4f90-a6ae-d4654b4e1ea3">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0xLTEtMS0w_e9711446-a025-49bc-a8f1-c614a8a6ab41">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0zLTEtMS0w_71cf051f-f3e3-46a2-83fa-d895d02c9c53">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS01LTEtMS0w_66a98565-ba11-4092-a774-26f99375cc90">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0xNy0xLTEtMA_7af24a39-4005-445a-b58c-6098f485e167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe19bca84d574046993a13ff28023c51_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtNy0xLTEtMA_affe204a-ecca-47f2-acb8-4cd038af2418">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe19bca84d574046993a13ff28023c51_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtOS0xLTEtMA_8c86c7e0-3ca1-42df-abcf-34af627e0bc2">50,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtMTctMS0xLTA_08598ba6-f072-4414-89e4-59017c530016">50,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefd508b4186429aa4691a4a839c0b30_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTMtMTUtMS0xLTA_a5ea0d74-0df9-4264-a40f-ffd42cbff81d">105,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTMtMTctMS0xLTA_c4ed552b-3a43-4018-81d2-23747100f8f3">105,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67b246cfd86a4d3abc3d648d4bf23971_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTYtMTEtMS0xLTA_b6f2c3b8-6d79-4503-b6a5-46da270a6adc">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTYtMTctMS0xLTA_c4448308-b607-4eaf-9b3b-027ffeb496b7">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMS0xLTEtMA_a850433d-92b1-4df0-a0cb-8d126cf3f8b1">53,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMy0xLTEtMA_0a7bdb7d-b5e6-4ca4-a03e-a47988b2a7a6">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02378009299044fcbaadf8c1f71fbbc3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtNS0xLTEtMA_291cece5-0453-4a2a-9399-36b546f31e4d">485,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtNy0xLTEtMA_90b060ff-438b-4020-beb1-d27c9365f2e9">3,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtOS0xLTEtMA_8bf381d2-fc96-48da-8546-e93b1e42803d">110,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f65082bbe1549b9984db1760459d732_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTEtMS0xLTA_e31e4dde-8e8b-4580-a698-4cb80ee92702">26,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTUtMS0xLTA_5169aace-f522-40ea-a536-8af1dcfdeeb8">807,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTctMS0xLTA_aade57ca-f95a-4920-95cc-d67e7554d0f7">1,156,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:67.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.854%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.856%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMy0xLTEtMS0w_642da39e-5f3f-48af-afee-ecdf59088408">129,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMy0zLTEtMS0w_2909efb2-12cd-48f7-b327-5cf5f8255ed0">105,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNS0xLTEtMS0w_8c8a4de9-3b0e-4ed8-8d8f-dbf8a47a0da2">22,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNS0zLTEtMS0w_742a194d-28d9-4d6b-8886-5e47c7dc9c0d">21,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNy0xLTEtMS0w_c08a0fa1-07ca-4cf0-93fc-d573a9dce3e2">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNy0zLTEtMS0w_61b88f5e-d544-444e-bb08-3d8b30878bdf">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOC0xLTEtMS0w_8cc71bc2-dc87-44f0-901e-fa8621e3de4e">7,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOC0zLTEtMS0w_3aeefa6f-d1cb-4a17-856c-0d4ea50f2b2a">7,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt origination costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOS0xLTEtMS0w_80529774-94ed-4fd1-977e-25316f2011ea">3,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOS0zLTEtMS0w_19dcb484-8dfb-48ed-882f-14d828557f37">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTEtMS0xLTEtMA_f363e6ea-fd9c-4008-84f8-134dfe2be6e6">5,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTEtMy0xLTEtMA_b540f838-877d-47d1-8136-6917f48ff185">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTItMS0xLTEtMA_0f8ed9aa-7b63-44c1-94c1-b889e6f3049d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTItMy0xLTEtMA_31b0dc91-f75f-4612-9e61-3acf8ec9bf25">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTYtMS0xLTEtMA_d7647836-ca23-40bd-bc2c-be966b5c9ab8">5,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTYtMy0xLTEtMA_4275fba5-a928-44ef-9918-fa4506f9fa09">6,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTctMS0xLTEtMA_99fd337d-7d6e-4a96-9486-175333ae3d61">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTctMy0xLTEtMA_12183dc4-a86c-4038-98d9-e568bed5686f">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjAtMS0xLTEtMA_37e9e382-4b65-482b-a2e4-ecc822c4ef9e">36,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjAtMy0xLTEtMA_cafab953-a441-46ac-9408-077cfeb1eecf">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjEtMS0xLTEtMA_99977ebc-0b3d-4e16-9c7f-2872edb158c8">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjEtMy0xLTEtMA_b2d9845b-ce8c-4905-a856-b734d8c798df">817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjItMS0xLTEtMA_d8674cfa-5545-4807-8c9d-f88b52290589">1,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjItMy0xLTEtMA_b2bf9c47-dcf1-4d26-994a-e7ea17997cc4">879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjMtMS0xLTEtMA_2228c7da-325c-49f0-9626-053fc47dbd37">35,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjMtMy0xLTEtMA_208f483b-d66c-47ee-8b2e-f859b8a4d62a">6,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjQtMS0xLTEtMA_8c0a8227-40a8-4a7f-9ffa-eb5c8fa20193">8,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjQtMy0xLTEtMA_c862e2b8-680f-447c-8ab5-c39fc7d774b4">20,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjUtMS0xLTEtMA_b68ed56e-8d3b-4e02-ac56-bf4aa9f3a0e3">5,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjUtMy0xLTEtMA_89ee6520-98d6-4568-9e48-160a47e63420">6,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjctMS0xLTEtMA_91b7aaef-f019-4813-a4eb-8e9e4515cf1b">3,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjctMy0xLTEtMA_d4d88997-a727-4748-8793-7f95f3d1f9f4">1,353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjgtMS0xLTEtMA_7fd5fbb6-102f-456d-b490-ee8398296c73">176,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjgtMy0xLTEtMA_258739e7-a440-47f4-9c9e-9b6c596adff9">160,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzEtMS0xLTEtMA_29031609-6b8b-4423-8d61-3753cee1e7a9">17,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzEtMy0xLTEtMA_bd286421-11d9-401e-b3ad-e0f94f4f2946">9,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow receipt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="pbh:EscrowReceipt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzItMS0xLTEtMA_88dedaae-922d-4991-b978-e3741de15df7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="pbh:EscrowReceipt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzItMy0xLTEtMA_aad988d5-7fdb-4176-94e2-73ebe404f1f5">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDAtMS0xLTEtMA_aa163095-033d-4c38-8858-040c68950437">17,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDAtMy0xLTEtMA_ca1d2406-6831-4029-a1f7-2bf291d9d67a">8,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of <ix:nonFraction unitRef="number" contextRef="ic19a2270b9564c688d8a49573152aa2c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOjE5ZjlhYTcwZDQ1OTRkZmE5YWQzMjY1ZWQzMWMzNDc0XzIxOTkwMjMyNTU2MTE_186cb665-37a7-46b3-8fb8-4161797184df"><ix:nonFraction unitRef="number" contextRef="i5ca4dcc6702e4728b7857d76f6eef369_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOjE5ZjlhYTcwZDQ1OTRkZmE5YWQzMjY1ZWQzMWMzNDc0XzIxOTkwMjMyNTU2MTE_8e2357bd-1f9d-4d8f-bc9b-e27a5bd4aeab">5.125</ix:nonFraction></ix:nonFraction>% Senior Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMS0xLTEtMA_85dfaf5a-e07f-4f34-9226-165bd7ab8395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMy0xLTEtMA_5a6d079c-6685-43c9-9d50-244bdc9d965e">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of <ix:nonFraction unitRef="number" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOmM0YWU0N2E4NjZjNTRkMGRhYTg5NDAyNGQ0ZTMzODhhXzIxOTkwMjMyNTU1OTg_368a6cca-e690-420b-8afc-47df8c7c24e4"><ix:nonFraction unitRef="number" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOmM0YWU0N2E4NjZjNTRkMGRhYTg5NDAyNGQ0ZTMzODhhXzIxOTkwMjMyNTU1OTg_648b98e4-c8c9-4235-82e4-ff14e907d2a6">5.375</ix:nonFraction></ix:nonFraction>% Senior Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMS0xLTEtMA_195d65e7-0510-498c-aaec-d33dac581239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMy0xLTEtMA_b7fef4ac-f413-456c-aa3c-ef97584bb9fc">400,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan repayments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDYtMS0xLTEtMA_4a826541-e798-488e-8406-474289afec8d">130,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDYtMy0xLTEtMA_510cce07-dc1c-4909-96b8-25a26424fcfa">21,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDctMS0xLTEtMA_1a2cb023-2b8a-4850-883d-b76da31dd3cd">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDctMy0xLTEtMA_26039a82-874b-4654-b130-91f3d78f496a">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments under revolving credit agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDgtMS0xLTEtMA_8795e633-0507-46dc-9a33-bad6108857d2">70,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDgtMy0xLTEtMA_6899a467-b375-4388-91b6-2ec4d91fc3ab">120,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of debt costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDktMS0xLTEtMA_52369308-39bb-47a9-9cae-816692309093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDktMy0xLTEtMA_d20a845c-c73f-491b-a6e8-8f013460a1d8">5,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTAtMS0xLTEtMA_e2bfb905-9469-48c8-b2b1-5ab19a55ac96">918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTAtMy0xLTEtMA_0c7a740a-a945-47e0-ae9b-94fbe6aa5df9">252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTEtMS0xLTEtMA_ffa72f3e-63c5-40cf-9f64-c01ed2e3f4a0">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTEtMy0xLTEtMA_cca70ed9-78d8-47c0-9628-8296e62f3c34">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of shares surrendered as payment of tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTQtMS0xLTEtMA_13ba3e47-6bf1-4f83-b8ea-a982f381ef4f">1,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTQtMy0xLTEtMA_3d1cacd4-76bc-4fdc-881c-06654f7cb7ff">974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTUtMS0xLTEtMA_8cf48c0f-5bca-4ac6-8c27-a97bf160cf34">9,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTUtMy0xLTEtMA_47cf55de-64a8-420f-81d5-af735fe81bbe">49,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTYtMS0xLTEtMA_8a8789a1-093d-407b-a7cb-bd35330000f5">195,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTYtMy0xLTEtMA_8ed61052-966c-4e0a-b8f6-d9b988ab7c53">151,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTgtMS0xLTEtMA_b8aa6937-7ad9-4652-bb27-d3917ca6aa0f">3,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTgtMy0xLTEtMA_1c6148ed-e16d-4e57-893f-3853ea79af62">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTktMS0xLTEtMA_56e8b7e0-a39b-4374-830f-d6471aded161">32,657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTktMy0xLTEtMA_c7dc716c-3ab8-4f28-a2ca-1839450e576d">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjAtMS0xLTEtMA_a33feabc-d38d-42dc-8f9c-b1f55122594d">94,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec6216b1c544040948237d6bac14880_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjAtMy0xLTEtMA_6d2038c6-d47c-479e-bf42-bfdf6cecd1e7">27,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjEtMS0xLTEtMA_1716359d-d019-4a0b-91ea-f74e58546ad5">62,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjEtMy0xLTEtMA_ac3d8f9f-95af-4583-9c9a-b5c8dde51585">28,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjMtMS0xLTEtMA_faffabfa-3cec-478b-9655-614a777f39d6">46,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjMtMy0xLTEtMA_f8b1979b-0c9c-42f4-a4d3-49a85885e9c2">66,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjQtMS0xLTEtMA_93a55876-7bf2-4936-947f-d4409d39793a">29,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjQtMy0xLTEtMA_c0745be5-b9de-438e-801a-efe631e4edf4">21,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">   See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MTk_f916d525-3aaa-47c2-bbbc-2aff70766ee1" continuedAt="if7efcd987d62466f87a5b69c161d291f" escape="true">Business and Basis of Presentation </ix:nonNumeric></span></div><div style="padding-left:18pt"><span><br/></span></div><ix:continuation id="if7efcd987d62466f87a5b69c161d291f" continuedAt="i0b4f3027657f45089749f74db1d35c23"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we,&#8221; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 7 to these Condensed Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus Outbreak </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In January 2020, the World Health Organization ("WHO") announced a global health crisis due to a new strain of coronavirus ("COVID-19").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In March 2020, the WHO classified the COVID-19 outbreak as a pandemic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This pandemic is affecting the United States and global economies, including causing significant volatility in the global economy and resulting in materially reduced economic activity since early 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The COVID-19 pandemic and the corresponding government responses have also led to increased unemployment, which led to a reduction in consumer spending.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Economic conditions are, and we expect that they will continue to be, highly volatile and uncertain and could continue to reduce demand for our products and put downward pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We did see an increase in sales at the end of March 2020 related to shelter-at-home restrictions as we believe consumers stocked up as a result of COVID-19, followed by a temporary but significant decline in consumption in the first quarter.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Since then, we have seen more stable consumer consumption and customer orders. Sales have varied throughout the year with some categories positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold, and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19. Early in our first quarter of fiscal 2021, we received reports of an increase in absenteeism at our distribution center and with some of our suppliers; however, we have not experienced a material disruption to our overall supply chain to date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">To date the pandemic has not had a material negative impact on our operations, overall demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">These circumstances could change in this dynamic, unprecedented environment. If the outbreak continues to spread, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. We may need to limit operations and may experience material limitations in employee resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The extent to which COVID-19 impacts our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19, and the actions to contain COVID-19 or treat its impact, among others. We do not yet know the full extent of its impacts on our business or the global economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">However, these effects could have a material, adverse impact on our liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MjQ_67f794fc-92de-49e3-a290-21d22fd9e3f2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2021) mean our fiscal year ending or ended on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of that year.  Operating results for the nine months ended December 31, 2020 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2021.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0b4f3027657f45089749f74db1d35c23"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MjU_94b0428a-1800-4d80-92c5-24da7bb77e7b" continuedAt="ifa3171bb6ebf49cf82e05720945ceae2" escape="true">Use of Estimates</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifa3171bb6ebf49cf82e05720945ceae2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</ix:continuation>&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MzY_c967bd2a-8b2d-4df0-9517-4a921a749378" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued.  The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for reference rate reform.  An entity may elect to apply the amendments prospectively through December 31, 2022.  We are currently evaluating the impact of adopting this guidance on our Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjk1_74400bde-5527-4909-8e6f-9668d22c6197" continuedAt="i5347ee6ee3e548f3bf770018b8235370" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5347ee6ee3e548f3bf770018b8235370" continuedAt="i69adf9d005ff4287aca939d3dd4b9821"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMzAx_cb8d1a5e-6055-4c64-bd3f-44acf6acdc9d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMi0xLTEtMS0w_27f84059-c14f-4dd3-80ae-40e252383d77">8,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMi0zLTEtMS0w_ade626f6-0bd3-48d5-8be6-972dd8dd4cc0">9,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMy0xLTEtMS0w_f809c800-48e8-43e6-9d8a-3da5f5cb84d7">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMy0zLTEtMS0w_e6d9d9d9-c6e8-4141-822b-95aa6fd1dd2e">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNC0xLTEtMS0w_34bf0906-057c-4e9f-bc06-cfb33d9a200e">108,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNC0zLTEtMS0w_02f768b5-4425-4326-b871-558263e6fddb">105,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNi0xLTEtMS0w_d025b010-e4f7-4ce4-9132-e0633a65b60f">117,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNi0zLTEtMS0w_193e8228-0603-4c34-8415-31bf0e34643b">116,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-8-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i69adf9d005ff4287aca939d3dd4b9821">Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjAy_332f0047-4368-480c-94c2-2e6ccb8e3782">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjA5_0fd778eb-6863-4d41-8e3f-9c136ff8ee86">6.5</ix:nonFraction> million at December&#160;31, 2020 and March&#160;31, 2020, respectively, related to obsolete and slow-moving inventory.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RleHRyZWdpb246YTI0ZTJkODRlZDA1NDRjYmI3YWE3YzhjNzI2MDkwYjFfMjAyNQ_33170d65-944d-4ea7-9acd-c34919b1e119" continuedAt="id6d9bdef372346c3be73233509a4ea75" escape="true">Goodwill </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id6d9bdef372346c3be73233509a4ea75" continuedAt="ide936de8a1784623b88f9d9747a9195a"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RleHRyZWdpb246YTI0ZTJkODRlZDA1NDRjYmI3YWE3YzhjNzI2MDkwYjFfMjA0MQ_2cecc43d-0768-42bb-948f-4dcd96e37f22" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi0yLTEtMS0w_e3bbadbe-34e0-443a-b3dd-34ecec59460e">710,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi00LTEtMS0w_ff1f3605-543b-4868-9841-0d7140d3ddcd">28,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi04LTEtMS0w_f5042326-5906-47db-b605-be9abe02b444">738,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy0yLTEtMS0w_1b3a7c38-2279-4604-87d3-6f01ba15a93d">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy00LTEtMS0w_b1d7dd43-dde9-47b1-aed7-643638c35da2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy04LTEtMS0w_6d99f18a-896b-42d5-bb4b-94a7a69c66fe">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC0yLTEtMS0w_190250d9-ec22-4efd-ba2a-786607682875">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC00LTEtMS0w_f045f706-12f5-4a24-ac96-d663e97ef887">28,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC04LTEtMS0w_246d8561-0197-4b1e-8b40-2300b9670b89">575,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS0yLTEtMS0w_62a0d4a5-6ce8-43a4-902e-dd5a7af65d32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS00LTEtMS0w_2f29737f-606a-4461-a4a4-31c22ec99f73">4,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS04LTEtMS0w_5b28073a-bf15-4714-a5fb-a14c01f1046a">4,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtMi0xLTEtMA_cb3e09a1-fcf3-49e8-94bc-df47fb8ea5de">710,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtNC0xLTEtMA_dd278e2e-f884-44ba-a437-b57366ede3e8">32,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtOC0xLTEtMA_a1c294ea-e4b3-46d5-842c-ae049a363ed5">743,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItMi0xLTEtMA_eba98edc-3e0c-4424-8dfe-65e08bc649eb">163,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItNC0xLTEtMA_9ad5a4e9-a68c-4bd3-a850-5710dcef485d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItOC0xLTEtMA_9e94d1ec-ea2f-4ca3-86d4-21112fe5ca5a">163,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtMi0xLTEtMA_b3fa1c38-daf1-4200-a05d-140b3f670703">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtNC0xLTEtMA_97fb6555-a3f1-4bd0-9f5d-9a42c5b700b0">32,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtOC0xLTEtMA_ff92c3b3-b767-4b47-8de3-fe56441e1582">579,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ide936de8a1784623b88f9d9747a9195a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, no impairment charge was taken on our March&#160;31, 2020 financial statements.  We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;29, 2020 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties.  Consequently, changing rates of interest and inflation, declining sales or margins, increasing competition, changing consumer preferences, technical advances, or reductions in advertising and marketing may require an impairment charge to be recorded in the future. We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, we determined no events have occurred that would indicate potential impairment of goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our goodwill, including long-term growth rates and discount rates.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-9-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwOQ_20afc207-bb2b-490e-8bbb-5809700da018" continuedAt="id77ebef77dba41f2bb0ae8c5173287f9" escape="true">Intangible Assets, net </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id77ebef77dba41f2bb0ae8c5173287f9" continuedAt="idb3ffa1df86c45258b052c6845af05d1"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwNw_b4564240-d7b5-4025-b61d-5856d9efd219" escape="true"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcyMA_acfabf0b-422a-46b0-a1fd-2bbd1fea3a31" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6867e4a90c294f1fa8dddbeab438a6bc_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi0xLTEtMS0w_c3377a71-d1ee-4fbd-872e-43b0febe2410">2,265,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103b63c927b0400b8db4ba9ce800eedf_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi0zLTEtMS0w_fe97d908-8f0a-446c-b056-9b24c825ab86">389,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi01LTEtMS0w_16ab9f7d-8d31-4ffe-b3e1-83cbfc2ffcb5">2,655,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNS0zLTEtMS02NjA_9e362c93-c9db-45f6-87ab-63a0d28d655e">1,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNS01LTEtMS02NjA_33af48a9-05ac-4eae-ab1e-c2e3bf1671c2">1,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a1fb9b631a4bfe88b529e766619c4c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi0xLTEtMS0w_4646a4da-e0a8-4d85-903e-b908d5450980">17,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi0zLTEtMS0w_7f68ab8b-795c-4397-b12e-8759a051c471">752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:IntangibleAssetsTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi01LTEtMS0w_d2027ba6-d667-4493-ba57-1042703af20b">18,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664da185858d4792aa10a4f8624f5074_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy0xLTEtMS0w_aadd390e-66a0-404a-a12e-86bdaede586f">2,283,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abf53f8afa1439081a520747b145a31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy0zLTEtMS0w_6b590aa9-ce6f-42ec-9c1b-dd4b1a226d34">389,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy01LTEtMS0w_153db80d-e955-411f-a945-695f2f935df9">2,672,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103b63c927b0400b8db4ba9ce800eedf_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTAtMy0xLTEtMA_3edc02d0-b5f4-4152-8c13-d3ea3d2ef091">175,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTAtNS0xLTEtMA_0d3edbd8-7294-4293-805c-8a90eb198d34">175,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTItMy0xLTEtMA_4e453cca-1dbe-4567-a0aa-b952b531bedd">14,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTItNS0xLTEtMA_378b4b96-545a-4847-9197-a40102338a09">14,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231" decimals="-3" sign="-" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTQtMy0xLTEtMA_be60eb81-7454-4f61-b9e0-1158a336daba">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTQtNS0xLTEtMA_01af9ab1-8e73-4af3-a672-b52344ac5086">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abf53f8afa1439081a520747b145a31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTUtMy0xLTEtMA_7d2f0fd5-55b1-4156-bdd5-f5c294956d53">190,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTUtNS0xLTEtMA_88582ed6-f9b3-447a-93cc-e6f1ad906e0e">190,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664da185858d4792aa10a4f8624f5074_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctMS0xLTEtMA_fbb507b4-1340-445c-9d4b-235824410607">2,283,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abf53f8afa1439081a520747b145a31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctMy0xLTEtMA_8955dd5e-cf11-4e11-8e3f-e16f6272cf6d">198,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctNS0xLTEtMA_1251fb30-606c-4420-bfdf-77cdf3b5f940">2,481,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTQz_060da192-08f1-4a35-8d74-729d78483354">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTUw_9d6c2303-695e-4e03-ade1-47eabdd0d401">14.7</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTkz_af059a53-3df7-436a-9b42-c8391e49e84d">4.9</ix:nonFraction> million and&#160;$<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjAw_aef2448d-d8d4-4879-8afc-d79fd72e7c9c">14.7</ix:nonFraction> million for the three and nine months ended December 31, 2019, respectively.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwMQ_e87fba68-0ee8-4968-8cc1-3382f6b0f36e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of <ix:nonNumeric contextRef="iba357660d1fc4f7787eef1e9535f4bee_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMzY2_37238d9b-84a6-4b3e-9e68-6c6c8071eb0f">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i0609d20d39b84155990b8eeece18a13b_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMzcy_b2cce673-da53-4344-b32b-4c63676abdcb">30</ix:nonNumeric> years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ended March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfMi0xLTEtMS0w_6d8068a8-6f46-45ce-be99-8d58551f556f">4,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfMy0xLTEtMS0w_59152f6d-1dfc-4703-af16-d515216f2f27">19,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNC0xLTEtMS0w_5cbcc055-fd6a-4c05-969f-690d326191dd">19,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNS0xLTEtMS0w_e403f877-824c-4534-b194-1f17ae734ca6">19,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNi0xLTEtMS0w_de8d701e-6145-43ec-9442-9fbbf2e47257">17,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNy0xLTEtMS0w_cf755a33-ce40-49ad-bbaa-298662b66f26">117,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfOC0xLTEtMS0w_4a330b09-6a2a-44d7-9a36-99d92394ac6d">198,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, <ix:nonFraction unitRef="usd" contextRef="i354ed91ee4f3409bab9d6df5ad7c5aa6_D20200101-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfOTI3_949d9ae2-1f84-4eeb-9cd9-ea98895a1691">no</ix:nonFraction> impairment charge was taken on our March&#160;31, 2020 financial statements.   Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The discount rate utilized in the analyses, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation.&#160;&#160;Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer preferences, technological advances or reductions in advertising and marketing expenses, we may be required to record impairment charges in the future.  During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="idb3ffa1df86c45258b052c6845af05d1" continuedAt="if7768e02f5e441da8dcfdbd8a0200665"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, did not exceed its carrying amount.  As such, we recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjE5OTAyMzI1OTUyNw_5193ff0f-ffff-43f9-86db-3e5e961982ae">1.2</ix:nonFraction>&#160;million. The decline in the fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was primarily related to a decline in expected future sales due to a regulatory change that now requires </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to be prescribed by physicians rather than sold over-the-counter direct to consumers</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="if7768e02f5e441da8dcfdbd8a0200665"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020. As of December&#160;31, 2020, no other events have occurred that would indicate potential additional impairment of intangible assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our intangible assets, including long-term growth rates and discount rates.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg0_b5f2c318-5d8b-4f28-bca2-cfa3ef9224a0" continuedAt="i81acc6de11be40eab7fddf4c4f6ec2bb" escape="true"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg1_cb1bec22-7f26-481e-b869-10d624eb4bc9" continuedAt="i98cfcda11ecf400fb362d0107daa1dc8" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i81acc6de11be40eab7fddf4c4f6ec2bb" continuedAt="ie204f256002642cf940cfbf72442d12a"><ix:continuation id="i98cfcda11ecf400fb362d0107daa1dc8" continuedAt="ic83e9ab602d34020b221550f3b444f26"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg2_caf59dca-9ecd-4fe6-b78d-f518572415d5" continuedAt="i798f0da3bd5a47ba8dada3a34595e0b1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy0yLTEtMS0w_8fef9493-3dd7-431f-a7b9-b5785e9df463">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy00LTEtMS0w_2d2dfbf7-28b1-4ce7-8c63-c89b8e954909">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy02LTEtMS0w_bcaffc20-b6d3-4ca6-a91d-da84683964b2">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy04LTEtMS0w_c4c9e76c-19c8-410c-9fe5-719c9c626a55">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC0yLTEtMS0w_d6390344-21ef-46df-b1a1-c731a2f171fa">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC00LTEtMS0w_552a5994-e9b1-44d7-87ce-1b7bfe3a9095">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC02LTEtMS0w_ae16f2d7-7087-420f-8d38-eed1ac8f8cff">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC04LTEtMS0w_78006686-39fe-455c-9d5c-58495a0944a0">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS0yLTEtMS0w_d85039b2-d0c0-43cb-987d-f0cec702b317">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS00LTEtMS0w_3e15ba85-22ea-4be8-a244-9838aa14057d">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS02LTEtMS0w_8fe44a98-fdf8-4344-b4af-5c8052731b33">5,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS04LTEtMS0w_eece889d-5e8d-4c03-bc97-2cb175936a6a">5,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi0yLTEtMS0w_e29c9ef4-0800-461a-84d3-3a53fad23696">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi00LTEtMS0w_a9714a5f-ad33-4598-85f5-b94a26e9afda">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi02LTEtMS0w_809a34a1-ae42-425f-9a29-3b050656612d">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi04LTEtMS0w_dc77595a-6ba3-475e-9dcd-7e7f041f2523">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy0yLTEtMS0w_8e47396f-babd-480e-9208-4a443cc107f5">11,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy00LTEtMS0w_a90fbeba-d600-4606-a455-0f7791eedd07">15,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy02LTEtMS0w_af7e4674-8db0-4eb8-8bc3-6ddfc82671e0">35,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy04LTEtMS0w_b869aa2e-9f21-4adb-819d-b9090ae48d5f">48,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC0yLTEtMS0w_3f74cbfd-dcf4-4730-a7b5-7c0cf2f82928">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC00LTEtMS0w_c0598efc-28c2-41db-98bc-b1701ebfbffa">833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC02LTEtMS0w_a8344522-89ff-4d44-9109-5129eb2d9640">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC04LTEtMS0w_9f181736-372b-4662-9509-53de2b649486">2,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS0yLTEtMS0w_621e6995-2d26-4c30-afb4-02cceae6ee54">13,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS00LTEtMS0w_8037b988-81fd-4923-859d-55db061b3607">17,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS02LTEtMS0w_762ee77b-dd8a-4c68-8ba9-ff8a09711bfa">41,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS04LTEtMS0w_7cd4f622-a46b-409e-8425-d52fe2699472">51,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of lease liabilities were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg4_824caf7a-2d78-4cfe-8ef8-cf6ad9eb1ac3" escape="true"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg5_4cbfc03b-fca5-446d-a529-67f24b8dffa9" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:56.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (Remaining three months ending March 31, 2021)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi0yLTEtMS0w_62b586c5-04f3-4515-9809-213c0248a965">1,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi00LTEtMS0w_c4aa17ee-9df6-4b16-a787-1157c1ef157d">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi02LTEtMS0w_408d9f09-cbd3-488b-a535-2314481ce8d1">2,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy0yLTEtMS0w_458382a7-635f-4bdd-94c2-faf58963bf95">6,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy00LTEtMS0w_10088aef-2789-420b-a966-9de1effe8043">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy02LTEtMS0w_f7a0d920-de75-42ac-8367-5f85a774cb01">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC0yLTEtMS0w_97e34aad-67f2-4056-9e49-598127703b8b">6,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC00LTEtMS0w_5aab4d26-1826-4cc0-8676-61629dc35b2a">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC02LTEtMS0w_c27742e5-6d84-404f-b07a-f47549f75b9d">9,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS0yLTEtMS0w_78b35bd1-d110-4d19-a761-394bd512318a">6,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS00LTEtMS0w_9d34bb19-01e5-48ae-afaa-652371e51ab2">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS02LTEtMS0w_4d9318d1-ca76-4313-8243-7a91a226dd63">9,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi0yLTEtMS0w_0bb1474a-c2ba-41e2-9ba8-54402cc6048a">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi00LTEtMS0w_b43b80b1-3c33-4e31-be0b-03f555ea2032">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi02LTEtMS0w_5afa8c0d-ef32-4104-9609-17c9e4583d12">5,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy0yLTEtMS0w_cefb9a89-da90-4723-a146-48d31956f64f">4,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy00LTEtMS0w_db7336ed-dd7c-4295-9c63-13402c1b13d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy02LTEtMS0w_354bb3ea-ac35-4f97-9578-d590cd3b91c1">4,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC0yLTEtMS0w_ec4db932-c70c-40e7-95d5-d672e745caa5">30,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC00LTEtMS0w_6220d785-486e-4074-8ca6-afd13def7476">10,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC02LTEtMS0w_c583b7b9-5183-424a-b486-e35c7d1f1062">40,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS0yLTEtMS0w_2b2f71fc-3c64-4cdd-bc0f-91da1aa1d4c3">3,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS00LTEtMS0w_443068ae-4fae-4ccd-a555-63c6294907ca">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS02LTEtMS0w_62cdaf0c-cb66-4d2e-beb9-5d2fa6374846">4,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtMi0xLTEtMA_4333b38d-3a05-4ab5-ba19-874e014c9918">26,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtNC0xLTEtMA_0ecc0978-a8fe-44a8-8232-ff16460f2111">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:OperatingAndFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtNi0xLTEtMA_7564b81f-d1cb-48fd-b830-4f6ebfe9ef09">36,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i798f0da3bd5a47ba8dada3a34595e0b1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfMi0zLTEtMS0w_1cb179d3-a01f-42ce-9d11-78cb12dcc4b1">4.88</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfMy0zLTEtMS0w_df34c3ca-5a78-4f62-82c1-68a69bc30f70">3.75</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfNS0zLTEtMS0w_b29d5da1-6296-46cc-90a8-867f707b3cef">5.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfNi0zLTEtMS0w_c456c403-35c7-4eb9-b624-30aa7c0e6d45">2.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ie204f256002642cf940cfbf72442d12a"><ix:continuation id="ic83e9ab602d34020b221550f3b444f26">Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during the three months ended September 30, 2020.  The right-of-use ("ROU") asset and lease liability at the commencement of this finance lease was $<ix:nonFraction unitRef="usd" contextRef="if14edde8dc2a46079acba1cc1a731adf_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTc4_a4e62689-f3a2-4087-82d5-a16573ec9310"><ix:nonFraction unitRef="usd" contextRef="if14edde8dc2a46079acba1cc1a731adf_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTc4_d1d3fb46-901b-4730-94b7-50e3945a65f3">5.2</ix:nonFraction></ix:nonFraction>&#160;million.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RleHRyZWdpb246M2E0ZGI4N2UwN2U4NGY0ZWJiMmFlODYyOTZlYWM0Y2VfOTE_6a0edea8-a35c-4e52-9eab-3f3c43f7bd1b" continuedAt="i96d831e852e34f66b149e5e60f72665e" escape="true">Other Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i96d831e852e34f66b149e5e60f72665e"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RleHRyZWdpb246M2E0ZGI4N2UwN2U4NGY0ZWJiMmFlODYyOTZlYWM0Y2VfMTAw_7447c901-78c4-4a87-8dfd-3cd5fa0d429d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMS0xLTEtMS0w_12b6ec27-b047-4c81-a65e-4dcaa3318965">40,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMS0zLTEtMS0w_85d9d7c3-b74d-4ce8-b0fe-a8f23a55aeb5">34,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMi0xLTEtMS0w_737504fd-a899-4dde-a4f4-2ceec42201af">10,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMi0zLTEtMS0w_634b9597-3371-49b5-a91f-17f6da7fe6c7">13,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMy0xLTEtMS0w_0e4f9699-b7b2-4a11-a4cc-e0634196ca1a">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMy0zLTEtMS0w_1f74ea56-ea21-4011-afb6-6e9bd6603c9c">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNC0xLTEtMS0w_1aeac841-b801-41e8-8135-ef5e9fcab3c0">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNC0zLTEtMS0w_3909df33-2d6c-4052-9a5e-fa87bd50fdf4">3,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNS0xLTEtMS0w_5117de62-28b5-43ef-992a-cda82fd15d60">3,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNS0zLTEtMS0w_f46e5e4f-1a4f-42de-9e12-6bf8e6286815">4,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedProductionCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNy0xLTEtMS0w_db19312a-9b26-4c1a-9876-55b5e5d40e23">3,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedProductionCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNy0zLTEtMS0w_a95349c5-906f-434b-89b1-5be82b4c26c4">5,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTAtMS0xLTEtMA_d049a3c0-2760-40bb-bb4b-3a9df59db8ca">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTAtMy0xLTEtMA_8a53a4e0-3fcc-4785-93c1-da2be826b379">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTEtMS0xLTEtMA_da5134de-4ce4-4006-8c00-21d19638116e">7,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTEtMy0xLTEtMA_dcc58090-8ee9-414e-b7fd-a03de8c6f3e3">6,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedAndOtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTItMS0xLTEtMA_88318eb2-d9fe-4cf4-9d3e-6ae801c1afd7">66,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="pbh:AccruedAndOtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTItMy0xLTEtMA_abffef40-222e-4d02-9017-369a4a9b5c27">70,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzcz_088ec6e5-9391-4522-8707-7b53ac1cf27a" continuedAt="id001a62df53945efa2896d12c65e0ea7" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id001a62df53945efa2896d12c65e0ea7" continuedAt="i532cd26c2d2941dcad2eb597f6f9a68e"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzYx_3f5cac38-c0bc-4a76-834b-911d17caa654" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="i81b414e215924c7b993b038bd3c3eee3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS0wLTEtMS0wL3RleHRyZWdpb246OTdlN2E4NjJlNzBkNDU2ZGE1MWI0MWMxOTAyMmE0YWVfNDI_226daa9a-4aa2-4257-80ec-44d702db5a34">6.375</ix:nonFraction>%, with interest payable on March 1 and September 1 of each year.  The 2016 Senior Notes mature on March 1, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81b414e215924c7b993b038bd3c3eee3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS0yLTEtMS0w_6c02b957-22fe-4661-b72d-010729fbf213">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a0c2ab86804016a4351c2ce5ed98f0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS00LTEtMS0w_b2a8edd5-f85d-40cc-bbe8-58447bb009f0">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="i1236a922afd44780b720fd4a3fbba105_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy0wLTEtMS0wL3RleHRyZWdpb246MTgyNDRjYmNiNTAxNDVjN2FmOWY2OTM4ZTJiYTU5MzJfNDI_83a81d68-9fa9-4112-900e-4e00379422da">5.125</ix:nonFraction>%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1236a922afd44780b720fd4a3fbba105_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy0yLTEtMS0w_ad75ca5a-2ee2-45db-a92a-66fac53630f7">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie859ec3583f54138ba3370f6e120dd0b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy00LTEtMS0w_e7566885-e814-4fbc-ac8e-559241211172">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfOTk_c3a2a9f3-90e9-402e-805d-03c432adbf66">2.00</ix:nonFraction>%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="ie10121816139428c94900de4ab354727_D20200401-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfMTc1_c6a11f1a-ceec-4171-ad3e-12ee1531be9d">1.00</ix:nonFraction>%, with a base rate floor of <ix:nonFraction unitRef="number" contextRef="ie10121816139428c94900de4ab354727_D20200401-20201231" decimals="INF" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfMjA1_0fc755e0-8e2c-443c-a305-0fe005e95a8e">1.00</ix:nonFraction>%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc1556813bf44cc90d54deefa6cec4d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0yLTEtMS0w_81f0d248-ba21-412a-ba20-31a180e47b5d">560,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f4d7a1b6a4434993fb587f62cd9893_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC00LTEtMS0w_8883ce4f-fae6-40a9-b7e8-8399855fb95a">690,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7242718fff7f4c5d99567a954c71eac2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNS0yLTEtMS0w_17ef304c-86c4-4996-8fff-30f24306e0d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038c52e6304749fab109d118081f602b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNS00LTEtMS0w_145f9c99-2c50-47bf-bc77-f09b5f8e0d89">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOC0yLTEtMS0w_bfea1716-cdd0-4402-99bf-300165d0ca34">1,560,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOC00LTEtMS0w_10cc3336-71c5-49f6-a995-ae67787e044c">1,745,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOS0yLTEtMS0w_2e9e6c72-82ae-4ba2-ae38-31c444e37e88">11,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOS00LTEtMS0w_ad49bf75-afec-4471-b8e9-7ba5ce20e05f">14,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMTEtMi0xLTEtMA_1995be47-6ed5-4f13-ae36-d1f74f440bcc">1,548,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMTEtNC0xLTEtMA_f305b7de-501d-4b19-8c1a-c09e9984362d">1,730,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had <ix:nonFraction unitRef="usd" contextRef="i7b28d9ff4d0544048ff592fc0fc0bb1f_D20200401-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:RepaymentsOfLongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMTEw_fac19369-fadb-4bb3-abfd-8af4f72cd642">no</ix:nonFraction> balance outstanding on the asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and a borrowing capacity of $<ix:nonFraction unitRef="usd" contextRef="i7242718fff7f4c5d99567a954c71eac2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMjc0_c37f0078-537c-4f73-94cf-17ff9c1a0049">123.3</ix:nonFraction> million. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Interest Rate Swaps:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We currently have two interest rate swaps to hedge a total of $<ix:nonFraction unitRef="usd" contextRef="i9b2d78644d694801a7c8a37b269dd418_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMzYz_9b958425-5b51-4b2f-ba8f-3d53c01cd59a">400.0</ix:nonFraction> million of our variable interest debt (see Note 9 for further details).            </span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-12-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i532cd26c2d2941dcad2eb597f6f9a68e"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzcx_7cbf50b2-6994-41ae-94d2-b32181fb6635" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2024 (the "2016 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ending March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfMi0yLTEtMS0w_55de5e9d-c0e8-4b26-accf-43a04f8367f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfMy0yLTEtMS0w_9194b661-f5fe-428c-b5e8-33e6501f0b08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNC0yLTEtMS0w_92fa1d43-c30d-491f-bd76-80f525fa3c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNS0yLTEtMS0w_a843a20f-5d16-4dfe-8210-d40c2784cf2e">1,160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNi0yLTEtMS0w_954afa5b-675b-408b-b71f-eca86030e2aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:LongTermDebtMaturityAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNy0yLTEtMS0w_6ffb384a-6e8e-4eea-8d84-51be23af6309">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfOC0yLTEtMS0w_9fd322dc-860b-4ed9-96f6-73c3004175f9">1,560,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RleHRyZWdpb246MWFhNjc5YjA3YjY5NDc1Mjk5NmJkOWFmYTViMmNmYmVfMTgxMw_71ca3384-eadc-4470-bd84-f7654e1c59cf" continuedAt="if94d1b12606d44d9a9e903c250a05879" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="if94d1b12606d44d9a9e903c250a05879" continuedAt="i64849733ea57444ea96f385f277c6334"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB Accounting Standards Codification ("ASC") 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2016 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy.  <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RleHRyZWdpb246MWFhNjc5YjA3YjY5NDc1Mjk5NmJkOWFmYTViMmNmYmVfMTgwNQ_b12c2c3f-c490-4a3f-98af-9bab4dd15c84" continuedAt="i7b687d21170e409b85aec24d98e86011" escape="true">See summary below detailing the carrying amounts and estimated fair values of these instruments at December&#160;31, 2020 and March&#160;31, 2020. </ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i7b687d21170e409b85aec24d98e86011"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ebb997344d403486b3f9420c112504_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi0yLTEtMS0w_46280cc6-5ad5-401a-b3b3-4da4c7b3281b">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0552db00f3c641ff80440074b49f730b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi00LTEtMS0w_e44a4c86-c22d-4f64-8d7b-e8addb809b2a">613,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd599e3926042aa8b5dbaf89e6bd1cf_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi02LTEtMS0w_9916feb2-fe00-4aa7-ab1c-80e830277682">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice64251d737d426195b9e1a793e60792_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi04LTEtMS0w_d559c8dc-1b9a-4876-b7d1-d9c43e63ea09">603,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f1631ffca449e3b2162aa6eb96cc1f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC0yLTEtMS0w_57cce11f-abcf-49ef-8974-232ec45f4c87">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5032d30a5899473b981a782119c9d2ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC00LTEtMS0w_bc358c8c-ee65-4226-92b4-dbc0d10d96b1">421,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06e52662eda44a78e9e8f9e560ad93f_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC02LTEtMS0w_5eaee4ee-e29b-42c9-a53a-5965692a1af6">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06feca35d8b343e0a416ad3c87b1d890_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC04LTEtMS0w_4bb8cf2b-b338-4b61-bdb5-737dc7384ad4">386,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cbb5a18397486680722f549c6889b0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS0yLTEtMS0w_077878d7-c747-4136-8ef0-2e6ae54599ae">560,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253eee16ff674e2a93a5287e7684fe79_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS00LTEtMS0w_2d3ba699-2a25-4305-9595-e8f3db38898f">560,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d826a5505c6474db66c7f96cda89129_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS02LTEtMS0w_dd9ddab3-acf8-4eaf-b503-ca72a19c6301">690,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7947344d11f749088f4c537fcf966dc3_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS04LTEtMS0w_662912e2-8b92-4aec-a996-646635e67e1c">638,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6c5d8a5f604fcea4fcd52e68353712_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LinesOfCreditFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi0yLTEtMS0w_8a304e00-9c2f-4fc5-91b3-285853af287f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221c06058a05456781dfa7d93133ca01_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LinesOfCreditFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi00LTEtMS0w_7c4b979d-4d1c-499b-9475-80a7d56574be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362a9c07939d4608b90d4ad15e3b6f16_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LinesOfCreditFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi02LTEtMS0w_5a5a6cbb-5199-4dc4-9892-11312447a65c">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24c56ca1f7f41289fa51152754d0628_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LinesOfCreditFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi04LTEtMS0w_f6af3b0b-d239-41b2-bae1-2a63c755a0b3">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12d98be53e544b7bec5cb41aded6489_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy0yLTEtMS0w_4b89a149-532f-44ea-906d-21bf1cde6d99">3,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae35f6c71da48feb7c77cf3d5184356_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy00LTEtMS0w_f2b98984-902e-48f2-be9f-8a7440b9137f">3,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3326065cf04377b74b6fbe21644c1a_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy02LTEtMS0w_0e65c318-916b-4b52-81b9-67327c34efd5">6,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd335d49025d49c487e470de1e7c354f_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy04LTEtMS0w_d166e6dd-c7ff-4186-b6a9-c479d9456544">6,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64849733ea57444ea96f385f277c6334">At December&#160;31, 2020 and March&#160;31, 2020, we did not have any assets or liabilities measured in Level 1 or 3.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1OA_2445ac6d-26b1-47d4-9841-cbb0f92e299f" continuedAt="i8bba9748db78463d958ae0f0c758b1cb" escape="true">Derivative Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8bba9748db78463d958ae0f0c758b1cb" continuedAt="idbd0fd2e637c4dae9d1d204bdd0baacb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into <ix:nonFraction unitRef="agreement" contextRef="i92532672091247fb97202d4dd7b0cdcd_I20200131" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTQy_24f45fef-2410-4c8c-ae43-9eb31c17ad3a">two</ix:nonFraction> interest rate swaps to hedge a total of $<ix:nonFraction unitRef="usd" contextRef="i9b2d78644d694801a7c8a37b269dd418_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTg1_9b958425-5b51-4b2f-ba8f-3d53c01cd59a">400.0</ix:nonFraction> million of our variable interest debt.  The fair value of these interest rate swaps is reflected in our Consolidated Balance Sheets in other accrued liabilities and other long-term liabilities.  We do not use derivatives for trading purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1Ng_4a4ee480-ef87-4976-ac41-c9c2ad062063" continuedAt="i26f44705aeb34bf08db73ca2ee3f4d74" escape="true">The following tables summarize the fair values of our derivative instruments as of the end of the periods shown:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idbd0fd2e637c4dae9d1d204bdd0baacb" continuedAt="i221785cb90f74124934131636d5d5951"><ix:continuation id="i26f44705aeb34bf08db73ca2ee3f4d74"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMi02LTEtMS0w_9b501edb-baca-4be9-a807-abb4f2342c42">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80c1300a1c4f4cad9a29affc4c223aff_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMi04LTEtMS0w_d85a50c4-977d-405c-bdc2-72b16ce5a11d">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMy02LTEtMS0w_97ab4504-9b95-402f-be56-be60537fa25e">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ded30b7f28349f78fd6ee06e33334cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMy0xMC0xLTEtMA_d42a5e43-7cb2-4192-ba50-f1209b3ebb5c">3,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80c1300a1c4f4cad9a29affc4c223aff_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfNC04LTEtMS0w_8e292899-5f29-4b2e-ac73-96246839ac39">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ded30b7f28349f78fd6ee06e33334cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfNC0xMC0xLTEtMA_8575300f-01d1-4377-8d3f-253984d0c66b">3,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3a6736b7e4455c835f368bcb184e94_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMi02LTEtMS0w_664df494-5c28-4a5f-8f73-d915a526b9e7">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i669fc4f1f78246bb8b0554fa4c73e813_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMi04LTEtMS0w_48d9d9f0-a6c0-4790-a33c-bf6344b319de">1,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3a6736b7e4455c835f368bcb184e94_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMy02LTEtMS0w_dcfcffff-4e56-4c97-9ea2-95c1d02b17ee">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMy0xMC0xLTEtMA_181aad10-f980-4137-9e24-9698813c2789">4,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i669fc4f1f78246bb8b0554fa4c73e813_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfNC04LTEtMS0w_fa9b6a7c-ae22-4f0f-8496-e815840cf095">1,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfNC0xMC0xLTEtMA_5bf0c64b-6bc3-4c8b-8a98-02094d36241a">4,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1Nw_d1e73e70-974c-4d9e-bd3f-944265cff4b1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:21.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fd7098c3ad41be8df870dde9d83eee_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi00LTEtMS0w_06c5a429-0341-485a-8a47-724de3eb0770">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254eb380c9514d3b9a242c7b4084efd0_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi02LTEtMS0w_ff5d421d-71bc-4dd4-b347-c2bc52b329b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ce8e70024f47edbefd0232eb83236a_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi04LTEtMS0w_faf88b36-bcab-415d-8bfe-f96c60b729f7">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd07a49514b46baa2e379f44d08a7e5_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi0xMC0xLTEtMA_a15a667d-a799-4710-8c69-384e7ce114a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy00LTEtMS0w_6d593065-55f3-4de2-9fd4-c7a34d730910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy02LTEtMS0w_5e53f69f-653c-4e6e-a4f1-000c24867fac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy04LTEtMS0w_9c753326-d45c-4b64-914c-911d97499179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84aca9e12e964a7cb990719431110348_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy0xMC0xLTEtMA_d408d570-38f3-4bc5-9615-4204696083cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Recognized as Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLossOnDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC00LTEtMS0w_87b3a000-a91d-4d65-ac94-826678e68678">1,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLossOnDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC02LTEtMS0w_ff76a56f-de2e-48e0-ada9-a707789a764a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLossOnDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC04LTEtMS0w_9df4343e-b3f5-46f6-a55b-ee4a5643c190">3,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84aca9e12e964a7cb990719431110348_D20190401-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLossOnDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC0xMC0xLTEtMA_32188061-dd94-4940-92d1-5f49fe747cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect pre-tax losses of $<ix:nonFraction unitRef="usd" contextRef="ifdae78c641ce4019acb0ab445a097687_I20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfNjY3_7ee32bf6-c994-40a3-8e32-eb4e878679e4">3.0</ix:nonFraction> million associated with interest rate swaps, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next twelve months.  The amount ultimately realized, however, will differ as interest rates change and the underlying contracts settle.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk:</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i221785cb90f74124934131636d5d5951">Interest rate swaps expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfOTQ5_ca987f35-d31e-4c9d-bd70-46d39701ee40" continuedAt="i4cf5572c9cad4d579aca59e9ee8c042b" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4cf5572c9cad4d579aca59e9ee8c042b" continuedAt="id4ce2b624c074f3aad2a98c6d32fb285"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfNTg_24bdb0f2-4070-4e32-becc-5fcdd59228ad">250.0</ix:nonFraction> million shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfODU_0fdb818f-91a8-4ce3-97e7-411057c121c2">0.01</ix:nonFraction> par value per share, and <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMTEz_18bd91ab-1682-4b06-a775-4543042b591f">5.0</ix:nonFraction> million shares of preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMTQz_a365f342-6342-43a3-a0d4-8b61185626dd">0.01</ix:nonFraction> par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to <ix:nonFraction unitRef="vote" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="pbh:VotingRightsNumberOfVotesPerCommonShareOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMzgy_3e679b19-09e7-46a9-83ef-43cdec24fae2">one</ix:nonFraction> vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfNzA0_7a93d6c5-c0e8-48a5-8e65-fb93d193f0a9">No</ix:nonFraction> dividends have been declared or paid on our common stock through December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2020 and 2019, we repurchased shares of our common stock and recorded them as treasury stock.  <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfOTQ3_604a50a2-b176-4018-82e7-e3364ecac8fd" continuedAt="i104d007b49c64963ae9e8c4c69d734cb" escape="true">Our share repurchases consisted of the following:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="id4ce2b624c074f3aad2a98c6d32fb285"><ix:continuation id="i104d007b49c64963ae9e8c4c69d734cb"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:35.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy0xLTEtMS0w_d108ae7b-adb5-4a26-a8dd-0e68e7e9bd37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy0zLTEtMS0w_85478dc0-8b22-4c5a-aaaa-76e547920c0e">2,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy01LTEtMS0w_89fedb25-96da-4bf6-b491-62eded01b7df">31,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy03LTEtMS0w_5092001b-5168-4985-b565-a27afde67f7b">31,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC0xLTEtMS0w_b48b4554-7968-45b8-bbe2-ee30df64eca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC0zLTEtMS0w_41939025-4c6c-47cf-9b7e-c1c6b41b5255">37.95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC01LTEtMS0w_93a36256-8929-46a6-abb8-36fe7a81d2ea">39.91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC03LTEtMS0w_a7bfb224-e09d-45e0-8e19-4ae93f2f17ab">31.39</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS0xLTEtMS0w_5b1dad6e-454f-4539-880b-5ce2e2e5a6d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS0zLTEtMS0w_4d2616f8-2033-4f7d-9ff7-15a5231482fb">0.1</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS01LTEtMS0w_344bbb21-75e5-4c1d-a503-1876aecc191c">1.2</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS03LTEtMS0w_237966a7-f670-4244-95ff-407a9137011e">1.0</ix:nonFraction> million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC0xLTEtMS0w_e312492a-acdf-4158-97cf-c2671ddfd3c8">253,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC0zLTEtMS0w_c91c9db9-636d-478b-903c-b0743ffa40b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC01LTEtMS0w_2e87b36e-3849-43e2-8f81-efa34f626d4b">282,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC03LTEtMS0w_e7813353-fccb-42e7-8e19-67ae6b9c9055">1,622,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS0xLTEtMS0w_f4b8772e-13da-4442-946c-0c41a4ae09d3">34.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS0zLTEtMS0w_e03b45c1-5c6f-4ed0-bd50-eabf4adf60b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS01LTEtMS0w_0a62def1-c891-425a-aff3-5038d75cf9d6">34.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS03LTEtMS0w_71a8fb20-7495-4e4f-91e5-426b643a5ee3">30.80</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtMS0xLTEtMA_baf038e2-60fe-431b-a08f-5b3662c5c33e">8.9</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtMy0xLTEtMA_720e8d36-0558-4bcf-9941-29244009910b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtNS0xLTEtMA_f8dea5ee-7d33-4f7a-b0d3-ffbacdbd6b1d">9.9</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtNy0xLTEtMA_cd8c472d-a902-41fa-ac25-f5f967dccc85">50.0</ix:nonFraction> million</span></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMjQ1_ee5cd1b8-172f-4e3d-89d1-5ca5da75638f" continuedAt="ief5ec4f0a1f545d18184fcf5f02bb6c6" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ief5ec4f0a1f545d18184fcf5f02bb6c6" continuedAt="i3b4df99c9ca04dc5a6ffe98edcb954be"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMjMz_a97493d8-242a-4b43-92d9-e95b5381b10e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at December&#160;31, 2020 and March&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89df545b4177486fb38f4b91b5bfbd05_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMi0xLTEtMS0w_4e91779f-160d-4d48-9aa3-940069e2ac1d">16,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf4c1b6e7914984877022bbf9681434_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMi0zLTEtMS0w_bd1214f6-56d0-4fde-81cc-9120d3381cfd">39,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i88373d93eefe43dfaf99307d1663985c_D20200401-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0wLTEtMS0wL3RleHRyZWdpb246M2JhMmRlZDdjZDYzNGRiMmIwMzE5M2RkZjc5ZWIwYWJfNTg_85c8d232-0222-4b76-9b61-841dd566e8f0">752</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib640d457ba2b4aacae15563b70a4f618_D20190401-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0wLTEtMS0wL3RleHRyZWdpb246M2JhMmRlZDdjZDYzNGRiMmIwMzE5M2RkZjc5ZWIwYWJfNjU_e0604998-2c24-4504-bba0-b4e3ea837bfd">1,453</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23ceed395390459d9e3572680ae73075_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0xLTEtMS0w_93e89c83-d874-46b0-b666-413c337b47b2">2,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab7ab2765fd5461eb0fcfe3149ec29af_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0zLTEtMS0w_7e80cf48-aea9-4e75-b4e1-4b9ef2d13cc5">4,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i5a87d78fa10e452580fd3a8922dd6800_I20201231" decimals="-3" sign="-" name="pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0wLTEtMS0wL3RleHRyZWdpb246Zjc2ZTE4ZGRlNjQ4NGE0Nzg4ZGRiYjdkYmVjOTM5NTFfNTg_598156ce-4e0d-44ed-a18b-45042b3bcebd">624</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i30fb3c6cba044feb86d6e4d785c34a76_I20200331" decimals="-3" name="pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0wLTEtMS0wL3RleHRyZWdpb246Zjc2ZTE4ZGRlNjQ4NGE0Nzg4ZGRiYjdkYmVjOTM5NTFfNjU_6f69983a-85c0-4fd4-9f8c-a7c7621030f9">17</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a87d78fa10e452580fd3a8922dd6800_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0xLTEtMS0w_14bb864d-3250-4d54-8d49-2ecdbde1dc1a">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30fb3c6cba044feb86d6e4d785c34a76_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0zLTEtMS0w_4dcbfa7a-84db-4b6d-98bf-2d8d5dd98b36">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNS0xLTEtMS0w_70130110-0259-401e-a9e5-1b809777ab47">17,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98e17addbc24768a91973f19003abe5_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNS0zLTEtMS0w_30aa0b11-d795-4779-a943-4d2f90b06b6d">44,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3b4df99c9ca04dc5a6ffe98edcb954be">As of December&#160;31, 2020 and March&#160;31, 2020, <ix:nonFraction unitRef="usd" contextRef="i00213381c2a14b5fb3a527097c5723e7_D20190401-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMTQ1_3cc331d0-3302-486a-b592-1e449bc5e92e"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMTQ1_4f4b1d41-49f5-4d6b-b7bc-9c72ee356fde">no</ix:nonFraction></ix:nonFraction> amounts were reclassified from accumulated other comprehensive loss into earnings.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTU2Mg_96250a44-8ac6-43bb-af4c-b1cdb111614c" continuedAt="ie7038b4c759640e9869c678e185521cb" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie7038b4c759640e9869c678e185521cb" continuedAt="i6ce03f610005400c84a194c7126c93cc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6ce03f610005400c84a194c7126c93cc" continuedAt="ib85165656113410dbd73e63f6045c8cd"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTU3Mg_c28cbb75-d9ce-4657-85b5-04a87338df07" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy0yLTEtMS0w_e51f6eb1-0c36-4356-8500-2a06220ac6e0">40,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy00LTEtMS0w_ac50d08a-24e4-4970-8070-a03e38872f93">38,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy02LTEtMS0w_c8189b52-0a18-44a2-bc1f-555f49583f45">129,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy04LTEtMS0w_3f14bc61-62d9-4675-b834-fa64e47ca2a7">105,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi0yLTEtMS0w_eb0caea6-8822-4757-8c84-7a1a5ab4df8b">50,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi00LTEtMS0w_2983a4db-5388-48f6-be1b-4f96b86df3cb">50,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi02LTEtMS0w_8e0e2b89-9910-44d0-aa39-1bf4e87150be">50,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi04LTEtMS0w_34c008c8-994e-4979-9aaf-8af2570d20d8">50,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy0yLTEtMS0w_43419a26-3e3d-46fd-9088-7cdbcc43a143">349</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy00LTEtMS0w_1d621253-75df-448a-b25d-0962cab74375">453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy02LTEtMS0w_1ad42f65-b449-4b61-8d24-f8721e024255">367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy04LTEtMS0w_94b99fcd-d84c-42db-b447-270f5729c3af">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC0yLTEtMS0w_2ed9497a-ddd9-457b-9de4-4690e700e817">50,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC00LTEtMS0w_16c06da9-e44a-4c6a-917b-5746e76babea">50,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC02LTEtMS0w_5f9d7aba-1f90-44bd-b51c-0e678ed7af7c">50,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC04LTEtMS0w_538622ac-a4d9-4852-ae8f-4bca1d36151b">51,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtMi0xLTEtMA_0dacb513-51ed-4f19-8589-8d79eea90e8e">0.81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtNC0xLTEtMA_5f89580f-2de9-40a4-90a2-cac6a9ba34d3">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtNi0xLTEtMA_7b3dd48d-f057-4dca-a3eb-64ffa94d629f">2.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtOC0xLTEtMA_fcd5568e-602f-49b2-a949-7f589a8536e4">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtMi0xLTEtMA_657955e3-934c-4b60-883f-2e9b21b557e7">0.81</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtNC0xLTEtMA_4e460804-11e9-4389-9fa2-445148079074">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtNi0xLTEtMA_a35a5389-b5be-4bf8-a5e5-f14b4d028a58">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtOC0xLTEtMA_c75ffdca-8d2f-42da-bf2c-4345fd304423">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib85165656113410dbd73e63f6045c8cd">For the three months ended December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="shares" contextRef="i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTExNw_1807a4ea-73be-4e2f-ae35-3f1a2e3724a6">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i594c5314ab0a48398a297ebae00548bc_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTEyNA_68152f16-df01-4b25-9965-f60d7498e9ac">0.6</ix:nonFraction> million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. For the nine months ended December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="shares" contextRef="i51ebd4afe08246cfb5c144ac9fd55615_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTM1NA_d0c65555-e35e-4192-a5be-37a2cf4d22d1">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i63281ab682614b949d3bfa93e92d8a4d_D20190401-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTM2MQ_4d8344fd-6aee-4567-8820-3f52cc9a09ab">0.9</ix:nonFraction> million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.</ix:continuation> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzc5OQ_5096c9dc-9e63-4d37-b9bd-13a86bfe69ee" continuedAt="i5170fe6fa8a841a0ac52b8d6b6d1b1c2" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5170fe6fa8a841a0ac52b8d6b6d1b1c2" continuedAt="i6d3c48db310846e3a4f3264cdf47e657"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i03dbfb445d744e408d4f455fbf1b0147_I20140531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjIy_198fa282-a897-4ea6-8402-42a15584498b">5.0</ix:nonFraction> million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional <ix:nonFraction unitRef="shares" contextRef="i4e33b766bd5b4b77b3a15f8f572127a5_D20140601-20140630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNDI2_2e7cca29-b3fa-434c-8e1d-2c72837f9cc8">1.8</ix:nonFraction> million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from <ix:nonFraction unitRef="shares" contextRef="if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNjYz_585d9ea8-0017-4069-bd25-0b314734f354">1.0</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNjY5_610876b0-53ce-4a38-90a5-ae4147fc86f7">2.5</ix:nonFraction> million shares, and an extension of the term of the 2005 Plan by <ix:nonNumeric contextRef="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630" format="ixt-sec:durwordsen" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgyNA_4b49a33a-8907-48c7-b3ff-c7ab7d58647d">ten years</ix:nonNumeric>, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  A total of <ix:nonFraction unitRef="shares" contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTE5Mg_f734343e-09e9-42fc-a5a8-9a6b456ea65b">2,827,210</ix:nonFraction> shares are available for issuance under the 2020 Plan (comprised of <ix:nonFraction unitRef="shares" contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804" decimals="INF" format="ixt:numdotdecimal" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTI2Mw_862f6d08-a848-493f-bdaf-70347d1c6842">2,000,000</ix:nonFraction> new shares plus <ix:nonFraction unitRef="shares" contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804" decimals="INF" format="ixt:numdotdecimal" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTI4Mg_bb553753-c952-4786-9c37-fccfe5d54a33">827,210</ix:nonFraction> shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxNQ_b83207c4-49a5-42e8-ba89-6540dfaa92bd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi0yLTEtMS0w_5bfc062a-859a-45af-8a3b-d5fa5c6b9eaa">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi00LTEtMS0w_bb99346d-93d7-45eb-840c-5b42ee308fdf">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi02LTEtMS0w_e2df4660-c3d5-4587-83db-79f6b265a599">5,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi04LTEtMS0w_61107233-75c9-49dc-bf83-86da2f95d31e">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy0yLTEtMS0w_7d50edad-f685-426c-bb07-63c6978aa5a3">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy00LTEtMS0w_fadab530-57b4-4094-8dcc-a89fe5807390">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy02LTEtMS0w_792acf6f-c348-4b55-b325-21431829ca89">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy04LTEtMS0w_feed3fd4-0103-47a2-a40e-b898c4ce2df7">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:zerodash" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC0yLTEtMS0w_8d98af72-e558-49ad-b1e7-d5d30c9d9b7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC00LTEtMS0w_e11599e5-589c-43fb-a076-fe1ed0cc6b0b">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC02LTEtMS0w_490e6ff4-54d8-4180-861f-b49dab544f09">6,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC04LTEtMS0w_4ad57550-9eeb-441a-a905-e473820a0021">7,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS0yLTEtMS0w_58b6b32a-2897-4a0a-a5df-d68fcd1422c7">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS00LTEtMS0w_32387264-3cdf-49ef-b412-4c2487f44997">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS02LTEtMS0w_1271c018-7522-4ffd-a86a-67f9849dc567">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS04LTEtMS0w_0f1b8588-4c34-4582-9467-70442195709e">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi0yLTEtMS0w_744b8a14-5c5c-4a34-9c0f-b105eea12b3c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi00LTEtMS0w_2182428a-04fa-431b-8c74-19f0d96b37a5">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi02LTEtMS0w_e282aa6e-71c6-443c-8957-7552a828316d">963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi04LTEtMS0w_88995d09-f3d3-4de3-8c14-dd679c53ab7e">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6d3c48db310846e3a4f3264cdf47e657" continuedAt="ie70c913813df4c92ae04f1708f656584"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At December&#160;31, 2020, there were $<ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTU2OQ_0f661144-f0e7-4c7a-9e43-498f8640b933">7.9</ix:nonFraction> million of unrecognized compensation costs related to unvested share-based compensation arrangements under the 2005 Plan, based on management's estimate of the shares that will ultimately vest.&#160;&#160;We expect to recognize such costs over a weighted average period of <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTgyNw_bad31f71-ff6c-4bea-a4b7-4d08ee302e90">1</ix:nonNumeric> year.  At December&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTg1NQ_95b7999d-09c3-433d-9be3-e4481a2a33ac">2.8</ix:nonFraction> million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 4, 2020, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="i2b1a9cb50b5b44418cfc024476a41782_D20200504-20200504" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjAyNw_ebe2730c-e08f-4249-8cee-b3a76e9d2a46">79,070</ix:nonFraction> performance stock units, <ix:nonFraction unitRef="shares" contextRef="id1cdfb4a0aef433a8562a57ce988186a_D20200504-20200504" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjA1NQ_b12b7186-e72c-4072-8c72-d03d56b60fb2">73,636</ix:nonFraction> RSUs and stock options to acquire <ix:nonFraction unitRef="shares" contextRef="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjA5Mg_9a75059f-729f-4d3d-ad10-32cd35609faa">249,875</ix:nonFraction> shares of our common stock under the 2005 Plan to certain executive officers and employees.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the three-year anniversary of the date of grant.  In light of the uncertain economic environment, the Committee elected to set the performance objectives applicable to these awards at a later date.  The stock options were granted at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjU4NQ_b7732934-202e-4b94-a726-bedc8f4a0f18">39.98</ix:nonFraction> per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">A newly appointed independent member of the Board of Directors received a grant under the 2005 Plan of <ix:nonFraction unitRef="shares" contextRef="i573a83e08488462c9f111c2bdfd78f3d_D20200504-20200504" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjc4Nw_00bea76b-bd84-4be0-baed-92c2e158a377">907</ix:nonFraction> RSUs on May 4, 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On August 4, 2020, each of the independent members of the Board of Directors received a grant of <ix:nonFraction unitRef="shares" contextRef="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjkwOA_76d4110a-cc21-4cb1-a9c2-4cf80dd64dbe">3,732</ix:nonFraction> RSUs under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of <ix:nonFraction unitRef="shares" contextRef="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804" decimals="INF" format="ixt-sec:numwordsen" name="pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzA0Mg_6e698ee5-dc69-4c83-976b-0be4701a2124">one</ix:nonFraction> share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. <ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxMQ_32d467b7-bda7-4c20-8795-fffb11aaa1a0" continuedAt="id478061482dd4d55bc67a70181e0a98e" escape="true">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="id478061482dd4d55bc67a70181e0a98e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44304ca391ad4b1694746195e1122111_I20190331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMi0yLTEtMS0w_b25cad58-5d80-406c-ae90-fd070ca78529">413.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i44304ca391ad4b1694746195e1122111_I20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMi00LTEtMS0w_cdf057f6-e91d-44c8-9f16-f029723137e7">36.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMy0yLTEtMS0w_96e4e71e-7100-4508-8889-5cf1486e7fd6">220.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMy00LTEtMS0w_0b08d74b-b790-43d4-a70f-72ef031047ac">31.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNC0yLTEtMS0w_ddb4ba6a-ae4a-4b76-9a3d-4999af02b37d">73.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNC00LTEtMS0w_b2e90768-5aec-43de-a90a-71f3e7984d42">47.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNS0yLTEtMS0w_6fdd854a-6c69-4615-8f52-78939a7448db">34.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNS00LTEtMS0w_1910ecd8-588a-4995-96b0-35dfa707e61a">35.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNi0yLTEtMS0w_704866fc-5818-439f-9b3e-b90d2120eb8e">526.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNi00LTEtMS0w_4b904264-8ce6-4576-95b6-2feaeab0be41">32.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNy0yLTEtMS0w_d6b2c9cf-0df2-4598-9da4-68b69edd6c65">138.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNy00LTEtMS0w_4d309738-0e2c-46f9-8e91-a4184e35c5fc">31.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTAtMi0xLTEtMA_c3b8f817-6f47-41aa-9807-c7145b9d4c17">512.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTAtNC0xLTEtMA_c9eb36b1-9f5e-4469-98ea-57981df787db">32.49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTEtMi0xLTEtMA_f9426256-218d-41dd-a251-4544247245b6">179.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTEtNC0xLTEtMA_4de354ad-0fa4-486e-a6e4-dfb05d84b8cb">39.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTItMi0xLTEtMA_bc6d6ae6-9592-40f6-b3f6-836487ca66a4">74.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTItNC0xLTEtMA_b839f904-67a4-4892-b89a-b9f551257cff">44.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTMtMi0xLTEtMA_f73f77ce-22c0-4d9e-9be5-4b81f3d24639">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTMtNC0xLTEtMA_780a408e-0367-47e6-a10f-d4a6a7157195">56.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTQtMi0xLTEtMA_7e9e79d3-626a-4d73-9109-bfbbd9263898">613.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTQtNC0xLTEtMA_0cb472a5-ce9f-4d2a-9253-69fe27ed724a">33.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTUtMi0xLTEtMA_5db8013d-406e-4a37-b7e0-d26eea81387b">150.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTUtNC0xLTEtMA_94bf5882-dece-44dd-8fbf-ad9d7473adea">31.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie70c913813df4c92ae04f1708f656584"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxOQ_9477aba6-7198-4213-8f60-512fce5de997" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi0yLTEtMS0wL3RleHRyZWdpb246ZmM5NmE0OGUzODZjNGE4Y2I5YjRlYTEzYTJhY2I5NWFfNA_95261334-6110-429e-905f-fab0f72fd833">32.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi0yLTEtMS0wL3RleHRyZWdpb246ZmM5NmE0OGUzODZjNGE4Y2I5YjRlYTEzYTJhY2I5NWFfOQ_99d4a950-732a-4981-bf2f-a85256c092c7">32.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi00LTEtMS0wL3RleHRyZWdpb246MjdkMDM5Yzk5NTk4NGQxZGFlY2Y0Y2Q1NGRhZTFkMjNfNA_8262d987-dc3c-4ece-891d-1bb5a3e82aae">30.9</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi00LTEtMS0wL3RleHRyZWdpb246MjdkMDM5Yzk5NTk4NGQxZGFlY2Y0Y2Q1NGRhZTFkMjNfOQ_32769f49-b6eb-484e-86a6-4522fcd700b6">31.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMy0yLTEtMS0w_dfffbf39-c60c-4f5a-ac14-43894fad2c6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMy00LTEtMS0w_1650eec5-a378-40fe-b4cb-9e9e5efa673d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC0yLTEtMS0wL3RleHRyZWdpb246NmMxNTdkNTYxZDg4NDFlNmJkYjUxZjA5MDkyOTIxNWFfNA_be89d4b2-4f4b-42d2-8591-81527377b73b">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC0yLTEtMS0wL3RleHRyZWdpb246NmMxNTdkNTYxZDg4NDFlNmJkYjUxZjA5MDkyOTIxNWFfMTA_45d070db-9eb4-40ff-8cd8-f63a75d960c5">7.0</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC00LTEtMS0wL3RleHRyZWdpb246NzU5YTc4NGYzZWI1NGJmMjkxNjBjZDFlNjc4MjNhOTZfNA_6e578fc6-98f0-4de5-8e77-e0156142f88d">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC00LTEtMS0wL3RleHRyZWdpb246NzU5YTc4NGYzZWI1NGJmMjkxNjBjZDFlNjc4MjNhOTZfMTA_f99545a9-4620-47df-b6e9-168252e680ed">7.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS0yLTEtMS0w_9dffbb6f-7e95-48cb-bd15-68cbda5c848c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS00LTEtMS0wL3RleHRyZWdpb246MjgyNDZlMTIyN2VmNDUwZGFmNjE5Y2ZjYWE1NzIzYzBfNA_ebfcced2-ab3f-46b3-895c-e106a90d0d08">2.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS00LTEtMS0wL3RleHRyZWdpb246MjgyNDZlMTIyN2VmNDUwZGFmNjE5Y2ZjYWE1NzIzYzBfMTA_57a45b98-a19c-47e4-ad43-da6c7086c231">2.4</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNi0yLTEtMS0w_cc4b9d9b-c017-4a62-972c-637099ec2601">12.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNi00LTEtMS0w_ee89d3d9-3ca3-4403-b3ed-3ed531a3c389">10.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgwNw_c0feb86e-d552-46df-b2e9-ca0ce7221b79" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ec6216b1c544040948237d6bac14880_I20190331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMi0yLTEtMS0w_1d658d55-e9fc-49a2-bf74-fada25483eae">944.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ec6216b1c544040948237d6bac14880_I20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMi00LTEtMS0w_1f9dc09e-ac83-448c-a9e7-ca2430865a2b">38.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMy0yLTEtMS0w_f14271d7-2015-49f3-ba55-a979a6cd854c">302.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMy00LTEtMS0w_0eea02a5-f30f-4501-ade0-7733806ab5ab">30.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNC0yLTEtMS0w_167f6149-5f60-4e6f-9f67-90eba81e351c">36.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNC00LTEtMS0w_d48042ab-14eb-4a49-93d6-aa2a6c38c449">27.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNS0yLTEtMS0w_bd0bbe45-59b4-4a2e-919a-e30aed1575af">155.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNS00LTEtMS0w_c42f3a67-56ac-4d24-970d-51b42733744c">41.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi0yLTEtMS0w_bf1593da-aa98-498c-9de7-6570359c10b9">1,056.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi00LTEtMS0w_7ba03708-441e-4801-b48f-c281d8e45ba1">36.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi02LTEtMS0w_74edb6ec-bb83-4744-8bcc-c8cb9de5591d">6.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi04LTEtMS0w_7f058ac5-b7c0-4aa4-ab7e-9927d09fbe3f">9,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy0yLTEtMS0w_e7faa11a-6e1c-4937-9397-680fc97804ba">602.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy00LTEtMS0w_de444328-98df-46f8-97b2-91e5a0d8cbee">38.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy02LTEtMS0w_d70eeb89-80c9-45c3-b06c-f64f4192f6be">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy04LTEtMS0w_3ae9c10e-82de-4091-87bf-c3289df9d4e5">4,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTAtMi0xLTEtMA_0c4b88c3-76f3-4e22-ace4-a36dcef0e654">1,020.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTAtNC0xLTEtMA_d4e73236-8624-46b7-ae03-eff236ef41fa">35.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTEtMi0xLTEtMA_9895795d-3c91-4dc9-b04f-3f09d252b6a0">249.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTEtNC0xLTEtMA_07eb2c48-57f9-49e6-a6cf-9f6f04da12ff">39.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTItMi0xLTEtMA_dbe0f3d4-e92f-4c38-9dbf-4fef951d8abe">65.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTItNC0xLTEtMA_05c3ef28-a629-428a-83dd-b34a26501c38">20.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTMtMi0xLTEtMA_7dd638e5-eab2-4db8-92cf-d1e91644ae4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTMtNC0xLTEtMA_e69ef38b-99c2-4942-821d-a76b0d4825d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtMi0xLTEtMA_a49a0f0c-9232-41fb-bc44-c53d1ccef5f3">1,204.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtNC0xLTEtMA_21d92276-1ca8-4a1a-9240-49af0f27acc7">37.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtNi0xLTEtMA_b658fe3c-5a02-4459-a8bc-657ccdc27589">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtOC0xLTEtMA_dbe12df4-2aea-4c4d-8d8f-9f64df621784">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtMi0xLTEtMA_3e8b9654-5025-46ef-af12-0f8a78740723">696.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtNC0xLTEtMA_18b32e9b-48a7-410e-a999-103fbc815e4b">39.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtNi0xLTEtMA_f9f8c83e-ce55-4d12-ba91-c80a80a7f393">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtOC0xLTEtMA_7030aa2a-eb32-45ce-85a4-a0dedb4ad09d">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the nine months ended December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzc5Mw_f16573da-26de-4d6e-aa10-2a1099b0a2b1">1.3</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTM2Mw_830bc6e6-2e2d-41da-99ad-9f69ad12dcff" continuedAt="i635641a3afde4e118c649f7718a2f2dd" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i635641a3afde4e118c649f7718a2f2dd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act was signed into law. The Tax Cuts and Jobs Act, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  We calculated the potential impact of these final regulations and accounted for those impacts in the quarterly provision for the period ended September 30, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were <ix:nonFraction unitRef="number" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfOTUx_c62efbc5-792a-4dc3-88ba-771914e08ae9">23.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfOTU4_5da28520-f313-4198-9163-8a3e83b4b3f7">24.7</ix:nonFraction>% for the three months ended December 31, 2020 and 2019, respectively.   The effective tax rates used in the calculation of income taxes were <ix:nonFraction unitRef="number" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTA2NQ_9946da02-5f39-41a8-afe8-d72cca249bc3">21.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTA3Mg_9f3c9af7-11c9-4309-adc7-2bbf0f6b8957">25.2</ix:nonFraction>% for the nine months ended December 31, 2020 and 2019, respectively.  The decrease in the effective tax rate for the nine months ended December 31, 2020 versus the prior year period was primarily due to the final GILTI regulations issued in July 2020, which resulted in the release of the valuation allowance on foreign tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTM1NA_e271a789-bf20-41ce-b590-f06d29e9791d">5.1</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_76"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-18-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfNDEy_a8424568-fc66-4617-b6f0-9e9c26e85a0a" continuedAt="i5272101ad9064be1846c142b3901c6fe" escape="true">Employee Retirement Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5272101ad9064be1846c142b3901c6fe"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfNDA3_383ecb6f-596e-4021-98e1-6a1a8dcb2a22" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi0yLTEtMS0w_81542abe-b9ec-48f2-8cf6-51c2b9b68abb">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi00LTEtMS0w_2ad410a7-f9a2-428a-96c7-607934964936">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi02LTEtMS0w_6be04057-a318-4a08-a588-eccf4a66933e">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi04LTEtMS0w_911953df-90d8-46d9-a4a8-a9440e7430fe">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy0yLTEtMS0w_3c3ee25c-a55e-4f0e-93d7-53a8dfb59c69">653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy00LTEtMS0w_f2e59640-fbd1-4652-8ac1-5a1ef66bed7a">722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy02LTEtMS0w_6f29f321-767d-475b-a8b6-bf6482fd4807">1,947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy04LTEtMS0w_e2cbf759-5ac9-4761-af0e-3f373d2a08df">2,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC0yLTEtMS0w_ef640a65-de4b-4067-a2f3-253183349847">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC00LTEtMS0w_5f97f218-61f4-4963-9e91-0851be5f82d6">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC02LTEtMS0w_cf5936cf-7fa3-40eb-a1cc-39f8edbbdf47">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC04LTEtMS0w_11567f9e-7f8f-4cf8-8d75-bb44bf947906">435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2020, we contributed $<ix:nonFraction unitRef="usd" contextRef="ia1e9892fc40644c89bbe3123ab2c9d39_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMTQ0_502ba8e7-7b4f-45c4-8a20-65506f4c1d29">0.3</ix:nonFraction> million to our non-qualified defined benefit plan and $<ix:nonFraction unitRef="usd" contextRef="i8b72b1eb3c7c438ca17d1bd5b4bcebab_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1NjAwNg_60a84c75-f5b7-40e0-9eda-247156cb872c">3.0</ix:nonFraction> million to the qualified defined benefit plan.  During the remainder of fiscal 2021, we expect to contribute an additional $<ix:nonFraction unitRef="usd" contextRef="ice5fa425e6fa455fa7fd4d3c4eb57f48_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMzI4_7774d486-de37-4fca-a531-243f2d4d9059">0.1</ix:nonFraction> million to our non-qualified plan and make no further contribution to the qualified plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1Njc2Ng_9ce59940-3559-4fa6-b921-a948e16de79b">7.0</ix:nonFraction>&#160;million and we recognized a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1Njk1MA_3c84264b-dd70-40c7-871d-5850995fc557">0.2</ix:nonFraction>&#160;million as a result of the payout.</span></div></ix:continuation><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83OS9mcmFnOmNkZDAxNTJmZjgxMTQ2Njk4YjkwNTMwOWM1ZjA5NGJmL3RleHRyZWdpb246Y2RkMDE1MmZmODExNDY2OThiOTA1MzA5YzVmMDk0YmZfMTI0NA_c792219c-b97f-4210-ad6c-f229354224d0" continuedAt="i153879e9fb9b431fab5a25c19f700f8b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i153879e9fb9b431fab5a25c19f700f8b">We are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</ix:continuation></span></div><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzMxMQ_65bb4cb6-78c0-4dca-91f1-99e4b8015991" continuedAt="i8e06db3f99ee4e2e9a5a0af345c034e5" escape="true">Concentrations of Risk</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:continuation id="i8e06db3f99ee4e2e9a5a0af345c034e5" continuedAt="i9a3793a91b2c48009facc661e83fc23f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels. During the three and nine months ended December 31, 2020, approximately <ix:nonFraction unitRef="number" contextRef="i9c31348066374fe7ba878c4902bff844_D20201001-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjUx_8042cbed-a071-4a2c-b93d-da11d2ccfd40">43.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i52df2ac531a04db9891c78e2953258fb_D20200401-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjU4_0d8c4176-dd61-4507-825e-2e04a54cbbd6">45.6</ix:nonFraction>%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and nine months ended December 31, 2019, approximately <ix:nonFraction unitRef="number" contextRef="i500b594756b84b84a2b9d22008165363_D20191001-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzgz_e5ccd991-d960-4d1a-80ad-b86b63d057d5">41.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ieda365d016dc42ae9860c7df30b2f158_D20190401-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzkw_9d0f0e17-d387-436f-9da3-fe0fdd47b549">42.8</ix:nonFraction>%, respectively of our gross revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately <ix:nonFraction unitRef="number" contextRef="i6b9ae14e79e641269492a1e0e4ee76c3_D20201001-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNjA2_47c5d41a-175e-42a3-b192-ef9c5d245901">20.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i62cb921e0c1343f998a11bcd1f9d95cb_D20200401-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNjEz_cc27bcc3-62a9-4a75-83f6-d98a11d3b67d">21.7</ix:nonFraction>%, respectively, of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately <ix:nonFraction unitRef="number" contextRef="i8f1844d37745467a92c46cb8d2c20da4_D20191001-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNzEy_550f41b5-5363-41c4-990c-e2f67953e866">23.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i008c0e348a60478bb9f7213b666b06e6_D20190401-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNzE5_afc85d2b-b08e-493e-8ea8-becb1c65732a">23.4</ix:nonFraction>%, respectively, of our gross revenues for the three and nine months ended December 31, 2019.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third party distribution manager or COVID-19 or other public health emergencies could also materially impact our product distribution. Any disruption as a result of third party performance at our distribution center could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  In addition, any serious disruption to our Lynchburg manufacturing facility could materially impair our ability to manufacture many of the products associated with our acquisition of C.B. Fleet Company, Inc. ("Fleet"), which would also limit our ability to provide those products to customers in a timely manner or at a reasonable cost.&#160; We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had relationships with <ix:nonFraction unitRef="manufacturer" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="INF" name="pbh:NumberOfThirdPartyManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjM3Ng_5c190417-edc9-4373-bb0f-a65142d50382">113</ix:nonFraction> third party manufacturers.&#160;&#160;Of those, we had long-term contracts with <ix:nonFraction unitRef="manufacturer" contextRef="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjQ0OQ_7e109aaf-c1f2-48f1-bd57-5a3f0c58ee41">18</ix:nonFraction> manufacturers that produced items that accounted for approximately <ix:nonFraction unitRef="number" contextRef="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjUxOQ_177fa402-fb8d-48f7-af81-76e225e63caa">68.9</ix:nonFraction>% of gross sales for the nine months ended December&#160;31, 2020.  At December&#160;31, 2019, we had relationships with <ix:nonFraction unitRef="manufacturer" contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231" decimals="INF" name="pbh:NumberOfThirdPartyManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjU4Ng_cb3eb696-11ea-4d20-8368-037a6a6c9fbf">113</ix:nonFraction> third party manufacturers.&#160;&#160;Of those, we had long-</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a3793a91b2c48009facc661e83fc23f">term contracts with <ix:nonFraction unitRef="manufacturer" contextRef="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjY1OQ_ddc14298-f468-4c35-b9be-080df0d5dc10">17</ix:nonFraction> manufacturers that produced items that accounted for approximately <ix:nonFraction unitRef="number" contextRef="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjcyOQ_c1e665f7-99d7-4786-86bb-89761b931e4b">66.2</ix:nonFraction>% of gross sales for the nine months ended December&#160;31, 2019.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIyOQ_82f53f00-efab-4074-ac23-d5ee227d8ea4" continuedAt="i190955095ca24d759082beab3ebd0c82" escape="true">Business Segments</ix:nonNumeric></span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i190955095ca24d759082beab3ebd0c82" continuedAt="i563b12be9486457b9e0e9412464a6d7f"> </ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i563b12be9486457b9e0e9412464a6d7f" continuedAt="i1aa15d58090f4e3daf18a9129cc1e8f1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIxMA_4d634f6c-8c86-4f1f-9d93-0b164e08066c" continuedAt="i2e3b40e6d2414f81b867937197730d7a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi0xLTEtMS0w_c264f4a3-734a-4858-a282-723c5098ecd3">210,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi0zLTEtMS0w_966e1b69-f32f-4c9d-b3c2-5f7b96341e85">28,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi03LTEtMS0w_30e2d709-bd2e-4762-9be1-1e66a05d3801">238,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy0xLTEtMS0w_e03aadd0-f5f2-4392-b48c-a1363e07225e">88,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy0zLTEtMS0w_c5a23866-595d-4b19-92b0-f0c18c5f0345">11,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy03LTEtMS0w_402e2caf-fb68-4497-b5fd-49c7b54eba7c">99,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC0xLTEtMS0w_279a67e5-22ae-4da8-b76b-9e651bf0a5a9">121,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC0zLTEtMS0w_19173bda-4164-49d6-9c8c-885699bf5f78">17,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC03LTEtMS0w_b7e5ca2b-9867-4808-bcdc-dfc14dd435f4">138,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS0xLTEtMS0w_0aa640ec-cab8-437b-b880-fb1ae77b6e8e">32,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS0zLTEtMS0w_2733925e-7fd8-4fe4-8d7f-9e510a994834">5,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS03LTEtMS0w_147c2f57-c9a5-499c-975f-ff53d50462fa">38,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi0xLTEtMS0w_91a921f4-5bbc-4382-b165-7d15c5670192">88,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi0zLTEtMS0w_4dd68958-fb21-4b64-abcc-4f186bcd115c">11,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi03LTEtMS0w_a1808f3d-ff25-460f-a963-f6c6b8e221ac">100,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNy03LTEtMS0w_cb70d5f9-ebb6-4e5f-89b9-57d378547961">27,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfOC03LTEtMS0w_8d71a8ba-4ef3-4b42-b525-a9889a3d5166">73,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="ie6dcd2ebbac947c5b6cee797817560d4_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNTYy_960889f9-6e46-4698-907d-05ee20266a5e">0.8</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi0xLTEtMS0w_0fad1a22-844d-4618-a369-aeab69ff5cf9">637,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi0zLTEtMS0w_00e16f04-d0e1-40ae-a796-7f9e2e494b0e">67,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi03LTEtMS0w_18368e08-ec39-4a48-987e-c3d9da7804de">705,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy0xLTEtMS0w_9efe480b-9e81-401a-902c-75d13a99fcfd">267,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy0zLTEtMS0w_0f8f7675-897e-406a-b225-9084ed2f1bc4">27,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy03LTEtMS0w_935085fc-a530-413e-a9d2-de328f314778">295,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC0xLTEtMS0w_e349a93e-80f7-47f9-a0ca-edb3ea4128fa">370,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC0zLTEtMS0w_3a8c65c0-0c78-46fc-b5c2-30cf80eb1f05">40,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC03LTEtMS0w_a25d4a0d-4d5d-4967-8c23-b393505602e3">410,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS0xLTEtMS0w_a51aecf0-57c2-4ca1-89ba-bc99ac414565">91,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS0zLTEtMS0w_984b2ab3-85e5-4daa-bcd6-39b4c81f3251">12,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS03LTEtMS0w_1d14faa1-b140-4330-8d58-cdd00c1a33a7">104,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi0xLTEtMS0w_019541d2-8153-464a-b33c-29d7c2c49906">278,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi0zLTEtMS0w_f48af2c8-bc4f-42d8-8ab1-0a963c5b8133">27,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi03LTEtMS0w_a6ba37b8-dcb9-41c2-b14c-f930df083811">306,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNy03LTEtMS0w_f8efae22-1c70-471d-9ad8-b301791b0cdc">79,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfOC03LTEtMS0w_8201f510-b978-450a-883a-db0df97949f7">226,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i20f6fb1bf2a34c35a01cae3374745b5b_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNjU5_4fd86f5e-2086-4f23-98da-0e49e3364b61">2.4</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi0xLTEtMS0w_b035faba-c7f3-4af8-b2e8-fcf107db37c4">214,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi0zLTEtMS0w_6d540249-cc5a-4fd3-8cf5-0026deaf0ae1">26,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi03LTEtMS0w_13e0e68a-9148-48a7-820b-f444d02ca2bc">241,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy0xLTEtMS0w_290e3e37-ae2d-4e3a-9ceb-9c6929919981">93,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy0zLTEtMS0w_e3949117-69ae-4e25-b316-c328279e97eb">10,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy03LTEtMS0w_4cf24ac1-c069-477b-b4af-b4dab1b47f74">104,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC0xLTEtMS0w_25f7ae7a-e84b-4c2f-82c7-c7d1ddcb3678">120,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC0zLTEtMS0w_0fe7e9b0-3b0d-4a91-8e3e-c75c51a019a6">16,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC03LTEtMS0w_ddb9feff-b814-45e5-b569-fda0775967e6">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS0xLTEtMS0w_0b44e14a-17d8-4a3b-b61b-e0bbfd4fab51">29,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS0zLTEtMS0w_0799befe-4771-46f6-b814-aeadac13d003">4,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS03LTEtMS0w_a2e83677-3c75-4de8-a28f-c6e5283e536d">33,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi0xLTEtMS0w_316d44ee-4899-4df6-bf4f-63db137e2189">91,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi0zLTEtMS0w_94c16087-8fb5-4ff0-856b-269bddb4d6e4">12,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi03LTEtMS0w_7767b258-3deb-41f0-99b2-28a823f8b85c">103,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNy03LTEtMS0w_ad5aa8b9-22f5-4d95-be04-a59e8579331c">27,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfOC03LTEtMS0w_44adf843-a203-4e8c-a510-83be2f62e65f">76,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="ia68e63de10454e24894bd16a7a088bcf_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNzU3_3d7fbff5-b7dc-46d0-8eba-b2e48722aa77">0.6</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1aa15d58090f4e3daf18a9129cc1e8f1" continuedAt="ibcb905d1e37b4b46aa0090c62d9f2af8"><ix:continuation id="i2e3b40e6d2414f81b867937197730d7a"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi0xLTEtMS0w_2984bbff-ac1d-44b6-9f8a-7bc1e2ede756">639,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi0zLTEtMS0w_ca73f52a-b518-4bbd-b5c7-5eae6061eb0f">72,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi03LTEtMS0w_fce11db2-4d39-49da-bed9-f9ec1cd81c7a">711,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy0xLTEtMS0w_3487f99a-78bc-4fe6-a4f3-badfa37d7260">275,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy0zLTEtMS0w_a055dbcd-039e-46f9-bd9e-0a9665357f47">27,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy03LTEtMS0w_18e553a1-1a64-4dd4-8551-9452a95d9bf3">303,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC0xLTEtMS0w_5b51ca7f-1094-4822-be24-36b3cf5d2208">363,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC0zLTEtMS0w_98bec433-8161-4952-be71-1a64cfd1012f">44,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC03LTEtMS0w_568a2ec5-c015-4edb-b6f0-e3406aba896c">408,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS0xLTEtMS0w_3c9aee87-1735-4ca1-8942-3dad4e27003b">94,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS0zLTEtMS0w_b96445ff-7e3c-4da4-866d-e247750de278">12,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS03LTEtMS0w_417c5784-1a0c-4841-bf8b-624820cf1207">107,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi0xLTEtMS0w_7a45ac4d-9e3e-431f-a07f-824912e9a0ac">269,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi0zLTEtMS0w_a6c3a38e-ac96-40b9-baf3-b1a599b50f59">32,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:ContributionMargin" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi03LTEtMS0w_2ef8fd22-6235-4e6c-822a-a9423fc14705">301,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNy03LTEtMS0w_4de117ae-110d-4229-8856-0e4d02913998">84,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfOC03LTEtMS0w_a254b0d5-9c13-49bd-9b6a-75a3ecf9f315">217,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="id8407d623fa84556b0397c38088abbf6_D20190401-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfODU0_1eb3c7f2-5599-4c74-a2de-0d1fc02ddf7a">2.1</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIyMA_30c83376-85e9-48e4-a851-232daa54f5a7" continuedAt="i6de2c19ac75e481ba3b85e3349c2c6db" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d198cc6856d470c8ec71c81c8103522_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi0xLTEtMS0w_2b4b9ba3-7340-4c1f-a838-2d56db552906">29,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46feb4fd7be74db89bc3151dc91f92e2_D20201001-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi0zLTEtMS0w_c7add1a8-41fb-4410-8498-6957d3ac0d98">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f81090cc714b74b8d03f28025f19b1_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi03LTEtMS0w_4da155cd-a9d6-49e0-ad4a-f3bd394163ea">29,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96855186767b4db9a00fb69b716c41f6_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy0xLTEtMS0w_44659735-2824-4280-9fb6-72980611b300">16,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c7a94528d9490fb08b81ebf1d7a00b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy0zLTEtMS0w_e46e7671-ba6b-4e62-9d62-fedfd384fa4c">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9dde9deb0240549add526728474f42_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy03LTEtMS0w_63eee901-65b1-4318-a3a6-c0ffd0d7c392">20,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d09d2b366144f2aff1fd2e7f593171_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC0xLTEtMS0w_8d1ee615-ffbb-489d-a6e5-ca012e421840">60,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0694c66689742c5b90557d956ca3f32_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC0zLTEtMS0w_50ca7225-c21e-441a-8d19-9f5f44843140">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d320cc345b49a2a8fbdada2529df4e_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC03LTEtMS0w_f5f2bf66-b1d2-45f1-b576-c5d7524951f9">64,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e950986bcf4e108adee0564716cb37_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS0xLTEtMS0w_1e5bcdfd-7e95-4e52-930a-d6574e83bfff">31,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3f00e6b81ef4c3482182a197d4a4e32_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS0zLTEtMS0w_55ba19b0-4fc1-4582-8fe9-3f1632a98388">13,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4244f86df364e5ebcde26a945e3142b_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS03LTEtMS0w_23013b3e-0185-4543-898e-dc21ed1f2c7d">45,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia738781a6462445a9d482d900ef06acb_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi0xLTEtMS0w_c049a3a0-4ac6-45a6-b16b-508c40557725">23,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a85023eca74a8fac623c88ab9c8e78_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi0zLTEtMS0w_52421e9e-3558-454c-81b0-ed5348697309">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80964bb76f874e5281347932224ff34a_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi03LTEtMS0w_525addfa-d080-4e4c-99cd-45dd534af9c6">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41001c9e538a41ed8464330160dc13e6_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy0xLTEtMS0w_aeb42851-196a-4291-b7f0-06d2c7bae972">24,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28bad73d72f456e8b79877569af8a18_D20201001-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy0zLTEtMS0w_fae4cf65-75c1-4e43-910d-7ee1fdc3600b">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81550b7b21bc4feea06a01fcc70f411f_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy03LTEtMS0w_2983aabd-70f3-4690-ab3f-40514e4a4964">25,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db11a316bb0453ba064a9b94c08d6e7_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC0xLTEtMS0w_c86fb951-b7a1-43c6-a417-77687592f91f">22,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7739148e504bf886e60a2197004803_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC0zLTEtMS0w_9a4014ad-544d-40f5-b2f5-11653437a3be">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43dc6fc89aff41f88710ff54c5a7ed8f_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC03LTEtMS0w_f856c5f4-b4f1-4935-9b92-e68b0c334b51">25,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice70e5b8d1064b52aebc31f31f0a7884_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS0xLTEtMS0w_319d1d32-eac3-4d37-9b8e-ba12c2c9c307">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id657b6e10bb145bd9e3b992a5952b584_D20201001-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS0zLTEtMS0w_5938c216-b555-4c05-ac57-1ca6d0a2274e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d12927a6dbe43b78aef3d34a6229cfd_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS03LTEtMS0w_f565573d-307d-4306-a7cb-a21b50d0d754">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id23c3e9b79a94d9789d9b7517a275164_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtMS0xLTEtMA_f389cb18-7576-47d6-9c4b-f40cb16bb544">210,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e73ad0358e14775a2e9849dd271ff14_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtMy0xLTEtMA_031a120f-f245-431f-a9bb-e43df01041ce">28,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtNy0xLTEtMA_35ccde72-ba1a-46be-93f8-78cea4323bc1">238,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd9073a48464bd7b51b74613aafa24f_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi0xLTEtMS0w_1bdd7f6c-637f-40f7-b7b3-89dab4da19d0">87,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49b14bc7d42b468ba1f64dd1c0abaea3_D20200401-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi0zLTEtMS0w_4f6179da-e171-42e6-a78e-975e2361911a">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a7cd80cd5a4b1bad14f4a51c7ada4e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi03LTEtMS0w_ae0cf480-9a8c-48de-931c-4bb67641ed46">88,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97460044a83f440fa7584652350076da_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy0xLTEtMS0w_52e361ac-d934-4e4f-834a-63391bd97bab">45,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie688265c2fe64317a2d953ab3115c665_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy0zLTEtMS0w_c26d8f4b-3ec3-4842-8fe7-b6973f00bf2c">10,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2746c8904701432ab60720e86c50447b_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy03LTEtMS0w_2204671e-d1ee-40c4-8458-a589f2955f17">55,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8993e25574f54284bfbbbd9dd41772f5_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC0xLTEtMS0w_f4538d2c-8c2d-4abc-a404-913aad6ed1c3">187,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae8a85f75464471a53bd0ba32db5176_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC0zLTEtMS0w_2d3d5048-93a3-4c39-8045-0d03c11a01df">10,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cc2559678948b9aef06ac76f4e1522_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC03LTEtMS0w_445d7a36-c0fa-4dcd-8610-e1a438308c33">197,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173fab1b453f4560849f0dc00c3452a5_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS0xLTEtMS0w_67fe45ac-629e-43d3-8e6e-4cb3b9dcd965">93,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19fe27a1e60e4cbeb166294c0bede61e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS0zLTEtMS0w_465d55dc-32c3-4a59-950b-4f183d1f039a">25,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic014bbc1359641b1a2b5b3a0a76876d2_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS03LTEtMS0w_7aeacf3d-6810-4772-9a4c-dfbfc711d7a7">119,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7877fc9a7f02493996cb66d50ec3afe5_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi0xLTEtMS0w_c9203e70-96bf-4301-9c3b-11801d45a8d4">72,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5d5430fb96e440aae81e6b0952da7b6_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi0zLTEtMS0w_73d043ce-ce91-4354-9d36-a063c475e78c">7,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4ec554d2bc4d29b952a1b545f2b547_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi03LTEtMS0w_b525a424-d32d-48a1-9b9e-cee208d3fded">80,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic58ac387c2ff481c9484454d90ef155c_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy0xLTEtMS0w_ac74b10d-5afe-40dd-8922-5e64bb34a3c7">80,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6d6045fb4442a2895c9ec699f1811e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy0zLTEtMS0w_5ca7470d-a440-489c-a0a4-792339f44d6a">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965dae78c4ba4d53871050f36805d7c2_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy03LTEtMS0w_3eea46d9-6dc4-4945-b72c-96f7315964bf">82,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6593e8a130e4e3f9f3cdf45d175d28f_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC0xLTEtMS0w_f18764d8-5d0e-49de-a94b-04acc738cd03">67,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac53dedfbbed4030a17b1545923bc589_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC0zLTEtMS0w_9d9ed49c-5598-499a-a457-9c4fdb4d4259">9,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a3d3deecd14f63bd429eb4e3e8430e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC03LTEtMS0w_5e947174-c533-493d-b0f7-2dbbf8c6cfd7">76,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39009ec2cf5647779e9d225f923247c3_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS0xLTEtMS0w_870cf9e7-5046-47c7-961b-41b3693da66b">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6166e5bdf88b40a8992f759071b12983_D20200401-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS0zLTEtMS0w_bfe34275-5f18-49b7-9515-f2e5fe6f421f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d710e027cd54fd8aee0485eba0c6cf5_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS03LTEtMS0w_2f314abb-5eb6-4658-89ea-16cba1a38bab">4,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtMS0xLTEtMA_7d99fe44-398f-4cb0-94e0-ad85d834bb55">637,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtMy0xLTEtMA_9de756c3-772a-4827-b2d8-c38d89863c4c">67,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtNy0xLTEtMA_13f869f8-95f0-41c1-9abc-0521f5af2887">705,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-22-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibcb905d1e37b4b46aa0090c62d9f2af8" continuedAt="i7947cd210e274394adfbba89fe92f59d"><ix:continuation id="i6de2c19ac75e481ba3b85e3349c2c6db"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87392d270c0486a93ceaf137e98399d_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi0xLTEtMS0w_9890346b-7ff9-4f42-9739-b37d7611e0f0">28,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7e602fc5d9444ebdd4c853c09b50d5_D20191001-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi0zLTEtMS0w_5276770d-453f-45ef-9802-d226dd8e8c82">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a79924f9ce947458d38df1406320d6d_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi03LTEtMS0w_e7d93ff2-3551-475f-a24c-7420f6a4920f">28,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ee54ef632d4869892e5474c4128689_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy0xLTEtMS0w_8ed89749-b1d5-4e51-b46a-debbed5fa285">25,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd84840900f7404d8225e673a8394f3c_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy0zLTEtMS0w_058aea86-1d34-4315-8a25-1dc3e458374e">4,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b5fa469fe0648758a18c8204ec783a2_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy03LTEtMS0w_e72436f6-e97f-45db-a383-2ec497a97e71">29,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8e154d8fdb4c5ca334f3b074e96118_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC0xLTEtMS0w_7f72af3c-2c51-4dc3-8dd6-6388269ae80f">58,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaa79a619a94571be5a3e33b1b9b727_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC0zLTEtMS0w_91774120-82ce-4068-aef8-baf05bb16af5">3,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75cc8b1bbf84638bba89e388838032b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC03LTEtMS0w_c3dc1b50-3a71-4fd6-a11f-6fe2a95f3541">62,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d019c5be754bedb9da5cb867242c80_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS0xLTEtMS0w_ea6a3f59-c393-4f83-ae60-9803d957a3b7">32,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a054fe50c8445ffbe95cd9a6dae0e73_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS0zLTEtMS0w_20d36c06-e19e-4a3e-865a-9748755257bb">12,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07318d3f13404727be431e43ee6a10a9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS03LTEtMS0w_4a07dc5d-d4c3-4b31-9818-e4d3c92a9197">44,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0956b5a03a4aac9860d3e814a7a613_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi0xLTEtMS0w_2b43aa74-99e8-44bf-8578-03badb75c7c6">24,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4a0ae5763540aebd26fc7b0246574f_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi0zLTEtMS0w_c93e6830-e696-4157-ba85-0e3923cc4152">3,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc317e3286f405d8d099420e0ffdce4_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi03LTEtMS0w_c06b695c-46df-4c66-965c-5e198c33c705">27,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb8aa6b9b0b4441b011f07d5309b81a_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy0xLTEtMS0w_97d315a5-2d5f-4121-ac26-6fda3b9fd6ff">23,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404178ff281443bf9ced03a0238bf1f6_D20191001-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy0zLTEtMS0w_e55a9392-8952-4e9b-9df1-e406e6081e2f">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3395ce8af8e428c9ad73baa0b989bc5_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy03LTEtMS0w_63dbd29a-3a63-43eb-9890-ba78216579a7">23,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a647598543421a924f09921ad19ce3_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC0xLTEtMS0w_8ec6edbe-729b-4faa-8d40-f3ae1bb05365">21,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726fc7d1df344b5831a872a1ef09b6f_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC0zLTEtMS0w_4dfd7eac-7334-4862-99f7-75ede03a78d7">2,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac032030eede416e8cce85237744c04c_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC03LTEtMS0w_04f14075-308f-4106-877e-119e18890677">23,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd0d5b78dd6488a90023e73337561c2_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS0xLTEtMS0w_051ed05b-3081-4e21-a6f4-3c5696da3711">1,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b5ea8663fe460eb915122aa37bb218_D20191001-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS0zLTEtMS0w_f1ef6748-4944-42d4-a27f-d563131aa654">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic326287529e8474aa6d710df42ce383a_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS03LTEtMS0w_c4b1676a-7c1c-4ae8-b1e1-51a86dea3b3f">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b582ceef6b94530a0a15643c10b9bdd_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtMS0xLTEtMA_f2a18e64-d0df-47c3-ba4d-f0d3f6b53aeb">214,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfa30afe9ba4d0ab14d9df91c38845b_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtMy0xLTEtMA_3008c95f-c0ba-4508-a305-5034d484e4b8">26,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtNy0xLTEtMA_faf5389f-5da1-42ac-af68-0707cdf653f9">241,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf96e727a648328bd0ddbaf8c22e9f_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi0xLTEtMS0w_66f0c988-6edb-485e-8d88-a6d870ff76b8">85,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1aa98178171483c8a80105d8260faf3_D20190401-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi0zLTEtMS0w_6aabc1f2-3a64-4fa5-a4c5-71f7679da933">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74206d6c1ef94f85a77a706a302a2921_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi03LTEtMS0w_69be6d24-df02-472a-b118-2654339bfe78">86,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e224bfc0f2f4f9bbd343fcf36f723d5_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy0xLTEtMS0w_05f21a68-358e-40ee-bfd7-259e1067ab1c">63,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b281d13ce44cac9f9e545ad208695f_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy0zLTEtMS0w_f38d9d1c-cde5-485a-ad4f-c11398881212">15,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24eb7719094a43d584a2034ea978272d_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy03LTEtMS0w_b3454271-c305-4289-b59d-0a3ac8b681f3">79,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb01bf909b914824bd367b98c9aaf43e_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC0xLTEtMS0w_19d94aef-39e0-429c-93ef-72188d4a9274">177,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31318cf15ae24534bba25f86a4dd84c1_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC0zLTEtMS0w_b6fbaaea-6f36-4c95-8a2f-48b8ba5c8b9c">8,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc78679f204d4b82b27f94f4ab6bf2c6_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC03LTEtMS0w_1d25d268-6f0b-4137-b807-e8838f920b96">186,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19de88ae5c20400eb8842116fc3aece9_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS0xLTEtMS0w_39c86754-52c9-4002-b48b-8b593f559060">96,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fffc560ee1744808937bcbe9f0620d4_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS0zLTEtMS0w_40731542-13ff-4697-890f-3545734e3e05">28,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b490d84f1fb4012b05a6af473ef1a5b_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS03LTEtMS0w_83c436de-c474-44bc-8a58-8822ecd0a177">124,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed85d9a18a4444b8d4767cd042125e2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi0xLTEtMS0w_a42ba233-e443-4e84-908c-700c4c483369">73,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a173370c5b48a196971ab3b9d7d458_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi0zLTEtMS0w_0d4151fb-7d0b-4f11-adbd-c43e4141119c">9,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b30c22a1b5488eb65d429328bcc1a7_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi03LTEtMS0w_2239931f-c932-4d1e-97fb-463418d72f83">82,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376458bf47654387b6b570f09075e008_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy0xLTEtMS0w_083eced5-3acd-4cce-8780-d26ea1c519ff">77,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec6dd84935741f89edaadd7dc45c6c8_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy0zLTEtMS0w_bc91ef9d-1ed8-48eb-a354-e904dfc45d34">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia561de999a564dc38eed19fc55917452_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy03LTEtMS0w_b259d06d-c802-437f-848c-f3dba91aa785">78,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607b8d0fdd5346f9a3cabe2c53ee8951_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC0xLTEtMS0w_012cba1d-eb08-4e70-a333-1aef98c2015b">62,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64ffd54f7d44b71837a1ffd999561dd_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC0zLTEtMS0w_ccbbf825-b825-4f9f-a88e-b43eef3a2a86">7,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec031e57d3cb43a2833a47073eb677ec_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC03LTEtMS0w_d8d44eb7-8366-4954-820e-19c5ad09bf06">69,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f1a28867e44d3f9deec4c5458df1e8_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS0xLTEtMS0w_404a6d2a-c7ff-4e42-a9f1-f532bf77a7c8">3,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879386f7739b4709a9a498c439de1dd0_D20190401-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS0zLTEtMS0w_464cb3ef-5248-4852-bf2d-e939cb49f695">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5c3472bd6f439b818e26dba211fba1_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS03LTEtMS0w_6b1a7426-85ee-47a8-9931-248562876aaa">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726c3b7978984c9c89776dace3512cd6_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtMS0xLTEtMA_89a2b035-82f7-407e-a580-07697495be55">639,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b3334441a4b4ebd90c904bf63af74_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtMy0xLTEtMA_0d5de638-aab5-4898-840b-47c1fa5b7e12">72,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtNy0xLTEtMA_985cffaf-3dc0-4439-aefe-505d3dfbe5ec">711,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIzMQ_f9f975aa-d3ad-4f73-a992-6cc4394bb317" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbf0d2f0f0b45de8dbc05c513975980_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi0xLTEtMS0w_34b47b4d-3b8f-4256-90f5-25869501d453">197,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia047992a234e4a6e93507979ba924334_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi0zLTEtMS0w_0ca4e0d3-fca0-4e52-a977-31d6adbff1e9">203,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ac168c392241e985f758d09dfff28a_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi01LTEtMS0w_cee2c43b-f9a3-47f5-b47d-69891f971bca">599,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ffb79e853904250bd4a61db331e3d55_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi03LTEtMS0w_213289c2-e61d-44a3-9ada-5e81fd906781">604,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb23c99f72dd4b83a90f3c672526d24d_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy0xLTEtMS0w_de95bcbe-1d3f-4f37-b09e-6b16d3df19d3">41,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b9c1ebb674451b8abea4c22d7a9b9d_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy0zLTEtMS0w_e0912428-71dc-4f39-b64f-39d7f7587a28">37,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfd9152348e4e888243321c3a99add2_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy01LTEtMS0w_24e97fd4-0ad1-489e-aee7-2850c50aedc8">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7cb897e70f478cb92e199f2d901a81_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy03LTEtMS0w_ddd0fa92-d965-44d8-a1d7-7bf153fefdc6">107,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC0xLTEtMS0w_a02fef9d-3755-4a23-bf95-301531ff9534">238,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC0zLTEtMS0w_74fbd42b-2c42-4e3a-984e-f13178f66ce5">241,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC01LTEtMS0w_330f806e-211c-4f3e-98cc-d9dd83b6fad8">705,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC03LTEtMS0w_27b024a9-cf42-436c-b2ef-de5b2de1c8e6">711,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTI0NA_8b32f59b-3235-41c0-b285-781b01a01e0d" continuedAt="i1c5779c123be4022b87d5d98728a8791" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi0xLTEtMS0w_b3fa1c38-daf1-4200-a05d-140b3f670703">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi0zLTEtMS0w_97fb6555-a3f1-4bd0-9f5d-9a42c5b700b0">32,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi03LTEtMS0w_712c4164-c2c1-40a0-8214-9e2bdb05f158">579,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS0xLTEtMS0w_47a4d5d1-7218-47e4-960d-76478d26bca3">2,195,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS0zLTEtMS0w_69507fda-9c69-4480-a7aa-94f3724d7682">87,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS03LTEtMS0w_4feb3b8d-3534-43ac-b870-1a1ddca42c00">2,283,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi0xLTEtMS0w_ce694d4d-e76e-4bb6-bd56-19ae5af4f6a9">195,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi0zLTEtMS0w_714a1c62-7591-47b9-8458-ed69558c37a1">3,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi03LTEtMS0w_e52ba386-d159-49af-a109-64e1026f52e0">198,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy0xLTEtMS0w_1c044e61-4774-4851-849f-f556c0372694">2,390,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy0zLTEtMS0w_506c3c23-7890-45f4-8029-bd4aac51e74a">90,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy03LTEtMS0w_feb5a822-7419-4809-8ca3-ebf128512de8">2,481,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC0xLTEtMS0w_75e2ff35-d69a-4e63-b91c-caf3dec81d17">2,937,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC0zLTEtMS0w_43c1ce02-8f66-4e73-935e-7512ed94fd72">123,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC03LTEtMS0w_358820a3-2f78-4d52-b825-3a53514ca252">3,061,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-23-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i7947cd210e274394adfbba89fe92f59d"><ix:continuation id="i1c5779c123be4022b87d5d98728a8791"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi0xLTEtMS0w_190250d9-ec22-4efd-ba2a-786607682875">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi0zLTEtMS0w_f045f706-12f5-4a24-ac96-d663e97ef887">28,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi03LTEtMS0w_246d8561-0197-4b1e-8b40-2300b9670b89">575,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS0xLTEtMS0w_dc66cd12-0f40-4f92-93e6-cb2b88926838">2,195,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS0zLTEtMS0w_c19a3d20-5ccc-406a-bb69-83cfe3b11a83">69,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS03LTEtMS0w_fe3910df-c7d7-4587-8352-5af256752d57">2,265,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi0xLTEtMS0w_b5e0ed67-b8ec-447e-b61e-481c82744b27">209,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi0zLTEtMS0w_c83a8b8c-071c-46fa-ba23-f8fbeb909914">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi03LTEtMS0w_0e135f60-8166-4789-8860-a2fc5369962b">214,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy0xLTEtMS0w_26ac1069-b718-4b4c-8c88-fffe9275d62f">2,405,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy0zLTEtMS0w_f5cadb34-5eca-4c7d-8cef-0fad19eb9b43">74,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy03LTEtMS0w_11adc3ae-6319-4030-ab53-c24ecd403590">2,479,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC0xLTEtMS0w_55ece78a-d0b6-455d-a475-b9afa8e4b1d9">2,951,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC0zLTEtMS0w_7e5df4dd-9d2e-402d-b597-e97c05667786">102,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC03LTEtMS0w_f85f40c4-5fa5-460c-a3cd-6150d4fe9994">3,054,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-24-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read together with the Condensed Consolidated Financial Statements and the related notes included in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.&#160;&#160;This discussion and analysis may contain forward-looking statements that involve certain risks, assumptions and uncertainties.&#160;&#160;Future results could differ materially from the discussion that follows for many reasons, including the factors described in Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020 and in future reports filed with the U.S. Securities and Exchange Commission ("SEC").</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See also &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i877786c68c0b4e62bc2be287a69c3d84_106">35</a> of this Quarterly Report on Form 10-Q.</span></div></td></tr></table></div><div style="margin-top:11.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated by the context, all references in this Quarterly Report on Form 10-Q to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;Prestige&#8221; refer to Prestige Consumer Healthcare Inc. and our subsidiaries.  Similarly, reference to a year (e.g., 2021) refers to our fiscal year ended March 31 of that year.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name over-the-counter ("OTC") healthcare products to mass merchandisers, drug, food, dollar, convenience, and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;We use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team to our competitive advantage.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown our brand portfolio both organically and through acquisitions.  We develop our existing brands by investing in new product lines, brand extensions and strong advertising support.  Acquisitions of OTC brands have also been an important part of our growth strategy.  We have acquired strong and well-recognized brands from consumer products and pharmaceutical companies, as well as private equity firms.  While many of these brands have long histories of brand development and investment, we believe that, at the time we acquired them, most were considered &#8220;non-core&#8221; by their previous owners.  As a result, these acquired brands did not benefit from adequate management focus and marketing support during the period prior to their acquisition, which created opportunities for us to reinvigorate these brands and improve their performance post-acquisition.  After adding a core brand to our portfolio, we seek to increase its sales, market share and distribution in both existing and new channels through our established retail distribution network.&#160; We pursue this growth through increased spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations, and innovative development of brand extensions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Coronavirus Outbreak </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2020, the World Health Organization ("WHO") announced a global health crisis due to a new strain of coronavirus ("COVID-19").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the WHO classified the COVID-19 outbreak as a pandemic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This pandemic is affecting the United States and global economies, including causing significant volatility in the global economy and resulting in materially reduced economic activity since early 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The COVID-19 pandemic and the corresponding government responses have also led to increased unemployment, which led to a reduction in consumer spending.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic conditions are, and we expect that they will continue to be, highly volatile and uncertain and could continue to reduce demand for our products and put downward pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We did see an increase in sales at the end of March 2020 related to shelter-at-home restrictions as we believe consumers stocked up as a result of COVID-19, followed by a temporary but significant decline in consumption in the first quarter.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since then, we have seen more stable consumer consumption and customer orders. Sales have varied throughout the year with some categories positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold, and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19. Early in our first quarter of fiscal 2021, we received reports of an increase in absenteeism at our distribution center and with some of our suppliers; however, we have not experienced a material disruption to our overall supply chain to date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To date the pandemic has not had a material negative impact on our operations, overall demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These circumstances could change in this dynamic, unprecedented environment. If the outbreak continues to spread, it may materially affect our operations and those of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">third parties on which we rely, including causing disruptions in the supply and distribution of our products. We may need to limit operations and may experience material limitations in employee resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The extent to which COVID-19 impacts our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19, and the actions to contain COVID-19 or treat its impact, among others. We do not yet know the full extent of its impacts on our business or the global economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, these effects could have a material, adverse impact on our liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tax Regulations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act was signed into law.  The Tax Cuts and Jobs Act, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. On July 20, 2020, final regulations were issued for GILTI which include a high-tax exception for income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. tax rate of 21%.  We calculated the potential impact of these final regulations and accounted for those impacts in the quarterly provision for the period ended September 30, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-26-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31, 2020 compared to the Three Months Ended December 31, 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Segment Revenues</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents total revenue by segment, including product groups, for the three months ended December&#160;31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total North American OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,274)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">International OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,764)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment revenues for the three months ended December 31, 2020 were $238.8 million, a decrease of $2.8 million, or 1.1%, versus the three months ended December 31, 2019.  The $2.8 million decrease was related to the decrease in our North American OTC Healthcare segment, partly offset by an increase in our International OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the North American OTC Healthcare segment decreased $4.3 million, or 2.0%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019. The three months ended December&#160;31, 2020 were negatively impacted by the Cough &amp; Cold category, but were partly offset by the higher Women&#8217;s Health and Oral Care revenues. The Cough &amp; Cold category was impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19.  The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the International OTC Healthcare segment increased $1.5 million, or 5.7%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019. The $1.5 million increase was attributable to increased sales in our Australian subsidiary primarily related to increase in sales of Hydralyte.  The increase in sales of Hydralyte was related to an easing of shelter-at-home restrictions in Australia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the three months ended December 31, 2020 was relatively flat, increasing $1.4 million, or 1.0%, when compared with the three months ended December 31, 2019.&#160;As a percentage of total revenues, gross profit increased to 58.2% during the three months ended December 31, 2020, from 56.9% during the three months ended December 31, 2019.  The increase in gross profit as a percentage of revenues was primarily a result of the fourth quarter 2020 completion of transitional costs associated with a new warehouse and distribution center.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the North American OTC Healthcare segment increased $0.8 million, or 0.6%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019.  As a percentage of North American OTC Healthcare revenues, gross profit increased to 57.8% during the three months ended December 31, 2020 from 56.3% during the three months ended December 31, 2019, primarily due to the fourth quarter 2020 completion of transitional costs associated with a new warehouse and distribution center and improved logistics costs resulting from our warehouse transition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the International OTC Healthcare segment increased $0.6 million, or 3.7%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019.  As a percentage of International OTC Healthcare revenues, gross profit decreased to 60.9% during the three months ended December 31, 2020 from 62.0% during the three months ended December 31, 2019, primarily due to product mix.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contribution Margin</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin is our segment measure of profitability.  It is defined as gross profit less advertising and marketing expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our contribution margin and contribution margin as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contribution Margin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,054)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contribution margin for the North American OTC Healthcare segment decreased $3.1 million, or 3.3%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019.  As a percentage of North American OTC Healthcare revenues, contribution margin decreased to 42.2% during the three months ended December 31, 2020 from 42.8% during the three months ended December 31, 2019.  The contribution margin decrease as a percentage of revenues was primarily due to an increase in advertising and marketing expenses, partly offset by the increase in gross profit noted above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin for the International OTC Healthcare segment decreased $0.1 million, or 0.6%, during the three months ended December 31, 2020 versus the three months ended December 31, 2019.  As a percentage of International OTC </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare revenues, contribution margin decreased to 42.4% during the three months ended December 31, 2020 from 45.0% during the three months ended December 31, 2019.  The contribution margin decrease as a percentage of revenues was due to a decrease in gross profit noted above as well as incremental advertising and marketing expense.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative expenses of $21.4 million for the three months ended December 31, 2020 were relatively flat versus $21.3 million for the three months ended December 31, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $6.0 million for the three months ended December 31, 2020 and $6.2 million for the three months ended December 31, 2019. The decrease in depreciation and amortization was primarily due to certain assets being fully depreciated in the first quarter of fiscal 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $20.1 million during the three months ended December 31, 2020, versus $24.3 million during the three months ended December 31, 2019.  The average indebtedness decreased to $1.6 billion during the three months ended December 31, 2020 from $1.8 billion during the three months ended December 31, 2019.  The average cost of borrowing decreased to 5.1% for the three months ended December 31, 2020 from 5.4% for the three months ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2019, we recorded a loss on extinguishment of debt of $2.2 million to write off the debt costs related to our 5.375% 2013 Senior Notes, which we redeemed in December 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision for income taxes during the three months ended December 31, 2020 was $12.8 million versus $12.5 million during the three months ended December 31, 2019.&#160;&#160;The effective tax rate during the three months ended December 31, 2020 was 23.9% versus 24.7% during the three months ended December 31, 2019.  The decrease in the effective tax rate for the three months ended December 31, 2020 was based on our estimated annual effective income tax rate which fluctuates based on the mix of earnings from our U.S. and foreign jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended December 31, 2020 compared to the Nine Months Ended December 31, 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Segment Revenues</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents total revenue by segment, including product groups, for the nine months ended December&#160;31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total North American OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,554&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">International OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,590)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,171)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Total segment revenues for the nine months ended December 31, 2020 were $705.6 million, a decrease of $6.2 million, or 0.9%, versus the nine months ended December 31, 2019.  The $6.2 million decrease was primarily related to our International OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues for the North American OTC Healthcare segment decreased $1.7 million, or 0.3%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019.  The nine months ended December 31, 2020 were negatively impacted by lower Cough &amp; Cold and Gastrointestinal revenues, partly offset by positively impacted Women&#8217;s Health and Oral Care categories. The Cough &amp; Cold and Gastrointestinal categories faced declines in incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the International OTC Healthcare segment decreased $4.5 million, or 6.2%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019. The $4.5 million decrease was primarily attributable to decreased sales in our Australian subsidiary, primarily related to both lower general consumer illnesses and activities such as athletics resulting from the various social distancing measures brought on by COVID-19. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the nine months ended December 31, 2020 increased $2.1 million, or 0.5%, when compared with the nine months ended December 31, 2019.&#160;&#160;The increase in gross profit was due to the increase in the North American OTC Healthcare segment.  As a percentage of total revenues, gross profit increased to 58.2% during the nine months ended December 31, 2020, from 57.4% during the nine months ended December 31, 2019.  The increase in gross profit as a percentage of revenues was primarily a result of the fourth quarter 2020 completion of transitional costs associated with a new warehouse and distribution center and improved logistics costs resulting from our warehouse transition.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the North American OTC Healthcare segment increased $6.2 million, or 1.7%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019.  As a percentage of North American OTC Healthcare revenues, gross profit increased to 58.0% during the nine months ended December 31, 2020 from 56.9% during the nine months ended December 31, 2019, primarily due to the fourth quarter completion of transitional costs associated with a new warehouse and distribution center and improved logistics costs resulting from our warehouse transition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the International OTC Healthcare segment decreased $4.1 million, or 9.2%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019.  As a percentage of International OTC Healthcare revenues, gross profit decreased to 59.5% during the nine months ended December 31, 2020 from 61.5% during the nine months ended December 31, 2019, primarily due to product mix.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contribution Margin</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin is our segment measure of profitability.  It is defined as gross profit less advertising and marketing expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our contribution margin and contribution margin as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contribution Margin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contribution margin for the North American OTC Healthcare segment increased $9.3 million, or 3.4%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019.  As a percentage of North American OTC Healthcare revenues, contribution margin increased to 43.7% during the nine months ended December 31, 2020 from 42.1% during the nine months ended December 31, 2019.  The contribution margin increase as a percentage of revenues was primarily due to the increase in gross profit noted above as well as a decrease in the first quarter of 2021 in advertising and marketing reflecting spend efficiencies and reductions across brands/categories driven by consumer behavior.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin for the International OTC Healthcare segment decreased $4.3 million, or 13.5%, during the nine months ended December 31, 2020 versus the nine months ended December 31, 2019.  As a percentage of International OTC Healthcare revenues, contribution margin decreased to 40.9% during the nine months ended December 31, 2020 from 44.4% during the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended December 31, 2019.  The contribution margin decrease as a percentage of revenues was primarily due to the decrease in gross profit noted above.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative expenses decreased $3.8 million, or 5.8%, during the nine months ended December 31, 2020 versus  the nine months ended December 31, 2019.  The decrease in general and administrative expenses was primarily due to decreases in compensation costs resulting from attrition as well as reduced travel costs relating to COVID-19.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $18.1 million for the nine months ended December 31, 2020 and $18.5 million for the nine months ended December 31, 2019. The decrease in depreciation and amortization expenses was primarily due to certain assets being fully depreciated in the first quarter of fiscal 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $63.3 million during the nine months ended December 31, 2020, versus $73.8 million during the nine months ended December 31, 2019.  The average indebtedness decreased to $1.6 billion during the nine months ended December 31, 2020 from $1.8 billion during the nine months ended December 31, 2019.  The average cost of borrowing decreased to 5.1% for the nine months ended December 31, 2020 from 5.4% for the nine months ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2019, we recorded a loss on extinguishment of debt of $2.2 million to write off the debt costs related to our 5.375% 2013 Senior Notes, which we redeemed in December 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes during the nine months ended December 31, 2020 was $34.6 million versus $35.4 million during the nine months ended December 31, 2019.&#160;&#160;The effective tax rate during the nine months ended December 31, 2020 was 21.1% versus 25.2% during the nine months ended December 31, 2019.  The decrease in the effective tax rate for the nine months ended December 31, 2020 was primarily due to the application of final tax regulations issued for GILTI, and the discrete event pertaining to the release of the valuation allowance on prior year foreign tax credits.</span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_100"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of cash comes from our cash flow from operations.  In the past, we have supplemented this source of cash with various debt facilities, primarily in connection with acquisitions.  We have financed our operations, and expect to continue to finance our operations over the next twelve months, with a combination of funds generated from operations and borrowings.&#160; Our principal uses of cash are for operating expenses, debt service, share repurchases, capital expenditures, and acquisitions.  Based on our current levels of operations and anticipated growth, excluding acquisitions, we believe that our cash generated from operations and our existing credit facilities will be adequate to finance our working capital and capital expenditures through the next twelve months.  See "Coronavirus Outbreak" above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had cash and cash equivalents of $62.1 million, a decrease of $32.7 million from March&#160;31, 2020.  The following table summarizes the change: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,042)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,657)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,718)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $176.5 million for the nine months ended December&#160;31, 2020, compared to $161.0 million for the nine months ended December&#160;31, 2019.  The $15.5 million increase was due to an increase in net income after non-cash items partly offset by increased working capital.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-32-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $17.3 million for the nine months ended December&#160;31, 2020, compared to $8.3 million for the nine months ended December&#160;31, 2019.  The increase was due to an increase in capital expenditures in the current period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $195.7 million for the nine months ended December&#160;31, 2020, compared to $152.0 million for the nine months ended December&#160;31, 2019.&#160;&#160;The increase was primarily due to increased repayments of debt of $59.0 million and decreased borrowings of $30.0 million in the nine months ended December&#160;31, 2020, partly offset by a decrease in our repurchase of common stock of $40.1 million compared to the prior period as well as a payment of debt costs of $5.8 million in the nine months ended December 31, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had an aggregate of $1.6 billion of outstanding indebtedness, which consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$400.0 million of 5.125% 2019 Senior Notes, which mature on January 15, 2028;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$600.0 million of 6.375% 2016 Senior Notes, which mature on March 1, 2024; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$560.0 million of borrowings under the 2012 Term B-5 Loans due January 26, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had no balance outstanding on 2012 ABL Revolver and a borrowing capacity of $123.3 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2020 and 2019, under the 2012 Term Loan, we made voluntary principal payments against outstanding indebtedness of $48.0 million and $200.0 million, respectively.  During the nine months ended December 31, 2020, we made voluntary principal payments against outstanding indebtedness of $130.0 million under the 2012 Term Loan.  Under the Term Loan Amendment No. 5, we are required to make quarterly payments each equal to 0.25% of the aggregate principal amount, which, as of December&#160;31, 2020, was $560.0 million.  Since we have made optional payments this year and in prior years that exceed a significant portion of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity on January 26, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:40.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ending March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt facilities contain various financial covenants, including provisions that require us to maintain certain leverage, interest coverage and fixed charge ratios.&#160; The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2016 Senior Notes and 2019 Senior Notes contain provisions that accelerate our indebtedness on certain changes in control and restrict us from undertaking specified corporate actions, including asset dispositions, acquisitions, payments of dividends and other specified payments, repurchasing our equity securities in the public markets, incurrence of indebtedness, creation of liens, making loans and investments and transactions with affiliates. Specifically, we must:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a leverage ratio of less than 6.50 to 1.0 for the quarter ended December&#160;31, 2020 and thereafter (defined as, with certain adjustments, the ratio of our consolidated total net debt as of the last day of the fiscal quarter to our trailing twelve month consolidated net income before interest, taxes, depreciation, amortization, non-cash charges and certain other items (&#8220;EBITDA&#8221;));</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have an interest coverage ratio of greater than 2.25 to 1.0 for the quarter ended December&#160;31, 2020 and thereafter (defined as, with certain adjustments, the ratio of our consolidated EBITDA to our trailing twelve month consolidated cash interest expense); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a fixed charge ratio of greater than 1.0 to 1.0 for the quarter ended December&#160;31, 2020 (defined as, with certain adjustments, the ratio of our consolidated EBITDA minus capital expenditures to our trailing twelve month consolidated interest paid, taxes paid and other specified payments).  Our fixed charge requirement remains level throughout the term of the debt facilities.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we were in compliance with the applicable financial and restrictive covenants under the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2016 Senior Notes and the 2019 Senior Notes.  Additionally, management anticipates that in the normal course of operations, we will be in compliance with the financial and restrictive covenants during the next twelve months. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have had two interest rate swaps to hedge a total of $400.0&#160;million of our variable interest debt.  Of these, $200.0 million matured on January 31, 2021 and $200.0 million matures on January 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off-balance sheet arrangements or financing activities with special-purpose entities.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160; Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160; A summary of our critical accounting policies is presented in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.&#160; There were no material changes to our critical accounting policies during the nine months ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued and recently adopted accounting pronouncements is included in the notes to the unaudited Condensed Consolidated Financial Statements in Part I, Item I, Note 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-34-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;), including, without limitation, information within Management's Discussion and Analysis of Financial Condition and Results of Operations.&#160;&#160;The following cautionary statements are being made pursuant to the provisions of the PSLRA and with the intention of obtaining the benefits of the &#8220;safe harbor&#8221; provisions of the PSLRA.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q.&#160;&#160;Except as required under federal securities laws and the rules and regulations of the SEC, we do not intend to update any forward-looking statements to reflect events or circumstances arising after the date of this Quarterly Report on Form 10-Q, whether as a result of new information, future events or otherwise.&#160;&#160;As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on forward-looking statements included in this Quarterly Report on Form 10-Q or that may be made elsewhere from time to time by, or on behalf of, us.&#160;&#160;All forward-looking statements attributable to us are expressly qualified by these cautionary statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements generally can be identified by the use of words or phrases such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; "intend," "strategy," "goal," "future," "seek," "may," "should," "would," "will,"  or other similar words and phrases.&#160;&#160;Forward-looking statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic or other disease outbreaks on global economic conditions, consumer demand, retailer product availability, and business operations including manufacturing, supply chain and distribution;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The high level of competition in our industry and markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to increase organic growth via new product introductions, line extensions, increased spending on advertising and marketing support, and other new sales and marketing strategies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of customers for a large portion of our sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to successfully identify, negotiate, complete and integrate suitable acquisition candidates and to obtain necessary financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to invest successfully in research and development to develop new products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in inventory management practices by retailers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to grow our international sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General economic conditions and incidence levels affecting sales of our products and their respective markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Economic factors, such as increases in interest rates and currency exchange rate fluctuations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing consumer trends, additional store brand or branded competition or other pricing pressures which may cause us to lower our prices;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third party manufacturers to produce many of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third party logistics providers to distribute our products to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price increases for raw materials, labor, energy and transportation costs, and for other input costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our distribution center or manufacturing facility;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Shortages of supply of sourced goods;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions, dispositions or other strategic transactions diverting managerial resources, the incurrence of additional liabilities or problems associated with integration of those businesses and facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actions of government agencies in connection with our products, advertising or regulatory matters governing our industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims, product recalls and related negative publicity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third parties for intellectual property relating to some of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our internal information technology systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third party information technology service providers and their ability to protect against security threats and disruptions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our assets being comprised virtually entirely of goodwill and intangibles and possible changes in their value based on adverse operating results and/or changes in the discount rate used to value our brands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The costs associated with any claims in litigation or arbitration and any adverse judgments rendered in such litigation or arbitration;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our level of indebtedness and possible inability to service our debt;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to obtain additional financing; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The restrictions imposed by our financing agreements on our operations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in federal, state and other geographic tax laws.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-35-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Part I, Item 1A., "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-36-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in interest rates because our 2012 Term Loan and 2012 ABL Revolver are variable rate debt.  To manage this risk, we use interest rate swaps to hedge a total o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $400.0 million of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> this variable rate debt.&#160;&#160;At December&#160;31, 2020, approximately $160.0 million of our debt carries a variable rate of interest.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holding other variables constant, including levels of indebtedness, a 1.0% increase in interest rates on our variable rate debt would have an adverse impact on pre-tax earnings and cash flows for the three and nine months ended December 31, 2020 of approximately $0.4 million and $1.8 million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2020, approximately 13.9% and 11.7%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  During the three and nine months ended December 31, 2019, approximately 12.7% and 11.6%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.   As such, we are exposed to transactions that are sensitive to foreign currency exchange rates.  These transactions are primarily with respect to the Canadian and Australian Dollars.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis with respect to exchange rates for the three and nine months ended December 31, 2020 and 2019.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a less than 5.0% impact on pre-tax income of approximately $1.2 million for the three months ended December 31, 2020 and approximately $3.2 million for the nine months ended December 31, 2020.  It represented a less than 5% impact on pre-tax income of approximately $1.4 million for the three months ended December 31, 2019 and approximately $4.0 million for the nine months ended December 31, 2019.  </span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_112"></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures, as defined in Rule 13a&#8211;15(e) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), as of December&#160;31, 2020.&#160;&#160;Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of December&#160;31, 2020, the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting that occurred during the quarter ended December&#160;31, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-37-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the risk factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended March&#160;31, 2020, which could materially affect our business, financial condition or future results of operations.  The risk factors described in our Annual Report on Form 10-K have not materially changed in the period covered by this Quarterly Report on Form 10-Q, but such risks are not the only risks facing us.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly operating results and revenues may fluctuate as a result of any of these or other factors.  Accordingly, results for any one quarter are not necessarily indicative of results to be expected for any other quarter or for any year, and revenues for any particular future period may decrease.&#160;&#160;In the future, operating results may fall below the expectations of securities analysts and investors.&#160;&#160;In that event, the market price of our outstanding securities could be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i877786c68c0b4e62bc2be287a69c3d84_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 to October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,265,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1 to November 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,769,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1 to December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,380,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These repurchases were made pursuant to our share repurchase program, which was announced on March 2, 2020 and permits the repurchase of up to $25.0 million of our common stock through March 2021.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-38-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.017%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000104746905002633/a2149526zex-3_1.txt">Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare Inc. (filed as Exhibit 3.1 to the Company's Form S-1/A filed with the SEC on February 8, 2005).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594718000018/exhibit31certofamendment.htm">Amendment to Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare Inc. (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 2, 2018).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594719000007/exhibit32redlinepbhbylaw.htm">Amended and Restated Bylaws of Prestige Consumer Healthcare Inc., as amended, effective October 29, 2018 (filed as Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q filed with the SEC on February 7, 2019).</a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3112020-12x31.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3122020-12x31.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3212020-12x31.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3222020-12x31.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated herein by reference.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-39-</span></div></div></div><div id="i877786c68c0b4e62bc2be287a69c3d84_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESTIGE CONSUMER HEALTHCARE INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/&#160;Christine Sacco</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</span></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Duly Authorized Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-40-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit3112020-12x31.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i082aaa9711284dfd88b06c633ca64222_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of Prestige Consumer Healthcare Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47; Ronald M. Lombardi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald M. Lombardi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit3122020-12x31.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0aa6da8c9c1a4b6da03096dc0c18833c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of Prestige Consumer Healthcare Inc.&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47;&#160;Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit3212020-12x31.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iead63e02968d46d78426a380a527856a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Prestige Consumer Healthcare Inc. on Form 10-Q for the quarter ended December&#160;31, 2020, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc. </font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#47;s&#47; Ronald M. Lombardi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Ronald M. Lombardi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February&#160;4, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit3222020-12x31.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i52b2de88acbb4ed68b22607b8207664c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Prestige Consumer Healthcare Inc. on Form 10-Q for the quarter ended December&#160;31, 2020, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc.</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:54.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#47;s&#47; Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February&#160;4, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>pbh-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pbh="http://www.prestigebrandsinc.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.prestigebrandsinc.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.prestigebrandsinc.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>1406401 - Statement - Condensed Consolidated Statements of Cash Flows - Parenthetical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentation" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationPolicies" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Business and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.prestigebrandsinc.com/role/Inventories">
        <link:definition>2103102 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables">
        <link:definition>2304301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails">
        <link:definition>2405402 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.prestigebrandsinc.com/role/Goodwill">
        <link:definition>2106103 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables">
        <link:definition>2307302 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillDetails" roleURI="http://www.prestigebrandsinc.com/role/GoodwillDetails">
        <link:definition>2408403 - Disclosure - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnet" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet">
        <link:definition>2109104 - Disclosure - Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetTables" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables">
        <link:definition>2310303 - Disclosure - Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails">
        <link:definition>2411404 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails">
        <link:definition>2412405 - Disclosure - Intangible Assets, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails">
        <link:definition>2413406 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.prestigebrandsinc.com/role/Leases">
        <link:definition>2114105 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.prestigebrandsinc.com/role/LeasesTables">
        <link:definition>2315304 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails">
        <link:definition>2416407 - Disclosure - Leases (Lease Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails">
        <link:definition>2417408 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>2417408 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_2" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2">
        <link:definition>2417408 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails">
        <link:definition>2418409 - Disclosure - Leases (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails">
        <link:definition>2419410 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilities" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities">
        <link:definition>2120106 - Disclosure - Other Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesTables" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables">
        <link:definition>2321305 - Disclosure - Other Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails">
        <link:definition>2422411 - Disclosure - Other Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt">
        <link:definition>2123107 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables">
        <link:definition>2324306 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails">
        <link:definition>2425412 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2426413 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtMaturitiesofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails">
        <link:definition>2427414 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements">
        <link:definition>2128108 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables">
        <link:definition>2329307 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails">
        <link:definition>2430415 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments">
        <link:definition>2131109 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables">
        <link:definition>2332308 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails">
        <link:definition>2433416 - Disclosure - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails">
        <link:definition>2434417 - Disclosure - Derivative Instruments - Summary of Fair Values of Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsSummaryofInterestRateSwapsDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails">
        <link:definition>2435418 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity">
        <link:definition>2136110 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables">
        <link:definition>2337309 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails">
        <link:definition>2438419 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofRepurchasedSharesDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails">
        <link:definition>2439420 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2140111 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2341310 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossDetails" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails">
        <link:definition>2442421 - Disclosure - Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare">
        <link:definition>2143112 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables">
        <link:definition>2344311 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails">
        <link:definition>2445422 - Disclosure - Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAntidilutiveSecuritiesDetails" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails">
        <link:definition>2446423 - Disclosure - Earnings Per Share (Antidilutive Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation">
        <link:definition>2147113 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables">
        <link:definition>2348312 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2449424 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockBasedCompensationInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails">
        <link:definition>2450425 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockUnitsActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails">
        <link:definition>2451426 - Disclosure - Share-Based Compensation (Restricted Stock Units Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionValuationAssumptionsDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails">
        <link:definition>2452427 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>2453428 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes">
        <link:definition>2154114 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails">
        <link:definition>2455429 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlans" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans">
        <link:definition>2156115 - Disclosure - Employee Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansTables" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables">
        <link:definition>2357313 - Disclosure - Employee Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails">
        <link:definition>2458430 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails">
        <link:definition>2459431 - Disclosure - Employee Retirement Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies">
        <link:definition>2160116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRisk" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk">
        <link:definition>2161117 - Disclosure - Concentrations of Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRiskDetails" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails">
        <link:definition>2462432 - Disclosure - Concentrations of Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegments" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments">
        <link:definition>2163118 - Disclosure - Business Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsTables" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables">
        <link:definition>2364314 - Disclosure - Business Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
        <link:definition>2465433 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsRevenueDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails">
        <link:definition>2466434 - Disclosure - Business Segments (Revenue) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsRevenuebyGeographicAreaDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails">
        <link:definition>2467435 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsGoodwillandIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails">
        <link:definition>2468436 - Disclosure - Business Segments (Goodwill and Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pbh_VotingRightsNumberOfVotesPerCommonShareOwned" abstract="false" name="VotingRightsNumberOfVotesPerCommonShareOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="pbh_AccruedProductionCostsCurrent" abstract="false" name="AccruedProductionCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_AccruedAndOtherLiabilitiesCurrent" abstract="false" name="AccruedAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_TotalOtherIncomeExpense" abstract="false" name="TotalOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_GastrointestinalMember" abstract="true" name="GastrointestinalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_DermatologicalsMember" abstract="true" name="DermatologicalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_IntangibleAssetsRollForward" abstract="true" name="IntangibleAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_LongTermIncentivePlan2020Member" abstract="true" name="LongTermIncentivePlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" abstract="true" name="FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_InternationalOTCHealthcareMember" abstract="true" name="InternationalOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="pbh_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" abstract="false" name="GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceNewShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_LongtermEquityIncentivePlan2005Member" abstract="true" name="LongtermEquityIncentivePlan2005Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_IntangibleAssetsGrossAbstract" abstract="true" name="IntangibleAssetsGrossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_TopFiveBrandsMember" abstract="true" name="TopFiveBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_EyeAndEarCareMember" abstract="true" name="EyeAndEarCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CostOfSalesExclusiveOfDepreciation" abstract="false" name="CostOfSalesExclusiveOfDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OtherOtcMember" abstract="true" name="OtherOtcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_WalmartMember" abstract="true" name="WalmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" abstract="true" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_LoansPayableTermB4Member" abstract="true" name="LoansPayableTermB4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturers" abstract="false" name="NumberOfThirdPartyManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" abstract="false" name="NumberOfThirdPartyManufacturersWithLongTermContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="pbh_EscrowReceipt" abstract="false" name="EscrowReceipt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IndefinitelivedTradenamesMember" abstract="true" name="IndefinitelivedTradenamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_AblRevolver2012Member" abstract="true" name="AblRevolver2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" abstract="true" name="FiniteLivedTradenamesandCustomerRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_NorthAmericanOTCHealthcareMember" abstract="true" name="NorthAmericanOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_AnalgesicsMember" abstract="true" name="AnalgesicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_SeniorNotes2012Member" abstract="true" name="SeniorNotes2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_CoughAndColdMember" abstract="true" name="CoughAndColdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" abstract="false" name="AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="pbh_GEODISLogisticsLLCMember" abstract="true" name="GEODISLogisticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsLineItems" abstract="true" name="ScheduleOfIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_DebtInstrumentVariableRateMinimum" abstract="false" name="DebtInstrumentVariableRateMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WeightedAverageDiscountRateAbstract" abstract="true" name="WeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_AdditionsToOperatingLeaseRightOfUseAssets" abstract="false" name="AdditionsToOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsRSUsStockOptionsMember" abstract="true" name="RestrictedStockUnitsRSUsStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" abstract="false" name="RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_SeniorNotes2016Member" abstract="true" name="SeniorNotes2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" abstract="true" name="OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_A2019SeniorNotesMember" abstract="true" name="A2019SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_LoansPayableTermB5Member" abstract="true" name="LoansPayableTermB5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" abstract="false" name="IntangibleAssetsTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="pbh_IncreaseDecreaseInOperatingLeasesLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeasesLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>pbh-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="simple" xlink:href="pbh-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7ca3b51b-9720-40f7-84a0-4432af05ecad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_6cc9a227-1e60-4204-8bca-0c7f472e72fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7ca3b51b-9720-40f7-84a0-4432af05ecad" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_6cc9a227-1e60-4204-8bca-0c7f472e72fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_336ce1fc-666e-4361-a700-2fe7a83f6feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7ca3b51b-9720-40f7-84a0-4432af05ecad" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_336ce1fc-666e-4361-a700-2fe7a83f6feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_78c0a677-feeb-4458-9c1a-ec59ac32aa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7ca3b51b-9720-40f7-84a0-4432af05ecad" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_78c0a677-feeb-4458-9c1a-ec59ac32aa07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e85d8b66-3e3f-4dc3-ae85-c7be822db6fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3e4c0f36-4994-4e34-bc90-6ea873d7e5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e85d8b66-3e3f-4dc3-ae85-c7be822db6fc" xlink:to="loc_us-gaap_NetIncomeLoss_3e4c0f36-4994-4e34-bc90-6ea873d7e5e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a480c28b-db60-4368-9735-47e8baec997f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e85d8b66-3e3f-4dc3-ae85-c7be822db6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a480c28b-db60-4368-9735-47e8baec997f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ae853f71-f290-49df-b701-040aa934c666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_701ad9d8-7859-44c9-aeb8-8deb67d7d458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ae853f71-f290-49df-b701-040aa934c666" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_701ad9d8-7859-44c9-aeb8-8deb67d7d458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_9d3f1bef-44c7-4410-86d8-576d82174f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ae853f71-f290-49df-b701-040aa934c666" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_9d3f1bef-44c7-4410-86d8-576d82174f77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_8e4aca4b-6c18-4382-93d6-975cf8aea3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_bf1c3830-316a-4282-934c-9d59626c4643" xlink:href="pbh-20201231.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_8e4aca4b-6c18-4382-93d6-975cf8aea3b0" xlink:to="loc_pbh_TotalOtherIncomeExpense_bf1c3830-316a-4282-934c-9d59626c4643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ef9a41ed-00fd-4c9e-8c26-71d67bc2bfa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_8e4aca4b-6c18-4382-93d6-975cf8aea3b0" xlink:to="loc_us-gaap_OperatingIncomeLoss_ef9a41ed-00fd-4c9e-8c26-71d67bc2bfa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e781959c-2ffc-4c23-acfc-1567a1de98a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7203bdb0-ad95-4941-82da-8fecb1f757f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e781959c-2ffc-4c23-acfc-1567a1de98a2" xlink:to="loc_us-gaap_GrossProfit_7203bdb0-ad95-4941-82da-8fecb1f757f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_786361fc-8e49-4717-a934-788cbae537d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e781959c-2ffc-4c23-acfc-1567a1de98a2" xlink:to="loc_us-gaap_OperatingExpenses_786361fc-8e49-4717-a934-788cbae537d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_344dff65-4808-4bdd-8d9f-00ae0b51ed88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0eddb920-8adb-49e8-a906-b72cd756f028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_344dff65-4808-4bdd-8d9f-00ae0b51ed88" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0eddb920-8adb-49e8-a906-b72cd756f028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8f6fd04f-96f0-416c-a7c8-b8ebf40a6d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_344dff65-4808-4bdd-8d9f-00ae0b51ed88" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8f6fd04f-96f0-416c-a7c8-b8ebf40a6d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c471f846-3659-423b-bb19-ef9664172889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_344dff65-4808-4bdd-8d9f-00ae0b51ed88" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c471f846-3659-423b-bb19-ef9664172889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_91bb19f4-ad6f-4ab8-8b70-81194267a3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_344dff65-4808-4bdd-8d9f-00ae0b51ed88" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_91bb19f4-ad6f-4ab8-8b70-81194267a3c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_c311fb41-1fb1-4e6d-88a1-a99ccf0a8918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_23605d80-91e8-4149-938f-8d863c5e4b61" xlink:href="pbh-20201231.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_c311fb41-1fb1-4e6d-88a1-a99ccf0a8918" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_23605d80-91e8-4149-938f-8d863c5e4b61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9804486f-3bb2-4503-b0d2-b904d0cb6790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_c311fb41-1fb1-4e6d-88a1-a99ccf0a8918" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9804486f-3bb2-4503-b0d2-b904d0cb6790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_452152c7-378d-4dbd-a258-35c63e37b3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a6c395a-b860-4ba7-bec3-6db45511883b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_452152c7-378d-4dbd-a258-35c63e37b3e0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a6c395a-b860-4ba7-bec3-6db45511883b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ca019233-df75-431c-ba6b-11b4bed5f327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_452152c7-378d-4dbd-a258-35c63e37b3e0" xlink:to="loc_us-gaap_CostOfRevenue_ca019233-df75-431c-ba6b-11b4bed5f327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_c10871ed-5bb1-4c57-a53e-c2b0d6e93a33" xlink:href="pbh-20201231.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_94c7205c-fecb-4aa1-8455-85c72544eb7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_c10871ed-5bb1-4c57-a53e-c2b0d6e93a33" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_94c7205c-fecb-4aa1-8455-85c72544eb7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fbe83a39-e6a4-4b62-a5db-67498cd4cc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_c10871ed-5bb1-4c57-a53e-c2b0d6e93a33" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fbe83a39-e6a4-4b62-a5db-67498cd4cc07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_381a93ee-5c68-485f-849d-a1fd1e4e5963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_c10871ed-5bb1-4c57-a53e-c2b0d6e93a33" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_381a93ee-5c68-485f-849d-a1fd1e4e5963" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_230ff525-ee99-4a8c-812d-577b16715b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_PreferredStockValue_230ff525-ee99-4a8c-812d-577b16715b0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b4f20fa8-f92a-4747-b035-94decfc3c015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_CommonStockValue_b4f20fa8-f92a-4747-b035-94decfc3c015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_aa40b32d-d3c8-420a-8e37-8327591c4df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_AdditionalPaidInCapital_aa40b32d-d3c8-420a-8e37-8327591c4df5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_390716a2-560f-4f89-880d-d95b1f79fdc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_TreasuryStockValue_390716a2-560f-4f89-880d-d95b1f79fdc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f8253de-e267-455c-86f7-5ca84a6250f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f8253de-e267-455c-86f7-5ca84a6250f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7c61217a-328b-4733-aca0-28365e8a7600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6b3a1a4e-6992-40f7-b30d-ae25498e15ba" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7c61217a-328b-4733-aca0-28365e8a7600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ff9392ea-0b98-4c8b-9f8a-2b3805040980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:to="loc_us-gaap_AccountsPayableCurrent_ff9392ea-0b98-4c8b-9f8a-2b3805040980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_e2d52ebe-eecf-4465-96aa-c9e6b1210ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_e2d52ebe-eecf-4465-96aa-c9e6b1210ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bdf345d9-8eea-4c3e-ba28-4e92780e294f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bdf345d9-8eea-4c3e-ba28-4e92780e294f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_00464a89-c516-45dc-b44c-682164773864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_00464a89-c516-45dc-b44c-682164773864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_72be1c12-3c54-42e0-a53f-ca371630b9a0" xlink:href="pbh-20201231.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2d22eeac-e418-46e1-be86-02335dbd5b62" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_72be1c12-3c54-42e0-a53f-ca371630b9a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_77da1b36-c9ce-4f2b-81e4-7ef577cfaaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e2f5bdc-9d0e-48ed-a83c-b5b413509fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_77da1b36-c9ce-4f2b-81e4-7ef577cfaaea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e2f5bdc-9d0e-48ed-a83c-b5b413509fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_880fec85-f68e-4e20-9d62-ffae98338ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_77da1b36-c9ce-4f2b-81e4-7ef577cfaaea" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_880fec85-f68e-4e20-9d62-ffae98338ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ebb130e0-ce76-4339-9acc-c763a0caec3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_77da1b36-c9ce-4f2b-81e4-7ef577cfaaea" xlink:to="loc_us-gaap_InventoryNet_ebb130e0-ce76-4339-9acc-c763a0caec3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d72e7f71-9a9d-411e-8594-b121b1ac8d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_77da1b36-c9ce-4f2b-81e4-7ef577cfaaea" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d72e7f71-9a9d-411e-8594-b121b1ac8d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c513ed68-9a35-4b18-84e5-7b2c7af140bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_AssetsCurrent_c513ed68-9a35-4b18-84e5-7b2c7af140bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d12326c8-c103-41a0-9ac4-0f03769e1464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d12326c8-c103-41a0-9ac4-0f03769e1464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_52be7e5b-da27-4bb3-a0f0-06e51f8321f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_52be7e5b-da27-4bb3-a0f0-06e51f8321f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4363e0cd-c6a6-4fe7-bcea-d7da5fbfd212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4363e0cd-c6a6-4fe7-bcea-d7da5fbfd212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_45fe5eb9-4981-4979-8819-996965ff5a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_Goodwill_45fe5eb9-4981-4979-8819-996965ff5a58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c3846c7b-f3da-4ac6-a876-77771ec2eec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c3846c7b-f3da-4ac6-a876-77771ec2eec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_65357930-3769-436e-92fd-1434a884e8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3ad8c3ef-66e1-4bb6-ac0b-c022f25aac27" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_65357930-3769-436e-92fd-1434a884e8c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4eda20cb-e04e-477c-8d57-4a06726f678c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a4c674fc-fb27-43dc-8b59-94942a1d3303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4eda20cb-e04e-477c-8d57-4a06726f678c" xlink:to="loc_us-gaap_Liabilities_a4c674fc-fb27-43dc-8b59-94942a1d3303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_95694b6b-3e01-4fef-913f-2cac1307a52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4eda20cb-e04e-477c-8d57-4a06726f678c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_95694b6b-3e01-4fef-913f-2cac1307a52d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b987a92f-58d1-4b8f-89f4-a2c81b23c175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4eda20cb-e04e-477c-8d57-4a06726f678c" xlink:to="loc_us-gaap_StockholdersEquity_b987a92f-58d1-4b8f-89f4-a2c81b23c175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d1ebfdf3-5e56-4dee-b898-a77dcbb56054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_LiabilitiesCurrent_d1ebfdf3-5e56-4dee-b898-a77dcbb56054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5fb69d48-72d4-4b90-b089-f0024fef4729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5fb69d48-72d4-4b90-b089-f0024fef4729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5df13a71-ed42-476c-ae61-d99f0edd015c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5df13a71-ed42-476c-ae61-d99f0edd015c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a7e7d9cd-6490-4bc8-b3cc-40e7774da3c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a7e7d9cd-6490-4bc8-b3cc-40e7774da3c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_aa8aa7ab-241e-4bab-b676-f6192c5c7a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_aa8aa7ab-241e-4bab-b676-f6192c5c7a36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c8453a7c-13d5-4391-a8f1-791c9df250eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fcfc210b-4890-4dd5-8932-99fdc5f99015" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c8453a7c-13d5-4391-a8f1-791c9df250eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_99a33b80-c6ab-4143-be71-b902cf66167d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ee08c4ff-ca52-4e2a-a9c0-dc29642ebba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_99a33b80-c6ab-4143-be71-b902cf66167d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ee08c4ff-ca52-4e2a-a9c0-dc29642ebba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt_022345e1-8fc6-4180-8f64-cf4b7b9424de" xlink:href="pbh-20201231.xsd#pbh_EscrowReceipt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_99a33b80-c6ab-4143-be71-b902cf66167d" xlink:to="loc_pbh_EscrowReceipt_022345e1-8fc6-4180-8f64-cf4b7b9424de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d916b9fa-0ac2-4dff-96b0-abed660e9b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_NetIncomeLoss_d916b9fa-0ac2-4dff-96b0-abed660e9b2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_342b3873-5104-41d0-8d90-40786b6337ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_342b3873-5104-41d0-8d90-40786b6337ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c4b08a6d-b08f-4432-a962-c66968c7e25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c4b08a6d-b08f-4432-a962-c66968c7e25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82415745-9dd7-40d8-94b1-a7b95873914e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82415745-9dd7-40d8-94b1-a7b95873914e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fff14d3f-9595-4c92-8292-ed910768216b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fff14d3f-9595-4c92-8292-ed910768216b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae2adf13-5b6e-435c-ae26-23e04ef059e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_ShareBasedCompensation_ae2adf13-5b6e-435c-ae26-23e04ef059e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97548acf-ca8e-4202-bf9e-1cb5d66b810a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_97548acf-ca8e-4202-bf9e-1cb5d66b810a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_57b1457a-ba48-4dc9-bc9c-db3c1597dfc8" xlink:href="pbh-20201231.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_57b1457a-ba48-4dc9-bc9c-db3c1597dfc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_92e37d31-ef89-4aa5-bacd-298fb7bc18f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_OtherNoncashExpense_92e37d31-ef89-4aa5-bacd-298fb7bc18f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f86cbddd-fec8-4f80-b910-c44b919b0515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f86cbddd-fec8-4f80-b910-c44b919b0515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9c69ae74-b73c-4a7f-885a-4b16d3f951a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9c69ae74-b73c-4a7f-885a-4b16d3f951a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3a5d923b-fd13-4d12-8437-1b80788f91c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3a5d923b-fd13-4d12-8437-1b80788f91c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a1932bd4-69f6-4b3f-91da-9da3efc22c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a1932bd4-69f6-4b3f-91da-9da3efc22c2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e42d260b-6528-481f-a209-2af150172726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e42d260b-6528-481f-a209-2af150172726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_9f201d82-0c4a-4e31-bd4b-f2e3f1d7cdd1" xlink:href="pbh-20201231.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_9f201d82-0c4a-4e31-bd4b-f2e3f1d7cdd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1efcc07e-c59d-4c5e-b5f0-b822ef11eee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1856fea5-e78a-45ce-a18d-608995620281" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1efcc07e-c59d-4c5e-b5f0-b822ef11eee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a1d9f0b8-2054-4904-86a2-8eb34a01d4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a1d9f0b8-2054-4904-86a2-8eb34a01d4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_283ce525-eaa9-4bb4-a08a-92c78545a8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_283ce525-eaa9-4bb4-a08a-92c78545a8ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_ddab4205-9baf-48da-8434-efd803795d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_ddab4205-9baf-48da-8434-efd803795d66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_e5286eb8-e9e1-4816-91dc-2e91bc750cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_e5286eb8-e9e1-4816-91dc-2e91bc750cfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_c109eba4-d134-4735-9ebd-b7d6b9edc182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_c109eba4-d134-4735-9ebd-b7d6b9edc182" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f2c2238e-2fa3-4300-a2ee-9fa338cc5d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f2c2238e-2fa3-4300-a2ee-9fa338cc5d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_dae9191a-9ef1-4ee4-8466-98f167dae52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_dae9191a-9ef1-4ee4-8466-98f167dae52e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e6a1e264-32e8-4aaa-8c89-152596d59b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e6a1e264-32e8-4aaa-8c89-152596d59b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fb227d69-98d9-45d3-bafb-cf6b108f23d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fb227d69-98d9-45d3-bafb-cf6b108f23d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73e46f9d-bcfb-4e90-b808-4ceab8eda939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d85482e-2442-4daa-b3db-6a7b805426d8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73e46f9d-bcfb-4e90-b808-4ceab8eda939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1877cf8-3764-4827-900f-20ac287a99c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_45d88f1b-53d7-4160-bf5c-10be4268f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1877cf8-3764-4827-900f-20ac287a99c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_45d88f1b-53d7-4160-bf5c-10be4268f8a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a2929346-00dc-4a2e-a102-625a7b59a223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1877cf8-3764-4827-900f-20ac287a99c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a2929346-00dc-4a2e-a102-625a7b59a223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22588867-180a-4e6a-9ef2-450ff1d61f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1877cf8-3764-4827-900f-20ac287a99c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22588867-180a-4e6a-9ef2-450ff1d61f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_402a5010-cc63-4289-a137-abeaac0b6f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a1877cf8-3764-4827-900f-20ac287a99c6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_402a5010-cc63-4289-a137-abeaac0b6f73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="simple" xlink:href="pbh-20201231.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8746ac5b-7a6c-4a8e-88bf-52584ed6ac43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_da68c515-e260-4260-82bf-f0b2e5bd5368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8746ac5b-7a6c-4a8e-88bf-52584ed6ac43" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_da68c515-e260-4260-82bf-f0b2e5bd5368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_74088bde-4d80-4db5-acf1-974fbfcf7356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8746ac5b-7a6c-4a8e-88bf-52584ed6ac43" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_74088bde-4d80-4db5-acf1-974fbfcf7356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_372fa992-8068-4a12-a037-523dfcbf4bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8746ac5b-7a6c-4a8e-88bf-52584ed6ac43" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_372fa992-8068-4a12-a037-523dfcbf4bb1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="simple" xlink:href="pbh-20201231.xsd#Goodwill"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnet"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_18d3e7df-04de-48cf-9c70-9bf9de2d570a" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_73927a18-76b8-4993-8cae-61282fff0207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_18d3e7df-04de-48cf-9c70-9bf9de2d570a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_73927a18-76b8-4993-8cae-61282fff0207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_8dc2adba-62f9-454b-af12-935db7667855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_18d3e7df-04de-48cf-9c70-9bf9de2d570a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_8dc2adba-62f9-454b-af12-935db7667855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2ef8be62-f11f-495f-a103-0007542b39e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d6524fe0-2dbe-4956-9695-75d493e75c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2ef8be62-f11f-495f-a103-0007542b39e1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_d6524fe0-2dbe-4956-9695-75d493e75c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4699a065-9fd4-47f5-a282-41c82f915a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7988f2e8-3139-4ae2-9704-d1400d1bc69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4699a065-9fd4-47f5-a282-41c82f915a2a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7988f2e8-3139-4ae2-9704-d1400d1bc69c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_645aa958-8cc6-4cbf-b2d7-6f7223b7fd38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4699a065-9fd4-47f5-a282-41c82f915a2a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_645aa958-8cc6-4cbf-b2d7-6f7223b7fd38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9471a2ac-1f1d-4f5c-80f9-f208c7dca114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f013ae1-cf01-4292-91bf-007daa0ed0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9471a2ac-1f1d-4f5c-80f9-f208c7dca114" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f013ae1-cf01-4292-91bf-007daa0ed0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c9cc09de-c92d-4b9b-b1b1-688b82c42ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9471a2ac-1f1d-4f5c-80f9-f208c7dca114" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c9cc09de-c92d-4b9b-b1b1-688b82c42ae4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6284ee3f-1962-45dc-bddc-70f81f712571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6284ee3f-1962-45dc-bddc-70f81f712571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_28ce8b52-6c24-4ddf-8efd-e313f39b5bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_28ce8b52-6c24-4ddf-8efd-e313f39b5bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfa2b761-096c-4971-a65f-6ce8dd6d69db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cfa2b761-096c-4971-a65f-6ce8dd6d69db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f50aa5a7-224a-4436-9dfc-f996e59b5e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f50aa5a7-224a-4436-9dfc-f996e59b5e82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba716c0c-e74f-4e10-af62-e9fd7f4561d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba716c0c-e74f-4e10-af62-e9fd7f4561d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c84341a8-aaba-4488-8add-e459856f02f5" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f3962b6e-99f2-4aba-9c94-bbc6991e4156" xlink:to="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c84341a8-aaba-4488-8add-e459856f02f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Leases" xlink:type="simple" xlink:href="pbh-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c8deb9c1-d3ae-42b4-9063-f3dc81a8f13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c8deb9c1-d3ae-42b4-9063-f3dc81a8f13a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ebaffbb2-8277-4139-b377-56642733db84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ebaffbb2-8277-4139-b377-56642733db84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_b6c58b8f-e174-45e1-836d-1c836801b051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_OperatingLeaseCost_b6c58b8f-e174-45e1-836d-1c836801b051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_5404d978-bda5-4657-a00a-2c3ff1fb3e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_ShortTermLeaseCost_5404d978-bda5-4657-a00a-2c3ff1fb3e77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_65205358-c95f-42b3-bf93-69ade681abe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_VariableLeaseCost_65205358-c95f-42b3-bf93-69ade681abe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_9a3236eb-f7d7-4b75-8c78-bfcdfe189608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_37262fb4-22ae-49af-96e6-db062849661b" xlink:to="loc_us-gaap_SubleaseIncome_9a3236eb-f7d7-4b75-8c78-bfcdfe189608" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_355ce285-ca97-4a75-8f8a-68ebe6fa0a0a" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_0a3c6622-5f4d-424d-aa48-c554aba32a6f" xlink:href="pbh-20201231.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_355ce285-ca97-4a75-8f8a-68ebe6fa0a0a" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_0a3c6622-5f4d-424d-aa48-c554aba32a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_c252db69-e393-4a2d-b8fd-e4575be092f2" xlink:href="pbh-20201231.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_355ce285-ca97-4a75-8f8a-68ebe6fa0a0a" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_c252db69-e393-4a2d-b8fd-e4575be092f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_a49256d5-fd1a-4019-af0f-e9bb89623b96" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_adbbca0d-6649-4133-acdb-2d0fe15487fe" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_a49256d5-fd1a-4019-af0f-e9bb89623b96" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_adbbca0d-6649-4133-acdb-2d0fe15487fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_77810b2b-3866-4476-b7ac-6ae2835f5c8b" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_a49256d5-fd1a-4019-af0f-e9bb89623b96" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_77810b2b-3866-4476-b7ac-6ae2835f5c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b505c2e2-c650-4f54-b7a8-9e43b8a387c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8f143bf0-3a9f-4228-89db-8d92bc6c656f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b505c2e2-c650-4f54-b7a8-9e43b8a387c6" xlink:to="loc_us-gaap_FinanceLeaseLiability_8f143bf0-3a9f-4228-89db-8d92bc6c656f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ee9fec6-98f1-4ee1-811b-0896696cd0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b505c2e2-c650-4f54-b7a8-9e43b8a387c6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ee9fec6-98f1-4ee1-811b-0896696cd0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_7c9ed5c6-2760-4431-9b36-13632ebc91a5" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6075267f-dbd1-4306-a3e8-b93adf881d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_7c9ed5c6-2760-4431-9b36-13632ebc91a5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6075267f-dbd1-4306-a3e8-b93adf881d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6c05d108-4ff5-4e87-8f3c-7265a7be5c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_7c9ed5c6-2760-4431-9b36-13632ebc91a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6c05d108-4ff5-4e87-8f3c-7265a7be5c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_bdafc47f-de12-4d56-a9df-acb33dc59e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_bdafc47f-de12-4d56-a9df-acb33dc59e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d70b7e4c-1a20-498d-b356-0b864bf97bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d70b7e4c-1a20-498d-b356-0b864bf97bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e2b12975-9595-470e-a639-544d2260ba85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e2b12975-9595-470e-a639-544d2260ba85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_240acb56-2a15-4b96-be9f-61dc8ffc9f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_240acb56-2a15-4b96-be9f-61dc8ffc9f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d31e95fe-6e76-41e8-96b3-c0d807b2969b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d31e95fe-6e76-41e8-96b3-c0d807b2969b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2f841579-7f16-4329-a8cd-d9366361e6be" xlink:href="pbh-20201231.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d2d8ccd-4e97-4ce5-b28e-3af250751fdd" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2f841579-7f16-4329-a8cd-d9366361e6be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_17bef515-5d3a-4bc4-bf5a-016778a3c48b" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_82574cae-2c98-4e8b-84a9-62170d12a288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_17bef515-5d3a-4bc4-bf5a-016778a3c48b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_82574cae-2c98-4e8b-84a9-62170d12a288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_38385835-d8db-4ecb-9df2-cd64596dfb76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_17bef515-5d3a-4bc4-bf5a-016778a3c48b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_38385835-d8db-4ecb-9df2-cd64596dfb76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_0234fada-ee14-41ef-95dc-b2a1c73dfa5f" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3c6d10ac-ac82-415d-9d66-19b858944a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_0234fada-ee14-41ef-95dc-b2a1c73dfa5f" xlink:to="loc_us-gaap_FinanceLeaseLiability_3c6d10ac-ac82-415d-9d66-19b858944a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1853a2e1-6604-4484-a564-3c118429ef9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_0234fada-ee14-41ef-95dc-b2a1c73dfa5f" xlink:to="loc_us-gaap_OperatingLeaseLiability_1853a2e1-6604-4484-a564-3c118429ef9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_346839c4-2828-4ba1-96cf-1af0f8ddb7a5" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a2480771-3e35-421a-be17-63c2d9b8b28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_346839c4-2828-4ba1-96cf-1af0f8ddb7a5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a2480771-3e35-421a-be17-63c2d9b8b28d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_515bee09-513e-47ac-b77d-6f027fbc8cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_346839c4-2828-4ba1-96cf-1af0f8ddb7a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_515bee09-513e-47ac-b77d-6f027fbc8cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f716da37-1e9f-4ec6-a297-630fc5df4811" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c717434e-efc8-432e-86e8-f1960fdf17be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f716da37-1e9f-4ec6-a297-630fc5df4811" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c717434e-efc8-432e-86e8-f1960fdf17be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_26eda81d-eff5-4cb7-aaea-36d4c6e9d6a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f716da37-1e9f-4ec6-a297-630fc5df4811" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_26eda81d-eff5-4cb7-aaea-36d4c6e9d6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_08e88e4b-6096-4c3e-8cad-0a445877f427" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bd52bb36-9c7f-4003-bfba-285a1b680102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_08e88e4b-6096-4c3e-8cad-0a445877f427" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bd52bb36-9c7f-4003-bfba-285a1b680102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f8938944-62f1-4edc-821d-d576ee7bbd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_08e88e4b-6096-4c3e-8cad-0a445877f427" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f8938944-62f1-4edc-821d-d576ee7bbd4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_9147c64f-bef9-4aa5-8dcc-a00d9b1ff5f3" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_91ec3dcd-7d5f-4bb9-a212-6ba550a03190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_9147c64f-bef9-4aa5-8dcc-a00d9b1ff5f3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_91ec3dcd-7d5f-4bb9-a212-6ba550a03190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_baba6ca6-df0f-4704-a82a-55cb50e52d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_9147c64f-bef9-4aa5-8dcc-a00d9b1ff5f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_baba6ca6-df0f-4704-a82a-55cb50e52d3c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_3e86f685-d2df-4201-b798-5f0d0ee651ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_3e86f685-d2df-4201-b798-5f0d0ee651ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ac33cf6b-3768-49bd-9804-ce632e29fa80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ac33cf6b-3768-49bd-9804-ce632e29fa80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_af742293-a63c-45f1-b113-982ed7a85cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_af742293-a63c-45f1-b113-982ed7a85cb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_aaa950d2-71cd-4ca1-a366-e5c87c47e7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_aaa950d2-71cd-4ca1-a366-e5c87c47e7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_460dd3be-dbde-4b54-bbf7-795ea2b5ac8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_460dd3be-dbde-4b54-bbf7-795ea2b5ac8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_b5181bb5-92b8-4ecf-aac4-174c056c7d16" xlink:href="pbh-20201231.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0a4bd5a8-b173-4905-b4af-6d5f54c74128" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_b5181bb5-92b8-4ecf-aac4-174c056c7d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9ac20769-0774-4a49-8329-7a0f430befbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5d28a32e-6a75-4c22-a6ce-830239c750f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9ac20769-0774-4a49-8329-7a0f430befbf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5d28a32e-6a75-4c22-a6ce-830239c750f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8184179f-739d-4d44-9ef3-0b3dc8a567b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9ac20769-0774-4a49-8329-7a0f430befbf" xlink:to="loc_us-gaap_OperatingLeaseLiability_8184179f-739d-4d44-9ef3-0b3dc8a567b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_cb8eae32-3616-4ba2-a18a-3e58c4270cc1" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d2f83f0a-2568-4c31-a1c2-7fd855d4e30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_cb8eae32-3616-4ba2-a18a-3e58c4270cc1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d2f83f0a-2568-4c31-a1c2-7fd855d4e30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d8029af-e718-43e2-9bc8-fed243731131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_cb8eae32-3616-4ba2-a18a-3e58c4270cc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d8029af-e718-43e2-9bc8-fed243731131" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6ec4536d-1d16-40a1-ac5f-61bd20f93000" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6ec4536d-1d16-40a1-ac5f-61bd20f93000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_88c88dce-0f27-47d0-bde4-20510adb3908" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_88c88dce-0f27-47d0-bde4-20510adb3908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_1250be57-0d90-4d6f-b5e4-074340d8d84f" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_1250be57-0d90-4d6f-b5e4-074340d8d84f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_f8da5e2c-3072-4b8f-b56d-16341bfce287" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_f8da5e2c-3072-4b8f-b56d-16341bfce287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_c2f26f55-ddb6-420f-ac40-b5e07f16b0b8" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_c2f26f55-ddb6-420f-ac40-b5e07f16b0b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_9df788a4-8fdf-4b98-818d-e25b212b94a6" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_86357360-a651-4f82-a9d0-375ebe4166e0" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_9df788a4-8fdf-4b98-818d-e25b212b94a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilities"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:href="pbh-20201231.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_3c306bb2-a46a-48d5-b3f5-7252f7d11ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_3c306bb2-a46a-48d5-b3f5-7252f7d11ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9212762-875e-44f2-85ac-cadc0a6a27ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9212762-875e-44f2-85ac-cadc0a6a27ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_141a1d89-731e-4999-b6b7-97f9bc7e58da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_141a1d89-731e-4999-b6b7-97f9bc7e58da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_38a9e57d-5b96-456a-83e2-fcc1fcaa0b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_38a9e57d-5b96-456a-83e2-fcc1fcaa0b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_8f57019d-b57e-4c8e-8de5-a02ca02ac22e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_8f57019d-b57e-4c8e-8de5-a02ca02ac22e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_bd28a396-75ee-49ac-9402-ef2508161b53" xlink:href="pbh-20201231.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_pbh_AccruedProductionCostsCurrent_bd28a396-75ee-49ac-9402-ef2508161b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_db1e29b4-9a7c-48e8-ac35-1f53db3bad71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_db1e29b4-9a7c-48e8-ac35-1f53db3bad71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_15f644ed-be91-4403-8ec1-50f2684f3e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_98ea20e2-06e1-4573-965b-cadcd5d34ee6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_15f644ed-be91-4403-8ec1-50f2684f3e12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2eff9ad8-77a9-4e9d-a468-d5fcb52c29fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d2551d4b-426a-4137-82a9-143078fef6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2eff9ad8-77a9-4e9d-a468-d5fcb52c29fd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d2551d4b-426a-4137-82a9-143078fef6f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1dcdd489-f4ce-4bff-826c-190e9daca753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2eff9ad8-77a9-4e9d-a468-d5fcb52c29fd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1dcdd489-f4ce-4bff-826c-190e9daca753" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_75dc39c7-8be9-4441-bbeb-b0a592e640c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_75dc39c7-8be9-4441-bbeb-b0a592e640c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_12faa9ea-64fb-4356-b33d-4e264f88c286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_12faa9ea-64fb-4356-b33d-4e264f88c286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d6d92f0d-a7c7-4fce-987a-6283668a0cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d6d92f0d-a7c7-4fce-987a-6283668a0cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_31f15df7-9278-416f-b1f9-d961774f2ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_31f15df7-9278-416f-b1f9-d961774f2ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_280ac7b3-247c-4338-b78a-8a81f3cfc589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_280ac7b3-247c-4338-b78a-8a81f3cfc589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour_e855a44b-04ae-47bc-8f8b-d196cf628b2d" xlink:href="pbh-20201231.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c98493cd-4da7-4d90-a699-3f1b58fd651b" xlink:to="loc_pbh_LongTermDebtMaturityAfterYearFour_e855a44b-04ae-47bc-8f8b-d196cf628b2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstruments"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofInterestRateSwapsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityScheduleofRepurchasedSharesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2af6176c-ca8a-4628-88fe-2b283f3e4cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfc57b84-5163-483f-966d-8db52744d214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2af6176c-ca8a-4628-88fe-2b283f3e4cee" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfc57b84-5163-483f-966d-8db52744d214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_efca6238-54cd-452f-a117-fa8d41b9c882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2af6176c-ca8a-4628-88fe-2b283f3e4cee" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_efca6238-54cd-452f-a117-fa8d41b9c882" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlans"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb3dc304-f4b0-4bf1-9c51-2f69626764c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_50ee2ffd-598c-4c74-9262-11d1e100b2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb3dc304-f4b0-4bf1-9c51-2f69626764c3" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_50ee2ffd-598c-4c74-9262-11d1e100b2e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3a830a74-3cfe-48a6-8c03-cd52c612b534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bb3dc304-f4b0-4bf1-9c51-2f69626764c3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3a830a74-3cfe-48a6-8c03-cd52c612b534" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pbh-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRisk"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRiskDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegments"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsTables"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ad206f3-9824-4f2e-80a0-15723ed1903c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_db8bae1e-f12f-4c2a-ad7d-47cf2ef1acc2" xlink:href="pbh-20201231.xsd#pbh_ContributionMargin"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad206f3-9824-4f2e-80a0-15723ed1903c" xlink:to="loc_pbh_ContributionMargin_db8bae1e-f12f-4c2a-ad7d-47cf2ef1acc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_9695e15d-56c9-4a46-9eb1-f24d599f2906" xlink:href="pbh-20201231.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad206f3-9824-4f2e-80a0-15723ed1903c" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_9695e15d-56c9-4a46-9eb1-f24d599f2906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_2e7883ea-0c0d-4e7d-b738-cb46f1890dff" xlink:href="pbh-20201231.xsd#pbh_ContributionMargin"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2a87c18a-6438-4553-8070-f81aee68db3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_2e7883ea-0c0d-4e7d-b738-cb46f1890dff" xlink:to="loc_us-gaap_GrossProfit_2a87c18a-6438-4553-8070-f81aee68db3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_52491fa7-3128-4c4b-8a35-9bfbc5a9ae79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_2e7883ea-0c0d-4e7d-b738-cb46f1890dff" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_52491fa7-3128-4c4b-8a35-9bfbc5a9ae79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenuebyGeographicAreaDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsGoodwillandIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f44f5bce-3664-4487-a164-b83c4b3477fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_58e85a8d-0c1b-473a-99fd-74a07d75acd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f44f5bce-3664-4487-a164-b83c4b3477fb" xlink:to="loc_us-gaap_Goodwill_58e85a8d-0c1b-473a-99fd-74a07d75acd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd5e7449-4d33-48a6-808f-ed2095b76c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f44f5bce-3664-4487-a164-b83c4b3477fb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd5e7449-4d33-48a6-808f-ed2095b76c16" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>pbh-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="simple" xlink:href="pbh-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="extended" id="ib09b5a63a7144b20b0cba662d831d4dd_CoverPage"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended" id="ie92b189728934fa1b406315369dec8ab_CondensedConsolidatedStatementsofIncomeandComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d62b6d5-9cd0-426a-9cf2-33d2ecce2720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d62b6d5-9cd0-426a-9cf2-33d2ecce2720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_99f1b424-2e2a-470d-84fc-d6985f0f59f8" xlink:href="pbh-20201231.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_99f1b424-2e2a-470d-84fc-d6985f0f59f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0b65d0d2-ab28-40b4-974a-de4ff5652f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0b65d0d2-ab28-40b4-974a-de4ff5652f9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_6d0231dc-fafd-462f-a026-4d5c687b698b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_us-gaap_CostOfRevenue_6d0231dc-fafd-462f-a026-4d5c687b698b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_73dbee35-5276-498d-bfcc-cb731f212e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_GrossProfit_73dbee35-5276-498d-bfcc-cb731f212e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_32b161d5-dca6-4d20-9014-4cb28a137b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_32b161d5-dca6-4d20-9014-4cb28a137b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9bb6e525-3469-40fd-88d5-ccaa4d72d145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9bb6e525-3469-40fd-88d5-ccaa4d72d145" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_05b0f21c-74b9-4251-99a5-f5f88766eca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_05b0f21c-74b9-4251-99a5-f5f88766eca8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_910caaf3-2d02-4a65-9772-a5ec44f64efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_OperatingExpenses_910caaf3-2d02-4a65-9772-a5ec44f64efe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_597b0534-b109-4856-abb2-5397413434f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_OperatingIncomeLoss_597b0534-b109-4856-abb2-5397413434f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_fa8d7580-b5af-4096-996f-46b3511ba7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_fa8d7580-b5af-4096-996f-46b3511ba7a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2887aecf-9968-46b8-bb46-8fad711a1219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2887aecf-9968-46b8-bb46-8fad711a1219" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7253c646-d704-4881-8b0c-d9cae9280d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7253c646-d704-4881-8b0c-d9cae9280d7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_79bf0e5f-6498-49b3-a5eb-0e57c4141135" xlink:href="pbh-20201231.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_pbh_TotalOtherIncomeExpense_79bf0e5f-6498-49b3-a5eb-0e57c4141135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_352b368b-5067-4d79-a0a8-b7ee7837357c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_352b368b-5067-4d79-a0a8-b7ee7837357c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6237c8b8-2e71-4558-8979-3905b9549739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6237c8b8-2e71-4558-8979-3905b9549739" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_efe8d169-5feb-4dca-8715-a83208631315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_NetIncomeLoss_efe8d169-5feb-4dca-8715-a83208631315" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_91a2c4a7-680b-4165-92cb-595b9f7721ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:to="loc_us-gaap_EarningsPerShareBasic_91a2c4a7-680b-4165-92cb-595b9f7721ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d17fb592-a8bf-4c69-8dd6-3db0a3e2b255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d17fb592-a8bf-4c69-8dd6-3db0a3e2b255" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e32b6a7e-9907-4579-9db2-fea44cb838b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e32b6a7e-9907-4579-9db2-fea44cb838b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_838034ce-9d8e-418e-af60-5445450f83f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_838034ce-9d8e-418e-af60-5445450f83f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4ad37aad-2ec7-4ca5-aa9e-ea615c06010f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4ad37aad-2ec7-4ca5-aa9e-ea615c06010f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_5397343c-d133-432a-acfb-0937cae1077d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_5397343c-d133-432a-acfb-0937cae1077d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6c2c75a2-e1f8-4e05-bc47-66060be8855a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6c2c75a2-e1f8-4e05-bc47-66060be8855a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_aedc322d-574c-4678-bf74-cab59f4d7593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_aedc322d-574c-4678-bf74-cab59f4d7593" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca3551c4-9b8c-46d9-8317-5ec60fec76d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca3551c4-9b8c-46d9-8317-5ec60fec76d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9a869c02-6192-41d9-bc2d-0f0f176a7e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9a869c02-6192-41d9-bc2d-0f0f176a7e9d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:to="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31a09d77-8451-4e59-85c7-fd3082973bea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:to="loc_srt_ProductsAndServicesDomain_31a09d77-8451-4e59-85c7-fd3082973bea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:to="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_7b0e3874-6f22-4778-9163-1730c2e9c10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:to="loc_us-gaap_ProductMember_7b0e3874-6f22-4778-9163-1730c2e9c10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_013a05f6-c1e2-4836-b430-94720aeae926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_013a05f6-c1e2-4836-b430-94720aeae926" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="ib832dbdee0404b4f947a9fa4ebbfa764_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i3552afa72fc24af682448ed9c5ec899c_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended" id="ibc687ebedcbd46a1a1c2199faeccde09_CondensedConsolidatedStatementsofChangesinStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7018ec92-e58e-4fdf-be63-e68930d6ce2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7018ec92-e58e-4fdf-be63-e68930d6ce2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d38e71af-ff32-4efb-bac7-7e520d218c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockholdersEquity_d38e71af-ff32-4efb-bac7-7e520d218c27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_85a1df6e-0990-4995-b42f-713136a98ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockShares_85a1df6e-0990-4995-b42f-713136a98ac5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d23b1ab-dfe9-4fce-bd77-9d4f57dfd1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d23b1ab-dfe9-4fce-bd77-9d4f57dfd1cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9a7c72cf-1d36-4dae-a543-cb17e1d05239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9a7c72cf-1d36-4dae-a543-cb17e1d05239" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_441503e7-36eb-4ca2-b6cd-debdabfe8dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_441503e7-36eb-4ca2-b6cd-debdabfe8dfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7800d7c5-ac33-4fc9-a01d-7ea7054fc683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7800d7c5-ac33-4fc9-a01d-7ea7054fc683" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_91e137d1-7675-4405-919b-a8c06b802b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_91e137d1-7675-4405-919b-a8c06b802b78" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ea5a8f6b-a0f4-4e53-bdb3-495220d2f9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ea5a8f6b-a0f4-4e53-bdb3-495220d2f9f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bbb3460b-0360-49ab-be10-1706e970543c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bbb3460b-0360-49ab-be10-1706e970543c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17a19838-aa0e-4cbb-8745-a43367184219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_NetIncomeLoss_17a19838-aa0e-4cbb-8745-a43367184219" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0731496f-3d6e-44d0-a522-c1fde899b676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0731496f-3d6e-44d0-a522-c1fde899b676" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_58857560-3e42-44e6-bac4-60b13feea421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_545a9010-e2d1-4e9f-9e9b-7ad395389ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_916e438f-d7e4-483c-b795-603c494ebdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:to="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:to="loc_us-gaap_EquityComponentDomain_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:to="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdf735bb-1e3f-49f8-9a78-1d7a683fed7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_CommonStockMember_bdf735bb-1e3f-49f8-9a78-1d7a683fed7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6d88eeeb-1cee-4a4a-b57c-76d968d6861b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6d88eeeb-1cee-4a4a-b57c-76d968d6861b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cabb8130-a74a-4bed-8e71-c39a4368fc01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_TreasuryStockMember_cabb8130-a74a-4bed-8e71-c39a4368fc01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12902fb-13c5-4c96-bdba-45a0e9df63e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12902fb-13c5-4c96-bdba-45a0e9df63e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_574403b4-a1d7-4460-992f-8dfca698530e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_RetainedEarningsMember_574403b4-a1d7-4460-992f-8dfca698530e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i0b390962a8524043b3d85044bf518023_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended" id="icec46f7700524ef5a02b99bac3697dbb_CondensedConsolidatedStatementsofCashFlowsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_61eec483-3af8-45f8-bcb3-916076b7fe13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_61eec483-3af8-45f8-bcb3-916076b7fe13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:to="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8d2e08d-21de-4b9e-83e0-6637a6e28efe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8d2e08d-21de-4b9e-83e0-6637a6e28efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_4bf7c39f-5bee-48e0-9af3-09f329abf8b4" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:to="loc_pbh_A2019SeniorNotesMember_4bf7c39f-5bee-48e0-9af3-09f329abf8b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="extended" id="i171e9b4179644ff3ae9f1de74eabb1b1_BusinessandBasisofPresentation"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="extended" id="i258c8afeba8548688432305bbd6ff677_BusinessandBasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="simple" xlink:href="pbh-20201231.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="extended" id="i0cd29936df6d4bc696403bf88af008f4_Inventories"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="extended" id="ie074860705744b9ea3c13c58bbd20775_InventoriesTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="extended" id="i492ad39fa4fa4f0f842384ae9648d1ce_InventoriesDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="simple" xlink:href="pbh-20201231.xsd#Goodwill"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="extended" id="ibf509d8ba3cd4c7ba34c1af042fae683_Goodwill"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="extended" id="ia61b7457b6cf414299d97eebcf53a3aa_GoodwillTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="extended" id="i0631d180607c4de4816fc01582604013_GoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:to="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_25712fee-cb87-4190-a591-0ff4ee96ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillGross_25712fee-cb87-4190-a591-0ff4ee96ede3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c1c2db99-17f5-4de9-9185-6d0cf2686b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c1c2db99-17f5-4de9-9185-6d0cf2686b69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1746aa2-1504-4dde-abdc-3f5d69341ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_Goodwill_d1746aa2-1504-4dde-abdc-3f5d69341ffd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9dc612a6-7945-4569-ae47-1abd024cd817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9dc612a6-7945-4569-ae47-1abd024cd817" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_dcf4e6d0-e68d-43eb-b2bc-868aedbb62c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2f1c3e77-b363-4342-891f-ee619d6ee0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d002bd72-7f15-4bdb-b249-0a74338d200f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3e567b37-9dfb-415d-ae04-dedf7d421469_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:to="loc_us-gaap_SegmentDomain_3e567b37-9dfb-415d-ae04-dedf7d421469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:to="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_6221cb27-2612-4180-902d-a96f4e1608be" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_6221cb27-2612-4180-902d-a96f4e1608be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_5056fa81-02ff-48ae-b6a9-de0b6edc46cb" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:to="loc_pbh_InternationalOTCHealthcareMember_5056fa81-02ff-48ae-b6a9-de0b6edc46cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnet"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="extended" id="i9d2825f99212467ca11d5176e1b82a15_IntangibleAssetsnet"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="extended" id="i2723fd3690144fdfa116c82a4c7a988a_IntangibleAssetsnetTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended" id="idd0d8d1678444ff5b3ed08640cf489b4_IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9d137601-0234-432d-9509-317331432d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9d137601-0234-432d-9509-317331432d62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_15e9ac38-8855-4dc0-a4c1-ec38e1b2b89d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_15e9ac38-8855-4dc0-a4c1-ec38e1b2b89d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3892606a-47c0-4b7e-b685-abd53dd8f6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e94f670-7596-4932-bd8e-2f619cb5cda5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e94f670-7596-4932-bd8e-2f619cb5cda5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cd76715e-1771-4ae3-b861-e89d191082a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cd76715e-1771-4ae3-b861-e89d191082a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_93b4a65f-892c-4e9e-b3e2-942fbd998349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_93b4a65f-892c-4e9e-b3e2-942fbd998349" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ae588ecb-b5bf-401b-ae5c-0717c764e592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:to="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_193bd201-d856-41bd-a6e0-c32910f2eb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_193bd201-d856-41bd-a6e0-c32910f2eb7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fd4eed7f-1852-4b66-888a-bca3e9fbfc6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fd4eed7f-1852-4b66-888a-bca3e9fbfc6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_f86ac0e0-330d-4a61-9258-c1dac7d7ffa1" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_f86ac0e0-330d-4a61-9258-c1dac7d7ffa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_89bc1fe7-463f-443f-9e03-60009b18053a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:href="pbh-20201231.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_937db1f7-778d-44f8-a945-0eaca0c750d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_937db1f7-778d-44f8-a945-0eaca0c750d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a42b0bf8-8211-4365-b3e0-61446cb8bbf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a42b0bf8-8211-4365-b3e0-61446cb8bbf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_6672638c-dff1-4e98-97d7-1447cd9e586f" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_6672638c-dff1-4e98-97d7-1447cd9e586f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e8897123-5b64-485d-a47f-7ede4251fa47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19cbe56c-d85b-425d-99e5-69f830625b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19cbe56c-d85b-425d-99e5-69f830625b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_53b7e6f7-ed25-446e-80db-b7e3d78375b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_53b7e6f7-ed25-446e-80db-b7e3d78375b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8188c4b5-e9de-4cdd-a173-2984364f4244_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8188c4b5-e9de-4cdd-a173-2984364f4244_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_37c3b052-dd85-47ac-ad4e-94b32d640087" xlink:href="pbh-20201231.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_37c3b052-dd85-47ac-ad4e-94b32d640087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d3e8cf5-4957-4223-b98c-1795ad4f75b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d3e8cf5-4957-4223-b98c-1795ad4f75b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_590093ca-0f26-41fa-9ad6-e762b891802a" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_590093ca-0f26-41fa-9ad6-e762b891802a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="i12f20e5f120a47b9b32fc50b697f9f28_IntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7d0a5138-b200-4280-a277-ddf5979c0ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7d0a5138-b200-4280-a277-ddf5979c0ded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_982182f0-48ab-402b-aee1-74a5b4e7651b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_982182f0-48ab-402b-aee1-74a5b4e7651b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fbff331b-1669-4728-85cc-7ed4fa678708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fbff331b-1669-4728-85cc-7ed4fa678708" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c768eaa5-66a5-4572-be37-ae8887a3eee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c768eaa5-66a5-4572-be37-ae8887a3eee7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:to="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16e238eb-b009-46fe-ab34-69a0eb54c283_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:to="loc_srt_RangeMember_16e238eb-b009-46fe-ab34-69a0eb54c283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:to="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bdb80260-6f49-404e-a4e1-c3942e5b7a0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:to="loc_srt_MinimumMember_bdb80260-6f49-404e-a4e1-c3942e5b7a0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cfc273b9-34c9-4dff-acdc-06c3d277341d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:to="loc_srt_MaximumMember_cfc273b9-34c9-4dff-acdc-06c3d277341d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="extended" id="i2eb829f19e2547aca64453bb127a5c05_IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Leases" xlink:type="simple" xlink:href="pbh-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/Leases" xlink:type="extended" id="i75e46c6af1944841b380be893f257804_Leases"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="extended" id="i6f1d52f879df430ab89c4399cfa058b9_LeasesTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended" id="ic7f1b23298e949a99ad2d8c4f8d47f26_LeasesLeaseCostDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended" id="i65a35575199044e7928e17178b7e5870_LeasesLeaseMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="extended" id="i4ebc32ba35624aa0a843a6c11884a8df_LeasesAdditionalInformationDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i581e8ea6f0af43dcaafcac6a113b4abe_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c4845bc6-3898-4c2e-893a-730b6eb48840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:to="loc_us-gaap_FinanceLeaseLiability_c4845bc6-3898-4c2e-893a-730b6eb48840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_17cb5f1d-2d98-4f09-87d6-9977a9cd2008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_17cb5f1d-2d98-4f09-87d6-9977a9cd2008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:to="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e640773a-804d-4311-968c-3635c82768dd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e640773a-804d-4311-968c-3635c82768dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember_c65f3507-ace3-4d9e-addb-5af1e0f90e98" xlink:href="pbh-20201231.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:to="loc_pbh_GEODISLogisticsLLCMember_c65f3507-ace3-4d9e-addb-5af1e0f90e98" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilities"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="extended" id="if6c33cdf5bd8442cbb0672d090e8ee8e_OtherAccruedLiabilities"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="extended" id="i19767df2de71451bac5f68babeb49ae4_OtherAccruedLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended" id="i1500f8380bf04944a9ba64a0f2bf653a_OtherAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="extended" id="ie83ea9a0ef4f4c888d6cf0c9c9bd0206_LongTermDebt"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="extended" id="idffed02079914399b62678d8491aea8e_LongTermDebtTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended" id="i4cff1b5773f747158a8a8d0501560661_LongTermDebtScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e46ae807-60e6-4bc7-807b-b3bcd1fd75cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e46ae807-60e6-4bc7-807b-b3bcd1fd75cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4c29d8c-79e0-41da-a365-dad0b1b74f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4c29d8c-79e0-41da-a365-dad0b1b74f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_0ddfbd8c-7a86-4a81-86ec-4a276da2be21" xlink:href="pbh-20201231.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_0ddfbd8c-7a86-4a81-86ec-4a276da2be21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_27992542-06c8-40ec-adaf-0ad937766c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_27992542-06c8-40ec-adaf-0ad937766c0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b2aff219-5ca6-43b4-a15d-d1f1802dfea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b2aff219-5ca6-43b4-a15d-d1f1802dfea9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e1a3ef26-08fa-4cdb-9ed4-93ab9ff95b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_LongTermDebt_e1a3ef26-08fa-4cdb-9ed4-93ab9ff95b3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a85abb21-c720-46bc-b7f4-6a08126927e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a85abb21-c720-46bc-b7f4-6a08126927e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1e62709d-d268-4f8a-926b-2b8fd6e713c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:to="loc_us-gaap_SeniorNotesMember_1e62709d-d268-4f8a-926b-2b8fd6e713c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5Member_8a69a633-9188-42e3-a2e2-35e75270e7a8" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:to="loc_pbh_LoansPayableTermB5Member_8a69a633-9188-42e3-a2e2-35e75270e7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da52163f-f49c-4edc-9007-22cd0da609ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da52163f-f49c-4edc-9007-22cd0da609ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_bab8c7a7-2d81-4a0a-9604-bf8fc6d3a1f1" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_SeniorNotes2016Member_bab8c7a7-2d81-4a0a-9604-bf8fc6d3a1f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_1ba92ae5-27a6-4844-aaa0-d60a3f4e3aa8" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_A2019SeniorNotesMember_1ba92ae5-27a6-4844-aaa0-d60a3f4e3aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_f29deb9b-891f-4763-ae44-2487b3ba3db2" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_SeniorNotes2012Member_f29deb9b-891f-4763-ae44-2487b3ba3db2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_f0452c93-2102-4719-ac70-e50479c11a3a" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_AblRevolver2012Member_f0452c93-2102-4719-ac70-e50479c11a3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:to="loc_us-gaap_VariableRateDomain_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:to="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_19f08881-92cc-41cd-b3e0-03048cbd265a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_19f08881-92cc-41cd-b3e0-03048cbd265a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e291b4f9-4bcb-446d-9f69-2cd88c9cb518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:to="loc_us-gaap_BaseRateMember_e291b4f9-4bcb-446d-9f69-2cd88c9cb518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e61b83b2-3178-4eca-b829-c84c143d71a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:to="loc_us-gaap_CreditFacilityDomain_e61b83b2-3178-4eca-b829-c84c143d71a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:to="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_63732566-4846-4120-a280-6a408dbae4c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_63732566-4846-4120-a280-6a408dbae4c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i7571bfed8bdd48368cbafbcb8fcdc3b1_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b5230a5e-a935-4627-92c1-ca2dae3cc825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b5230a5e-a935-4627-92c1-ca2dae3cc825" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d4b2577c-cd2d-4d96-b80e-e1dbd58bf4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d4b2577c-cd2d-4d96-b80e-e1dbd58bf4c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9529d8e3-3448-433c-814e-eb40cbbe49f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9529d8e3-3448-433c-814e-eb40cbbe49f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0566905d-7aaf-4982-be21-576e86014abb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:to="loc_us-gaap_CreditFacilityDomain_0566905d-7aaf-4982-be21-576e86014abb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:to="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75ee9294-f0db-40a7-be09-f788933e969f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75ee9294-f0db-40a7-be09-f788933e969f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_8e4682fd-18bf-432c-b604-260f6344930d" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:to="loc_pbh_AblRevolver2012Member_8e4682fd-18bf-432c-b604-260f6344930d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e151dfe-1cd4-4073-9305-f460e4081f0c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e151dfe-1cd4-4073-9305-f460e4081f0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fec1b1f0-4d83-4bff-a6c4-a509332354fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:to="loc_us-gaap_InterestRateSwapMember_fec1b1f0-4d83-4bff-a6c4-a509332354fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0d11e8e6-78aa-41b9-a8f6-9345888cee3b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:to="loc_us-gaap_HedgingDesignationDomain_0d11e8e6-78aa-41b9-a8f6-9345888cee3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:to="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_09193db3-9e31-45d0-808e-c337d7d7d0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_09193db3-9e31-45d0-808e-c337d7d7d0d9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended" id="ia43acd52f7ae44e48f6ad735a12505ed_LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="extended" id="ibebd443e63f1411797426164b546f1ce_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="extended" id="ibb91d892af6941ca80e991340a072e53_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i059faa0ee15042ec8ab048ad256b2a68_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_27de6726-afea-45d8-a752-3d67345f977a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_LongTermDebtFairValue_27de6726-afea-45d8-a752-3d67345f977a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_d0fef309-5c09-4cb1-99c3-51c22b06910f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_d0fef309-5c09-4cb1-99c3-51c22b06910f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_f89d86a6-9c06-406d-befc-e964a5e40447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_f89d86a6-9c06-406d-befc-e964a5e40447" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7f8daddb-3009-4781-821f-39054311f0c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7f8daddb-3009-4781-821f-39054311f0c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_93bf7025-52e9-49d5-8d25-038c3858b4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_93bf7025-52e9-49d5-8d25-038c3858b4b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bea9203-a61d-40c0-88f1-95d86228b493_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bea9203-a61d-40c0-88f1-95d86228b493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0d72b496-a896-4996-b4ee-d30f230fa7e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_SeniorNotesMember_0d72b496-a896-4996-b4ee-d30f230fa7e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_392484a5-0807-473b-80ac-892a45a57224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_LoansPayableMember_392484a5-0807-473b-80ac-892a45a57224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_39c57cbd-9409-4c1f-a3b3-9798f0f149c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_39c57cbd-9409-4c1f-a3b3-9798f0f149c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_327ea466-fb54-45b7-b297-e03804edff5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_327ea466-fb54-45b7-b297-e03804edff5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_e7348ec4-cb86-4719-bb1c-a0d94bf634e0" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_SeniorNotes2016Member_e7348ec4-cb86-4719-bb1c-a0d94bf634e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_03478c49-261b-47e7-b52f-620c0043b2c2" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_A2019SeniorNotesMember_03478c49-261b-47e7-b52f-620c0043b2c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member_1fb99bcf-2665-4634-846a-195201eb7a1c" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_LoansPayableTermB4Member_1fb99bcf-2665-4634-846a-195201eb7a1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_ed3f9be4-d8a5-48c5-a580-e56e04066b30" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_AblRevolver2012Member_ed3f9be4-d8a5-48c5-a580-e56e04066b30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_12d2342d-2c10-4da5-be7f-ce0d731d7086_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_12d2342d-2c10-4da5-be7f-ce0d731d7086_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fa2008ca-8f7f-4e94-be63-f0927f63bcea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fa2008ca-8f7f-4e94-be63-f0927f63bcea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_40b6573b-d3b5-4c7d-b019-77412a535745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_40b6573b-d3b5-4c7d-b019-77412a535745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b8b55bc3-dd8c-4959-ba16-c2fd14a05486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b8b55bc3-dd8c-4959-ba16-c2fd14a05486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_36178af5-5ed3-4273-8c1e-784245590efc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_36178af5-5ed3-4273-8c1e-784245590efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_577f85a3-090a-4f5c-9203-1074c20ce56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_577f85a3-090a-4f5c-9203-1074c20ce56d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f8f3536-7320-4948-a6e3-13dfa6bb07c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f8f3536-7320-4948-a6e3-13dfa6bb07c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_65f8b2b0-a3ad-40ec-aa84-4eb282bc1184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:to="loc_us-gaap_InterestRateSwapMember_65f8b2b0-a3ad-40ec-aa84-4eb282bc1184" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstruments"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="extended" id="ie7099f67360b44e3bf09baf6e17d4e93_DerivativeInstruments"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="extended" id="ib01f57f7e2904996b04cfefe9a84a028_DerivativeInstrumentsTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="extended" id="i04ef0492dca14ce8998e939f75699dea_DerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_f8535ca7-2db0-40a5-80f9-398e12c375ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_f8535ca7-2db0-40a5-80f9-398e12c375ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f86e5837-25d4-44f6-97e2-6cdeb3af84aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f86e5837-25d4-44f6-97e2-6cdeb3af84aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_44e75071-1b96-45d7-94b0-5ca39c47d22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_44e75071-1b96-45d7-94b0-5ca39c47d22b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_227bd7f5-8484-4c31-8343-6d90e4568d9c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_227bd7f5-8484-4c31-8343-6d90e4568d9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3436f500-d2dc-4077-af3d-d278c2209bd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:to="loc_us-gaap_InterestRateSwapMember_3436f500-d2dc-4077-af3d-d278c2209bd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1f1b90a5-72ad-47ba-9076-86ae4e5fc953_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:to="loc_us-gaap_HedgingDesignationDomain_1f1b90a5-72ad-47ba-9076-86ae4e5fc953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:to="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2836b513-6c2e-4b1a-b7fb-e62567ff4aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2836b513-6c2e-4b1a-b7fb-e62567ff4aeb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="extended" id="ifca8781acbd4438faa1d4ee4cc083d2c_DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_37cf596a-fa27-4886-accd-29d765d07e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_37cf596a-fa27-4886-accd-29d765d07e4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0a1d8095-4e8e-4d99-a35f-51dcddf3b594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0a1d8095-4e8e-4d99-a35f-51dcddf3b594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d0d735f-e960-4028-86ef-465a5c670f7c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d0d735f-e960-4028-86ef-465a5c670f7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05bb7049-7626-438e-8085-18d42c58ec5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:to="loc_us-gaap_InterestRateSwapMember_05bb7049-7626-438e-8085-18d42c58ec5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_045dd764-a895-47c6-b8aa-7b007598ec04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_045dd764-a895-47c6-b8aa-7b007598ec04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a4b67246-c116-42f1-9c9d-b7eddc057760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a4b67246-c116-42f1-9c9d-b7eddc057760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d3949446-4e06-4bc0-a97e-1ff3ff52515e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d3949446-4e06-4bc0-a97e-1ff3ff52515e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:to="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_728709bd-763a-45cc-9d79-5ca814cbff8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_728709bd-763a-45cc-9d79-5ca814cbff8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fab6a6b9-cf2f-4c74-9324-e4fb24d44133_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fab6a6b9-cf2f-4c74-9324-e4fb24d44133_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4c83ccb4-ec3b-482f-9774-d12519950460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:to="loc_us-gaap_CashFlowHedgingMember_4c83ccb4-ec3b-482f-9774-d12519950460" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="extended" id="i06f9eb9b3daa4acba429c553f0dd86f3_DerivativeInstrumentsSummaryofInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_6baa3fda-666f-4796-bdca-baef79083976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_6baa3fda-666f-4796-bdca-baef79083976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_6c650fb0-7fb2-48c8-a904-d3d7df4717c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_6c650fb0-7fb2-48c8-a904-d3d7df4717c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative_4270ad71-37e3-4ffc-81d5-4ec36bd3baf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeLossOnDerivative_4270ad71-37e3-4ffc-81d5-4ec36bd3baf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_4f4e5945-8a73-4ec7-918a-509457a411b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_4f4e5945-8a73-4ec7-918a-509457a411b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_3c646d9b-f139-48d3-8de0-0e670dc6cc63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_3c646d9b-f139-48d3-8de0-0e670dc6cc63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_74263580-9f03-42c5-87d8-3aa36d8cc653_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_74263580-9f03-42c5-87d8-3aa36d8cc653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f76f6989-5245-43c2-8f18-2b5c949f54d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:to="loc_us-gaap_InterestExpenseMember_f76f6989-5245-43c2-8f18-2b5c949f54d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7917fd4b-5ee0-42e9-ae4f-9a12bb079315_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:to="loc_us-gaap_HedgingDesignationDomain_7917fd4b-5ee0-42e9-ae4f-9a12bb079315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:to="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda3b99f-31f0-40ca-b599-750f1e3a2e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda3b99f-31f0-40ca-b599-750f1e3a2e6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="extended" id="i84bcee814b3d482dbb09526cf77259ef_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="extended" id="ie21e2d2a585242cc9dec5cd9503b157e_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="extended" id="i62c8217d2e2e4b08b0f7bf488924ed1d_StockholdersEquityDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityScheduleofRepurchasedSharesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="extended" id="id4f7b048b0fc474da3ef4bf018d96044_StockholdersEquityScheduleofRepurchasedSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ec1e78d3-713b-4137-b8bb-2813a038e84b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ec1e78d3-713b-4137-b8bb-2813a038e84b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7e479fe8-b189-4dd4-81c7-c0a8e45dc55b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7e479fe8-b189-4dd4-81c7-c0a8e45dc55b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e6314932-a07a-4464-97ff-29350b2ededd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e6314932-a07a-4464-97ff-29350b2ededd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:to="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd0375f-ce16-4a13-9b6d-66a1314564b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd0375f-ce16-4a13-9b6d-66a1314564b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_edf9cfc6-d50d-454d-bf57-6c0bc11905e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:to="loc_us-gaap_RestrictedStockMember_edf9cfc6-d50d-454d-bf57-6c0bc11905e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f16b4af6-1a4d-453a-9563-1b7b0e89952a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f16b4af6-1a4d-453a-9563-1b7b0e89952a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_1e6672cb-c85d-453e-9911-46642328182f" xlink:href="pbh-20201231.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:to="loc_pbh_ShareRepurchaseProgramMember_1e6672cb-c85d-453e-9911-46642328182f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="i1a5be5ba5a5141f6bddfa776eefb5d42_AccumulatedOtherComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="ide08ed10f46144538a5e3855287ed9ba_AccumulatedOtherComprehensiveLossTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i649dd6df8da142efa746dfd94b0e3089_AccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_961b2bbb-38b4-4b17-b16d-a1b0700498ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_StockholdersEquity_961b2bbb-38b4-4b17-b16d-a1b0700498ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_042a83a7-43cf-4b1e-b38b-3a5785150de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_042a83a7-43cf-4b1e-b38b-3a5785150de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_da78a328-264f-43e7-88d1-c44a45fffe2e" xlink:href="pbh-20201231.xsd#pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_da78a328-264f-43e7-88d1-c44a45fffe2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_f17b4ba0-f575-4b45-847d-88b2911342b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_f17b4ba0-f575-4b45-847d-88b2911342b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_710875b3-fb2d-45c5-b762-86c611f2bcc1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:to="loc_us-gaap_EquityComponentDomain_710875b3-fb2d-45c5-b762-86c611f2bcc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:to="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b6970ba4-4e76-48fa-8572-a6173f56ed91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b6970ba4-4e76-48fa-8572-a6173f56ed91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fd620743-2c14-4e04-bb0a-98b68ff6df7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fd620743-2c14-4e04-bb0a-98b68ff6df7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d4954341-2765-461a-877b-41c29e545d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d4954341-2765-461a-877b-41c29e545d61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4d7cb600-3da3-4734-b590-fe947a215515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4d7cb600-3da3-4734-b590-fe947a215515" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="extended" id="ib9350e5b7fc348e282779a101645b534_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="extended" id="i9bc709f358e643d698698dbbf141f2d0_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="extended" id="i93808a05266a4803ad950feed4ca427f_EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" id="i29e28ade8c19416ab7be65cef518b9e8_EarningsPerShareAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b823c4ab-05ec-4ca3-8c95-555865a718d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b823c4ab-05ec-4ca3-8c95-555865a718d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4fa669f1-9198-4f74-bd34-9bb58dcc2e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:to="loc_us-gaap_StockCompensationPlanMember_4fa669f1-9198-4f74-bd34-9bb58dcc2e2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="extended" id="ic17d180fab264ce3a32a3355b54ad7e8_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="extended" id="ie79751a9e86d4e10a2d84319b7948e7a_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i4cfcea491f7b40c1aae9c80ae0fbc361_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ddd985bb-244a-4c5c-a374-ba397f5085be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ddd985bb-244a-4c5c-a374-ba397f5085be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dd1b5d27-17a7-42cf-a10a-76dbed29635e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dd1b5d27-17a7-42cf-a10a-76dbed29635e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_afdd5a68-7795-49dd-bd00-749cd43323db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_afdd5a68-7795-49dd-bd00-749cd43323db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_6113988e-11d5-4767-a03a-486030740c99" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_6113988e-11d5-4767-a03a-486030740c99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0bb57726-22d8-4f6f-9910-c21edc3d54fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0bb57726-22d8-4f6f-9910-c21edc3d54fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_a9a1a057-dd7d-4502-b194-5d3f39c23753" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_a9a1a057-dd7d-4502-b194-5d3f39c23753" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_fc46c247-ff68-43ce-8419-2b94f3d4a2dc" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_fc46c247-ff68-43ce-8419-2b94f3d4a2dc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8b6d0ce2-7ff2-4b3a-9d0f-30ad99da9ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8b6d0ce2-7ff2-4b3a-9d0f-30ad99da9ab1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ffe84a33-0594-4482-8c62-ebcbf04ee5e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ffe84a33-0594-4482-8c62-ebcbf04ee5e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c07255c0-df00-4efa-990e-65a6abb19da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c07255c0-df00-4efa-990e-65a6abb19da4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77c9dbc0-11bf-4e21-841e-779e4d240c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77c9dbc0-11bf-4e21-841e-779e4d240c80" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93be6c50-6b72-46e7-8b0b-06a1c2532a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93be6c50-6b72-46e7-8b0b-06a1c2532a5b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94e995b3-c95c-492c-9bba-d2a1ba67e89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94e995b3-c95c-492c-9bba-d2a1ba67e89a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_20f0cb08-3f25-4795-90f1-d288c2e6ce8e" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_20f0cb08-3f25-4795-90f1-d288c2e6ce8e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bcd49a29-c464-46bb-a2a8-07cb95426455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bcd49a29-c464-46bb-a2a8-07cb95426455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4401b48a-ed4b-4dd0-8284-457b7514654b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:to="loc_us-gaap_PlanNameDomain_4401b48a-ed4b-4dd0-8284-457b7514654b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:to="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_57480c04-80ba-47f5-a631-0d8b1aa0bfc3" xlink:href="pbh-20201231.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_57480c04-80ba-47f5-a631-0d8b1aa0bfc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_1ef6f0ad-2c90-4c1a-9e36-f13e45b1a99b" xlink:href="pbh-20201231.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_1ef6f0ad-2c90-4c1a-9e36-f13e45b1a99b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_73a011bb-4355-4413-be7c-e9bee5db58be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_PerformanceSharesMember_73a011bb-4355-4413-be7c-e9bee5db58be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_902ba3c3-9289-49a5-9ecb-028e230636f1" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_902ba3c3-9289-49a5-9ecb-028e230636f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_01be4596-33d8-4c99-ad03-4f0314317641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_01be4596-33d8-4c99-ad03-4f0314317641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_51948c4e-5b1f-4801-9726-f83ac2ed2c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_51948c4e-5b1f-4801-9726-f83ac2ed2c64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_21645503-08a0-4d54-9390-26d013ebb991_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_21645503-08a0-4d54-9390-26d013ebb991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_7a1b1ff3-79a5-4a6c-8f78-29b86e452f8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:to="loc_srt_DirectorMember_7a1b1ff3-79a5-4a6c-8f78-29b86e452f8e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="extended" id="ia22bbdb3ad9e4109b2e5d280152a044f_ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i5f96b6b342b24f0c81d376c345f0f0d9_ShareBasedCompensationRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d3474858-fb2e-485f-aecb-b41a54ab5a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d3474858-fb2e-485f-aecb-b41a54ab5a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cb7e361e-46da-4006-9a75-f4700b939bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cb7e361e-46da-4006-9a75-f4700b939bcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_287a570c-9de6-44f2-8099-68ab24823a33" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_287a570c-9de6-44f2-8099-68ab24823a33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4ca4a86e-069a-4ccb-9876-0621675f2fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4ca4a86e-069a-4ccb-9876-0621675f2fe0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2c802c3-2ff6-41f0-919e-579ffc572639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_6da021b2-c876-4bb2-84f2-aeda8c85fd11" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_6da021b2-c876-4bb2-84f2-aeda8c85fd11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7fe3e3d3-5697-4271-9ad1-4bd2845c8c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7fe3e3d3-5697-4271-9ad1-4bd2845c8c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dff97cf6-66ba-40eb-b653-e8334f7c5c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dff97cf6-66ba-40eb-b653-e8334f7c5c95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_c7dfde37-7a14-422b-b604-9436759a5d0c" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_c7dfde37-7a14-422b-b604-9436759a5d0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_957ff73e-bda8-44da-8561-b7cc8579f3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_957ff73e-bda8-44da-8561-b7cc8579f3d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4d66a1ff-6d2d-4872-997a-5f415cf3d241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_f7f615ac-1fa6-48a0-99c4-51e17c547d27" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_f7f615ac-1fa6-48a0-99c4-51e17c547d27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:to="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a622649a-4f54-453a-b09d-1bf8e2b21dce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a622649a-4f54-453a-b09d-1bf8e2b21dce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f88b76f0-d223-4e89-a8ad-2d94475d159e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f88b76f0-d223-4e89-a8ad-2d94475d159e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended" id="i00a6573dc20c4518a4ec1a88adabb1e6_ShareBasedCompensationStockOptionValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_219fada7-3243-494e-bf4d-5cbe66088119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_219fada7-3243-494e-bf4d-5cbe66088119" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8fd7d330-a748-4128-95df-94d45c32834a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8fd7d330-a748-4128-95df-94d45c32834a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_76ae2632-5567-4eaf-be2c-8ed0e6b1f7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_76ae2632-5567-4eaf-be2c-8ed0e6b1f7ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_85304a3c-1ca0-4529-926d-516f643edd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_85304a3c-1ca0-4529-926d-516f643edd8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6737397d-fc5c-4747-ae33-acb07289303b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6737397d-fc5c-4747-ae33-acb07289303b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:to="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89fa0523-c1be-46cf-95dc-787750079b90_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:to="loc_srt_RangeMember_89fa0523-c1be-46cf-95dc-787750079b90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:to="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cfb6dbc-a9c7-4e3c-b7a4-469373193044" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:to="loc_srt_MinimumMember_6cfb6dbc-a9c7-4e3c-b7a4-469373193044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a94ffdf7-39e3-42c3-b94d-c351a1f4124a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:to="loc_srt_MaximumMember_a94ffdf7-39e3-42c3-b94d-c351a1f4124a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:to="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213004cf-e783-40e3-8292-decf797e4080_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213004cf-e783-40e3-8292-decf797e4080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0838844e-df1b-40c4-8708-7b54fd21794b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0838844e-df1b-40c4-8708-7b54fd21794b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended" id="iad9a8e09c18846c982053b056929bb38_ShareBasedCompensationStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="extended" id="icb7999a9598949db9fb00acca1541792_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="extended" id="i2add8825269b4cb6be141fc9ff67ac4c_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlans"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="extended" id="i827b6691e5744bb29175ba18ab4e5f11_EmployeeRetirementPlans"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="extended" id="ie1b8138f99884b4d98f3fe5674210138_EmployeeRetirementPlansTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended" id="i3a722883cd434536bda8fad00e6a2cf4_EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended" id="ic94e6c7ffdb949afb669180712dcf09f_EmployeeRetirementPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0f6d2e6d-f9ca-445b-8abd-592b35dc3999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0f6d2e6d-f9ca-445b-8abd-592b35dc3999" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_ce497ae2-c3bc-4407-8736-ed81c010cf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_ce497ae2-c3bc-4407-8736-ed81c010cf5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_858386e0-fc15-49ab-a294-ee75a13e420e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_858386e0-fc15-49ab-a294-ee75a13e420e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_9ba66cac-b105-4209-a21b-e5c5e8b0ee37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_9ba66cac-b105-4209-a21b-e5c5e8b0ee37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_36a7160a-4751-42a1-a7de-d26be9f2736c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_36a7160a-4751-42a1-a7de-d26be9f2736c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_d5fb2d38-e01b-41ee-9a03-b890542c68b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:to="loc_us-gaap_NonqualifiedPlanMember_d5fb2d38-e01b-41ee-9a03-b890542c68b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_c136df82-3973-4bfe-83e8-ef5b6c9a5d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:to="loc_us-gaap_QualifiedPlanMember_c136df82-3973-4bfe-83e8-ef5b6c9a5d6a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pbh-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="extended" id="ib55ee0d17a314b60896340300d0ba612_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRisk"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="extended" id="i4669c2004e0a4e49ae53befa9cbd3250_ConcentrationsofRisk"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRiskDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended" id="i7d6e9408122a4719b81400675c8f87b9_ConcentrationsofRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e718b709-fff0-47b3-aa19-2c2343957491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e718b709-fff0-47b3-aa19-2c2343957491" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_03a8c83d-2286-4410-9812-635a53234d05" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_03a8c83d-2286-4410-9812-635a53234d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_167f267e-963c-465a-873b-fcb1d04c7991" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_167f267e-963c-465a-873b-fcb1d04c7991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_11979aff-1ed9-4477-8ab1-c840167f9ea3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:to="loc_srt_ProductsAndServicesDomain_11979aff-1ed9-4477-8ab1-c840167f9ea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:to="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember_8aa3d0e7-b9ef-45d2-9635-8ed1c6d3dfbc" xlink:href="pbh-20201231.xsd#pbh_TopFiveBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:to="loc_pbh_TopFiveBrandsMember_8aa3d0e7-b9ef-45d2-9635-8ed1c6d3dfbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84602503-6403-4788-af0c-dd5cfc82f088_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84602503-6403-4788-af0c-dd5cfc82f088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_dc1c5c55-685a-4fc8-8e15-6e5cbfb039a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:to="loc_us-gaap_SalesMember_dc1c5c55-685a-4fc8-8e15-6e5cbfb039a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e355f14e-ac3c-4e8d-a258-f4578946b78b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e355f14e-ac3c-4e8d-a258-f4578946b78b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_e44b3913-25d3-43c9-a5d7-dc7a11de376c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_e44b3913-25d3-43c9-a5d7-dc7a11de376c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_03d49181-77d0-4a6f-ad67-973e525cab43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_03d49181-77d0-4a6f-ad67-973e525cab43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_41ac09a0-5998-4e9d-bc01-c2c269701d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_41ac09a0-5998-4e9d-bc01-c2c269701d9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_be931aa0-151c-4610-b336-0d22264dcc1f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:to="loc_srt_NameOfMajorCustomerDomain_be931aa0-151c-4610-b336-0d22264dcc1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:to="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_069cea59-66d6-4b86-b122-e8db88ee61c4" xlink:href="pbh-20201231.xsd#pbh_WalmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:to="loc_pbh_WalmartMember_069cea59-66d6-4b86-b122-e8db88ee61c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegments"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="extended" id="i4dec25959b8646cea040e54afd3a2a01_BusinessSegments"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsTables"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="extended" id="ib08c934ffcdc4d318d79f59947f665fb_BusinessSegmentsTables"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended" id="i31c9f2ce47434918991bf9e227b3d309_BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5cad72dd-2052-434c-9eb8-2249d312ff86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5cad72dd-2052-434c-9eb8-2249d312ff86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_192561d2-f6d8-49d3-90a8-5850a6e4d090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_CostOfRevenue_192561d2-f6d8-49d3-90a8-5850a6e4d090" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_af5147c2-a8f9-4be1-9bf8-24781c50f3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_GrossProfit_af5147c2-a8f9-4be1-9bf8-24781c50f3fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_e43ab45c-7917-44c6-8442-1dcd913c8ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_e43ab45c-7917-44c6-8442-1dcd913c8ec1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_a4772bb2-2a7f-4773-9eee-3d8a43b8ebf0" xlink:href="pbh-20201231.xsd#pbh_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_pbh_ContributionMargin_a4772bb2-2a7f-4773-9eee-3d8a43b8ebf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_f216edb9-af99-4ba3-a07d-cc3c63fde092" xlink:href="pbh-20201231.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_f216edb9-af99-4ba3-a07d-cc3c63fde092" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dc194284-6287-48e4-98d3-13ca33b9bf24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_OperatingIncomeLoss_dc194284-6287-48e4-98d3-13ca33b9bf24" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:to="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8c16e6be-c192-418a-8f6c-2f022ec305d3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:to="loc_srt_ConsolidationItemsDomain_8c16e6be-c192-418a-8f6c-2f022ec305d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:to="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b04c9356-f54d-4a35-9548-5b8bfb2857dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:to="loc_us-gaap_OperatingSegmentsMember_b04c9356-f54d-4a35-9548-5b8bfb2857dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_cfd837cf-43dd-4714-8642-f2802d350053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_cfd837cf-43dd-4714-8642-f2802d350053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5165218-589d-43ea-87ac-fcfbdd43d2e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:to="loc_us-gaap_SegmentDomain_d5165218-589d-43ea-87ac-fcfbdd43d2e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:to="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_ac9a0691-d4d9-4344-8d27-23ba51b509fd" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_ac9a0691-d4d9-4344-8d27-23ba51b509fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_88a7dac5-c6af-47ae-9041-a14dd3559bca" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:to="loc_pbh_InternationalOTCHealthcareMember_88a7dac5-c6af-47ae-9041-a14dd3559bca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="extended" id="idd21e43e464c4e698f5cf82d4228165a_BusinessSegmentsRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb0983-4814-499e-901d-f520cae126f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb0983-4814-499e-901d-f520cae126f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:to="loc_us-gaap_SegmentDomain_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:to="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_e9353e10-27c7-4d94-9573-5615545b92fc" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_e9353e10-27c7-4d94-9573-5615545b92fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_f05327f5-9460-4ac4-bf33-782d03622f10" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:to="loc_pbh_InternationalOTCHealthcareMember_f05327f5-9460-4ac4-bf33-782d03622f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:to="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3afcd91-09d4-4b01-926f-acb0277c69b1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:to="loc_srt_ProductsAndServicesDomain_c3afcd91-09d4-4b01-926f-acb0277c69b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:to="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_f457550c-bcb5-4e60-8936-5f021f5f8027" xlink:href="pbh-20201231.xsd#pbh_AnalgesicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_AnalgesicsMember_f457550c-bcb5-4e60-8936-5f021f5f8027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f0b48854-dd12-4547-bdb7-a860175498d8" xlink:href="pbh-20201231.xsd#pbh_CoughAndColdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_CoughAndColdMember_f0b48854-dd12-4547-bdb7-a860175498d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_7f0b59e4-770f-47cd-9b98-856051ca3bf7" xlink:href="pbh-20201231.xsd#pbh_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_WomensHealthMember_7f0b59e4-770f-47cd-9b98-856051ca3bf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_ca7544c4-6f84-4fb6-8a03-0a7fe53ae395" xlink:href="pbh-20201231.xsd#pbh_GastrointestinalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_GastrointestinalMember_ca7544c4-6f84-4fb6-8a03-0a7fe53ae395" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_5c1a99b9-cee7-4307-8a3f-1f8d307beb54" xlink:href="pbh-20201231.xsd#pbh_EyeAndEarCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_EyeAndEarCareMember_5c1a99b9-cee7-4307-8a3f-1f8d307beb54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_ffecdcb5-aff8-4167-83a3-b82d2c6edc75" xlink:href="pbh-20201231.xsd#pbh_DermatologicalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_DermatologicalsMember_ffecdcb5-aff8-4167-83a3-b82d2c6edc75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_f837d61c-e684-4bf1-a927-4c63cb9b15ac" xlink:href="pbh-20201231.xsd#pbh_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_OralCareMember_f837d61c-e684-4bf1-a927-4c63cb9b15ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_cbe2a68a-30d4-4be6-867e-f879e0154505" xlink:href="pbh-20201231.xsd#pbh_OtherOtcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_OtherOtcMember_cbe2a68a-30d4-4be6-867e-f879e0154505" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenuebyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="extended" id="iabb7b2e6490f4a519dcbf9ffa793ae43_BusinessSegmentsRevenuebyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9ac732e-b52d-4eaf-88ec-75a6cf904484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9ac732e-b52d-4eaf-88ec-75a6cf904484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:to="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:to="loc_srt_SegmentGeographicalDomain_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:to="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8c07b0f5-b1f1-4277-a895-390a83dba93f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:to="loc_country_US_8c07b0f5-b1f1-4277-a895-390a83dba93f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ea4a0cf3-2756-4bc7-9234-3da40f84f7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:to="loc_us-gaap_NonUsMember_ea4a0cf3-2756-4bc7-9234-3da40f84f7fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsGoodwillandIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="extended" id="i6cc8beb21f4547b793154cf3fde333d0_BusinessSegmentsGoodwillandIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ba2fcc86-e109-4c4e-8741-78cf7c28e420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_Goodwill_ba2fcc86-e109-4c4e-8741-78cf7c28e420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26e19456-0074-4565-a3c3-93bf5036a29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26e19456-0074-4565-a3c3-93bf5036a29c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10a0703b-9168-4533-999e-c6b35eb3324d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10a0703b-9168-4533-999e-c6b35eb3324d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4522785a-c65d-4d26-91da-e59a592f3e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4522785a-c65d-4d26-91da-e59a592f3e88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8feea79-1364-4cfd-9492-35810ca035ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8feea79-1364-4cfd-9492-35810ca035ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_876708ed-ab1e-42ad-be12-bacad4ee5bb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:to="loc_us-gaap_SegmentDomain_876708ed-ab1e-42ad-be12-bacad4ee5bb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:to="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_c02b8225-73a4-427b-a2e0-d47974ebc2db" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_c02b8225-73a4-427b-a2e0-d47974ebc2db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_a9fdcdbd-0ac9-4aca-9677-3dc97c55e06b" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:to="loc_pbh_InternationalOTCHealthcareMember_a9fdcdbd-0ac9-4aca-9677-3dc97c55e06b" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>pbh-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f395b5de-0fcb-4020-a188-b58eff152f2c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76fa02eb-2c38-4f47-98e5-e0dfdef8e956_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_81ebf335-716d-49f7-8289-5ccd61e08086_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_825ddb5e-a385-4a06-b25c-28384be0648b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9b238723-38e5-4550-83f9-90cdf68e640a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_fda01ce0-a556-4c48-8995-c89d7db6ecc8_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_fac4f104-6452-454a-bfe3-c1e59d451a02_terseLabel_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income, accumulated tax</link:label>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_label_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income, Accumulated Tax Expense (Benefit)</link:label>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_documentation_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income, Accumulated Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:href="pbh-20201231.xsd#pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:to="lab_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dd634950-b559-4dfe-9f09-a653b6786f76_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_33600348-5992-45c2-968f-b9e7fb914385_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_cdd5e736-8a06-4096-bc5c-9183b064bbb3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_ef5337d7-acc1-4027-bb2a-2aa426fd186d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_6d336720-42f6-45d9-8c34-7759c59c13bb_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_3c451503-1fc9-44d9-b9c9-c98864159cfb_terseLabel_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour" xlink:href="pbh-20201231.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongTermDebtMaturityAfterYearFour" xlink:to="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_aa73b227-2257-4388-ad19-362127488989_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_08b28242-a905-4aaa-ab55-97c5f35e5871_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_6b197615-2112-4c77-947d-96166edf9aad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2dedeb90-e599-4888-a8a9-60f9bba750a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_b9cab7b3-1bac-401c-8f7a-bf24f13f0b9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AnalgesicsMember_f9a08887-948a-4585-9575-e5ac5a431985_terseLabel_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_label_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_documentation_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember" xlink:href="pbh-20201231.xsd#pbh_AnalgesicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AnalgesicsMember" xlink:to="lab_pbh_AnalgesicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_8d529aca-a3d5-4f0b-853d-5a60facc45e0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ffc9f723-bc78-4078-a2a4-c8c1d4238933_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3265971c-92ac-4248-9b37-628430d665dd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_8bc22cfe-4d6e-46d8-ac87-8bf897e727d7_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a2b0eea-829b-466a-a8dd-65618ae9b092_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_12196795-25c5-44f3-ad63-b7110105d2d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ff2d7464-5b58-4fb8-8239-652cc1dfd5aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_10b21283-81b0-46ff-bbbb-758a72268d96_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_5fd38bec-7b62-4ed7-9a05-cbeaf8734d95_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued And Other Liabilities [Table Text Block]</link:label>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:to="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_db9a9ffa-1512-4c0b-8847-5ac93adc9cba_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8afb04eb-f645-43a8-955e-d4cf388ab4e3_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f75646d7-0598-4979-b873-96e0fbe42afb_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ddb6cd57-7b82-438f-8b1f-307742b7f233_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of 5.125% Senior Notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fd2df063-77a7-484e-a516-7e58916942bd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_10c1fa69-c419-4d26-a2ec-7d76dd73d0c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c87661bc-5b9d-4edb-9d7f-2ed0bf78c70c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_c8d89f24-2464-4e4f-9901-d5b4d134a54c_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_c2e375df-573d-4f93-a10b-ef0bae928418_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_375201e9-ccac-45b7-b983-726bea80eded_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_745e6087-0c10-4288-a307-196e46468616_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_371ba2be-f3c0-4221-9b1d-b8b2a8b589a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ffd5ebc5-9862-4d46-abbb-1eac9fe2bed0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_5fdcda06-2fec-4c52-baa9-133d15843829_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_e0cc4646-3d4d-4e22-a45f-2e1db92e1b97_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_63ab009f-1df3-42c7-b3c5-33f09bf0733e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies &#8212; Note 16</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_bbbe815d-9f01-43d9-8567-9d8f2e888a3f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b500915a-38ac-4de0-96ff-e3267b500213_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_48db40c7-93a5-42cb-8bb5-ac283b1c1a6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_79242cc1-4e53-4b35-81c5-5369e42631c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ba17622b-4dd4-4a50-ae63-b9a9399ca81d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_804cfb3f-4b5b-424e-9ec2-9a2c292f72c5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_78f0ede3-588e-41e3-8f21-697013791e64_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_adf6b88b-761a-4965-b66d-8b5c8cf01c58_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_2550fbdf-7978-4233-86d5-44a835fb73b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_f1a09ee1-0fbb-40d8-968a-c16f1436be98_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_abc6d6d3-e087-4fad-a574-f1fb8b9d00d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OralCareMember_79c04a73-ac87-43b0-a8c4-7e915df85d21_terseLabel_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_pbh_OralCareMember_label_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_pbh_OralCareMember_documentation_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember" xlink:href="pbh-20201231.xsd#pbh_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OralCareMember" xlink:to="lab_pbh_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9f79acdb-56d2-4b6d-9927-a2bca4fbdc86_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5e801e05-beac-4074-85d3-4b8664c262d6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_61ed54d0-47c2-4c64-bb14-2e0053b11656_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_ef5bf817-eea8-434b-9e2a-7848ab10885d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f9f824fb-b842-403c-ad53-9824264ec6f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WalmartMember_135a8fd9-c645-483e-bbfd-f539279ecd42_terseLabel_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart</link:label>
    <link:label id="lab_pbh_WalmartMember_label_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:label id="lab_pbh_WalmartMember_documentation_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember" xlink:href="pbh-20201231.xsd#pbh_WalmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WalmartMember" xlink:to="lab_pbh_WalmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_a387051a-1324-4f41-a67e-50a31b516e7a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued broker commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_0a303645-8452-4a5d-8063-c073bd8adce5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_566e4e45-2c03-49f6-b02e-f93a5e1d98e8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c300018e-dcf3-4b8d-b9f0-dc703c5840eb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b45df495-426b-49d6-af26-8912717bb0e8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cfd7b07f-6c4e-478c-8a04-7ff3d1130b24_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_84424c8c-7ee2-4c15-a447-484b32774561_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_eaaa64ba-6f18-4dc3-af07-8c4c0e4c5d70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_131388f3-f6c7-4ad3-9af4-76460b88e198_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b0cf1e4d-933f-431b-bfb7-8f0d5a3060bd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_1239c5cd-56d8-48f4-a326-d8314f26574d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_d7555a19-d1de-4905-a57f-c3f9e2a1a69d_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:to="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_64765edc-f40a-47d4-abdb-9add5e4823c7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_3ea22291-d5c9-469b-ab00-32f31d0008c6_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_label_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract" xlink:to="lab_pbh_IntangibleAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_71032e9d-7996-404d-b9dd-c1e135b69f1e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_da102854-3fa9-43c8-b4c9-615a577609b9_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_cf6c1675-8858-41a2-aa7f-9c7a3a42fc13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per participant, 12 month period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_2c55e297-1b4c-49ed-9f8b-488b27feda21_terseLabel_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified Plan</link:label>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonqualifiedPlanMember" xlink:to="lab_us-gaap_NonqualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_afc3f04f-5ef6-428c-8126-c08b63c4413f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2016Member_532d61a2-c781-46e6-bb2e-6d661ba8214b_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2016Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2016 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2016Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2016Member" xlink:to="lab_pbh_SeniorNotes2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_74120060-b39a-45ca-8eea-f9de817a4c12_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0e6325a8-bbd6-4fbd-a537-0409bc4960ef_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_7dd150b9-b4bb-4c08-98c3-bdc951ca8be3_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_53203e20-fe32-42fb-a8d7-1bd68a2484d9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40cc8db6-cdd2-4d36-a1ab-a5358c68638c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_9ff85e9b-a40d-47cd-889a-c5026763c33c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging and raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_b2575a95-275a-4a74-a956-6b3b0b0fcce5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c424b35c-4489-48af-a8d8-d01baf2c3b16_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_fd2eb140-e4cb-4c86-82ff-8a6de94be281_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_4adac4c3-b8a9-4a70-a8a3-8c2a7155190d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_7dfc83f3-7ebb-4869-a929-91a807c714ce_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3de438c6-2704-4c29-8870-5b554f9553ef_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_2d436788-2da6-47e5-8fac-006fbbe720d5_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising and marketing</link:label>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4edca66b-7689-4448-8f15-4655afc45ce3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_7173d310-5f26-4b16-9043-bab37e188b83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a2e7b518-e607-4b8f-958c-137a1e224de1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5e80151e-f57e-424c-9364-92981a065790_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3d4d2ec-1ae3-452d-b4aa-47373d3096b8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_0966e3e3-d814-4704-898b-67e3b3fa9c2a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump sum payout</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6bd2d674-30bf-4618-86a0-1c56b9974956_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_b7312898-7e58-4ac6-9baa-615c0271b343_terseLabel_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_label_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_documentation_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:href="pbh-20201231.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:to="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_be493715-ff48-47f3-a46f-c579e97b0eb8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c46fa60b-f349-4476-b647-6ac950500413_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_fdd7ab12-8dd9-4878-8fc3-52e85f2d9584_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employer contributions, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_35ea661b-58bb-42c8-a85c-10bd6822ffef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_00d188bd-4b98-44a3-b945-63884cfcb5d8_terseLabel_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease cost</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:href="pbh-20201231.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:to="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b962d2fd-8f4d-48c0-9bf3-5c9113863256_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_6120310a-0462-49ef-b57e-e19cc47ccb32_totalLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_eba79968-2b34-4ecc-9122-ddabf777e635_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cb706afc-4f10-45bb-bb35-75eeca8d3c99_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_57bf9912-2005-4582-a5a2-46e50193848a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GastrointestinalMember_d1a6eebe-d9ea-4e28-8fa3-0cb52e6ed8c5_terseLabel_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_label_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_documentation_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember" xlink:href="pbh-20201231.xsd#pbh_GastrointestinalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GastrointestinalMember" xlink:to="lab_pbh_GastrointestinalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_3855fe11-a991-4734-9184-5904412a31e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_53c624bb-0d39-42d6-8bc0-7d853698dad9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_8c6cca3b-da2a-45cb-83af-8e9f84adee73_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WomensHealthMember_6f7e4a80-298c-40e8-a2d2-0e2bed8e3c3a_terseLabel_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_pbh_WomensHealthMember_label_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_pbh_WomensHealthMember_documentation_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember" xlink:href="pbh-20201231.xsd#pbh_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WomensHealthMember" xlink:to="lab_pbh_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_99c8836a-a643-4a84-9cf3-6b22e482c8b4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_b7350125-5e16-4874-92ab-fe884198ee5c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_b4a28126-668f-4b59-9b2f-0c47ece0a0b2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:to="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_bf91687c-0969-4fe7-a7c6-3eb3d528c08b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2dc3279c-9f21-40d4-90cf-aca5c73c2fc4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_9a54a44f-52da-4b65-8ea4-45e1493750b3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0fba6bd1-04bb-4d7c-8351-2402d42ca415_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_859f72d7-9d57-4e8c-9a8d-7cbcb03739dc_terseLabel_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_label_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020 [Member]</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_documentation_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member" xlink:href="pbh-20201231.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongTermIncentivePlan2020Member" xlink:to="lab_pbh_LongTermIncentivePlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06b0dfdb-0f14-4dfb-bb5f-25e213f3b25f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f6bb6bba-1201-4ccc-84cc-9f299695c990_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_8e4db38c-193c-47b3-88ed-c208485ed758_negatedTerseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_8e360b1b-2e27-4e46-b3a6-4925eba69e6f_terseLabel_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS</link:label>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_label_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS Logistics LLC [Member]</link:label>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_documentation_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS Logistics LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember" xlink:href="pbh-20201231.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GEODISLogisticsLLCMember" xlink:to="lab_pbh_GEODISLogisticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_4ef2a5d4-4499-41ce-8acd-1bf0b8700ae0_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_43ced330-3f18-45f5-b5ce-8efaf56b6d6e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_03c83f58-e4f6-44cb-96bc-892c046450cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_57fe0929-c8d5-4cb9-bc62-818e8344a491_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_40f17e31-d221-4720-8826-5a5d0c467c40_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4990a15f-76ca-41ae-8ea8-bc9c7d8d69c4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b0c7947c-e1fa-42a5-ba22-afa2a37d21f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_37fdb847-a7ab-4352-8783-59baa1f78132_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ae605105-155a-42b6-9b05-9edf37bf1dc0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cc0cb1f8-f73c-4bd9-b4ed-655626def03d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_549f2472-6a4a-4fb2-9e8f-825f68c6de99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f8468e36-9cbd-459d-b7be-102594395391_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_c33d8315-bd13-44b8-a2f2-f1726fb15cc1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ccd4c9bb-f0c4-4c22-b148-25f722e0be2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_bfb02654-886f-47ba-b316-6a8764098144_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_41b91914-65ec-4adc-96c0-f3cd79b028ee_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive loss into earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c347e7d-b1de-4777-9342-7c740a0951cf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_de867c90-204b-4d59-90e6-dc1a7de32dee_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_09033796-4341-4452-827a-57e5f6828475_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9de3ed97-956b-4577-8c6f-af78ee6a9943_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3fa9c27e-2b00-40dd-844f-e92b56404eac_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_de53a2d8-690e-4971-9f99-889bacb4c65f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_94afd569-1f51-49fd-800d-cc6c82e6b48f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e7ed5938-5953-4809-95ac-718be71b9fca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_5e3f2178-f741-43fe-b8cc-2d3a3ee8c9f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_2a42f184-7989-412f-bce0-8edb6e160201_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Disclosure Item Amounts [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ef423bf4-a001-4280-969c-254eb0368ec4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Finite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_86ffeb2c-c4a2-4ff7-8aa0-f09711301f7a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3ce86b93-58cd-4170-a272-6f2174a2c7a0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB5Member_812aa6ef-302c-4e00-9866-afdd616d146a_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term B-5 Loans</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5Member" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB5Member" xlink:to="lab_pbh_LoansPayableTermB5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_bd4c73cb-8c8e-4093-8b65-36a5624265c8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_a7138b0b-3c28-40b0-beb8-de9edaebc3ed_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest payable</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:to="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d867167a-2c56-4d53-824b-ce4dba0fe90e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_76e17ffe-d79d-4ce7-8e51-6abbce36d56f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_2431485f-8c47-47bb-bcb0-5199c4a50e69_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_05837b87-4489-4514-a3d4-016930578751_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_5865d503-67dc-4232-9cc9-627e9fc7b8ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Revenues from Similar Product Groups</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5c707926-0ef5-4fa5-aed8-a9c28e0a828e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ca9c46f0-18f5-4986-93eb-d2a677b9f6e8_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts receivable, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_90b8c4cd-e57f-422c-b06a-1f1bbcfe8761_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ffab9b44-7d62-4506-b82a-1616b68e55d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8633fde3-3dd8-40a0-8b33-aecd6d18ce64_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6cc94110-4880-47d4-a709-70de7c6d32b2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3bd27010-96f0-4d1f-bc8f-cfc907af70ed_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2d0f0a35-4126-4d1f-b49c-2dfcadff256b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_47500eb7-cc57-4477-a504-299588d86b69_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing costs</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_96185413-7ac4-4b0c-82d5-59b24798f91c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d004a18a-e9d2-413c-b9ef-641e307207cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2012Member_307823ee-3411-4378-a924-e2577b3b8143_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2012Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2012Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2012Member" xlink:to="lab_pbh_SeniorNotes2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7c3ab618-a2fa-4380-96bb-503cf6367c7c_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, additions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_681acbc2-50d5-4b8b-9619-968bcbcc80a3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f29a4a6d-4db6-4bc6-9533-b0ae68ee4b6e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c5475206-90ca-494b-b2dc-a38e116b081e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4091c17d-5efc-40bc-8cc9-3e5f0b315c04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8eb0ee07-2565-46ac-a397-288bd7645004_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9974b116-3378-4fa3-b84e-64396cd59439_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_36c9fa46-29f0-4ec0-87df-5dc43188363c_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e3062d44-3fdd-402c-aca9-f4a09990f566_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_4e1f4c46-f144-4f35-8381-73f469bb6107_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a21125e3-caf6-49cf-bdb8-fa94b46a4610_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5c3786f3-ed1d-48fa-8bc3-fc1795e4fc6d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d547e682-7b50-4364-8ca7-b27839e6572d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_053fef20-9d46-4ddb-9760-fb7b2c681033_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_89479915-8615-4aac-8562-ed18d6a3f49f_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6e8a9f7b-a714-4749-9212-3b75768c627c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_7656906e-3029-4fac-afa5-d107ecafe898_terseLabel_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_InternationalOTCHealthcareMember" xlink:to="lab_pbh_InternationalOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QualifiedPlanMember_88c9d0ac-94b0-4e5e-9e22-4bee2df9e727_terseLabel_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan</link:label>
    <link:label id="lab_us-gaap_QualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QualifiedPlanMember" xlink:to="lab_us-gaap_QualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87d52694-8f00-4682-b9fb-092890f8f775_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_969df1e2-b7d6-4318-93d5-b0a828d45dc9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_8c299fe5-508f-4bf3-93c3-880b01e1881e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_cc4374bf-45da-4783-a969-2660da54e144_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Primary Components of Net Periodic Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_6b220bc4-362f-4ebc-9e7c-769ab78c020b_terseLabel_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_label_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_documentation_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:href="pbh-20201231.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:to="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_84293662-dc9a-4ae2-88e6-2f2de0e44bf7_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_b95f651f-94ce-4edb-9f33-ee903b1527b0_negatedLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, effects of foreign exchange rates</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b7dee62e-1b70-40ac-9f76-260d79e08f8c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_e80e08ee-f8c5-4ed1-b5e3-64204a706ed4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_bccdc7c9-ccf1-49c7-8c34-06e41d4d20d0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:to="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c1878659-5da0-46aa-b066-355682fcbc33_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to nonvested awards, weighted average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_28f6e876-9e01-4a6c-a710-89f0049a785f_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_61b941c9-c1bf-4fe7-b740-d97549b77ffc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2e56d1a1-a9b9-42e8-baa4-7a88e4d139ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_61eceaa5-a0ac-4089-afc5-b9b0be471cd7_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_f8859202-6391-4a92-9ca9-3f36babcf958_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:to="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a222a89d-b053-4de3-957d-50d4ed6988eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_aa9e225d-cbb2-4ae4-bf75-41d544f5b486_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_336cc3e5-51e2-4ee2-9edd-1bec0656d674_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_00957ce2-8e17-4200-995d-c2d18f01000a_negatedTotalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d5f32cb3-e713-48ab-9530-989f7253add9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_3e3ceb59-ab9a-4628-b0d2-325a65e1ae68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DermatologicalsMember_d722f2a8-d251-49a0-a647-ba3c40fb1f56_terseLabel_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_label_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_documentation_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember" xlink:href="pbh-20201231.xsd#pbh_DermatologicalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DermatologicalsMember" xlink:to="lab_pbh_DermatologicalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_64a68377-01cb-47f4-988d-da62ad0fded8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b842c025-ea3b-4c6b-835f-1dab1bc561cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2288ede2-6bab-4fdb-be34-51ee8d98b967_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ContributionMargin_57708050-2592-4a71-b585-f8b8b0bc87f2_totalLabel_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_label_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_documentation_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin" xlink:href="pbh-20201231.xsd#pbh_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ContributionMargin" xlink:to="lab_pbh_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_bc33e47d-474a-4a1e-8e3a-8c6320c73459_terseLabel_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_label_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:href="pbh-20201231.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_14773f99-c65b-4948-a431-40704ba44398_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_51e3a6e5-9796-47d8-9c09-5446e6e18e6c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_8c7c187c-3b88-44e8-88bd-4ee2ab0958b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_664c439d-8fe7-4a7d-8d13-7df4b8f08ed3_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1b38ed80-977b-4bd1-a110-1df0cde62350_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5cfa4850-0f39-4439-8289-87d51b11a035_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_2aca3279-7ea1-420e-980a-9edbbe2fbcc6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_64967a41-3b01-4b0e-bc82-f3bf76735439_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_c11d8698-cee5-4090-83fd-a2b0266eb977_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5a0bb01a-b925-4de3-819a-6f50f2c5f8b2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amount repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ad75ed6-9b0d-411c-a015-72cf1b29ef0f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_da2ae217-339b-46fd-bca8-9d44252d7861_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4b6f53b0-b5fb-4647-ae68-d8ff86a3e330_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5ed402ab-a525-46ab-bb8c-a5b1ae086354_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4b3a9403-04e3-4a69-80a8-1ef9cc2a4314_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_90689db3-a323-4248-8499-f9c36f1ba5d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_55a4f635-c96f-410e-9317-9399c3abda73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_91a770e7-6ff5-4dec-abc5-6ed9c352d121_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_6e9e1673-88cf-4987-a4b0-b79db75cfcc2_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension of plan term</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_aeae5f9b-68c2-40cb-879e-14591cb5689b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9863b24f-175f-44d9-9658-40554550a35f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03722473-6e60-47a1-9bc6-de8ab5f7b526_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_608c2af3-1e7e-4aef-9097-4040a79522d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_4283125b-df3a-453c-93d5-e19b534d39ad_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_948d72e9-cf36-416d-b27f-2c10932af25c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d36d6ce2-5c4f-4ff0-ac46-3a0ffc97fd9c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_d3f2a813-bf79-4a52-8c12-57268d74cdd4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Segment Revenues by Geographic Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ed843306-bbd3-4622-b1f0-6d892d915527_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of nonvested restricted stock units and options issued to employees and directors (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_f8f4d31b-d7d9-4e5f-a59b-ed02d6bf35cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_26bab3e6-8741-475d-9a38-4d560e06e4e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_9a002340-8fb9-4f04-b43c-2a6c8c6035d2_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d2e31f71-933e-404e-bd34-b4cd3fa756ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Operating and Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b1147b24-5464-481e-88e0-e38ade5f30c8_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ed721650-a162-41c7-a070-403c5ab1be15_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ac51e63-9442-49ae-9e50-d50e7400aea4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e516f20d-9d78-4fad-8c8b-066094dc877d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_75b929bb-d2f8-4a3f-bea5-6a5e92f6624c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e7e43534-9bc8-4516-a0b4-edc65ac1a625_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5f8d4a05-3bdb-4f5e-8a5b-f98236de0c24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bdaf949-211c-4e9d-a4ed-8043989a6456_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0ca7fdcf-f2db-49c0-bd35-77063042e087_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_209912c2-51b6-4105-aa72-9c74f7f9c315_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_c7189722-79a3-45bf-9e3e-ff6a03f3ffab_negatedTotalLabel_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_label_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Income (Expense)</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_documentation_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense" xlink:href="pbh-20201231.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TotalOtherIncomeExpense" xlink:to="lab_pbh_TotalOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_37dd5607-bc4b-4d7b-8028-85483c20463f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_1a4cd1d8-88d5-417f-8424-96366bb15f0a_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers with long-term contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:to="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_b7b5fc1e-3939-4943-a777-199a28c5d65c_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_a67d6770-edee-4aa4-ae8b-337a393f047c_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_cbcfa369-7483-4289-a185-b16099c17dba_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturers" xlink:to="lab_pbh_NumberOfThirdPartyManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d6d58bb0-6db0-4d2a-9177-e861540f45fa_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_774f9673-b267-422d-bec4-587c216a163e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_466f3d32-df49-4684-bc1a-c22b0d9a69c7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_b23d9a2b-4754-425c-82e9-67b949e2be85_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Recognized in Other Comprehensive Loss (effective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d0d0a320-1062-4f9b-9df2-d3b5f9fc62c4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_69fbc187-e01b-47fc-9580-a7bc2dedecee_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c41f888-6a36-45cc-a589-b4ed4737c048_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d0c2ba3e-a3c6-451d-8680-fda97ab9b270_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_cf577892-47df-494c-93ea-e1742e5533bf_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b55e355f-4563-4349-9e47-92f602c2a241_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_112100fe-4e62-4b3a-9947-a053039d86c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_53fa13b7-2791-49e7-93c6-21169ed584f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_8dbb9d9a-febf-4f73-8bc9-d17bd8a247ba_terseLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due [Abstract]</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_35fefe1b-3da6-41e0-a8ae-3055462c2261_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_b55f0645-c0c5-4328-90ac-f3105bf9ccc8_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_04768920-bd4a-4d23-98c3-5981fd8fb9fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_bab8fcd7-b32c-40ca-b5aa-310e452e246f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2e11be1a-6e7c-4d17-a110-67c6267c0b10_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_70f70880-6b56-424a-87ce-8f3760a35493_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_aeb41ef8-3ca3-497b-950d-0368b6b0e308_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (Remaining three months ending March 31, 2021)</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_31690dd7-464d-4236-8dd8-0d35ee387678_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f7dcfa92-79fa-42b8-81cf-1ac870cf43c8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_88f04ca7-73a6-4f8b-8a8f-7680e8952c72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_dbaa73ac-aaad-424f-8291-3b21e1d030df_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining three months ending March 31, 2021)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_6dc3ed9c-d0cd-4d77-a541-8f884be8b89e_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8e557072-6845-42a2-8a09-b84a5eefa1dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares surrendered as payment of tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_276498f4-2fcc-4b8e-b2e8-b5fcc732b041_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_94d35ae7-b425-4d9c-9596-33f02b03867a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_f52741c0-2e6d-4936-8748-a7123a0959b8_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_accd9c65-4308-49a5-8f62-936e1f05f93c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_6c33944b-481b-4319-8bb7-933b31471b7d_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLossOnDerivative_24ac80ea-7af8-469a-98fb-b440c19a8408_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLossOnDerivative" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Recognized as Expense</link:label>
    <link:label id="lab_us-gaap_DerivativeLossOnDerivative_label_en-US" xlink:label="lab_us-gaap_DerivativeLossOnDerivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Loss on Derivative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLossOnDerivative" xlink:to="lab_us-gaap_DerivativeLossOnDerivative" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_b81bfcfb-72b9-4472-98c1-8356f580ccd5_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_b297d239-6282-405f-b17b-1332b4158e82_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_254e56ae-c3bc-418a-b1ab-d1b406bf3a20_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_2dfc0e1d-40eb-419c-b591-fd2ab0f1a830_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e2965126-00a4-4d7f-adb8-7421690cd6c6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ee80be73-3eed-41d5-a0b0-dfc97a58b573_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashExpense_5a98d93d-e9cc-4499-8df9-665bf7902d42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashExpense" xlink:to="lab_us-gaap_OtherNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_843bf80c-25dc-44a2-ba83-6da60ba0814b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d6ffbc96-52ca-440e-b391-29e242f2092d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_7da76060-16fa-48ab-aa24-f6df80b6bb56_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_721481a5-ad87-4ef1-a280-96931bc5cc2c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_023350c6-2cb9-479b-ad8c-6eac970f862b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_845ec971-b247-4fbe-8af3-85a03f25a1c2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_159f6062-9286-4e01-8e0f-5cc42e048076_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_fbb5bc9f-95ff-4de2-bea3-4196a7a3c16b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cab498fa-5cff-45a1-bfd9-9c7a0ee2125e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_09d4ba93-e762-4329-8edb-39eb7f648249_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_583a0200-de82-4cb7-a36b-4058e763d068_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_1df3e411-758f-45e6-b121-e23e106960e3_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e1a168d5-42ce-4b32-b314-ee5b0e125c1f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_df55eb22-695e-4928-8fbe-7e2093909f55_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c7c11469-7320-4491-be78-f143d4958914_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_37e45f19-c7d4-4d93-aa7b-6729b50eedcd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0b2945d0-f4cd-4a41-a099-6548faf833ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_33a71c9d-7380-4d3d-ac15-1023501f4e13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3ef96ac3-bd3d-4376-bd94-6fbf131752e1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d196641d-a7fc-4ed1-8407-33cf76b0e2d7_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_15150792-ba1a-4a03-bf97-dd7dd8458ac6_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_64280ffd-9e43-4d9f-90fe-3e9ce74b95d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_92dd06e3-ca39-4e96-8921-6a09be1779eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_7c73d46b-c3bc-47f0-9a96-637ef57c545f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_30cd22ef-bc26-434c-993e-7777a339cc61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6976a4f9-092d-4d40-a2d8-89e424b2e6f3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_010459bc-a828-4424-9e03-e0a43ee0f55b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_35dd1675-1d40-465d-8b29-a80dae829362_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_b710199f-9282-41f2-85b9-53b1893f1a92_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_f64d6ef0-11d6-4bfd-a0fe-db82207deff1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1ef8fe9e-cf5a-4b1f-8746-74d30de2a06b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of the year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_6bf34e47-6401-4df1-a7bc-3bc0e7476bb6_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0d174095-5ae4-42a7-8c7d-d5031e7380a1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fac3d003-f881-4a0b-ba3a-4f8c3e66b4c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_40b432c0-b4b6-4cf6-ba66-b2c5892da841_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4271545b-33e0-4377-acfa-758486774070_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_1f01363c-dae8-448a-a4d6-14cc28764ccf_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_cfe6bf5f-8343-4286-908b-c74b38c9bf11_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options [Member]</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:to="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fc70c39e-54c8-4840-a59b-9c280808c264_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_450ee78a-7b2a-4c3b-9383-198562b5a8a6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Aggregate Disclosures:</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Additional Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29530ab8-9dca-4f13-bdc9-5a4cc35f58a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals, gross, beginning balance</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2f666bc0-a47e-49e5-a861-80d2cdb94e29_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals, gross, ending balance</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d58fc66d-980e-4b02-b7da-c5a5b64ec92b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_24577b37-1c4f-4bc3-8955-d9850247f855_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:href="pbh-20201231.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_b2adefb9-a576-419a-9284-c3a3fc7ffae9_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_76075290-a59a-406c-affc-d39667dabec7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_945e2b51-535e-4d70-bf3e-772082c5085d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $19,025 and $20,194, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b218386-ded6-4b8c-a022-062c28ef3d54_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_265eb778-4554-4b47-99c6-1d09e6fe3234_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Trademarks and Customer Relationships</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_label_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_documentation_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:to="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_83082ea1-f5b4-4fc4-9966-c217c1b12210_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f71dfcaa-56ea-427f-9df7-3dfd0aaaa4f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_489f58b3-3cd5-460e-b741-5921a0af6679_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a12528ff-90d1-42a1-845a-e582d0cd43fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_546c2247-90c8-4847-87e9-e024d805c78c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7f0a32f0-55c0-49c1-9e62-a16805cfa670_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ea59647d-3a19-443d-b05e-b395cd80a83d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_16c7252c-e1de-40fd-8f65-7e374e950127_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_51aa58e9-1831-49e3-ad7c-b93638f7b22c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_165e9a95-f9a6-4ade-b3bb-c916d29a7775_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d14a52a6-84e9-42ad-afdf-25f21869070a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_fa2340fb-c135-49b1-b842-9e4e582afd33_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_461751fc-6e5f-4f9e-a8d9-97536cde24f7_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities into which each RSU may be converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:to="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_35f27b03-1830-4efa-a5f4-8cefb19b05d7_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_71f43e80-6e97-4bea-9f70-0c0cc18d0fd4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_aff37305-f524-47dd-bc38-1b66cb0411c1_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b3a205c4-6a22-476d-a454-e0b34bba3674_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_265e7efd-e9ed-4447-8695-28daaeb746e3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Carry Amounts and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_eed361c8-ec1f-40c0-9e10-11c3261fec64_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_633a3e28-54cd-44f4-bd11-848d64db9501_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, tax credit, foreign, amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_94c8119e-421d-4547-955b-79b959d62e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84e7fbed-5317-43f1-9d09-e69b04c90466_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_e7731c41-8064-4314-9f5e-49ce0ade8817_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_68e2629e-8a09-44e3-9e3b-68ec577faabf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_22ef82da-4bc6-448f-9a24-f8431e271bf3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_876db352-b6b5-45ee-93ec-ce53038406e8_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_6777bd16-38e0-4328-8fd8-176b6a6362fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e852b19b-3dd8-49c1-8fb5-30a690a42c93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ddaf9f68-1e3d-4fac-b52c-1aef39a2b814_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c5ee6f1-6084-4a96-91b5-173c70b5372d_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0e675fd9-557e-414d-bf89-2beb8c2e9833_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7dad94d9-48ef-44f1-9414-5d2743e4e2ab_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f28ec919-2771-4ba1-9b5e-569c8c0ac995_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4cf57b60-6eee-40ff-8788-4ff0594e655d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_a0c8d672-b2c3-4f0f-a4d9-86a110186361_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a53ccdd4-0c50-49a7-81cf-16903aea092b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_be0261a2-e6fa-4db6-903a-378b837741f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_49bdf399-ff29-47d8-9e9f-9859dce18fde_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_add081b3-dc2c-4665-8464-c44fa459bf45_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OtherOtcMember_7241bb24-4e76-4c75-afbb-dc2a6d9d1695_terseLabel_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC</link:label>
    <link:label id="lab_pbh_OtherOtcMember_label_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:label id="lab_pbh_OtherOtcMember_documentation_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember" xlink:href="pbh-20201231.xsd#pbh_OtherOtcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OtherOtcMember" xlink:to="lab_pbh_OtherOtcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_062a71fc-85f0-4f91-97e1-722c485c210b_terseLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_e3174510-4cc4-4f77-b291-3c389f7eb961_totalLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:href="pbh-20201231.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:to="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_800401f2-9e3b-4f52-b2dc-326e839f3751_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt origination costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CoughAndColdMember_4fa34258-bab1-4ff4-97dc-320089f0b88f_terseLabel_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough &amp; Cold</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_label_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_documentation_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember" xlink:href="pbh-20201231.xsd#pbh_CoughAndColdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CoughAndColdMember" xlink:to="lab_pbh_CoughAndColdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4746912-d977-4c1e-b3e7-51f984e12705_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_664b2527-865a-48b7-b9ce-aaf4715256b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of 5.375% Senior Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_2c3e05d8-83df-4bf3-971a-be2ae5bb8736_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_a1b4ca04-c4d6-4486-9b03-b8d9e8998dac_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_0edbd231-3736-4fa5-970f-9741fd6137e7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves related to obsolete and slow-moving inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3d1f08b6-f020-428b-a4ce-28b58ca6de65_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a26dd33e-b83a-4df5-84e0-8ed6a7df3a0c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax share-based compensation costs charged against income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_151e9b4e-1e65-48d3-b756-385a7670b0e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_b190087e-4930-4f9a-a1c8-e6209c110c10_terseLabel_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales excluding depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_label_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Exclusive Of Depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_documentation_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:href="pbh-20201231.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:to="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_db52b337-9bbf-4d5f-89e4-09a2c1c8e621_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_2ea3b173-6d80-4a9e-b0a6-e48a93fb2277_terseLabel_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting rights, number of votes per common share owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_label_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_documentation_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:href="pbh-20201231.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:to="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_e61bef79-1a20-4e5b-a482-f7e500fc722e_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_13bc76a4-1c43-4cee-b418-ac3205ed0a27_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f71285a2-0877-445e-b579-0eb7200cd2cb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_be8e966f-07da-4e22-bb6f-07c7c28dcf95_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_7b97c08d-9bda-4c4b-a857-66747cb345ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, impairment of intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_450bff01-5ad6-4ec3-b7bb-7dd8c5672c47_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_819a4e1a-7d6c-4788-adb1-d148870c7ea3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8abe8293-e504-40fc-818e-796f6758a416_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_17b11495-46e0-4a06-80cb-31837736f4fd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9d641305-2de9-4432-a53a-367d58a0f03a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit recognized on compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b7024685-22c0-4523-b047-c0835065bf42_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_469c6c11-a751-4c8c-9512-cf9281d92294_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_231128b0-c5cb-4d9c-a861-6b0bb3910927_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_1af9eba2-c06f-4b8f-af27-aba1578717d1_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, variable rate, minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_label_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:href="pbh-20201231.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:to="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2e22e72d-ce80-4372-aa89-7dde9f0694d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad4c689d-1c3b-47f4-ad4e-8fc99ba43b5f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_0a970b1d-5b4a-4802-910a-d56035f04d84_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB4Member_3614dccb-a3af-46a2-a7ed-6c22019bef55_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-5 Loans</link:label>
    <link:label id="lab_pbh_LoansPayableTermB4Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-4 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB4Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB4Member" xlink:to="lab_pbh_LoansPayableTermB4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_77c866e2-537c-4296-8ba2-e7b6ddecb3ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_88ecfe2c-7f1b-4ba0-a434-8526e143c531_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8db31da-4f51-4545-ab3a-f6bdcc3955ad_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f0a330cd-d003-42f5-b48f-5f60498f28fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_eebc9f02-a51a-4130-b910-e9c29cf6c477_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_01438927-6e79-4722-8ab2-e9c63c697a80_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c6cded7f-5677-45e9-aa93-8b1abbbadb0e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_3958acfb-acb7-4e17-bc44-5212b2bb079d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_354117ae-9de6-4602-be40-8bcdc0fbb800_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_07102507-59ab-4b17-b64c-25118e47d9b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e4810b35-e46e-4942-bb4b-5a6017bbd22a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_deade7fa-18ae-49be-a4d8-46a9325184e9_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b915721c-d1c6-4983-94a1-b99e4c067c83_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_26fefd3a-f1e3-4c31-80d5-6bd53838e42d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_65664605-38f7-4567-9b55-86fe372683d9_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_fe7d2454-7eac-4d6f-8f1e-91b564d62d2c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_be70e274-fed2-4bc0-ae75-e53a68fb0c26_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_50a43f02-c471-44e3-85ab-af1fcde6ca6f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8e8a3e53-07b8-405f-bc0f-a04018ae92a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ef911453-a2f1-4ea3-9d5c-b69c4849b2a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_d38f21e0-ea43-4765-9605-9704be04ac67_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_a5a8fbf0-f916-4f5d-9fcc-3fc9335c92e9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales depreciation</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3e6c9145-b472-43af-8d9e-e06099ea5e34_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d92a246c-2a70-4352-87aa-557516c4729d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_28db7f96-0141-4792-b8ef-7bc2a316ed35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ca8dfb70-cc18-499d-8392-c2698a1d3d06_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b90d355e-5458-46b5-8c49-87db1831b019_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1e010fa9-f2c5-44d6-b0ff-7f8fad3c61e4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_8411c479-2a35-4a6f-ab44-1b0422747043_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e77e4c41-2465-47f8-8fe9-17beef3d3942_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_519a465c-448c-498d-89c4-75eb998f4e3e_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TopFiveBrandsMember_d03a3c87-8dc1-4ebe-9ec3-4436aab61e24_terseLabel_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top 5 brands</link:label>
    <link:label id="lab_pbh_TopFiveBrandsMember_label_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Five Brands [Member]</link:label>
    <link:label id="lab_pbh_TopFiveBrandsMember_documentation_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Five Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember" xlink:href="pbh-20201231.xsd#pbh_TopFiveBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TopFiveBrandsMember" xlink:to="lab_pbh_TopFiveBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_0562aed3-d4b6-407d-a21f-40ffb273dca5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_e6ddf6f5-cd97-416b-a391-2aaa1ce9ffe8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_7f6e27d2-b461-48f4-9e6f-d06840072cda_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6ba0c1ee-3ed1-4aa9-9990-308ab3fa75dc_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_15f1b10e-8d4a-44ea-90b9-18cadf72e313_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_18580ec8-9ed0-459b-b6dc-a030e4c9dbc0_terseLabel_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued production costs</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_label_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent" xlink:href="pbh-20201231.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedProductionCostsCurrent" xlink:to="lab_pbh_AccruedProductionCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d101c32a-95fb-4bd5-8eb5-4af43c7ed75b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0039eb57-71e8-4150-b945-55aa5f91c7b6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f047fb57-4edf-4ce5-bd37-ff8f147c4f87_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3ea00e64-b775-4c33-a171-64a6d486718e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c87b4b7a-856e-49aa-8c7e-555e1ae56e3f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f5e3d66b-1a48-4edc-a0ce-47a84c368fa6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_948ffb6d-c332-4f0e-98d0-f126368a4026_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c7631d06-c1e9-468a-8cce-69a2cd425aad_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_52a2d948-fe92-466a-b3d3-1ee667e42dfd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_463a2ba4-2a3b-4781-8b9f-d4e48f22a547_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_73da39d7-5d97-472b-9224-31a55fedc848_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_64fb1f66-1fa1-45cb-97cf-56b8aadc2143_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_498fcc7a-7e9c-478b-997b-971a9c6f1ab3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_296883ff-54d8-4433-aba1-1c127f469949_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (Remaining three months ending March 31, 2021)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_318a3a05-b68a-46ed-af19-59adf9a927bb_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_3895007e-4627-4b84-92c9-8de4bb0b567d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_bc98669c-b07d-4008-acf4-29462e7109b6_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_93ba4f59-c193-43df-9d8e-66d827d79167_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a4d2f04d-7c1b-49f5-aafa-5fba5ed2bf39_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c2a91486-ccdb-4f6f-857e-c0337d0c4d87_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_313f26a6-eb06-4a7c-a13c-5606f77122b4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_51cfe2c3-b229-4398-bfe7-0430203b62f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_6379c00b-880d-4213-8815-a430bed828ef_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_4f52e84a-40d4-48ba-8be2-b29e9e428804_terseLabel_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="pbh-20201231.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EscrowReceipt_e6c47d96-a00d-4ed2-ba8a-dc12ef7bee0b_terseLabel_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow receipt</link:label>
    <link:label id="lab_pbh_EscrowReceipt_label_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Receipt</link:label>
    <link:label id="lab_pbh_EscrowReceipt_documentation_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt" xlink:href="pbh-20201231.xsd#pbh_EscrowReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EscrowReceipt" xlink:to="lab_pbh_EscrowReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a976be15-877b-452d-a76a-0f91ca187ade_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e8dffc3-1d8e-43f3-b1b4-fe1fa51e3327_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6a000f2f-d2d2-4763-8a3d-e63c538d185c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_2282ec14-63e4-4462-b0ca-a273553fd52a_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d78f2aa6-accc-44a2-8e4a-463127e6786c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_32fcdbb7-0bc3-4aaf-90fd-576b4089dc58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, reclassification tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_498d2872-b9bf-4241-97af-3378ac215993_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_78490c09-5403-4d21-80ed-2a47b99d71f1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9554447f-0158-4eaa-897e-6ba72672cd6a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fee345c8-57d4-4e2c-91c3-09224ad20a6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4ab01ac3-b50d-4b4e-bdc2-573fcbe50442_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ac130af5-b68c-4422-a16d-dd35c80161f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on pension distribution reclassified to net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d850359d-0bff-4b6b-be41-c395d22f38f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net gain on pension plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_5f0e4f37-188a-47b2-964e-c8530e5be4d7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_23381413-1882-4aa8-8791-89a1fb367fd0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_bf27d2cc-6400-4438-8d1d-f28f45b93107_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_1460dd68-25f7-4655-8b68-f52c1a541833_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_780e7e55-037d-4f54-970a-2519d6efc563_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_bb2b489c-89a7-437d-898b-fed047294c81_terseLabel_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:to="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_7a9219ee-fa5a-4d0b-b70f-5f334352c5c6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_be3478e4-e6aa-470c-91ce-0ae57d89cb98_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1b6a1e54-fb28-49fd-99c7-72ed0b861276_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_98b562c0-d61e-4488-9ea5-7bc78eedb0dc_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3a066259-417f-464d-9735-22623a972189_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_b4424d8c-bdbd-4725-8963-9a5146f5bcfe_terseLabel_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember" xlink:href="pbh-20201231.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareRepurchaseProgramMember" xlink:to="lab_pbh_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_353b85ba-b67e-4027-8273-62487e0132f1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_c8133fd0-5411-41c2-ac2a-6d3d496a0c7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, beginning balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5aebf28b-4d8c-467e-83ce-80faa19c9e5a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, ending balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_a446f930-8ff9-4971-ac43-7a6d04dff8e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_2d7100c8-fc15-43fe-be2f-c795ce41a453_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e36e633d-8369-428c-9283-638803409942_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_9e1c6d15-6c9e-40ce-b6bd-75c56bc3b802_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_177e86f2-566b-48db-8c9e-fa349a412f0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_99db6f86-3774-4d85-8923-333fd9be679a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a7b0afa4-0147-4701-ba74-0ae65864e858_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_5b8ef966-4f3a-44ba-bec8-dcd02db5b475_verboseLabel_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_label_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_documentation_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:href="pbh-20201231.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:to="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_244a700b-fc57-4fe0-812b-fe7a0a72a7f3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_99f0c131-2223-4069-81ec-089a17d6d6db_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_142c4bf8-c2c9-4f89-85e4-2236007dcd06_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1aa7fbc0-a4c6-469b-be66-def3beda9555_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_cf41a09f-620b-476d-a849-c62f57b25a14_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_8daadfe1-ab17-4418-832c-4c55d5dfb7b1_terseLabel_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite- Lived Trademarks</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_label_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_documentation_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember" xlink:href="pbh-20201231.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IndefinitelivedTradenamesMember" xlink:to="lab_pbh_IndefinitelivedTradenamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_dfb58953-9069-4e2c-a8a8-af97eefc2fa2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d44f5b52-b9b5-4424-a114-3e323230abac_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_909bbce3-bb14-4f84-87b3-0e8775cd54ed_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of options and RSUs vested during the period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6e48d83f-31b2-475c-a201-7c28708e1200_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f1f5889f-d7e4-4e45-834d-c9971ada3126_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic earnings per share &#8212; weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_feb17af4-bbeb-4039-a2a0-b5abff143ca0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b49f6a84-eb71-41b3-bcbc-1cacd26487f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_63664753-22b2-43ad-8e75-548d8e87a09d_terseLabel_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_label_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_documentation_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:href="pbh-20201231.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:to="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_948d283c-eec8-4b63-9419-9601abfbdb4d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_5b28e837-614b-4581-b3d6-e11937c61a47_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_931aac6d-1972-44c2-926c-b8a04108ea98_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_f14eefec-0685-409b-b1d3-efa4d419f8f0_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_2a5e326b-2c4c-4820-bb6f-66a679bf9513_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_fe67b730-0406-4e94-b09d-7c1f1d44b7f0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_78cddd15-6f9a-4efa-ad61-77ef6dd202f2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_72943113-9bc8-4d63-90cf-df6ca9bd8e92_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_bdd4c52a-e309-432a-a471-f61f2e13d175_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (Remaining three months ending March 31, 2021)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_ea3109b6-9080-4000-ad73-e6c6e2e45a0f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_7543dab5-35c8-4f63-a669-9cf559c176b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, senior notes and term loans</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0be34580-bba7-4d12-b5d0-b05b9b9b8bfa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_08a9f194-c20e-40d6-8cdb-36ffdb31e2d0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_f6ca85c4-22f3-4b29-aadf-c436e173a641_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_357ca374-03c1-4a08-9d86-b6c8824f6cf3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d3f1e4b4-99f9-4493-880c-75baa600a1ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3bdf2d51-dda4-47fa-b553-794fbb76fa67_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_11a182e6-1830-4618-b22a-756a14fb30dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_c9657ad5-fe41-44da-8dad-e8f93c70612c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_60a05405-b9e0-468c-b236-c5fa0eba9725_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_17ecd109-a542-4a6c-9a2a-4bedcd6c70d6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8e98f7f8-82ce-4cf4-a348-d61e95051be8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_b5a89da2-fb03-4c86-9c23-9d79abf21113_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f46e8155-8e1e-4779-8b15-b01e7a36743a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_a17ceaa8-2024-4255-b618-bdcda67ad258_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Consolidated Goodwill and Intangible Assets Allocated to Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_7577bb10-2784-4551-9818-09666219df6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_078ed211-9822-44b4-afe1-8d713520fe38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_76c1526b-c194-464c-bf6e-46f3f3fa8089_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_028fade9-abf0-4688-96fb-53e51bcf9ca7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt (including current portion)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_77d636d0-8324-4c64-a7fd-d3d339c1ce46_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt (including current portion)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d558f082-3e4f-4379-aeb7-0051406c59d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_d3437437-3f70-4f47-8aff-886bc2516ae3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4cf371cc-85b2-492f-ba6e-a68a96bed58a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3da83f8f-dd14-4f1d-b35b-1c95712945bf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_df513110-1885-4b5d-a404-2a52f1aaf992_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b9bff212-df96-4bf4-98a0-592d70957464_periodStartLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived trademarks, beginning balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d641f9c-2eec-4e26-ac00-5b90f750ca69_periodEndLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived trademarks, ending balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8074600d-1b81-4219-9789-ab1e24667429_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3e242ddb-87ed-444f-b299-ec1432a2b721_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_a7103519-4ab4-4a8c-b676-6f8874219505_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_label_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsRollForward" xlink:to="lab_pbh_IntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f28ff271-dabb-4d17-acef-50c38af8570b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_3cdcf519-4fd3-41b2-b6e3-5e750d098ac0_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_bc2ad99f-9113-4a99-9c24-9ff417d5d3dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c265aab8-2518-4f16-84f9-b5498544aa57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c064970f-34ed-46d5-bd47-18812b13ea45_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8a22e3-c6f9-4879-a6e5-e8fd86a037a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b86de930-da1b-417b-a2e4-872e23e76229_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, beginning balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b952005d-b108-47f5-bf20-191d1cf61a93_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, ending balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_957fabd7-9e45-42f7-828f-edff270852f1_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_0a92b119-684d-49fc-8396-eb1b52bcfec9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_4425110c-25ca-4b03-bd9f-7adf947590b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss):</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_b842f182-3313-4095-b40a-bfcfeb5579f6_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_25df22ba-78fc-4519-891d-becb83632c9a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AblRevolver2012Member_fa1577e8-bc83-4268-9f74-01be09d8450b_terseLabel_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_label_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_documentation_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AblRevolver2012Member" xlink:to="lab_pbh_AblRevolver2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7a9db49c-3ed4-4208-94bc-e5e752c9f7e3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_50ddf7f4-3b1f-4b13-8f90-4d3ac2614526_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_97f01def-8d83-4582-9149-1faa5649b87c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5ca9544-9fe0-4254-afb9-86e2d3df8210_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ca5daf85-1413-45f5-884c-66db9043aee4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Additional Disclosures:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_b5b9b2fa-ef0a-4905-8910-2cf5303591c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3747dfef-7a9c-447f-b0a3-042562bcd145_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc738d17-2ccb-41a1-82e3-f4ab92af4287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b66763a-37f9-4250-997a-0314df79117b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2019SeniorNotesMember_fd018cab-c050-4778-96ee-42cee21f0281_terseLabel_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_label_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes [Member]</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_documentation_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2019SeniorNotesMember" xlink:to="lab_pbh_A2019SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_844a90b4-c899-4ca1-be5f-4f5faef7a76c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived trademarks, effects of foreign currency exchange rate</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fe327fc0-7aa2-4455-8bad-1c57b1057096_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e4985dbd-5617-4b74-bfee-01d78417ff97_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c159bba1-9a81-44ad-848e-4c6c506324db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted, exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d218a5ea-3bd9-4486-9433-3fbdb6267197_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_76c27edb-fead-4dac-88ce-c3050f67228f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5af262b2-75fc-4a84-842f-cf665061b5e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_bb4672b3-b36d-4f4b-a77e-942604bad3fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_afd8e298-a720-48b9-ba04-bb11e8169b70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 4,033 shares at December 31, 2020 and 3,719 shares at March 31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0f2b0ec5-bf20-4ad8-ae5f-516571b51647_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EyeAndEarCareMember_b2386708-fca2-4c77-8097-3c39a11ffbd9_terseLabel_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye &amp; Ear Care</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_label_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_documentation_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember" xlink:href="pbh-20201231.xsd#pbh_EyeAndEarCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EyeAndEarCareMember" xlink:to="lab_pbh_EyeAndEarCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e5073952-78af-472e-a770-9e193d5550db_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_59f80234-923f-4dd1-8145-b1bf458b3d82_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d6bf6844-d4e3-4807-90f8-fee1065fed41_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2136dabe-0d4a-45cf-86ac-f1eba1382e31_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d9434459-d3c2-4fa0-9d93-16382a8295ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_62cf1054-0769-41d0-b1bb-22f1f0f594c3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dad26867-97d8-4dc8-bd03-e4d1418dae4c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_18baa944-3fda-4ef7-a60d-2308b81cd089_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_02ce381a-5937-4fba-a2c7-95fb920cb3ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>pbh-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fbfc543b-660c-4d73-b034-6fef186fd9eb,g:bd46f1cb-8378-49c4-aa63-4b8343c3ea6e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="simple" xlink:href="pbh-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9da075e5-008b-4c2b-912b-4aef1c8984da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentType_9da075e5-008b-4c2b-912b-4aef1c8984da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_08549622-9977-4fb9-be10-ff7babab47ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentQuarterlyReport_08549622-9977-4fb9-be10-ff7babab47ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4bfaf8e0-2adb-46a7-bf55-8397e5b89812" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentPeriodEndDate_4bfaf8e0-2adb-46a7-bf55-8397e5b89812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_96b3e742-d591-4bb1-b325-bf9d61c7d41d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentTransitionReport_96b3e742-d591-4bb1-b325-bf9d61c7d41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2d9ae418-a37a-4b66-8cac-cb9e86a998be" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityFileNumber_2d9ae418-a37a-4b66-8cac-cb9e86a998be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ec1a8192-78a7-467d-a32e-341ef00eacb1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityRegistrantName_ec1a8192-78a7-467d-a32e-341ef00eacb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d6464edf-443c-4cd3-90a4-8efcd3d6d102" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityCentralIndexKey_d6464edf-443c-4cd3-90a4-8efcd3d6d102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c0456511-59e8-4711-ad81-57f246ca0884" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_CurrentFiscalYearEndDate_c0456511-59e8-4711-ad81-57f246ca0884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0e60d8f1-f2ee-4721-8312-5288b064fbf7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentFiscalYearFocus_0e60d8f1-f2ee-4721-8312-5288b064fbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c2c558d3-2056-4ac3-9934-efbcc6b3f4f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c2c558d3-2056-4ac3-9934-efbcc6b3f4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b8fa06e3-89ae-4f8c-8dcd-486ffa82e71c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_AmendmentFlag_b8fa06e3-89ae-4f8c-8dcd-486ffa82e71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_732a8c72-2fa0-48ab-830e-0e99cbea35db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_732a8c72-2fa0-48ab-830e-0e99cbea35db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8cfc5463-c4d2-4a67-b686-5c94f1516473" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityTaxIdentificationNumber_8cfc5463-c4d2-4a67-b686-5c94f1516473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_167dddce-f36b-475e-9628-190664baec9b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityAddressAddressLine1_167dddce-f36b-475e-9628-190664baec9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2e795872-8aaf-4591-bdac-d5403fe21590" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityAddressCityOrTown_2e795872-8aaf-4591-bdac-d5403fe21590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_eea5f1cd-32bf-4457-af3b-afcd71892c38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityAddressStateOrProvince_eea5f1cd-32bf-4457-af3b-afcd71892c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8e0048bb-6100-4c16-a1ee-23a1eaa45d0a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityAddressPostalZipCode_8e0048bb-6100-4c16-a1ee-23a1eaa45d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f007dcf1-2bc9-4b11-a7d0-adc77b7b4c0c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_CityAreaCode_f007dcf1-2bc9-4b11-a7d0-adc77b7b4c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_97a4d9b6-8a46-470f-a9e4-56143c541b86" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_LocalPhoneNumber_97a4d9b6-8a46-470f-a9e4-56143c541b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6870eb4d-2036-4c99-8233-2acde42f2b0c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_Security12bTitle_6870eb4d-2036-4c99-8233-2acde42f2b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1751a0d1-8ed1-46a2-9aac-4e3012632cc5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_TradingSymbol_1751a0d1-8ed1-46a2-9aac-4e3012632cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c7b9c9a2-d275-47a0-bc4f-70e993fe8bc7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_SecurityExchangeName_c7b9c9a2-d275-47a0-bc4f-70e993fe8bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_baca6d43-8615-4d5b-a963-b0c65c9eb86a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityCurrentReportingStatus_baca6d43-8615-4d5b-a963-b0c65c9eb86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a3d51052-c407-4b70-9605-643761446ba7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityInteractiveDataCurrent_a3d51052-c407-4b70-9605-643761446ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b31369b4-6a99-43ab-9db6-714d5cbe5f02" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityFilerCategory_b31369b4-6a99-43ab-9db6-714d5cbe5f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6e2318b5-7ed2-4284-94c8-8a404448d129" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntitySmallBusiness_6e2318b5-7ed2-4284-94c8-8a404448d129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_50e76a0f-f145-41b6-be76-96e5001d688f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityEmergingGrowthCompany_50e76a0f-f145-41b6-be76-96e5001d688f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_790c9120-800a-4ac4-97b1-cd12fda0bc07" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityShellCompany_790c9120-800a-4ac4-97b1-cd12fda0bc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_478cd344-7d97-485c-a362-5263778041ed" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9bd89f55-5228-4816-9b3a-6e3b15fee92b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_478cd344-7d97-485c-a362-5263778041ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f1f53005-8a8b-442b-8b05-997f2328904c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f1f53005-8a8b-442b-8b05-997f2328904c" xlink:to="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:to="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_31a09d77-8451-4e59-85c7-fd3082973bea" xlink:to="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_7b0e3874-6f22-4778-9163-1730c2e9c10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:to="loc_us-gaap_ProductMember_7b0e3874-6f22-4778-9163-1730c2e9c10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_013a05f6-c1e2-4836-b430-94720aeae926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d47f5216-695a-49a4-8983-1471a5729dee" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_013a05f6-c1e2-4836-b430-94720aeae926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_500151c1-52c8-4d92-a3d7-d41e11fff926" xlink:to="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d62b6d5-9cd0-426a-9cf2-33d2ecce2720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2a03f4e3-f905-45c5-91de-13e0f9296f8a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d62b6d5-9cd0-426a-9cf2-33d2ecce2720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_99f1b424-2e2a-470d-84fc-d6985f0f59f8" xlink:href="pbh-20201231.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_99f1b424-2e2a-470d-84fc-d6985f0f59f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0b65d0d2-ab28-40b4-974a-de4ff5652f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0b65d0d2-ab28-40b4-974a-de4ff5652f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_6d0231dc-fafd-462f-a026-4d5c687b698b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_532d4341-5aa2-4f46-a558-2fe42d47bc5f" xlink:to="loc_us-gaap_CostOfRevenue_6d0231dc-fafd-462f-a026-4d5c687b698b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_73dbee35-5276-498d-bfcc-cb731f212e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_GrossProfit_73dbee35-5276-498d-bfcc-cb731f212e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_32b161d5-dca6-4d20-9014-4cb28a137b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_32b161d5-dca6-4d20-9014-4cb28a137b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9bb6e525-3469-40fd-88d5-ccaa4d72d145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9bb6e525-3469-40fd-88d5-ccaa4d72d145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_05b0f21c-74b9-4251-99a5-f5f88766eca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_05b0f21c-74b9-4251-99a5-f5f88766eca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_910caaf3-2d02-4a65-9772-a5ec44f64efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_45857c0d-4fa9-4834-aafc-b05132d12d7c" xlink:to="loc_us-gaap_OperatingExpenses_910caaf3-2d02-4a65-9772-a5ec44f64efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_597b0534-b109-4856-abb2-5397413434f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_OperatingIncomeLoss_597b0534-b109-4856-abb2-5397413434f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_fa8d7580-b5af-4096-996f-46b3511ba7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_fa8d7580-b5af-4096-996f-46b3511ba7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2887aecf-9968-46b8-bb46-8fad711a1219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2887aecf-9968-46b8-bb46-8fad711a1219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7253c646-d704-4881-8b0c-d9cae9280d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7253c646-d704-4881-8b0c-d9cae9280d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_79bf0e5f-6498-49b3-a5eb-0e57c4141135" xlink:href="pbh-20201231.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a41798a4-8445-4fc2-82eb-e0a324027385" xlink:to="loc_pbh_TotalOtherIncomeExpense_79bf0e5f-6498-49b3-a5eb-0e57c4141135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_352b368b-5067-4d79-a0a8-b7ee7837357c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_352b368b-5067-4d79-a0a8-b7ee7837357c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6237c8b8-2e71-4558-8979-3905b9549739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6237c8b8-2e71-4558-8979-3905b9549739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_efe8d169-5feb-4dca-8715-a83208631315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_NetIncomeLoss_efe8d169-5feb-4dca-8715-a83208631315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_91a2c4a7-680b-4165-92cb-595b9f7721ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:to="loc_us-gaap_EarningsPerShareBasic_91a2c4a7-680b-4165-92cb-595b9f7721ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d17fb592-a8bf-4c69-8dd6-3db0a3e2b255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcc29525-4e1a-4cb7-a8c7-4db6a5d39717" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d17fb592-a8bf-4c69-8dd6-3db0a3e2b255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e32b6a7e-9907-4579-9db2-fea44cb838b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e32b6a7e-9907-4579-9db2-fea44cb838b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_838034ce-9d8e-418e-af60-5445450f83f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_571e00d8-a78e-463b-b450-c2eb604ab128" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_838034ce-9d8e-418e-af60-5445450f83f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4ad37aad-2ec7-4ca5-aa9e-ea615c06010f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4ad37aad-2ec7-4ca5-aa9e-ea615c06010f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_5397343c-d133-432a-acfb-0937cae1077d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_5397343c-d133-432a-acfb-0937cae1077d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6c2c75a2-e1f8-4e05-bc47-66060be8855a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6c2c75a2-e1f8-4e05-bc47-66060be8855a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_aedc322d-574c-4678-bf74-cab59f4d7593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_aedc322d-574c-4678-bf74-cab59f4d7593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca3551c4-9b8c-46d9-8317-5ec60fec76d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_696ffa6a-b8cd-4463-b3fa-d3d6c59d6e0d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca3551c4-9b8c-46d9-8317-5ec60fec76d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9a869c02-6192-41d9-bc2d-0f0f176a7e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_232ff1c0-968d-4c3d-99a9-54fe62e3f81d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9a869c02-6192-41d9-bc2d-0f0f176a7e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_421f35d4-7b45-40ce-a604-4916b4b1f509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_421f35d4-7b45-40ce-a604-4916b4b1f509" xlink:to="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7024b6e5-5ab5-48b8-a417-2b945433386c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7024b6e5-5ab5-48b8-a417-2b945433386c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_20c0af0a-0d73-4782-9c60-8715b72bcebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_20c0af0a-0d73-4782-9c60-8715b72bcebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5c8cbf50-8e94-4821-9f56-9771eeaea2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:to="loc_us-gaap_InventoryNet_5c8cbf50-8e94-4821-9f56-9771eeaea2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b91038ba-3764-4e29-804a-493f0c8c7bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b91038ba-3764-4e29-804a-493f0c8c7bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_671dfcb6-8c0a-4db7-8bef-7cde64597eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95a50116-ed5a-44bf-8222-5e803216cbb7" xlink:to="loc_us-gaap_AssetsCurrent_671dfcb6-8c0a-4db7-8bef-7cde64597eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2afe9e06-0be8-41b3-81be-ea167e11b989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2afe9e06-0be8-41b3-81be-ea167e11b989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d7040ed-ecc5-4713-a79d-9e75e49b95f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d7040ed-ecc5-4713-a79d-9e75e49b95f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_71ad7c37-f13c-4224-a6bb-c77ebcd048da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_71ad7c37-f13c-4224-a6bb-c77ebcd048da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a832dcf5-44ca-4c64-a45c-562b6870f4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_Goodwill_a832dcf5-44ca-4c64-a45c-562b6870f4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a08fc73-5f78-44e0-a937-44796976d6d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a08fc73-5f78-44e0-a937-44796976d6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a90a2951-c5fb-4f14-94d1-808a9714a4a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a90a2951-c5fb-4f14-94d1-808a9714a4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ff147592-c0c1-43b0-abf9-08722c0684c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ccf05da4-b7ad-4766-beb2-76bd5c3b39d8" xlink:to="loc_us-gaap_Assets_ff147592-c0c1-43b0-abf9-08722c0684c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_421f35d4-7b45-40ce-a604-4916b4b1f509" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_318c0ecb-ad5a-44b0-9d71-a99c1d1ece94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_us-gaap_AccountsPayableCurrent_318c0ecb-ad5a-44b0-9d71-a99c1d1ece94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_24753872-3c7a-48c4-b8ee-c71ac4c24e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_24753872-3c7a-48c4-b8ee-c71ac4c24e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_dbbaf177-48e6-4630-9b2f-b2558b25eff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_dbbaf177-48e6-4630-9b2f-b2558b25eff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_98c6ac94-845f-4867-9b6c-420e842f0c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_98c6ac94-845f-4867-9b6c-420e842f0c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_8e038c3e-fe76-40d2-8268-8ef8bd47e1eb" xlink:href="pbh-20201231.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_8e038c3e-fe76-40d2-8268-8ef8bd47e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a38fed4e-c7ae-4c26-ace3-6d8b043e1603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_232085d0-8c3e-4a1a-9845-a65d7ce9e57c" xlink:to="loc_us-gaap_LiabilitiesCurrent_a38fed4e-c7ae-4c26-ace3-6d8b043e1603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d3e08e1e-b5cb-46da-9a05-5b69352100f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d3e08e1e-b5cb-46da-9a05-5b69352100f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_49f0938c-c076-44c7-b0a1-6c493332941f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_49f0938c-c076-44c7-b0a1-6c493332941f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0cf1ca75-50aa-426b-9e27-ecc698a525a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0cf1ca75-50aa-426b-9e27-ecc698a525a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af1e9c08-0ec0-44ca-bfa7-aef4669bf100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af1e9c08-0ec0-44ca-bfa7-aef4669bf100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_76157f77-1843-42d7-a718-08eca250f401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_76157f77-1843-42d7-a718-08eca250f401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ba446c7c-8886-4ca1-ba34-22975e64b700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_Liabilities_ba446c7c-8886-4ca1-ba34-22975e64b700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a664af66-e978-4b79-aff8-ab947bfd02f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a664af66-e978-4b79-aff8-ab947bfd02f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cf48572e-b3dd-4cc4-8cc7-2b120890055e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_PreferredStockValue_cf48572e-b3dd-4cc4-8cc7-2b120890055e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b8d541bf-5dc4-46d1-b588-3f072f869c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_CommonStockValue_b8d541bf-5dc4-46d1-b588-3f072f869c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d56842fa-ec90-456d-97ea-aae4e67733c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d56842fa-ec90-456d-97ea-aae4e67733c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_99244949-dd7b-4185-8e25-1da4ca2d3959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_TreasuryStockValue_99244949-dd7b-4185-8e25-1da4ca2d3959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_576737aa-ff84-4bd5-9462-0a574347db85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_576737aa-ff84-4bd5-9462-0a574347db85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbeb5b6d-e72c-45ab-a1a3-db7768eb12bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbeb5b6d-e72c-45ab-a1a3-db7768eb12bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8441621f-9dcc-423c-a183-9bce2967abb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ff061b92-3e68-42c5-b6ce-79b52faac38c" xlink:to="loc_us-gaap_StockholdersEquity_8441621f-9dcc-423c-a183-9bce2967abb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfe3cc62-332b-4532-b755-12db9f001cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4233f2a2-84c3-443d-b914-bd421f02989b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfe3cc62-332b-4532-b755-12db9f001cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bd7f328e-51cb-4fe0-b87b-473ea91966ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee9377a5-a4e5-4ec2-afa3-9c68c1a97eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bd7f328e-51cb-4fe0-b87b-473ea91966ed" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee9377a5-a4e5-4ec2-afa3-9c68c1a97eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bd7f328e-51cb-4fe0-b87b-473ea91966ed" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b9f2f93b-9cf4-46db-bf22-f7b6ead674f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b9f2f93b-9cf4-46db-bf22-f7b6ead674f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8471424f-588e-46db-8024-086e1b63a4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8471424f-588e-46db-8024-086e1b63a4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a00273bf-ce9c-4c42-aac6-19a501d2e3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a00273bf-ce9c-4c42-aac6-19a501d2e3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3436a2f7-17aa-4dde-b157-690c7d122e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3436a2f7-17aa-4dde-b157-690c7d122e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ec1f8463-59b3-436a-8c21-717206c7e31c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ec1f8463-59b3-436a-8c21-717206c7e31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b7af0d96-fa3a-49f9-84ca-45d6a6906140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b7af0d96-fa3a-49f9-84ca-45d6a6906140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b0126215-ee7b-4362-b379-d541a3fbc8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_CommonStockSharesIssued_b0126215-ee7b-4362-b379-d541a3fbc8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_57cf0c5c-5a7c-481c-8b01-8d5738f1852d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_93b6fb8a-3123-4112-8602-28bf7e950211" xlink:to="loc_us-gaap_TreasuryStockShares_57cf0c5c-5a7c-481c-8b01-8d5738f1852d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2aa9ba6c-e34d-4757-bdf1-f1bb1b479d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2aa9ba6c-e34d-4757-bdf1-f1bb1b479d29" xlink:to="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8dcb2d90-cbe0-45dc-9ce0-9ab2ac5d5c69" xlink:to="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdf735bb-1e3f-49f8-9a78-1d7a683fed7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_CommonStockMember_bdf735bb-1e3f-49f8-9a78-1d7a683fed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6d88eeeb-1cee-4a4a-b57c-76d968d6861b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6d88eeeb-1cee-4a4a-b57c-76d968d6861b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cabb8130-a74a-4bed-8e71-c39a4368fc01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_TreasuryStockMember_cabb8130-a74a-4bed-8e71-c39a4368fc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12902fb-13c5-4c96-bdba-45a0e9df63e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12902fb-13c5-4c96-bdba-45a0e9df63e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_574403b4-a1d7-4460-992f-8dfca698530e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d81b729-8887-4116-b870-8c5f1f10f36c" xlink:to="loc_us-gaap_RetainedEarningsMember_574403b4-a1d7-4460-992f-8dfca698530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_33503d0b-f426-4a22-b07d-4ff03b9f6ae8" xlink:to="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b321e40d-cc31-4ff4-a292-67a822d3b09f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7018ec92-e58e-4fdf-be63-e68930d6ce2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7018ec92-e58e-4fdf-be63-e68930d6ce2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d38e71af-ff32-4efb-bac7-7e520d218c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockholdersEquity_d38e71af-ff32-4efb-bac7-7e520d218c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_85a1df6e-0990-4995-b42f-713136a98ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockShares_85a1df6e-0990-4995-b42f-713136a98ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d23b1ab-dfe9-4fce-bd77-9d4f57dfd1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d23b1ab-dfe9-4fce-bd77-9d4f57dfd1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9a7c72cf-1d36-4dae-a543-cb17e1d05239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9a7c72cf-1d36-4dae-a543-cb17e1d05239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_441503e7-36eb-4ca2-b6cd-debdabfe8dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_441503e7-36eb-4ca2-b6cd-debdabfe8dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7800d7c5-ac33-4fc9-a01d-7ea7054fc683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7800d7c5-ac33-4fc9-a01d-7ea7054fc683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_91e137d1-7675-4405-919b-a8c06b802b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_91e137d1-7675-4405-919b-a8c06b802b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ea5a8f6b-a0f4-4e53-bdb3-495220d2f9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ea5a8f6b-a0f4-4e53-bdb3-495220d2f9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bbb3460b-0360-49ab-be10-1706e970543c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bbb3460b-0360-49ab-be10-1706e970543c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17a19838-aa0e-4cbb-8745-a43367184219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_NetIncomeLoss_17a19838-aa0e-4cbb-8745-a43367184219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0731496f-3d6e-44d0-a522-c1fde899b676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0731496f-3d6e-44d0-a522-c1fde899b676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_58857560-3e42-44e6-bac4-60b13feea421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_58857560-3e42-44e6-bac4-60b13feea421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_545a9010-e2d1-4e9f-9e9b-7ad395389ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_StockholdersEquity_545a9010-e2d1-4e9f-9e9b-7ad395389ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_916e438f-d7e4-483c-b795-603c494ebdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c484a925-5c28-45ca-9194-108f529dded1" xlink:to="loc_us-gaap_TreasuryStockShares_916e438f-d7e4-483c-b795-603c494ebdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8429d162-f379-4f63-ad3c-584e1433aa06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8429d162-f379-4f63-ad3c-584e1433aa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_964caf54-34cb-4ebd-ba89-1c9c5d00af45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8429d162-f379-4f63-ad3c-584e1433aa06" xlink:to="loc_us-gaap_NetIncomeLoss_964caf54-34cb-4ebd-ba89-1c9c5d00af45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8429d162-f379-4f63-ad3c-584e1433aa06" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_01be72e3-43e9-4fd5-8dcc-8a4a90b8ef03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_01be72e3-43e9-4fd5-8dcc-8a4a90b8ef03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a30a3bb9-1cfd-4003-861b-02016db7c576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a30a3bb9-1cfd-4003-861b-02016db7c576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_813844b3-5797-4f98-90c4-de1568107257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_813844b3-5797-4f98-90c4-de1568107257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0ca47eb3-1505-4f5e-8009-fb2e704487fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0ca47eb3-1505-4f5e-8009-fb2e704487fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cd3791cb-cd21-474c-90e2-06b7077efc36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_ShareBasedCompensation_cd3791cb-cd21-474c-90e2-06b7077efc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2fdd24a0-c4c3-4c3d-a54d-2df91723ed17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2fdd24a0-c4c3-4c3d-a54d-2df91723ed17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_775d4051-8432-4bd0-a76e-022bfcc6535e" xlink:href="pbh-20201231.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_775d4051-8432-4bd0-a76e-022bfcc6535e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_1debeabb-9482-4fc4-920c-d31779b57cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_OtherNoncashExpense_1debeabb-9482-4fc4-920c-d31779b57cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f2d75ce0-99ab-4476-b7f7-dc01d7800c22" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bcb44bab-2e8d-43cd-b121-ea58773d4b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bcb44bab-2e8d-43cd-b121-ea58773d4b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c77d79b3-3daf-48ec-8683-2aacf667b41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c77d79b3-3daf-48ec-8683-2aacf667b41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_723c68f4-cd3c-4740-b703-0c9f95593bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_723c68f4-cd3c-4740-b703-0c9f95593bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_250f37bc-b3d0-43da-aa3c-a0aabf13203c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_250f37bc-b3d0-43da-aa3c-a0aabf13203c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_dfe2d961-9e23-45e7-8be7-43926adb417c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_dfe2d961-9e23-45e7-8be7-43926adb417c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_3e8eb0ea-935b-45f8-ab7f-19ebc7fc9775" xlink:href="pbh-20201231.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_3e8eb0ea-935b-45f8-ab7f-19ebc7fc9775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f2d5c6c6-5a95-482f-8b6e-32f9f01993a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36533fee-13da-4f7f-a49c-b8b8cc935d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f2d5c6c6-5a95-482f-8b6e-32f9f01993a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_255c1eaf-07c6-4a8e-b7b4-8843ef564802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8429d162-f379-4f63-ad3c-584e1433aa06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_255c1eaf-07c6-4a8e-b7b4-8843ef564802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e6d91d5f-4036-44d5-b247-eded6b628c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e6d91d5f-4036-44d5-b247-eded6b628c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_544384db-dece-4a60-a935-390498340eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e6d91d5f-4036-44d5-b247-eded6b628c7c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_544384db-dece-4a60-a935-390498340eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt_c161b72d-2c60-440d-8b56-5cee8f4545d1" xlink:href="pbh-20201231.xsd#pbh_EscrowReceipt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e6d91d5f-4036-44d5-b247-eded6b628c7c" xlink:to="loc_pbh_EscrowReceipt_c161b72d-2c60-440d-8b56-5cee8f4545d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_43cc1664-4b77-48a5-9089-5fe258e45427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e6d91d5f-4036-44d5-b247-eded6b628c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_43cc1664-4b77-48a5-9089-5fe258e45427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_138d2a76-5564-4429-bc3d-cacd454b303d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_138d2a76-5564-4429-bc3d-cacd454b303d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_df3e8501-5766-41e9-8a3b-e00aa49ab6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_df3e8501-5766-41e9-8a3b-e00aa49ab6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_acb346de-b194-4374-b9fc-d6002c7b2059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_acb346de-b194-4374-b9fc-d6002c7b2059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_0deb86eb-344e-4835-af70-1ba5d972f638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_0deb86eb-344e-4835-af70-1ba5d972f638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_aac5284f-98c7-4806-a070-64b50e5dc3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_aac5284f-98c7-4806-a070-64b50e5dc3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c775c0af-566b-4594-a34a-1ac9b2e6a29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c775c0af-566b-4594-a34a-1ac9b2e6a29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_0e09bbd8-94fd-4aa6-abe9-af9ab30434ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_0e09bbd8-94fd-4aa6-abe9-af9ab30434ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4b265227-2b67-4c0f-af2e-ae85323b3911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4b265227-2b67-4c0f-af2e-ae85323b3911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a2fa96f-340b-4d9f-bba4-39011a4573ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a2fa96f-340b-4d9f-bba4-39011a4573ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5f83c16e-02a7-4162-abe3-087e0ff37c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5f83c16e-02a7-4162-abe3-087e0ff37c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf6f4c04-0e47-41ac-ab2d-153bb0a728bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f933c71a-3868-494e-8684-9bb1f203ead1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf6f4c04-0e47-41ac-ab2d-153bb0a728bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf7610c9-ee02-4e6b-992c-c04264fea178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf7610c9-ee02-4e6b-992c-c04264fea178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3720e580-f8ef-4e9d-b783-2623868b9e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3720e580-f8ef-4e9d-b783-2623868b9e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_208522d9-658a-4b4e-b33d-c2a0702b4bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_208522d9-658a-4b4e-b33d-c2a0702b4bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ce507dd-6244-45ba-8f74-398c31f03975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ce507dd-6244-45ba-8f74-398c31f03975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f7d33014-8c0f-400c-a811-ea35b7e08f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f7d33014-8c0f-400c-a811-ea35b7e08f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_a7a47968-f7c2-483e-b78b-4656d0e37a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f7d33014-8c0f-400c-a811-ea35b7e08f1f" xlink:to="loc_us-gaap_InterestPaidNet_a7a47968-f7c2-483e-b78b-4656d0e37a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_d4eb4842-f062-41dd-b5ff-4d2c081c9aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f7d33014-8c0f-400c-a811-ea35b7e08f1f" xlink:to="loc_us-gaap_IncomeTaxesPaid_d4eb4842-f062-41dd-b5ff-4d2c081c9aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0271cda8-0602-49cb-956c-03fb42e5c56c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_76d1fda7-8716-48e1-a3b2-7599c03f7d40" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0271cda8-0602-49cb-956c-03fb42e5c56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="pbh-20201231.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f3af7c2a-5207-41ee-9a48-a931e54480c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f3af7c2a-5207-41ee-9a48-a931e54480c1" xlink:to="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8d2e08d-21de-4b9e-83e0-6637a6e28efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_4bf7c39f-5bee-48e0-9af3-09f329abf8b4" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84b3f69f-7765-46a5-bea7-6a374d7161b7" xlink:to="loc_pbh_A2019SeniorNotesMember_4bf7c39f-5bee-48e0-9af3-09f329abf8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd9db25d-deb4-409f-874a-7a736d407c36" xlink:to="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_61eec483-3af8-45f8-bcb3-916076b7fe13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ae40e213-a617-4ba0-ac26-50f8dfc3ce06" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_61eec483-3af8-45f8-bcb3-916076b7fe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4702546-2840-45f2-9490-ae431baaea25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2ccd9d24-697c-44e6-9c6b-8a1d3f312160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4702546-2840-45f2-9490-ae431baaea25" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_2ccd9d24-697c-44e6-9c6b-8a1d3f312160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ff3656f7-c75c-445b-9017-4beac64b99a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2db04e2f-38f4-462c-bc6a-febf0fe3298c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ff3656f7-c75c-445b-9017-4beac64b99a7" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2db04e2f-38f4-462c-bc6a-febf0fe3298c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_194978bc-7b28-459d-a482-0f393956b957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ff3656f7-c75c-445b-9017-4beac64b99a7" xlink:to="loc_us-gaap_UseOfEstimates_194978bc-7b28-459d-a482-0f393956b957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_03288305-f4b6-47a7-b0f6-390ed868bccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ff3656f7-c75c-445b-9017-4beac64b99a7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_03288305-f4b6-47a7-b0f6-390ed868bccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="simple" xlink:href="pbh-20201231.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_9cb2e49b-0b13-469b-abef-1243ac203cad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_eb9e1f17-4597-4e2f-9a69-385ca507693c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_9cb2e49b-0b13-469b-abef-1243ac203cad" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_eb9e1f17-4597-4e2f-9a69-385ca507693c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_bad57cca-e35e-4297-8aa4-6403073f6d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a89958e9-4047-447a-b071-90ed6aea3502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_bad57cca-e35e-4297-8aa4-6403073f6d03" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a89958e9-4047-447a-b071-90ed6aea3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_ed27ad34-f1a8-468d-b387-fc11b6afb83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_ed27ad34-f1a8-468d-b387-fc11b6afb83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d0a39fa4-0919-4a53-a80a-85bd15ad2420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d0a39fa4-0919-4a53-a80a-85bd15ad2420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_50944d54-5670-4f05-994f-5866822b12a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_50944d54-5670-4f05-994f-5866822b12a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8b1a02cd-98e1-4747-844b-279bbe88a735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:to="loc_us-gaap_InventoryNet_8b1a02cd-98e1-4747-844b-279bbe88a735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_c583cce1-ff50-472a-b56c-6a715e83320b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8469f97d-1d85-47d6-9282-8d5ac271d132" xlink:to="loc_us-gaap_InventoryValuationReserves_c583cce1-ff50-472a-b56c-6a715e83320b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="simple" xlink:href="pbh-20201231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_412e9c1f-7c49-4f39-b84a-bd99e03edc20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_35ed201c-f15e-4b4e-8001-20a7157f173b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_412e9c1f-7c49-4f39-b84a-bd99e03edc20" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_35ed201c-f15e-4b4e-8001-20a7157f173b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03565902-28d6-4d17-8dea-cbba5b84cb09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_0b469381-ff33-46d5-af55-27931d6c5d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03565902-28d6-4d17-8dea-cbba5b84cb09" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_0b469381-ff33-46d5-af55-27931d6c5d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#GoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7f684b2-d82b-4a80-ae1f-055e099c8f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7f684b2-d82b-4a80-ae1f-055e099c8f7f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3e567b37-9dfb-415d-ae04-dedf7d421469" xlink:to="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_6221cb27-2612-4180-902d-a96f4e1608be" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_6221cb27-2612-4180-902d-a96f4e1608be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_5056fa81-02ff-48ae-b6a9-de0b6edc46cb" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_006ebc29-c448-4330-bf5a-0ad559fa988a" xlink:to="loc_pbh_InternationalOTCHealthcareMember_5056fa81-02ff-48ae-b6a9-de0b6edc46cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_642895a5-eef9-40a3-88f8-759066b7ae4d" xlink:to="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4567a2fd-f185-4566-bdff-30522194bd4f" xlink:to="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_25712fee-cb87-4190-a591-0ff4ee96ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillGross_25712fee-cb87-4190-a591-0ff4ee96ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c1c2db99-17f5-4de9-9185-6d0cf2686b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c1c2db99-17f5-4de9-9185-6d0cf2686b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1746aa2-1504-4dde-abdc-3f5d69341ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_Goodwill_d1746aa2-1504-4dde-abdc-3f5d69341ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9dc612a6-7945-4569-ae47-1abd024cd817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9dc612a6-7945-4569-ae47-1abd024cd817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_dcf4e6d0-e68d-43eb-b2bc-868aedbb62c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_GoodwillGross_dcf4e6d0-e68d-43eb-b2bc-868aedbb62c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2f1c3e77-b363-4342-891f-ee619d6ee0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d002bd72-7f15-4bdb-b249-0a74338d200f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f865862-1fae-4f31-8c33-e685b9182680" xlink:to="loc_us-gaap_Goodwill_d002bd72-7f15-4bdb-b249-0a74338d200f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96338276-10e0-49df-836c-0dafff90e0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_3c54ebd8-5b9c-4b5e-8133-963b196b6aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_96338276-10e0-49df-836c-0dafff90e0a7" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_3c54ebd8-5b9c-4b5e-8133-963b196b6aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbf3c60f-4e69-4157-a7f2-1fa88b8fa63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c93663e9-fe92-4294-ad1b-608edfba3e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbf3c60f-4e69-4157-a7f2-1fa88b8fa63e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c93663e9-fe92-4294-ad1b-608edfba3e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_e38c24b1-bd2d-4b95-8003-25fd9620d8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbf3c60f-4e69-4157-a7f2-1fa88b8fa63e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_e38c24b1-bd2d-4b95-8003-25fd9620d8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f925062e-4397-4e21-b20e-431fb022180a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbf3c60f-4e69-4157-a7f2-1fa88b8fa63e" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f925062e-4397-4e21-b20e-431fb022180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c40dcc4-d160-45ed-acf4-d1973531bd23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c40dcc4-d160-45ed-acf4-d1973531bd23" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8188c4b5-e9de-4cdd-a173-2984364f4244" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_37c3b052-dd85-47ac-ad4e-94b32d640087" xlink:href="pbh-20201231.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f9b9cab5-f678-4c01-b284-9f8de27aea11" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_37c3b052-dd85-47ac-ad4e-94b32d640087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d3e8cf5-4957-4223-b98c-1795ad4f75b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_590093ca-0f26-41fa-9ad6-e762b891802a" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd0b304f-b33f-4744-aa22-1edbc96dfde3" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_590093ca-0f26-41fa-9ad6-e762b891802a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_50755c77-0bd0-453b-8a84-498d1d3c3d6a" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b1f6bdb3-48e4-4f9e-bf1c-7b2b3b702b2e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9d137601-0234-432d-9509-317331432d62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9d137601-0234-432d-9509-317331432d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_15e9ac38-8855-4dc0-a4c1-ec38e1b2b89d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_15e9ac38-8855-4dc0-a4c1-ec38e1b2b89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3892606a-47c0-4b7e-b685-abd53dd8f6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_321229ff-51ab-4e34-8d65-916be9636ed4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3892606a-47c0-4b7e-b685-abd53dd8f6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_62d55d1d-7a11-477a-9ed1-e7b9612358fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e94f670-7596-4932-bd8e-2f619cb5cda5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e94f670-7596-4932-bd8e-2f619cb5cda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cd76715e-1771-4ae3-b861-e89d191082a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cd76715e-1771-4ae3-b861-e89d191082a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_93b4a65f-892c-4e9e-b3e2-942fbd998349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_93b4a65f-892c-4e9e-b3e2-942fbd998349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ae588ecb-b5bf-401b-ae5c-0717c764e592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_590671a2-25f5-4aa4-8459-74d426cf8150" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ae588ecb-b5bf-401b-ae5c-0717c764e592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_57683e09-6f09-4db3-8433-42b2f8123822" xlink:to="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_193bd201-d856-41bd-a6e0-c32910f2eb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_193bd201-d856-41bd-a6e0-c32910f2eb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fd4eed7f-1852-4b66-888a-bca3e9fbfc6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fd4eed7f-1852-4b66-888a-bca3e9fbfc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_f86ac0e0-330d-4a61-9258-c1dac7d7ffa1" xlink:href="pbh-20201231.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_f86ac0e0-330d-4a61-9258-c1dac7d7ffa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_89bc1fe7-463f-443f-9e03-60009b18053a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_27c9b4e3-3f91-4286-81b2-268d0dbcc48d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_89bc1fe7-463f-443f-9e03-60009b18053a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:href="pbh-20201231.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_3ca67d5c-b983-4f34-90f8-9e44916634a1" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_937db1f7-778d-44f8-a945-0eaca0c750d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_937db1f7-778d-44f8-a945-0eaca0c750d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a42b0bf8-8211-4365-b3e0-61446cb8bbf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a42b0bf8-8211-4365-b3e0-61446cb8bbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_6672638c-dff1-4e98-97d7-1447cd9e586f" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_6672638c-dff1-4e98-97d7-1447cd9e586f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e8897123-5b64-485d-a47f-7ede4251fa47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_4dba819e-6e1f-49d8-a60e-04108712f07b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e8897123-5b64-485d-a47f-7ede4251fa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19cbe56c-d85b-425d-99e5-69f830625b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_050d3cc1-1ef9-4b36-a642-afc54a18df8c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19cbe56c-d85b-425d-99e5-69f830625b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_e3982674-61af-4532-baae-db221b0761d4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_53b7e6f7-ed25-446e-80db-b7e3d78375b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3d592bf3-5e87-4b34-9a75-410a24f77589" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_53b7e6f7-ed25-446e-80db-b7e3d78375b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_275e935d-6f9a-4d13-9fef-aa4b474773c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_275e935d-6f9a-4d13-9fef-aa4b474773c2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:to="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16e238eb-b009-46fe-ab34-69a0eb54c283" xlink:to="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bdb80260-6f49-404e-a4e1-c3942e5b7a0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:to="loc_srt_MinimumMember_bdb80260-6f49-404e-a4e1-c3942e5b7a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cfc273b9-34c9-4dff-acdc-06c3d277341d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d61dd57c-d9ba-497c-9c40-1750fac965fb" xlink:to="loc_srt_MaximumMember_cfc273b9-34c9-4dff-acdc-06c3d277341d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f5f9eecf-364c-44bb-8cf3-4dbb105cc5e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7d0a5138-b200-4280-a277-ddf5979c0ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7d0a5138-b200-4280-a277-ddf5979c0ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_982182f0-48ab-402b-aee1-74a5b4e7651b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_982182f0-48ab-402b-aee1-74a5b4e7651b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fbff331b-1669-4728-85cc-7ed4fa678708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_fbff331b-1669-4728-85cc-7ed4fa678708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c768eaa5-66a5-4572-be37-ae8887a3eee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b1f17691-7f28-466a-94fb-ffbe0cb18ede" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c768eaa5-66a5-4572-be37-ae8887a3eee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6188c9e3-f347-459c-aa52-326d784f7691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6188c9e3-f347-459c-aa52-326d784f7691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ad43bc0c-e0c6-4d13-8da9-14127fefa68f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ad43bc0c-e0c6-4d13-8da9-14127fefa68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01e7458b-eb95-44c4-8236-0ab8a898677b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01e7458b-eb95-44c4-8236-0ab8a898677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_036fddf1-0b6a-49fd-93be-be22e017575c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_036fddf1-0b6a-49fd-93be-be22e017575c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b979d8e5-3feb-48f0-a124-b58392df80ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b979d8e5-3feb-48f0-a124-b58392df80ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_bf4c91db-6b0d-409b-bf6e-a761bf06d0fd" xlink:href="pbh-20201231.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_bf4c91db-6b0d-409b-bf6e-a761bf06d0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_baeb92e4-dac3-4292-acd4-313d72b23aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c54f082-5d15-4733-904b-fa48c52b46ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_baeb92e4-dac3-4292-acd4-313d72b23aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Leases" xlink:type="simple" xlink:href="pbh-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_50907b4c-9a64-4aee-a78a-5dbec19b66b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_988f85c2-ee02-4651-b744-9081a4bea2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50907b4c-9a64-4aee-a78a-5dbec19b66b6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_988f85c2-ee02-4651-b744-9081a4bea2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_ee1d9588-aa18-42d8-afd4-90010432a43a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50907b4c-9a64-4aee-a78a-5dbec19b66b6" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_ee1d9588-aa18-42d8-afd4-90010432a43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_57d8c9cc-6a8a-4212-8d8a-9307c3afa221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_3bd8c21d-b0f0-4fb2-8632-80bbd0b258e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_57d8c9cc-6a8a-4212-8d8a-9307c3afa221" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_3bd8c21d-b0f0-4fb2-8632-80bbd0b258e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a90fe03f-f293-4822-bbfb-d7ffbfcfa9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_57d8c9cc-6a8a-4212-8d8a-9307c3afa221" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a90fe03f-f293-4822-bbfb-d7ffbfcfa9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b534dc62-f5eb-4e07-a46d-8885bc096fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_57d8c9cc-6a8a-4212-8d8a-9307c3afa221" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b534dc62-f5eb-4e07-a46d-8885bc096fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1ed17b08-2038-4c9d-a596-222ed4abb69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1ed17b08-2038-4c9d-a596-222ed4abb69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_13120750-796d-4e4c-b8e7-ec9512ee0f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_13120750-796d-4e4c-b8e7-ec9512ee0f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_26d42b5e-1d6b-4879-8a3f-511322a23d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_OperatingLeaseCost_26d42b5e-1d6b-4879-8a3f-511322a23d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e183d635-c592-4b23-bdef-c035e95161e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_ShortTermLeaseCost_e183d635-c592-4b23-bdef-c035e95161e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3e2dd62f-eb08-4615-9ae9-baf1934d0ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_VariableLeaseCost_3e2dd62f-eb08-4615-9ae9-baf1934d0ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_39edbe27-b771-4825-8ca8-e71d25e2cd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_SubleaseIncome_39edbe27-b771-4825-8ca8-e71d25e2cd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a88fbeb1-6ba0-432b-b740-8f3c0dd318ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1218ce8a-33ae-47ae-bfb7-4d6fa4f316f9" xlink:to="loc_us-gaap_LeaseCost_a88fbeb1-6ba0-432b-b740-8f3c0dd318ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_36d85560-dc69-43ee-8c9d-ca1c77eca502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d85560-dc69-43ee-8c9d-ca1c77eca502" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_41224797-6ac8-4464-af27-c5acf556b6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_41224797-6ac8-4464-af27-c5acf556b6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2775e6ab-6ba8-456c-a365-901df3cf8c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2775e6ab-6ba8-456c-a365-901df3cf8c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b70a5fd9-d097-4088-91b8-7f1492036edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b70a5fd9-d097-4088-91b8-7f1492036edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0cb51361-6f83-462d-8f09-4f048ee63134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0cb51361-6f83-462d-8f09-4f048ee63134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_daf81f72-4474-4772-ad76-e6f497b302a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_daf81f72-4474-4772-ad76-e6f497b302a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_eec6f925-c159-443f-bab9-f5f17fdca0cc" xlink:href="pbh-20201231.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_eec6f925-c159-443f-bab9-f5f17fdca0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f560fec2-a544-407d-b393-afa5e0a0961a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f560fec2-a544-407d-b393-afa5e0a0961a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_516f2ec4-b96c-4e18-9293-797626ccd700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_516f2ec4-b96c-4e18-9293-797626ccd700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_759f7338-6485-42c2-8833-8b4a9afe1f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_697a671c-0fb8-45e4-b120-e2091e968edb" xlink:to="loc_us-gaap_OperatingLeaseLiability_759f7338-6485-42c2-8833-8b4a9afe1f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d85560-dc69-43ee-8c9d-ca1c77eca502" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_badef7d1-3928-4f52-a2d4-4e091f55743a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_badef7d1-3928-4f52-a2d4-4e091f55743a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_504c2a0f-0982-49c5-95a0-903c0a741f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_504c2a0f-0982-49c5-95a0-903c0a741f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3737740c-3686-4ce9-9a34-a856a6901de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3737740c-3686-4ce9-9a34-a856a6901de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5e853a98-3140-4870-9c7d-434ab4b487bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5e853a98-3140-4870-9c7d-434ab4b487bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2cd149bd-6af2-4af9-9e23-4189917b0c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2cd149bd-6af2-4af9-9e23-4189917b0c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_ca46b146-182e-4c35-8dc0-3cabce58b796" xlink:href="pbh-20201231.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_ca46b146-182e-4c35-8dc0-3cabce58b796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_437dcc64-a9e4-4a71-9dc0-193a67627bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_437dcc64-a9e4-4a71-9dc0-193a67627bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_916f9d84-1c30-4296-8754-98393b41e0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_916f9d84-1c30-4296-8754-98393b41e0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_87ebb88e-c1c7-4640-b3c4-ed933fb07935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3dd34940-431f-4f4a-9a31-fd1fe1fa301f" xlink:to="loc_us-gaap_FinanceLeaseLiability_87ebb88e-c1c7-4640-b3c4-ed933fb07935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d85560-dc69-43ee-8c9d-ca1c77eca502" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_afe7ecc2-0715-455f-85df-14a90b38bd70" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_afe7ecc2-0715-455f-85df-14a90b38bd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_7bc60bf1-1b1b-4b75-9d53-bc5488de50a1" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_7bc60bf1-1b1b-4b75-9d53-bc5488de50a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_b14a79b8-f8dc-4572-b104-10669eb48884" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_b14a79b8-f8dc-4572-b104-10669eb48884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_addfd1fc-f74f-466f-a396-7856ea3cd3ca" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_addfd1fc-f74f-466f-a396-7856ea3cd3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_30f74784-54ba-4737-a6eb-a0f14c414bed" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_30f74784-54ba-4737-a6eb-a0f14c414bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_4eddd297-f8a4-497b-b87e-ec52c2d0f0ed" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_4eddd297-f8a4-497b-b87e-ec52c2d0f0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_516b57b5-fff4-4efd-bf86-8decc8ec78ca" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_516b57b5-fff4-4efd-bf86-8decc8ec78ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_de91ff3c-5dcf-4261-ae02-aa2d7e984ceb" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_de91ff3c-5dcf-4261-ae02-aa2d7e984ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_953322fb-f3a8-4dd0-8ef6-9095b6f2e29c" xlink:href="pbh-20201231.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_462d1f52-e624-46f4-b546-faed94155902" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_953322fb-f3a8-4dd0-8ef6-9095b6f2e29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8a225952-13e0-4530-8697-3618ebd0da95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_30fb5d90-574e-47a0-84ed-1633e035fbda" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a225952-13e0-4530-8697-3618ebd0da95" xlink:to="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_30fb5d90-574e-47a0-84ed-1633e035fbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5859f36e-4968-4c3a-ae25-8cb38d6456bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_30fb5d90-574e-47a0-84ed-1633e035fbda" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5859f36e-4968-4c3a-ae25-8cb38d6456bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dc90c7e9-ff8b-4ed8-8e86-6a070304db0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_30fb5d90-574e-47a0-84ed-1633e035fbda" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dc90c7e9-ff8b-4ed8-8e86-6a070304db0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract_a1556b0f-21e7-485d-bc74-cb1a309c2fac" xlink:href="pbh-20201231.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8a225952-13e0-4530-8697-3618ebd0da95" xlink:to="loc_pbh_WeightedAverageDiscountRateAbstract_a1556b0f-21e7-485d-bc74-cb1a309c2fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c4066294-8667-4b2b-a49c-91871bd43531" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_a1556b0f-21e7-485d-bc74-cb1a309c2fac" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c4066294-8667-4b2b-a49c-91871bd43531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_38dcb6f5-a65e-4ad5-a60d-f9f32fcdc9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_a1556b0f-21e7-485d-bc74-cb1a309c2fac" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_38dcb6f5-a65e-4ad5-a60d-f9f32fcdc9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_86b8f84a-9753-4660-9387-07e91f249966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_86b8f84a-9753-4660-9387-07e91f249966" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:to="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e640773a-804d-4311-968c-3635c82768dd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember_c65f3507-ace3-4d9e-addb-5af1e0f90e98" xlink:href="pbh-20201231.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_91808c3b-4c91-40a7-9e66-f20cb4db8a40" xlink:to="loc_pbh_GEODISLogisticsLLCMember_c65f3507-ace3-4d9e-addb-5af1e0f90e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ab518c33-407d-4681-abe8-b742518f4690" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c4845bc6-3898-4c2e-893a-730b6eb48840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:to="loc_us-gaap_FinanceLeaseLiability_c4845bc6-3898-4c2e-893a-730b6eb48840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_17cb5f1d-2d98-4f09-87d6-9977a9cd2008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d1c6a976-60c1-449c-a2d0-f36ce623ce06" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_17cb5f1d-2d98-4f09-87d6-9977a9cd2008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e32a22aa-a0e9-4c72-955f-ae4db9f15037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_d46fb8f3-c15c-4ae5-9ce7-6dd855ca05bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e32a22aa-a0e9-4c72-955f-ae4db9f15037" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_d46fb8f3-c15c-4ae5-9ce7-6dd855ca05bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_98f9caba-a5c9-4347-a642-491a8656bd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_87c14d22-5e21-4d87-b8f5-505ac0da4af4" xlink:href="pbh-20201231.xsd#pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_98f9caba-a5c9-4347-a642-491a8656bd57" xlink:to="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_87c14d22-5e21-4d87-b8f5-505ac0da4af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_f45ddf8e-9ece-496c-ac17-1f372d3e2f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_f45ddf8e-9ece-496c-ac17-1f372d3e2f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cc207b33-c40f-46db-8adc-0bd9099707ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cc207b33-c40f-46db-8adc-0bd9099707ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_44defd81-ea56-43bc-9c4b-1771e32eba8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_44defd81-ea56-43bc-9c4b-1771e32eba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_63b97a16-8e77-4fe7-aaef-9b66acc933bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_63b97a16-8e77-4fe7-aaef-9b66acc933bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_47e9ee9d-89d7-4969-80a6-98b90bd059e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_47e9ee9d-89d7-4969-80a6-98b90bd059e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_599fb92e-1fab-42fc-8510-e365459079f1" xlink:href="pbh-20201231.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_pbh_AccruedProductionCostsCurrent_599fb92e-1fab-42fc-8510-e365459079f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_503e3d98-55e7-4a45-9d6a-2cef1457a02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_503e3d98-55e7-4a45-9d6a-2cef1457a02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fb8a3102-2f50-4190-815a-cf27fc562ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fb8a3102-2f50-4190-815a-cf27fc562ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_728bc403-a31e-48a1-992f-148a4aea9e58" xlink:href="pbh-20201231.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f452663a-bebc-4705-bb1e-0a1eddb4b077" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_728bc403-a31e-48a1-992f-148a4aea9e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b2cc8478-6869-4342-8996-3a6a0e2fadcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_db03b15a-4fd8-41a9-bdd0-e75912879b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2cc8478-6869-4342-8996-3a6a0e2fadcc" xlink:to="loc_us-gaap_LongTermDebtTextBlock_db03b15a-4fd8-41a9-bdd0-e75912879b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4a00479f-8bfa-4171-a613-8e43299671e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_89e611ad-1293-4d6d-8ed3-b4e557f9a5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4a00479f-8bfa-4171-a613-8e43299671e5" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_89e611ad-1293-4d6d-8ed3-b4e557f9a5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_99babd43-4801-4d02-8234-9d84a37cc957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4a00479f-8bfa-4171-a613-8e43299671e5" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_99babd43-4801-4d02-8234-9d84a37cc957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6dd6686-e396-4068-8b7f-57baeacc23cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6dd6686-e396-4068-8b7f-57baeacc23cb" xlink:to="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a85abb21-c720-46bc-b7f4-6a08126927e6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1e62709d-d268-4f8a-926b-2b8fd6e713c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:to="loc_us-gaap_SeniorNotesMember_1e62709d-d268-4f8a-926b-2b8fd6e713c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5Member_8a69a633-9188-42e3-a2e2-35e75270e7a8" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB5Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_28fc912c-50da-4d7f-ac5f-2bc98bfbd52a" xlink:to="loc_pbh_LoansPayableTermB5Member_8a69a633-9188-42e3-a2e2-35e75270e7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_da52163f-f49c-4edc-9007-22cd0da609ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_bab8c7a7-2d81-4a0a-9604-bf8fc6d3a1f1" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_SeniorNotes2016Member_bab8c7a7-2d81-4a0a-9604-bf8fc6d3a1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_1ba92ae5-27a6-4844-aaa0-d60a3f4e3aa8" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_A2019SeniorNotesMember_1ba92ae5-27a6-4844-aaa0-d60a3f4e3aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_f29deb9b-891f-4763-ae44-2487b3ba3db2" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2012Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_SeniorNotes2012Member_f29deb9b-891f-4763-ae44-2487b3ba3db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_f0452c93-2102-4719-ac70-e50479c11a3a" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d93e1a1b-2bc1-4aa1-b00c-518acaca22e6" xlink:to="loc_pbh_AblRevolver2012Member_f0452c93-2102-4719-ac70-e50479c11a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_6abfb7f9-8c87-4383-9bd8-d57e7e5104a0" xlink:to="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_19f08881-92cc-41cd-b3e0-03048cbd265a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_19f08881-92cc-41cd-b3e0-03048cbd265a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e291b4f9-4bcb-446d-9f69-2cd88c9cb518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e72dd86a-600a-4ba6-a44b-bcda3b7af29d" xlink:to="loc_us-gaap_BaseRateMember_e291b4f9-4bcb-446d-9f69-2cd88c9cb518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e61b83b2-3178-4eca-b829-c84c143d71a5" xlink:to="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_63732566-4846-4120-a280-6a408dbae4c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a50400d0-59fa-4f53-b90f-4c238edbf501" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_63732566-4846-4120-a280-6a408dbae4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f5baefb5-6d31-4631-8111-15fd4ebd7558" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e46ae807-60e6-4bc7-807b-b3bcd1fd75cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e46ae807-60e6-4bc7-807b-b3bcd1fd75cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4c29d8c-79e0-41da-a365-dad0b1b74f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b4c29d8c-79e0-41da-a365-dad0b1b74f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_0ddfbd8c-7a86-4a81-86ec-4a276da2be21" xlink:href="pbh-20201231.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_0ddfbd8c-7a86-4a81-86ec-4a276da2be21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_27992542-06c8-40ec-adaf-0ad937766c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_27992542-06c8-40ec-adaf-0ad937766c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b2aff219-5ca6-43b4-a15d-d1f1802dfea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b2aff219-5ca6-43b4-a15d-d1f1802dfea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e1a3ef26-08fa-4cdb-9ed4-93ab9ff95b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1b3f6258-b3dc-4509-becd-607b7bfbbe57" xlink:to="loc_us-gaap_LongTermDebt_e1a3ef26-08fa-4cdb-9ed4-93ab9ff95b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_76d6f59f-a491-4e03-a4cd-49c74f841e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_76d6f59f-a491-4e03-a4cd-49c74f841e29" xlink:to="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0566905d-7aaf-4982-be21-576e86014abb" xlink:to="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75ee9294-f0db-40a7-be09-f788933e969f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4ed3d166-efa7-4f7c-8174-2c4667d082cb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75ee9294-f0db-40a7-be09-f788933e969f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fa9cb162-2dfe-4697-ab39-e4ba8b28c40e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_8e4682fd-18bf-432c-b604-260f6344930d" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ab89eb2-3d02-4222-9909-a92b74405fcc" xlink:to="loc_pbh_AblRevolver2012Member_8e4682fd-18bf-432c-b604-260f6344930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3e151dfe-1cd4-4073-9305-f460e4081f0c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fec1b1f0-4d83-4bff-a6c4-a509332354fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59588c55-71ca-4007-85d8-5a774aef963b" xlink:to="loc_us-gaap_InterestRateSwapMember_fec1b1f0-4d83-4bff-a6c4-a509332354fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0d11e8e6-78aa-41b9-a8f6-9345888cee3b" xlink:to="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_09193db3-9e31-45d0-808e-c337d7d7d0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_aee35b9e-68f6-4677-9c88-c7d8e42b640f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_09193db3-9e31-45d0-808e-c337d7d7d0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_63298a63-e1bd-4785-8534-1c1ff7d2ed47" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b5230a5e-a935-4627-92c1-ca2dae3cc825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b5230a5e-a935-4627-92c1-ca2dae3cc825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d4b2577c-cd2d-4d96-b80e-e1dbd58bf4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d4b2577c-cd2d-4d96-b80e-e1dbd58bf4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9529d8e3-3448-433c-814e-eb40cbbe49f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a335175d-b1bc-49a8-81ac-7ce66eaa9c37" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9529d8e3-3448-433c-814e-eb40cbbe49f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b2d43d5d-61c3-41a5-973f-eb287e769583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2d43d5d-61c3-41a5-973f-eb287e769583" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_3a69c4b7-1b2e-4872-9340-c7f73f7f3d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_3a69c4b7-1b2e-4872-9340-c7f73f7f3d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_56ef10d6-ab69-453a-8ae9-b472b15cc63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_56ef10d6-ab69-453a-8ae9-b472b15cc63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_72c25402-001c-4243-8d97-879ba2276cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_72c25402-001c-4243-8d97-879ba2276cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ff72ea5e-df9a-458a-8726-57e43bb177e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ff72ea5e-df9a-458a-8726-57e43bb177e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_667d0ffe-966c-48a1-90ad-7ec825fedcbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_667d0ffe-966c-48a1-90ad-7ec825fedcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour_f218d436-780b-447d-8674-3f85207e71e9" xlink:href="pbh-20201231.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_pbh_LongTermDebtMaturityAfterYearFour_f218d436-780b-447d-8674-3f85207e71e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a864a24a-873e-462e-a021-681919763d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_de67d8a1-8cee-4743-8a08-0f7a7c383e9b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a864a24a-873e-462e-a021-681919763d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4e48f5c3-95c3-43d9-8ae3-afef03d1694c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d4efacee-a6b2-4a13-92b8-80901c465a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e48f5c3-95c3-43d9-8ae3-afef03d1694c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d4efacee-a6b2-4a13-92b8-80901c465a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4e2a5f90-2944-47a0-ba8d-6b1b966019bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f5a00480-ad96-4d3b-96ab-f27af807bceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e2a5f90-2944-47a0-ba8d-6b1b966019bd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_f5a00480-ad96-4d3b-96ab-f27af807bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_612413fc-fdf8-418d-8ff7-d27149399d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_612413fc-fdf8-418d-8ff7-d27149399d9f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7f8daddb-3009-4781-821f-39054311f0c1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_93bf7025-52e9-49d5-8d25-038c3858b4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_12c812d2-b4c5-4657-8316-bf9a7e52dfa8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_93bf7025-52e9-49d5-8d25-038c3858b4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bea9203-a61d-40c0-88f1-95d86228b493" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0d72b496-a896-4996-b4ee-d30f230fa7e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_SeniorNotesMember_0d72b496-a896-4996-b4ee-d30f230fa7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_392484a5-0807-473b-80ac-892a45a57224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_LoansPayableMember_392484a5-0807-473b-80ac-892a45a57224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_39c57cbd-9409-4c1f-a3b3-9798f0f149c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_17242c2b-c5c5-4e98-99a5-ed5a7b303308" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_39c57cbd-9409-4c1f-a3b3-9798f0f149c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_327ea466-fb54-45b7-b297-e03804edff5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_e7348ec4-cb86-4719-bb1c-a0d94bf634e0" xlink:href="pbh-20201231.xsd#pbh_SeniorNotes2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_SeniorNotes2016Member_e7348ec4-cb86-4719-bb1c-a0d94bf634e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_03478c49-261b-47e7-b52f-620c0043b2c2" xlink:href="pbh-20201231.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_A2019SeniorNotesMember_03478c49-261b-47e7-b52f-620c0043b2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member_1fb99bcf-2665-4634-846a-195201eb7a1c" xlink:href="pbh-20201231.xsd#pbh_LoansPayableTermB4Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_LoansPayableTermB4Member_1fb99bcf-2665-4634-846a-195201eb7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_ed3f9be4-d8a5-48c5-a580-e56e04066b30" xlink:href="pbh-20201231.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f75fff9f-b60c-4e91-9922-5d4ff178c2a7" xlink:to="loc_pbh_AblRevolver2012Member_ed3f9be4-d8a5-48c5-a580-e56e04066b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_12d2342d-2c10-4da5-be7f-ce0d731d7086" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fa2008ca-8f7f-4e94-be63-f0927f63bcea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fa2008ca-8f7f-4e94-be63-f0927f63bcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_40b6573b-d3b5-4c7d-b019-77412a535745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_40b6573b-d3b5-4c7d-b019-77412a535745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b8b55bc3-dd8c-4959-ba16-c2fd14a05486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8cdb206d-9f4d-4959-8890-38a59998d2d2" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b8b55bc3-dd8c-4959-ba16-c2fd14a05486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_36178af5-5ed3-4273-8c1e-784245590efc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_577f85a3-090a-4f5c-9203-1074c20ce56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46debbdb-67ce-47cf-b9e9-be7dc735522f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_577f85a3-090a-4f5c-9203-1074c20ce56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f8f3536-7320-4948-a6e3-13dfa6bb07c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_65f8b2b0-a3ad-40ec-aa84-4eb282bc1184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_306e3512-3c4c-4be0-b433-47ced7b6931e" xlink:to="loc_us-gaap_InterestRateSwapMember_65f8b2b0-a3ad-40ec-aa84-4eb282bc1184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d472f619-9a52-4134-81e5-f7a5ed5a2349" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_27de6726-afea-45d8-a752-3d67345f977a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_LongTermDebtFairValue_27de6726-afea-45d8-a752-3d67345f977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_d0fef309-5c09-4cb1-99c3-51c22b06910f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_d0fef309-5c09-4cb1-99c3-51c22b06910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_f89d86a6-9c06-406d-befc-e964a5e40447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f73acec-4dde-49d4-8f2e-2b33f5c12e9a" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_f89d86a6-9c06-406d-befc-e964a5e40447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd8846f5-a539-4410-a63e-df016c6e73f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2ba9f5b0-eac0-4a47-b219-ac24ecf9d15e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd8846f5-a539-4410-a63e-df016c6e73f2" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2ba9f5b0-eac0-4a47-b219-ac24ecf9d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3717d44-e619-4abe-a6c7-f6dc44469924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f0bdbf35-6150-4435-81a5-f3de15c90d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3717d44-e619-4abe-a6c7-f6dc44469924" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f0bdbf35-6150-4435-81a5-f3de15c90d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ad43a180-e599-4e21-84b4-71f67e2797a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3717d44-e619-4abe-a6c7-f6dc44469924" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ad43a180-e599-4e21-84b4-71f67e2797a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2350c59-8b04-4dab-8cc0-09730aefeb37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2350c59-8b04-4dab-8cc0-09730aefeb37" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_227bd7f5-8484-4c31-8343-6d90e4568d9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3436f500-d2dc-4077-af3d-d278c2209bd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7846b17b-e8eb-4ad6-a96b-980b1a1df3d9" xlink:to="loc_us-gaap_InterestRateSwapMember_3436f500-d2dc-4077-af3d-d278c2209bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1f1b90a5-72ad-47ba-9076-86ae4e5fc953" xlink:to="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2836b513-6c2e-4b1a-b7fb-e62567ff4aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_97ba1bcc-4939-4ea2-8dbb-afc065cda7a9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2836b513-6c2e-4b1a-b7fb-e62567ff4aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_655ab010-5da5-4aaa-b99e-7d0d4780d7a1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_f8535ca7-2db0-40a5-80f9-398e12c375ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_f8535ca7-2db0-40a5-80f9-398e12c375ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f86e5837-25d4-44f6-97e2-6cdeb3af84aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f86e5837-25d4-44f6-97e2-6cdeb3af84aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_44e75071-1b96-45d7-94b0-5ca39c47d22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_177ad74f-1336-4b0c-8708-e0562cd5729f" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_44e75071-1b96-45d7-94b0-5ca39c47d22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3dd60ba-9372-40b3-ba95-f83ddff6680a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f3dd60ba-9372-40b3-ba95-f83ddff6680a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0d735f-e960-4028-86ef-465a5c670f7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05bb7049-7626-438e-8085-18d42c58ec5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_03926670-c5f7-4e5b-8efc-afb63b646030" xlink:to="loc_us-gaap_InterestRateSwapMember_05bb7049-7626-438e-8085-18d42c58ec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_63ae208f-93fb-4ae7-a28b-2ee22bc1cef0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_045dd764-a895-47c6-b8aa-7b007598ec04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_045dd764-a895-47c6-b8aa-7b007598ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a4b67246-c116-42f1-9c9d-b7eddc057760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85f4896c-4c93-4571-8c4c-4ac2f96ae3a1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a4b67246-c116-42f1-9c9d-b7eddc057760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d3949446-4e06-4bc0-a97e-1ff3ff52515e" xlink:to="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_728709bd-763a-45cc-9d79-5ca814cbff8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5faa3bf9-f913-4b64-9d8d-24e4e5be270c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_728709bd-763a-45cc-9d79-5ca814cbff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fab6a6b9-cf2f-4c74-9324-e4fb24d44133" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4c83ccb4-ec3b-482f-9774-d12519950460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a1fbda32-7368-4c1d-bce0-390f14e9f61f" xlink:to="loc_us-gaap_CashFlowHedgingMember_4c83ccb4-ec3b-482f-9774-d12519950460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96911711-ea19-4dfb-97df-db5209e5b5b4" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_37cf596a-fa27-4886-accd-29d765d07e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_37cf596a-fa27-4886-accd-29d765d07e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0a1d8095-4e8e-4d99-a35f-51dcddf3b594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3e8ae0d2-e540-4118-82b0-06146c0a351a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0a1d8095-4e8e-4d99-a35f-51dcddf3b594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#DerivativeInstrumentsSummaryofInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4f7c8458-0c59-44b0-adf4-47f0468b38ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4f7c8458-0c59-44b0-adf4-47f0468b38ad" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_4f4e5945-8a73-4ec7-918a-509457a411b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_3c646d9b-f139-48d3-8de0-0e670dc6cc63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_af863f55-7d60-419a-a34d-8fa05fdae3db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_3c646d9b-f139-48d3-8de0-0e670dc6cc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74263580-9f03-42c5-87d8-3aa36d8cc653" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f76f6989-5245-43c2-8f18-2b5c949f54d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4e83b264-72f3-4174-b471-5c32c92d101a" xlink:to="loc_us-gaap_InterestExpenseMember_f76f6989-5245-43c2-8f18-2b5c949f54d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7917fd4b-5ee0-42e9-ae4f-9a12bb079315" xlink:to="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda3b99f-31f0-40ca-b599-750f1e3a2e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fb157a58-647e-4f7c-a355-5db2e33bc1b6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fda3b99f-31f0-40ca-b599-750f1e3a2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e3e269bc-4a5e-4d42-ace4-bf943071d9b0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_6baa3fda-666f-4796-bdca-baef79083976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_6baa3fda-666f-4796-bdca-baef79083976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_6c650fb0-7fb2-48c8-a904-d3d7df4717c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_6c650fb0-7fb2-48c8-a904-d3d7df4717c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLossOnDerivative_4270ad71-37e3-4ffc-81d5-4ec36bd3baf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLossOnDerivative"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_0f7a1577-e00c-46a6-a515-b5c5fa8d06e9" xlink:to="loc_us-gaap_DerivativeLossOnDerivative_4270ad71-37e3-4ffc-81d5-4ec36bd3baf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_282f41ca-79e8-4352-a754-eb334e2888db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_621440a1-f8ce-4e68-a0dc-c8431b3edb17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_282f41ca-79e8-4352-a754-eb334e2888db" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_621440a1-f8ce-4e68-a0dc-c8431b3edb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c0ac1c43-5b47-4cd6-887c-ad9562f8ab44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_a508f5d7-a6f9-4e76-8aff-94db870c569d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c0ac1c43-5b47-4cd6-887c-ad9562f8ab44" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_a508f5d7-a6f9-4e76-8aff-94db870c569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8be7f729-b23f-48f5-8716-99d450a3af48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8be7f729-b23f-48f5-8716-99d450a3af48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c5fa852a-6100-4cc1-84d8-15af2eb69be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c5fa852a-6100-4cc1-84d8-15af2eb69be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d2253420-da77-4e9f-8f4c-348125244854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d2253420-da77-4e9f-8f4c-348125244854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_083327e5-4a6c-44a2-80b7-69e96c2839d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_083327e5-4a6c-44a2-80b7-69e96c2839d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_e6746d4d-acb0-4908-931b-fc18beb94cde" xlink:href="pbh-20201231.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_e6746d4d-acb0-4908-931b-fc18beb94cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_3cdbe74c-b0af-4530-89bc-58086a2909aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9e8e8b2-efce-49a1-962b-2a261304f884" xlink:to="loc_us-gaap_DividendsCommonStock_3cdbe74c-b0af-4530-89bc-58086a2909aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#StockholdersEquityScheduleofRepurchasedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c6f4a934-e0cd-4a33-b8ac-3b937c5c711a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c6f4a934-e0cd-4a33-b8ac-3b937c5c711a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:to="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0375f-ce16-4a13-9b6d-66a1314564b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_edf9cfc6-d50d-454d-bf57-6c0bc11905e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90a87ca3-e8ec-4dea-a5be-125705add98e" xlink:to="loc_us-gaap_RestrictedStockMember_edf9cfc6-d50d-454d-bf57-6c0bc11905e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f16b4af6-1a4d-453a-9563-1b7b0e89952a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_1e6672cb-c85d-453e-9911-46642328182f" xlink:href="pbh-20201231.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_fae37f3a-b520-4f1e-972f-92c9503fc9ad" xlink:to="loc_pbh_ShareRepurchaseProgramMember_1e6672cb-c85d-453e-9911-46642328182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_71af81b6-fef9-4745-a1c0-5dd845a5ab3a" xlink:to="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ec1e78d3-713b-4137-b8bb-2813a038e84b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ec1e78d3-713b-4137-b8bb-2813a038e84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7e479fe8-b189-4dd4-81c7-c0a8e45dc55b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7e479fe8-b189-4dd4-81c7-c0a8e45dc55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e6314932-a07a-4464-97ff-29350b2ededd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67e868be-d13f-48d3-bf02-a54a5392e5b5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e6314932-a07a-4464-97ff-29350b2ededd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e5f914b9-477c-421b-b72c-b34c45f1ab58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6b7128d8-85c8-4d78-8e88-6d9b6729b380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e5f914b9-477c-421b-b72c-b34c45f1ab58" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6b7128d8-85c8-4d78-8e88-6d9b6729b380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_56a6b3c3-2fbf-4818-983c-c3d4d50f15ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0fd99c25-1c77-416f-87ad-bd58c6f3af87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_56a6b3c3-2fbf-4818-983c-c3d4d50f15ce" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0fd99c25-1c77-416f-87ad-bd58c6f3af87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#AccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_01149579-d2c8-4000-a27d-207753e0d900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_01149579-d2c8-4000-a27d-207753e0d900" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_710875b3-fb2d-45c5-b762-86c611f2bcc1" xlink:to="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b6970ba4-4e76-48fa-8572-a6173f56ed91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b6970ba4-4e76-48fa-8572-a6173f56ed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fd620743-2c14-4e04-bb0a-98b68ff6df7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fd620743-2c14-4e04-bb0a-98b68ff6df7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d4954341-2765-461a-877b-41c29e545d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d4954341-2765-461a-877b-41c29e545d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4d7cb600-3da3-4734-b590-fe947a215515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11b7709e-7d0e-412d-a9c5-7520d2d557aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4d7cb600-3da3-4734-b590-fe947a215515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5729322-193a-49d3-bdd7-d018b6aa25ed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_961b2bbb-38b4-4b17-b16d-a1b0700498ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_StockholdersEquity_961b2bbb-38b4-4b17-b16d-a1b0700498ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_042a83a7-43cf-4b1e-b38b-3a5785150de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_042a83a7-43cf-4b1e-b38b-3a5785150de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_da78a328-264f-43e7-88d1-c44a45fffe2e" xlink:href="pbh-20201231.xsd#pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit_da78a328-264f-43e7-88d1-c44a45fffe2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_f17b4ba0-f575-4b45-847d-88b2911342b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c34c8d17-b79a-482e-8f8b-6699a387aa84" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_f17b4ba0-f575-4b45-847d-88b2911342b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1df58a00-f456-42ca-a40c-2694144dfbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_af70b671-bba5-4a62-9a0d-66c89e81a06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1df58a00-f456-42ca-a40c-2694144dfbb5" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_af70b671-bba5-4a62-9a0d-66c89e81a06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_edb97c7d-0313-4610-85fa-826009259077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4188892e-21ec-47e0-a0f1-fa46e66b502e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_edb97c7d-0313-4610-85fa-826009259077" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4188892e-21ec-47e0-a0f1-fa46e66b502e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9b7dffb4-84c4-4a92-be8d-f7ea150ec1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_2478f39e-fb54-488a-a7fc-f1b7a0c7d776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9b7dffb4-84c4-4a92-be8d-f7ea150ec1a3" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_2478f39e-fb54-488a-a7fc-f1b7a0c7d776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_306a50b4-27fb-4344-85cf-8bcb3fe3013d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_2478f39e-fb54-488a-a7fc-f1b7a0c7d776" xlink:to="loc_us-gaap_NetIncomeLossAbstract_306a50b4-27fb-4344-85cf-8bcb3fe3013d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_601d7e19-8073-4201-bff8-e71e00f4b3a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_306a50b4-27fb-4344-85cf-8bcb3fe3013d" xlink:to="loc_us-gaap_NetIncomeLoss_601d7e19-8073-4201-bff8-e71e00f4b3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2c10e4a7-dd23-4a6e-ba27-34e16e84835a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_2478f39e-fb54-488a-a7fc-f1b7a0c7d776" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2c10e4a7-dd23-4a6e-ba27-34e16e84835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06b34b52-2ceb-4880-b718-dfbcb5c797d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2c10e4a7-dd23-4a6e-ba27-34e16e84835a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06b34b52-2ceb-4880-b718-dfbcb5c797d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4bfd5a27-2d41-4691-b61a-f54f877076ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2c10e4a7-dd23-4a6e-ba27-34e16e84835a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4bfd5a27-2d41-4691-b61a-f54f877076ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea98e2c3-87de-49d8-8ee0-b5403093b6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2c10e4a7-dd23-4a6e-ba27-34e16e84835a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea98e2c3-87de-49d8-8ee0-b5403093b6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6232d5dd-3b87-4326-95d7-4cb409307600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_2478f39e-fb54-488a-a7fc-f1b7a0c7d776" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6232d5dd-3b87-4326-95d7-4cb409307600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ebaa0989-85fd-4cc0-a004-27635dfdc7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6232d5dd-3b87-4326-95d7-4cb409307600" xlink:to="loc_us-gaap_EarningsPerShareBasic_ebaa0989-85fd-4cc0-a004-27635dfdc7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_79e64a14-0502-4aa4-bd56-7ebc2194e201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6232d5dd-3b87-4326-95d7-4cb409307600" xlink:to="loc_us-gaap_EarningsPerShareDiluted_79e64a14-0502-4aa4-bd56-7ebc2194e201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_496103c3-6700-4f4e-9fe1-c5c015beb618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_496103c3-6700-4f4e-9fe1-c5c015beb618" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_02e6e60d-7c17-4c89-8346-c1eef2e0d6c8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4fa669f1-9198-4f74-bd34-9bb58dcc2e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96d53a76-b975-4b55-b15b-5d0754d393bb" xlink:to="loc_us-gaap_StockCompensationPlanMember_4fa669f1-9198-4f74-bd34-9bb58dcc2e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_560faec3-d260-4636-bf02-17350e2f581c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b823c4ab-05ec-4ca3-8c95-555865a718d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2d86ad9f-d2d1-4680-bef5-95b10b5c8509" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b823c4ab-05ec-4ca3-8c95-555865a718d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b533f35f-2c57-40ee-8a4e-e9f9021fcd22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e580f521-af46-426b-99b8-e66e781b42f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b533f35f-2c57-40ee-8a4e-e9f9021fcd22" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e580f521-af46-426b-99b8-e66e781b42f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f398058-55ec-4115-94b6-73e2148494bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c20ccc10-44e0-4ae7-bcde-27fb4d6b4770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f398058-55ec-4115-94b6-73e2148494bc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c20ccc10-44e0-4ae7-bcde-27fb4d6b4770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_2cbd19d1-c4cf-4ff8-9ab0-189cbde326fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f398058-55ec-4115-94b6-73e2148494bc" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_2cbd19d1-c4cf-4ff8-9ab0-189cbde326fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8e5d4771-8da0-46fe-a081-82109fe8641b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f398058-55ec-4115-94b6-73e2148494bc" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8e5d4771-8da0-46fe-a081-82109fe8641b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3ca84239-6871-4c5a-8405-8949ea140848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f398058-55ec-4115-94b6-73e2148494bc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3ca84239-6871-4c5a-8405-8949ea140848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f1eb3acd-06f1-41d7-a5cb-02ea8d85038a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f1eb3acd-06f1-41d7-a5cb-02ea8d85038a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4401b48a-ed4b-4dd0-8284-457b7514654b" xlink:to="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_57480c04-80ba-47f5-a631-0d8b1aa0bfc3" xlink:href="pbh-20201231.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_57480c04-80ba-47f5-a631-0d8b1aa0bfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_1ef6f0ad-2c90-4c1a-9e36-f13e45b1a99b" xlink:href="pbh-20201231.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5ce7b853-ca52-4114-bdb9-ac51aab2cd97" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_1ef6f0ad-2c90-4c1a-9e36-f13e45b1a99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a1f10c4c-a85a-43b5-a8b0-13ae91bf794f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_73a011bb-4355-4413-be7c-e9bee5db58be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_PerformanceSharesMember_73a011bb-4355-4413-be7c-e9bee5db58be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_902ba3c3-9289-49a5-9ecb-028e230636f1" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_902ba3c3-9289-49a5-9ecb-028e230636f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_01be4596-33d8-4c99-ad03-4f0314317641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_01be4596-33d8-4c99-ad03-4f0314317641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_51948c4e-5b1f-4801-9726-f83ac2ed2c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73815dcc-8a7e-4997-b4c8-5607af8b2ff5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_51948c4e-5b1f-4801-9726-f83ac2ed2c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_21645503-08a0-4d54-9390-26d013ebb991" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_7a1b1ff3-79a5-4a6c-8f78-29b86e452f8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7c0f6499-ff76-49d7-bbf5-00a8338a1d2f" xlink:to="loc_srt_DirectorMember_7a1b1ff3-79a5-4a6c-8f78-29b86e452f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc71c0b1-71e3-4152-9d60-ae40c596ed61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ddd985bb-244a-4c5c-a374-ba397f5085be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ddd985bb-244a-4c5c-a374-ba397f5085be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dd1b5d27-17a7-42cf-a10a-76dbed29635e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dd1b5d27-17a7-42cf-a10a-76dbed29635e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_afdd5a68-7795-49dd-bd00-749cd43323db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_afdd5a68-7795-49dd-bd00-749cd43323db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_6113988e-11d5-4767-a03a-486030740c99" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_6113988e-11d5-4767-a03a-486030740c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0bb57726-22d8-4f6f-9910-c21edc3d54fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0bb57726-22d8-4f6f-9910-c21edc3d54fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_a9a1a057-dd7d-4502-b194-5d3f39c23753" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_a9a1a057-dd7d-4502-b194-5d3f39c23753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_fc46c247-ff68-43ce-8419-2b94f3d4a2dc" xlink:href="pbh-20201231.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_fc46c247-ff68-43ce-8419-2b94f3d4a2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8b6d0ce2-7ff2-4b3a-9d0f-30ad99da9ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8b6d0ce2-7ff2-4b3a-9d0f-30ad99da9ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ffe84a33-0594-4482-8c62-ebcbf04ee5e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ffe84a33-0594-4482-8c62-ebcbf04ee5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c07255c0-df00-4efa-990e-65a6abb19da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c07255c0-df00-4efa-990e-65a6abb19da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77c9dbc0-11bf-4e21-841e-779e4d240c80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77c9dbc0-11bf-4e21-841e-779e4d240c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93be6c50-6b72-46e7-8b0b-06a1c2532a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93be6c50-6b72-46e7-8b0b-06a1c2532a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94e995b3-c95c-492c-9bba-d2a1ba67e89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94e995b3-c95c-492c-9bba-d2a1ba67e89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_20f0cb08-3f25-4795-90f1-d288c2e6ce8e" xlink:href="pbh-20201231.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_6e338e74-2382-4cc9-8fb7-fe84e3384d0c" xlink:to="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_20f0cb08-3f25-4795-90f1-d288c2e6ce8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42ffc0a9-65c7-416c-97a1-ef2b9116d0dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bcd49a29-c464-46bb-a2a8-07cb95426455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cabc1dca-ef75-4052-b9d8-855c8342b437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bcd49a29-c464-46bb-a2a8-07cb95426455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_61940f66-c5e4-4583-9130-694b96cf65ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_61940f66-c5e4-4583-9130-694b96cf65ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_58496715-0834-4d3e-a6b9-ece8957e13b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_58496715-0834-4d3e-a6b9-ece8957e13b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_06ac5140-dac8-4f1c-8d27-4063ba593f71" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_06ac5140-dac8-4f1c-8d27-4063ba593f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_de763078-7e99-495a-9681-7fc2692290ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_de763078-7e99-495a-9681-7fc2692290ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_cd4ada8a-80c6-4051-a7d2-924ac0761cc4" xlink:href="pbh-20201231.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce5d0269-43c6-43c3-bd20-a6e1db9b0fe5" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_cd4ada8a-80c6-4051-a7d2-924ac0761cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1eff830-4a29-4bdb-a169-ccc7bc0a7744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1eff830-4a29-4bdb-a169-ccc7bc0a7744" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:to="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a622649a-4f54-453a-b09d-1bf8e2b21dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f88b76f0-d223-4e89-a8ad-2d94475d159e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd296b5-8171-45f5-97cf-13009d1c91e1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f88b76f0-d223-4e89-a8ad-2d94475d159e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_caa3ac15-3d99-4f73-a3fe-6d85f628b490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d3474858-fb2e-485f-aecb-b41a54ab5a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d3474858-fb2e-485f-aecb-b41a54ab5a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cb7e361e-46da-4006-9a75-f4700b939bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cb7e361e-46da-4006-9a75-f4700b939bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_287a570c-9de6-44f2-8099-68ab24823a33" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_287a570c-9de6-44f2-8099-68ab24823a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4ca4a86e-069a-4ccb-9876-0621675f2fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4ca4a86e-069a-4ccb-9876-0621675f2fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2c802c3-2ff6-41f0-919e-579ffc572639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2c802c3-2ff6-41f0-919e-579ffc572639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_6da021b2-c876-4bb2-84f2-aeda8c85fd11" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8412300-3ff2-4fe2-9ded-2772772b6926" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_6da021b2-c876-4bb2-84f2-aeda8c85fd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5a14c101-a16e-404d-8939-4c657c286e52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7fe3e3d3-5697-4271-9ad1-4bd2845c8c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7fe3e3d3-5697-4271-9ad1-4bd2845c8c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dff97cf6-66ba-40eb-b653-e8334f7c5c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dff97cf6-66ba-40eb-b653-e8334f7c5c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_c7dfde37-7a14-422b-b604-9436759a5d0c" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_c7dfde37-7a14-422b-b604-9436759a5d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_957ff73e-bda8-44da-8561-b7cc8579f3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_957ff73e-bda8-44da-8561-b7cc8579f3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4d66a1ff-6d2d-4872-997a-5f415cf3d241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4d66a1ff-6d2d-4872-997a-5f415cf3d241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_f7f615ac-1fa6-48a0-99c4-51e17c547d27" xlink:href="pbh-20201231.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_30bf6c12-7244-4e03-ad7b-c3bf25f24a5b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_f7f615ac-1fa6-48a0-99c4-51e17c547d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_440f1658-845f-42ee-a28c-e9424477bc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_440f1658-845f-42ee-a28c-e9424477bc02" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:to="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_89fa0523-c1be-46cf-95dc-787750079b90" xlink:to="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cfb6dbc-a9c7-4e3c-b7a4-469373193044" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:to="loc_srt_MinimumMember_6cfb6dbc-a9c7-4e3c-b7a4-469373193044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a94ffdf7-39e3-42c3-b94d-c351a1f4124a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f795cd20-633e-4a7b-ace3-ddcc042bb7fe" xlink:to="loc_srt_MaximumMember_a94ffdf7-39e3-42c3-b94d-c351a1f4124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:to="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_213004cf-e783-40e3-8292-decf797e4080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0838844e-df1b-40c4-8708-7b54fd21794b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f4ea718-4285-451a-aa83-c46e32c87844" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0838844e-df1b-40c4-8708-7b54fd21794b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c5c015b-22c0-4523-b80e-ae43438247c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_219fada7-3243-494e-bf4d-5cbe66088119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_219fada7-3243-494e-bf4d-5cbe66088119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8fd7d330-a748-4128-95df-94d45c32834a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8fd7d330-a748-4128-95df-94d45c32834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_76ae2632-5567-4eaf-be2c-8ed0e6b1f7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_76ae2632-5567-4eaf-be2c-8ed0e6b1f7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_85304a3c-1ca0-4529-926d-516f643edd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_85304a3c-1ca0-4529-926d-516f643edd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6737397d-fc5c-4747-ae33-acb07289303b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9733fd2a-bbd6-49d0-8f7f-9a926010114a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6737397d-fc5c-4747-ae33-acb07289303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a40b015-f3bf-4b85-b610-28f81fdda792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a40b015-f3bf-4b85-b610-28f81fdda792" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8387bb1-390e-4863-bd55-d806f373bc33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8387bb1-390e-4863-bd55-d806f373bc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c11a37a-3432-4121-848e-157e94778675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6c11a37a-3432-4121-848e-157e94778675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fecc5f64-f702-4785-a623-ebd26694dc1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fecc5f64-f702-4785-a623-ebd26694dc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8debe592-421a-473f-97ca-8412cf1fb702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8debe592-421a-473f-97ca-8412cf1fb702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4163291-4a43-4dfc-9a9e-3de0e191f62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4163291-4a43-4dfc-9a9e-3de0e191f62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cd9eccf6-4820-4c88-aa31-02d5d632db18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3e20f9c2-438a-4e4a-80bc-d6495c51306f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cd9eccf6-4820-4c88-aa31-02d5d632db18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a40b015-f3bf-4b85-b610-28f81fdda792" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0a01aa57-4e5d-46c1-9aad-7a73e5b06d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0a01aa57-4e5d-46c1-9aad-7a73e5b06d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_78e818b9-6176-4f87-8cb6-7a31786d8fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_78e818b9-6176-4f87-8cb6-7a31786d8fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_05e207b2-845f-44e7-8137-c717d1b92f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_05e207b2-845f-44e7-8137-c717d1b92f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0bbd7188-4ee2-43d8-a75f-57091008d864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0bbd7188-4ee2-43d8-a75f-57091008d864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2c3af016-0b81-476c-8307-2d39445cb4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2c3af016-0b81-476c-8307-2d39445cb4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_21c11fa6-9430-4704-9fea-22dba3fb8722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f2c67ba9-7fe8-4b8f-9c3c-5cceac8a0273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_21c11fa6-9430-4704-9fea-22dba3fb8722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a40b015-f3bf-4b85-b610-28f81fdda792" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_36385ecd-d441-4621-8211-509e1329b679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_36385ecd-d441-4621-8211-509e1329b679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e53d7a3d-f8d3-41af-9b7d-3bdb5ca40a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e53d7a3d-f8d3-41af-9b7d-3bdb5ca40a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c7b0faa5-1a43-4efe-9ca1-d94e799e9313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c7b0faa5-1a43-4efe-9ca1-d94e799e9313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ca2cbe14-ab35-44d0-b6c7-4151a4968dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_92af7131-0921-4663-88c1-c159116c403d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ca2cbe14-ab35-44d0-b6c7-4151a4968dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8882714f-7627-46a7-9413-fcb5a52206e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f30a757b-504f-478f-870e-96ef02daff16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8882714f-7627-46a7-9413-fcb5a52206e4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f30a757b-504f-478f-870e-96ef02daff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01f104-38f7-4359-a49f-bfbf29bb67d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f70b1407-e69c-42d5-823a-e8a953953f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01f104-38f7-4359-a49f-bfbf29bb67d3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f70b1407-e69c-42d5-823a-e8a953953f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_77ee097a-af98-4c79-abda-e41179270323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01f104-38f7-4359-a49f-bfbf29bb67d3" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_77ee097a-af98-4c79-abda-e41179270323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlans"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53dda0f0-2d50-44e5-ac50-fa3e3830b003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f5c95b3c-d96d-47d6-87cb-5da89f0eb16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53dda0f0-2d50-44e5-ac50-fa3e3830b003" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f5c95b3c-d96d-47d6-87cb-5da89f0eb16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b3d77d37-5182-4518-acc5-35796fdf0712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_0b4ee0fa-1c22-4ca6-a170-9e3fc50b5a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b3d77d37-5182-4518-acc5-35796fdf0712" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_0b4ee0fa-1c22-4ca6-a170-9e3fc50b5a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_065ad264-d0ca-4349-8e6d-2de67a0fea84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_93c9890c-85e5-4514-ad64-ad4c7e0f383d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_065ad264-d0ca-4349-8e6d-2de67a0fea84" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_93c9890c-85e5-4514-ad64-ad4c7e0f383d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_98adbf08-6ff9-427c-8fd6-bbb95df3588d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_065ad264-d0ca-4349-8e6d-2de67a0fea84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_98adbf08-6ff9-427c-8fd6-bbb95df3588d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fd7f7564-963e-42d8-be72-25726907e691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_065ad264-d0ca-4349-8e6d-2de67a0fea84" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_fd7f7564-963e-42d8-be72-25726907e691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b20b3ea-83ab-4b74-8197-2affbd6de572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b20b3ea-83ab-4b74-8197-2affbd6de572" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_36a7160a-4751-42a1-a7de-d26be9f2736c" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_d5fb2d38-e01b-41ee-9a03-b890542c68b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:to="loc_us-gaap_NonqualifiedPlanMember_d5fb2d38-e01b-41ee-9a03-b890542c68b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_c136df82-3973-4bfe-83e8-ef5b6c9a5d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_a6e1c17e-8b84-4064-b892-ebfd2d7f1100" xlink:to="loc_us-gaap_QualifiedPlanMember_c136df82-3973-4bfe-83e8-ef5b6c9a5d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_604e66f7-81b1-4da6-82a7-25827222ad6f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0f6d2e6d-f9ca-445b-8abd-592b35dc3999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0f6d2e6d-f9ca-445b-8abd-592b35dc3999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_ce497ae2-c3bc-4407-8736-ed81c010cf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_ce497ae2-c3bc-4407-8736-ed81c010cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_858386e0-fc15-49ab-a294-ee75a13e420e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_858386e0-fc15-49ab-a294-ee75a13e420e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_9ba66cac-b105-4209-a21b-e5c5e8b0ee37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4e4f9395-fc72-4d83-a6fd-1d308e832edf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_9ba66cac-b105-4209-a21b-e5c5e8b0ee37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pbh-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f4873062-e334-4e9b-9a6a-19ca051b1aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_629add85-a83f-4fe1-8f12-e1ac10238a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f4873062-e334-4e9b-9a6a-19ca051b1aed" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_629add85-a83f-4fe1-8f12-e1ac10238a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRisk"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_c37dfedd-0fd5-4f0d-952d-e4987c0cb851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_42cafbed-4fdf-443a-8399-64dd21c45b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_c37dfedd-0fd5-4f0d-952d-e4987c0cb851" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_42cafbed-4fdf-443a-8399-64dd21c45b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#ConcentrationsofRiskDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_109cd878-cc14-445c-900b-77351f3c56f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_109cd878-cc14-445c-900b-77351f3c56f9" xlink:to="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_11979aff-1ed9-4477-8ab1-c840167f9ea3" xlink:to="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember_8aa3d0e7-b9ef-45d2-9635-8ed1c6d3dfbc" xlink:href="pbh-20201231.xsd#pbh_TopFiveBrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6118a712-302f-490b-b760-21740aae3b2a" xlink:to="loc_pbh_TopFiveBrandsMember_8aa3d0e7-b9ef-45d2-9635-8ed1c6d3dfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84602503-6403-4788-af0c-dd5cfc82f088" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_dc1c5c55-685a-4fc8-8e15-6e5cbfb039a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a77c1d9e-c922-4f94-bd04-763b801e6229" xlink:to="loc_us-gaap_SalesMember_dc1c5c55-685a-4fc8-8e15-6e5cbfb039a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e355f14e-ac3c-4e8d-a258-f4578946b78b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_e44b3913-25d3-43c9-a5d7-dc7a11de376c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_e44b3913-25d3-43c9-a5d7-dc7a11de376c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_03d49181-77d0-4a6f-ad67-973e525cab43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_03d49181-77d0-4a6f-ad67-973e525cab43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_41ac09a0-5998-4e9d-bc01-c2c269701d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_18a85139-accf-48c6-a4e1-0f63df8818a2" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_41ac09a0-5998-4e9d-bc01-c2c269701d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_be931aa0-151c-4610-b336-0d22264dcc1f" xlink:to="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_069cea59-66d6-4b86-b122-e8db88ee61c4" xlink:href="pbh-20201231.xsd#pbh_WalmartMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d81eb14e-a57a-45b8-ad42-527e2832a40d" xlink:to="loc_pbh_WalmartMember_069cea59-66d6-4b86-b122-e8db88ee61c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_25451b8b-3d02-4812-8bc3-c60641004264" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e718b709-fff0-47b3-aa19-2c2343957491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e718b709-fff0-47b3-aa19-2c2343957491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_03a8c83d-2286-4410-9812-635a53234d05" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_03a8c83d-2286-4410-9812-635a53234d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_167f267e-963c-465a-873b-fcb1d04c7991" xlink:href="pbh-20201231.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_40a4e4e3-284b-4d02-afd4-ba636a1bc255" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_167f267e-963c-465a-873b-fcb1d04c7991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5999f9fa-e2c5-49b0-90fb-340c609fe6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_eb5a6c0d-549a-471f-aaab-3a182ab56c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5999f9fa-e2c5-49b0-90fb-340c609fe6ce" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_eb5a6c0d-549a-471f-aaab-3a182ab56c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_87900b84-13d3-40a9-acbe-a5f4ad8de089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7f45cf6e-9143-458d-ae3b-4a8e18ea9b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87900b84-13d3-40a9-acbe-a5f4ad8de089" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7f45cf6e-9143-458d-ae3b-4a8e18ea9b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_a0ad5b8b-e5de-4cf9-b081-29ec4c407056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87900b84-13d3-40a9-acbe-a5f4ad8de089" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_a0ad5b8b-e5de-4cf9-b081-29ec4c407056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_06b452f9-0da9-44e4-a9b9-244904408c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87900b84-13d3-40a9-acbe-a5f4ad8de089" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_06b452f9-0da9-44e4-a9b9-244904408c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_f9af27cb-1090-42e1-9597-2ad4b24b9d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87900b84-13d3-40a9-acbe-a5f4ad8de089" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_f9af27cb-1090-42e1-9597-2ad4b24b9d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1d109169-0119-478f-ba6e-b05e53dd62e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1d109169-0119-478f-ba6e-b05e53dd62e4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:to="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8c16e6be-c192-418a-8f6c-2f022ec305d3" xlink:to="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b04c9356-f54d-4a35-9548-5b8bfb2857dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:to="loc_us-gaap_OperatingSegmentsMember_b04c9356-f54d-4a35-9548-5b8bfb2857dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_cfd837cf-43dd-4714-8642-f2802d350053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a4fc5445-c566-46c3-8572-d1402a35d57e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_cfd837cf-43dd-4714-8642-f2802d350053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5165218-589d-43ea-87ac-fcfbdd43d2e5" xlink:to="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_ac9a0691-d4d9-4344-8d27-23ba51b509fd" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_ac9a0691-d4d9-4344-8d27-23ba51b509fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_88a7dac5-c6af-47ae-9041-a14dd3559bca" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68b8da63-eb43-4f25-8e06-3fe592084b94" xlink:to="loc_pbh_InternationalOTCHealthcareMember_88a7dac5-c6af-47ae-9041-a14dd3559bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f7f52ceb-7ec5-4561-a6cc-6222c88044a2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6d8fa6ee-2434-4c03-97ee-573a2c277482" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5cad72dd-2052-434c-9eb8-2249d312ff86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5cad72dd-2052-434c-9eb8-2249d312ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_192561d2-f6d8-49d3-90a8-5850a6e4d090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_CostOfRevenue_192561d2-f6d8-49d3-90a8-5850a6e4d090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_af5147c2-a8f9-4be1-9bf8-24781c50f3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_GrossProfit_af5147c2-a8f9-4be1-9bf8-24781c50f3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_e43ab45c-7917-44c6-8442-1dcd913c8ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_e43ab45c-7917-44c6-8442-1dcd913c8ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_a4772bb2-2a7f-4773-9eee-3d8a43b8ebf0" xlink:href="pbh-20201231.xsd#pbh_ContributionMargin"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_pbh_ContributionMargin_a4772bb2-2a7f-4773-9eee-3d8a43b8ebf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_f216edb9-af99-4ba3-a07d-cc3c63fde092" xlink:href="pbh-20201231.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_f216edb9-af99-4ba3-a07d-cc3c63fde092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dc194284-6287-48e4-98d3-13ca33b9bf24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_f33eb3f4-4a64-466f-a0e0-054f216a226f" xlink:to="loc_us-gaap_OperatingIncomeLoss_dc194284-6287-48e4-98d3-13ca33b9bf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1e4210f7-a046-4f93-9c2a-bc7ab4064f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1e4210f7-a046-4f93-9c2a-bc7ab4064f53" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fee17aac-84d9-4d69-b5c2-f1d5eb57caf7" xlink:to="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_e9353e10-27c7-4d94-9573-5615545b92fc" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_e9353e10-27c7-4d94-9573-5615545b92fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_f05327f5-9460-4ac4-bf33-782d03622f10" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d56f5165-3a29-4304-8801-7cd39a7581d4" xlink:to="loc_pbh_InternationalOTCHealthcareMember_f05327f5-9460-4ac4-bf33-782d03622f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:to="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c3afcd91-09d4-4b01-926f-acb0277c69b1" xlink:to="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_f457550c-bcb5-4e60-8936-5f021f5f8027" xlink:href="pbh-20201231.xsd#pbh_AnalgesicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_AnalgesicsMember_f457550c-bcb5-4e60-8936-5f021f5f8027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f0b48854-dd12-4547-bdb7-a860175498d8" xlink:href="pbh-20201231.xsd#pbh_CoughAndColdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_CoughAndColdMember_f0b48854-dd12-4547-bdb7-a860175498d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_7f0b59e4-770f-47cd-9b98-856051ca3bf7" xlink:href="pbh-20201231.xsd#pbh_WomensHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_WomensHealthMember_7f0b59e4-770f-47cd-9b98-856051ca3bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_ca7544c4-6f84-4fb6-8a03-0a7fe53ae395" xlink:href="pbh-20201231.xsd#pbh_GastrointestinalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_GastrointestinalMember_ca7544c4-6f84-4fb6-8a03-0a7fe53ae395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_5c1a99b9-cee7-4307-8a3f-1f8d307beb54" xlink:href="pbh-20201231.xsd#pbh_EyeAndEarCareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_EyeAndEarCareMember_5c1a99b9-cee7-4307-8a3f-1f8d307beb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_ffecdcb5-aff8-4167-83a3-b82d2c6edc75" xlink:href="pbh-20201231.xsd#pbh_DermatologicalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_DermatologicalsMember_ffecdcb5-aff8-4167-83a3-b82d2c6edc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_f837d61c-e684-4bf1-a927-4c63cb9b15ac" xlink:href="pbh-20201231.xsd#pbh_OralCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_OralCareMember_f837d61c-e684-4bf1-a927-4c63cb9b15ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_cbe2a68a-30d4-4be6-867e-f879e0154505" xlink:href="pbh-20201231.xsd#pbh_OtherOtcMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1c187c01-f668-4452-bb62-4bb2f32f3a05" xlink:to="loc_pbh_OtherOtcMember_cbe2a68a-30d4-4be6-867e-f879e0154505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f8976be4-c644-4566-9a3e-b96ce077761d" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7dfc257f-d1ce-4231-8be5-434a05296a55" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb0983-4814-499e-901d-f520cae126f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_a8698119-e440-463b-96f6-fa74b2a61d91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb0983-4814-499e-901d-f520cae126f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsRevenuebyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fae4ba67-447a-42c4-b3a0-b43cc64ec260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fae4ba67-447a-42c4-b3a0-b43cc64ec260" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:to="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9cbb6b36-c6d9-4f63-bff0-260ecdbbe3b4" xlink:to="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8c07b0f5-b1f1-4277-a895-390a83dba93f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:to="loc_country_US_8c07b0f5-b1f1-4277-a895-390a83dba93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ea4a0cf3-2756-4bc7-9234-3da40f84f7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a132565b-69a6-47d1-bf85-0d902ca477c4" xlink:to="loc_us-gaap_NonUsMember_ea4a0cf3-2756-4bc7-9234-3da40f84f7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b071b2a9-7e64-4ee4-9dcd-acb8dc97bdba" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9ac732e-b52d-4eaf-88ec-75a6cf904484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2126cf39-b8aa-4490-ad5a-f0df88f39447" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9ac732e-b52d-4eaf-88ec-75a6cf904484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20201231.xsd#BusinessSegmentsGoodwillandIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dde90984-c54d-472c-afcb-8b82e345ab64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dde90984-c54d-472c-afcb-8b82e345ab64" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_876708ed-ab1e-42ad-be12-bacad4ee5bb8" xlink:to="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_c02b8225-73a4-427b-a2e0-d47974ebc2db" xlink:href="pbh-20201231.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_c02b8225-73a4-427b-a2e0-d47974ebc2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_a9fdcdbd-0ac9-4aca-9677-3dc97c55e06b" xlink:href="pbh-20201231.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_69526706-a473-4fbf-9a1c-5210984bc7e3" xlink:to="loc_pbh_InternationalOTCHealthcareMember_a9fdcdbd-0ac9-4aca-9677-3dc97c55e06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_d7584309-c0ec-4c3d-a37c-50dda9bed201" xlink:to="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ba2fcc86-e109-4c4e-8741-78cf7c28e420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_Goodwill_ba2fcc86-e109-4c4e-8741-78cf7c28e420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26e19456-0074-4565-a3c3-93bf5036a29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26e19456-0074-4565-a3c3-93bf5036a29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10a0703b-9168-4533-999e-c6b35eb3324d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10a0703b-9168-4533-999e-c6b35eb3324d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4522785a-c65d-4d26-91da-e59a592f3e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06d2834e-2f34-4599-8ce7-554fe30ff494" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4522785a-c65d-4d26-91da-e59a592f3e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8feea79-1364-4cfd-9492-35810ca035ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a4003ea4-8588-48e6-8b50-931f99c3a28c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8feea79-1364-4cfd-9492-35810ca035ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>pbh-20201231_g1.jpg
<TEXT>
begin 644 pbh-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-A;6%N=&AA
M+D-H:71T96YD96X   60 P "    %   $*R0!  "    %   $,"2D0 "
M S4R  "2D@ "     S4R  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **9)*D,9>5U1%Y+,< ?C6->>-/#-@I-UKVGICJHN59OR!)II-[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK,S'+$D^YI***HD**** "BBB@ HHHH **** "BBB@ HHIZ02R?ZN)V_W5)H
M915Z+1=4FYBTV[<>JP,?Z5;A\(>(I_\ 5:+>M_VQ-*Z'9F-174Q_#3QC)TT"
M[7_>7%7(/A%XSG( TDIG_GI*JX_,U//'N/EEV.*HKT./X(^,GQOMK9/K<*<?
ME5N#X#>*)642W%A"#U+2DX_(&E[6'<?LY=CS&BO6D_9]UPX\S5]/'KM#G_V6
MK,?[/5\1^^UVW4Y_A@8_U%+VU/N/V<^QXY17N"?L[P@G?XE<_2R _P#9ZGC_
M &>M/&/,UZY;UVP*,_J:7MZ?</92/"**^@H?V?O#RD_:-4U-QVV-&N/S4U87
MX!^% N#=:JWN9X__ (BE]8@/V4CYUHKZ17X%^$ 03]O;'4&X'/Y+5F/X*>"D
MD#-8W$@'\+73X/Y$&E]8@/V,CYEHKZB7X/>!E;(T3/UNIC_[/4@^$G@A6!&A
M)QZSRG_V:E]9AV#V,CY9HKZJ_P"%5>"O^@##_P!_'_\ BJE'PT\'  ?\(_9_
M]\G_ !I?68]A^Q?<^4**^M(?AYX1@)V>'=/.>N^ /_/-3?\ "">$_P#H6]+_
M / 1/\*/K,>P>Q?<^1:*^O%\#^%D^YX=TQ?I:)_A3O\ A"_#'_0OZ;_X"I_A
M1]978/8ON?(-%?7W_"%^&/\ H7]-_P# 5/\ "C_A"_#'_0OZ;_X"I_A1]978
M/8ON?(-%?7W_  A?AC_H7]-_\!4_PH_X0OPQ_P!"_IO_ ("I_A1]978/8ON?
M(-%?7W_"%^&/^A?TW_P%3_"C_A"_#'_0OZ;_ . J?X4?65V#V+[GR#17U]_P
MA?AC_H7]-_\  5/\*C/@7PHQ)/AS2R3_ -.B?X4?65V#V+[GR+17UU_P@GA/
M_H6]+_\  1/\*KM\-_!SN6/AZRR3DXCP/R%'UF/8/8ON?)M%?5TGPQ\&R+AM
M M0/]G*_R-1?\*J\%?\ 0!A_[^/_ /%4?68]@]B^Y\K45]2_\*C\#_\ 0#7_
M ,")?_BJC_X4[X%)_P"0)_Y-S?\ Q=/ZS#L+V,CY>HKZ8;X)>#"Q/V2Y ST%
MRW%5C\"?")4@-J ]Q<#C_P =I_6(![&1\X45]%-\ _"C# N]57W$\?\ \15>
M;]G[P\V/L^J:G'Z^8T;9_)!3^L0%[*1\^T5[P_[/6G$GR]=NE'8- IQ^HJNW
M[.\)^YXDD'KFR!_]GI^WI]P]E(\/HKV:7]GFZ!;R/$$+#^'?;%<_7#'%57_9
M\UD?ZO6+$_[RN/Z4_;4^XO9S['D=%>I3? +Q)&H,=]ITO/17<8_-:IR? WQ>
MF=D=I)Z8G S^=/VL.XO9R['G-%=Y-\&/&D*EO[/BD _N7"$G\,U2E^%GC*(G
M.B3-C^X0?ZT_:0[BY)=CD**Z2;X>>+;=2TN@7H4'&1'FJ$GA;7H21)H]ZI!Q
M_J&_PI\T>XN5]C*HJW)I.HP_ZZPNH_\ >A8?TJNT4B??1E^HQ57$,HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** )K>[N;2026MQ+"XZ-&Y4C\175
MZ3\5_&.D8$>KR748ZI=J)<_B?F_(UQU%)Q3W0U)K8]GTK]H.X7:NMZ-&XS\T
MEI(5X_W6S_.NUTGXR^$=3VK+>/8R'JMRA 'XCBOF.BL98>#-%5DC[-L-6T_5
M(P^G7L%RI&<Q2!OTJY7Q7!=7%K('MIY(7!R&1BI'Y5UVC_%GQAHY4)JC7D2G
M_57BB4'VR?F_(BL989]&:*LNI]345XKH_P"T&C;4U[1BA[RVDF1_WRW^)KO-
M'^)_A/6MJV^JQPRMC]W< QG/IS6$J4X[HT4XO9G744R&:.>,202)(AZ,C @_
MB*?6984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !113))8XEW2NJ+ZL<"@!]%<QJWQ&\)Z-D7FM6Y<9S'"3*P_!
M<XKA]7_:!TN'*Z)I-S=-C[]PXB7/T&XD?E6D:<Y;(ERBMV>OTUY$B0O(ZHHZ
MEC@"OFW5?C=XLU#<MJ]OIZ$8Q!'D_FV37':CXEUK5W9M2U2ZN"W4/*<?E6RP
MTGN9NM'H?4FJ>._#.C;AJ&LVJ.O5$?>WY#)KC=4^/?AZUW+IEG>7[ \,0(D/
MXGG]*^>:*UCAXK<S=:70]2U3X]^(KHLNF6=GIZ$\$@RN/Q.!_P".UQ^J>/O%
M&L%OMVM73*QR41]B_DN!7.T5LJ<([(S<Y/J.DEDF;=*[.QZECDTVBBK)"BBB
M@ HJ2.WFF.(89)#Z*I-:MGX1\0ZA_P >6BWTP]4@;'\J3:6X[-F-17:V?PA\
M:WB[ET@PKZSS(GZ$Y_2MVT^ 7B690UW?:=; ]5\QW8?DN/UJ'4@NI7))]#RV
MBO;[7]GF,!3>^(78_P 2PVN,?B6/\JV[?X"^%X<&:YU"X]0TJJ#^2BH=>FBO
M92/G6BOJ.V^$/@RV(*Z2),?\]96?^9K8M_!'AFT8-;Z%8H1TQ"*AXF/1%>Q?
M<^1XX)93B*)W/^RI-7X/#FM71 M]*O)">F(6_P *^O8].LH3F*SMT/\ LQ*/
MZ5:J7B>R'[%=SY/@^&OC"X(V:!=KGO(FW^=:L'P5\:3 %[&"$$9^>Y3C\ 37
MTW14/$S*]C$^>;?X ^(Y%!N-0TV'U&]V(_\ '<?K6K:_L\3,N;SQ$B'^[%:%
MOU+C^5>XT5/MZG<KV43R.V_9\T9&_P!,UB_F'_3)4C_F&K3@^!7A&(CS#?S>
MTEP!G_OD"O2:*GVLWU'R1['$Q?"'P3%]W1MV/[\\C?S:M&#X>^$K90(_#]B?
M=H0Q_,UTM%1SR?4KE78R[?PUHEHP:VTFSB(Z%8%_PJZMC:)]RUA7Z1@5/12N
MQB*JH,(H4>@&*6BBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=E**70K6^G6=HV;6T@A(Z&.)5_E5FBBH*"BBB@ HHHH **** "BBB@ HHHH
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MS.*]\Q163Q$V:*E%'EVG? ;PY;8-]=7=X?3<$'Z5U6G?#CPEIA4VVB6S.O\
M%,OF$_\ ?6173T5DZDWNRU&*V1%;VT%I%Y5K#'!'UV1H%'Y"I,4M%04%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%>5^(]7^)OA[?*J6E]:+SYUM;;L#U*YR
M/Y5QW_"Y?%HZRVG_ (#C_&LG5BM&>K2RNM6CS4Y1:]?^ ?0M%?/7_"Y?%G_/
M6T_\!Q_C1_PN7Q9_SUM/_ <?XTO;1-/[%Q/E]_\ P#Z%HKYZ_P"%R^+/^>MI
M_P" X_QH_P"%R^+/^>MI_P" X_QH]M$/[%Q/E]__  #Z%HKYZ_X7+XL_YZVG
M_@./\:/^%R^+/^>MI_X#C_&CVT0_L7$^7W_\ ^A:*^?4^,_BE2-YM&_[8X_K
M6M9_'2_0J+[28)%'WC$Y4G\^*/;1(ED^*CLD_F>V45P.C?&'PWJ3+'>/+ITK
M?\]URG_?0_J!7=07$-U DUM*DT3C*R1L&5AZ@CK6D9*6QY]6A5HNU2+1)111
M5&(4444 %%%% !1110 445S_ (B\<^'O"R'^U]1C2;&1;QG?*?\ @(Z?4X%-
M)MV0MCH*KWNH6>FVS7&H74-M"HRTDSA5'XFO#?$?QZOKG?#X;LEM4Z">?YG/
MX=!^M<C9Z#XV^(ET+@QW=ZA/_'S<L5A7Z$\?@M;QH/>3L9NHMHZGJWB/XZ:%
MIQ>'0H9-4F''F8,<0/U/)_+\:\MUOXF>+?%,IMTN9(8Y#@6]DI&?;CDUZ!X>
M^ =K#ME\27[3MU,%M\J_]]'DUZ=HOA?1O#T(31]/@MN,%U7YS]6/-5S4H?"K
MBY9RW=CY]T#X-^*M=*SWT2Z9 YR7NS^\/_ !S^>*]/T#X(^'-*VR:D9-3F'7
MS3M3/^Z/ZUZ316<JTY%*G%%:RT^TTVW$%A;16T0Z)$@4?I5FBBL30**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK.J_>8#
MZFN2^(GC4>#]%5K=5DO[HE(%;HN.K'Z9'%?/>J:[J>LW)GU.^FN')SAG.!]!
MT%8SJJ+LCU<'EE3%1YV[(^L5=7^ZP;Z&G5\FZ7KNJ:-<";3+Z>W8'.$<X/U'
M0U]!_#SQH/&&BL]P$CO[<A9T7@-Z,!Z&B%52=F&,RRIA8\Z=T=?1116QY044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 45GZEKVDZ,F[5M2M+,8R!/,JD_0$Y-<K>?&/P7:'"Z
MF]R>X@@<X_$@"J49/9";2W.ZHKS1OCQX24X$6I-[B!?_ (JE3X[^$F/,>I)]
M8%_HU5[*?8GGCW/2J*X:S^,7@J[^]JC6Q])H''Z@$5TFF^)]#UC:-+U>RNF;
MHD4ZEO\ OG.:EQDMT4FGL:M%)FLJV\2:?=^)[O0;=G>\LX5FF( V*">!G/7D
M<8I6N,UJ***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX_M*Z7CR[4@J#[MT_+->0W6N>//B?<-;VR7$EJ3S!;C9"O\ O'O^)-=?X;^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\][&CGV.I5E;!!'(.:^M-*_Y UE_U[Q_^@BII+FNC7-ZCI2I5(]&W^1\W_\
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MBLCVCI?!7@N[\9:H\$$GD6T(#3W!7.P'H .Y/I7M^@?#3PUH&R2*S^UW"_\
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M16BITZJO'0ESG!ZGVK17AOPS^+TBSQ:+XLGWQMA+>^<\J>RO[>_;OZCW$$$
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MQ!8W"KKL4.IVY/S$((I!]"O'YC\:I>+O@WK7AC39=1M[F+4K.$9D:-2CHO\
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M# ]JEHH ^3_B%X0?P;XKFLDW-9R_O;60]T/8^X/'Z]Z^F_"__(HZ1_UY0_\
MH KC_C1X;&L^"VOH8]USIS>:I'4H>&']?PKL?#''A/2<\'[%#_Z *Z*D^>"N
M91CRR9J5S_CQ0W@#7 1D?8I/_0:Z"L#QU_R(.M_]>4G_ *#6,?B1H]CY%KU?
M]G]0?%^HG'(LN#_P-:\HKUC]G[_D;M2_Z\O_ &=:]&M_#9R4_C1] T445YAV
M!1110!Y3^T H/@_3R1R+T8/_  !J^?*^A/C_ /\ (FV'_7Z/_0&KY[KT</\
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M'_7I'_Z#7RM7U3X/_P"1+TC_ *](_P#T&MZ'Q'BYY_#AZFS11176?*A1110
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M/^WN/^35Z!7G_P :/^1 _P"WN/\ DU54^!F.!_WJGZH^?:***X#[X]]^"/\
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MS!?OQGAXSZ,O;^5;-<[33LS8*P/'7_(@ZW_UY2?^@UOU@>.O^1!UO_KRD_\
M0:<=T)['R+7K'[/W_(W:E_UY?^SK7D]>L?L_?\C=J7_7E_[.M>C6_ALY*?QH
M^@:***\P[ HHHH \J^/_ /R)MA_U^C_T!J^>Z^A/C_\ \B;8?]?H_P#0&KY[
MKT</\!R5?B/H[X$?\D\D_P"OV3^2UZ77FGP(_P"2>2?]?LG\EKTNN*K\;.F'
MPH****S*/D#QE_R/&M_]?TW_ *&:E\"_\C[HO_7Y'_.HO&7_ "/&M_\ 7]-_
MZ&:E\"_\C[HO_7Y'_.O5^Q\CB^V?75%%%>4=H4444 <_X\_Y)[K_ /V#YO\
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M_P"@[)_WY%<-J'<ZKU.QT?\ PO'P=_STO?\ P'_^O1_PO'P=_P ]+W_P'_\
MKUSG_#/4/_0=D_[\BC_AGJ'_ *#LG_?D46H=QWJ=CH)OCIX1CA9HOMTK@<((
M ,GZDUX9XS\4S>+_ !+/JD\?E*P"QQ9SL4=!7J?_  SU#_T'9/\ OR*/^&>H
M?^@[)_WY%7"5&#NF1)5)*S/#J]P_9ZN6-MK%M_"'23\<$4O_  SU!_T'9/\
MOR*[/X?_  [3P*]XR7[7?VH*#N3;MQ15JPE!I!"G*,KL[6N7^)7_ "3;6_\
MKW_J*ZBN7^)7_)-M;_Z]_P"HKDA\2-WL?)U>O?L]_P#(PZM_UZK_ .ABO(:]
M>_9[_P"1AU;_ *]5_P#0Q7HUOX;.2G\:/>Z***\P[ HHHH **** "BBB@#Y;
M\<_\C[K?_7[)_P"A5@UO>.?^1]UO_K]D_P#0JP:\T_1*'\&/HOR"OJGP?_R)
M>D?]>D?_ *#7RM7U3X/_ .1+TC_KTC_]!K>A\1XN>?PX>ILT445UGRH4444
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MXUY;7:?"74AIOQ*TPNVU+@M;L?7<.!_WUBN^HKP9RP=I(^I:***\L[0HHHH
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MM>3UZO\ L_L!XPU%>YL21_WVO^->C6_ALY*?QH^@J***\P[ HHHH \J^/_\
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MPK_Q&:TO@"BBBL#0*\?_ &A/^0#I'_7R_P#Z#7L%>/\ [0G_ " =(_Z^7_\
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MY9*S"BBBF2%%%% !112$@ DG '4T +7S?\5[E+KXC7YCZ1A(S]0H!KV'Q/\
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M\$[OQ[5U'P_^%MUJ]S#J6OPM!IZ$,L+C#3^V.RUU/QM18_"-@D:A46Y 50,
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MS3/$>CZQ"LNFZE;7"MTVR#/Y=:TR<#)KCV.D**Q]5\5Z%HL)EU+5+:$#/'F
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M\B&TA>WLX89)FG>.-4:5_O2$#!8^YZU-116IP/4**** "BBB@#F?$7P_\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX,_Y^+O_ ,!FH_X7?X,_Y^+O_P !FH]G/L'/'N>AT5YY_P +O\&?\_%W_P"
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M10 4451UG5K70M'N-3U!F6VMEW2%%W$#..GXT;@7J*\\_P"%W^#/^?B[_P#
M9J/^%W^#/^?B[_\  9JT]G/L1SQ[GH=%>>?\+O\ !G_/Q=_^ S4?\+O\&?\
M/Q=_^ S4>SGV#GCW/0Z*\\_X7?X,_P"?B[_\!FH_X7?X,_Y^+O\ \!FH]G/L
M'/'N>AT5YY_PN_P;_P _%W_X#-76^&_$FG^*M)_M'2'=[?S#'ETVG(QGC\:3
MA*.K0U)/8UJ***@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JK?:98ZFJ+J-G!=!#E1-&'V_3-6J*
M .8UGX>^&=9T^:VET>SA=U(2:&%4=#V(8#/X5\JZA9MI^I7-FYRT$K1D^N#B
MOM&OD'QFH7QMJX48'VM^!]:[,-)MM,YZR5KB^#-!'B;QCIVD.Q6.XE_>%>H1
M06;'O@&OI^S\$>&;"W6&VT*P5%&,M K,?JQR3^-> _!=-WQ1L#_=BF(_[]L/
MZU].5.(D^:Q5%+EN06=E;6$'DV-O%;Q YV1(%7/T%3T45RFQ3O=)T[4F1M1L
M;>Z* A#-$'VY],BL+6_AUX9UK39K=](M()74B.>&((Z-C@Y'\JZFBFI-;"LF
M?%EW;M:7LUN_WHI&0_@<5L>"= 7Q-XRT_2I21%-)F7;UV*"S?H*K>*0%\7:J
M , 7<N /]XUU7P44M\3K,C^&&8G_ +X(_K7J2;4&SC2]ZQ[[:>"?#-C L5MH
M5@JJ,9,"L3]21D_C6O:VEO96ZP6<$<$2](XU"J/P%345Y=V]SM"BBBD 4444
M %9=WX:T._DDDO=(L;AY#EVEMU8L?<D5J44]@/F_XR^"[#PMK-E=:/"+>TOT
M?,"DD(Z8SC/0$,./K7FU>Z_M#+_Q*]$;'2:49]/E6O"J]*BVX)LXZB2EH?5G
MA/PWHD_A#2I9M(L9)'M4+.UNI)..N<5K_P#"*Z!_T!-/_P# 9/\ "H_!W_(E
MZ1_UZ1_RK:KSI-W.M;&)-X,\-7"E9] TUP1CFU3_  K@/&_P4TRZL)+OPG";
M.\C&?LV\F.7V&>0?QQ[5ZU13C.47=,3BGN?*/PYD;3_B;I G5D9+GRW4C!!P
M1C\Z^KJ\!^(NC)X?^,FE:G"OEV^H7$4QP, .' ?^A_$U[Z#D9%:UWS6D135K
MH6BBBN<U"BBB@ HHHH **** "J6LZG#HVBW>HW) CMHFD.>^!TJ[7EGQIU:>
MXMM-\)Z9\UYJDH9U!Z(#@9^K?^@FKA'FE8F3LKG@VI:I<:EK5QJ<SG[1-,9B
MV>02<U]5>!/$*^)O!MCJ (,I01S#T=>#7R?>VDUA?3VERNR:!S&Z^A!Q7JWP
M%\2_9-9NO#]R_P"[O%\ZW!/ D4?,/Q7G_@-=M>%X770YZ<K2LSWRBBBO/.H*
M*** "BBB@ HHHH 0C/!Z5E2>%M E+&31=/?=RVZV0Y_2M:BG=H#P/XU>!M,T
M&*SU?1;5;2.>0Q311#"!L9! [=^!Z5Y%7T=\=U#?#N,G^&^C(_[Y>OG&O0H2
M;AJ<E56D>X_!KP%H]_X=;7-9LHKV6:5DA2==R(J]\'@DG^5>I#PKH X_L33P
M/^O9/\*P?A&BI\+=(*C&Y9"WN?,8?TKM*XZDFYLZ()**&QQI%&L<2!$4 *JC
M  ]*=116184444 %%%% !1110!X%^T$?^*DTO_KV;_T*K?PI^%5GJ6FIKWB:
MW\Z*;FUM7R%*_P!]O7/8?C3/C/9OJ_Q(T+3%_P"6\2Q@CMN?!->WVEM'9V<-
MM H2.%%C11T  P!75*;C221BHIS;9F1^$/#D*[8M"TY!Z"U0?TI__"*Z!_T!
M-/\ _ 9/\*UJ*YKLU//OB;X?T>S^'&KSVFEV<$R1KMDC@567YUZ$"OF>OJGX
MK?\ )+]9_P"N2_\ H:U\K5W8?X6<];='T-\&M#TJ_P#AY%/?:;:7$IN907EA
M5FQGU(KO?^$5T#_H":?_ . R?X5R/P/_ .2:1?\ 7U+_ #%>B5RU&^=FT/A1
MCOX2\.R+M?0M.8>AM4/]*\X^)/PBTZ329M6\+VHM+F!2\EM%]R11UP.Q'MQ7
MK](0",$9!J8SE%W3&XIJS/FSX'Y'Q(B'3_1Y<C\*^E*\*\'Z/_PCW[0][IL:
M[8@)GB'HC)O4?D0*]UK2N[ROY$4U96"BBBL#4**** ,ZZT#2+V=I[S2[.>9O
MO220*S'\2*\[^*WP]T,^#[K5M+T^"QO+(!R;= @D7.""!QWSFO5:Y[Q\H;X?
MZV&&1]D<\_2M(2:DK$R2:/D>O2_@SX+L/%&KWEWK$ N+6Q5<0L?E=VSC/J,
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M&^W3RF'OE<5U%%8<S74ULCYB^)'PVF\%7"W-G(]SI<S821Q\T9_NMC^=>C_
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M%&  .E.KS6[NYUI65@HHHI#"BBB@#)\4:+'XB\+ZAI<H'^DP,J$_POC*G\&
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M:76=2C,=W?J!'&PP8XNHS[D\X],5Z%:2C!G)33<CU&BBBO-.P**** "BBB@
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MD=OJ6)K1\#)YGCS15QG_ $R,X'LV:RM20QZK=HXPRS."/0[C6MX%D\KQ]HK
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M )'C6/\ K[?^==6&^)F%;8Z/X*?\E0L_^N,W_H!KZ:KYE^"G_)4+/_KC-_Z
M:^FJG$?&52^$****YS4**** /CSQ5_R-^K?]?DO_ *$:ZWX(?\E+@_Z]Y?\
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M._7),AC@SSMSV'T4 5K3TO/L1+7W3='P+\(;1G[>3W_T@?X4O_"B_!_I?_\
M@0/\*]'%%+VL^X<D>QYQ_P *+\'^E_\ ^! _PIK_  +\(E&V?;@V#@FX[_E7
MI-%'M9]PY(]CXTUG2YM%UJ[TZY!$EM*T9SWP>#^5=U\$_$@T?QH-.G?;;ZFO
ME#/02#[GY\C\16I\>?#GV/6K778$Q%>+Y4I X$BCC\Q_(UY/!/);7$<\#E)8
MG#HRG!4@Y!%=ZM5IG,_<F?:M%8WA+7H_$OA>QU2,C=-$/, _A<<,/SK9KS6F
MG9G8%%%%( HHHH **** /-OCM_R3E?\ K]C_ )-7S?7TA\=O^2<K_P!?L?\
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MNO,T^U++!$%&%VMMSGJ>AKK?&GB%/#'A&_U-R/,CC*PJ?XI#PH_/GZ UX]\
MG:3Q;J3N2S-;9)/<[JVA&\)2,Y2]Y(]_HHHK$T"BBB@ HHHH *\Z^-'B,Z/X
M+;3[9\76J-Y("GD1_P ?YCC\37HM>+2'_A/OCTD3?O-.T/YBIY4E#T_%\<>@
M-:TU[UWT(D]+&GHGP-\/OH=F^L?;/MS1*TX2;: QY(QCMTJ__P *+\'^E_\
M^! _PKT>BE[6?<.2/8\X_P"%%^#_ $O_ /P('^%)_P *+\'^E_\ ^! _PKTB
MBCVL^X<D>Q\H?$7PF/!WB^;3X-YM'19K9G.24/8GU!!'X51\&:\_AKQ=8:FA
M(6*0"4>J'AA^1KV_XY>&_P"U?"4>JP)FXTURS$#DQMPWY$ _G7SI7=3E[2&I
MS37)+0^UH94G@26([DD4,I]01D4^O/O@UXD_MSP1':RONN=.;R'!ZE>JG\N/
MP->@UY\H\K:.M.ZN%%%%2,**** "BBB@# \=_P#(@ZW_ ->4G_H-?(M?77CO
M_D0=;_Z\I/\ T&OD6N[#;,YJVZ/H#]GW_D4M3_Z_O_::UZS7DW[/O_(I:G_U
M_?\ M-:]9KFK?Q&;4_A1X7\9_A\+=Y/$^D1?NW;-Y&@^Z3_'^/>O&U8HP925
M8'((/(K[4G@BN;>2"XC62*52CHPR&4C!!'IBOEKXD>"9/!OB-XX59M.N"7MG
M/8?W"?45TT*EURLQJPM[R/7_ (2_$/\ X2;31I6JRYU2U3AR>9T'\7U'?\Z]
M*KXRTK5+O1=5M]0T^4Q7%NX=&'\C[5]5^"O%]GXR\/QW]J0DRX2XASS$_I]#
MV-95Z?*^9;&E.?,K,Z*BBBN8U"BBB@ HHHH **** "OD;QY_R4+7_P#L(3?^
MAFOKFOD;QY_R4+7_ /L(3?\ H9KJPWQ,PK;(WO@K_P E0LO^N,W_ * :^FZ^
M9/@K_P E0LO^N,W_ * :^FZ6(^,JE\(5R-QX(,_Q.MO%HNPH@A,9M]G+?(5S
MG\:ZZBN=-K8TM<***RO$^LIX?\,7^IR$#[/"S)GN_11^>*$KNPRW::E8WTDJ
M65[;W+Q'$BPRJY0^AP>*M5XU^SZGF6VNW3Y,C2QC)/7(8FO9:J<>65B8OF5P
MHHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***S-:\1Z1X>2)M:OX;-9B1&93]XCK_.G9O8#2KY!\8R+
M+XTU=TZ&[DQ^=>]:_P#&CPSIVGS'3+EK^[VD1)&AV[NQ)/&*^<+FXDN[J6XF
M.9)7+L?4DY-=F'A)-MG/5DFK([?X,2;/BEIR_P!^.9?_ "$Q_I7T[7QSX<UJ
M;P[XCL=6MAN>UE#[<XW+T9?Q!(_&OHW3/B_X0U"%&DU'[&[#+)<(1M/IFIQ$
M).5TATI*UF=S15+2M7L-;LA>:3=1W5N6*B2,Y&1U%7:Y#<**R=9\4:+X>>%-
M;U&&S:8$QB4D;@.N/SKC?$7QH\-Z?ILW]D7#7UX5(B5$(7=V))[5<82ELB7)
M+<\"\3N)/%>J.O1KN0C_ +Z-=5\%6V_$^R&<;HIACU^0FN$FE:>>260Y>1BS
M'W-:7AG79?#?B2RU:!=[6TFXIG[R]"/Q&:]*46X-'&G[US[$HKAM-^+_ (/U
M"%&DU+[([#E+A"NT^F:Z[3=4LM8L4O=,N$N;:3.V1#P<5YCC);H[4T]BW111
M4C"BBB@ HI'8(A9SA5&2?05R-W\4O!UFI+:U#(1G*Q L?Y4U%O83:6YQ/[0S
M#^S=#7/)EF('X+_C7A==O\4/'2>-M=A:R5TT^S0I '&"Q)^9B.V< ?A7$5Z5
M*+C!)G'4:<M#ZU^'L@E^'NBN.AM5KI*\,^&'Q7TK0_#T>BZ_YL/D,?*G5=RE
M2<X..F*]'A^*'@V6/?\ V];)GL^0?Y5PSIR4GH=49)K<ZRBN3E^)_@V)-QUZ
MV;V0DG^5<]K/QS\-V,+?V8L^HS8X55V+GW)_IFI5.;Z#YHKJ=9XU\66OA#P[
M/?W#*9R"MO$3S(_;\/6OG/P(\NK?%+2YKMV>2>\\V1\\DG))_.J'BOQ?JGC#
M53>:K*,+Q% G"1+Z ?UK6^$T/G?$S2_]AF?\E-=D:?LX.^YSN?/)'U,****X
M#J"BBB@ HHK@/$WQ@\.^'I+BUA:2^OH6*&&-< ,.,%CTYJHQ<G9";2W,[XW^
M*1I?A=='MWQ<ZB<.!U6,'G\S@5O_  ITI-*^&VEJHP]S']ID/J7Y'_CNT?A7
MS;XE\1WWBK79]4U)AYDAPJ+]V-1T4>PKU/X9_%S3M*T&#1/$9>'[,-L%RJ[@
M4SPK>F.GTKJG2DJ:2,8S3G=GN%%4=(UBPUW3DOM*N4N;9R0LB=,CJ*O5QFX4
M457O[ZVTVQEO+^98+>%=TDC]%'K0!A^/O#R^*/!5_I^T&;9YMN?21>1^?3Z&
MODME*L58$$'!![5]0:A\7O!UE$Y74OM3*#A8$+;CZ5\T:I=KJ&KWEY'&(EN)
MWE6,?PAF)Q^M=V'4DFFCFK6=FCUWX">)?+N;OP]</\L@\^W!/<?> _0U[E7Q
MEI&JW>AZO;:EITGEW-LX=&[?0^QZ&OH;P[\:?#NKV\*:D[Z?>-A61U)3=[,.
MWUJ*])\W,BJ<U:S/1Z*0'-+7(;A1110 44A( )/0=:Y2Z^)WA"SWB36[=F1B
MK(F201[8II-[";2W.>^/$@7X>Q(2,O?1@#/^R]?.=>D?%?XBVOC&6VL=(5_L
M5JQ<R.,&1CQT] *\WKT:,7&%F<E1IRT/J;X1L&^%NCA3G:L@/L?-:NSKP/X6
M?%/3O#FBG1=>$D<22%X9T7< #U4CZUZ=!\4?!LR[O[=MX_:3(/\ *N.I3DI/
M0Z(27*M3KJ*Y8_$SP:!G_A(+,_\  C_A69>?&3P=:1LR7[W# <+#$3FHY)=B
MN:/<[2_O8--L9KR\D6*"%"[NQX %?)OBGQ!)XJ\97.IR9"S3 1J?X4'"C\JZ
M#XA?%.]\9#[#9HUEI:MDQ9^:8]BY]/;^?&.&M%W7L"CJTBC]:[*-)P5WN<]2
M?-HC[*TY/+TNU3.=L*#/_ 15FH[>,Q6T4;')1 I(]A4E<!U!1110 4444 %%
M17-Q%:6TEQ<N(XHE+.YZ*!WKF)?B?X-BC+_V];/CLA))_2FHM[(3:6Y7^+C^
M7\+=8.<96-?SE45\M5ZS\5_BA8>)M+31=!WO;&023SNNW=CHH'IGG/L*\FKT
M*$7&.IRU9)RT/HKX#,&\"S*#RMTV1Z<"O3Z^;_A/\1K7P?)<V&L*_P!AN6#B
M6-<F-L8Y'<&O8H/BCX-GCW?V[;Q^TF0?Y5RU82YV[&T)+E1UU%5["^MM3L8K
MRPF6>WF7='(G1AZBK%8&H4444 %%%% !1110 5SGQ D$?P]UIFZ?9''Y\4[5
M?'7AK1+N6UU/5X(+F(#?"2=P_"O,/B=\6-+U?P[-HOAYWG-R0)IRFU0H.<#/
M4G K6G"3DM")221XM7NW[/+YTG6X_P"[-$?S5O\ "O":[GX7>.XO!6M3_;U=
MK&\0++L&2A'1L=^I_.NZM%R@TCFIM*6I]045R%K\4_!MT@*ZW#%TP)05/\JZ
MV-UDC5XSE6 *D=Q7FN+6YUII[#J**YO4O'_A?2;N>UO]9MXKB!MLD))+*?3&
M*$F]@NEN1_$EQ'\-M<+=#:,OXG '\Z^3J]F^*/Q6TS6_#TFA^'F>9;AE\^=E
MVJ%!!VC/7) YKQFN_#Q<8ZG+5DF]#WO]GQ\Z!JZY^[<)QZ?*:]>KYC^%GCV#
MP7JTZ:BCM878 D*#)C8=&QWKVZT^*/@^\ V:W"C,0 L@*DD_A7/6A+G;L;4Y
M+E.NHI%((!'0]*6N<U"BBB@ HHHH HZSI%IKNC7.F:A'OM[E"C#N/0CW!Y%?
M*?C#PE?>#]=DL+Y2T9),$X'RRIV/U]17UU6-XE\+Z9XKTE[#5H-Z'E)%X>)O
M53VK:E5Y'Y&<X<R/G'X:>-V\&>(M\Y9M/NL)<H.WHP]Q7U#9W<%_9Q75G*LT
M$RADD0Y# U\S^,/A/KOAB62:WB;4; $E9X5^8#_:7M4'@?XE:MX*E^SC-WIS
M-E[20XVGN4/\)_0UT5*:J+F@90DX>[(^I:*X;1?B[X3UB)=]]]AE(YCNAMP?
M3/0UT/\ PEGA\V_G?VS8^7G&?/7^6:XW&2W1T73-BD9@JDL< <DGM7$ZQ\6_
M".DQG&H_;),<1VJEB?;/05Q-WX@\9_%5S8>'[-](T5SMEN')!=?=O3V7]:J-
M.3U>B)<ET,+XN^-&\5:F=,T;?-INFY>62,95VZ;C[#. ?>K/[/\ _P C5J/_
M %ZC_P!"KU;PQ\/=&\->'IM+2$7)NXREW-(/FF!&"/8>U<%\)?#EYX<^(NN6
MD]O.L$*&..9XR%<;N"#T/&*WYXNFXKH9\KYTV>T4445R&X4444 %%%<KXI^(
MOA_PE.UMJ=PYN@@<01(68@]/84TFW9";2W)?'WB>/PGX/N]0+#[0R^5;(?XI
M&X'Y=?PKB/@'IX70]3U60EI[JX"%B>H49_F37F'C_P ?7?CC5$D=#;V5OD06
M^[.,]6/N:VOA7\28/!S3Z?JT;M87#AQ+&,M$W0\=Q77[*2I-=3#VB<SZ1HK&
M\/\ BS1?$\<CZ)>I<^7C>H!!3/3(-;-<C36C.@***#2 @OK.+4+">TN5W13Q
MF-P1V(Q7Q]X@TF30O$%[IDP^:VF9/J,\'\J^F+SXI^#[)F6368I&7J(E+$'T
MZ5\^?$+Q%:^*?&EWJEA&R6\@5$W#!8*H&3]<5V8=23=UH<]5IHU/A'XG_P"$
M<\<0),^VSU ?9YLG@$GY6_ _H37T_7Q.K%&#*2&4Y!':O>/!7QMTYM+BL_%3
M2074*A/M*IN64#H3CH?6G7IMOF04II*S/8**K:??VVJ6$-[8RB:WG7=&Z]&%
M6:XCH"BBB@ HH-<WJ/Q \+Z5=36M_K-O%<0';)$2=RGTQBFDWL*Z6XOQ!D$7
MP\UQB0/]"D SZXKY)KVCXH?%?2]9\.R:)X>9Y_M!'GSLI554'.!ZDX'X5XO7
M?AXN,=3EJR3>A[Y^SY,I\.:K!_$MV'/T* ?TKUVOF+X6>/8?!6K7":C&[V%X
MJB1D&6C89PV.XY.?PKVZV^*?@VYCW_VW!%[2@J?Y5SUH2YVTC:G)<IU]87C#
MPK:>+_#LVFW8"N1N@EQS$_8_XUI:9JEEK%BE[IERES;29VR(>#BK=8)M,TW1
M\::UH]YH&L7&FZE$8KB!MK#L?0CU!K4\%>,+SP;KR7UJ2\+?+<0YXD3_ !]*
M]Y^)_P /8_&.E_:K%%35K93Y38QYJ_W#_2OFFZMI[*ZDMKJ)HIHF*NCC!4CM
M7HTYJK&S.247!W1]A:#KUAXDT>'4=+F$L,HY&>4/=2.Q%:5?(OA+QGJW@W4?
MM.E2YC<CSK=^8Y1[CU]^M>V:+\<_#E_"HU1)].GQ\P9=Z9]B/ZURU*$HO35&
M\:B:U/3J*S]'UO3]?T\7ND7*W-NQ*[U[$=16A7/L:A1110 445G:SX@TKP_!
M'-K5]%9QRML1I3@,<9Q3U>P&C7R!XRG^T^-]:FP!YE[*V <]7->\>(?C1X;T
M_39O[)N3?7FTB)40[=WJ2>U?.,\SW-Q)/*<O(Q=CZDG-=F'@U=LYZTD]$=K\
M'+A;?XH::7. ZRI^)C;'ZU]05\;Z!J\F@^(++5(5W/:S+)M/\6#TKZ*TWXR>
M$;^W1IKU[.1A\T<\9^4_4<4L1"3E=(=*2M9G?45RW_"R_!O_ $,-G_WT?\*J
M7?Q:\&VN<ZNLV/\ GBC-_2N;DEV->9=SM*\(^.'C5+R=/#6GR[D@??=LIX+C
MHOX=Z?XQ^.CW=I)9>$X9+<R JUY*,,!_L#L?<]*\;=V=R[L69CDDG))KIHT6
MGS2,:E16LCW[]GZ$KX7U*;'$ET%!QZ+_ /7KUJO-O@3'L^'3-_?O9&_\=4?T
MKTFL*OQLUA\*"BBBLBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *RM;\.Z1X@2%=:L(;Q823&)1G:3UQ^5%
M%.[6P&1_PK;P=_T+]G_WR?\ &C_A6W@[_H7[/_OD_P"-%%/GEW%9!_PK;P=_
MT+]G_P!\G_&C_A6W@[_H7[/_ +Y/^-%%'/+N%D;VD:18:)8"STJUCM;<,6$<
M8P,GJ:O445(S'UOPQHOB!X7UK3H;QH01&91G:#UQ^59?_"MO!W_0OV?_ 'R?
M\:**I2DMF*R#_A6W@[_H7[/_ +Y/^-'_  K;P=_T+]G_ -\G_&BBCGEW"R#_
M (5MX._Z%^S_ .^3_C70Z7IEEI&GI9Z9;I;6Z9VQH.!FBBDY-[L+)%NBBBD,
M**** $=0Z,KC*L,$'N*Y5OAQX/9BS>'[,DG).T_XT44TVMA63$_X5MX._P"A
M?L_^^3_C1_PK;P=_T+]G_P!\G_&BBGSR[A9!_P *V\'?]"_9_P#?)_QH_P"%
M;>#O^A?L_P#OD_XT44<\NX60?\*V\'?]"_9_]\G_ !H_X5MX._Z%^S_[Y/\
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@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>pbh-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pbh="http://www.prestigebrandsinc.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pbh-20201231.xsd" xlink:type="simple"/>
    <context id="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d954142956a41f08ae4450c1ea47581_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="ifcbae86d41084c1b9bf384e98fee23c6_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i770a1ceeef2b4323aed9a7f2952570b0_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i89ce9dea78194c07bc2f1b60510b73eb_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46a0f5641ebb4c7f9fd27977e8172092_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56ccdab8819b486492b15139e175675c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8446af5a29e740a9b3b8a4f709825b08_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a4436ee22a94d41a44d64367ead5b9c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia00cb6b7127748e28d119cdb054cd965_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i807901cbcf5e40229536f551bebc8109_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a14a79783154ed0b8aa034b4889e75d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02e9c2b24c2343449c5f786157e9131b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i645bab1208e440d6bba1b2b50e83f8f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifabce0a4ec3648aba15ce1da427edc94_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7e0388c23a904078a68ee55997708edc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib79098f710394f8bad4b6249ed402365_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i206f386ef65e4efcbd26b97188566221_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id92b5649f7cd473c927b77aec8349b02_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2cf491c304bf462bbe422c10205da933_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86c6bf5384d2448ab19ea3c25d18c047_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id87378b869354db2bcff3f2e742011c8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3ce94650fa9445f823db6a5338d8dbc_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff48eb475ee34d5f9e4435434ac71fab_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b39e4d0e2104f938f396d07693f6bb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i232a04fb585849d7b62b28529e631e02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id285b7d072c846c49d7bfc6c90dbb60c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68a428b3ad4d41caa61dc1bda82e2223_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6597d0aa1a884ca6aa3023579166d059_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7f3e3881699a45b699f355c9807a956f_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3870a17f657247418f8246de8f8e95d8_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9ac3f4783ca6476bb7e3eedcfcdd97ac_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i8182d3e7d5ab4ed39c4c86631d2af0a0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7998bc70e21a48d585baf03e6e7fb122_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i895d5defc18447a5924a8b792118d974_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i552ef8c73a164d62926cecf57d47ab48_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0c33b8ad9e0d4cd78038bc3e069d0540_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7b6ea02b421b48a483d6068027b2b09e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i02378009299044fcbaadf8c1f71fbbc3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic85eaea3b41443acbf6c4b736e319a28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f65082bbe1549b9984db1760459d732_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a5377f8b470400fbb8f9121777eccba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaae9f252e2294b9992531339cd343ab0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i88d5db478bde46f3bf4070353ddfd2d0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1e1a6f3463264049a9bc9dc455379e33_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie98e17addbc24768a91973f19003abe5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia194dc098eda4f59bfcb88c060c36e3d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5cd8e3092d1646ac9ed4f22b175be42f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i894492e356c24389904183d445eebdf6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c7980a5567149ff9eb9001647b782d7_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ieec46f6b9a8249da93011c913c7e73b9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i25e9032e71334883b53310db29ee9dcf_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2cb539dc22d348d2a949a23eec4d43ac_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i919b953b16b64c2594759f09f5b6ad4a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1ec6216b1c544040948237d6bac14880_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibe19bca84d574046993a13ff28023c51_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifefd508b4186429aa4691a4a839c0b30_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i67b246cfd86a4d3abc3d648d4bf23971_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic19a2270b9564c688d8a49573152aa2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ca4dcc6702e4728b7857d76f6eef369_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia89f0f45b3414ccab552e76bdf9df478_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia11c055523a04b699e5d7a78fc046593_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i302701c033d5435ebe15ac3c6d5c337f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c0818a176a94086a756b654b26eedb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6867e4a90c294f1fa8dddbeab438a6bc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i103b63c927b0400b8db4ba9ce800eedf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70a1fb9b631a4bfe88b529e766619c4c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i664da185858d4792aa10a4f8624f5074_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4abf53f8afa1439081a520747b145a31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba357660d1fc4f7787eef1e9535f4bee_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0609d20d39b84155990b8eeece18a13b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i354ed91ee4f3409bab9d6df5ad7c5aa6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if14edde8dc2a46079acba1cc1a731adf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81b414e215924c7b993b038bd3c3eee3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98a0c2ab86804016a4351c2ce5ed98f0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1236a922afd44780b720fd4a3fbba105_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie859ec3583f54138ba3370f6e120dd0b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie10121816139428c94900de4ab354727_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iadc1556813bf44cc90d54deefa6cec4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72f4d7a1b6a4434993fb587f62cd9893_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7242718fff7f4c5d99567a954c71eac2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i038c52e6304749fab109d118081f602b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7b28d9ff4d0544048ff592fc0fc0bb1f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b2d78644d694801a7c8a37b269dd418_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7ebb997344d403486b3f9420c112504_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0552db00f3c641ff80440074b49f730b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bd599e3926042aa8b5dbaf89e6bd1cf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice64251d737d426195b9e1a793e60792_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib1f1631ffca449e3b2162aa6eb96cc1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5032d30a5899473b981a782119c9d2ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if06e52662eda44a78e9e8f9e560ad93f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i06feca35d8b343e0a416ad3c87b1d890_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i95cbb5a18397486680722f549c6889b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i253eee16ff674e2a93a5287e7684fe79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d826a5505c6474db66c7f96cda89129_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7947344d11f749088f4c537fcf966dc3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibe6c5d8a5f604fcea4fcd52e68353712_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i221c06058a05456781dfa7d93133ca01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i362a9c07939d4608b90d4ad15e3b6f16_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if24c56ca1f7f41289fa51152754d0628_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib12d98be53e544b7bec5cb41aded6489_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icae35f6c71da48feb7c77cf3d5184356_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e3326065cf04377b74b6fbe21644c1a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifd335d49025d49c487e470de1e7c354f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i92532672091247fb97202d4dd7b0cdcd_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80c1300a1c4f4cad9a29affc4c223aff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ded30b7f28349f78fd6ee06e33334cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad3a6736b7e4455c835f368bcb184e94_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i669fc4f1f78246bb8b0554fa4c73e813_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie4fd7098c3ad41be8df870dde9d83eee_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i254eb380c9514d3b9a242c7b4084efd0_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib2ce8e70024f47edbefd0232eb83236a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fd07a49514b46baa2e379f44d08a7e5_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84aca9e12e964a7cb990719431110348_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifdae78c641ce4019acb0ab445a097687_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39df23d267604e6189a005f399da0bd9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i242bdd6173d64a318c041525df6090be_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6a1431127e184ca5b894517035890a0d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i89df545b4177486fb38f4b91b5bfbd05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1cf4c1b6e7914984877022bbf9681434_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i88373d93eefe43dfaf99307d1663985c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib640d457ba2b4aacae15563b70a4f618_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i23ceed395390459d9e3572680ae73075_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab7ab2765fd5461eb0fcfe3149ec29af_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5a87d78fa10e452580fd3a8922dd6800_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30fb3c6cba044feb86d6e4d785c34a76_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i00213381c2a14b5fb3a527097c5723e7_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i594c5314ab0a48398a297ebae00548bc_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51ebd4afe08246cfb5c144ac9fd55615_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63281ab682614b949d3bfa93e92d8a4d_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03dbfb445d744e408d4f455fbf1b0147_I20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="i4e33b766bd5b4b77b3a15f8f572127a5_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-05-31</startDate>
            <endDate>2014-05-31</endDate>
        </period>
    </context>
    <context id="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="id3ea26f332a940caa0e1a0c9c84992cb_I20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-04</instant>
        </period>
    </context>
    <context id="i2b1a9cb50b5b44418cfc024476a41782_D20200504-20200504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="id1cdfb4a0aef433a8562a57ce988186a_D20200504-20200504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="i573a83e08488462c9f111c2bdfd78f3d_D20200504-20200504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-04</startDate>
            <endDate>2020-08-04</endDate>
        </period>
    </context>
    <context id="i44304ca391ad4b1694746195e1122111_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id062323b9871449988cd3af690123a42_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57c40fb8e1f0479081115a63e83ad551_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09345f1e737c46baa82ce81fda75550b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia1e9892fc40644c89bbe3123ab2c9d39_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b72b1eb3c7c438ca17d1bd5b4bcebab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice5fa425e6fa455fa7fd4d3c4eb57f48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c31348066374fe7ba878c4902bff844_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52df2ac531a04db9891c78e2953258fb_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i500b594756b84b84a2b9d22008165363_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieda365d016dc42ae9860c7df30b2f158_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b9ae14e79e641269492a1e0e4ee76c3_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62cb921e0c1343f998a11bcd1f9d95cb_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f1844d37745467a92c46cb8d2c20da4_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i008c0e348a60478bb9f7213b666b06e6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6dcd2ebbac947c5b6cee797817560d4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i501a3213c11d461591927d286d9b027c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i20f6fb1bf2a34c35a01cae3374745b5b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia68e63de10454e24894bd16a7a088bcf_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i565b9bce16444927976c88402045c3d4_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id8407d623fa84556b0397c38088abbf6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0d198cc6856d470c8ec71c81c8103522_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46feb4fd7be74db89bc3151dc91f92e2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6f81090cc714b74b8d03f28025f19b1_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96855186767b4db9a00fb69b716c41f6_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if3c7a94528d9490fb08b81ebf1d7a00b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf9dde9deb0240549add526728474f42_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88d09d2b366144f2aff1fd2e7f593171_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0694c66689742c5b90557d956ca3f32_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7d320cc345b49a2a8fbdada2529df4e_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01e950986bcf4e108adee0564716cb37_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if3f00e6b81ef4c3482182a197d4a4e32_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4244f86df364e5ebcde26a945e3142b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia738781a6462445a9d482d900ef06acb_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5a85023eca74a8fac623c88ab9c8e78_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80964bb76f874e5281347932224ff34a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41001c9e538a41ed8464330160dc13e6_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie28bad73d72f456e8b79877569af8a18_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81550b7b21bc4feea06a01fcc70f411f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8db11a316bb0453ba064a9b94c08d6e7_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida7739148e504bf886e60a2197004803_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43dc6fc89aff41f88710ff54c5a7ed8f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice70e5b8d1064b52aebc31f31f0a7884_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id657b6e10bb145bd9e3b992a5952b584_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d12927a6dbe43b78aef3d34a6229cfd_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id23c3e9b79a94d9789d9b7517a275164_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e73ad0358e14775a2e9849dd271ff14_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4dd9073a48464bd7b51b74613aafa24f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49b14bc7d42b468ba1f64dd1c0abaea3_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0a7cd80cd5a4b1bad14f4a51c7ada4e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97460044a83f440fa7584652350076da_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie688265c2fe64317a2d953ab3115c665_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2746c8904701432ab60720e86c50447b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8993e25574f54284bfbbbd9dd41772f5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ae8a85f75464471a53bd0ba32db5176_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3cc2559678948b9aef06ac76f4e1522_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i173fab1b453f4560849f0dc00c3452a5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i19fe27a1e60e4cbeb166294c0bede61e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic014bbc1359641b1a2b5b3a0a76876d2_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7877fc9a7f02493996cb66d50ec3afe5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5d5430fb96e440aae81e6b0952da7b6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf4ec554d2bc4d29b952a1b545f2b547_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic58ac387c2ff481c9484454d90ef155c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b6d6045fb4442a2895c9ec699f1811e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i965dae78c4ba4d53871050f36805d7c2_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6593e8a130e4e3f9f3cdf45d175d28f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac53dedfbbed4030a17b1545923bc589_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85a3d3deecd14f63bd429eb4e3e8430e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39009ec2cf5647779e9d225f923247c3_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6166e5bdf88b40a8992f759071b12983_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d710e027cd54fd8aee0485eba0c6cf5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id87392d270c0486a93ceaf137e98399d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaf7e602fc5d9444ebdd4c853c09b50d5_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6a79924f9ce947458d38df1406320d6d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03ee54ef632d4869892e5474c4128689_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd84840900f7404d8225e673a8394f3c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4b5fa469fe0648758a18c8204ec783a2_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d8e154d8fdb4c5ca334f3b074e96118_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3eaa79a619a94571be5a3e33b1b9b727_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia75cc8b1bbf84638bba89e388838032b_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i38d019c5be754bedb9da5cb867242c80_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a054fe50c8445ffbe95cd9a6dae0e73_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07318d3f13404727be431e43ee6a10a9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c0956b5a03a4aac9860d3e814a7a613_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa4a0ae5763540aebd26fc7b0246574f_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3dc317e3286f405d8d099420e0ffdce4_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3bb8aa6b9b0b4441b011f07d5309b81a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i404178ff281443bf9ced03a0238bf1f6_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib3395ce8af8e428c9ad73baa0b989bc5_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i43a647598543421a924f09921ad19ce3_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic726fc7d1df344b5831a872a1ef09b6f_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iac032030eede416e8cce85237744c04c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6fd0d5b78dd6488a90023e73337561c2_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic1b5ea8663fe460eb915122aa37bb218_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic326287529e8474aa6d710df42ce383a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b582ceef6b94530a0a15643c10b9bdd_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7dfa30afe9ba4d0ab14d9df91c38845b_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7cf96e727a648328bd0ddbaf8c22e9f_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib1aa98178171483c8a80105d8260faf3_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74206d6c1ef94f85a77a706a302a2921_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e224bfc0f2f4f9bbd343fcf36f723d5_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id0b281d13ce44cac9f9e545ad208695f_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24eb7719094a43d584a2034ea978272d_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibb01bf909b914824bd367b98c9aaf43e_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i31318cf15ae24534bba25f86a4dd84c1_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifc78679f204d4b82b27f94f4ab6bf2c6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19de88ae5c20400eb8842116fc3aece9_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9fffc560ee1744808937bcbe9f0620d4_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b490d84f1fb4012b05a6af473ef1a5b_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ed85d9a18a4444b8d4767cd042125e2_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if7a173370c5b48a196971ab3b9d7d458_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i06b30c22a1b5488eb65d429328bcc1a7_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i376458bf47654387b6b570f09075e008_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ec6dd84935741f89edaadd7dc45c6c8_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia561de999a564dc38eed19fc55917452_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i607b8d0fdd5346f9a3cabe2c53ee8951_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib64ffd54f7d44b71837a1ffd999561dd_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iec031e57d3cb43a2833a47073eb677ec_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i60f1a28867e44d3f9deec4c5458df1e8_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i879386f7739b4709a9a498c439de1dd0_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief5c3472bd6f439b818e26dba211fba1_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i726c3b7978984c9c89776dace3512cd6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d7b3334441a4b4ebd90c904bf63af74_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2cbf0d2f0f0b45de8dbc05c513975980_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia047992a234e4a6e93507979ba924334_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic1ac168c392241e985f758d09dfff28a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ffb79e853904250bd4a61db331e3d55_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icb23c99f72dd4b83a90f3c672526d24d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5b9c1ebb674451b8abea4c22d7a9b9d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3bfd9152348e4e888243321c3a99add2_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e7cb897e70f478cb92e199f2d901a81_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>pbh:agreement</measure>
    </unit>
    <unit id="vote">
        <measure>pbh:vote</measure>
    </unit>
    <unit id="manufacturer">
        <measure>pbh:manufacturer</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV8zLTEtMS0xLTA_142bee87-9bba-4414-bef9-72bb8716e80e">0001295947</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV80LTItMS0xLTA_ad8471e2-09c3-4cb1-ba29-b7925bacaefc">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV81LTEtMS0xLTA_d5fe1d25-d4dd-4f26-8287-407b100a040f">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV82LTEtMS0xLTA_ec9e7b40-1376-4b5b-88b2-f86001b68a1f">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80L2ZyYWc6ZjdmZTg0YjMxZmU2NDRiYmI2NmY5Y2MzZWFlZDZiMzQvdGFibGU6MWVjMDI5MWI2ZTIyNDgwM2E2MjBhN2ZjNjg4NzgyMDkvdGFibGVyYW5nZToxZWMwMjkxYjZlMjI0ODAzYTYyMGE3ZmM2ODg3ODIwOV83LTEtMS0xLTA_e14e1ffb-8e4e-4aff-9b05-ceb0ff700476">false</dei:AmendmentFlag>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81Mi9mcmFnOmI3NTEyZTQ4Mzc3YzRkYmNiNWE4MDliNTZiODRmODY5L3RhYmxlOjcxZGMyNzU5MWYyYzRhNjc4MzcwMzZlMDQ0MmI2YTNkL3RhYmxlcmFuZ2U6NzFkYzI3NTkxZjJjNGE2NzgzNzAzNmUwNDQyYjZhM2RfMTAtMS0xLTEtMA_49c6dcd1-c5c4-44f1-8d5a-a7e6a1693d27"
      unitRef="number">0</pbh:DebtInstrumentVariableRateMinimum>
    <dei:DocumentType
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV85Mw_9a5511a0-37e3-4070-a554-bed65acf5148">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6NDE1NjA1ZWViNzQ5NDU4MzgwMmQ4N2JmYThjN2E5NzIvdGFibGVyYW5nZTo0MTU2MDVlZWI3NDk0NTgzODAyZDg3YmZhOGM3YTk3Ml8wLTAtMS0xLTA_6c49300e-3b4d-47e2-890c-d6dbb8a66719">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xODY_542eb93e-825d-4e2e-bdb0-3d9dd9a618f7">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6NDgzYTg2MGY5MGM1NDZmYzgxNmJlZTU0ZjQ4YjdmMDUvdGFibGVyYW5nZTo0ODNhODYwZjkwYzU0NmZjODE2YmVlNTRmNDhiN2YwNV8wLTAtMS0xLTA_26e68692-12e7-427f-b54d-a85aec5c7e26">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yMjM_d3e60962-a5e8-4136-9b05-5cc7e48c6d47">001-32433</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yMzA_023324d0-7359-482e-af42-be9380910b1b">PRESTIGE CONSUMER HEALTHCARE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZWFkNmM5MDJmOGI3NGE2YWI2NTEzZDU4MmFiNDk1ODIvdGFibGVyYW5nZTplYWQ2YzkwMmY4Yjc0YTZhYjY1MTNkNTgyYWI0OTU4Ml8wLTAtMS0xLTA_66b7bd0b-4e7f-4a3a-9ea2-c07d06bb6984">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZWFkNmM5MDJmOGI3NGE2YWI2NTEzZDU4MmFiNDk1ODIvdGFibGVyYW5nZTplYWQ2YzkwMmY4Yjc0YTZhYjY1MTNkNTgyYWI0OTU4Ml8wLTItMS0xLTA_9eb0978f-22c7-44f3-9a6e-f386c0c9160b">20-1297589</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTE_9151a7d5-2f7b-4da6-8ae6-951b20d9b8c2">660 White Plains Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTU_70ba391c-f837-4b9a-a825-2342c981e743">Tarrytown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8yOTk_97497426-84ac-4e26-b366-4a08b8b80d91">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zMDI_78fc5879-e234-4a5e-918f-03a4ea20de7d">10591</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zNTk_d06fcbea-e043-4c9d-9e4d-d4ea0041b9ca">914</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8zNjM_5ecd5449-0599-4edd-bfd3-9eab6ff85e19">524-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTAtMS0xLTA_699bd20f-deee-462a-b22c-654cdaa2af75">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTEtMS0xLTA_d76fa12e-9db0-4b26-a4e6-ce566df32947">PBH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6MmNkYjc3YjY0YWJhNDNlMjljZmIyMWZiMDZlODNhMmQvdGFibGVyYW5nZToyY2RiNzdiNjRhYmE0M2UyOWNmYjIxZmIwNmU4M2EyZF8yLTItMS0xLTA_5bbb48a3-a45b-4a17-81a4-2a048abe8a16">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV83MTk_9c08b852-b3fe-4ab1-9434-55263997f461">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xMDQw_e4336e15-556b-49ac-8944-4006acddedaf">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8wLTAtMS0xLTA_dc05ec32-3a84-4333-bb98-8fd8467c5509">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8xLTUtMS0xLTA_98bd8ada-7245-4cc2-a75c-0526c099fbfe">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGFibGU6ZTEyMmExYWJmMTk5NDc1ZWE0MjQ5YTg4YzcwODcxYmUvdGFibGVyYW5nZTplMTIyYTFhYmYxOTk0NzVlYTQyNDlhODhjNzA4NzFiZV8yLTUtMS0xLTA_f17eb4ed-97fd-42fd-a794-327af12e71e5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xNzgw_7d213cfb-7cc4-4d5c-bd06-746dfe5a9647">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8d954142956a41f08ae4450c1ea47581_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xL2ZyYWc6YzZiMDQ3ZTlmNjdhNGQ2YmEzZjkwNjc3NTU2NGE4MTUvdGV4dHJlZ2lvbjpjNmIwNDdlOWY2N2E0ZDZiYTNmOTA2Nzc1NTY0YTgxNV8xODIz_c50fbb3e-e8d5-41dc-b26a-2e274d56d8a6"
      unitRef="shares">49864752</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcbae86d41084c1b9bf384e98fee23c6_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy0xLTEtMS0w_36e2e4fd-113f-45ab-8143-4aa483a829fe"
      unitRef="usd">238779000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i770a1ceeef2b4323aed9a7f2952570b0_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy0zLTEtMS0w_ea084f83-47cb-4224-b973-084af6203ac4"
      unitRef="usd">241545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89ce9dea78194c07bc2f1b60510b73eb_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy01LTEtMS0w_a3656c30-9d6b-41dc-8536-ab0a89e8f796"
      unitRef="usd">705572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46a0f5641ebb4c7f9fd27977e8172092_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMy03LTEtMS0w_6ac5ddac-3fd0-4331-a5f0-c8eeda187949"
      unitRef="usd">711729000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56ccdab8819b486492b15139e175675c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC0xLTEtMS0w_c520ab41-89b6-4229-b9ba-344127395a49"
      unitRef="usd">9000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8446af5a29e740a9b3b8a4f709825b08_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC0zLTEtMS0w_50ba96ab-2fbd-4b46-ac64-1ba237543a23"
      unitRef="usd">7000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a4436ee22a94d41a44d64367ead5b9c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC01LTEtMS0w_e3b62855-23cd-451d-8b07-d99118dfda25"
      unitRef="usd">32000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia00cb6b7127748e28d119cdb054cd965_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNC03LTEtMS0w_7823e575-6943-4521-a985-9284341b6069"
      unitRef="usd">46000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS0xLTEtMS0w_0a969594-c740-40ee-8815-3bd049ec769b"
      unitRef="usd">238788000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS0zLTEtMS0w_8c90ca22-4c39-4465-ad9f-beb52468b08b"
      unitRef="usd">241552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS01LTEtMS0w_c983c7a1-c8ad-45f8-89ce-c1bf2b06d356"
      unitRef="usd">705604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNS03LTEtMS0w_8bff6665-55d6-45f7-b8b6-26169387fba6"
      unitRef="usd">711775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC0xLTEtMS0w_b795d968-c017-473e-b754-d72e25de8ae4"
      unitRef="usd">98260000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC0zLTEtMS0w_6bde64f0-3580-4cd7-9b21-c568a48014e6"
      unitRef="usd">102900000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC01LTEtMS0w_833efd98-c908-41e2-ba3e-63496cc11420"
      unitRef="usd">290623000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOC03LTEtMS0w_f17bb9c1-aac9-496e-baf0-011708f47e06"
      unitRef="usd">300318000</pbh:CostOfSalesExclusiveOfDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS0xLTEtMS0w_9f14063f-e063-4af7-a340-7d91949476e1"
      unitRef="usd">1641000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS0zLTEtMS0w_b3dbedf5-68a0-4d56-bed2-a9939692b304"
      unitRef="usd">1157000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS01LTEtMS0w_60a88cd8-7a95-4d50-a134-e9da918f7dca"
      unitRef="usd">4565000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfOS03LTEtMS0w_537b5fa6-deb4-4193-b06f-68121e0d49e2"
      unitRef="usd">3144000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfRevenue
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtMS0xLTEtMA_f057f329-2464-47d9-b494-785e3f41539c"
      unitRef="usd">99901000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtMy0xLTEtMA_1ef22bd3-ca4e-4514-8e96-58823eda6ea0"
      unitRef="usd">104057000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtNS0xLTEtMA_97c3a282-ade5-4b60-8587-4af61d9b3110"
      unitRef="usd">295188000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTAtNy0xLTEtMA_e1f34066-78e2-4a15-8213-8bfd152fcbf6"
      unitRef="usd">303462000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtMS0xLTEtMA_51da1e14-059d-4804-89da-7e0ecf5bcc7f"
      unitRef="usd">138887000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtMy0xLTEtMA_2e7c7734-7f36-4da1-856b-014785cdffd4"
      unitRef="usd">137495000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtNS0xLTEtMA_b49bf149-c564-4aff-ba23-b9fbb5b9d15e"
      unitRef="usd">410416000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTEtNy0xLTEtMA_e6dd74e0-79ee-4a8b-bb9c-687b2da01be7"
      unitRef="usd">408313000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtMS0xLTEtMA_ba05df2b-dd65-4c84-a50e-29551905f4bd"
      unitRef="usd">38081000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtMy0xLTEtMA_36fdae6c-cb52-4786-8a46-49dd7a33f58e"
      unitRef="usd">33559000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtNS0xLTEtMA_ccc8bc36-7b5c-4529-9730-f6fc73fa1d1d"
      unitRef="usd">104172000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTQtNy0xLTEtMA_3258245f-8c73-4045-adb5-0fd8e776138b"
      unitRef="usd">107027000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtMS0xLTEtMA_5da4943c-c959-4d00-8791-51ebc98be7e9"
      unitRef="usd">21395000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtMy0xLTEtMA_4cb5e2ad-3394-49b8-b34d-498295b51dcb"
      unitRef="usd">21308000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtNS0xLTEtMA_3316bcb4-af25-4319-8aa5-b886d13d5278"
      unitRef="usd">61717000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTUtNy0xLTEtMA_e4cab816-09a0-4e8a-8f75-94433538e5c8"
      unitRef="usd">65528000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtMS0xLTEtMA_a83f23d4-c710-4134-95e1-bc4e13c1966f"
      unitRef="usd">5968000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtMy0xLTEtMA_6293ab5d-218d-4299-849c-9628d92482de"
      unitRef="usd">6224000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtNS0xLTEtMA_8de705b0-5d38-484e-b21b-1193887fa930"
      unitRef="usd">18062000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTYtNy0xLTEtMA_ebeba9f6-72bc-4202-9595-b5d612a40988"
      unitRef="usd">18520000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktMS0xLTEtMA_f91030a1-52d2-4371-ab64-18d53df601b9"
      unitRef="usd">65444000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktMy0xLTEtMA_f8360b0f-44bd-4e3e-a2c8-e293260fe3cb"
      unitRef="usd">61091000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktNS0xLTEtMA_74d26096-f3dd-48ae-b1b7-e05a0582a73a"
      unitRef="usd">183951000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMTktNy0xLTEtMA_a3218925-6b9e-4ced-9c5c-cb18da298d4d"
      unitRef="usd">191075000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtMS0xLTEtMA_442d3c3f-7654-45d2-85e6-c79e85c18b22"
      unitRef="usd">73443000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtMy0xLTEtMA_d9d507cf-7486-4df6-a4b7-a16276e7b485"
      unitRef="usd">76404000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtNS0xLTEtMA_3041792b-eefb-48ee-bec9-64e647c99883"
      unitRef="usd">226465000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjAtNy0xLTEtMA_a254b0d5-9c13-49bd-9b6a-75a3ecf9f315"
      unitRef="usd">217238000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtMS0xLTEtMA_50b093e3-b2d7-4ad5-bb5d-6c0884109a24"
      unitRef="usd">-20138000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtMy0xLTEtMA_5bf6c801-d91a-4d85-80bd-984f8be4c0aa"
      unitRef="usd">-24275000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtNS0xLTEtMA_f7db40b5-5193-4dc4-99b1-461856d24d4a"
      unitRef="usd">-63345000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjUtNy0xLTEtMA_7e8d9514-44f8-4b06-b38e-2d4b88bc2ba0"
      unitRef="usd">-73772000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtMS0xLTEtNTc_d16ba6bb-e83b-4726-afce-94898e4b9279"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtMy0xLTEtNTc_bf238f27-88fc-43b8-b7f3-67bdc93e9823"
      unitRef="usd">-2155000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtNS0xLTEtMA_acda17f5-c3ae-4c6b-b2e9-ee943caffe28"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjYtNy0xLTEtMA_04bdf43a-d8ef-4bd1-b70e-cd460c22de31"
      unitRef="usd">-2155000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctMS0xLTEtMA_5fa642f3-659d-466c-8654-abb670575444"
      unitRef="usd">371000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctMy0xLTEtMA_f03a8713-cd8e-48e7-88b8-ca22cd491c22"
      unitRef="usd">580000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctNS0xLTEtMA_e6e1f65b-5928-416f-94d0-33e0dde1a17a"
      unitRef="usd">620000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjctNy0xLTEtMA_fe3a419c-46f0-43c8-bc71-57810a3641ad"
      unitRef="usd">-695000</us-gaap:OtherNonoperatingIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtMS0xLTEtMA_01897424-6d83-42c4-8bf3-f3664afc1042"
      unitRef="usd">-19767000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtMy0xLTEtMA_e3f98c16-e808-4d68-be3d-dce4fdc9dba2"
      unitRef="usd">-25850000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtNS0xLTEtMA_404ce3c3-d74a-4fda-ab0e-6e3175ead8a0"
      unitRef="usd">-62725000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjgtNy0xLTEtMA_a6da66ca-46be-419a-aa6f-4a9356b63103"
      unitRef="usd">-76622000</pbh:TotalOtherIncomeExpense>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktMS0xLTEtMA_350ee5df-c603-4ab5-95f8-184ee0699fab"
      unitRef="usd">53676000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktMy0xLTEtMA_971804ef-1741-4413-8a35-d11390f05b26"
      unitRef="usd">50554000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktNS0xLTEtMA_ceea4856-8e18-4c10-9afd-451cf524cbb0"
      unitRef="usd">163740000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMjktNy0xLTEtMA_1efbd8cb-9306-431b-8d73-a85c422ad6bd"
      unitRef="usd">140616000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtMS0xLTEtMA_c9952761-f01f-414b-a1a9-33822af437b0"
      unitRef="usd">12803000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtMy0xLTEtMA_ecdb6e37-6f9c-488e-b14a-a2edd7ac9b1b"
      unitRef="usd">12496000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtNS0xLTEtMA_52ee9b7f-5564-4e33-a0fb-3c7081a28fda"
      unitRef="usd">34572000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzAtNy0xLTEtMA_0014201b-dcb4-4fb7-bb40-25000801748a"
      unitRef="usd">35381000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtMS0xLTEtMA_c4bd849c-de17-489f-968e-fe413c165963"
      unitRef="usd">40873000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtMy0xLTEtMA_a245e4b0-0488-4224-8c01-a578a0212315"
      unitRef="usd">38058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtNS0xLTEtMA_4dcf8d79-2854-4011-8d8e-add11c9684be"
      unitRef="usd">129168000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzUtNy0xLTEtMA_f2bce67c-fc6a-4444-a943-1c35ec84d40a"
      unitRef="usd">105235000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtMS0xLTEtMA_da57acda-2067-460c-bae3-52cab30bfe2b"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtMy0xLTEtMA_6ed6163b-35da-4ef9-90e6-af0fde589d0d"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtNS0xLTEtMA_f4192c87-e665-42fb-bf2a-34c6c956f8aa"
      unitRef="usdPerShare">2.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzgtNy0xLTEtMA_f8eaaca2-75d9-4677-ba11-947ecb4de2fe"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktMS0xLTEtMA_89770fef-39d5-4754-8b6c-e81084465790"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktMy0xLTEtMA_2c6837bf-64a2-4a7c-b5f5-625e7da7be02"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktNS0xLTEtMA_6abd2fd7-3931-4468-96d2-b423868e9136"
      unitRef="usdPerShare">2.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfMzktNy0xLTEtMA_dc02ff5a-cb99-4c8a-987c-6317fc6f60af"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItMS0xLTEtMA_645fc91d-6375-4b38-97e7-1c9624402cfa"
      unitRef="shares">50212000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItMy0xLTEtMA_58d697e2-aae8-4a74-861f-66b67a6c62b0"
      unitRef="shares">50378000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItNS0xLTEtMA_f8e61c46-167c-490e-9d53-93d5eefa4df5"
      unitRef="shares">50268000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDItNy0xLTEtMA_ed899baa-c3af-4afd-a19e-83cd15d5ae2b"
      unitRef="shares">50840000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtMS0xLTEtMA_c7b85d59-16af-42e1-a6a4-ff9e4f00d2e5"
      unitRef="shares">50561000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtMy0xLTEtMA_221e7eff-1744-4352-9425-43ad8b7e4ea6"
      unitRef="shares">50831000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtNS0xLTEtMA_03242e07-5e80-4d99-b6b1-4eb919854e78"
      unitRef="shares">50635000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDMtNy0xLTEtMA_44f90425-4b44-4171-b597-c4280faabcde"
      unitRef="shares">51226000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtMS0xLTEtMA_8afb422e-3a04-468b-b439-99d63f9299f8"
      unitRef="usd">8184000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtMy0xLTEtMA_c39e9936-1275-4e90-a091-60f84c954bdf"
      unitRef="usd">3497000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtNS0xLTEtMA_3b45a6d4-dedb-44ab-9c7e-9f74c095c5ad"
      unitRef="usd">22439000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDYtNy0xLTEtMA_95beb3e8-b995-492f-abec-e5665360a8e4"
      unitRef="usd">-311000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctMS0xLTEtMA_8b914188-cc59-4c3c-ae33-be527967307c"
      unitRef="usd">1053000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctMy0xLTEtMA_2b9b8539-0bdc-4f42-b4fb-2a2181aced83"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctNS0xLTEtMA_87888464-a5a4-4efb-8dd7-3ff492796abf"
      unitRef="usd">2347000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDctNy0xLTEtMA_2237ea17-0d73-4289-bf2f-8a5e5ee830a9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtMS0xLTEtMA_eee47d6b-e88a-42d4-a64e-bf7c55f90def"
      unitRef="usd">-2334000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtMy0xLTEtMA_5cfcf562-b9e3-47ed-b14f-9076d67873ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtNS0xLTEtMA_9166fdfc-5671-48c9-a8a3-7213eeb09a8c"
      unitRef="usd">-2334000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDgtNy0xLTEtMA_7279daf3-098c-433e-84b2-1b17c59c69b7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMS0xLTEtMTQ5Ng_8bef9ca6-56db-4486-80a6-017e914d65d3"
      unitRef="usd">190000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMy0xLTEtMTQ5Ng_420f6d42-c52a-478d-9a85-0e1bc5d8314a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNS0xLTEtMTQ5Mg_b4e48534-cc72-4fc3-aa79-13368b9a6fa7"
      unitRef="usd">190000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNy0xLTEtMTQ5Mg_b69d68a7-c1db-475f-ad42-28d9e6a157cc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMS0xLTEtMA_b4aa09d6-1f26-4e19-b52f-3455165d6beb"
      unitRef="usd">11381000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktMy0xLTEtMA_b8d2fd09-11f2-4995-88d6-8f719350c096"
      unitRef="usd">3497000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNS0xLTEtMA_81a0b9e1-87dc-4cde-9286-607cad5405f5"
      unitRef="usd">26930000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNDktNy0xLTEtMA_1fc000e8-970a-4659-9ac0-7063a7d42336"
      unitRef="usd">-311000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtMS0xLTEtMA_7ffbdfbf-c628-4aaa-a1f4-146704f40643"
      unitRef="usd">52254000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtMy0xLTEtMA_4d28e7cd-b83f-4983-9d6a-e424587d0a45"
      unitRef="usd">41555000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtNS0xLTEtMA_df8f9e06-4734-4152-97c0-0b511b56f7a7"
      unitRef="usd">156098000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xNi9mcmFnOjMxZjZlNTg2OTJkNDRlMjM4Y2VkMGFlMjhmNTY1M2E5L3RhYmxlOmUwNWRhMmU0MjFiMTQyZDQ4ZDQ2MmMwYzY5YjA2MDA2L3RhYmxlcmFuZ2U6ZTA1ZGEyZTQyMWIxNDJkNDhkNDYyYzBjNjliMDYwMDZfNTAtNy0xLTEtMA_045db7a4-2612-4910-b018-668733114565"
      unitRef="usd">104924000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNC0xLTEtMS0w_ff9d013a-2a61-4bc5-af13-ed41b4ecff51"
      unitRef="usd">62103000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNC0zLTEtMS0w_10c83445-8a5e-4cd3-ac9d-24f31aae8f6c"
      unitRef="usd">94760000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0wLTEtMS0wL3RleHRyZWdpb246Y2NiYmViOTljN2UyNGZlYmJkMzFmZWIyZjJiZGU2NzhfNDU_89fddc51-7f49-452f-9616-fbbe9724ee08"
      unitRef="usd">19025000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0wLTEtMS0wL3RleHRyZWdpb246Y2NiYmViOTljN2UyNGZlYmJkMzFmZWIyZjJiZGU2NzhfNTI_8a5b8bbf-45dc-4071-9309-b9d1f1a8fb81"
      unitRef="usd">20194000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0xLTEtMS0w_7af17989-9615-409c-8799-b0c18240fcd7"
      unitRef="usd">116004000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNS0zLTEtMS0w_a6b4bcf9-047d-4f05-8402-03ed3c28f7dd"
      unitRef="usd">150517000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNi0xLTEtMS0w_7758d82b-c6fc-4398-b853-ea1e99005a08"
      unitRef="usd">117011000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNi0zLTEtMS0w_5867d963-40a6-4399-a4de-2ec0e94639ef"
      unitRef="usd">116026000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfOC0xLTEtMS0w_fe86503a-a9e0-427b-8111-ed0e30736f14"
      unitRef="usd">6093000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfOC0zLTEtMS0w_da50c044-6a4d-47f9-b17c-7e796d0e5c75"
      unitRef="usd">4351000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTAtMS0xLTEtMA_46257b0e-6419-458f-8e12-d09dc468903f"
      unitRef="usd">301211000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTAtMy0xLTEtMA_40baba8d-9209-477d-ad65-14a9ebeeea19"
      unitRef="usd">365654000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTItMS0xLTEtMA_f26cbdd8-697f-4037-95e9-97c3fcb8d1d6"
      unitRef="usd">68620000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTItMy0xLTEtMA_577b25f6-b50b-4c97-b956-4700b86fd8e2"
      unitRef="usd">55988000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTMtMS0xLTEtMA_0d9b4296-f620-4eaf-8d8b-a9f82ce38006"
      unitRef="usd">24867000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTMtMy0xLTEtMA_db90cbec-4663-4f0e-8723-1c3c75f3f919"
      unitRef="usd">28888000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTQtMS0xLTEtMA_a4022529-b038-445d-a277-8af348229cdd"
      unitRef="usd">9628000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTQtMy0xLTEtMA_87569283-3c4c-434c-ba9f-de26193c80d6"
      unitRef="usd">5842000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTUtMS0xLTEtMA_3ab14c32-f20b-4156-a33d-730af902062b"
      unitRef="usd">579559000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTUtMy0xLTEtMA_e7f1d056-fff8-4952-8279-92f317e92c7a"
      unitRef="usd">575179000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTYtMS0xLTEtMA_d3ae15f7-7f75-412f-baec-2ef807949cbd"
      unitRef="usd">2481725000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTYtMy0xLTEtMA_b0192e8a-d00f-4ac0-82da-b9632cfb4d74"
      unitRef="usd">2479391000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTctMS0xLTEtMA_c5cfaa06-09df-44d7-a5d0-49043d8816e2"
      unitRef="usd">3159000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTctMy0xLTEtMA_99767ec2-f6bb-40f3-bf24-cb8ce2360e86"
      unitRef="usd">2963000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTktMS0xLTEtMA_19025b31-8bf4-4ee9-b565-8d3a40aadaf2"
      unitRef="usd">3468769000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMTktMy0xLTEtMA_1c7dcf78-601e-47cd-92ff-7e3b2e51474b"
      unitRef="usd">3513905000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjQtMS0xLTEtMA_beae7b64-184d-482f-b6ec-edde7082e94f"
      unitRef="usd">29114000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjQtMy0xLTEtMA_53b30390-b5c4-41b9-a76d-e8fab9e69379"
      unitRef="usd">62375000</us-gaap:AccountsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjUtMS0xLTEtMA_02a7d3a3-9765-4c40-9fbf-497c815a7ab3"
      unitRef="usd">22312000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjUtMy0xLTEtMA_c5cc1612-28ad-40a0-9890-a7be7c05e9ac"
      unitRef="usd">9911000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjYtMS0xLTEtMA_eec47764-609c-4957-95fd-ca7a88588e5d"
      unitRef="usd">5599000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjYtMy0xLTEtMA_df5a0fae-f6dc-4bdb-97a3-6808cdc2124b"
      unitRef="usd">5612000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjctMS0xLTEtMA_24549760-223d-4eae-bd63-810789ac7584"
      unitRef="usd">2569000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjctMy0xLTEtMA_2034648f-ff34-4e38-9a68-8091e59e0185"
      unitRef="usd">1220000</us-gaap:FinanceLeaseLiabilityCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjgtMS0xLTEtMA_d144c77a-05f4-4f8d-a95f-376e5c0fbe9b"
      unitRef="usd">66569000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMjgtMy0xLTEtMA_853ad77c-0de3-4dc2-81fe-13753f06c0bf"
      unitRef="usd">70763000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzAtMS0xLTEtMA_43ead510-2906-43cf-88c4-ee823630072b"
      unitRef="usd">126163000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzAtMy0xLTEtMA_e84516b5-d802-4f89-a39c-31c5735863b8"
      unitRef="usd">149881000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzUtMS0xLTEtMA_b87683c9-043f-492d-b9cf-b0eb3b7bdce3"
      unitRef="usd">1548692000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzUtMy0xLTEtMA_1b80f08f-d170-483a-8e2e-5cc628cd76c0"
      unitRef="usd">1730300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzctMS0xLTEtMA_3fd3c8d0-fdb4-44f3-82b4-3038ba9b753b"
      unitRef="usd">424364000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzctMy0xLTEtMA_b1eb943f-d9a9-4f54-9f16-b7600e27d1d8"
      unitRef="usd">407812000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzgtMS0xLTEtMA_2305e869-fb19-420b-a5b4-780205a35a36"
      unitRef="usd">21017000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzgtMy0xLTEtMA_f2411b9e-87ca-481f-b458-0b8d94ee4fd0"
      unitRef="usd">24877000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzktMS0xLTEtMA_4a3edaae-f26e-4c22-8747-8401f6c8c967"
      unitRef="usd">7471000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfMzktMy0xLTEtMA_185e031e-6e0e-4bad-9ead-935ea6b77158"
      unitRef="usd">4626000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDAtMS0xLTEtMA_9ab71550-a7d2-4e42-b4dc-c8cc1e950c32"
      unitRef="usd">17841000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDAtMy0xLTEtMA_70060e06-98ac-43bf-b832-f2c5f8e496fd"
      unitRef="usd">25438000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDEtMS0xLTEtMA_ec2e08d5-6345-4dc6-9eb7-a6e90b380c69"
      unitRef="usd">2145548000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDEtMy0xLTEtMA_b966f8c0-94a2-46a3-bb4f-0c9dac8580fc"
      unitRef="usd">2342934000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDMtMS0xLTEtMA_145078ba-a6d2-48a2-8ff2-b9f113f60fea"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDMtMy0xLTEtMA_0382286e-3f86-48f9-8362-56530cd3af39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOjViOTc4Njk3MWZlYzQyNTdiZjdiNWQ1NmVjMDA4ZjhkXzIy_9e3ac873-2ae2-47f2-b3b1-822e1571602c"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOjViOTc4Njk3MWZlYzQyNTdiZjdiNWQ1NmVjMDA4ZjhkXzIy_b6b39535-0590-49d4-9edd-1dd0e0156da2"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDctMC0xLTEtMC90ZXh0cmVnaW9uOjVjZWMwNWMxNjVlNjQ0NmFiYmRmZDUwMGFmNDZhODczXzE3_a9ee0cbc-5066-4a0d-a0c0-eda2841f7790"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDctMC0xLTEtMC90ZXh0cmVnaW9uOjVjZWMwNWMxNjVlNjQ0NmFiYmRmZDUwMGFmNDZhODczXzE3_dfd81fd1-cff7-4001-b06d-c1f8fdfa7a39"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_2e9898d5-cbb3-48f5-9882-73978fe1598c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_657064db-c406-4c97-b5d9-e3cf7fb67abc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_797e61ad-d954-4be4-81d8-c6801a44aa13"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMC0xLTEtMC90ZXh0cmVnaW9uOmUxOGI1ODE5YTU2NjRkZWE4MTI3ZDE2YTAwOTcyOGU1XzI5_ec3a92ce-8cc8-4716-b030-b4d37edeaca0"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMS0xLTEtMA_a102b09e-3a14-405d-b51c-567f70de3c35"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDgtMy0xLTEtMA_0b8b0c0c-09c5-452b-bc2d-f264e6d31c9a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDktMC0xLTEtMC90ZXh0cmVnaW9uOjRhZjU5M2QyZmZmNDQxZjJiYTk5NTRmMTc2NGM1ZTNmXzE5_32525059-a593-4256-9a07-42213eca9d5b"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNDktMC0xLTEtMC90ZXh0cmVnaW9uOjRhZjU5M2QyZmZmNDQxZjJiYTk5NTRmMTc2NGM1ZTNmXzE5_8284ee06-790f-4665-b8c5-df4cec10c9c9"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOmFlYWMzYzkxNTUyNzRiZjdhMzBhYTNiNDY5OTkwYjQzXzE3_0ca90044-953d-4d2f-aec2-c2ed027068af"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOmFlYWMzYzkxNTUyNzRiZjdhMzBhYTNiNDY5OTkwYjQzXzE3_1533f2a9-4aa9-482c-ba93-82ff5ee110b3"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMC0xLTEtMC90ZXh0cmVnaW9uOjg5N2I4MDgzNDg1MzQ4N2NiMTlmZTg0NzlkM2M0NzczXzEz_603a5975-0ff1-4abe-a4c6-5421ca7decb6"
      unitRef="shares">53945000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMC0xLTEtMC90ZXh0cmVnaW9uOjg5N2I4MDgzNDg1MzQ4N2NiMTlmZTg0NzlkM2M0NzczXzQ5_44488116-2f27-4d4e-8fcd-92190972eafe"
      unitRef="shares">53805000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMS0xLTEtMA_4b392820-f20c-4d1b-9866-90c228f2ad04"
      unitRef="usd">539000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTEtMy0xLTEtMA_44f70277-771b-4d38-9198-2fab50291dc4"
      unitRef="usd">538000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTItMS0xLTEtMA_5c3eccc4-a47d-4232-81e9-cf93a1050444"
      unitRef="usd">495383000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTItMy0xLTEtMA_463589ac-d97d-4200-8059-76e6f49874a8"
      unitRef="usd">488116000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMC0xLTEtMC90ZXh0cmVnaW9uOjAwNWZlYmNkMjVhOTQ3M2NiMzZlYmZjNzE4ZmFhMTQ3XzMw_143793cf-2ee0-4c90-a6df-77a88469aa68"
      unitRef="shares">4033000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMC0xLTEtMC90ZXh0cmVnaW9uOjAwNWZlYmNkMjVhOTQ3M2NiMzZlYmZjNzE4ZmFhMTQ3XzY2_3e3368ca-353a-4795-be9d-0e02e770eebe"
      unitRef="shares">3719000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMS0xLTEtMA_032a06fc-bbed-43d5-b18e-bb19c8c46541"
      unitRef="usd">128739000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTMtMy0xLTEtMA_21d16489-6ee6-41d3-a100-cf2529b8f57b"
      unitRef="usd">117623000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTQtMS0xLTEtMA_4bdddb89-0315-4508-84ac-bef9574d628a"
      unitRef="usd">-17231000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTQtMy0xLTEtMA_5aa79671-7542-45e6-8cbd-06cd8c1b9890"
      unitRef="usd">-44161000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTUtMS0xLTEtMA_a30b4412-44d4-438c-b613-5a3d44bf5930"
      unitRef="usd">973269000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTUtMy0xLTEtMA_442a293f-be4f-4c07-83e4-bb71c2106374"
      unitRef="usd">844101000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTYtMS0xLTEtMA_5d0095a4-094a-484e-8f87-334a5ab6a6aa"
      unitRef="usd">1323221000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTYtMy0xLTEtMA_570b4ccc-b045-4930-9858-1f39ca8b4f6f"
      unitRef="usd">1170971000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTctMS0xLTEtMA_8032e8f3-2d28-423a-b5a8-27a951173d54"
      unitRef="usd">3468769000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8xOS9mcmFnOjNiMzY5ZWYwYjhjODQ1ZWFhNTdjYzU1NDA5NzgyMWZlL3RhYmxlOjc0MjY2YjZlMDcyZTQwOTZiOWY3MzE3OTAyNzE5NzQzL3RhYmxlcmFuZ2U6NzQyNjZiNmUwNzJlNDA5NmI5ZjczMTc5MDI3MTk3NDNfNTctMy0xLTEtMA_2e6ceb6a-bc39-4008-8a74-de3e5a5d2e57"
      unitRef="usd">3513905000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i645bab1208e440d6bba1b2b50e83f8f7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xLTEtMS0w_fb701717-8143-4dbd-acc8-69910694f923"
      unitRef="shares">53941000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i645bab1208e440d6bba1b2b50e83f8f7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0zLTEtMS0w_06f45e0f-c32d-471f-bad9-ec9c28ec6ac1"
      unitRef="usd">539000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifabce0a4ec3648aba15ce1da427edc94_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy01LTEtMS0w_e908b6e3-ba34-4864-ae52-9f5275cbedb7"
      unitRef="usd">493756000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i7e0388c23a904078a68ee55997708edc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy03LTEtMS0w_670bc303-8051-41a2-95ff-1964992efee6"
      unitRef="shares">3779000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i7e0388c23a904078a68ee55997708edc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy05LTEtMS0w_b915239b-c8ae-4678-beca-7669cfdf81bf"
      unitRef="usd">-119862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib79098f710394f8bad4b6249ed402365_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xMS0xLTEtMA_b235a443-32f4-4ac2-8c79-b00106deffa2"
      unitRef="usd">-28612000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i206f386ef65e4efcbd26b97188566221_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xNS0xLTEtMA_e3e20fc1-ba73-4893-8b73-dfec27a3f30a"
      unitRef="usd">932396000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id92b5649f7cd473c927b77aec8349b02_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMy0xNy0xLTEtMA_043bdd74-6712-402f-930c-16579e249f0f"
      unitRef="usd">1278217000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2cf491c304bf462bbe422c10205da933_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNS01LTEtMS0w_54db2a6c-5247-48df-ba3f-900fe889e9b0"
      unitRef="usd">1588000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNS0xNy0xLTEtMA_82d7f9ad-95bf-4675-b6c8-746ffb43114a"
      unitRef="usd">1588000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i86c6bf5384d2448ab19ea3c25d18c047_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi0xLTEtMS0w_ed7c2b1c-df98-49b8-be02-74af4f25fd49"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2cf491c304bf462bbe422c10205da933_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi01LTEtMS0w_dafe01a6-97e6-4d8b-a6e8-0dbb6fab062b"
      unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfNi0xNy0xLTEtMA_8a6ad57f-a220-405e-a01b-9f237fc7fe91"
      unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id87378b869354db2bcff3f2e742011c8_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS03LTEtMS0w_08b1c59c-3ed1-4cc6-87ba-35f74ace21cf"
      unitRef="shares">254000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id87378b869354db2bcff3f2e742011c8_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS05LTEtMS0w_9381317e-0f78-49f2-9613-5bdaac1b1315"
      unitRef="usd">8877000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfOS0xNy0xLTEtMA_8598e237-b8a6-414e-9a34-1f7c7934630b"
      unitRef="usd">8877000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="id3ce94650fa9445f823db6a5338d8dbc_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTQtMTUtMS0xLTA_e4c22f7c-5986-4d8a-a58b-3426d52a084d"
      unitRef="usd">40873000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTQtMTctMS0xLTA_c0e73b31-df04-4d72-800f-c1dcc96eaba7"
      unitRef="usd">40873000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iff48eb475ee34d5f9e4435434ac71fab_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTctMTEtMS0xLTA_bd084478-633f-4960-937c-9cd7b82cd433"
      unitRef="usd">11381000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTctMTctMS0xLTA_0dc64638-0af2-408e-adc1-b22b4c3ca28d"
      unitRef="usd">11381000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMS0xLTEtMA_fc3dc53b-1b53-4ad9-95ae-37fa9bb3306c"
      unitRef="shares">53945000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMy0xLTEtMA_11fc2d0b-4488-46f9-a2ee-aea7a9ae4ae3"
      unitRef="usd">539000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i232a04fb585849d7b62b28529e631e02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktNS0xLTEtMA_e3c95f77-b329-478a-b1af-930e9abc23ae"
      unitRef="usd">495383000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktNy0xLTEtMA_8a7a3502-ac22-45e9-a68c-2e9daa838636"
      unitRef="shares">4033000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktOS0xLTEtMA_f143905e-17bd-478c-87e9-a5098a6b907d"
      unitRef="usd">-128739000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTEtMS0xLTA_5a601146-b170-45e2-9f5d-dbc19c2545ba"
      unitRef="usd">-17231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i68a428b3ad4d41caa61dc1bda82e2223_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTUtMS0xLTA_e381a8e8-621a-490a-b932-97535d620a5f"
      unitRef="usd">973269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjBiMjk4ODU2MDk0YzRhYzdiOGFiNmRhZTJiZTIzMTVlL3RhYmxlcmFuZ2U6MGIyOTg4NTYwOTRjNGFjN2I4YWI2ZGFlMmJlMjMxNWVfMTktMTctMS0xLTA_3865158f-947a-47d6-91c9-0ca2f72d6f92"
      unitRef="usd">1323221000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6597d0aa1a884ca6aa3023579166d059_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xLTEtMS0w_666d2c1f-16ed-4007-816e-cd432ec7e71d"
      unitRef="shares">53755000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6597d0aa1a884ca6aa3023579166d059_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0zLTEtMS0w_13623ed5-0713-4b97-892c-52fa6d3cc05d"
      unitRef="usd">537000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f3e3881699a45b699f355c9807a956f_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy01LTEtMS0w_463ba186-9e05-4fa3-bd90-f9e9f0513647"
      unitRef="usd">483595000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i3870a17f657247418f8246de8f8e95d8_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy03LTEtMS0w_aa95260a-66ef-4d60-9fc8-50a07684bbd0"
      unitRef="shares">3523000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i3870a17f657247418f8246de8f8e95d8_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy05LTEtMS0w_5de68607-2008-4be4-8596-4eb56e1f1240"
      unitRef="usd">-110784000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ac3f4783ca6476bb7e3eedcfcdd97ac_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xMS0xLTEtMA_64219522-91d4-4eb6-8a88-1e14131bb5b0"
      unitRef="usd">-29555000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8182d3e7d5ab4ed39c4c86631d2af0a0_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xNS0xLTEtMA_be51d0a6-aacd-46ad-b5b7-cc2c5aabfb1a"
      unitRef="usd">768997000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7998bc70e21a48d585baf03e6e7fb122_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMy0xNy0xLTEtMA_cf3b5f7d-6788-42e3-ab61-e38babafdc98"
      unitRef="usd">1112790000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNi01LTEtMS0w_d3b0a6e0-6d27-4d11-8cd9-5f4437ebaf35"
      unitRef="usd">1780000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNi0xNy0xLTEtMA_dd8113e8-e334-493e-8bce-61d97f5c0b17"
      unitRef="usd">1780000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy0xLTEtMS0w_b3ececc1-e384-4ad2-973b-545ecb8bb592"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9dacacbe3246497aaea1fdf6a6c2fb4e_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy01LTEtMS0w_4768dd43-5fd8-43ac-b0c1-eec75ce32687"
      unitRef="usd">463000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfNy0xNy0xLTEtMA_81afbd24-f54f-4f37-aebb-cbd9216a970b"
      unitRef="usd">463000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ib5c1ead2832f4e9285ab9bdbaf56a086_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfOS0xLTEtMS0w_4b92ba29-09c1-411f-aaf9-8041bf1b198e"
      unitRef="shares">6000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfOS0xNy0xLTEtMA_d71ed54b-f1ac-4aee-90eb-be0c5f577d0f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i895d5defc18447a5924a8b792118d974_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtNy0xLTEtMA_a11de9e5-29d3-493b-a633-687fca888e5f"
      unitRef="shares">2000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i895d5defc18447a5924a8b792118d974_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtOS0xLTEtMA_f75416e9-89bf-4491-89f2-98f1083e3902"
      unitRef="usd">94000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTAtMTctMS0xLTA_0af8f288-c893-4250-849f-979d15ea5f45"
      unitRef="usd">94000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i552ef8c73a164d62926cecf57d47ab48_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTMtMTUtMS0xLTA_67349240-0372-41a6-a52f-a55ef92c57cf"
      unitRef="usd">38058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTMtMTctMS0xLTA_be935af8-6590-4db4-958a-9b0885a0e283"
      unitRef="usd">38058000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0c33b8ad9e0d4cd78038bc3e069d0540_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTYtMTEtMS0xLTA_13dafa90-7db3-4837-bd5b-1da5b7e83578"
      unitRef="usd">3497000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTYtMTctMS0xLTA_da954cb9-fc0d-4447-83d7-27fbd870b5f2"
      unitRef="usd">3497000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMS0xLTEtMA_667e846c-f11f-4505-9c2b-9e13cef9a61f"
      unitRef="shares">53779000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMy0xLTEtMA_24a2430d-2ffd-4a2e-b7e2-4129af7d4c85"
      unitRef="usd">537000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02378009299044fcbaadf8c1f71fbbc3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtNS0xLTEtMA_92ff9a10-3156-4d73-bc0f-2e3fbf9d98c4"
      unitRef="usd">485838000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtNy0xLTEtMA_1ae4d6b8-307c-4e93-bbbd-a40e5e1690a0"
      unitRef="shares">3525000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtOS0xLTEtMA_e71f4290-a399-42fc-8c14-22f002985ed6"
      unitRef="usd">-110878000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f65082bbe1549b9984db1760459d732_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTEtMS0xLTA_cee8b55f-fc73-45e8-afcd-16ecb1c3303a"
      unitRef="usd">-26058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTUtMS0xLTA_1e7789bf-e41f-47c7-b4e6-30e4c923afa5"
      unitRef="usd">807055000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjE1YjI0NzFjNGM2ZjRhY2Y4ZjZjNmUzYWJhZGI2ZWU2L3RhYmxlcmFuZ2U6MTViMjQ3MWM0YzZmNGFjZjhmNmM2ZTNhYmFkYjZlZTZfMTgtMTctMS0xLTA_df76fdc5-4215-4c9d-90b4-cacba9e6c619"
      unitRef="usd">1156494000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaae9f252e2294b9992531339cd343ab0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xLTEtMS0w_38855c35-fd3c-4cb4-a92c-4c95bed38a39"
      unitRef="shares">53805000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaae9f252e2294b9992531339cd343ab0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0zLTEtMS0w_24ec5a75-53ed-4f63-8e17-229d860ae6ad"
      unitRef="usd">538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i88d5db478bde46f3bf4070353ddfd2d0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy01LTEtMS0w_76a51638-01df-4275-83fd-26b9dce9c7b7"
      unitRef="usd">488116000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i1e1a6f3463264049a9bc9dc455379e33_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy03LTEtMS0w_6a470698-2454-436c-9464-6f6441c0d71f"
      unitRef="shares">3719000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i1e1a6f3463264049a9bc9dc455379e33_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy05LTEtMS0w_5e1f7a53-386a-42fc-8899-4fc7f487cbf7"
      unitRef="usd">-117623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie98e17addbc24768a91973f19003abe5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xMS0xLTEtMA_5a8d0e1b-7426-4124-9a11-d1147edf5719"
      unitRef="usd">-44161000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia194dc098eda4f59bfcb88c060c36e3d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xNS0xLTEtMA_e1b67b16-4c5f-46b1-9f29-31e0d5fffe99"
      unitRef="usd">844101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMy0xNy0xLTEtMA_b1495f49-bb87-41d0-aba6-e49d51d67003"
      unitRef="usd">1170971000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNS01LTEtMS0w_1e8a31dc-c11c-4c8a-bb28-7b317a42a35e"
      unitRef="usd">5944000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNS0xNy0xLTEtMA_bf855086-1c91-4ed2-8d0f-e5ae235b36a0"
      unitRef="usd">5944000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi0xLTEtMS0w_52da54fe-ef21-42d6-a349-774766117e7b"
      unitRef="shares">66000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi01LTEtMS0w_d9c60142-cc69-4387-afdc-4ae5aed4d9b3"
      unitRef="usd">1324000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfNi0xNy0xLTEtMA_e6f094e4-2c27-4d77-864f-adef91e8783c"
      unitRef="usd">1324000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0xLTEtMS0w_90a37d77-769e-41cc-9af3-af8a672a56f2"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ibd841f590d8a4f28961a3ad355014421_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0zLTEtMS0w_24077a98-4e45-4424-bb10-86375275daa1"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ida6f14ac6bc84359951e377efec279ae_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC01LTEtMS0w_1097187b-7081-40ac-9cbf-e9464392e08a"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOC0xNy0xLTEtMA_33a02550-f6a2-46fd-8ea6-73de30985f92"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS03LTEtMS0w_2417f48e-f23a-4492-aef5-d995d03b5778"
      unitRef="shares">314000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i54bd03ee3c6f4a84b50d31f9f5f2d2e3_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS05LTEtMS0w_9a50e554-1f78-401a-a8b3-f6eaadcd1b73"
      unitRef="usd">11116000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfOS0xNy0xLTEtMA_909b557d-fa15-4aa6-a628-7128c00b4668"
      unitRef="usd">11116000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i5cd8e3092d1646ac9ed4f22b175be42f_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTQtMTUtMS0xLTA_fc0cf4a2-f2b8-4824-8798-7d127b11a45b"
      unitRef="usd">129168000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTQtMTctMS0xLTA_e289a573-69c9-4a15-863e-02ba256c280d"
      unitRef="usd">129168000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i894492e356c24389904183d445eebdf6_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTctMTEtMS0xLTA_f9b352ea-d33a-45ee-a3f3-e86c51812d4d"
      unitRef="usd">26930000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTctMTctMS0xLTA_a571597f-f1fa-498c-a13f-79cc5d9d122a"
      unitRef="usd">26930000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMS0xLTEtMA_dbb265b0-9aa5-4095-bb2b-bbe6ab69d557"
      unitRef="shares">53945000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6b39e4d0e2104f938f396d07693f6bb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMy0xLTEtMA_ef67ccbd-7ffa-4c11-b48e-3a021a7bd786"
      unitRef="usd">539000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i232a04fb585849d7b62b28529e631e02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktNS0xLTEtMA_c6c3b35c-8050-44ac-a6bc-2e95563d444d"
      unitRef="usd">495383000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktNy0xLTEtMA_a29fac5d-f1c0-406b-85ba-69bf202e44c6"
      unitRef="shares">4033000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i4d6f3b88fbfa4df3a12dc054f8bcae99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktOS0xLTEtMA_59a89f2c-be14-4f89-bc88-3faf036c217c"
      unitRef="usd">-128739000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTEtMS0xLTA_9df53df7-5b72-422c-b088-a3e151aa0c79"
      unitRef="usd">-17231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i68a428b3ad4d41caa61dc1bda82e2223_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTUtMS0xLTA_2be533e7-637c-4b69-a94c-78b52d2b5201"
      unitRef="usd">973269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOjc2ZTU0YTU4OThkZTQ2YTc4ZjE3NTM0YWYzNTZlNGFkL3RhYmxlcmFuZ2U6NzZlNTRhNTg5OGRlNDZhNzhmMTc1MzRhZjM1NmU0YWRfMTktMTctMS0xLTA_80398755-b058-48e6-b616-579a8d2709fb"
      unitRef="usd">1323221000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0c7980a5567149ff9eb9001647b782d7_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xLTEtMS0w_5bc57fe9-02a5-4e97-bfb6-35cafcee4992"
      unitRef="shares">53670000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0c7980a5567149ff9eb9001647b782d7_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0zLTEtMS0w_e28ecea3-c628-41cb-9e06-9aa0bf48f4b4"
      unitRef="usd">536000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieec46f6b9a8249da93011c913c7e73b9_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy01LTEtMS0w_bdbc13fa-511f-408a-956b-979fc8ede2a6"
      unitRef="usd">479150000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i25e9032e71334883b53310db29ee9dcf_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy03LTEtMS0w_967da122-be7a-4db6-96ac-556857cda1aa"
      unitRef="shares">1871000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i25e9032e71334883b53310db29ee9dcf_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy05LTEtMS0w_879dba79-5820-43ae-b092-985a6879ff93"
      unitRef="usd">-59928000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2cb539dc22d348d2a949a23eec4d43ac_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xMS0xLTEtMA_00943f4a-ddbc-49ac-b089-d1c0478f1ca2"
      unitRef="usd">-25747000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i919b953b16b64c2594759f09f5b6ad4a_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xNS0xLTEtMA_5e4c0c4d-f9be-463c-ab96-6eead45b9bae"
      unitRef="usd">701820000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1ec6216b1c544040948237d6bac14880_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMy0xNy0xLTEtMA_5210993e-921c-4e32-8d43-75895132e875"
      unitRef="usd">1095831000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNi01LTEtMS0w_c5f5c152-8239-4903-a93a-00ee13052028"
      unitRef="usd">5682000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNi0xNy0xLTEtMA_fd1d36e5-d437-4053-b4a9-d54fa1403aa1"
      unitRef="usd">5682000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy0xLTEtMS0w_ac0884ee-4d7a-489e-8cb3-1b3eb42b6882"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy01LTEtMS0w_7aaf88cd-fab2-4dad-9bb1-acbe68ceeaa1"
      unitRef="usd">1007000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfNy0xNy0xLTEtMA_9495ba60-e202-4f90-a6ae-d4654b4e1ea3"
      unitRef="usd">1007000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0xLTEtMS0w_e9711446-a025-49bc-a8f1-c614a8a6ab41"
      unitRef="shares">73000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib8b909bea5c44f149c3b18cf6a5014e3_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0zLTEtMS0w_71cf051f-f3e3-46a2-83fa-d895d02c9c53"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="if90342d22c414611a603c00bb6ebcf44_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS01LTEtMS0w_66a98565-ba11-4092-a774-26f99375cc90"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfOS0xNy0xLTEtMA_7af24a39-4005-445a-b58c-6098f485e167"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibe19bca84d574046993a13ff28023c51_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtNy0xLTEtMA_affe204a-ecca-47f2-acb8-4cd038af2418"
      unitRef="shares">1654000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibe19bca84d574046993a13ff28023c51_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtOS0xLTEtMA_8c86c7e0-3ca1-42df-abcf-34af627e0bc2"
      unitRef="usd">50950000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTAtMTctMS0xLTA_08598ba6-f072-4414-89e4-59017c530016"
      unitRef="usd">50950000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="ifefd508b4186429aa4691a4a839c0b30_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTMtMTUtMS0xLTA_a5ea0d74-0df9-4264-a40f-ffd42cbff81d"
      unitRef="usd">105235000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTMtMTctMS0xLTA_c4ed552b-3a43-4018-81d2-23747100f8f3"
      unitRef="usd">105235000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i67b246cfd86a4d3abc3d648d4bf23971_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTYtMTEtMS0xLTA_b6f2c3b8-6d79-4503-b6a5-46da270a6adc"
      unitRef="usd">-311000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTYtMTctMS0xLTA_c4448308-b607-4eaf-9b3b-027ffeb496b7"
      unitRef="usd">-311000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMS0xLTEtMA_a850433d-92b1-4df0-a0cb-8d126cf3f8b1"
      unitRef="shares">53779000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7b6ea02b421b48a483d6068027b2b09e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMy0xLTEtMA_0a7bdb7d-b5e6-4ca4-a03e-a47988b2a7a6"
      unitRef="usd">537000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02378009299044fcbaadf8c1f71fbbc3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtNS0xLTEtMA_291cece5-0453-4a2a-9399-36b546f31e4d"
      unitRef="usd">485838000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtNy0xLTEtMA_90b060ff-438b-4020-beb1-d27c9365f2e9"
      unitRef="shares">3525000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ic85eaea3b41443acbf6c4b736e319a28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtOS0xLTEtMA_8bf381d2-fc96-48da-8546-e93b1e42803d"
      unitRef="usd">-110878000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f65082bbe1549b9984db1760459d732_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTEtMS0xLTA_e31e4dde-8e8b-4580-a698-4cb80ee92702"
      unitRef="usd">-26058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50c8afa8ec8f4777a0733006a0baf6b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTUtMS0xLTA_5169aace-f522-40ea-a536-8af1dcfdeeb8"
      unitRef="usd">807055000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yMi9mcmFnOjU1Y2QzNDQxNjQ0NTRjNWJiNTViNzUyMmIzMTE3N2NjL3RhYmxlOmNmYmJkZjA2Njg2OTRmNjRiZDc0ZDFmMzY3ZGJiNDMyL3RhYmxlcmFuZ2U6Y2ZiYmRmMDY2ODY5NGY2NGJkNzRkMWYzNjdkYmI0MzJfMTgtMTctMS0xLTA_aade57ca-f95a-4920-95cc-d67e7554d0f7"
      unitRef="usd">1156494000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMy0xLTEtMS0w_642da39e-5f3f-48af-afee-ecdf59088408"
      unitRef="usd">129168000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMy0zLTEtMS0w_2909efb2-12cd-48f7-b327-5cf5f8255ed0"
      unitRef="usd">105235000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNS0xLTEtMS0w_8c8a4de9-3b0e-4ed8-8d8f-dbf8a47a0da2"
      unitRef="usd">22627000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNS0zLTEtMS0w_742a194d-28d9-4d6b-8886-5e47c7dc9c0d"
      unitRef="usd">21664000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNy0xLTEtMS0w_c08a0fa1-07ca-4cf0-93fc-d573a9dce3e2"
      unitRef="usd">-210000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNy0zLTEtMS0w_61b88f5e-d544-444e-bb08-3d8b30878bdf"
      unitRef="usd">-184000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOC0xLTEtMS0w_8cc71bc2-dc87-44f0-901e-fa8621e3de4e"
      unitRef="usd">7970000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOC0zLTEtMS0w_3aeefa6f-d1cb-4a17-856c-0d4ea50f2b2a"
      unitRef="usd">7383000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOS0xLTEtMS0w_80529774-94ed-4fd1-977e-25316f2011ea"
      unitRef="usd">3569000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfOS0zLTEtMS0w_19dcb484-8dfb-48ed-882f-14d828557f37"
      unitRef="usd">2766000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ShareBasedCompensation
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTEtMS0xLTEtMA_f363e6ea-fd9c-4008-84f8-134dfe2be6e6"
      unitRef="usd">5944000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTEtMy0xLTEtMA_b540f838-877d-47d1-8136-6917f48ff185"
      unitRef="usd">5682000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTItMS0xLTEtMA_0f8ed9aa-7b63-44c1-94c1-b889e6f3049d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTItMy0xLTEtMA_31b0dc91-f75f-4612-9e61-3acf8ec9bf25"
      unitRef="usd">-2155000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTYtMS0xLTEtMA_d7647836-ca23-40bd-bc2c-be966b5c9ab8"
      unitRef="usd">5362000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTYtMy0xLTEtMA_4275fba5-a928-44ef-9918-fa4506f9fa09"
      unitRef="usd">6117000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <us-gaap:OtherNoncashExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTctMS0xLTEtMA_99fd337d-7d6e-4a96-9486-175333ae3d61"
      unitRef="usd">937000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMTctMy0xLTEtMA_12183dc4-a86c-4038-98d9-e568bed5686f"
      unitRef="usd">34000</us-gaap:OtherNoncashExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjAtMS0xLTEtMA_37e9e382-4b65-482b-a2e4-ecc822c4ef9e"
      unitRef="usd">-36725000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjAtMy0xLTEtMA_cafab953-a441-46ac-9408-077cfeb1eecf"
      unitRef="usd">-4624000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjEtMS0xLTEtMA_99977ebc-0b3d-4e16-9c7f-2872edb158c8"
      unitRef="usd">-1269000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjEtMy0xLTEtMA_b2d9845b-ce8c-4905-a856-b734d8c798df"
      unitRef="usd">817000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjItMS0xLTEtMA_d8674cfa-5545-4807-8c9d-f88b52290589"
      unitRef="usd">1439000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjItMy0xLTEtMA_b2bf9c47-dcf1-4d26-994a-e7ea17997cc4"
      unitRef="usd">879000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjMtMS0xLTEtMA_2228c7da-325c-49f0-9626-053fc47dbd37"
      unitRef="usd">-35789000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjMtMy0xLTEtMA_208f483b-d66c-47ee-8b2e-f859b8a4d62a"
      unitRef="usd">-6091000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjQtMS0xLTEtMA_8c0a8227-40a8-4a7f-9ffa-eb5c8fa20193"
      unitRef="usd">8236000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjQtMy0xLTEtMA_c862e2b8-680f-447c-8ab5-c39fc7d774b4"
      unitRef="usd">20724000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjUtMS0xLTEtMA_b68ed56e-8d3b-4e02-ac56-bf4aa9f3a0e3"
      unitRef="usd">-5085000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjUtMy0xLTEtMA_89ee6520-98d6-4568-9e48-160a47e63420"
      unitRef="usd">-6430000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjctMS0xLTEtMA_91b7aaef-f019-4813-a4eb-8e9e4515cf1b"
      unitRef="usd">3184000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjctMy0xLTEtMA_d4d88997-a727-4748-8793-7f95f3d1f9f4"
      unitRef="usd">1353000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjgtMS0xLTEtMA_7fd5fbb6-102f-456d-b490-ee8398296c73"
      unitRef="usd">176520000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMjgtMy0xLTEtMA_258739e7-a440-47f4-9c9e-9b6c596adff9"
      unitRef="usd">160998000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzEtMS0xLTEtMA_29031609-6b8b-4423-8d61-3753cee1e7a9"
      unitRef="usd">17347000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzEtMy0xLTEtMA_bd286421-11d9-401e-b3ad-e0f94f4f2946"
      unitRef="usd">9055000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <pbh:EscrowReceipt
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzItMS0xLTEtMA_88dedaae-922d-4991-b978-e3741de15df7"
      unitRef="usd">0</pbh:EscrowReceipt>
    <pbh:EscrowReceipt
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfMzItMy0xLTEtMA_aad988d5-7fdb-4176-94e2-73ebe404f1f5"
      unitRef="usd">750000</pbh:EscrowReceipt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDAtMS0xLTEtMA_aa163095-033d-4c38-8858-040c68950437"
      unitRef="usd">-17347000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDAtMy0xLTEtMA_ca1d2406-6831-4029-a1f7-2bf291d9d67a"
      unitRef="usd">-8305000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic19a2270b9564c688d8a49573152aa2c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOjE5ZjlhYTcwZDQ1OTRkZmE5YWQzMjY1ZWQzMWMzNDc0XzIxOTkwMjMyNTU2MTE_186cb665-37a7-46b3-8fb8-4161797184df"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ca4dcc6702e4728b7857d76f6eef369_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOjE5ZjlhYTcwZDQ1OTRkZmE5YWQzMjY1ZWQzMWMzNDc0XzIxOTkwMjMyNTU2MTE_8e2357bd-1f9d-4d8f-bc9b-e27a5bd4aeab"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMS0xLTEtMA_85dfaf5a-e07f-4f34-9226-165bd7ab8395"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDMtMy0xLTEtMA_5a6d079c-6685-43c9-9d50-244bdc9d965e"
      unitRef="usd">400000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOmM0YWU0N2E4NjZjNTRkMGRhYTg5NDAyNGQ0ZTMzODhhXzIxOTkwMjMyNTU1OTg_368a6cca-e690-420b-8afc-47df8c7c24e4"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOmM0YWU0N2E4NjZjNTRkMGRhYTg5NDAyNGQ0ZTMzODhhXzIxOTkwMjMyNTU1OTg_648b98e4-c8c9-4235-82e4-ff14e907d2a6"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMS0xLTEtMA_195d65e7-0510-498c-aaec-d33dac581239"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDQtMy0xLTEtMA_b7fef4ac-f413-456c-aa3c-ef97584bb9fc"
      unitRef="usd">400000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDYtMS0xLTEtMA_4a826541-e798-488e-8406-474289afec8d"
      unitRef="usd">130000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDYtMy0xLTEtMA_510cce07-dc1c-4909-96b8-25a26424fcfa"
      unitRef="usd">21000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDctMS0xLTEtMA_1a2cb023-2b8a-4850-883d-b76da31dd3cd"
      unitRef="usd">15000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDctMy0xLTEtMA_26039a82-874b-4654-b130-91f3d78f496a"
      unitRef="usd">45000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDgtMS0xLTEtMA_8795e633-0507-46dc-9a33-bad6108857d2"
      unitRef="usd">70000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDgtMy0xLTEtMA_6899a467-b375-4388-91b6-2ec4d91fc3ab"
      unitRef="usd">120000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDktMS0xLTEtMA_52369308-39bb-47a9-9cae-816692309093"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNDktMy0xLTEtMA_d20a845c-c73f-491b-a6e8-8f013460a1d8"
      unitRef="usd">5793000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTAtMS0xLTEtMA_e2bfb905-9469-48c8-b2b1-5ab19a55ac96"
      unitRef="usd">918000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTAtMy0xLTEtMA_0c7a740a-a945-47e0-ae9b-94fbe6aa5df9"
      unitRef="usd">252000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTEtMS0xLTEtMA_ffa72f3e-63c5-40cf-9f64-c01ed2e3f4a0"
      unitRef="usd">1324000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTEtMy0xLTEtMA_cca70ed9-78d8-47c0-9628-8296e62f3c34"
      unitRef="usd">1007000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTQtMS0xLTEtMA_13ba3e47-6bf1-4f83-b8ea-a982f381ef4f"
      unitRef="usd">1242000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTQtMy0xLTEtMA_3d1cacd4-76bc-4fdc-881c-06654f7cb7ff"
      unitRef="usd">974000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTUtMS0xLTEtMA_8cf48c0f-5bca-4ac6-8c27-a97bf160cf34"
      unitRef="usd">9874000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTUtMy0xLTEtMA_47cf55de-64a8-420f-81d5-af735fe81bbe"
      unitRef="usd">49976000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTYtMS0xLTEtMA_8a8789a1-093d-407b-a7cb-bd35330000f5"
      unitRef="usd">-195710000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTYtMy0xLTEtMA_8ed61052-966c-4e0a-b8f6-d9b988ab7c53"
      unitRef="usd">-151988000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTgtMS0xLTEtMA_b8aa6937-7ad9-4652-bb27-d3917ca6aa0f"
      unitRef="usd">3880000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTgtMy0xLTEtMA_1c6148ed-e16d-4e57-893f-3853ea79af62"
      unitRef="usd">356000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTktMS0xLTEtMA_56e8b7e0-a39b-4374-830f-d6471aded161"
      unitRef="usd">-32657000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNTktMy0xLTEtMA_c7dc716c-3ab8-4f28-a2ca-1839450e576d"
      unitRef="usd">1061000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjAtMS0xLTEtMA_a33feabc-d38d-42dc-8f9c-b1f55122594d"
      unitRef="usd">94760000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1ec6216b1c544040948237d6bac14880_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjAtMy0xLTEtMA_6d2038c6-d47c-479e-bf42-bfdf6cecd1e7"
      unitRef="usd">27530000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjEtMS0xLTEtMA_1716359d-d019-4a0b-91ea-f74e58546ad5"
      unitRef="usd">62103000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjEtMy0xLTEtMA_ac3d8f9f-95af-4583-9c9a-b5c8dde51585"
      unitRef="usd">28591000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjMtMS0xLTEtMA_faffabfa-3cec-478b-9655-614a777f39d6"
      unitRef="usd">46927000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjMtMy0xLTEtMA_f8b1979b-0c9c-42f4-a4d3-49a85885e9c2"
      unitRef="usd">66305000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjQtMS0xLTEtMA_93a55876-7bf2-4936-947f-d4409d39793a"
      unitRef="usd">29677000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8yNS9mcmFnOmYxZjk4N2UzMDljZDRiZTFiZDg2OWRjZDNiNDMxMDY0L3RhYmxlOjM1Yzk5ZDY0MzI2MzRhOTRhODcwM2RjNDFkYmJjNDFjL3RhYmxlcmFuZ2U6MzVjOTlkNjQzMjYzNGE5NGE4NzAzZGM0MWRiYmM0MWNfNjQtMy0xLTEtMA_c0745be5-b9de-438e-801a-efe631e4edf4"
      unitRef="usd">21212000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MTk_f916d525-3aaa-47c2-bbbc-2aff70766ee1">Business and Basis of Presentation &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prestige Consumer Healthcare Inc. (referred to herein as the &#x201c;Company&#x201d; or &#x201c;we,&#x201d; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#x201c;OTC&#x201d;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 7 to these Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Coronavirus Outbreak &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;In January 2020, the World Health Organization ("WHO") announced a global health crisis due to a new strain of coronavirus ("COVID-19").&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;In March 2020, the WHO classified the COVID-19 outbreak as a pandemic.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;This pandemic is affecting the United States and global economies, including causing significant volatility in the global economy and resulting in materially reduced economic activity since early 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The COVID-19 pandemic and the corresponding government responses have also led to increased unemployment, which led to a reduction in consumer spending.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;Economic conditions are, and we expect that they will continue to be, highly volatile and uncertain and could continue to reduce demand for our products and put downward pressure on prices.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;We did see an increase in sales at the end of March 2020 related to shelter-at-home restrictions as we believe consumers stocked up as a result of COVID-19, followed by a temporary but significant decline in consumption in the first quarter.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;Since then, we have seen more stable consumer consumption and customer orders. Sales have varied throughout the year with some categories positively impacted (for instance, Women&#x2019;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp;amp; Cold, and Gastrointestinal).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19. Early in our first quarter of fiscal 2021, we received reports of an increase in absenteeism at our distribution center and with some of our suppliers; however, we have not experienced a material disruption to our overall supply chain to date.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;To date the pandemic has not had a material negative impact on our operations, overall demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;We continue to generate operating cash flows to meet our short-term liquidity needs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;These circumstances could change in this dynamic, unprecedented environment. If the outbreak continues to spread, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. We may need to limit operations and may experience material limitations in employee resources.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;   &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The extent to which COVID-19 impacts our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19, and the actions to contain COVID-19 or treat its impact, among others. We do not yet know the full extent of its impacts on our business or the global economy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;However, these effects could have a material, adverse impact on our liquidity, capital resources, and results of operations and those of the third parties on which we rely.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2021) mean our fiscal year ending or ended on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of that year.  Operating results for the nine months ended December 31, 2020 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2021.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-14,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in this update are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued.  The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for reference rate reform.  An entity may elect to apply the amendments prospectively through December 31, 2022.  We are currently evaluating the impact of adopting this guidance on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MjQ_67f794fc-92de-49e3-a290-21d22fd9e3f2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2021) mean our fiscal year ending or ended on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of that year.  Operating results for the nine months ended December 31, 2020 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2021.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MjU_94b0428a-1800-4d80-92c5-24da7bb77e7b">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zMS9mcmFnOjAzYTJhZGVjNjliYjQwMDRiNTkzMGQ1MjZkYTA5ZjU4L3RleHRyZWdpb246MDNhMmFkZWM2OWJiNDAwNGI1OTMwZDUyNmRhMDlmNThfMTA2MzY_c967bd2a-8b2d-4df0-9517-4a921a749378">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-14,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in this update are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued.  The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for reference rate reform.  An entity may elect to apply the amendments prospectively through December 31, 2022.  We are currently evaluating the impact of adopting this guidance on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjk1_74400bde-5527-4909-8e6f-9668d22c6197">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.1 million and $6.5 million at December&#160;31, 2020 and March&#160;31, 2020, respectively, related to obsolete and slow-moving inventory.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMzAx_cb8d1a5e-6055-4c64-bd3f-44acf6acdc9d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMi0xLTEtMS0w_27f84059-c14f-4dd3-80ae-40e252383d77"
      unitRef="usd">8370000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMi0zLTEtMS0w_ade626f6-0bd3-48d5-8be6-972dd8dd4cc0"
      unitRef="usd">9803000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMy0xLTEtMS0w_f809c800-48e8-43e6-9d8a-3da5f5cb84d7"
      unitRef="usd">321000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfMy0zLTEtMS0w_e6d9d9d9-c6e8-4141-822b-95aa6fd1dd2e"
      unitRef="usd">355000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNC0xLTEtMS0w_34bf0906-057c-4e9f-bc06-cfb33d9a200e"
      unitRef="usd">108320000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNC0zLTEtMS0w_02f768b5-4425-4326-b871-558263e6fddb"
      unitRef="usd">105868000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNi0xLTEtMS0w_d025b010-e4f7-4ce4-9132-e0633a65b60f"
      unitRef="usd">117011000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RhYmxlOjk0NTM4YjU3OTM1OTQ4YjdiNTRiZGJkZjE4Zjg3ZGIyL3RhYmxlcmFuZ2U6OTQ1MzhiNTc5MzU5NDhiN2I1NGJkYmRmMThmODdkYjJfNi0zLTEtMS0w_193e8228-0603-4c34-8415-31bf0e34643b"
      unitRef="usd">116026000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjAy_332f0047-4368-480c-94c2-2e6ccb8e3782"
      unitRef="usd">4100000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNC9mcmFnOjg0M2I3MGE2ZWYyMjQ3ZGM4NTgyYzcwZjBhYTZlOWZlL3RleHRyZWdpb246ODQzYjcwYTZlZjIyNDdkYzg1ODJjNzBmMGFhNmU5ZmVfMjA5_0fd778eb-6863-4d41-8e3f-9c136ff8ee86"
      unitRef="usd">6500000</us-gaap:InventoryValuationReserves>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RleHRyZWdpb246YTI0ZTJkODRlZDA1NDRjYmI3YWE3YzhjNzI2MDkwYjFfMjAyNQ_33170d65-944d-4ea7-9acd-c34919b1e119">Goodwill &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting goodwill by operating segment is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC &lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, no impairment charge was taken on our March&#160;31, 2020 financial statements.  We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;29, 2020 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties.  Consequently, changing rates of interest and inflation, declining sales or margins, increasing competition, changing consumer preferences, technical advances, or reductions in advertising and marketing may require an impairment charge to be recorded in the future. We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2020, we determined no events have occurred that would indicate potential impairment of goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our goodwill, including long-term growth rates and discount rates.&lt;/span&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RleHRyZWdpb246YTI0ZTJkODRlZDA1NDRjYmI3YWE3YzhjNzI2MDkwYjFfMjA0MQ_2cecc43d-0768-42bb-948f-4dcd96e37f22">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting goodwill by operating segment is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC &lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi0yLTEtMS0w_e3bbadbe-34e0-443a-b3dd-34ecec59460e"
      unitRef="usd">710354000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi00LTEtMS0w_ff1f3605-543b-4868-9841-0d7140d3ddcd"
      unitRef="usd">28536000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMi04LTEtMS0w_f5042326-5906-47db-b605-be9abe02b444"
      unitRef="usd">738890000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy0yLTEtMS0w_1b3a7c38-2279-4604-87d3-6f01ba15a93d"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy00LTEtMS0w_b1d7dd43-dde9-47b1-aed7-643638c35da2"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMy04LTEtMS0w_6d99f18a-896b-42d5-bb4b-94a7a69c66fe"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC0yLTEtMS0w_190250d9-ec22-4efd-ba2a-786607682875"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC00LTEtMS0w_f045f706-12f5-4a24-ac96-d663e97ef887"
      unitRef="usd">28536000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfNC04LTEtMS0w_246d8561-0197-4b1e-8b40-2300b9670b89"
      unitRef="usd">575179000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS0yLTEtMS0w_62a0d4a5-6ce8-43a4-902e-dd5a7af65d32"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS00LTEtMS0w_2f29737f-606a-4461-a4a4-31c22ec99f73"
      unitRef="usd">4380000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfOS04LTEtMS0w_5b28073a-bf15-4714-a5fb-a14c01f1046a"
      unitRef="usd">4380000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillGross
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtMi0xLTEtMA_cb3e09a1-fcf3-49e8-94bc-df47fb8ea5de"
      unitRef="usd">710354000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtNC0xLTEtMA_dd278e2e-f884-44ba-a437-b57366ede3e8"
      unitRef="usd">32916000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTEtOC0xLTEtMA_a1c294ea-e4b3-46d5-842c-ae049a363ed5"
      unitRef="usd">743270000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItMi0xLTEtMA_eba98edc-3e0c-4424-8dfe-65e08bc649eb"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItNC0xLTEtMA_9ad5a4e9-a68c-4bd3-a850-5710dcef485d"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTItOC0xLTEtMA_9e94d1ec-ea2f-4ca3-86d4-21112fe5ca5a"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtMi0xLTEtMA_b3fa1c38-daf1-4200-a05d-140b3f670703"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtNC0xLTEtMA_97fb6555-a3f1-4bd0-9f5d-9a42c5b700b0"
      unitRef="usd">32916000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF8zNy9mcmFnOmEyNGUyZDg0ZWQwNTQ0Y2JiN2FhN2M4YzcyNjA5MGIxL3RhYmxlOmI2YTcyMGFlZWQ5ZDRmZDZiY2U3ZTAwMzU5ODhiYTlmL3RhYmxlcmFuZ2U6YjZhNzIwYWVlZDlkNGZkNmJjZTdlMDAzNTk4OGJhOWZfMTMtOC0xLTEtMA_ff92c3b3-b767-4b47-8de3-fe56441e1582"
      unitRef="usd">579559000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwOQ_20afc207-bb2b-490e-8bbb-5809700da018">Intangible Assets, net &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,672,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $4.9 million and $14.7 million for the three and nine months ended December 31, 2020, respectively, and $4.9 million and&#160;$14.7 million for the three and nine months ended December 31, 2019, respectively.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months ended March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, no impairment charge was taken on our March&#160;31, 2020 financial statements.   Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The discount rate utilized in the analyses, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation.&#160;&#160;Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer preferences, technological advances or reductions in advertising and marketing expenses, we may be required to record impairment charges in the future.  During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, did not exceed its carrying amount.  As such, we recorded an impairment charge of $1.2&#160;million. The decline in the fair value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was primarily related to a decline in expected future sales due to a regulatory change that now requires &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; to be prescribed by physicians rather than sold over-the-counter direct to consumers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020. As of December&#160;31, 2020, no other events have occurred that would indicate potential additional impairment of intangible assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our intangible assets, including long-term growth rates and discount rates.&lt;/span&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwNw_b4564240-d7b5-4025-b61d-5856d9efd219">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,672,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcyMA_acfabf0b-422a-46b0-a1fd-2bbd1fea3a31">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,672,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6867e4a90c294f1fa8dddbeab438a6bc_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi0xLTEtMS0w_c3377a71-d1ee-4fbd-872e-43b0febe2410"
      unitRef="usd">2265331000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i103b63c927b0400b8db4ba9ce800eedf_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi0zLTEtMS0w_fe97d908-8f0a-446c-b056-9b24c825ab86"
      unitRef="usd">389801000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMi01LTEtMS0w_16ab9f7d-8d31-4ffe-b3e1-83cbfc2ffcb5"
      unitRef="usd">2655132000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNS0zLTEtMS02NjA_9e362c93-c9db-45f6-87ab-63a0d28d655e"
      unitRef="usd">1186000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNS01LTEtMS02NjA_33af48a9-05ac-4eae-ab1e-c2e3bf1671c2"
      unitRef="usd">1186000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i70a1fb9b631a4bfe88b529e766619c4c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi0xLTEtMS0w_4646a4da-e0a8-4d85-903e-b908d5450980"
      unitRef="usd">17800000</us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi0zLTEtMS0w_7f68ab8b-795c-4397-b12e-8759a051c471"
      unitRef="usd">752000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <pbh:IntangibleAssetsTranslationAdjustmentsGainLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNi01LTEtMS0w_d2027ba6-d667-4493-ba57-1042703af20b"
      unitRef="usd">18552000</pbh:IntangibleAssetsTranslationAdjustmentsGainLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i664da185858d4792aa10a4f8624f5074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy0xLTEtMS0w_aadd390e-66a0-404a-a12e-86bdaede586f"
      unitRef="usd">2283131000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4abf53f8afa1439081a520747b145a31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy0zLTEtMS0w_6b590aa9-ce6f-42ec-9c1b-dd4b1a226d34"
      unitRef="usd">389367000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfNy01LTEtMS0w_153db80d-e955-411f-a945-695f2f935df9"
      unitRef="usd">2672498000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i103b63c927b0400b8db4ba9ce800eedf_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTAtMy0xLTEtMA_3edc02d0-b5f4-4152-8c13-d3ea3d2ef091"
      unitRef="usd">175741000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTAtNS0xLTEtMA_0d3edbd8-7294-4293-805c-8a90eb198d34"
      unitRef="usd">175741000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTItMy0xLTEtMA_4e453cca-1dbe-4567-a0aa-b952b531bedd"
      unitRef="usd">14729000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTItNS0xLTEtMA_378b4b96-545a-4847-9197-a40102338a09"
      unitRef="usd">14729000</us-gaap:AmortizationOfIntangibleAssets>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="id85a4b0af7ab4b3e973c03af188e9d01_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTQtMy0xLTEtMA_be60eb81-7454-4f61-b9e0-1158a336daba"
      unitRef="usd">-303000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTQtNS0xLTEtMA_01af9ab1-8e73-4af3-a672-b52344ac5086"
      unitRef="usd">-303000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4abf53f8afa1439081a520747b145a31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTUtMy0xLTEtMA_7d2f0fd5-55b1-4156-bdd5-f5c294956d53"
      unitRef="usd">190773000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTUtNS0xLTEtMA_88582ed6-f9b3-447a-93cc-e6f1ad906e0e"
      unitRef="usd">190773000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i664da185858d4792aa10a4f8624f5074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctMS0xLTEtMA_fbb507b4-1340-445c-9d4b-235824410607"
      unitRef="usd">2283131000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4abf53f8afa1439081a520747b145a31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctMy0xLTEtMA_8955dd5e-cf11-4e11-8e3f-e16f6272cf6d"
      unitRef="usd">198594000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjk3NTg1NzNiZTZkZDQzNDJiODAzMjAwODc3OGQzNjJjL3RhYmxlcmFuZ2U6OTc1ODU3M2JlNmRkNDM0MmI4MDMyMDA4Nzc4ZDM2MmNfMTctNS0xLTEtMA_1251fb30-606c-4420-bfdf-77cdf3b5f940"
      unitRef="usd">2481725000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTQz_060da192-08f1-4a35-8d74-729d78483354"
      unitRef="usd">4900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTUw_9d6c2303-695e-4e03-ade1-47eabdd0d401"
      unitRef="usd">14700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMTkz_af059a53-3df7-436a-9b42-c8391e49e84d"
      unitRef="usd">4900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjAw_aef2448d-d8d4-4879-8afc-d79fd72e7c9c"
      unitRef="usd">14700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjcwMQ_e87fba68-0ee8-4968-8cc1-3382f6b0f36e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months ended March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iba357660d1fc4f7787eef1e9535f4bee_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMzY2_37238d9b-84a6-4b3e-9e68-6c6c8071eb0f">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0609d20d39b84155990b8eeece18a13b_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMzcy_b2cce673-da53-4344-b32b-4c63676abdcb">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfMi0xLTEtMS0w_6d8068a8-6f46-45ce-be99-8d58551f556f"
      unitRef="usd">4917000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfMy0xLTEtMS0w_59152f6d-1dfc-4703-af16-d515216f2f27"
      unitRef="usd">19670000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNC0xLTEtMS0w_5cbcc055-fd6a-4c05-969f-690d326191dd"
      unitRef="usd">19670000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNS0xLTEtMS0w_e403f877-824c-4534-b194-1f17ae734ca6"
      unitRef="usd">19637000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNi0xLTEtMS0w_de8d701e-6145-43ec-9442-9fbbf2e47257"
      unitRef="usd">17592000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfNy0xLTEtMS0w_cf755a33-ce40-49ad-bbaa-298662b66f26"
      unitRef="usd">117108000</pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RhYmxlOjMxZDE0NTFjMmZhNzQ1MmNiNmQzYWIzMzJmYTBmZmNhL3RhYmxlcmFuZ2U6MzFkMTQ1MWMyZmE3NDUyY2I2ZDNhYjMzMmZhMGZmY2FfOC0xLTEtMS0w_4a330b09-6a2a-44d7-9a36-99d92394ac6d"
      unitRef="usd">198594000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i354ed91ee4f3409bab9d6df5ad7c5aa6_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfOTI3_949d9ae2-1f84-4eeb-9cd9-ea98895a1691"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80MC9mcmFnOjViZmJkNGI3NTJhYjQxZjliZGEyYjFkZjBmMGZmMDAyL3RleHRyZWdpb246NWJmYmQ0Yjc1MmFiNDFmOWJkYTJiMWRmMGYwZmYwMDJfMjE5OTAyMzI1OTUyNw_5193ff0f-ffff-43f9-86db-3e5e961982ae"
      unitRef="usd">1200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg0_b5f2c318-5d8b-4f28-bca2-cfa3ef9224a0">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (Remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during the three months ended September 30, 2020.  The right-of-use ("ROU") asset and lease liability at the commencement of this finance lease was $5.2&#160;million.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg1_cb1bec22-7f26-481e-b869-10d624eb4bc9">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (Remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during the three months ended September 30, 2020.  The right-of-use ("ROU") asset and lease liability at the commencement of this finance lease was $5.2&#160;million.</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg2_caf59dca-9ecd-4fe6-b78d-f518572415d5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy0yLTEtMS0w_8fef9493-3dd7-431f-a7b9-b5785e9df463"
      unitRef="usd">629000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy00LTEtMS0w_2d2dfbf7-28b1-4ce7-8c63-c89b8e954909"
      unitRef="usd">207000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy02LTEtMS0w_bcaffc20-b6d3-4ca6-a91d-da84683964b2"
      unitRef="usd">1397000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfMy04LTEtMS0w_c4c9e76c-19c8-410c-9fe5-719c9c626a55"
      unitRef="usd">207000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC0yLTEtMS0w_d6390344-21ef-46df-b1a1-c731a2f171fa"
      unitRef="usd">76000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC00LTEtMS0w_552a5994-e9b1-44d7-87ce-1b7bfe3a9095"
      unitRef="usd">34000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC02LTEtMS0w_ae16f2d7-7087-420f-8d38-eed1ac8f8cff"
      unitRef="usd">185000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNC04LTEtMS0w_78006686-39fe-455c-9d5c-58495a0944a0"
      unitRef="usd">34000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS0yLTEtMS0w_d85039b2-d0c0-43cb-987d-f0cec702b317"
      unitRef="usd">1679000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS00LTEtMS0w_3e15ba85-22ea-4be8-a244-9838aa14057d"
      unitRef="usd">2239000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS02LTEtMS0w_8fe44a98-fdf8-4344-b4af-5c8052731b33"
      unitRef="usd">5068000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNS04LTEtMS0w_eece889d-5e8d-4c03-bc97-2cb175936a6a"
      unitRef="usd">5697000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi0yLTEtMS0w_e29c9ef4-0800-461a-84d3-3a53fad23696"
      unitRef="usd">24000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi00LTEtMS0w_a9714a5f-ad33-4598-85f5-b94a26e9afda"
      unitRef="usd">28000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi02LTEtMS0w_809a34a1-ae42-425f-9a29-3b050656612d"
      unitRef="usd">69000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNi04LTEtMS0w_dc77595a-6ba3-475e-9dcd-7e7f041f2523"
      unitRef="usd">78000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy0yLTEtMS0w_8e47396f-babd-480e-9208-4a443cc107f5"
      unitRef="usd">11220000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy00LTEtMS0w_a90fbeba-d600-4606-a455-0f7791eedd07"
      unitRef="usd">15731000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy02LTEtMS0w_af7e4674-8db0-4eb8-8bc3-6ddfc82671e0"
      unitRef="usd">35230000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfNy04LTEtMS0w_b869aa2e-9f21-4adb-819d-b9090ae48d5f"
      unitRef="usd">48396000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC0yLTEtMS0w_3f74cbfd-dcf4-4730-a7b5-7c0cf2f82928"
      unitRef="usd">54000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC00LTEtMS0w_c0598efc-28c2-41db-98bc-b1701ebfbffa"
      unitRef="usd">833000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC02LTEtMS0w_a8344522-89ff-4d44-9109-5129eb2d9640"
      unitRef="usd">163000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOC04LTEtMS0w_9f181736-372b-4662-9509-53de2b649486"
      unitRef="usd">2607000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS0yLTEtMS0w_621e6995-2d26-4c30-afb4-02cceae6ee54"
      unitRef="usd">13574000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS00LTEtMS0w_8037b988-81fd-4923-859d-55db061b3607"
      unitRef="usd">17406000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS02LTEtMS0w_762ee77b-dd8a-4c68-8ba9-ff8a09711bfa"
      unitRef="usd">41786000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU1Yzg2ZTY4OTg5MTRkMDliYzA2NDExNGY2OTljZmMwL3RhYmxlcmFuZ2U6ZTVjODZlNjg5ODkxNGQwOWJjMDY0MTE0ZjY5OWNmYzBfOS04LTEtMS0w_7cd4f622-a46b-409e-8425-d52fe2699472"
      unitRef="usd">51805000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg4_824caf7a-2d78-4cfe-8ef8-cf6ad9eb1ac3">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (Remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTg5_4cbfc03b-fca5-446d-a529-67f24b8dffa9">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (Remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi0yLTEtMS0w_62b586c5-04f3-4515-9809-213c0248a965"
      unitRef="usd">1983000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi00LTEtMS0w_c4aa17ee-9df6-4b16-a787-1157c1ef157d"
      unitRef="usd">706000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMi02LTEtMS0w_408d9f09-cbd3-488b-a535-2314481ce8d1"
      unitRef="usd">2689000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy0yLTEtMS0w_458382a7-635f-4bdd-94c2-faf58963bf95"
      unitRef="usd">6557000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy00LTEtMS0w_10088aef-2789-420b-a966-9de1effe8043"
      unitRef="usd">2826000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMy02LTEtMS0w_f7a0d920-de75-42ac-8367-5f85a774cb01"
      unitRef="usd">9383000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC0yLTEtMS0w_97e34aad-67f2-4056-9e49-598127703b8b"
      unitRef="usd">6293000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC00LTEtMS0w_5aab4d26-1826-4cc0-8676-61629dc35b2a"
      unitRef="usd">2826000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNC02LTEtMS0w_c27742e5-6d84-404f-b07a-f47549f75b9d"
      unitRef="usd">9119000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS0yLTEtMS0w_78b35bd1-d110-4d19-a761-394bd512318a"
      unitRef="usd">6303000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS00LTEtMS0w_9d34bb19-01e5-48ae-afaa-652371e51ab2"
      unitRef="usd">2826000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNS02LTEtMS0w_4d9318d1-ca76-4313-8243-7a91a226dd63"
      unitRef="usd">9129000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi0yLTEtMS0w_0bb1474a-c2ba-41e2-9ba8-54402cc6048a"
      unitRef="usd">4132000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi00LTEtMS0w_b43b80b1-3c33-4e31-be0b-03f555ea2032"
      unitRef="usd">1412000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNi02LTEtMS0w_5afa8c0d-ef32-4104-9609-17c9e4583d12"
      unitRef="usd">5544000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour>
    <pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy0yLTEtMS0w_cefb9a89-da90-4723-a146-48d31956f64f"
      unitRef="usd">4974000</pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy00LTEtMS0w_db7336ed-dd7c-4295-9c63-13402c1b13d8"
      unitRef="usd">0</pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfNy02LTEtMS0w_354bb3ea-ac35-4f97-9578-d590cd3b91c1"
      unitRef="usd">4974000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC0yLTEtMS0w_ec4db932-c70c-40e7-95d5-d672e745caa5"
      unitRef="usd">30242000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC00LTEtMS0w_6220d785-486e-4074-8ca6-afd13def7476"
      unitRef="usd">10596000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentDue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOC02LTEtMS0w_c583b7b9-5183-424a-b486-e35c7d1f1062"
      unitRef="usd">40838000</pbh:OperatingAndFinanceLeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS0yLTEtMS0w_2b2f71fc-3c64-4cdd-bc0f-91da1aa1d4c3"
      unitRef="usd">3626000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS00LTEtMS0w_443068ae-4fae-4ccd-a555-63c6294907ca"
      unitRef="usd">556000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfOS02LTEtMS0w_62cdaf0c-cb66-4d2e-beb9-5d2fa6374846"
      unitRef="usd">4182000</pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtMi0xLTEtMA_4333b38d-3a05-4ab5-ba19-874e014c9918"
      unitRef="usd">26616000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtNC0xLTEtMA_0ecc0978-a8fe-44a8-8232-ff16460f2111"
      unitRef="usd">10040000</us-gaap:FinanceLeaseLiability>
    <pbh:OperatingAndFinanceLeaseLiability
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmVlZDk3MDMxY2ZhNjQ5NmViMWQzMjhhMzQyZDc2ZjBmL3RhYmxlcmFuZ2U6ZWVkOTcwMzFjZmE2NDk2ZWIxZDMyOGEzNDJkNzZmMGZfMTAtNi0xLTEtMA_7564b81f-d1cb-48fd-b830-4f6ebfe9ef09"
      unitRef="usd">36656000</pbh:OperatingAndFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfMi0zLTEtMS0w_1cb179d3-a01f-42ce-9d11-78cb12dcc4b1">P4Y10M17D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfMy0zLTEtMS0w_df34c3ca-5a78-4f62-82c1-68a69bc30f70">P3Y9M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfNS0zLTEtMS0w_b29d5da1-6296-46cc-90a8-867f707b3cef"
      unitRef="number">0.0528</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RhYmxlOmU3NDA0ZGE1ZDg4YTQ2Yzg4NDlhZDE2OTVlM2FkM2NjL3RhYmxlcmFuZ2U6ZTc0MDRkYTVkODhhNDZjODg0OWFkMTY5NWUzYWQzY2NfNi0zLTEtMS0w_c456c403-35c7-4eb9-b624-30aa7c0e6d45"
      unitRef="number">0.0298</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="if14edde8dc2a46079acba1cc1a731adf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTc4_a4e62689-f3a2-4087-82d5-a16573ec9310"
      unitRef="usd">5200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiability
      contextRef="if14edde8dc2a46079acba1cc1a731adf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80My9mcmFnOmEzMzA0ZDMzOGI4ZTQ4M2ZiMjIyZTI5NDUxMTA2Njc3L3RleHRyZWdpb246YTMzMDRkMzM4YjhlNDgzZmIyMjJlMjk0NTExMDY2NzdfNTc4_d1d3fb46-901b-4730-94b7-50e3945a65f3"
      unitRef="usd">5200000</us-gaap:FinanceLeaseLiability>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RleHRyZWdpb246M2E0ZGI4N2UwN2U4NGY0ZWJiMmFlODYyOTZlYWM0Y2VfOTE_6a0edea8-a35c-4e52-9eab-3f3c43f7bd1b">Other Accrued Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RleHRyZWdpb246M2E0ZGI4N2UwN2U4NGY0ZWJiMmFlODYyOTZlYWM0Y2VfMTAw_7447c901-78c4-4a87-8dfd-3cd5fa0d429d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMS0xLTEtMS0w_12b6ec27-b047-4c81-a65e-4dcaa3318965"
      unitRef="usd">40377000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMS0zLTEtMS0w_85d9d7c3-b74d-4ce8-b0fe-a8f23a55aeb5"
      unitRef="usd">34450000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMi0xLTEtMS0w_737504fd-a899-4dde-a4f4-2ceec42201af"
      unitRef="usd">10901000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMi0zLTEtMS0w_634b9597-3371-49b5-a91f-17f6da7fe6c7"
      unitRef="usd">13393000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMy0xLTEtMS0w_0e4f9699-b7b2-4a11-a4cc-e0634196ca1a"
      unitRef="usd">479000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMy0zLTEtMS0w_1f74ea56-ea21-4011-afb6-6e9bd6603c9c"
      unitRef="usd">1491000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNC0xLTEtMS0w_1aeac841-b801-41e8-8135-ef5e9fcab3c0"
      unitRef="usd">294000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNC0zLTEtMS0w_3909df33-2d6c-4052-9a5e-fa87bd50fdf4"
      unitRef="usd">3210000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNS0xLTEtMS0w_5117de62-28b5-43ef-992a-cda82fd15d60"
      unitRef="usd">3647000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNS0zLTEtMS0w_f46e5e4f-1a4f-42de-9e12-6bf8e6286815"
      unitRef="usd">4183000</us-gaap:AccruedProfessionalFeesCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNy0xLTEtMS0w_db19312a-9b26-4c1a-9876-55b5e5d40e23"
      unitRef="usd">3229000</pbh:AccruedProductionCostsCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfNy0zLTEtMS0w_a95349c5-906f-434b-89b1-5be82b4c26c4"
      unitRef="usd">5628000</pbh:AccruedProductionCostsCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTAtMS0xLTEtMA_d049a3c0-2760-40bb-bb4b-3a9df59db8ca"
      unitRef="usd">228000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTAtMy0xLTEtMA_8a53a4e0-3fcc-4785-93c1-da2be826b379"
      unitRef="usd">1917000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTEtMS0xLTEtMA_da5134de-4ce4-4006-8c00-21d19638116e"
      unitRef="usd">7414000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTEtMy0xLTEtMA_dcc58090-8ee9-414e-b7fd-a03de8c6f3e3"
      unitRef="usd">6491000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTItMS0xLTEtMA_88318eb2-d9fe-4cf4-9d3e-6ae801c1afd7"
      unitRef="usd">66569000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80Ni9mcmFnOjNhNGRiODdlMDdlODRmNGViYjJhZTg2Mjk2ZWFjNGNlL3RhYmxlOjEwNjI0YTNiOTVmZDRhMGM4YzgzZWRhM2Y4OTkwNjhmL3RhYmxlcmFuZ2U6MTA2MjRhM2I5NWZkNGEwYzhjODNlZGEzZjg5OTA2OGZfMTItMy0xLTEtMA_abffef40-222e-4d02-9017-369a4a9b5c27"
      unitRef="usd">70763000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzcz_088ec6e5-9391-4522-8707-7b53ac1cf27a">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year.  The 2016 Senior Notes mature on March 1, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a base rate floor of 1.00%, due on January 26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had no balance outstanding on the asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and a borrowing capacity of $123.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Interest Rate Swaps:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We currently have two interest rate swaps to hedge a total of $400.0 million of our variable interest debt (see Note 9 for further details).            &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2024 (the "2016 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzYx_3f5cac38-c0bc-4a76-834b-911d17caa654">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year.  The 2016 Senior Notes mature on March 1, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a base rate floor of 1.00%, due on January 26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i81b414e215924c7b993b038bd3c3eee3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS0wLTEtMS0wL3RleHRyZWdpb246OTdlN2E4NjJlNzBkNDU2ZGE1MWI0MWMxOTAyMmE0YWVfNDI_226daa9a-4aa2-4257-80ec-44d702db5a34"
      unitRef="number">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i81b414e215924c7b993b038bd3c3eee3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS0yLTEtMS0w_6c02b957-22fe-4661-b72d-010729fbf213"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i98a0c2ab86804016a4351c2ce5ed98f0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMS00LTEtMS0w_b2a8edd5-f85d-40cc-bbe8-58447bb009f0"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1236a922afd44780b720fd4a3fbba105_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy0wLTEtMS0wL3RleHRyZWdpb246MTgyNDRjYmNiNTAxNDVjN2FmOWY2OTM4ZTJiYTU5MzJfNDI_83a81d68-9fa9-4112-900e-4e00379422da"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1236a922afd44780b720fd4a3fbba105_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy0yLTEtMS0w_ad75ca5a-2ee2-45db-a92a-66fac53630f7"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie859ec3583f54138ba3370f6e120dd0b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMy00LTEtMS0w_e7566885-e814-4fbc-ac8e-559241211172"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i28cabfca47a44d998d6b2aa85bad9494_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfOTk_c3a2a9f3-90e9-402e-805d-03c432adbf66"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie10121816139428c94900de4ab354727_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfMTc1_c6a11f1a-ceec-4171-ad3e-12ee1531be9d"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="ie10121816139428c94900de4ab354727_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGRlY2Q1NTg4Y2VkNGY3MzllNDE2MmRlMWY1OTBkNjBfMjA1_0fc755e0-8e2c-443c-a305-0fe005e95a8e"
      unitRef="number">0.0100</pbh:DebtInstrumentVariableRateMinimum>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iadc1556813bf44cc90d54deefa6cec4d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC0yLTEtMS0w_81f0d248-ba21-412a-ba20-31a180e47b5d"
      unitRef="usd">560000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i72f4d7a1b6a4434993fb587f62cd9893_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNC00LTEtMS0w_8883ce4f-fae6-40a9-b7e8-8399855fb95a"
      unitRef="usd">690000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7242718fff7f4c5d99567a954c71eac2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNS0yLTEtMS0w_17ef304c-86c4-4996-8fff-30f24306e0d2"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i038c52e6304749fab109d118081f602b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfNS00LTEtMS0w_145f9c99-2c50-47bf-bc77-f09b5f8e0d89"
      unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOC0yLTEtMS0w_bfea1716-cdd0-4402-99bf-300165d0ca34"
      unitRef="usd">1560000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOC00LTEtMS0w_10cc3336-71c5-49f6-a995-ae67787e044c"
      unitRef="usd">1745000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOS0yLTEtMS0w_2e9e6c72-82ae-4ba2-ae38-31c444e37e88"
      unitRef="usd">11308000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfOS00LTEtMS0w_ad49bf75-afec-4471-b8e9-7ba5ce20e05f"
      unitRef="usd">14700000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMTEtMi0xLTEtMA_1995be47-6ed5-4f13-ae36-d1f74f440bcc"
      unitRef="usd">1548692000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjE2NDQ3YTM2ZTYyNjRhMGY4MWI3YmMzODc3ZDQ5NWUzL3RhYmxlcmFuZ2U6MTY0NDdhMzZlNjI2NGEwZjgxYjdiYzM4NzdkNDk1ZTNfMTEtNC0xLTEtMA_f305b7de-501d-4b19-8c1a-c09e9984362d"
      unitRef="usd">1730300000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7b28d9ff4d0544048ff592fc0fc0bb1f_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMTEw_fac19369-fadb-4bb3-abfd-8af4f72cd642"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7242718fff7f4c5d99567a954c71eac2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMjc0_c37f0078-537c-4f73-94cf-17ff9c1a0049"
      unitRef="usd">123300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b2d78644d694801a7c8a37b269dd418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfMzYz_9b958425-5b51-4b2f-ba8f-3d53c01cd59a"
      unitRef="usd">400000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RleHRyZWdpb246NjUzZjVhNGJlZDA5NGE1OTg1YTU0NjVlZTQxMTI2MDdfNzcx_7cbf50b2-6994-41ae-94d2-b32181fb6635">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2024 (the "2016 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months ending March 31, 2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfMi0yLTEtMS0w_55de5e9d-c0e8-4b26-accf-43a04f8367f7"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfMy0yLTEtMS0w_9194b661-f5fe-428c-b5e8-33e6501f0b08"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNC0yLTEtMS0w_92fa1d43-c30d-491f-bd76-80f525fa3c99"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNS0yLTEtMS0w_a843a20f-5d16-4dfe-8210-d40c2784cf2e"
      unitRef="usd">1160000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNi0yLTEtMS0w_954afa5b-675b-408b-b71f-eca86030e2aa"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <pbh:LongTermDebtMaturityAfterYearFour
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfNy0yLTEtMS0w_6ffb384a-6e8e-4eea-8d84-51be23af6309"
      unitRef="usd">400000000</pbh:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF80OS9mcmFnOjY1M2Y1YTRiZWQwOTRhNTk4NWE1NDY1ZWU0MTEyNjA3L3RhYmxlOjBlYzY4NzZjM2I0NjQ3ZmM5NTNlNmE0ODBmMjU2YzQyL3RhYmxlcmFuZ2U6MGVjNjg3NmMzYjQ2NDdmYzk1M2U2YTQ4MGYyNTZjNDJfOC0yLTEtMS0w_9fd322dc-860b-4ed9-96f6-73c3004175f9"
      unitRef="usd">1560000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RleHRyZWdpb246MWFhNjc5YjA3YjY5NDc1Mjk5NmJkOWFmYTViMmNmYmVfMTgxMw_71ca3384-eadc-4470-bd84-f7654e1c59cf">Fair Value Measurements &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB Accounting Standards Codification ("ASC") 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Quoted market prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2016 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy.  See summary below detailing the carrying amounts and estimated fair values of these instruments at December&#160;31, 2020 and March&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;At December&#160;31, 2020 and March&#160;31, 2020, we did not have any assets or liabilities measured in Level 1 or 3.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RleHRyZWdpb246MWFhNjc5YjA3YjY5NDc1Mjk5NmJkOWFmYTViMmNmYmVfMTgwNQ_b12c2c3f-c490-4a3f-98af-9bab4dd15c84">See summary below detailing the carrying amounts and estimated fair values of these instruments at December&#160;31, 2020 and March&#160;31, 2020. &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia7ebb997344d403486b3f9420c112504_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi0yLTEtMS0w_46280cc6-5ad5-401a-b3b3-4da4c7b3281b"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0552db00f3c641ff80440074b49f730b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi00LTEtMS0w_e44a4c86-c22d-4f64-8d7b-e8addb809b2a"
      unitRef="usd">613500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0bd599e3926042aa8b5dbaf89e6bd1cf_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi02LTEtMS0w_9916feb2-fe00-4aa7-ab1c-80e830277682"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ice64251d737d426195b9e1a793e60792_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfMi04LTEtMS0w_d559c8dc-1b9a-4876-b7d1-d9c43e63ea09"
      unitRef="usd">603000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib1f1631ffca449e3b2162aa6eb96cc1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC0yLTEtMS0w_57cce11f-abcf-49ef-8974-232ec45f4c87"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5032d30a5899473b981a782119c9d2ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC00LTEtMS0w_bc358c8c-ee65-4226-92b4-dbc0d10d96b1"
      unitRef="usd">421000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="if06e52662eda44a78e9e8f9e560ad93f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC02LTEtMS0w_5eaee4ee-e29b-42c9-a53a-5965692a1af6"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i06feca35d8b343e0a416ad3c87b1d890_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNC04LTEtMS0w_4bb8cf2b-b338-4b61-bdb5-737dc7384ad4"
      unitRef="usd">386000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i95cbb5a18397486680722f549c6889b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS0yLTEtMS0w_077878d7-c747-4136-8ef0-2e6ae54599ae"
      unitRef="usd">560000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i253eee16ff674e2a93a5287e7684fe79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS00LTEtMS0w_2d3ba699-2a25-4305-9595-e8f3db38898f"
      unitRef="usd">560700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i2d826a5505c6474db66c7f96cda89129_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS02LTEtMS0w_dd9ddab3-acf8-4eaf-b503-ca72a19c6301"
      unitRef="usd">690000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i7947344d11f749088f4c537fcf966dc3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNS04LTEtMS0w_662912e2-8b92-4aec-a996-646635e67e1c"
      unitRef="usd">638250000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="ibe6c5d8a5f604fcea4fcd52e68353712_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi0yLTEtMS0w_8a304e00-9c2f-4fc5-91b3-285853af287f"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i221c06058a05456781dfa7d93133ca01_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi00LTEtMS0w_7c4b979d-4d1c-499b-9475-80a7d56574be"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i362a9c07939d4608b90d4ad15e3b6f16_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi02LTEtMS0w_5a5a6cbb-5199-4dc4-9892-11312447a65c"
      unitRef="usd">55000000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="if24c56ca1f7f41289fa51152754d0628_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNi04LTEtMS0w_f6af3b0b-d239-41b2-bae1-2a63c755a0b3"
      unitRef="usd">55000000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ib12d98be53e544b7bec5cb41aded6489_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy0yLTEtMS0w_4b89a149-532f-44ea-906d-21bf1cde6d99"
      unitRef="usd">3269000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="icae35f6c71da48feb7c77cf3d5184356_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy00LTEtMS0w_f2b98984-902e-48f2-be9f-8a7440b9137f"
      unitRef="usd">3269000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i6e3326065cf04377b74b6fbe21644c1a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy02LTEtMS0w_0e65c318-916b-4b52-81b9-67327c34efd5"
      unitRef="usd">6317000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ifd335d49025d49c487e470de1e7c354f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81NS9mcmFnOjFhYTY3OWIwN2I2OTQ3NTI5OTZiZDlhZmE1YjJjZmJlL3RhYmxlOjRjMWM5Njc2NDFmMzQ2NzJiODAxOGZjMTFlZTcyZmM2L3RhYmxlcmFuZ2U6NGMxYzk2NzY0MWYzNDY3MmI4MDE4ZmMxMWVlNzJmYzZfNy04LTEtMS0w_d166e6dd-c7ff-4186-b6a9-c479d9456544"
      unitRef="usd">6317000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1OA_2445ac6d-26b1-47d4-9841-cbb0f92e299f">Derivative Instruments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into two interest rate swaps to hedge a total of $400.0 million of our variable interest debt.  The fair value of these interest rate swaps is reflected in our Consolidated Balance Sheets in other accrued liabilities and other long-term liabilities.  We do not use derivatives for trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the fair values of our derivative instruments as of the end of the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain Recognized in Other Comprehensive Loss (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss Recognized as Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect pre-tax losses of $3.0 million associated with interest rate swaps, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next twelve months.  The amount ultimately realized, however, will differ as interest rates change and the underlying contracts settle.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk:&lt;/span&gt;&lt;/div&gt;Interest rate swaps expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i92532672091247fb97202d4dd7b0cdcd_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTQy_24f45fef-2410-4c8c-ae43-9eb31c17ad3a"
      unitRef="agreement">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b2d78644d694801a7c8a37b269dd418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTg1_9b958425-5b51-4b2f-ba8f-3d53c01cd59a"
      unitRef="usd">400000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1Ng_4a4ee480-ef87-4976-ac41-c9c2ad062063">The following tables summarize the fair values of our derivative instruments as of the end of the periods shown:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMi02LTEtMS0w_9b501edb-baca-4be9-a807-abb4f2342c42"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i80c1300a1c4f4cad9a29affc4c223aff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMi04LTEtMS0w_d85a50c4-977d-405c-bdc2-72b16ce5a11d"
      unitRef="usd">224000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id0ea53ed9d43427ba9d14f65f8ec8329_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMy02LTEtMS0w_97ab4504-9b95-402f-be56-be60537fa25e"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3ded30b7f28349f78fd6ee06e33334cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfMy0xMC0xLTEtMA_d42a5e43-7cb2-4192-ba50-f1209b3ebb5c"
      unitRef="usd">3045000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i80c1300a1c4f4cad9a29affc4c223aff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfNC04LTEtMS0w_8e292899-5f29-4b2e-ac73-96246839ac39"
      unitRef="usd">224000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3ded30b7f28349f78fd6ee06e33334cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjI3NDU1OGRlMDFmODQxZTg4MjlhMDEyZWM4OWYxNmFmL3RhYmxlcmFuZ2U6Mjc0NTU4ZGUwMWY4NDFlODgyOWEwMTJlYzg5ZjE2YWZfNC0xMC0xLTEtMA_8575300f-01d1-4377-8d3f-253984d0c66b"
      unitRef="usd">3045000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad3a6736b7e4455c835f368bcb184e94_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMi02LTEtMS0w_664df494-5c28-4a5f-8f73-d915a526b9e7"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i669fc4f1f78246bb8b0554fa4c73e813_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMi04LTEtMS0w_48d9d9f0-a6c0-4790-a33c-bf6344b319de"
      unitRef="usd">1905000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad3a6736b7e4455c835f368bcb184e94_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMy02LTEtMS0w_dcfcffff-4e56-4c97-9ea2-95c1d02b17ee"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfMy0xMC0xLTEtMA_181aad10-f980-4137-9e24-9698813c2789"
      unitRef="usd">4412000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i669fc4f1f78246bb8b0554fa4c73e813_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfNC04LTEtMS0w_fa9b6a7c-ae22-4f0f-8496-e815840cf095"
      unitRef="usd">1905000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibc033d16ea6f4336a0fe22d6896ec9e7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOmJmZjczZmNiYTZiNzRlNThiZjNmMjU3MDkwMjU2ZGI5L3RhYmxlcmFuZ2U6YmZmNzNmY2JhNmI3NGU1OGJmM2YyNTcwOTAyNTZkYjlfNC0xMC0xLTEtMA_5bf0c64b-6bc3-4c8b-8a98-02094d36241a"
      unitRef="usd">4412000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfMTI1Nw_d1e73e70-974c-4d9e-bd3f-944265cff4b1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain Recognized in Other Comprehensive Loss (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss Recognized as Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ie4fd7098c3ad41be8df870dde9d83eee_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi00LTEtMS0w_06c5a429-0341-485a-8a47-724de3eb0770"
      unitRef="usd">1053000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i254eb380c9514d3b9a242c7b4084efd0_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi02LTEtMS0w_ff5d421d-71bc-4dd4-b347-c2bc52b329b8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ib2ce8e70024f47edbefd0232eb83236a_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi04LTEtMS0w_faf88b36-bcab-415d-8bfe-f96c60b729f7"
      unitRef="usd">2347000</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i4fd07a49514b46baa2e379f44d08a7e5_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMi0xMC0xLTEtMA_a15a667d-a799-4710-8c69-384e7ce114a3"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy00LTEtMS0w_6d593065-55f3-4de2-9fd4-c7a34d730910"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy02LTEtMS0w_5e53f69f-653c-4e6e-a4f1-000c24867fac"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy04LTEtMS0w_9c753326-d45c-4b64-914c-911d97499179"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i84aca9e12e964a7cb990719431110348_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfMy0xMC0xLTEtMA_d408d570-38f3-4bc5-9615-4204696083cf"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeLossOnDerivative
      contextRef="i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC00LTEtMS0w_87b3a000-a91d-4d65-ac94-826678e68678"
      unitRef="usd">1415000</us-gaap:DerivativeLossOnDerivative>
    <us-gaap:DerivativeLossOnDerivative
      contextRef="i06e4aa86843546668b9fd4c1f008b1ea_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC02LTEtMS0w_ff76a56f-de2e-48e0-ada9-a707789a764a"
      unitRef="usd">0</us-gaap:DerivativeLossOnDerivative>
    <us-gaap:DerivativeLossOnDerivative
      contextRef="ie5413ae7ce4044e3b4d9b95a40dbe382_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC04LTEtMS0w_9df4343e-b3f5-46f6-a55b-ee4a5643c190"
      unitRef="usd">3837000</us-gaap:DerivativeLossOnDerivative>
    <us-gaap:DerivativeLossOnDerivative
      contextRef="i84aca9e12e964a7cb990719431110348_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RhYmxlOjJhNTMxZWVjZmM4NjRlNGNhOTA4ZjIyOGI0NjFkNmY1L3RhYmxlcmFuZ2U6MmE1MzFlZWNmYzg2NGU0Y2E5MDhmMjI4YjQ2MWQ2ZjVfNC0xMC0xLTEtMA_32188061-dd94-4940-92d1-5f49fe747cce"
      unitRef="usd">0</us-gaap:DerivativeLossOnDerivative>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ifdae78c641ce4019acb0ab445a097687_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF81OC9mcmFnOjBmMGNmYThkNTVmYjRmMDQ4NjY5ZTVlZjczMzFjMWE3L3RleHRyZWdpb246MGYwY2ZhOGQ1NWZiNGYwNDg2NjllNWVmNzMzMWMxYTdfNjY3_7ee32bf6-c994-40a3-8e32-eb4e878679e4"
      unitRef="usd">-3000000.0</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfOTQ5_ca987f35-d31e-4c9d-bd70-46d39701ee40">Stockholders' Equity&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on our common stock through December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2020 and 2019, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$37.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$31.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.1 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.0 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$30.80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.0 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfNTg_24bdb0f2-4070-4e32-becc-5fcdd59228ad"
      unitRef="shares">250000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfODU_0fdb818f-91a8-4ce3-97e7-411057c121c2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMTEz_18bd91ab-1682-4b06-a775-4543042b591f"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMTQz_a365f342-6342-43a3-a0d4-8b61185626dd"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <pbh:VotingRightsNumberOfVotesPerCommonShareOwned
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfMzgy_3e679b19-09e7-46a9-83ef-43cdec24fae2"
      unitRef="vote">1</pbh:VotingRightsNumberOfVotesPerCommonShareOwned>
    <us-gaap:DividendsCommonStock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfNzA0_7a93d6c5-c0e8-48a5-8e65-fb93d193f0a9"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RleHRyZWdpb246NmYzNzhhNWQ5ZGQxNDM4ODg5OWEwYTM3NzE3NjdmNGVfOTQ3_604a50a2-b176-4018-82e7-e3364ecac8fd">Our share repurchases consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.676%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$37.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$31.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.1 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.0 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$30.80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.0 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy0xLTEtMS0w_d108ae7b-adb5-4a26-a8dd-0e68e7e9bd37"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy0zLTEtMS0w_85478dc0-8b22-4c5a-aaaa-76e547920c0e"
      unitRef="shares">2481</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy01LTEtMS0w_89fedb25-96da-4bf6-b491-62eded01b7df"
      unitRef="shares">31117</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMy03LTEtMS0w_5092001b-5168-4985-b565-a27afde67f7b"
      unitRef="shares">31018</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC0xLTEtMS0w_b48b4554-7968-45b8-bbe2-ee30df64eca6"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC0zLTEtMS0w_41939025-4c6c-47cf-9b7e-c1c6b41b5255"
      unitRef="usdPerShare">37.95</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC01LTEtMS0w_93a36256-8929-46a6-abb8-36fe7a81d2ea"
      unitRef="usdPerShare">39.91</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNC03LTEtMS0w_a7bfb224-e09d-45e0-8e19-4ae93f2f17ab"
      unitRef="usdPerShare">31.39</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0489d5c8d6344cd8ae46a0c8b947dc98_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS0xLTEtMS0w_5b1dad6e-454f-4539-880b-5ce2e2e5a6d0"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i39df23d267604e6189a005f399da0bd9_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS0zLTEtMS0w_4d2616f8-2033-4f7d-9ff7-15a5231482fb"
      unitRef="usd">100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i242bdd6173d64a318c041525df6090be_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS01LTEtMS0w_344bbb21-75e5-4c1d-a503-1876aecc191c"
      unitRef="usd">1200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i277a7eb328e341168b7d83ef1863e765_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfNS03LTEtMS0w_237966a7-f670-4244-95ff-407a9137011e"
      unitRef="usd">1000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC0xLTEtMS0w_e312492a-acdf-4158-97cf-c2671ddfd3c8"
      unitRef="shares">253771</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC0zLTEtMS0w_c91c9db9-636d-478b-903c-b0743ffa40b1"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC01LTEtMS0w_2e87b36e-3849-43e2-8f81-efa34f626d4b"
      unitRef="shares">282636</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOC03LTEtMS0w_e7813353-fccb-42e7-8e19-67ae6b9c9055"
      unitRef="shares">1622544</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS0xLTEtMS0w_f4b8772e-13da-4442-946c-0c41a4ae09d3"
      unitRef="usdPerShare">34.98</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS0zLTEtMS0w_e03b45c1-5c6f-4ed0-bd50-eabf4adf60b3"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS01LTEtMS0w_0a62def1-c891-425a-aff3-5038d75cf9d6"
      unitRef="usdPerShare">34.93</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfOS03LTEtMS0w_71a8fb20-7495-4e4f-91e5-426b643a5ee3"
      unitRef="usdPerShare">30.80</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6a1431127e184ca5b894517035890a0d_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtMS0xLTEtMA_baf038e2-60fe-431b-a08f-5b3662c5c33e"
      unitRef="usd">8900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i107ebc65eb014fef8718a75080f062c8_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtMy0xLTEtMA_720e8d36-0558-4bcf-9941-29244009910b"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0353c6486d2d4572842f7ee102e65e4d_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtNS0xLTEtMA_f8dea5ee-7d33-4f7a-b0d3-ffbacdbd6b1d"
      unitRef="usd">9900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i54c9187a5f2e42518f08ec04e51cc67f_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82MS9mcmFnOjZmMzc4YTVkOWRkMTQzODg4OTlhMGEzNzcxNzY3ZjRlL3RhYmxlOjM1ZGExYjkzN2NkNjRkMmZhMzM4Y2VlOGVhZGYwMWY4L3RhYmxlcmFuZ2U6MzVkYTFiOTM3Y2Q2NGQyZmEzMzhjZWU4ZWFkZjAxZjhfMTAtNy0xLTEtMA_cd8c472d-a902-41fa-ac25-f5f967dccc85"
      unitRef="usd">50000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMjQ1_ee5cd1b8-172f-4e3d-89d1-5ca5da75638f">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consisted of the following at December&#160;31, 2020 and March&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of December&#160;31, 2020 and March&#160;31, 2020, no amounts were reclassified from accumulated other comprehensive loss into earnings.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMjMz_a97493d8-242a-4b43-92d9-e95b5381b10e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consisted of the following at December&#160;31, 2020 and March&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i89df545b4177486fb38f4b91b5bfbd05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMi0xLTEtMS0w_4e91779f-160d-4d48-9aa3-940069e2ac1d"
      unitRef="usd">-16802000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1cf4c1b6e7914984877022bbf9681434_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMi0zLTEtMS0w_bd1214f6-56d0-4fde-81cc-9120d3381cfd"
      unitRef="usd">-39241000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i88373d93eefe43dfaf99307d1663985c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0wLTEtMS0wL3RleHRyZWdpb246M2JhMmRlZDdjZDYzNGRiMmIwMzE5M2RkZjc5ZWIwYWJfNTg_85c8d232-0222-4b76-9b61-841dd566e8f0"
      unitRef="usd">752000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ib640d457ba2b4aacae15563b70a4f618_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0wLTEtMS0wL3RleHRyZWdpb246M2JhMmRlZDdjZDYzNGRiMmIwMzE5M2RkZjc5ZWIwYWJfNjU_e0604998-2c24-4504-bba0-b4e3ea837bfd"
      unitRef="usd">1453000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:StockholdersEquity
      contextRef="i23ceed395390459d9e3572680ae73075_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0xLTEtMS0w_93e89c83-d874-46b0-b666-413c337b47b2"
      unitRef="usd">-2517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab7ab2765fd5461eb0fcfe3149ec29af_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfMy0zLTEtMS0w_7e80cf48-aea9-4e75-b4e1-4b9ef2d13cc5"
      unitRef="usd">-4864000</us-gaap:StockholdersEquity>
    <pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit
      contextRef="i5a87d78fa10e452580fd3a8922dd6800_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0wLTEtMS0wL3RleHRyZWdpb246Zjc2ZTE4ZGRlNjQ4NGE0Nzg4ZGRiYjdkYmVjOTM5NTFfNTg_598156ce-4e0d-44ed-a18b-45042b3bcebd"
      unitRef="usd">-624000</pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit>
    <pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit
      contextRef="i30fb3c6cba044feb86d6e4d785c34a76_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0wLTEtMS0wL3RleHRyZWdpb246Zjc2ZTE4ZGRlNjQ4NGE0Nzg4ZGRiYjdkYmVjOTM5NTFfNjU_6f69983a-85c0-4fd4-9f8c-a7c7621030f9"
      unitRef="usd">17000</pbh:AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit>
    <us-gaap:StockholdersEquity
      contextRef="i5a87d78fa10e452580fd3a8922dd6800_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0xLTEtMS0w_14bb864d-3250-4d54-8d49-2ecdbde1dc1a"
      unitRef="usd">2088000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30fb3c6cba044feb86d6e4d785c34a76_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNC0zLTEtMS0w_4dcbfa7a-84db-4b6d-98bf-2d8d5dd98b36"
      unitRef="usd">-56000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id285b7d072c846c49d7bfc6c90dbb60c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNS0xLTEtMS0w_70130110-0259-401e-a9e5-1b809777ab47"
      unitRef="usd">-17231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie98e17addbc24768a91973f19003abe5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RhYmxlOjZiNTJhYzg4ZDZhZjQ2YTA5ZDg4Zjg4N2YzYTllNDE4L3RhYmxlcmFuZ2U6NmI1MmFjODhkNmFmNDZhMDlkODhmODg3ZjNhOWU0MThfNS0zLTEtMS0w_30aa0b11-d795-4779-a943-4d2f90b06b6d"
      unitRef="usd">-44161000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i00213381c2a14b5fb3a527097c5723e7_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMTQ1_3cc331d0-3302-486a-b592-1e449bc5e92e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82NC9mcmFnOjhlYzQ3Y2FlZWIzMzRjMzBhMzdiMzA4MmRmOTY4MzZiL3RleHRyZWdpb246OGVjNDdjYWVlYjMzNGMzMGEzN2IzMDgyZGY5NjgzNmJfMTQ1_4f4b1d41-49f5-4d6b-b7bc-9c72ee356fde"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTU2Mg_96250a44-8ac6-43bb-af4c-b1cdb111614c">Earnings Per Share&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.745%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2014; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;For the three months ended December&#160;31, 2020 and 2019, there were 0.6 million and 0.6 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. For the nine months ended December&#160;31, 2020 and 2019, there were 0.6 million and 0.9 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTU3Mg_c28cbb75-d9ce-4657-85b5-04a87338df07">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.745%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2014; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy0yLTEtMS0w_e51f6eb1-0c36-4356-8500-2a06220ac6e0"
      unitRef="usd">40873000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy00LTEtMS0w_ac50d08a-24e4-4970-8070-a03e38872f93"
      unitRef="usd">38058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy02LTEtMS0w_c8189b52-0a18-44a2-bc1f-555f49583f45"
      unitRef="usd">129168000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMy04LTEtMS0w_3f14bc61-62d9-4675-b834-fa64e47ca2a7"
      unitRef="usd">105235000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi0yLTEtMS0w_eb0caea6-8822-4757-8c84-7a1a5ab4df8b"
      unitRef="shares">50212000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi00LTEtMS0w_2983a4db-5388-48f6-be1b-4f96b86df3cb"
      unitRef="shares">50378000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi02LTEtMS0w_8e0e2b89-9910-44d0-aa39-1bf4e87150be"
      unitRef="shares">50268000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNi04LTEtMS0w_34c008c8-994e-4979-9aaf-8af2570d20d8"
      unitRef="shares">50840000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy0yLTEtMS0w_43419a26-3e3d-46fd-9088-7cdbcc43a143"
      unitRef="shares">349000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy00LTEtMS0w_1d621253-75df-448a-b25d-0962cab74375"
      unitRef="shares">453000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy02LTEtMS0w_1ad42f65-b449-4b61-8d24-f8721e024255"
      unitRef="shares">367000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfNy04LTEtMS0w_94b99fcd-d84c-42db-b447-270f5729c3af"
      unitRef="shares">386000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC0yLTEtMS0w_2ed9497a-ddd9-457b-9de4-4690e700e817"
      unitRef="shares">50561000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC00LTEtMS0w_16c06da9-e44a-4c6a-917b-5746e76babea"
      unitRef="shares">50831000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC02LTEtMS0w_5f9d7aba-1f90-44bd-b51c-0e678ed7af7c"
      unitRef="shares">50635000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfOC04LTEtMS0w_538622ac-a4d9-4852-ae8f-4bca1d36151b"
      unitRef="shares">51226000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtMi0xLTEtMA_0dacb513-51ed-4f19-8589-8d79eea90e8e"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtNC0xLTEtMA_5f89580f-2de9-40a4-90a2-cac6a9ba34d3"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtNi0xLTEtMA_7b3dd48d-f057-4dca-a3eb-64ffa94d629f"
      unitRef="usdPerShare">2.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTEtOC0xLTEtMA_fcd5568e-602f-49b2-a949-7f589a8536e4"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtMi0xLTEtMA_657955e3-934c-4b60-883f-2e9b21b557e7"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtNC0xLTEtMA_4e460804-11e9-4389-9fa2-445148079074"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtNi0xLTEtMA_a35a5389-b5be-4bf8-a5e5-f14b4d028a58"
      unitRef="usdPerShare">2.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RhYmxlOmU4MDc1NTg2ZjcxODQ4ZDg4YWVlYmI0MDU1ZDI2NzliL3RhYmxlcmFuZ2U6ZTgwNzU1ODZmNzE4NDhkODhhZWViYjQwNTVkMjY3OWJfMTMtOC0xLTEtMA_c75ffdca-8d2f-42da-bf2c-4345fd304423"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTExNw_1807a4ea-73be-4e2f-ae35-3f1a2e3724a6"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i594c5314ab0a48398a297ebae00548bc_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTEyNA_68152f16-df01-4b25-9965-f60d7498e9ac"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i51ebd4afe08246cfb5c144ac9fd55615_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTM1NA_d0c65555-e35e-4192-a5be-37a2cf4d22d1"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i63281ab682614b949d3bfa93e92d8a4d_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF82Ny9mcmFnOjA2ZDZhMjEyNDhiZDRmODA4NjRjNzNjODczODgyYjliL3RleHRyZWdpb246MDZkNmEyMTI0OGJkNGY4MDg2NGM3M2M4NzM4ODJiOWJfMTM2MQ_4d8344fd-6aee-4567-8820-3f52cc9a09ab"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzc5OQ_5096c9dc-9e63-4d37-b9bd-13a86bfe69ee">Share-Based Compensation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#x201c;2005 Plan&#x201d;), which provided for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and an extension of the term of the 2005 Plan by ten years, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#x201c;2020 Plan&#x201d;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  A total of 2,827,210 shares are available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;At December&#160;31, 2020, there were $7.9 million of unrecognized compensation costs related to unvested share-based compensation arrangements under the 2005 Plan, based on management's estimate of the shares that will ultimately vest.&#160;&#160;We expect to recognize such costs over a weighted average period of 1 year.  At December&#160;31, 2020, there were 2.8 million shares available for issuance under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;On May 4, 2020, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 79,070 performance stock units, 73,636 RSUs and stock options to acquire 249,875 shares of our common stock under the 2005 Plan to certain executive officers and employees.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the three-year anniversary of the date of grant.  In light of the uncertain economic environment, the Committee elected to set the performance objectives applicable to these awards at a later date.  The stock options were granted at an exercise price of $39.98 per share, which was equal to the closing price for our common stock on the date of the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;A newly appointed independent member of the Board of Directors received a grant under the 2005 Plan of 907 RSUs on May 4, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;On August 4, 2020, each of the independent members of the Board of Directors received a grant of 3,732 RSUs under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of one share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1% - 32.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9% - 31.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3% to 2.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options exercised during the nine months ended December&#160;31, 2020 was $1.3 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i03dbfb445d744e408d4f455fbf1b0147_I20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjIy_198fa282-a897-4ea6-8402-42a15584498b"
      unitRef="shares">5000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i4e33b766bd5b4b77b3a15f8f572127a5_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNDI2_2e7cca29-b3fa-434c-8e1d-2c72837f9cc8"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNjYz_585d9ea8-0017-4069-bd25-0b314734f354"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfNjY5_610876b0-53ce-4a38-90a5-ae4147fc86f7"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod
      contextRef="i765ee962a20a43e586b805211dfff3fc_D20140601-20140630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgyNA_4b49a33a-8907-48c7-b3ff-c7ab7d58647d">P10Y</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTE5Mg_f734343e-09e9-42fc-a5a8-9a6b456ea65b"
      unitRef="shares">2827210</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares
      contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTI2Mw_862f6d08-a848-493f-bdaf-70347d1c6842"
      unitRef="shares">2000000</pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares
      contextRef="id3ea26f332a940caa0e1a0c9c84992cb_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTI4Mg_bb553753-c952-4786-9c37-fccfe5d54a33"
      unitRef="shares">827210</pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxNQ_b83207c4-49a5-42e8-ba89-6540dfaa92bd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi0yLTEtMS0w_5bfc062a-859a-45af-8a3b-d5fa5c6b9eaa"
      unitRef="usd">1588000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi00LTEtMS0w_bb99346d-93d7-45eb-840c-5b42ee308fdf"
      unitRef="usd">1780000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi02LTEtMS0w_e2df4660-c3d5-4587-83db-79f6b265a599"
      unitRef="usd">5944000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMi04LTEtMS0w_61107233-75c9-49dc-bf83-86da2f95d31e"
      unitRef="usd">5682000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy0yLTEtMS0w_7d50edad-f685-426c-bb07-63c6978aa5a3"
      unitRef="usd">263000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy00LTEtMS0w_fadab530-57b4-4094-8dcc-a89fe5807390"
      unitRef="usd">275000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy02LTEtMS0w_792acf6f-c348-4b55-b325-21431829ca89"
      unitRef="usd">826000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfMy04LTEtMS0w_feed3fd4-0103-47a2-a40e-b898c4ce2df7"
      unitRef="usd">886000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC0yLTEtMS0w_8d98af72-e558-49ad-b1e7-d5d30c9d9b7d"
      unitRef="usd">0</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC00LTEtMS0w_e11599e5-589c-43fb-a076-fe1ed0cc6b0b"
      unitRef="usd">465000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC02LTEtMS0w_490e6ff4-54d8-4180-861f-b49dab544f09"
      unitRef="usd">6796000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNC04LTEtMS0w_4ad57550-9eeb-441a-a905-e473820a0021"
      unitRef="usd">7830000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS0yLTEtMS0w_58b6b32a-2897-4a0a-a5df-d68fcd1422c7"
      unitRef="usd">39000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS00LTEtMS0w_32387264-3cdf-49ef-b412-4c2487f44997"
      unitRef="usd">463000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS02LTEtMS0w_1271c018-7522-4ffd-a86a-67f9849dc567"
      unitRef="usd">1324000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNS04LTEtMS0w_0f1b8588-4c34-4582-9467-70442195709e"
      unitRef="usd">1007000</us-gaap:ProceedsFromStockOptionsExercised>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi0yLTEtMS0w_744b8a14-5c5c-4a34-9c0f-b105eea12b3c"
      unitRef="usd">15000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi00LTEtMS0w_2182428a-04fa-431b-8c74-19f0d96b37a5"
      unitRef="usd">105000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi02LTEtMS0w_e282aa6e-71c6-443c-8957-7552a828316d"
      unitRef="usd">963000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmI3MjkxMmYxNDIxMTQ1MTNhN2I5MWNjZTk2ZDlhNjRiL3RhYmxlcmFuZ2U6YjcyOTEyZjE0MjExNDUxM2E3YjkxY2NlOTZkOWE2NGJfNi04LTEtMS0w_88995d09-f3d3-4de3-8c14-dd679c53ab7e"
      unitRef="usd">587000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTU2OQ_0f661144-f0e7-4c7a-9e43-498f8640b933"
      unitRef="usd">7900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTgyNw_bad31f71-ff6c-4bea-a4b7-4d08ee302e90">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMTg1NQ_95b7999d-09c3-433d-9be3-e4481a2a33ac"
      unitRef="shares">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2b1a9cb50b5b44418cfc024476a41782_D20200504-20200504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjAyNw_ebe2730c-e08f-4249-8cee-b3a76e9d2a46"
      unitRef="shares">79070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id1cdfb4a0aef433a8562a57ce988186a_D20200504-20200504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjA1NQ_b12b7186-e72c-4072-8c72-d03d56b60fb2"
      unitRef="shares">73636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjA5Mg_9a75059f-729f-4d3d-ad10-32cd35609faa"
      unitRef="shares">249875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="ie88cbe89db744faf9d6b970c15082d9b_D20200504-20200504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjU4NQ_b7732934-202e-4b94-a726-bedc8f4a0f18"
      unitRef="usdPerShare">39.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i573a83e08488462c9f111c2bdfd78f3d_D20200504-20200504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjc4Nw_00bea76b-bd84-4be0-baed-92c2e158a377"
      unitRef="shares">907</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMjkwOA_76d4110a-cc21-4cb1-a9c2-4cf80dd64dbe"
      unitRef="shares">3732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted
      contextRef="i751db3577c8d401985016227cc7d7e3c_D20200804-20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzA0Mg_6e698ee5-dc69-4c83-976b-0be4701a2124"
      unitRef="shares">1</pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxMQ_32d467b7-bda7-4c20-8795-fffb11aaa1a0">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i44304ca391ad4b1694746195e1122111_I20190331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMi0yLTEtMS0w_b25cad58-5d80-406c-ae90-fd070ca78529"
      unitRef="shares">413000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i44304ca391ad4b1694746195e1122111_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMi00LTEtMS0w_cdf057f6-e91d-44c8-9f16-f029723137e7"
      unitRef="usdPerShare">36.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMy0yLTEtMS0w_96e4e71e-7100-4508-8889-5cf1486e7fd6"
      unitRef="shares">220300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMy00LTEtMS0w_0b08d74b-b790-43d4-a70f-72ef031047ac"
      unitRef="usdPerShare">31.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNC0yLTEtMS0w_ddb4ba6a-ae4a-4b76-9a3d-4999af02b37d"
      unitRef="shares">73000.0</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNC00LTEtMS0w_b2e90768-5aec-43de-a90a-71f3e7984d42"
      unitRef="usdPerShare">47.68</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNS0yLTEtMS0w_6fdd854a-6c69-4615-8f52-78939a7448db"
      unitRef="shares">34200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id062323b9871449988cd3af690123a42_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNS00LTEtMS0w_1910ecd8-588a-4995-96b0-35dfa707e61a"
      unitRef="usdPerShare">35.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNi0yLTEtMS0w_704866fc-5818-439f-9b3e-b90d2120eb8e"
      unitRef="shares">526100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNi00LTEtMS0w_4b904264-8ce6-4576-95b6-2feaeab0be41"
      unitRef="usdPerShare">32.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNy0yLTEtMS0w_d6b2c9cf-0df2-4598-9da4-68b69edd6c65"
      unitRef="shares">138300</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i57c40fb8e1f0479081115a63e83ad551_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfNy00LTEtMS0w_4d309738-0e2c-46f9-8e91-a4184e35c5fc"
      unitRef="usdPerShare">31.71</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTAtMi0xLTEtMA_c3b8f817-6f47-41aa-9807-c7145b9d4c17"
      unitRef="shares">512100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTAtNC0xLTEtMA_c9eb36b1-9f5e-4469-98ea-57981df787db"
      unitRef="usdPerShare">32.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTEtMi0xLTEtMA_f9426256-218d-41dd-a251-4544247245b6"
      unitRef="shares">179700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTEtNC0xLTEtMA_4de354ad-0fa4-486e-a6e4-dfb05d84b8cb"
      unitRef="usdPerShare">39.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTItMi0xLTEtMA_bc6d6ae6-9592-40f6-b3f6-836487ca66a4"
      unitRef="shares">74000.0</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTItNC0xLTEtMA_b839f904-67a4-4892-b89a-b9f551257cff"
      unitRef="usdPerShare">44.38</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTMtMi0xLTEtMA_f73f77ce-22c0-4d9e-9be5-4b81f3d24639"
      unitRef="shares">4700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i770480d146f24bf1ba4306fe2cd407c0_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTMtNC0xLTEtMA_780a408e-0367-47e6-a10f-d4a6a7157195"
      unitRef="usdPerShare">56.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTQtMi0xLTEtMA_7e9e79d3-626a-4d73-9109-bfbbd9263898"
      unitRef="shares">613100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTQtNC0xLTEtMA_0cb472a5-ce9f-4d2a-9253-69fe27ed724a"
      unitRef="usdPerShare">33.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTUtMi0xLTEtMA_5db8013d-406e-4a37-b7e0-d26eea81387b"
      unitRef="shares">150400</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i09345f1e737c46baa82ce81fda75550b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjllOGQwNTc1ZDkxMDQxZGY4ODMzYTIxMzc3ZGYzZGJiL3RhYmxlcmFuZ2U6OWU4ZDA1NzVkOTEwNDFkZjg4MzNhMjEzNzdkZjNkYmJfMTUtNC0xLTEtMA_94bf5882-dece-44dd-8fbf-ad9d7473adea"
      unitRef="usdPerShare">31.98</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgxOQ_9477aba6-7198-4213-8f60-512fce5de997">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1% - 32.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9% - 31.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3% to 2.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi0yLTEtMS0wL3RleHRyZWdpb246ZmM5NmE0OGUzODZjNGE4Y2I5YjRlYTEzYTJhY2I5NWFfNA_95261334-6110-429e-905f-fab0f72fd833"
      unitRef="number">0.321</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi0yLTEtMS0wL3RleHRyZWdpb246ZmM5NmE0OGUzODZjNGE4Y2I5YjRlYTEzYTJhY2I5NWFfOQ_99d4a950-732a-4981-bf2f-a85256c092c7"
      unitRef="number">0.322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi00LTEtMS0wL3RleHRyZWdpb246MjdkMDM5Yzk5NTk4NGQxZGFlY2Y0Y2Q1NGRhZTFkMjNfNA_8262d987-dc3c-4ece-891d-1bb5a3e82aae"
      unitRef="number">0.309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMi00LTEtMS0wL3RleHRyZWdpb246MjdkMDM5Yzk5NTk4NGQxZGFlY2Y0Y2Q1NGRhZTFkMjNfOQ_32769f49-b6eb-484e-86a6-4522fcd700b6"
      unitRef="number">0.313</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMy0yLTEtMS0w_dfffbf39-c60c-4f5a-ac14-43894fad2c6d"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfMy00LTEtMS0w_1650eec5-a378-40fe-b4cb-9e9e5efa673d"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib688fc39ffcd4179b3b6e56f3a2e10fa_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC0yLTEtMS0wL3RleHRyZWdpb246NmMxNTdkNTYxZDg4NDFlNmJkYjUxZjA5MDkyOTIxNWFfNA_be89d4b2-4f4b-42d2-8591-81527377b73b">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifb5e33dfa4d04975a6b257ec3eb1993f_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC0yLTEtMS0wL3RleHRyZWdpb246NmMxNTdkNTYxZDg4NDFlNmJkYjUxZjA5MDkyOTIxNWFfMTA_45d070db-9eb4-40ff-8cd8-f63a75d960c5">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC00LTEtMS0wL3RleHRyZWdpb246NzU5YTc4NGYzZWI1NGJmMjkxNjBjZDFlNjc4MjNhOTZfNA_6e578fc6-98f0-4de5-8e77-e0156142f88d">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNC00LTEtMS0wL3RleHRyZWdpb246NzU5YTc4NGYzZWI1NGJmMjkxNjBjZDFlNjc4MjNhOTZfMTA_f99545a9-4620-47df-b6e9-168252e680ed">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS0yLTEtMS0w_9dffbb6f-7e95-48cb-bd15-68cbda5c848c"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i111576903d334ab19507e6dfd663dcc6_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS00LTEtMS0wL3RleHRyZWdpb246MjgyNDZlMTIyN2VmNDUwZGFmNjE5Y2ZjYWE1NzIzYzBfNA_ebfcced2-ab3f-46b3-895c-e106a90d0d08"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia66758430ea5414295722b35bcfcbae0_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNS00LTEtMS0wL3RleHRyZWdpb246MjgyNDZlMTIyN2VmNDUwZGFmNjE5Y2ZjYWE1NzIzYzBfMTA_57a45b98-a19c-47e4-ad43-da6c7086c231"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNi0yLTEtMS0w_cc4b9d9b-c017-4a62-972c-637099ec2601"
      unitRef="usdPerShare">12.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b891a682ff14ff098cc43ce39a7739d_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOmQxYTA5MDMyYzI2NjRiNTZhYmU3ZDUwZGIwZDBhYWE1L3RhYmxlcmFuZ2U6ZDFhMDkwMzJjMjY2NGI1NmFiZTdkNTBkYjBkMGFhYTVfNi00LTEtMS0w_ee89d3d9-3ca3-4403-b3ed-3ed531a3c389"
      unitRef="usdPerShare">10.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzgwNw_c0feb86e-d552-46df-b2e9-ca0ce7221b79">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1ec6216b1c544040948237d6bac14880_I20190331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMi0yLTEtMS0w_1d658d55-e9fc-49a2-bf74-fada25483eae"
      unitRef="shares">944600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1ec6216b1c544040948237d6bac14880_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMi00LTEtMS0w_1f9dc09e-ac83-448c-a9e7-ca2430865a2b"
      unitRef="usdPerShare">38.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMy0yLTEtMS0w_f14271d7-2015-49f3-ba55-a979a6cd854c"
      unitRef="shares">302700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMy00LTEtMS0w_0eea02a5-f30f-4501-ade0-7733806ab5ab"
      unitRef="usdPerShare">30.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNC0yLTEtMS0w_167f6149-5f60-4e6f-9f67-90eba81e351c"
      unitRef="shares">36000.0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNC00LTEtMS0w_d48042ab-14eb-4a49-93d6-aa2a6c38c449"
      unitRef="usdPerShare">27.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNS0yLTEtMS0w_bd0bbe45-59b4-4a2e-919a-e30aed1575af"
      unitRef="shares">155300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNS00LTEtMS0w_c42f3a67-56ac-4d24-970d-51b42733744c"
      unitRef="usdPerShare">41.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi0yLTEtMS0w_bf1593da-aa98-498c-9de7-6570359c10b9"
      unitRef="shares">1056000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi00LTEtMS0w_7ba03708-441e-4801-b48f-c281d8e45ba1"
      unitRef="usdPerShare">36.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi02LTEtMS0w_74edb6ec-bb83-4744-8bcc-c8cb9de5591d">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNi04LTEtMS0w_7f058ac5-b7c0-4aa4-ab7e-9927d09fbe3f"
      unitRef="usd">9035000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy0yLTEtMS0w_e7faa11a-6e1c-4937-9397-680fc97804ba"
      unitRef="shares">602000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy00LTEtMS0w_de444328-98df-46f8-97b2-91e5a0d8cbee"
      unitRef="usdPerShare">38.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy02LTEtMS0w_d70eeb89-80c9-45c3-b06c-f64f4192f6be">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfNy04LTEtMS0w_3ae9c10e-82de-4091-87bf-c3289df9d4e5"
      unitRef="usd">4756000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTAtMi0xLTEtMA_0c4b88c3-76f3-4e22-ace4-a36dcef0e654"
      unitRef="shares">1020200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTAtNC0xLTEtMA_d4e73236-8624-46b7-ae03-eff236ef41fa"
      unitRef="usdPerShare">35.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTEtMi0xLTEtMA_9895795d-3c91-4dc9-b04f-3f09d252b6a0"
      unitRef="shares">249900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTEtNC0xLTEtMA_07eb2c48-57f9-49e6-a6cf-9f6f04da12ff"
      unitRef="usdPerShare">39.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTItMi0xLTEtMA_dbe0f3d4-e92f-4c38-9dbf-4fef951d8abe"
      unitRef="shares">65800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTItNC0xLTEtMA_05c3ef28-a629-428a-83dd-b34a26501c38"
      unitRef="usdPerShare">20.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTMtMi0xLTEtMA_7dd638e5-eab2-4db8-92cf-d1e91644ae4c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTMtNC0xLTEtMA_e69ef38b-99c2-4942-821d-a76b0d4825d0"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtMi0xLTEtMA_a49a0f0c-9232-41fb-bc44-c53d1ccef5f3"
      unitRef="shares">1204300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtNC0xLTEtMA_21d92276-1ca8-4a1a-9240-49af0f27acc7"
      unitRef="usdPerShare">37.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtNi0xLTEtMA_b658fe3c-5a02-4459-a8bc-657ccdc27589">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTQtOC0xLTEtMA_dbe12df4-2aea-4c4d-8d8f-9f64df621784"
      unitRef="usd">3987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtMi0xLTEtMA_3e8b9654-5025-46ef-af12-0f8a78740723"
      unitRef="shares">696200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtNC0xLTEtMA_18b32e9b-48a7-410e-a999-103fbc815e4b"
      unitRef="usdPerShare">39.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtNi0xLTEtMA_f9f8c83e-ce55-4d12-ba91-c80a80a7f393">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RhYmxlOjBkMTQzOWJiYTNkYTRhMTdhMzdkMzM4ODNhMGRhMDFlL3RhYmxlcmFuZ2U6MGQxNDM5YmJhM2RhNGExN2EzN2QzMzg4M2EwZGEwMWVfMTUtOC0xLTEtMA_7030aa2a-eb32-45ce-85a4-a0dedb4ad09d"
      unitRef="usd">2786000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83MC9mcmFnOjljYmQ3OTYzOGQ0ZTQ0MGZiMjAzYmUwYTY2YTM0ZGFiL3RleHRyZWdpb246OWNiZDc5NjM4ZDRlNDQwZmIyMDNiZTBhNjZhMzRkYWJfMzc5Mw_f16573da-26de-4d6e-aa10-2a1099b0a2b1"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTM2Mw_830bc6e6-2e2d-41da-99ad-9f69ad12dcff">Income Taxes&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 22, 2017, the Tax Cuts and Jobs Act was signed into law. The Tax Cuts and Jobs Act, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  We calculated the potential impact of these final regulations and accounted for those impacts in the quarterly provision for the period ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were 23.9% and 24.7% for the three months ended December 31, 2020 and 2019, respectively.   The effective tax rates used in the calculation of income taxes were 21.1% and 25.2% for the nine months ended December 31, 2020 and 2019, respectively.  The decrease in the effective tax rate for the nine months ended December 31, 2020 versus the prior year period was primarily due to the final GILTI regulations issued in July 2020, which resulted in the release of the valuation allowance on foreign tax credit carryforwards of $5.1&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfOTUx_c62efbc5-792a-4dc3-88ba-771914e08ae9"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfOTU4_5da28520-f313-4198-9163-8a3e83b4b3f7"
      unitRef="number">0.247</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTA2NQ_9946da02-5f39-41a8-afe8-d72cca249bc3"
      unitRef="number">0.211</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTA3Mg_9f3c9af7-11c9-4309-adc7-2bbf0f6b8957"
      unitRef="number">0.252</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83My9mcmFnOmZhZDA1OGQ3NTFhNzQ3NTZiZjEzZTg0NzU3YjcyZDg1L3RleHRyZWdpb246ZmFkMDU4ZDc1MWE3NDc1NmJmMTNlODQ3NTdiNzJkODVfMTM1NA_e271a789-bf20-41ce-b590-f06d29e9791d"
      unitRef="usd">5100000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfNDEy_a8424568-fc66-4617-b6f0-9e9c26e85a0a">Employee Retirement Plans&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefits consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended December 31, 2020, we contributed $0.3 million to our non-qualified defined benefit plan and $3.0 million to the qualified defined benefit plan.  During the remainder of fiscal 2021, we expect to contribute an additional $0.1 million to our non-qualified plan and make no further contribution to the qualified plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0&#160;million and we recognized a settlement gain of $0.2&#160;million as a result of the payout.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfNDA3_383ecb6f-596e-4021-98e1-6a1a8dcb2a22">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefits consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi0yLTEtMS0w_81542abe-b9ec-48f2-8cf6-51c2b9b68abb"
      unitRef="usd">283000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi00LTEtMS0w_2ad410a7-f9a2-428a-96c7-607934964936"
      unitRef="usd">575000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi02LTEtMS0w_6be04057-a318-4a08-a588-eccf4a66933e"
      unitRef="usd">1333000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMi04LTEtMS0w_911953df-90d8-46d9-a4a8-a9440e7430fe"
      unitRef="usd">1729000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy0yLTEtMS0w_3c3ee25c-a55e-4f0e-93d7-53a8dfb59c69"
      unitRef="usd">653000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy00LTEtMS0w_f2e59640-fbd1-4652-8ac1-5a1ef66bed7a"
      unitRef="usd">722000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy02LTEtMS0w_6f29f321-767d-475b-a8b6-bf6482fd4807"
      unitRef="usd">1947000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfMy04LTEtMS0w_e2cbf759-5ac9-4761-af0e-3f373d2a08df"
      unitRef="usd">2164000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC0yLTEtMS0w_ef640a65-de4b-4067-a2f3-253183349847"
      unitRef="usd">-370000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC00LTEtMS0w_5f97f218-61f4-4963-9e91-0851be5f82d6"
      unitRef="usd">-147000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC02LTEtMS0w_cf5936cf-7fa3-40eb-a1cc-39f8edbbdf47"
      unitRef="usd">-614000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RhYmxlOjIzYWM2YTcwMWM4OTRiMmU4YzE0MmMzYWUxNDE0YWZmL3RhYmxlcmFuZ2U6MjNhYzZhNzAxYzg5NGIyZThjMTQyYzNhZTE0MTRhZmZfNC04LTEtMS0w_11567f9e-7f8f-4cf8-8d75-bb44bf947906"
      unitRef="usd">-435000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia1e9892fc40644c89bbe3123ab2c9d39_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMTQ0_502ba8e7-7b4f-45c4-8a20-65506f4c1d29"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i8b72b1eb3c7c438ca17d1bd5b4bcebab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1NjAwNg_60a84c75-f5b7-40e0-9eda-247156cb872c"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="ice5fa425e6fa455fa7fd4d3c4eb57f48_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMzI4_7774d486-de37-4fca-a531-243f2d4d9059"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1Njc2Ng_9ce59940-3559-4fa6-b921-a948e16de79b"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83Ni9mcmFnOjJkZTQyMGIyOTM0MTRhODZhNjc0MWNkYmEzYjNhODZjL3RleHRyZWdpb246MmRlNDIwYjI5MzQxNGE4NmE2NzQxY2RiYTNiM2E4NmNfMjE5OTAyMzI1Njk1MA_3c84264b-dd70-40c7-871d-5850995fc557"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF83OS9mcmFnOmNkZDAxNTJmZjgxMTQ2Njk4YjkwNTMwOWM1ZjA5NGJmL3RleHRyZWdpb246Y2RkMDE1MmZmODExNDY2OThiOTA1MzA5YzVmMDk0YmZfMTI0NA_c792219c-b97f-4210-ad6c-f229354224d0">Commitments and ContingenciesWe are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzMxMQ_65bb4cb6-78c0-4dca-91f1-99e4b8015991">Concentrations of Risk&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels. During the three and nine months ended December 31, 2020, approximately 43.6% and 45.6%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and nine months ended December 31, 2019, approximately 41.7% and 42.8%, respectively of our gross revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately 20.7% and 21.7%, respectively, of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately 23.2% and 23.4%, respectively, of our gross revenues for the three and nine months ended December 31, 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third party distribution manager or COVID-19 or other public health emergencies could also materially impact our product distribution. Any disruption as a result of third party performance at our distribution center could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  In addition, any serious disruption to our Lynchburg manufacturing facility could materially impair our ability to manufacture many of the products associated with our acquisition of C.B. Fleet Company, Inc. ("Fleet"), which would also limit our ability to provide those products to customers in a timely manner or at a reasonable cost.&#160; We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had relationships with 113 third party manufacturers.&#160;&#160;Of those, we had long-term contracts with 18 manufacturers that produced items that accounted for approximately 68.9% of gross sales for the nine months ended December&#160;31, 2020.  At December&#160;31, 2019, we had relationships with 113 third party manufacturers.&#160;&#160;Of those, we had long-&lt;/span&gt;&lt;/div&gt;term contracts with 17 manufacturers that produced items that accounted for approximately 66.2% of gross sales for the nine months ended December&#160;31, 2019.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c31348066374fe7ba878c4902bff844_D20201001-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjUx_8042cbed-a071-4a2c-b93d-da11d2ccfd40"
      unitRef="number">0.436</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i52df2ac531a04db9891c78e2953258fb_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjU4_0d8c4176-dd61-4507-825e-2e04a54cbbd6"
      unitRef="number">0.456</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i500b594756b84b84a2b9d22008165363_D20191001-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzgz_e5ccd991-d960-4d1a-80ad-b86b63d057d5"
      unitRef="number">0.417</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ieda365d016dc42ae9860c7df30b2f158_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMzkw_9d0f0e17-d387-436f-9da3-fe0fdd47b549"
      unitRef="number">0.428</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6b9ae14e79e641269492a1e0e4ee76c3_D20201001-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNjA2_47c5d41a-175e-42a3-b192-ef9c5d245901"
      unitRef="number">0.207</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i62cb921e0c1343f998a11bcd1f9d95cb_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNjEz_cc27bcc3-62a9-4a75-83f6-d98a11d3b67d"
      unitRef="number">0.217</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f1844d37745467a92c46cb8d2c20da4_D20191001-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNzEy_550f41b5-5363-41c4-990c-e2f67953e866"
      unitRef="number">0.232</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i008c0e348a60478bb9f7213b666b06e6_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfNzE5_afc85d2b-b08e-493e-8ea8-becb1c65732a"
      unitRef="number">0.234</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturers
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjM3Ng_5c190417-edc9-4373-bb0f-a65142d50382"
      unitRef="manufacturer">113</pbh:NumberOfThirdPartyManufacturers>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjQ0OQ_7e109aaf-c1f2-48f1-bd57-5a3f0c58ee41"
      unitRef="manufacturer">18</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie0fce1126f6943279b3f324d4f0a1ec6_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjUxOQ_177fa402-fb8d-48f7-af81-76e225e63caa"
      unitRef="number">0.689</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturers
      contextRef="i8a5377f8b470400fbb8f9121777eccba_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjU4Ng_cb3eb696-11ea-4d20-8368-037a6a6c9fbf"
      unitRef="manufacturer">113</pbh:NumberOfThirdPartyManufacturers>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjY1OQ_ddc14298-f468-4c35-b9be-080df0d5dc10"
      unitRef="manufacturer">17</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2a8030d85f8c41d285049e42fa6f3c5c_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84Mi9mcmFnOjJmZWU0ZWExODc3MTQ1YmFhMDkzNzAzOWMwNmNjMWRkL3RleHRyZWdpb246MmZlZTRlYTE4NzcxNDViYWEwOTM3MDM5YzA2Y2MxZGRfMjcyOQ_c1e665f7-99d7-4786-86bb-89761b931e4b"
      unitRef="number">0.662</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIyOQ_82f53f00-efab-4074-ac23-d5ee227d8ea4">Business Segments &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $2.1 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total segment revenues by geographic area are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,390,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIxMA_4d634f6c-8c86-4f1f-9d93-0b164e08066c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $2.1 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi0xLTEtMS0w_c264f4a3-734a-4858-a282-723c5098ecd3"
      unitRef="usd">210618000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi0zLTEtMS0w_966e1b69-f32f-4c9d-b3c2-5f7b96341e85"
      unitRef="usd">28170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMi03LTEtMS0w_30e2d709-bd2e-4762-9be1-1e66a05d3801"
      unitRef="usd">238788000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy0xLTEtMS0w_e03aadd0-f5f2-4392-b48c-a1363e07225e"
      unitRef="usd">88883000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy0zLTEtMS0w_c5a23866-595d-4b19-92b0-f0c18c5f0345"
      unitRef="usd">11018000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfMy03LTEtMS0w_402e2caf-fb68-4497-b5fd-49c7b54eba7c"
      unitRef="usd">99901000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC0xLTEtMS0w_279a67e5-22ae-4da8-b76b-9e651bf0a5a9"
      unitRef="usd">121735000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC0zLTEtMS0w_19173bda-4164-49d6-9c8c-885699bf5f78"
      unitRef="usd">17152000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNC03LTEtMS0w_b7e5ca2b-9867-4808-bcdc-dfc14dd435f4"
      unitRef="usd">138887000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS0xLTEtMS0w_0aa640ec-cab8-437b-b880-fb1ae77b6e8e"
      unitRef="usd">32859000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS0zLTEtMS0w_2733925e-7fd8-4fe4-8d7f-9e510a994834"
      unitRef="usd">5222000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNS03LTEtMS0w_147c2f57-c9a5-499c-975f-ff53d50462fa"
      unitRef="usd">38081000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="icf64bc02f4fd4154b38bc2ca5f58b937_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi0xLTEtMS0w_91a921f4-5bbc-4382-b165-7d15c5670192"
      unitRef="usd">88876000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i5bcd2de93a9644f9abfb2199bff5e79b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi0zLTEtMS0w_4dd68958-fb21-4b64-abcc-4f186bcd115c"
      unitRef="usd">11930000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNi03LTEtMS0w_a1808f3d-ff25-460f-a963-f6c6b8e221ac"
      unitRef="usd">100806000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfNy03LTEtMS0w_cb70d5f9-ebb6-4e5f-89b9-57d378547961"
      unitRef="usd">27363000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmUzNjhhMGNiMTBiNzRkZGFhY2JhN2Y1MjgwYjY5NjJkL3RhYmxlcmFuZ2U6ZTM2OGEwY2IxMGI3NGRkYWFjYmE3ZjUyODBiNjk2MmRfOC03LTEtMS0w_8d71a8ba-4ef3-4b42-b525-a9889a3d5166"
      unitRef="usd">73443000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6dcd2ebbac947c5b6cee797817560d4_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNTYy_960889f9-6e46-4698-907d-05ee20266a5e"
      unitRef="usd">800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi0xLTEtMS0w_0fad1a22-844d-4618-a369-aeab69ff5cf9"
      unitRef="usd">637851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi0zLTEtMS0w_00e16f04-d0e1-40ae-a796-7f9e2e494b0e"
      unitRef="usd">67753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMi03LTEtMS0w_18368e08-ec39-4a48-987e-c3d9da7804de"
      unitRef="usd">705604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy0xLTEtMS0w_9efe480b-9e81-401a-902c-75d13a99fcfd"
      unitRef="usd">267779000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy0zLTEtMS0w_0f8f7675-897e-406a-b225-9084ed2f1bc4"
      unitRef="usd">27409000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfMy03LTEtMS0w_935085fc-a530-413e-a9d2-de328f314778"
      unitRef="usd">295188000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC0xLTEtMS0w_e349a93e-80f7-47f9-a0ca-edb3ea4128fa"
      unitRef="usd">370072000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC0zLTEtMS0w_3a8c65c0-0c78-46fc-b5c2-30cf80eb1f05"
      unitRef="usd">40344000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNC03LTEtMS0w_a25d4a0d-4d5d-4967-8c23-b393505602e3"
      unitRef="usd">410416000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS0xLTEtMS0w_a51aecf0-57c2-4ca1-89ba-bc99ac414565"
      unitRef="usd">91553000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS0zLTEtMS0w_984b2ab3-85e5-4daa-bcd6-39b4c81f3251"
      unitRef="usd">12619000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNS03LTEtMS0w_1d14faa1-b140-4330-8d58-cdd00c1a33a7"
      unitRef="usd">104172000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i501a3213c11d461591927d286d9b027c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi0xLTEtMS0w_019541d2-8153-464a-b33c-29d7c2c49906"
      unitRef="usd">278519000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i7331b555c3a7401d9ac7210b39769add_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi0zLTEtMS0w_f48af2c8-bc4f-42d8-8ab1-0a963c5b8133"
      unitRef="usd">27725000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNi03LTEtMS0w_a6ba37b8-dcb9-41c2-b14c-f930df083811"
      unitRef="usd">306244000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfNy03LTEtMS0w_f8efae22-1c70-471d-9ad8-b301791b0cdc"
      unitRef="usd">79779000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjYzYjIxNTNiODNkODQ0M2U5ZDNiOWVhZDk1NDBjZjEwL3RhYmxlcmFuZ2U6NjNiMjE1M2I4M2Q4NDQzZTlkM2I5ZWFkOTU0MGNmMTBfOC03LTEtMS0w_8201f510-b978-450a-883a-db0df97949f7"
      unitRef="usd">226465000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20f6fb1bf2a34c35a01cae3374745b5b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNjU5_4fd86f5e-2086-4f23-98da-0e49e3364b61"
      unitRef="usd">2400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi0xLTEtMS0w_b035faba-c7f3-4af8-b2e8-fcf107db37c4"
      unitRef="usd">214892000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi0zLTEtMS0w_6d540249-cc5a-4fd3-8cf5-0026deaf0ae1"
      unitRef="usd">26660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMi03LTEtMS0w_13e0e68a-9148-48a7-820b-f444d02ca2bc"
      unitRef="usd">241552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy0xLTEtMS0w_290e3e37-ae2d-4e3a-9ceb-9c6929919981"
      unitRef="usd">93937000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy0zLTEtMS0w_e3949117-69ae-4e25-b316-c328279e97eb"
      unitRef="usd">10120000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfMy03LTEtMS0w_4cf24ac1-c069-477b-b4af-b4dab1b47f74"
      unitRef="usd">104057000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC0xLTEtMS0w_25f7ae7a-e84b-4c2f-82c7-c7d1ddcb3678"
      unitRef="usd">120955000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC0zLTEtMS0w_0fe7e9b0-3b0d-4a91-8e3e-c75c51a019a6"
      unitRef="usd">16540000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNC03LTEtMS0w_ddb9feff-b814-45e5-b569-fda0775967e6"
      unitRef="usd">137495000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS0xLTEtMS0w_0b44e14a-17d8-4a3b-b61b-e0bbfd4fab51"
      unitRef="usd">29025000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS0zLTEtMS0w_0799befe-4771-46f6-b814-aeadac13d003"
      unitRef="usd">4534000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNS03LTEtMS0w_a2e83677-3c75-4de8-a28f-c6e5283e536d"
      unitRef="usd">33559000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i3110b05d1fe549f2bc9bd55678978a7b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi0xLTEtMS0w_316d44ee-4899-4df6-bf4f-63db137e2189"
      unitRef="usd">91930000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i109453dfafd24d8796688ef075fe27b9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi0zLTEtMS0w_94c16087-8fb5-4ff0-856b-269bddb4d6e4"
      unitRef="usd">12006000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNi03LTEtMS0w_7767b258-3deb-41f0-99b2-28a823f8b85c"
      unitRef="usd">103936000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfNy03LTEtMS0w_ad5aa8b9-22f5-4d95-be04-a59e8579331c"
      unitRef="usd">27532000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmY1YTM1NmRmOGZmNjRhZmQ4NzFkZDA5ZmE5NzA5Mjc5L3RhYmxlcmFuZ2U6ZjVhMzU2ZGY4ZmY2NGFmZDg3MWRkMDlmYTk3MDkyNzlfOC03LTEtMS0w_44adf843-a203-4e8c-a510-83be2f62e65f"
      unitRef="usd">76404000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia68e63de10454e24894bd16a7a088bcf_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfNzU3_3d7fbff5-b7dc-46d0-8eba-b2e48722aa77"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi0xLTEtMS0w_2984bbff-ac1d-44b6-9f8a-7bc1e2ede756"
      unitRef="usd">639554000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi0zLTEtMS0w_ca73f52a-b518-4bbd-b5c7-5eae6061eb0f"
      unitRef="usd">72221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMi03LTEtMS0w_fce11db2-4d39-49da-bed9-f9ec1cd81c7a"
      unitRef="usd">711775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy0xLTEtMS0w_3487f99a-78bc-4fe6-a4f3-badfa37d7260"
      unitRef="usd">275679000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy0zLTEtMS0w_a055dbcd-039e-46f9-bd9e-0a9665357f47"
      unitRef="usd">27783000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfMy03LTEtMS0w_18e553a1-1a64-4dd4-8551-9452a95d9bf3"
      unitRef="usd">303462000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC0xLTEtMS0w_5b51ca7f-1094-4822-be24-36b3cf5d2208"
      unitRef="usd">363875000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC0zLTEtMS0w_98bec433-8161-4952-be71-1a64cfd1012f"
      unitRef="usd">44438000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNC03LTEtMS0w_568a2ec5-c015-4edb-b6f0-e3406aba896c"
      unitRef="usd">408313000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS0xLTEtMS0w_3c9aee87-1735-4ca1-8942-3dad4e27003b"
      unitRef="usd">94634000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS0zLTEtMS0w_b96445ff-7e3c-4da4-866d-e247750de278"
      unitRef="usd">12393000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNS03LTEtMS0w_417c5784-1a0c-4841-bf8b-624820cf1207"
      unitRef="usd">107027000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i263c5b3623ba4ccfbeb49922c9c17cb4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi0xLTEtMS0w_7a45ac4d-9e3e-431f-a07f-824912e9a0ac"
      unitRef="usd">269241000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i565b9bce16444927976c88402045c3d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi0zLTEtMS0w_a6c3a38e-ac96-40b9-baf3-b1a599b50f59"
      unitRef="usd">32045000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNi03LTEtMS0w_2ef8fd22-6235-4e6c-822a-a9423fc14705"
      unitRef="usd">301286000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfNy03LTEtMS0w_4de117ae-110d-4229-8856-0e4d02913998"
      unitRef="usd">84048000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjMzNTk3N2FjYjllNTRiYTg4OWI5N2I2ODAxNjIxOTFhL3RhYmxlcmFuZ2U6MzM1OTc3YWNiOWU1NGJhODg5Yjk3YjY4MDE2MjE5MWFfOC03LTEtMS0w_a254b0d5-9c13-49bd-9b6a-75a3ecf9f315"
      unitRef="usd">217238000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8407d623fa84556b0397c38088abbf6_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfODU0_1eb3c7f2-5599-4c74-a2de-0d1fc02ddf7a"
      unitRef="usd">2100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIyMA_30c83376-85e9-48e4-a851-232daa54f5a7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d198cc6856d470c8ec71c81c8103522_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi0xLTEtMS0w_2b4b9ba3-7340-4c1f-a838-2d56db552906"
      unitRef="usd">29427000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46feb4fd7be74db89bc3151dc91f92e2_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi0zLTEtMS0w_c7add1a8-41fb-4410-8498-6957d3ac0d98"
      unitRef="usd">423000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6f81090cc714b74b8d03f28025f19b1_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMi03LTEtMS0w_4da155cd-a9d6-49e0-ad4a-f3bd394163ea"
      unitRef="usd">29850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96855186767b4db9a00fb69b716c41f6_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy0xLTEtMS0w_44659735-2824-4280-9fb6-72980611b300"
      unitRef="usd">16871000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3c7a94528d9490fb08b81ebf1d7a00b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy0zLTEtMS0w_e46e7671-ba6b-4e62-9d62-fedfd384fa4c"
      unitRef="usd">3877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf9dde9deb0240549add526728474f42_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMy03LTEtMS0w_63eee901-65b1-4318-a3a6-c0ffd0d7c392"
      unitRef="usd">20748000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88d09d2b366144f2aff1fd2e7f593171_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC0xLTEtMS0w_8d1ee615-ffbb-489d-a6e5-ca012e421840"
      unitRef="usd">60257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0694c66689742c5b90557d956ca3f32_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC0zLTEtMS0w_50ca7225-c21e-441a-8d19-9f5f44843140"
      unitRef="usd">4229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d320cc345b49a2a8fbdada2529df4e_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNC03LTEtMS0w_f5f2bf66-b1d2-45f1-b576-c5d7524951f9"
      unitRef="usd">64486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01e950986bcf4e108adee0564716cb37_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS0xLTEtMS0w_1e5bcdfd-7e95-4e52-930a-d6574e83bfff"
      unitRef="usd">31886000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3f00e6b81ef4c3482182a197d4a4e32_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS0zLTEtMS0w_55ba19b0-4fc1-4582-8fe9-3f1632a98388"
      unitRef="usd">13436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4244f86df364e5ebcde26a945e3142b_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNS03LTEtMS0w_23013b3e-0185-4543-898e-dc21ed1f2c7d"
      unitRef="usd">45322000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia738781a6462445a9d482d900ef06acb_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi0xLTEtMS0w_c049a3a0-4ac6-45a6-b16b-508c40557725"
      unitRef="usd">23166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5a85023eca74a8fac623c88ab9c8e78_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi0zLTEtMS0w_52421e9e-3558-454c-81b0-ed5348697309"
      unitRef="usd">2326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80964bb76f874e5281347932224ff34a_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNi03LTEtMS0w_525addfa-d080-4e4c-99cd-45dd534af9c6"
      unitRef="usd">25492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41001c9e538a41ed8464330160dc13e6_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy0xLTEtMS0w_aeb42851-196a-4291-b7f0-06d2c7bae972"
      unitRef="usd">24602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie28bad73d72f456e8b79877569af8a18_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy0zLTEtMS0w_fae4cf65-75c1-4e43-910d-7ee1fdc3600b"
      unitRef="usd">791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81550b7b21bc4feea06a01fcc70f411f_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfNy03LTEtMS0w_2983aabd-70f3-4690-ab3f-40514e4a4964"
      unitRef="usd">25393000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8db11a316bb0453ba064a9b94c08d6e7_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC0xLTEtMS0w_c86fb951-b7a1-43c6-a417-77687592f91f"
      unitRef="usd">22907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida7739148e504bf886e60a2197004803_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC0zLTEtMS0w_9a4014ad-544d-40f5-b2f5-11653437a3be"
      unitRef="usd">3086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43dc6fc89aff41f88710ff54c5a7ed8f_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOC03LTEtMS0w_f856c5f4-b4f1-4935-9b92-e68b0c334b51"
      unitRef="usd">25993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice70e5b8d1064b52aebc31f31f0a7884_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS0xLTEtMS0w_319d1d32-eac3-4d37-9b8e-ba12c2c9c307"
      unitRef="usd">1502000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id657b6e10bb145bd9e3b992a5952b584_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS0zLTEtMS0w_5938c216-b555-4c05-ac57-1ca6d0a2274e"
      unitRef="usd">2000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d12927a6dbe43b78aef3d34a6229cfd_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfOS03LTEtMS0w_f565573d-307d-4306-a7cb-a21b50d0d754"
      unitRef="usd">1504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id23c3e9b79a94d9789d9b7517a275164_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtMS0xLTEtMA_f389cb18-7576-47d6-9c4b-f40cb16bb544"
      unitRef="usd">210618000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e73ad0358e14775a2e9849dd271ff14_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtMy0xLTEtMA_031a120f-f245-431f-a9bb-e43df01041ce"
      unitRef="usd">28170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjdkNzg3ZDliNjQ1ODRmYjlhM2M5ZGIzZDk5ZWQwNDU5L3RhYmxlcmFuZ2U6N2Q3ODdkOWI2NDU4NGZiOWEzYzlkYjNkOTllZDA0NTlfMTEtNy0xLTEtMA_35ccde72-ba1a-46be-93f8-78cea4323bc1"
      unitRef="usd">238788000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4dd9073a48464bd7b51b74613aafa24f_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi0xLTEtMS0w_1bdd7f6c-637f-40f7-b7b3-89dab4da19d0"
      unitRef="usd">87917000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49b14bc7d42b468ba1f64dd1c0abaea3_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi0zLTEtMS0w_4f6179da-e171-42e6-a78e-975e2361911a"
      unitRef="usd">964000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0a7cd80cd5a4b1bad14f4a51c7ada4e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMi03LTEtMS0w_ae0cf480-9a8c-48de-931c-4bb67641ed46"
      unitRef="usd">88881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97460044a83f440fa7584652350076da_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy0xLTEtMS0w_52e361ac-d934-4e4f-834a-63391bd97bab"
      unitRef="usd">45105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie688265c2fe64317a2d953ab3115c665_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy0zLTEtMS0w_c26d8f4b-3ec3-4842-8fe7-b6973f00bf2c"
      unitRef="usd">10865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2746c8904701432ab60720e86c50447b_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMy03LTEtMS0w_2204671e-d1ee-40c4-8458-a589f2955f17"
      unitRef="usd">55970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8993e25574f54284bfbbbd9dd41772f5_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC0xLTEtMS0w_f4538d2c-8c2d-4abc-a404-913aad6ed1c3"
      unitRef="usd">187159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ae8a85f75464471a53bd0ba32db5176_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC0zLTEtMS0w_2d3d5048-93a3-4c39-8045-0d03c11a01df"
      unitRef="usd">10766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3cc2559678948b9aef06ac76f4e1522_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNC03LTEtMS0w_445d7a36-c0fa-4dcd-8610-e1a438308c33"
      unitRef="usd">197925000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i173fab1b453f4560849f0dc00c3452a5_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS0xLTEtMS0w_67fe45ac-629e-43d3-8e6e-4cb3b9dcd965"
      unitRef="usd">93654000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19fe27a1e60e4cbeb166294c0bede61e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS0zLTEtMS0w_465d55dc-32c3-4a59-950b-4f183d1f039a"
      unitRef="usd">25520000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic014bbc1359641b1a2b5b3a0a76876d2_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNS03LTEtMS0w_7aeacf3d-6810-4772-9a4c-dfbfc711d7a7"
      unitRef="usd">119174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7877fc9a7f02493996cb66d50ec3afe5_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi0xLTEtMS0w_c9203e70-96bf-4301-9c3b-11801d45a8d4"
      unitRef="usd">72785000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5d5430fb96e440aae81e6b0952da7b6_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi0zLTEtMS0w_73d043ce-ce91-4354-9d36-a063c475e78c"
      unitRef="usd">7908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf4ec554d2bc4d29b952a1b545f2b547_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNi03LTEtMS0w_b525a424-d32d-48a1-9b9e-cee208d3fded"
      unitRef="usd">80693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic58ac387c2ff481c9484454d90ef155c_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy0xLTEtMS0w_ac74b10d-5afe-40dd-8922-5e64bb34a3c7"
      unitRef="usd">80097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b6d6045fb4442a2895c9ec699f1811e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy0zLTEtMS0w_5ca7470d-a440-489c-a0a4-792339f44d6a"
      unitRef="usd">2326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i965dae78c4ba4d53871050f36805d7c2_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfNy03LTEtMS0w_3eea46d9-6dc4-4945-b72c-96f7315964bf"
      unitRef="usd">82423000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6593e8a130e4e3f9f3cdf45d175d28f_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC0xLTEtMS0w_f18764d8-5d0e-49de-a94b-04acc738cd03"
      unitRef="usd">67017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac53dedfbbed4030a17b1545923bc589_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC0zLTEtMS0w_9d9ed49c-5598-499a-a457-9c4fdb4d4259"
      unitRef="usd">9399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85a3d3deecd14f63bd429eb4e3e8430e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOC03LTEtMS0w_5e947174-c533-493d-b0f7-2dbbf8c6cfd7"
      unitRef="usd">76416000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39009ec2cf5647779e9d225f923247c3_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS0xLTEtMS0w_870cf9e7-5046-47c7-961b-41b3693da66b"
      unitRef="usd">4117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6166e5bdf88b40a8992f759071b12983_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS0zLTEtMS0w_bfe34275-5f18-49b7-9515-f2e5fe6f421f"
      unitRef="usd">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d710e027cd54fd8aee0485eba0c6cf5_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfOS03LTEtMS0w_2f314abb-5eb6-4658-89ea-16cba1a38bab"
      unitRef="usd">4122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c328b4632ad49d1a79d4f1244a604f7_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtMS0xLTEtMA_7d99fe44-398f-4cb0-94e0-ad85d834bb55"
      unitRef="usd">637851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4f047caafca4e5a80e901776974cd39_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtMy0xLTEtMA_9de756c3-772a-4827-b2d8-c38d89863c4c"
      unitRef="usd">67753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjcxZjA3YjQ0YjQ0ODRkYmViYmY3NDg5N2ViMDk1Y2QxL3RhYmxlcmFuZ2U6NzFmMDdiNDRiNDQ4NGRiZWJiZjc0ODk3ZWIwOTVjZDFfMTEtNy0xLTEtMA_13f869f8-95f0-41c1-9abc-0521f5af2887"
      unitRef="usd">705604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id87392d270c0486a93ceaf137e98399d_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi0xLTEtMS0w_9890346b-7ff9-4f42-9739-b37d7611e0f0"
      unitRef="usd">28330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf7e602fc5d9444ebdd4c853c09b50d5_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi0zLTEtMS0w_5276770d-453f-45ef-9802-d226dd8e8c82"
      unitRef="usd">175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a79924f9ce947458d38df1406320d6d_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMi03LTEtMS0w_e7d93ff2-3551-475f-a24c-7420f6a4920f"
      unitRef="usd">28505000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03ee54ef632d4869892e5474c4128689_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy0xLTEtMS0w_8ed89749-b1d5-4e51-b46a-debbed5fa285"
      unitRef="usd">25221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd84840900f7404d8225e673a8394f3c_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy0zLTEtMS0w_058aea86-1d34-4315-8a25-1dc3e458374e"
      unitRef="usd">4742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b5fa469fe0648758a18c8204ec783a2_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMy03LTEtMS0w_e72436f6-e97f-45db-a383-2ec497a97e71"
      unitRef="usd">29963000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d8e154d8fdb4c5ca334f3b074e96118_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC0xLTEtMS0w_7f72af3c-2c51-4dc3-8dd6-6388269ae80f"
      unitRef="usd">58576000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3eaa79a619a94571be5a3e33b1b9b727_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC0zLTEtMS0w_91774120-82ce-4068-aef8-baf05bb16af5"
      unitRef="usd">3543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia75cc8b1bbf84638bba89e388838032b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNC03LTEtMS0w_c3dc1b50-3a71-4fd6-a11f-6fe2a95f3541"
      unitRef="usd">62119000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38d019c5be754bedb9da5cb867242c80_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS0xLTEtMS0w_ea6a3f59-c393-4f83-ae60-9803d957a3b7"
      unitRef="usd">32645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a054fe50c8445ffbe95cd9a6dae0e73_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS0zLTEtMS0w_20d36c06-e19e-4a3e-865a-9748755257bb"
      unitRef="usd">12097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07318d3f13404727be431e43ee6a10a9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNS03LTEtMS0w_4a07dc5d-d4c3-4b31-9818-e4d3c92a9197"
      unitRef="usd">44742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c0956b5a03a4aac9860d3e814a7a613_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi0xLTEtMS0w_2b43aa74-99e8-44bf-8578-03badb75c7c6"
      unitRef="usd">24095000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa4a0ae5763540aebd26fc7b0246574f_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi0zLTEtMS0w_c93e6830-e696-4157-ba85-0e3923cc4152"
      unitRef="usd">3159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3dc317e3286f405d8d099420e0ffdce4_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNi03LTEtMS0w_c06b695c-46df-4c66-965c-5e198c33c705"
      unitRef="usd">27254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bb8aa6b9b0b4441b011f07d5309b81a_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy0xLTEtMS0w_97d315a5-2d5f-4121-ac26-6fda3b9fd6ff"
      unitRef="usd">23286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i404178ff281443bf9ced03a0238bf1f6_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy0zLTEtMS0w_e55a9392-8952-4e9b-9df1-e406e6081e2f"
      unitRef="usd">598000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3395ce8af8e428c9ad73baa0b989bc5_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfNy03LTEtMS0w_63dbd29a-3a63-43eb-9890-ba78216579a7"
      unitRef="usd">23884000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43a647598543421a924f09921ad19ce3_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC0xLTEtMS0w_8ec6edbe-729b-4faa-8d40-f3ae1bb05365"
      unitRef="usd">21451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic726fc7d1df344b5831a872a1ef09b6f_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC0zLTEtMS0w_4dfd7eac-7334-4862-99f7-75ede03a78d7"
      unitRef="usd">2344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac032030eede416e8cce85237744c04c_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOC03LTEtMS0w_04f14075-308f-4106-877e-119e18890677"
      unitRef="usd">23795000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fd0d5b78dd6488a90023e73337561c2_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS0xLTEtMS0w_051ed05b-3081-4e21-a6f4-3c5696da3711"
      unitRef="usd">1288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1b5ea8663fe460eb915122aa37bb218_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS0zLTEtMS0w_f1ef6748-4944-42d4-a27f-d563131aa654"
      unitRef="usd">2000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic326287529e8474aa6d710df42ce383a_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfOS03LTEtMS0w_c4b1676a-7c1c-4ae8-b1e1-51a86dea3b3f"
      unitRef="usd">1290000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b582ceef6b94530a0a15643c10b9bdd_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtMS0xLTEtMA_f2a18e64-d0df-47c3-ba4d-f0d3f6b53aeb"
      unitRef="usd">214892000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dfa30afe9ba4d0ab14d9df91c38845b_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtMy0xLTEtMA_3008c95f-c0ba-4508-a305-5034d484e4b8"
      unitRef="usd">26660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjZjMmFiN2QzYzVlZjQyZmJiZGFhOTRkMzhlZGU1NWZiL3RhYmxlcmFuZ2U6NmMyYWI3ZDNjNWVmNDJmYmJkYWE5NGQzOGVkZTU1ZmJfMTEtNy0xLTEtMA_faf5389f-5da1-42ac-af68-0707cdf653f9"
      unitRef="usd">241552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7cf96e727a648328bd0ddbaf8c22e9f_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi0xLTEtMS0w_66f0c988-6edb-485e-8d88-a6d870ff76b8"
      unitRef="usd">85696000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1aa98178171483c8a80105d8260faf3_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi0zLTEtMS0w_6aabc1f2-3a64-4fa5-a4c5-71f7679da933"
      unitRef="usd">648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74206d6c1ef94f85a77a706a302a2921_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMi03LTEtMS0w_69be6d24-df02-472a-b118-2654339bfe78"
      unitRef="usd">86344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e224bfc0f2f4f9bbd343fcf36f723d5_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy0xLTEtMS0w_05f21a68-358e-40ee-bfd7-259e1067ab1c"
      unitRef="usd">63067000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0b281d13ce44cac9f9e545ad208695f_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy0zLTEtMS0w_f38d9d1c-cde5-485a-ad4f-c11398881212"
      unitRef="usd">15938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24eb7719094a43d584a2034ea978272d_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMy03LTEtMS0w_b3454271-c305-4289-b59d-0a3ac8b681f3"
      unitRef="usd">79005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb01bf909b914824bd367b98c9aaf43e_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC0xLTEtMS0w_19d94aef-39e0-429c-93ef-72188d4a9274"
      unitRef="usd">177832000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31318cf15ae24534bba25f86a4dd84c1_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC0zLTEtMS0w_b6fbaaea-6f36-4c95-8a2f-48b8ba5c8b9c"
      unitRef="usd">8867000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc78679f204d4b82b27f94f4ab6bf2c6_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNC03LTEtMS0w_1d25d268-6f0b-4137-b807-e8838f920b96"
      unitRef="usd">186699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19de88ae5c20400eb8842116fc3aece9_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS0xLTEtMS0w_39c86754-52c9-4002-b48b-8b593f559060"
      unitRef="usd">96431000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fffc560ee1744808937bcbe9f0620d4_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS0zLTEtMS0w_40731542-13ff-4697-890f-3545734e3e05"
      unitRef="usd">28110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b490d84f1fb4012b05a6af473ef1a5b_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNS03LTEtMS0w_83c436de-c474-44bc-8a58-8822ecd0a177"
      unitRef="usd">124541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ed85d9a18a4444b8d4767cd042125e2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi0xLTEtMS0w_a42ba233-e443-4e84-908c-700c4c483369"
      unitRef="usd">73134000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7a173370c5b48a196971ab3b9d7d458_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi0zLTEtMS0w_0d4151fb-7d0b-4f11-adbd-c43e4141119c"
      unitRef="usd">9355000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06b30c22a1b5488eb65d429328bcc1a7_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNi03LTEtMS0w_2239931f-c932-4d1e-97fb-463418d72f83"
      unitRef="usd">82489000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i376458bf47654387b6b570f09075e008_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy0xLTEtMS0w_083eced5-3acd-4cce-8780-d26ea1c519ff"
      unitRef="usd">77063000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ec6dd84935741f89edaadd7dc45c6c8_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy0zLTEtMS0w_bc91ef9d-1ed8-48eb-a354-e904dfc45d34"
      unitRef="usd">1864000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia561de999a564dc38eed19fc55917452_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfNy03LTEtMS0w_b259d06d-c802-437f-848c-f3dba91aa785"
      unitRef="usd">78927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i607b8d0fdd5346f9a3cabe2c53ee8951_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC0xLTEtMS0w_012cba1d-eb08-4e70-a333-1aef98c2015b"
      unitRef="usd">62493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib64ffd54f7d44b71837a1ffd999561dd_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC0zLTEtMS0w_ccbbf825-b825-4f9f-a88e-b43eef3a2a86"
      unitRef="usd">7435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec031e57d3cb43a2833a47073eb677ec_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOC03LTEtMS0w_d8d44eb7-8366-4954-820e-19c5ad09bf06"
      unitRef="usd">69928000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60f1a28867e44d3f9deec4c5458df1e8_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS0xLTEtMS0w_404a6d2a-c7ff-4e42-a9f1-f532bf77a7c8"
      unitRef="usd">3838000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i879386f7739b4709a9a498c439de1dd0_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS0zLTEtMS0w_464cb3ef-5248-4852-bf2d-e939cb49f695"
      unitRef="usd">4000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief5c3472bd6f439b818e26dba211fba1_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfOS03LTEtMS0w_6b1a7426-85ee-47a8-9931-248562876aaa"
      unitRef="usd">3842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726c3b7978984c9c89776dace3512cd6_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtMS0xLTEtMA_89a2b035-82f7-407e-a580-07697495be55"
      unitRef="usd">639554000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d7b3334441a4b4ebd90c904bf63af74_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtMy0xLTEtMA_0d5de638-aab5-4898-840b-47c1fa5b7e12"
      unitRef="usd">72221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOmQ3MDliODFkMDg1NjQyYTNiM2IwOWU1NTY0NDk4Y2ExL3RhYmxlcmFuZ2U6ZDcwOWI4MWQwODU2NDJhM2IzYjA5ZTU1NjQ0OThjYTFfMTEtNy0xLTEtMA_985cffaf-3dc0-4439-aefe-505d3dfbe5ec"
      unitRef="usd">711775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTIzMQ_f9f975aa-d3ad-4f73-a992-6cc4394bb317">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total segment revenues by geographic area are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cbf0d2f0f0b45de8dbc05c513975980_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi0xLTEtMS0w_34b47b4d-3b8f-4256-90f5-25869501d453"
      unitRef="usd">197296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia047992a234e4a6e93507979ba924334_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi0zLTEtMS0w_0ca4e0d3-fca0-4e52-a977-31d6adbff1e9"
      unitRef="usd">203920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1ac168c392241e985f758d09dfff28a_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi01LTEtMS0w_cee2c43b-f9a3-47f5-b47d-69891f971bca"
      unitRef="usd">599931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ffb79e853904250bd4a61db331e3d55_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMi03LTEtMS0w_213289c2-e61d-44a3-9ada-5e81fd906781"
      unitRef="usd">604263000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb23c99f72dd4b83a90f3c672526d24d_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy0xLTEtMS0w_de95bcbe-1d3f-4f37-b09e-6b16d3df19d3"
      unitRef="usd">41492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5b9c1ebb674451b8abea4c22d7a9b9d_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy0zLTEtMS0w_e0912428-71dc-4f39-b64f-39d7f7587a28"
      unitRef="usd">37632000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bfd9152348e4e888243321c3a99add2_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy01LTEtMS0w_24e97fd4-0ad1-489e-aee7-2850c50aedc8"
      unitRef="usd">105673000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e7cb897e70f478cb92e199f2d901a81_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfMy03LTEtMS0w_ddd0fa92-d965-44d8-a1d7-7bf153fefdc6"
      unitRef="usd">107512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i807901cbcf5e40229536f551bebc8109_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC0xLTEtMS0w_a02fef9d-3755-4a23-bf95-301531ff9534"
      unitRef="usd">238788000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a394d90a9641bd895f1a4be87b6db9_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC0zLTEtMS0w_74fbd42b-2c42-4e3a-984e-f13178f66ce5"
      unitRef="usd">241552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC01LTEtMS0w_330f806e-211c-4f3e-98cc-d9dd83b6fad8"
      unitRef="usd">705604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97b30c2a8f3242a19e67c726c016cdf2_D20190401-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ2NDE1MjBlOTk1YzQ0YjdiMTdlODVmZmUyZDg4ODBjL3RhYmxlcmFuZ2U6NDY0MTUyMGU5OTVjNDRiN2IxN2U4NWZmZTJkODg4MGNfNC03LTEtMS0w_27b024a9-cf42-436c-b2ef-de5b2de1c8e6"
      unitRef="usd">711775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RleHRyZWdpb246ZDAwNzBjMzJlMzgwNDY1Yzk5YjQ0ZTNhMmZjOWUzNGFfMTI0NA_8b32f59b-3235-41c0-b285-781b01a01e0d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,390,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Goodwill
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi0xLTEtMS0w_b3fa1c38-daf1-4200-a05d-140b3f670703"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi0zLTEtMS0w_97fb6555-a3f1-4bd0-9f5d-9a42c5b700b0"
      unitRef="usd">32916000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfMi03LTEtMS0w_712c4164-c2c1-40a0-8214-9e2bdb05f158"
      unitRef="usd">579559000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS0xLTEtMS0w_47a4d5d1-7218-47e4-960d-76478d26bca3"
      unitRef="usd">2195617000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS0zLTEtMS0w_69507fda-9c69-4480-a7aa-94f3724d7682"
      unitRef="usd">87514000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNS03LTEtMS0w_4feb3b8d-3534-43ac-b870-1a1ddca42c00"
      unitRef="usd">2283131000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi0xLTEtMS0w_ce694d4d-e76e-4bb6-bd56-19ae5af4f6a9"
      unitRef="usd">195248000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi0zLTEtMS0w_714a1c62-7591-47b9-8458-ed69558c37a1"
      unitRef="usd">3346000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNi03LTEtMS0w_e52ba386-d159-49af-a109-64e1026f52e0"
      unitRef="usd">198594000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy0xLTEtMS0w_1c044e61-4774-4851-849f-f556c0372694"
      unitRef="usd">2390865000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy0zLTEtMS0w_506c3c23-7890-45f4-8029-bd4aac51e74a"
      unitRef="usd">90860000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfNy03LTEtMS0w_feb5a822-7419-4809-8ca3-ebf128512de8"
      unitRef="usd">2481725000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i302701c033d5435ebe15ac3c6d5c337f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC0xLTEtMS0w_75e2ff35-d69a-4e63-b91c-caf3dec81d17"
      unitRef="usd">2937508000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i5c0818a176a94086a756b654b26eedb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC0zLTEtMS0w_43c1ce02-8f66-4e73-935e-7512ed94fd72"
      unitRef="usd">123776000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i8a14a79783154ed0b8aa034b4889e75d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjU0M2ZiODczZmFmODRkZmI5NDViN2Q3NjcwZTdmMmYyL3RhYmxlcmFuZ2U6NTQzZmI4NzNmYWY4NGRmYjk0NWI3ZDc2NzBlN2YyZjJfOC03LTEtMS0w_358820a3-2f78-4d52-b825-3a53514ca252"
      unitRef="usd">3061284000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi0xLTEtMS0w_190250d9-ec22-4efd-ba2a-786607682875"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi0zLTEtMS0w_f045f706-12f5-4a24-ac96-d663e97ef887"
      unitRef="usd">28536000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfMi03LTEtMS0w_246d8561-0197-4b1e-8b40-2300b9670b89"
      unitRef="usd">575179000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS0xLTEtMS0w_dc66cd12-0f40-4f92-93e6-cb2b88926838"
      unitRef="usd">2195617000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS0zLTEtMS0w_c19a3d20-5ccc-406a-bb69-83cfe3b11a83"
      unitRef="usd">69714000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNS03LTEtMS0w_fe3910df-c7d7-4587-8352-5af256752d57"
      unitRef="usd">2265331000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi0xLTEtMS0w_b5e0ed67-b8ec-447e-b61e-481c82744b27"
      unitRef="usd">209604000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi0zLTEtMS0w_c83a8b8c-071c-46fa-ba23-f8fbeb909914"
      unitRef="usd">4456000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNi03LTEtMS0w_0e135f60-8166-4789-8860-a2fc5369962b"
      unitRef="usd">214060000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy0xLTEtMS0w_26ac1069-b718-4b4c-8c88-fffe9275d62f"
      unitRef="usd">2405221000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy0zLTEtMS0w_f5cadb34-5eca-4c7d-8cef-0fad19eb9b43"
      unitRef="usd">74170000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfNy03LTEtMS0w_11adc3ae-6319-4030-ab53-c24ecd403590"
      unitRef="usd">2479391000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ia89f0f45b3414ccab552e76bdf9df478_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC0xLTEtMS0w_55ece78a-d0b6-455d-a475-b9afa8e4b1d9"
      unitRef="usd">2951864000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ia11c055523a04b699e5d7a78fc046593_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC0zLTEtMS0w_7e5df4dd-9d2e-402d-b597-e97c05667786"
      unitRef="usd">102706000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i02e9c2b24c2343449c5f786157e9131b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3Nzc4NmM2OGMwYjRlNjJiYzJiZTI4N2E2OWMzZDg0L3NlYzo4Nzc3ODZjNjhjMGI0ZTYyYmMyYmUyODdhNjljM2Q4NF84NS9mcmFnOmQwMDcwYzMyZTM4MDQ2NWM5OWI0NGUzYTJmYzllMzRhL3RhYmxlOjQ3OGMzZTdhYjM2NDRiNjliMDVhMjJlY2U4NzBjZmI4L3RhYmxlcmFuZ2U6NDc4YzNlN2FiMzY0NGI2OWIwNWEyMmVjZTg3MGNmYjhfOC03LTEtMS0w_f85f40c4-5fa5-460c-a3cd-6150d4fe9994"
      unitRef="usd">3054570000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100530200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRESTIGE CONSUMER HEALTHCARE INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001295947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1297589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">660 White Plains Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tarrytown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">524-6800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PBH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,864,752<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023920696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income and Comprehensive Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 238,788<span></span>
</td>
<td class="nump">$ 241,552<span></span>
</td>
<td class="nump">$ 705,604<span></span>
</td>
<td class="nump">$ 711,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CostOfSalesExclusiveOfDepreciation', window );">Cost of sales excluding depreciation</a></td>
<td class="nump">98,260<span></span>
</td>
<td class="nump">102,900<span></span>
</td>
<td class="nump">290,623<span></span>
</td>
<td class="nump">300,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Cost of sales depreciation</a></td>
<td class="nump">1,641<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
<td class="nump">4,565<span></span>
</td>
<td class="nump">3,144<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">99,901<span></span>
</td>
<td class="nump">104,057<span></span>
</td>
<td class="nump">295,188<span></span>
</td>
<td class="nump">303,462<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">138,887<span></span>
</td>
<td class="nump">137,495<span></span>
</td>
<td class="nump">410,416<span></span>
</td>
<td class="nump">408,313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">38,081<span></span>
</td>
<td class="nump">33,559<span></span>
</td>
<td class="nump">104,172<span></span>
</td>
<td class="nump">107,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">21,395<span></span>
</td>
<td class="nump">21,308<span></span>
</td>
<td class="nump">61,717<span></span>
</td>
<td class="nump">65,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">5,968<span></span>
</td>
<td class="nump">6,224<span></span>
</td>
<td class="nump">18,062<span></span>
</td>
<td class="nump">18,520<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">65,444<span></span>
</td>
<td class="nump">61,091<span></span>
</td>
<td class="nump">183,951<span></span>
</td>
<td class="nump">191,075<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">73,443<span></span>
</td>
<td class="nump">76,404<span></span>
</td>
<td class="nump">226,465<span></span>
</td>
<td class="nump">217,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (income) expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">20,138<span></span>
</td>
<td class="nump">24,275<span></span>
</td>
<td class="nump">63,345<span></span>
</td>
<td class="nump">73,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(580)<span></span>
</td>
<td class="num">(620)<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_TotalOtherIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">19,767<span></span>
</td>
<td class="nump">25,850<span></span>
</td>
<td class="nump">62,725<span></span>
</td>
<td class="nump">76,622<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income before income taxes</a></td>
<td class="nump">53,676<span></span>
</td>
<td class="nump">50,554<span></span>
</td>
<td class="nump">163,740<span></span>
</td>
<td class="nump">140,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">12,803<span></span>
</td>
<td class="nump">12,496<span></span>
</td>
<td class="nump">34,572<span></span>
</td>
<td class="nump">35,381<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 40,873<span></span>
</td>
<td class="nump">$ 38,058<span></span>
</td>
<td class="nump">$ 129,168<span></span>
</td>
<td class="nump">$ 105,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 2.57<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 2.55<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50,212<span></span>
</td>
<td class="nump">50,378<span></span>
</td>
<td class="nump">50,268<span></span>
</td>
<td class="nump">50,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">50,561<span></span>
</td>
<td class="nump">50,831<span></span>
</td>
<td class="nump">50,635<span></span>
</td>
<td class="nump">51,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="nump">$ 8,184<span></span>
</td>
<td class="nump">$ 3,497<span></span>
</td>
<td class="nump">$ 22,439<span></span>
</td>
<td class="num">$ (311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Unrealized gain on interest rate swaps</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,347<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrecognized net gain on pension plans</a></td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Net gain on pension distribution reclassified to net income</a></td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">11,381<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
<td class="nump">26,930<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">52,254<span></span>
</td>
<td class="nump">41,555<span></span>
</td>
<td class="nump">156,098<span></span>
</td>
<td class="nump">104,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">238,779<span></span>
</td>
<td class="nump">241,545<span></span>
</td>
<td class="nump">705,572<span></span>
</td>
<td class="nump">711,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CostOfSalesExclusiveOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CostOfSalesExclusiveOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_TotalOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_TotalOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Shares Outstanding [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182025253688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 62,103<span></span>
</td>
<td class="nump">$ 94,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $19,025 and $20,194, respectively</a></td>
<td class="nump">116,004<span></span>
</td>
<td class="nump">150,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">117,011<span></span>
</td>
<td class="nump">116,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,093<span></span>
</td>
<td class="nump">4,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">301,211<span></span>
</td>
<td class="nump">365,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">68,620<span></span>
</td>
<td class="nump">55,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">24,867<span></span>
</td>
<td class="nump">28,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">9,628<span></span>
</td>
<td class="nump">5,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">579,559<span></span>
</td>
<td class="nump">575,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,481,725<span></span>
</td>
<td class="nump">2,479,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,159<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,468,769<span></span>
</td>
<td class="nump">3,513,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">29,114<span></span>
</td>
<td class="nump">62,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendsPayableCurrent', window );">Accrued interest payable</a></td>
<td class="nump">22,312<span></span>
</td>
<td class="nump">9,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">5,599<span></span>
</td>
<td class="nump">5,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current portion</a></td>
<td class="nump">2,569<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">66,569<span></span>
</td>
<td class="nump">70,763<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">126,163<span></span>
</td>
<td class="nump">149,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">1,548,692<span></span>
</td>
<td class="nump">1,730,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">424,364<span></span>
</td>
<td class="nump">407,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities, net of current portion</a></td>
<td class="nump">21,017<span></span>
</td>
<td class="nump">24,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities, net of current portion</a></td>
<td class="nump">7,471<span></span>
</td>
<td class="nump">4,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">17,841<span></span>
</td>
<td class="nump">25,438<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,145,548<span></span>
</td>
<td class="nump">2,342,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies &#8212; Note 16</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">495,383<span></span>
</td>
<td class="nump">488,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 4,033 shares at December 31, 2020 and 3,719 shares at March 31, 2020</a></td>
<td class="num">(128,739)<span></span>
</td>
<td class="num">(117,623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(17,231)<span></span>
</td>
<td class="num">(44,161)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">973,269<span></span>
</td>
<td class="nump">844,101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">1,323,221<span></span>
</td>
<td class="nump">1,170,971<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 3,468,769<span></span>
</td>
<td class="nump">$ 3,513,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182101071656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts receivable, current</a></td>
<td class="nump">$ 19,025<span></span>
</td>
<td class="nump">$ 20,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">53,945,000<span></span>
</td>
<td class="nump">53,805,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">4,033,000<span></span>
</td>
<td class="nump">3,719,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182022243176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 1,095,831<span></span>
</td>
<td class="nump">$ 536<span></span>
</td>
<td class="nump">$ 479,150<span></span>
</td>
<td class="num">$ (59,928)<span></span>
</td>
<td class="num">$ (25,747)<span></span>
</td>
<td class="nump">$ 701,820<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,871,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 5,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">36,000.0<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(50,950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (50,950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">105,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive income (loss)</a></td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Dec. 31, 2019</a></td>
<td class="nump">1,156,494<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
<td class="nump">485,838<span></span>
</td>
<td class="num">$ (110,878)<span></span>
</td>
<td class="num">(26,058)<span></span>
</td>
<td class="nump">807,055<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Sep. 30, 2019</a></td>
<td class="nump">1,112,790<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
<td class="nump">483,595<span></span>
</td>
<td class="num">$ (110,784)<span></span>
</td>
<td class="num">(29,555)<span></span>
</td>
<td class="nump">768,997<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, beginning balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">38,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive income (loss)</a></td>
<td class="nump">3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Dec. 31, 2019</a></td>
<td class="nump">1,156,494<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
<td class="nump">485,838<span></span>
</td>
<td class="num">$ (110,878)<span></span>
</td>
<td class="num">(26,058)<span></span>
</td>
<td class="nump">807,055<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,805,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 1,170,971<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
<td class="nump">488,116<span></span>
</td>
<td class="num">$ (117,623)<span></span>
</td>
<td class="num">(44,161)<span></span>
</td>
<td class="nump">844,101<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">3,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 5,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">65,800<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(11,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">129,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive income (loss)</a></td>
<td class="nump">26,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,323,221<span></span>
</td>
<td class="nump">$ 539<span></span>
</td>
<td class="nump">495,383<span></span>
</td>
<td class="num">$ (128,739)<span></span>
</td>
<td class="num">(17,231)<span></span>
</td>
<td class="nump">973,269<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">4,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Sep. 30, 2020</a></td>
<td class="nump">$ 1,278,217<span></span>
</td>
<td class="nump">$ 539<span></span>
</td>
<td class="nump">493,756<span></span>
</td>
<td class="num">$ (119,862)<span></span>
</td>
<td class="num">(28,612)<span></span>
</td>
<td class="nump">932,396<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, beginning balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(8,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">40,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive income (loss)</a></td>
<td class="nump">11,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,323,221<span></span>
</td>
<td class="nump">$ 539<span></span>
</td>
<td class="nump">$ 495,383<span></span>
</td>
<td class="num">$ (128,739)<span></span>
</td>
<td class="num">$ (17,231)<span></span>
</td>
<td class="nump">$ 973,269<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">4,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024154488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 129,168<span></span>
</td>
<td class="nump">$ 105,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">22,627<span></span>
</td>
<td class="nump">21,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">7,970<span></span>
</td>
<td class="nump">7,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt origination costs</a></td>
<td class="nump">3,569<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation costs</a></td>
<td class="nump">5,944<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets', window );">Non-cash operating lease cost</a></td>
<td class="nump">5,362<span></span>
</td>
<td class="nump">6,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">36,725<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,269<span></span>
</td>
<td class="num">(817)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,439)<span></span>
</td>
<td class="num">(879)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(35,789)<span></span>
</td>
<td class="num">(6,091)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">8,236<span></span>
</td>
<td class="nump">20,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(5,085)<span></span>
</td>
<td class="num">(6,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(3,184)<span></span>
</td>
<td class="num">(1,353)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">176,520<span></span>
</td>
<td class="nump">160,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(17,347)<span></span>
</td>
<td class="num">(9,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EscrowReceipt', window );">Escrow receipt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(17,347)<span></span>
</td>
<td class="num">(8,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of 5.125% Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of 5.375% Senior Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Term loan repayments</a></td>
<td class="num">(130,000)<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under revolving credit agreement</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit agreement</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(120,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments of finance leases</a></td>
<td class="num">(918)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Fair value of shares surrendered as payment of tax withholding</a></td>
<td class="num">(1,242)<span></span>
</td>
<td class="num">(974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(9,874)<span></span>
</td>
<td class="num">(49,976)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(195,710)<span></span>
</td>
<td class="num">(151,988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(32,657)<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">94,760<span></span>
</td>
<td class="nump">27,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">62,103<span></span>
</td>
<td class="nump">28,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">46,927<span></span>
</td>
<td class="nump">66,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 29,677<span></span>
</td>
<td class="nump">$ 21,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions To Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AdditionsToOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EscrowReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow Receipt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EscrowReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Leases Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncreaseDecreaseInOperatingLeasesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024681048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - Parenthetical<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember', window );">2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019305128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Business and Basis of Presentation</a></td>
<td class="text">Business and Basis of Presentation <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we,&#8221; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 7 to these Condensed Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus Outbreak </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In January 2020, the World Health Organization ("WHO") announced a global health crisis due to a new strain of coronavirus ("COVID-19").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">In March 2020, the WHO classified the COVID-19 outbreak as a pandemic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This pandemic is affecting the United States and global economies, including causing significant volatility in the global economy and resulting in materially reduced economic activity since early 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The COVID-19 pandemic and the corresponding government responses have also led to increased unemployment, which led to a reduction in consumer spending.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Economic conditions are, and we expect that they will continue to be, highly volatile and uncertain and could continue to reduce demand for our products and put downward pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We did see an increase in sales at the end of March 2020 related to shelter-at-home restrictions as we believe consumers stocked up as a result of COVID-19, followed by a temporary but significant decline in consumption in the first quarter.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Since then, we have seen more stable consumer consumption and customer orders. Sales have varied throughout the year with some categories positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold, and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel related to COVID-19. Early in our first quarter of fiscal 2021, we received reports of an increase in absenteeism at our distribution center and with some of our suppliers; however, we have not experienced a material disruption to our overall supply chain to date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">To date the pandemic has not had a material negative impact on our operations, overall demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">These circumstances could change in this dynamic, unprecedented environment. If the outbreak continues to spread, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. We may need to limit operations and may experience material limitations in employee resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The extent to which COVID-19 impacts our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19, and the actions to contain COVID-19 or treat its impact, among others. We do not yet know the full extent of its impacts on our business or the global economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">However, these effects could have a material, adverse impact on our liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2021) mean our fiscal year ending or ended on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of that year.  Operating results for the nine months ended December 31, 2020 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2021.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued.  The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for reference rate reform.  An entity may elect to apply the amendments prospectively through December 31, 2022.  We are currently evaluating the impact of adopting this guidance on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019517432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.1 million and $6.5 million at December&#160;31, 2020 and March&#160;31, 2020, respectively, related to obsolete and slow-moving inventory.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019274312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.392%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, no impairment charge was taken on our March&#160;31, 2020 financial statements.  We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;29, 2020 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties.  Consequently, changing rates of interest and inflation, declining sales or margins, increasing competition, changing consumer preferences, technical advances, or reductions in advertising and marketing may require an impairment charge to be recorded in the future. We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, we determined no events have occurred that would indicate potential impairment of goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our goodwill, including long-term growth rates and discount rates.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019506136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, net</a></td>
<td class="text">Intangible Assets, net <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $4.9 million and $14.7 million for the three and nine months ended December 31, 2020, respectively, and $4.9 million and&#160;$14.7 million for the three and nine months ended December 31, 2019, respectively.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ended March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount.  On February&#160;29, 2020, the date of our annual impairment review, there were no indicators of impairment as a result of the analysis and, accordingly, no impairment charge was taken on our March&#160;31, 2020 financial statements.   Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The discount rate utilized in the analyses, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation.&#160;&#160;Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer preferences, technological advances or reductions in advertising and marketing expenses, we may be required to record impairment charges in the future.  During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, did not exceed its carrying amount.  As such, we recorded an impairment charge of $1.2&#160;million. The decline in the fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was primarily related to a decline in expected future sales due to a regulatory change that now requires </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to be prescribed by physicians rather than sold over-the-counter direct to consumers</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continuously monitor events which could trigger an interim impairment analysis, which included the impact of COVID-19 for the period ended December&#160;31, 2020. As of December&#160;31, 2020, no other events have occurred that would indicate potential additional impairment of intangible assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, the continued duration and severity of COVID-19 may result in future impairment charges as the prolonged pandemic could have an impact on our results due to changes in consumer habits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This could result in changes to the assumptions utilized in the annual impairment analysis to determine the estimated fair value of our intangible assets, including long-term growth rates and discount rates.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020967720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of lease liabilities were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (Remaining three months ending March 31, 2021)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during the three months ended September 30, 2020.  The right-of-use ("ROU") asset and lease liability at the commencement of this finance lease was $5.2&#160;million.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maturities of lease liabilities were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (Remaining three months ending March 31, 2021)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during the three months ended September 30, 2020.  The right-of-use ("ROU") asset and lease liability at the commencement of this finance lease was $5.2&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019517432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text">Other Accrued Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020923160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year.  The 2016 Senior Notes mature on March 1, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a base rate floor of 1.00%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had no balance outstanding on the asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and a borrowing capacity of $123.3 million. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Interest Rate Swaps:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We currently have two interest rate swaps to hedge a total of $400.0 million of our variable interest debt (see Note 9 for further details).            </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2024 (the "2016 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.324%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ending March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020907960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB Accounting Standards Codification ("ASC") 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2016 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy.  See summary below detailing the carrying amounts and estimated fair values of these instruments at December&#160;31, 2020 and March&#160;31, 2020. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>At December&#160;31, 2020 and March&#160;31, 2020, we did not have any assets or liabilities measured in Level 1 or 3.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019489400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">Derivative Instruments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into two interest rate swaps to hedge a total of $400.0 million of our variable interest debt.  The fair value of these interest rate swaps is reflected in our Consolidated Balance Sheets in other accrued liabilities and other long-term liabilities.  We do not use derivatives for trading purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the fair values of our derivative instruments as of the end of the periods shown:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,412)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:21.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Recognized as Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect pre-tax losses of $3.0 million associated with interest rate swaps, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next twelve months.  The amount ultimately realized, however, will differ as interest rates change and the underlying contracts settle.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk:</span></div>Interest rate swaps expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020907960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on our common stock through December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2020 and 2019, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:35.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.676%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.39</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.1 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.2 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.0 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.80</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.9 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.9 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.0 million</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024870456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at December&#160;31, 2020 and March&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,161)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of December&#160;31, 2020 and March&#160;31, 2020, no amounts were reclassified from accumulated other comprehensive loss into earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019613208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.745%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For the three months ended December&#160;31, 2020 and 2019, there were 0.6 million and 0.6 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. For the nine months ended December&#160;31, 2020 and 2019, there were 0.6 million and 0.9 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019316664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and an extension of the term of the 2005 Plan by ten years, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  A total of 2,827,210 shares are available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.792%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At December&#160;31, 2020, there were $7.9 million of unrecognized compensation costs related to unvested share-based compensation arrangements under the 2005 Plan, based on management's estimate of the shares that will ultimately vest.&#160;&#160;We expect to recognize such costs over a weighted average period of 1 year.  At December&#160;31, 2020, there were 2.8 million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 4, 2020, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 79,070 performance stock units, 73,636 RSUs and stock options to acquire 249,875 shares of our common stock under the 2005 Plan to certain executive officers and employees.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the three-year anniversary of the date of grant.  In light of the uncertain economic environment, the Committee elected to set the performance objectives applicable to these awards at a later date.  The stock options were granted at an exercise price of $39.98 per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">A newly appointed independent member of the Board of Directors received a grant under the 2005 Plan of 907 RSUs on May 4, 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On August 4, 2020, each of the independent members of the Board of Directors received a grant of 3,732 RSUs under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of one share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1% - 32.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9% - 31.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3% to 2.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the nine months ended December&#160;31, 2020 was $1.3 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019281112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act was signed into law. The Tax Cuts and Jobs Act, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  We calculated the potential impact of these final regulations and accounted for those impacts in the quarterly provision for the period ended September 30, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were 23.9% and 24.7% for the three months ended December 31, 2020 and 2019, respectively.   The effective tax rates used in the calculation of income taxes were 21.1% and 25.2% for the nine months ended December 31, 2020 and 2019, respectively.  The decrease in the effective tax rate for the nine months ended December 31, 2020 versus the prior year period was primarily due to the final GILTI regulations issued in July 2020, which resulted in the release of the valuation allowance on foreign tax credit carryforwards of $5.1&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019308232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Retirement Plans</a></td>
<td class="text">Employee Retirement Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(435)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2020, we contributed $0.3 million to our non-qualified defined benefit plan and $3.0 million to the qualified defined benefit plan.  During the remainder of fiscal 2021, we expect to contribute an additional $0.1 million to our non-qualified plan and make no further contribution to the qualified plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0&#160;million and we recognized a settlement gain of $0.2&#160;million as a result of the payout.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020920088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and ContingenciesWe are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020932648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations of Risk</a></td>
<td class="text">Concentrations of Risk<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels. During the three and nine months ended December 31, 2020, approximately 43.6% and 45.6%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and nine months ended December 31, 2019, approximately 41.7% and 42.8%, respectively of our gross revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately 20.7% and 21.7%, respectively, of our gross revenues for the three and nine months ended December 31, 2020.  Walmart accounted for approximately 23.2% and 23.4%, respectively, of our gross revenues for the three and nine months ended December 31, 2019.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third party distribution manager or COVID-19 or other public health emergencies could also materially impact our product distribution. Any disruption as a result of third party performance at our distribution center could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  In addition, any serious disruption to our Lynchburg manufacturing facility could materially impair our ability to manufacture many of the products associated with our acquisition of C.B. Fleet Company, Inc. ("Fleet"), which would also limit our ability to provide those products to customers in a timely manner or at a reasonable cost.&#160; We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had relationships with 113 third party manufacturers.&#160;&#160;Of those, we had long-term contracts with 18 manufacturers that produced items that accounted for approximately 68.9% of gross sales for the nine months ended December&#160;31, 2020.  At December&#160;31, 2019, we had relationships with 113 third party manufacturers.&#160;&#160;Of those, we had long-</span></div>term contracts with 17 manufacturers that produced items that accounted for approximately 66.2% of gross sales for the nine months ended December&#160;31, 2019.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020871112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments</a></td>
<td class="text">Business Segments <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $2.1 million were eliminated from the North American OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,390,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020871640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2021) mean our fiscal year ending or ended on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of that year.  Operating results for the nine months ended December 31, 2020 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2021.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in this update are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued.  The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for reference rate reform.  An entity may elect to apply the amendments prospectively through December 31, 2022.  We are currently evaluating the impact of adopting this guidance on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182021457336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019264840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Reconciliation of the Activity Affecting Goodwill</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.392%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182122799480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Reconciliation of the Activity Affecting Finite Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ended March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023374536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and nine months ended December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Leases</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (Remaining three months ending March 31, 2021)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Finance Leases</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (Remaining three months ending March 31, 2021)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,616&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019587912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued and Other Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020813192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year.  The 2016 Senior Notes mature on March 1, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a base rate floor of 1.00%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate Future Principal Payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2024 (the "2016 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.324%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months ending March 31, 2021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020873992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Summary of Carry Amounts and Fair Value Measurements</a></td>
<td class="text">See summary below detailing the carrying amounts and estimated fair values of these instruments at December&#160;31, 2020 and March&#160;31, 2020. <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019630712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The following tables summarize the fair values of our derivative instruments as of the end of the periods shown:<div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,412)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:21.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Recognized as Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019329016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock</a></td>
<td class="text">Our share repurchases consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:35.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.676%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37.95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.39</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.1 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.2 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.0 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.80</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.9 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.9 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.0 million</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020852472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at December&#160;31, 2020 and March&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,161)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019261928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.745%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023535416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Compensation Expense Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.792%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Shares</a></td>
<td class="text">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Options Granted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1% - 32.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9% - 31.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3% to 2.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182020888376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Primary Components of Net Periodic Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(435)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023374536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Information about our Operating and Reportable Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $2.4 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $2.1 million were eliminated from the North American OTC Healthcare segment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Information about our Revenues from Similar Product Groups</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Information about our Segment Revenues by Geographic Area</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Information about our Consolidated Goodwill and Intangible Assets Allocated to Reportable Segments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,390,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100694440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Packaging and raw materials</a></td>
<td class="nump">$ 8,370<span></span>
</td>
<td class="nump">$ 9,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">108,320<span></span>
</td>
<td class="nump">105,868<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">117,011<span></span>
</td>
<td class="nump">116,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves related to obsolete and slow-moving inventory</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100712232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">$ 738,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="num">(163,711)<span></span>
</td>
<td class="num">$ (163,711)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">575,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="nump">4,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">743,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">579,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">710,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="num">(163,711)<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">546,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">710,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">546,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">28,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">28,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="nump">4,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">32,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">$ 32,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182022480008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Activity Affecting Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,265,331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, ending balance</a></td>
<td class="nump">$ 2,283,131,000<span></span>
</td>
<td class="nump">$ 2,265,331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,283,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract', window );"><strong>Finite-Lived Intangible Assets, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Finite-lived trademarks and customer relationships, impairment of intangible assets, finite-lived</a></td>
<td class="num">(1,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsGrossAbstract', window );"><strong>Intangible Assets, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Totals, gross, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,655,132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,186,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss', window );">Intangible Assets, Translation Adjustments Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Totals, gross, ending balance</a></td>
<td class="nump">2,672,498,000<span></span>
</td>
<td class="nump">2,655,132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,672,498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated amortization, additions</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">14,729,000<span></span>
</td>
<td class="nump">$ 14,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Accumulated amortization, effects of foreign exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, ending balance</a></td>
<td class="nump">190,773,000<span></span>
</td>
<td class="nump">175,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived, net</a></td>
<td class="nump">198,594,000<span></span>
</td>
<td class="nump">214,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,481,725,000<span></span>
</td>
<td class="nump">2,479,391,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,481,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Trademarks and Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract', window );"><strong>Finite-Lived Intangible Assets, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived trademarks and customer relationships, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Finite-lived trademarks and customer relationships, impairment of intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,186,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived trademarks and customer relationships, ending balance</a></td>
<td class="nump">389,367,000<span></span>
</td>
<td class="nump">389,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated amortization, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Accumulated amortization, effects of foreign exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, ending balance</a></td>
<td class="nump">190,773,000<span></span>
</td>
<td class="nump">175,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived, net</a></td>
<td class="nump">198,594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,265,331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Indefinite lived trademarks, effects of foreign currency exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, ending balance</a></td>
<td class="nump">$ 2,283,131,000<span></span>
</td>
<td class="nump">$ 2,265,331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,283,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Gross [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024787352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 14,729,000<span></span>
</td>
<td class="nump">$ 14,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of finite-lived intangible assets</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182110650600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, net - Future Amortization of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of the year</a></td>
<td class="nump">$ 4,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">19,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">19,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">19,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">17,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">117,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 198,594<span></span>
</td>
<td class="nump">$ 214,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182025132184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Lease Cost) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 629<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 1,397<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">2,239<span></span>
</td>
<td class="nump">5,068<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">11,220<span></span>
</td>
<td class="nump">15,731<span></span>
</td>
<td class="nump">35,230<span></span>
</td>
<td class="nump">48,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(833)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(2,607)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total net lease cost</a></td>
<td class="nump">$ 13,574<span></span>
</td>
<td class="nump">$ 17,406<span></span>
</td>
<td class="nump">$ 41,786<span></span>
</td>
<td class="nump">$ 51,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023468248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Lease Maturities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (Remaining three months ending March 31, 2021)</a></td>
<td class="nump">$ 1,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">6,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">6,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">6,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">4,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">30,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(3,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">26,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (Remaining three months ending March 31, 2021)</a></td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">2,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">1,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">10,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Total present value of lease payments</a></td>
<td class="num">(556)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">10,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (Remaining three months ending March 31, 2021)</a></td>
<td class="nump">2,689<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne', window );">2022</a></td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">9,119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">9,129<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">5,544<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">4,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">40,838<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(4,182)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">$ 36,656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023814600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Additional Information) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">4 years 10 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">5.28%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">2.98%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182204731960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">$ 10,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">9,628<span></span>
</td>
<td class="nump">$ 5,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember', window );">GEODIS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100581288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing costs</a></td>
<td class="nump">$ 40,377<span></span>
</td>
<td class="nump">$ 34,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation costs</a></td>
<td class="nump">10,901<span></span>
</td>
<td class="nump">13,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Accrued broker commissions</a></td>
<td class="nump">479<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">3,647<span></span>
</td>
<td class="nump">4,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedProductionCostsCurrent', window );">Accrued production costs</a></td>
<td class="nump">3,229<span></span>
</td>
<td class="nump">5,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Accrued sales tax</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">7,414<span></span>
</td>
<td class="nump">6,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">$ 66,569<span></span>
</td>
<td class="nump">$ 70,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedProductionCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Production Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedProductionCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023345928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 1,560,000<span></span>
</td>
<td class="nump">$ 1,745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt costs</a></td>
<td class="num">(11,308)<span></span>
</td>
<td class="num">(14,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">$ 1,548,692<span></span>
</td>
<td class="nump">1,730,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember', window );">2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2016 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">6.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5Member', window );">Term B-5 Loans | 2012 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 560,000<span></span>
</td>
<td class="nump">$ 690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5Member', window );">Term B-5 Loans | 2012 Senior Notes | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5Member', window );">Term B-5 Loans | 2012 Senior Notes | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentVariableRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentVariableRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024992488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 123,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182101236712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Maturities of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate Future Principal Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021 (remaining three months ending March 31, 2021)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">1,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 1,560,000<span></span>
</td>
<td class="nump">$ 1,745,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023422792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="nump">$ 3,269<span></span>
</td>
<td class="nump">$ 6,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2016 Senior Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2019 Senior Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loans | 2012 Term B-5 Loans | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">560,000<span></span>
</td>
<td class="nump">690,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2012 ABL Revolver | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">2012 ABL Revolver</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Fair Value | Fair Value, Inputs, Level 2 | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="nump">3,269<span></span>
</td>
<td class="nump">6,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Senior Notes | 2016 Senior Notes | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">613,500<span></span>
</td>
<td class="nump">603,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Senior Notes | 2019 Senior Notes | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">421,000<span></span>
</td>
<td class="nump">386,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Term Loans | 2012 Term B-5 Loans | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">560,700<span></span>
</td>
<td class="nump">638,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Revolving Credit Facility | 2012 ABL Revolver | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">2012 ABL Revolver</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182101191256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net</a></td>
<td class="num">$ (3,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100430920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments - Summary of Fair Values of Derivatives (Details) - Interest rate swaps - Designated as Hedging Instrument - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="num">(224,000)<span></span>
</td>
<td class="num">(1,905,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Other Long-Term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="num">$ (3,045,000)<span></span>
</td>
<td class="num">$ (4,412,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100781304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments - Summary of Interest Rate Swaps (Details) - Designated as Hedging Instrument - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLossOnDerivative', window );">Loss Recognized as Expense</a></td>
<td class="num">(1,415)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,837)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Gain Recognized in Other Comprehensive Loss (effective portion)</a></td>
<td class="nump">$ 1,053<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,347<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLossOnDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLossOnDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182025091864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares) | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned', window );">Voting rights, number of votes per common share owned | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voting Rights, Number of Votes Per Common Share Owned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_VotingRightsNumberOfVotesPerCommonShareOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024690648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Repurchased Shares (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 8,877<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 11,116<span></span>
</td>
<td class="nump">$ 50,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of share (in shares)</a></td>
<td class="nump">253,771<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">282,636<span></span>
</td>
<td class="nump">1,622,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in USD per share)</a></td>
<td class="nump">$ 34.98<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34.93<span></span>
</td>
<td class="nump">$ 30.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 8,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,900<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,481<span></span>
</td>
<td class="nump">31,117<span></span>
</td>
<td class="nump">31,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 37.95<span></span>
</td>
<td class="nump">$ 39.91<span></span>
</td>
<td class="nump">$ 31.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023056248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">$ 1,323,221,000<span></span>
</td>
<td class="nump">$ 1,170,971,000<span></span>
</td>
<td class="nump">$ 1,278,217,000<span></span>
</td>
<td class="nump">$ 1,156,494,000<span></span>
</td>
<td class="nump">$ 1,112,790,000<span></span>
</td>
<td class="nump">$ 1,095,831,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive loss into earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="num">(16,802,000)<span></span>
</td>
<td class="num">(39,241,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="num">(2,517,000)<span></span>
</td>
<td class="num">(4,864,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, reclassification tax</a></td>
<td class="nump">752,000<span></span>
</td>
<td class="nump">1,453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">2,088,000<span></span>
</td>
<td class="num">(56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit', window );">Accumulated other comprehensive income, accumulated tax</a></td>
<td class="num">(624,000)<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="num">$ (17,231,000)<span></span>
</td>
<td class="num">$ (44,161,000)<span></span>
</td>
<td class="num">$ (28,612,000)<span></span>
</td>
<td class="num">$ (26,058,000)<span></span>
</td>
<td class="num">$ (29,555,000)<span></span>
</td>
<td class="num">$ (25,747,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income, Accumulated Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024804872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 40,873<span></span>
</td>
<td class="nump">$ 38,058<span></span>
</td>
<td class="nump">$ 129,168<span></span>
</td>
<td class="nump">$ 105,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic earnings per share &#8212; weighted average shares outstanding (in shares)</a></td>
<td class="nump">50,212<span></span>
</td>
<td class="nump">50,378<span></span>
</td>
<td class="nump">50,268<span></span>
</td>
<td class="nump">50,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of nonvested restricted stock units and options issued to employees and directors (in shares)</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">453<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share (in shares)</a></td>
<td class="nump">50,561<span></span>
</td>
<td class="nump">50,831<span></span>
</td>
<td class="nump">50,635<span></span>
</td>
<td class="nump">51,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per Common Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in USD per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 2.57<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in USD per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 2.55<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024887528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Antidilutive Securities) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182025151848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 04, 2020</div></th>
<th class="th"><div>May 04, 2020</div></th>
<th class="th"><div>May 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per participant, 12 month period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod', window );">Extension of plan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to nonvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation costs related to nonvested awards, weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,900<span></span>
</td>
<td class="nump">302,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options, Additional Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember', window );">Restricted Stock Units (RSUs) &amp; Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Stock options granted, exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,700<span></span>
</td>
<td class="nump">220,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period (in shares)</a></td>
<td class="nump">3,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted', window );">Number of securities into which each RSU may be converted</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member', window );">Long-term Equity Incentive Plan, 2005</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Share-based Compensation, Aggregate Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,827,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares', window );">Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares', window );">Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)</a></td>
<td class="nump">827,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024387432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Based Compensation Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pre-tax share-based compensation costs charged against income</a></td>
<td class="nump">$ 1,588<span></span>
</td>
<td class="nump">$ 1,780<span></span>
</td>
<td class="nump">$ 5,944<span></span>
</td>
<td class="nump">$ 5,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit recognized on compensation costs</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">826<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue', window );">Total fair value of options and RSUs vested during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="nump">6,796<span></span>
</td>
<td class="nump">7,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from the exercise of stock options</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount', window );">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 963<span></span>
</td>
<td class="nump">$ 587<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024236712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Restricted Stock Units Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 04, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512,100<span></span>
</td>
<td class="nump">413,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">179,700<span></span>
</td>
<td class="nump">220,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued', window );">Vested and issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,000.0)<span></span>
</td>
<td class="num">(73,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,700)<span></span>
</td>
<td class="num">(34,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">613,100<span></span>
</td>
<td class="nump">526,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber', window );">Vested, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,400<span></span>
</td>
<td class="nump">138,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.49<span></span>
</td>
<td class="nump">$ 36.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.82<span></span>
</td>
<td class="nump">31.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and issued, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.38<span></span>
</td>
<td class="nump">47.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.11<span></span>
</td>
<td class="nump">35.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.02<span></span>
</td>
<td class="nump">32.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31.98<span></span>
</td>
<td class="nump">$ 31.71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024883416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Valuation Assumptions) (Details) - Stock Options - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">$ 12.91<span></span>
</td>
<td class="nump">$ 10.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">32.10%<span></span>
</td>
<td class="nump">30.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">32.20%<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182101310744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">1,020,200<span></span>
</td>
<td class="nump">944,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">249,900<span></span>
</td>
<td class="nump">302,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(65,800)<span></span>
</td>
<td class="num">(36,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(155,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">1,204,300<span></span>
</td>
<td class="nump">1,056,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period (in shares)</a></td>
<td class="nump">696,200<span></span>
</td>
<td class="nump">602,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">$ 35.90<span></span>
</td>
<td class="nump">$ 38.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">39.98<span></span>
</td>
<td class="nump">30.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">20.14<span></span>
</td>
<td class="nump">27.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">41.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">37.61<span></span>
</td>
<td class="nump">36.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">$ 39.50<span></span>
</td>
<td class="nump">$ 38.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options, Additional Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, end of period, weighted-average remaining contractual term</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, end of period, weighted-average remaining contractual term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, end of period, aggregate intrinsic value</a></td>
<td class="nump">$ 3,987<span></span>
</td>
<td class="nump">$ 9,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, end of period, aggregate intrinsic value</a></td>
<td class="nump">$ 2,786<span></span>
</td>
<td class="nump">$ 4,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182019414504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (percent)</a></td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">21.10%<span></span>
</td>
<td class="nump">25.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Effective income tax rate reconciliation, tax credit, foreign, amount</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024465992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Expected Return on Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 1,333<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(653)<span></span>
</td>
<td class="num">(722)<span></span>
</td>
<td class="num">(1,947)<span></span>
</td>
<td class="num">(2,164)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit income</a></td>
<td class="num">$ (370)<span></span>
</td>
<td class="num">$ (147)<span></span>
</td>
<td class="num">$ (614)<span></span>
</td>
<td class="num">$ (435)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182023541400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement', window );">Lump sum payout</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement gain (loss), before tax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember', window );">Non-qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected employer contributions, remainder of fiscal year</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember', window );">Qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected employer contributions, remainder of fiscal year</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024488056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk (Details) - manufacturer<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturers', window );">Number of third-party manufacturers</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Customer Concentration Risk | Walmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.70%<span></span>
</td>
<td class="nump">23.20%<span></span>
</td>
<td class="nump">21.70%<span></span>
</td>
<td class="nump">23.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Supplier Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.90%<span></span>
</td>
<td class="nump">66.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts', window );">Number of third-party manufacturers with long-term contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember', window );">Top 5 brands | Sales | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">43.60%<span></span>
</td>
<td class="nump">41.70%<span></span>
</td>
<td class="nump">45.60%<span></span>
</td>
<td class="nump">42.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers with Long-term Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturersWithLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pbh_WalmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pbh_WalmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182106930216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 238,788<span></span>
</td>
<td class="nump">$ 241,552<span></span>
</td>
<td class="nump">$ 705,604<span></span>
</td>
<td class="nump">$ 711,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">99,901<span></span>
</td>
<td class="nump">104,057<span></span>
</td>
<td class="nump">295,188<span></span>
</td>
<td class="nump">303,462<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">138,887<span></span>
</td>
<td class="nump">137,495<span></span>
</td>
<td class="nump">410,416<span></span>
</td>
<td class="nump">408,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">38,081<span></span>
</td>
<td class="nump">33,559<span></span>
</td>
<td class="nump">104,172<span></span>
</td>
<td class="nump">107,027<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">100,806<span></span>
</td>
<td class="nump">103,936<span></span>
</td>
<td class="nump">306,244<span></span>
</td>
<td class="nump">301,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense', window );">Other operating expenses</a></td>
<td class="nump">27,363<span></span>
</td>
<td class="nump">27,532<span></span>
</td>
<td class="nump">79,779<span></span>
</td>
<td class="nump">84,048<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">73,443<span></span>
</td>
<td class="nump">76,404<span></span>
</td>
<td class="nump">226,465<span></span>
</td>
<td class="nump">217,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">210,618<span></span>
</td>
<td class="nump">214,892<span></span>
</td>
<td class="nump">637,851<span></span>
</td>
<td class="nump">639,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">28,170<span></span>
</td>
<td class="nump">26,660<span></span>
</td>
<td class="nump">67,753<span></span>
</td>
<td class="nump">72,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">210,618<span></span>
</td>
<td class="nump">214,892<span></span>
</td>
<td class="nump">637,851<span></span>
</td>
<td class="nump">639,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">88,883<span></span>
</td>
<td class="nump">93,937<span></span>
</td>
<td class="nump">267,779<span></span>
</td>
<td class="nump">275,679<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">121,735<span></span>
</td>
<td class="nump">120,955<span></span>
</td>
<td class="nump">370,072<span></span>
</td>
<td class="nump">363,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">32,859<span></span>
</td>
<td class="nump">29,025<span></span>
</td>
<td class="nump">91,553<span></span>
</td>
<td class="nump">94,634<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">88,876<span></span>
</td>
<td class="nump">91,930<span></span>
</td>
<td class="nump">278,519<span></span>
</td>
<td class="nump">269,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">28,170<span></span>
</td>
<td class="nump">26,660<span></span>
</td>
<td class="nump">67,753<span></span>
</td>
<td class="nump">72,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">11,018<span></span>
</td>
<td class="nump">10,120<span></span>
</td>
<td class="nump">27,409<span></span>
</td>
<td class="nump">27,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">17,152<span></span>
</td>
<td class="nump">16,540<span></span>
</td>
<td class="nump">40,344<span></span>
</td>
<td class="nump">44,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">5,222<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
<td class="nump">12,619<span></span>
</td>
<td class="nump">12,393<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">11,930<span></span>
</td>
<td class="nump">12,006<span></span>
</td>
<td class="nump">27,725<span></span>
</td>
<td class="nump">32,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contribution Margin</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and Administrative, and Depreciation and Amortization Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182029289144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Revenue) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 238,788<span></span>
</td>
<td class="nump">$ 241,552<span></span>
</td>
<td class="nump">$ 705,604<span></span>
</td>
<td class="nump">$ 711,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember', window );">Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">29,850<span></span>
</td>
<td class="nump">28,505<span></span>
</td>
<td class="nump">88,881<span></span>
</td>
<td class="nump">86,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember', window );">Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">20,748<span></span>
</td>
<td class="nump">29,963<span></span>
</td>
<td class="nump">55,970<span></span>
</td>
<td class="nump">79,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember', window );">Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">64,486<span></span>
</td>
<td class="nump">62,119<span></span>
</td>
<td class="nump">197,925<span></span>
</td>
<td class="nump">186,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember', window );">Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">45,322<span></span>
</td>
<td class="nump">44,742<span></span>
</td>
<td class="nump">119,174<span></span>
</td>
<td class="nump">124,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember', window );">Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,492<span></span>
</td>
<td class="nump">27,254<span></span>
</td>
<td class="nump">80,693<span></span>
</td>
<td class="nump">82,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember', window );">Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,393<span></span>
</td>
<td class="nump">23,884<span></span>
</td>
<td class="nump">82,423<span></span>
</td>
<td class="nump">78,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OralCareMember', window );">Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,993<span></span>
</td>
<td class="nump">23,795<span></span>
</td>
<td class="nump">76,416<span></span>
</td>
<td class="nump">69,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember', window );">Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">4,122<span></span>
</td>
<td class="nump">3,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">210,618<span></span>
</td>
<td class="nump">214,892<span></span>
</td>
<td class="nump">637,851<span></span>
</td>
<td class="nump">639,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">29,427<span></span>
</td>
<td class="nump">28,330<span></span>
</td>
<td class="nump">87,917<span></span>
</td>
<td class="nump">85,696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">16,871<span></span>
</td>
<td class="nump">25,221<span></span>
</td>
<td class="nump">45,105<span></span>
</td>
<td class="nump">63,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">60,257<span></span>
</td>
<td class="nump">58,576<span></span>
</td>
<td class="nump">187,159<span></span>
</td>
<td class="nump">177,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">31,886<span></span>
</td>
<td class="nump">32,645<span></span>
</td>
<td class="nump">93,654<span></span>
</td>
<td class="nump">96,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">23,166<span></span>
</td>
<td class="nump">24,095<span></span>
</td>
<td class="nump">72,785<span></span>
</td>
<td class="nump">73,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">24,602<span></span>
</td>
<td class="nump">23,286<span></span>
</td>
<td class="nump">80,097<span></span>
</td>
<td class="nump">77,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">22,907<span></span>
</td>
<td class="nump">21,451<span></span>
</td>
<td class="nump">67,017<span></span>
</td>
<td class="nump">62,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
<td class="nump">4,117<span></span>
</td>
<td class="nump">3,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">28,170<span></span>
</td>
<td class="nump">26,660<span></span>
</td>
<td class="nump">67,753<span></span>
</td>
<td class="nump">72,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">964<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">4,742<span></span>
</td>
<td class="nump">10,865<span></span>
</td>
<td class="nump">15,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">4,229<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
<td class="nump">10,766<span></span>
</td>
<td class="nump">8,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">13,436<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
<td class="nump">25,520<span></span>
</td>
<td class="nump">28,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">3,159<span></span>
</td>
<td class="nump">7,908<span></span>
</td>
<td class="nump">9,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,086<span></span>
</td>
<td class="nump">2,344<span></span>
</td>
<td class="nump">9,399<span></span>
</td>
<td class="nump">7,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_AnalgesicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_CoughAndColdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_GastrointestinalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_DermatologicalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OtherOtcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182100429192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Revenue by Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 238,788<span></span>
</td>
<td class="nump">$ 241,552<span></span>
</td>
<td class="nump">$ 705,604<span></span>
</td>
<td class="nump">$ 711,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">197,296<span></span>
</td>
<td class="nump">203,920<span></span>
</td>
<td class="nump">599,931<span></span>
</td>
<td class="nump">604,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 41,492<span></span>
</td>
<td class="nump">$ 37,632<span></span>
</td>
<td class="nump">$ 105,673<span></span>
</td>
<td class="nump">$ 107,512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140182024206664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segments (Goodwill and Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 579,559<span></span>
</td>
<td class="nump">$ 575,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived</a></td>
<td class="nump">2,283,131<span></span>
</td>
<td class="nump">2,265,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived, net</a></td>
<td class="nump">198,594<span></span>
</td>
<td class="nump">214,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,481,725<span></span>
</td>
<td class="nump">2,479,391<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total</a></td>
<td class="nump">3,061,284<span></span>
</td>
<td class="nump">3,054,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">546,643<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived</a></td>
<td class="nump">2,195,617<span></span>
</td>
<td class="nump">2,195,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived, net</a></td>
<td class="nump">195,248<span></span>
</td>
<td class="nump">209,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,390,865<span></span>
</td>
<td class="nump">2,405,221<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total</a></td>
<td class="nump">2,937,508<span></span>
</td>
<td class="nump">2,951,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">32,916<span></span>
</td>
<td class="nump">28,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived</a></td>
<td class="nump">87,514<span></span>
</td>
<td class="nump">69,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived, net</a></td>
<td class="nump">3,346<span></span>
</td>
<td class="nump">4,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">90,860<span></span>
</td>
<td class="nump">74,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total</a></td>
<td class="nump">$ 123,776<span></span>
</td>
<td class="nump">$ 102,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAssetReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M',C=VZ+=A1)M_\+E5B@EZO[CAC,0K@W@][4 &NXO]#N<X9W=ZC]02P,$%
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M!9#MFZ9<=]\_^%@V3;GJ7B[31(IV"Y!_ORO+YON;]BL-NZ_A7/P/4$L#!!0
M   ( +0R1%*K??O'\0<  .@@   8    >&PO=V]R:W-H965T<R]S:&5E=#8N
M>&ULG9IK;^.V$H;_"F&T0 NL8Y'4=9$$R&47#=!V@TW;\^'@?) EVF97$EU1
M=I+^^@XE6W3$BW.ZN]C(\I!Z.1S-,R1S^2S:;W+#6(=>ZJJ15[--UVT_+A:R
MV+ ZEQ=BRQKX9B7:.N_@8[M>R&W+\K)O5%<+$@3QHLYY,[N^[.\]MM>78M=5
MO&&/+9*[NL[;UUM6B>>K&9X=;WSEZTVG;BRN+[?YFCVQ[O?M8PN?%F,O):]9
M([EH4,M65[,;_/$NC%6#WN(/SI[ER3520UD*\4U]>"BO9H%2Q"I6=*J+''[L
MV1VK*M43Z/CKT.EL?*9J>'I][/US/W@8S#*7[$Y4_^%EM[F:I3-4LE6^J[JO
MXODG=AA0I/HK1"7[_]'SP3:8H6(G.U$?&H."FC?#S_SEX(B3!M"/O0$Y-"#3
M!J&C 3TTH/U !V7]L.[S+K^^;,4S:I4U]*8N>M_TK6$TO%'3^-2U\"V'=MWU
MG6A*F!16(KB2HN)EWL&'IPY^P&QU$HD5NLOE!GV&&9=HCGY_ND<_?/<C^@[Q
M!OVV$3N9-Z6\7'2@1O6Y* Y/OAV>3!Q/SM OHNDV$GT"!>7;]@L8Q3@4<AS*
M+?%V>,^*"T3Q!T0"$ECTW+V[.<X\<NCH6=KW1QW]?=FR-N]XLT8W*E1YQYGT
M=!N.W89]MZ&CVU_AU>9-(6IF<_G0-N[;JC=X?XU)AN/T<K$_]83%+(@(C4:S
M-]*B45KD'?%-^2<$[! UG8"7O!!-P2N&FE&SNJ\^%2JBMJW8<YA[M'Q%8O16
M/GKKH\==\:@I]KKKGD%V*W@^Y(RF1'DMVH[_W=^P>7#H+CIQ#2$Q228.M%CA
M. [M_DM&K8E7Z\]"PNO6H)++K9!YI5X]\!%XIGOMM;._=GRK_&L3GE@D!1/9
MI@U.':+3471ZQL$KUK8PB<<)SE^F<3[H2XUG)UDR%6@QHBFU*\Q&A9E7X<W)
MC"N7EFS9(='R-6^&>X60G55R9JBA49Q-))M&)(ECNV0<Z+0<>$4_=:+X-E>
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MF)HG'3W E["[-:M0E3 FM)&0 WI"NB885*TH>ZI 7%NE(-Y98X>F-<O.1MM
M7QJ<UY$6'K\*1+9O#5SF*]_>RN.3VTV@DJ5+!1RF+O\%E\QWM#W6)9&X1-G"
MS<MIN.Q"D2,LB5#\QL<NF:NNG:.R?H1^YE\0-JB2 GDS$>#W$*LR6\%,(<SL
M[_W^YFKO *(VB)<"9UFSK,(<1VF00"G/_"\[1S&M:5 NZ1(OX59,9-C?N[SZ
M[>W+P]/O]PZ.*,C/%J$T%>/-%6(%0>87WJEI^B=,Z!6P] T<4KK:PU6_KG!X
M_U.<L5BP+,-QNP,H2^\0I*%&]LU@9P2HNMH2JY8F^64#&0HXT=R$"J80?^4<
MW-I!O8B(0JWFHUB#@HX0!A;<XCJ2!^?GTPJE"MP+YR#\G8V5.H*:3-0=-.IC
M!(;$(6OXGZ<LF<8-_6ST:H)V*WOC-!8K12\< 9,Q6KK&U>LJW"IN*$#F15:%
M%&]#^*+/B01RQK..S*M>^(*GY\B/3E-P R4^K8EN[<KR'\=, 0X28WVC43''
MXA5(#'3-YE1@8$1IPDKRAJXJMYY3\R$E:MY?,*&Z.$(2+ZZ[%KBS:38VX@>,
MD:3L-/C;%PY9\#N>]P!<QR,'DU#5#)(B-'"V9+R.(8G#*TDNR $25,&GA[8]
M7(7:T>8 U2*;(M$(<U=Y8/-@OT3 *S[2]FN-68T1'M)[F;A9@;L2\!%'!IF[
M#I&I";S>"L+2%:S!HX/6O;\H^\+'U)H_D-00\LB\E]#"#3 02"9A ?41F$!@
MB&7GU2CGUG[B!6&&N!%B"36PG9A)=KEAO6(\QM M5TA).?X64:SHF&B< E9;
M!BELZY \J3'\[@&B!<VY3S?Z!F) RAF@!S')PG/ZW=.4(6@&#$*"71*/*=)+
M1Y(<JK"$-:H#N7;WJ,8M[5>.NJ30YF^V7C_%WU6I ?RCA2\#2P6* NK$@6;B
M+M$GQ\U=XQ8"+8L8ZIY4Y,Q9^47+L+E7:W?55<3&&#-CQN(Q'Q$?< >C>76[
M1#U5<Z#Q6!S*)HC='(]#J/:QI5IHW"BT#;)OP(M&I>8C2N%T7TK5KD@S-,&Z
M!/YAHN!G!ODOIP.>J7PMMD$9P#Z[Q7LET,<J@93>BF"FR,(GN)J)>"I!#/[D
MX TB+5*D%;YY)YWMG.S3.9]J&H;;;I&?PHD/!+2&8"4CZMA)KM?(WYB>PJ ;
M*!_'U$%9%HB+0FA8 'N Y_ZQT]2AN[$174X6*!O>DMYXN<<Z+5@D6_88I^#B
ME 8M7>H3>MV18TDI6MN6)";UD@ZQ,JU; @(DLY#PEBMO4)-A)/AVC"W!4X!M
MQ1_"5G.D2LD"P<D$B0LG FPA;I!6 +&E&F72DTL5'A!CK>R6D?K,S"'':!9+
M#31J-EAM O1U2&VO\WA\G%1:NUQ&;NTF;!=(Q&A/DMHSYE;J"N");T4Z*8X4
M<1=:\*3*HR$H69\U_T,C3IO6I"72D-G0*R"YE59F 2!7ELR!AP35"I%Z""O4
MDWT;Y\HDR8FH+7PLNEKQ*?7U3T)!(X&\ZK:Q,"[;ES63H&040]$&G"H( P"5
M4I8Y4*1>7!%')RIB@MK>3LF),J4[SLB$(R2GY-6SK"(M<Y^BU$$2LKK=19W&
ME!BB.>?"SFYDXEVQ-$6DB2BYH,A=T;A@S,8QRF2Q'<Y5NN,$FW"(, $"(KH^
MDB;LKIH,A$O#((E$&F,]E/6>$U93NK4PA<8L.FEP)PU9ZID5H3G3G3L,AS2Z
M98NY9BO L)O:D-39-SH.\X.Q16-D\%+B$-LU?<HG A5%V^(4/6.T&9"A*P."
M,HQL&DTMPJ*55E55QX-U8+ZS=<J\29/E%O'\L0D;A9D.5LA6S*WN8#I-['G?
M[_.0>W3YR+SI 59;&B=1V$>_<MC!K1"JQ-IT%SP&KZ#9M&LXOAH=/9LP<H7-
MSP:W^TJ 'WUFN,%(ZAH+K[7:BCVT*1.&JAF<QQNB\)SL#+?8/TK?9POP_9*P
MH+6*O[M&P :\%KNNB7@*19+*1>'6[3@FV&Y[(/[05>=N_\?S\W=#NZ\TB1:O
M47A[J;72"M+FB"*5BMT85AQ>FM.3PW^3%>=87(!9GI[PP&NW["JUUOO#?S\R
MYZ(1=B-L2)>0HTO#W_6S$SUGS &M!Z'5YC@/;(2U4 41G0UZY5HWD3U-VN!S
MEN,)EQ9-^Z8>#*5)=D)=$*J*QJ-C'+&EL=F\Q72F)VVL8.\:-$LQ#24,C$D[
MK7^X:]\RARW_#C*>H87G^B3^P"$-#40?%5V,XJ/I6FG%B$+R$&@\3FM0/%)B
M<T&;6;.PX)>#G:;T8A!PM&=?#6=?R*M)%5SDU.^#BG =RDGT'YDK87U"\J1_
M *I*_FD#]NC4:/EW%K^XX @1E0=Z?6'Y!RTKY$&)J :3-+]R^+X[6A[)#/CT
M /7;]J1T2SRQO/SERAV2BLU5TJN!&?36Z@W2L(FK=82M&[V$6^HY>&D_A!:_
M*4=1AWFAR:@6RJ)P5+^K',GR,.^;<%<.1^V0OI=8->U)R'\/R!1CI^8$W2&"
MSPF=MD^5OZ, :BTCC-&JD\,><$3V%,%2!QI,CK)O&\Z;IL,SUX)4]$F/2/_Z
M.3/@V2TKG!R9#UH-7B&W:H%+:?\$C(<Q_2YDR1H2JI0>0$'!I&&J/"*!3D\_
MPDW#*<+ 4]]Z9V=F2D;!%7[9;]2$?NUX4G(#+[%S3J7\..<MJI#RS%T9X)(G
M?^X9/458?(;=74K.=+Q!,$J?%2NBG@O=% J.0)1Q5"ECZ<E#4KT$"0C**,-L
MQS,)&,T"!>;2 >=23^91N7*I>@'MJ!0/S$H--(?VVRB#[.!HL*Z/;IB0"%F;
M<7&G7$$22#E'Z1><\N=&/DS%49R27F1:0D9Q>[C6YVI;]C.:QDWBGB+<V*H;
MX@G ");O.8A1_\QT7'2HJK,ZP8CY+9(@-1\7$Y1NWO8#?B1%%S/\6DZ2I'3-
M6-5*&3'4(0^_IW<]I_-M0"4(<Z2@2X63^8A:<R :R@H*=LFM_>2V4W[DM;@W
ME(=$E&:?#<@Z+X,PDO-QQW?H6&2*K/GSEM/[):H6$O'TB8Z 1R"8/ =,:$H;
M42 N L=\^WNOS]]?[/']2.JVCQB7?EA+;._OG;__@*4\XO#TT<R\IC5_$VO^
M["P31A)T_U>4\,(\.3LY^,&\')/I=;2UX^M?<V@N<Y>NX_CIJFM->=6+AMM]
MBO8@V+ I!PB1+J]38>N 6+S5Q!PWC]/-\<0@Z2R30^6O!?C69&+T$QL3\TB\
M/1 #T*:>S4C3EGTXT*KQU/QR _Z/G$DJ[\BMP1TEF++*XEF?A%VP1X!#!&EX
M88+"J7]ULTT-J(E8@WFTO7SNEKZ1IL<N.,$92N;I-\1P#I/0K-@<;V+/E,-@
M(M<YB'-E,NI/NB0^QJSDD%BG%UL=R)W&XP&O7?B&I4.9AV3?YJ!&M ZQ^OZ#
MW-%8'#9X*]1:[8E TQ=%/X5$(,VA^>CLVP/<FP8M^[ZMI2R!._?<UY%7-T\R
M)0+X6S24BN.](P^^%IX E!NPR5V%PG1\':CQ*&-F_$:KN$WEYYP8#T0EOPVK
M!LG';?U$<CI*7^?QI:'72&8*2A,Z;+-R59ZBC\5&0O"6I4YHY'A#IW%4=HDV
M4MJLH6@/<8LC.K[X^5->'.P2F_F*'),>)&?23AVF/;[4$L5GG6ER&C],#B!B
M90ME/'RHDY?A]X\$/;GQH4N<,"32Z0^L>.HL3A%DE8PP[0@@^8UV$5#(_AR+
MW%U/#)IRI%D4>:AIL)A>E30T\QA \:),JJ2<C5X>584PJ#(<V4\7S(8B/GV=
M)*7%)M2J>7XWQ*D1W"6_\;!#>]'>QYZA$] 0S</M;33JADG4O3'S79JOO/C_
M$YH,]?3MO5KWD')Z'WE0!1_S7<C(,  JUZ[-%<9<Z)L-PM!+_,&/%?(E\PZM
M,:__J'.''IB^._WF\"\JFSM/_ NJ)O?.(\&8J:*\-<7E,A^9W^B8=?XLC"\;
M!79 ;MHXVF<M1OA?*J3K;E[)BU=.*W85T[ZUVUD9V=V,8[SA->TD3'7$.XEP
M?G?S%Q3 01"6Y\^&XO>'IV<S?G%!COFK<,P^I!XSGM[CZ JN[=N(\VURNO7@
MUX)D&.)H'^YRI\Q6?_J] V<"X,NWP,?-RFG9R;YUGSAC4[B2@;:TF&2_'3R;
MV"R\;?450U+!Z;!Q2C7R9?< '+L?"]T.[W^%&A&:1CQ^,.7ZOXJ:N]^#W ^9
MLY/#$Z#7, HRU_0H?K+O[RG\XR>(G=?ZD8T=!7;F51XURWARUPY;].EZH M?
MBRWQ595=)5V4Q =C:4J$!7:&]W_\O@]U?X765B=%.BU-*[_.%%GA9VM"*5N,
M7[;]]/;BZMI(&.OB\9:\HIJ6\KFB8__F\:%<;_PF09T/PPR<B22,+U_E+6#@
M*P':;=[%TC7]%'N2KW>$BV+S(W/>]$1-WG14$FZAM^&VD) JK=70<E.^0[@W
M0SO3$L[YIU(-K'6Y_\Y0TH?G(D>U7(;V@VX/#MQ=GV@>3[Z:E3<W_#98Q@U-
MJQ_0#E>'SX_/]:O;<;E^NXR<0'PD4[D%'CTY^NZ;/1/U>V#]T8:U?(,[#VT;
M:OESY4 O(Q?@/H?G_0\>,'R4_>*_ %!+ P04    " "T,D12-AVM^'4"  !*
M!0  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;)U42V_;, S^*X2QPP8$
M]2M)TR )T+0KUD.!H,76P["#8M.Q4%OT)*5N__TH.7%=8,V 72R2XO?Q85*+
MEO23*1$MO-25,LN@M+:9AZ')2JR%.:,&%=\4I&MA6=6[T#0:1>Y!=14F430-
M:R%5L%IXVT:O%K2WE52XT6#V=2WTZQHK:I=!'!P-]W)76F<(5XM&[/ ![?=F
MHUD+>Y9<UJB,) 4:BV5P&<_78^?O'7Y(;,U !E?)ENC)*;?Y,HA<0EAA9AV#
MX.,9K["J'!&G\?O &?0A'7 H']EO?.U<RU88O*+J4>:V7 :S '(LQ+ZR]]1^
MPT,]$\>7467\%]K.-TT"R/;&4GT <P:U5-TI7@Y]& !FT0> Y !(?-Y=()_E
MM;!BM=#4@G;>S.8$7ZI'<W)2N9_R8#7?2L;9U:UZ1F5)2S2+T#*A,X?9 ;SN
MP,D'X NX(V5+ U]5COE[?,B)]-DDQVS6R4G":\S.((U'D$1)=((O[:M+/5_Z
MC^I>X5J:K"*SUP@_+[?&:AZ'7R<BC/L(8Q]A_'_].PEV"S<WC<AP&?!&&=3/
M& P982AGQ)M@+% !MD0HJ.*%DFHWA\^WBDVT-T+EY@MP$['>HNX;"7="9^6;
M>D5U0XJ)C2,;QMB([$GLF!28"K1H>=0L:BDJ Y]@-DK/(SXO1K,HA4?>-I *
M&DT9&@-I$D,ZF<"-5)+G,8<=46X@CAC&0>-H,II-9^_"?8(X/A]%<>REZ2A*
MIO"W?Q(.YKM&O?-;[#JR5[8;]=[:/Q27W7Z\N7>O#+>"ZS-08<'0Z.Q\$H#N
M-K=3+#5^6[9D>?>\6/)CA]HY\'U!9(^*"] _GZL_4$L#!!0    ( +0R1%(S
M0\GE/08  #,.   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;*U776_;
M-A3]*Q=>,;2 ZF_'<9<$2-)US4/7HNW:AV$/-$597"32):FXWJ_?N:2D.$O2
M#L. P)$HWJ]SSSV43G;67?M2J4!?Z\KXTT$9PO;%:.1EJ6KAAW:K#)X4UM4B
MX-9M1G[KE,BC45V-IN/QT:@6V@S.3N+:.W=V8IM0::/>.?)-70NWOU"5W9T.
M)H-NX;W>E($71F<G6[%1'U3X;?O.X6[4>\EUK8S7UI!3Q>G@?/+B8L[[XX9/
M6NW\P35Q)6MKK_GF*C\=C#DA52D9V(/ OQMUJ:J*'2&-+ZW/01^2#0^O.^^O
M8NVH92V\NK359YV'\G1P/*!<%:*IPGN[>ZW:>A;L3]K*QU_:I;V+V8!DXX.M
M6V-D4&N3_HNO+0X'!L?C1PRFK<$TYIT"Q2Q?BB#.3IS=D>/=\,87L=1HC>2T
MX:9\" Y/->S"V2_6YCM=52>C &^\-I*MY46RG#YBN:(WUH32T\\F5_E=^Q&R
MZ%.9=JE<3+_I\*620YI-,IJ.I^-O^)OUI<VBO]EW2B-A<KHR09B-7E>*SKU7
MP=-+[65E?>,4_7Z^]L&!(']\(^R\#SN/8>?_ =%_9TGGH+NT1NI*B\A=6U H
M5:*P#GL21<&L-AO:=#;K/6%2G8BK7FTP.(&T)^&IL!5FS[^@IU<&?FSC@8A_
M1K]:%THZKY734AAZ^_&285+.Q*"BBBN7UGA;Z5P$E=.%J(21BI[3&^%DV7>+
M^M2?T'(RSF:+.:ZFQ]EB=L1+L^/L>#6F<RF;NJFB*UUOA78Q2W3!T]/)T2Q;
M3B;/Z,<?CJ>3Z4\'*X^&7<R/LJ/YK(NT6"ZRR7)%/T=X/,,&V<)@&HR2<\K(
M/:FOL@03% $JY?M@\VQV/&Y_;\.!DJI>*_= H5V9LVFVFAS1<C[+ILO_H\3[
M,9_T=3[IPF%IN<H6BQ6]A;+QGVG0,.@36IXWCDG C"ELPSW^T@B'QC(@2@#
M MS']KT2+B/KJ 9*5#CUI4&RU9YT0>!?KID'GC2N)"J"1Q&B6RF<VW.,&U$U
MJJ<G#Q;$:4_&!EJKR.(;<!)3EV'=0.4C&N I'R<@)[;<L'2W'J([YJQ'SX!@
ML+<$YRE&QP+SV1U@.V0(7JFU0XU[FJX2:%GTQZQEWT"A@^B@*2EVW(GR=_QC
M;%>M=9$_!]M%RM=#[_N*,25[AAS)91A/:5T.6*I]%CW=VH)S#IS;P4<0UPH3
M;6)2_^!SH0U8H)&F#TB=3?V0/BMJ K3@+Y6*0O-L8YAA4G@T$\--M<)@1\
MD:Y3M]!3)'#;)([HU!9CS[UKC Y1'[8@1U=1#_=!\HQZS$)4WC(QO,X!5A[]
MX2B_1M>EV.H@D&,2+/#D7DLXE+1PZU)G(X";C5,;SO8V4_](JAD;,<<P2FR+
M=Q /F0*Y#"^U1EWY**MQOA&<O_T>;K:RF_V0/F+7K3T3#N&:>IO&H!:Y CO:
M%/H)^S["3-R6W'?DO,'!Z:HX1R*=2;P5FK]&LX/F%!Q'9'K&L?3-^D\(&Q?$
M Z(+UNT /U*Y@!<PMAE&Q>XF.:.H=APBZ1U3FC4>9<9HVA153"K#NXS$B12/
M#U'QUMA<V )Y;23#S0^YA2KH9--[9U8T.$D(KX8%YRL5-TS)TFB6&I'?B+1F
M&:&\D9VV\".DKZ-S3BDQBN]82EB4M.-1>V"> $0K,RYGP36I)4W J1X9B[3@
MJ<&1!_AJBWX@O+KAN:)=J3%[H$2%_CB]V2@7HS \NKXS^>V89ZT-T*@:#LC1
M>)^,\W/Y]M/5R^>3510H?@2=TQA*Q2](]W5]B#<1-KOW &' 5H4T\,('2TA)
MFW(I;D S&0^S/,GQ+N;?2_36!NS4=X4.0;JY'M)KNX,WEP2RQ0?.<&BTHXL6
M>-[!+QJ'5:5N1/D#T GD^SV)BA*+=Y@J'+0Y] 4 U%JV6,<BVG8R<*:=&O;,
MAU=L:SJD(S]Z:I48#-;#CZ7VK:_;?#J#3E@.!K<5SYX?]T^"7L=AW0,?]W9R
MD#\PZ!VF64L(IBR7_)P=T ;OC3AZ7:\EG?ZDI>%#KYJC@Q=Y5+R)GRNQ5A/2
M.WV_VG\1G:</@=OMZ7/J31I=JE0!T_%PN1B02Y\HZ2;8;?PL6-N CXQX6>*K
M3CG>@.>%!97:&P[0?R>>_0U02P,$%     @ M#)$4N5M(D11"   ?10  !D
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M7X,&P2 ./*!V*'Y#>CP&G]\CH'D99A$("XN&$Q62;X*\MO&>P3UC@QU]5'D
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MS^W?KN?MD^U!O'WXHJM71:UA<PE5']X/VIMMMS%RXQYP,VGP''3D&N]OH:P
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M*@L@>R6E.0HVP/"'L/@#4$L#!!0    ( +0R1%*_O/]R$P4  /@+   9
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M3J,Y&KY YQM-?F\WK* ?]B_^!U!+ P04    " "T,D12<U 1"44%  " #
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M.2!,M/6'-V68(A?&TTP:ECG]$8"6!>A\:8S??+"!]L^*V9]02P,$%     @
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MUV>'POG31_X!;;*!&G)"V."0*1&HA<PXO[HQCW/D"J.;;0'4#;#<4!(>.D(
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M]B3U174H#?O9<C<'0Z\MH%2X)4MZQ_;:L[GQ$'LJ]V:VW_L.]IU1SPUSO_E
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M',4ST%2"E*&RZ9H80C7W1ID-05UJS_16;A3">]._"&(%#,J_S]Y<OK^YS'X
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M2N?2I2^]8%.+%ZW<!M1;?$2GQE;' O@=^W38OK"!X>9]^B]02P,$%     @
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M)&=**''"7K+98Q+M)4?LK;;&WOMYTW9E/6'_N!J%KD5$_/.$>;TQKZ-Y_;]
M>-($*>]EF.>%OQA 6L&WCWZP;W=]P<JZ5R.%]30/;.1]S3!QGK=^C+>(]:)I
MQWE=>(13-V7=U+-]%+IF7A:L>8BO7U_=7[.K^QNFK#AC=XL6T=>V-*&-$_)1
MY5E8>U(TD&7H:/)/Y5_8;Q@P95<SWY9%7K.[#S?L5Y]7W;2 1RROQQB%8;=U
MY]LZ^IU7.Z/.V$?/_&->+?+.1X_FOHW;I%U@G08N(1>U>?1]XPD9SZNJ*6@:
ML,.PP@?LC6R$+9=)NV.@5"+YE-47!NRPBZXM1XL()!Y/RIJSY;0LIFSI2=O
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;,U9:V\;N17]*X066-B
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MBJ')^<4@ M.N;:LX:L*J+,GQX@6QXI<.C7?@^Q61VRL^0/=VSOX#4$L#!!0
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MEB:=7[;TM*!V"G1>*V7'C2.8'JO-WU!+ P04    " "T,D123/X]55P$  "
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MJMA=MZ0G$BJ[@+X74IK-P#KH'EW3?P%02P,$%     @ M#)$4BI8*J1I!
M9 P  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL[5?;;N,V$/V5@7J!
M VAMB=3-J6T@R>ZB 9IMD*2[*(H^T/+8%E8B79*.DW[]#BE;L7,QVN?VA2*'
M,V<N/$/3HXW27\T2T<)#4TLS#I;6KDX' U,NL1&FKU8H:6>N=",L+?5B8%8:
MQ<P;-?6 15$V:$0E@\G(RZ[U9*36MJXD7FLPZZ81^O$<:[49!W&P$]Q4BZ5U
M@L%DM!(+O$7[V^I:TVK0H<RJ!J6IE 2-\W%P%I^>9T[?*WRN<&/VYN RF2KU
MU2TN9^,@<@%AC:5U"((^]WB!=>V *(R_MIA!Y](9[L]WZ!]][I3+5!B\4/67
M:F:7XZ (8(9SL:[MC=K\C-M\4H=7JMKX$3:M+B>/Y=I8U6R-:=U4LOV*AVT=
M]@R*Z T#MC5@/N[6D8_RO;!B,M)J ]II$YJ;^%2]-05727<HMU;3;D5V=O(+
M4DH&>G=B6J,Y&0TL@;JM0;D%.&\!V!L 0[A2TBX-?) SG!W:#RB8+B*VB^B<
M'05\CV4?>!P"BUAT!(]W&7*/QX]G^,?9U%A-)/CS"&;2828>,WD#\T(U*R51
M6@-J#MX#?'B@1C'X6@6/@]TM$<H#P-H#8@L(U'E@2<<N-2((.0-)"-"T94=7
M=J"B83-%W17.Z[$H'L(&-5D9@JFI \TIW'F<_5,[-/_DT-_>[EU*"D6M#7DP
M)ZTS[^AI]K&20I:XS:-4QI["6:.TK?X6OA<I1^W:Y9V:OUL;%YY!2OU[R-B0
M1A;E-,8A'^;;U:6TE(:Q0,8M:EV):557MJ*SS3/@"<1%ZCZ_KE"3%[G8<T]8
M64X1AHP/(0VCK* Q(_3;)44%A-WL:[,$6 '9$/("/@M=N=XX0(M#1KG&:9CS
M&'A*L!$D!<6;P>UZVFI6D@X5H9<F)] K.*<QSMS(PBS*3^!.65&#I'MW#YFR
MYF&:)VZ2ATF4T22)P[QPDS0.BR@%QY>-OVWH:,0]9;M NA_=#?R4M4_)<>"%
MYJPRI5I+"U0E?,F.ETSZ\H]\]1Y1:.+#L_(;2/I%<<@( [R?IR]Q#R-[ 93V
MZ5!^> [%^D.2'NGIM.OI]&@;7@F[UBV?B)Y/WMO[X[6V/HKG?DU/S4J4. [H
MY]*@OL=@\JQY?J>:N1YS?JZ$+I>^ZL]]=RFWE*%#B:%WTQU">R\\70>'8$[[
MQ'?3L.#TS3VGB(.%[U@&69BF.0D*EL$PY*1$8DYB-N2=.&[[.R$QC_;$S(M3
M2,*8,_*1Q(PZ*TT2QU)Z),R)&[0Y)$;_^%W!8O;3=M6FLI:[,R<:M&1:B<?&
MWX,\"EE"F%&84ELE45CP@@IB#(C&LZ2[*#L3C;[2TM>NVET9/1YF+*/&2U,W
M4J@%V[7?5A_N1;W&5Q"I4EF8Q:YD%$B41#3A)$DS.$*YK*-<]B\HMSOEMPEW
M%.U_POT'"3?8>_DUJ!?^?6O 9]@^ CMI]X0^:U^.3^KM^YM.<%%)0P'-R32B
M&SIH?Z1W"ZM6_ATY599>I7ZZI+\!J)T"[<^5LKN%<]#]L9A\ U!+ P04
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M<FMS:&5E=',O<VAE970S,RYX;6R%5=MNVS ,_17"&X86R.);[*9=$B!I5ZQ
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M)G)<NDUYLIIF.?G9Q0UJ_LR<,G GC=4-"6X-C%9L+="<S")+BSC3*.L KUK
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M[0QHOE#*[CIN@?XQN?@+4$L#!!0    ( +0R1%*:C8VL"P,  .0&   9
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;)55VV[;, S]%<(K=@$"7Y/&[I(
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M-?2G$P]4UU,[P\C&];&E--05W;2DWQ J>X#V5Y+*>&M8@/['MO@'4$L#!!0
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M. :44D0_!UF]@U>"J5#G:/T0UJE",-P>9D$$HA]0ZT>836=O'[/0#Z W=,P
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M\1DC>#^QZ((AP0GK3_4^ZD 72Q#!>A Y_D@7=UO[OC-=+'L['AN:!Q2GNL?
M<J6XO>+&FHTOED" ]4!PY%%T)=WH+%I)VW,8;2:W]'G8N/028\2ZN)[,@)_N
M$E[>3]1OZRO0:7'Q]^[]-;R80<7[.;Q8E!><4GQYWWI+F*BZ#$1T)519YZY(
M$2NO,,L'GFZ+*[=ERL6,4_S<4!%@EA.([ZLTY6\/N8+Z(GGR+U!+ P04
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M9'FMK.8Y*:HW.M:):"E ?T3!K17<2Q6\6L$S@59D)JPEDF@^Y>P N)96UO3
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M,-<"ZO^&,7F:Z$.ZN93-_P)02P,$%     @ M#)$4HO,D*5Y!   $14  !D
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M/(H:"2<8GT K/((HB((=>L;OAH>]!CFMVK^6XVOMY2/7KH0V:D'%;>#G-07
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MM'HX/ ]HS2" H[=@-Z65P$YO6J2Z^0TRLP'99\-I\)[ @TZM !M9-A,!P;/
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M0%36@,XS*<W+PCIH)\OY#U!+ P04    " "T,D12\W-6-.T"  "U"   &0
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M#6S'S?1NZNDY9Z;G@B^T%"D'ZS(AB<%^-6X?C=C;TE6MOYQG?]TXHX0K$D^
MB]X#!SK0,)_EB\U19)+S_T9?_^?13YSAML'C:C[W#-\RQYRK$-%1!'Y\EOW@
MDR %_SG"[K7LGF;WSK!_I0+G !>T*H7<D]H@-$51S3353&IO?%J$81#,[*?N
MT@Q!D7<*60TA2/ZFIZCU$.7#R(<MZD2NW\KU1^7JU.HD&[AE=,=P,>+):4L]
M?8-U"EKV8'3B_U3% V&*7J<_N) I7V\$EZ:EJLG\CO,<WPT"U%NL(0SVULI
M%#I3M[]80QB:.H[O>>;E"EO5X:CJZR?"Y$D*]BR+Y5<ZX*A>;8EMB]$)-7?0
MF93K3:*PYX-P$&=]'YAYW)X+#"@X"<WZHU9_]&K9&0VS,X(]*<LAJ"]VB(@&
M-.LAR(<0GLE-!(_')!R5>T>XD"LMVC-P)'%0Y_!%;Y"8R#GR.Z^9F@W;2-(M
M#1#'"WO)NS*@7+F/]C;DM1$&T9G(1,=C";EOF)L-^4@D+AO(248%D\CON\$
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M%3QJ37,'7S9$: .8WW"N3AV]0/^MM/P74$L#!!0    ( +0R1%*=)\\MH@(
M ','   9    >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;*55;6^;,!#^*Q:?
M6FD+!)*NK0A2WJ956K6HT;8/TSZX< 2KQF;VT;3_?K8A-*E(%&U?\-L]SSUW
MG,_Q5JHG70 @>2FYT!.O0*QN?5^G!914#V0%PISD4I44S5)M?%TIH)D#E=P/
M@^#*+RD37A*[O95*8EDC9P)6BNBZ+*EZG0&7VXDW]'8;#VQ3H-WPD[BB&U@#
M?J]6RJS\CB5C)0C-I" *\HDW'=XNQ];>&?Q@L-5[<V(C>93RR2[NLHD76$'
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M(K67*T8AWV8 O'\00N]NS-?AZG\T9O\"4$L#!!0    ( +0R1%(\&?39J ,
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MPT&=2D?'R?,![P7]\Y9L;56 I,4V(+'*D:5YTDI0'5DP+LD&\P3(&<]M^!>
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MK=TD+L$23T:<[1'7:&5-#TSV#5OEBU!=)RO)U2Y1/#E9E%7!7@'0 TC"056
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M@X#WN+$K+,AP9?&A,+(LZBVUU,_W8B?F)'@=+W::2H9%]0PO^A)'(Q)BUXD
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M:_2?FL&;P7Q*2CW+M[^GJVIS/5$3M-+WR7Y;O<L??];M@'@=;YEOR^9_]'C
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MQ$I@=T\$;A W-MBH!>9'';^Y#UM@KMJ(D=^H8BLN"EVO449[YZ14>5N:*XJ
M.5M36?X3Z]7Z&G1I#O_&^M"]&+DMZV-];3(G\ZM\>>>Z(7R940$Y+I0IYSQ2
M/<?+:TPYD6QESND9DZJH9IBJJQ]R#5#?%XS)EXDV4%\F!_\ 4$L#!!0    (
M +0R1%+<PW=1 00  "@0   9    >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM
M;+V876_;-A2&_PHA]"(%THBD1'T4MH'$0=< W18DZ78Q[(*1:8NH1'HB'7?_
M?J2L2+*^[*Q ;V)*?L_A>P[%QV)F>UE\4REC&GS/,Z'F3JKU]J/KJB1E.557
M<LN$^68MBYQJ<UEL7+4M&%V507GF8@@#-Z=<.(M9>>^^6,SD3F=<L/L"J%V>
MT^+?&Y;)_=Q!SNN-![Y)M;WA+F9;NF&/3'_=WA?FRJVSK'C.A.)2@(*MY\XU
M^KC$O@TH%7]PME>M,;"E/$OYS5[<K>8.M(Y8QA)M4U#S\<*6+,ML)N/CGRJI
M4\]I ]OCU^R?RN)-,<]4L:7,_N0KG<Z=R $KMJ:[3#_(_6=6%41LOD1FJOP+
M]I46.B#9*2WS*M@XR+DX?-+O52-: <@?"<!5 #XWP*L"O++0@[.RK%NJZ6)6
MR#THK-IDLX.R-V6TJ88+NXR/NC#?<A.G%S<[9>XH!1[9QJR.5N#B%RE7>YYE
M@(H5N!.:B@U_SABX5HII]1Y<W#)->69&'\#7QUMP\>X]> >X $^IW"D3I&:N
M-M;L!&Y2V;@YV, C-FY9<@4\= DPQ' @?#D=_BLMQL)=TY"Z*[CN"B[S>2/Y
MJF: ![:5A>9B<WFHWMQ(I$BXT6_ G68Y^.N+"2V'ZN^)B;UZ8J^<V!^9^+7W
M0QT\1 9EI-V=+PL2QH3$,_>EW:DA&4%A(SLRYM?&_,F.M)X#6CX'$\62.B>9
M+/9.F/W&!=?L0V;V\FJHZ$,&TJH&X\A#'NI4/:0+B-?2'5D,:HO!I,5/+7N7
M0# ]Y#'HS8WBB,1^QV)?AI$/ SCL,*P=AB>:V%F849MA?WX_0B$F'9]#NC#V
MXI%61K71:-+HD]1T\+F.>O-Y,$ XZO9O2$=\$HXT,*Y]Q9.^?C,[/ 77.2MX
M0@7X_6D)/C.:Z32A!9MXRA%L$ M_+DU0B^[H?_.D"FTWE/A!X'N=OI_6'9MK
M((NF*?L6IJ"&H&@:H>=0I4IQO!=C$J"P6_MIX;'-AJ?(_W&R5#F.T4+,MNW:
M[.LPC /HC[AL"(U.(?I<NJ ! GLQC((N7H:$/B08C_ %-:Q&T[ >)0P:0&_L
MA03V^C@D)"@*QAK94!J=Q#0K!+6OKC1[ V0:NJ+H)T.F 2B:)N@D9.(^M7&,
M@F[C^S(<$2\8;CMNT(NGT?L6Q."&JGB:JN<@!O>I&9GWL.Z/VH LB$,T\KSA
MU@LL_G&\5#F.%L?SNVLSH/)],K8T#:?Q*4Z?BQ;<A[ %"^SZ[,M"'XV]'N"&
MU'B:U*-8J>+:K]H(>V'8:^" #N(0=EOHMHYQ]@QM3C4;+A3(V-H$PJO0E%8<
MCJ6'"RVWY<GN66IS3BR'J3G*L\(*S/=K*?7KA3TLUO\<6/P'4$L#!!0    (
M +0R1%+>M94310(  %H+   -    >&PO<W1Y;&5S+GAM;-566VO;,!3^*T(9
MHX51QTF3TM4V;(7"8"N%YF%O1;&/;8$NGBQG27_]),NWI/4H?=B2E^B<[YSS
MG4\71PI*O6/PF -HM.5,E"'.M2X^>UX9Y\!)>2$+$":22L6)-J[*O+)00)+2
M%G'FS:;3I<<)%3@*1,7ON"Y1+"NA0WS90<@-WY(0^\M+C!S=K4P@Q$]G'W]5
M4M]\0&Z<?)I,ID_G-X?X61TXQ]ZKI(LWD%Y,QWE-;(QZN4_=I!NFMG*L\.I-
MFOXBJ2;VFE6-@E2*?G'GV &F,^& -H2%^)8PNE;45J6$4[9S\,P"L612(6UV
MU4CQ+5(^N[#O/+OA#0^G0JJZM^O@?M=-^D&@]:Q RE@G<(8=$ 4%T1J4N#-.
MG5R#+T*HL5>[PBC,%-GYLP7N"^K!-%E+E8#JVOBXA:* 06KE*)KE=M2R\&Q0
M:\F-D5"224%J#6U%8QC:&!A[M%_#SW2/>YL.]G1J=U1TIA'4F([&.99_R.:X
MA[3OXT4%W4C]M3+3$;5OSPH\*$CIMO:W:2=@C-T?9R=%P79?&,T$!S?Y-S>,
M M+6H5PJ^FRZV:,2&P 41AM0FL9#Y+<BQ0JVNCU.VW1<\^P$-?_;=<Y @")L
M*-J<_6->Y7<KGE_]+\GUO\JAX%<U-E?<L8M<G(+(Y2F(/($S.;\^2HU><S4.
M[M^]V[=#D7WEA/C>OJ=8WQ2M*\HT%8V7TR0!\>(2-O2:K,U#=X_?Y">0DHKI
M51<,<6__@(16_+K+>K +T63U]G<[/7]9-^Q?T]$?4$L#!!0    ( +0R1%*7
MBKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E
M\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!
M2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/
M06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3
MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MWX_&:3?4_&-VOMXG%_;3/"*;'I??\=L9O];_9!\"I \)TH<"Z4.#]&% ^JA
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M<',O87!P+GAM;%!+ 0(4 Q0    ( +0R1%+BER%L[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    " "T,D122G,MMJT&  "_&P  &
M    @('J%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MM#)$4LU0OY-( P  TPH  !@              ("!S1P  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +0R1%)Q+1T:R @  )(S   8
M          " @4L@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " "T,D12JWW[Q_$'  #H(   &               @(%)*0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ M#)$4BU3^C<) @  < 4
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +0R1%(N9&2 ; 0  -T/   9
M      " @4M6  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ M#)$4K>G9>;( @  ' 8  !D              ("![EH  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "T,D12O[S_<A,%  #X"P
M&0              @('M70  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( +0R1%)S4!$)104  ( ,   9              " @3=C  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ M#)$4KD>$_#I
M!   8@P  !D              ("!LV@  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " "T,D12]-'>\7<$  "."@  &0
M@('3;0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( +0R
M1%+: U[2Y (  *4&   9              " @8%R  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ M#)$4C7(%>13!   \ H  !D
M         ("!G'4  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " "T,D12WV,MW)$*  "#&P  &0              @($F>@  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +0R1%*2Y+D;3P0  /,)
M   9              " @>Z$  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ M#)$4HP8QIFV P  A@@  !D              ("!=(D
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "T,D12Z6.Q
M$CL$  !O"0  &0              @(%AC0  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( +0R1%):7DIQS 4  (4/   9
M  " @=.1  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MM#)$4CQ$.9*%"   \A@  !D              ("!UI<  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " "T,D12I;Z?+8,*  #A'0  &0
M            @(&2H   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( +0R1%)!XY,,?0(  $<%   9              " @4RK  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ M#)$4O\3?IL/ P
MN 8  !D              ("! *X  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " "T,D123/X]55P$  " #0  &0              @(%&
ML0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( +0R1%(J
M6"JD:00  &0,   9              " @=FU  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ M#)$4L=![I[. @  "P8  !D
M     ("!>;H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +0R1%+$+\7-] (  )4&   9              "
M@</,  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ M#)$
M4K:[ZI-" P  20<  !D              ("![L\  'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " "T,D12D?]H6P0&  # #P  &0
M        @(%GTP  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( +0R1%*.$HQBM@(  ,L%   9              " @:+9  !X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ M#)$4A$H()93"   OAD
M !D              ("!C]P  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " "T,D126[0/"*0"   1!P  &0              @($9Y0
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( +0R1%*4F)RD
MK ,   ,/   9              " @?3G  !X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ M#)$4N:HAAC*!0  5!X  !D
M ("!U^L  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "T
M,D12,,5EUPT#   %"P  &0              @('8\0  >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +0R1%(0^(Y9I (  &$'   9
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M970T.2YX;6Q02P$"% ,4    " "T,D12-B1*L @#  "@"0  &0
M    @(&K! $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M +0R1%*+S)"E>00  !$5   9              " @>H' 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ M#)$4@U<3^OB @  /P@  !D
M             ("!F@P! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " "T,D12$_]:K9\"  !<!P  &0              @(&S#P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +0R1%)I1V)Z*00
M .P5   9              " @8D2 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ M#)$4GBHP#^K @  J0<  !D              ("!
MZ18! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "T,D12
M:A);>= "   &"0  &0              @('+&0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( +0R1%(]J1W&3P,  &4*   9
M      " @=(< 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ M#)$4O-S5C3M @  M0@  !D              ("!6" ! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "T,D12 FVW/<8#   %#@
M&0              @(%\(P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( +0R1%*A'"9J:00  *81   9              " @7DG 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ M#)$4E?@"ZKB
M P  -PT  !D              ("!&2P! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " "T,D12G2?/+:("  !S!P  &0
M@($R, $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( +0R
M1%*M?7 PN@4  -T8   9              " @0LS 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ M#)$4CP9]-FH P  .0L  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( +0R1%+O)+I]\@(  )D(   9
M  " @>%+ 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
MM#)$4E(ZQ@\) P  R D  !D              ("!"D\! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    " "T,D12X%BGTE,#   K#0  &0
M            @(%*4@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( +0R1%(RG@[Y# 8  !\=   9              " @=15 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ M#)$4GH(,[I("
M;#8  !D              ("!%UP! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    " "T,D12&,^-&2H#  !8"@  &0              @(&6
M9 $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( +0R1%+<
MPW=1 00  "@0   9              " @?=G 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ M#)$4MZUE1-% @  6@L   T
M     ( !+VP! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "T,D12EXJ[',
M   3 @  "P              @ &?;@$ 7W)E;',O+G)E;'-02P$"% ,4
M" "T,D12#4B-]IX%   U,0  #P              @ &(;P$ >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ M#)$4F?\4D), @  :"P  !H
M ( !4W4! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MM#)$4H:F8T@, @  82L  !,              ( !UW<! %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     %, 4P"\%@  %'H!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>313</ContextCount>
  <ElementCount>417</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income and Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1406401 - Statement - Condensed Consolidated Statements of Cash Flows - Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows - Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation</Role>
      <ShortName>Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnet</Role>
      <ShortName>Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Other Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</Role>
      <ShortName>Other Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2140111 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2154114 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156115 - Disclosure - Employee Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</Role>
      <ShortName>Employee Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2161117 - Disclosure - Concentrations of Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</Role>
      <ShortName>Concentrations of Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2163118 - Disclosure - Business Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegments</Role>
      <ShortName>Business Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Business and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies</Role>
      <ShortName>Business and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Inventories</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Goodwill</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2310303 - Disclosure - Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables</Role>
      <ShortName>Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssetsnet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2315304 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - Other Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</Role>
      <ShortName>Other Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2329307 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2332308 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstruments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2337309 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2341310 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2344311 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EarningsPerShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2348312 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2357313 - Disclosure - Employee Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</Role>
      <ShortName>Employee Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2364314 - Disclosure - Business Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</Role>
      <ShortName>Business Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegments</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/InventoriesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillDetails</Role>
      <ShortName>Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/GoodwillTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, net - Activity Affecting Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Intangible Assets, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Intangible Assets, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, net - Future Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Leases (Lease Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases (Lease Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Leases (Lease Maturities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases (Lease Maturities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Leases (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Other Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails</Role>
      <ShortName>Other Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Derivative Instruments - Summary of Fair Values of Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails</Role>
      <ShortName>Derivative Instruments - Summary of Fair Values of Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails</Role>
      <ShortName>Derivative Instruments - Summary of Interest Rate Swaps (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Repurchased Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2445422 - Disclosure - Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EarningsPerShareTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - Earnings Per Share (Antidilutive Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Earnings Per Share (Antidilutive Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EarningsPerShareTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2449424 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2450425 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails</Role>
      <ShortName>Share-Based Compensation (Stock Based Compensation Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - Share-Based Compensation (Restricted Stock Units Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Share-Based Compensation (Restricted Stock Units Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2452427 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2453428 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2455429 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxes</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2458430 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails</Role>
      <ShortName>Employee Retirement Plans (Expected Return on Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2459431 - Disclosure - Employee Retirement Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails</Role>
      <ShortName>Employee Retirement Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2462432 - Disclosure - Concentrations of Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails</Role>
      <ShortName>Concentrations of Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2465433 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails</Role>
      <ShortName>Business Segments (Information on Operating and Reportable Segments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2466434 - Disclosure - Business Segments (Revenue) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails</Role>
      <ShortName>Business Segments (Revenue) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2467435 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails</Role>
      <ShortName>Business Segments (Revenue by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="pbh-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2468436 - Disclosure - Business Segments (Goodwill and Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails</Role>
      <ShortName>Business Segments (Goodwill and Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="pbh-20201231.htm">pbh-20201231.htm</File>
    <File>exhibit3112020-12x31.htm</File>
    <File>exhibit3122020-12x31.htm</File>
    <File>exhibit3212020-12x31.htm</File>
    <File>exhibit3222020-12x31.htm</File>
    <File>pbh-20201231.xsd</File>
    <File>pbh-20201231_cal.xml</File>
    <File>pbh-20201231_def.xml</File>
    <File>pbh-20201231_lab.xml</File>
    <File>pbh-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pbh-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>94
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pbh-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "contextCount": 313,
   "dts": {
    "calculationLink": {
     "local": [
      "pbh-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pbh-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "pbh-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pbh-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pbh-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "pbh-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 588,
   "entityCount": 1,
   "hidden": {
    "http://www.prestigebrandsinc.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 6
   },
   "keyCustom": 40,
   "keyStandard": 377,
   "memberCustom": 25,
   "memberStandard": 44,
   "nsprefix": "pbh",
   "nsuri": "http://www.prestigebrandsinc.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.prestigebrandsinc.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Goodwill",
     "role": "http://www.prestigebrandsinc.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Intangible Assets, net",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnet",
     "shortName": "Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Leases",
     "role": "http://www.prestigebrandsinc.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Other Accrued Liabilities",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities",
     "shortName": "Other Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Long-Term Debt",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Fair Value Measurements",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - Derivative Instruments",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140111 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Earnings Per Share",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Income and Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:CostOfSalesExclusiveOfDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Share-Based Compensation",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154114 - Disclosure - Income Taxes",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156115 - Disclosure - Employee Retirement Plans",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans",
     "shortName": "Employee Retirement Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - Commitments and Contingencies",
     "role": "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161117 - Disclosure - Concentrations of Risk",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk",
     "shortName": "Concentrations of Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163118 - Disclosure - Business Segments",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegments",
     "shortName": "Business Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Business and Basis of Presentation (Policies)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies",
     "shortName": "Business and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Inventories (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Goodwill (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310303 - Disclosure - Intangible Assets, net (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables",
     "shortName": "Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315304 - Disclosure - Leases (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - Other Accrued Liabilities (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables",
     "shortName": "Other Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329307 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332308 - Disclosure - Derivative Instruments (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337309 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341310 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344311 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348312 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357313 - Disclosure - Employee Retirement Plans (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables",
     "shortName": "Employee Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364314 - Disclosure - Business Segments (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables",
     "shortName": "Business Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Inventories (Details)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i02e9c2b24c2343449c5f786157e9131b_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Goodwill (Details)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillDetails",
     "shortName": "Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i02e9c2b24c2343449c5f786157e9131b_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i02e9c2b24c2343449c5f786157e9131b_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
     "shortName": "Intangible Assets, net - Activity Affecting Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:IntangibleAssetsTranslationAdjustmentsGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Intangible Assets, net - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
     "shortName": "Intangible Assets, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "iba357660d1fc4f7787eef1e9535f4bee_D20200401-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails",
     "shortName": "Intangible Assets, net - Future Amortization of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Leases (Lease Cost) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases (Lease Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Leases (Lease Maturities) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases (Lease Maturities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Leases (Additional Information) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails",
     "shortName": "Leases (Additional Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinanceLeaseRightOfUseAsset",
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "if14edde8dc2a46079acba1cc1a731adf_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i0c7980a5567149ff9eb9001647b782d7_I20190331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i0c7980a5567149ff9eb9001647b782d7_I20190331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Other Accrued Liabilities (Details)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails",
     "shortName": "Other Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7b28d9ff4d0544048ff592fc0fc0bb1f_D20200401-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ib12d98be53e544b7bec5cb41aded6489_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueHedgeLiabilitiesAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ib12d98be53e544b7bec5cb41aded6489_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueHedgeLiabilitiesAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i92532672091247fb97202d4dd7b0cdcd_I20200131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "agreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - Derivative Instruments (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
     "shortName": "Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i92532672091247fb97202d4dd7b0cdcd_I20200131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "agreement",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i9b2d78644d694801a7c8a37b269dd418_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Derivative Instruments - Summary of Fair Values of Derivatives (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
     "shortName": "Derivative Instruments - Summary of Fair Values of Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "id0ea53ed9d43427ba9d14f65f8ec8329_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails",
     "shortName": "Derivative Instruments - Summary of Interest Rate Swaps (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i52fe5bb5977e4e26a72125bd31d1a029_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pbh:VotingRightsNumberOfVotesPerCommonShareOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails",
     "shortName": "Stockholders' Equity - Schedule of Repurchased Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i6a1431127e184ca5b894517035890a0d_D20201001-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - Accumulated Other Comprehensive Loss (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
     "shortName": "Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445422 - Disclosure - Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - Earnings Per Share (Antidilutive Securities) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails",
     "shortName": "Earnings Per Share (Antidilutive Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i34c292e405a3468b9374ead4bb156bc9_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449424 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "if7ff1ca8392048a1b11c1d5955cb6cfe_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450425 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails",
     "shortName": "Share-Based Compensation (Stock Based Compensation Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - Share-Based Compensation (Restricted Stock Units Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
     "shortName": "Share-Based Compensation (Restricted Stock Units Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ia0fe51de3df64a2ebd3b1dfe7c8ab63e_I20200331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452427 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
     "shortName": "Share-Based Compensation (Stock Option Valuation Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ie2e63efb561f4bf8b06f46f7a267a133_D20200401-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i02e9c2b24c2343449c5f786157e9131b_I20200331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453428 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation (Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i02e9c2b24c2343449c5f786157e9131b_I20200331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455429 - Disclosure - Income Taxes (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458430 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails",
     "shortName": "Employee Retirement Plans (Expected Return on Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406401 - Statement - Condensed Consolidated Statements of Cash Flows - Parenthetical",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows - Parenthetical",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459431 - Disclosure - Employee Retirement Plans (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
     "shortName": "Employee Retirement Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:NumberOfThirdPartyManufacturers",
      "reportCount": 1,
      "unitRef": "manufacturer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462432 - Disclosure - Concentrations of Risk (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
     "shortName": "Concentrations of Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i6b9ae14e79e641269492a1e0e4ee76c3_D20201001-20201231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465433 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
     "shortName": "Business Segments (Information on Operating and Reportable Segments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466434 - Disclosure - Business Segments (Revenue) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
     "shortName": "Business Segments (Revenue) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "ie6f81090cc714b74b8d03f28025f19b1_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i807901cbcf5e40229536f551bebc8109_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467435 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
     "shortName": "Business Segments (Revenue by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i2cbf0d2f0f0b45de8dbc05c513975980_D20201001-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468436 - Disclosure - Business Segments (Goodwill and Intangible Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
     "shortName": "Business Segments (Goodwill and Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i8a14a79783154ed0b8aa034b4889e75d_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Business and Basis of Presentation",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation",
     "shortName": "Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Inventories",
     "role": "http://www.prestigebrandsinc.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20201231.htm",
      "contextRef": "i7bdcb83711134b1c81c382b4b029fb7e_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pbh_A2019SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Senior Notes",
        "label": "2019 Senior Notes [Member]",
        "terseLabel": "2019 Senior Notes"
       }
      }
     },
     "localname": "A2019SeniorNotesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AblRevolver2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Revolver 2012 [Member]",
        "label": "ABL Revolver 2012 [Member]",
        "terseLabel": "2012 ABL Revolver"
       }
      }
     },
     "localname": "AblRevolver2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AccruedAndOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued and Other Liabilities, Current",
        "label": "Accrued and Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedAndOtherLiabilitiesCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AccruedProductionCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Production Costs, Current",
        "label": "Accrued Production Costs, Current",
        "terseLabel": "Accrued production costs"
       }
      }
     },
     "localname": "AccruedProductionCostsCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income, Accumulated Tax Expense (Benefit)",
        "label": "Accumulated Other Comprehensive Income, Accumulated Tax Expense (Benefit)",
        "terseLabel": "Accumulated other comprehensive income, accumulated tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAccumulatedTaxExpenseBenefit",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AdditionsToOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions To Operating Lease Right-Of-Use Assets",
        "label": "Additions To Operating Lease Right-Of-Use Assets",
        "terseLabel": "Non-cash operating lease cost"
       }
      }
     },
     "localname": "AdditionsToOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AnalgesicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analgesics [Member]",
        "label": "Analgesics [Member]",
        "terseLabel": "Analgesics"
       }
      }
     },
     "localname": "AnalgesicsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "label": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "terseLabel": "Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceNewShares",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "terseLabel": "Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Margin",
        "label": "Contribution Margin",
        "totalLabel": "Contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CostOfSalesExclusiveOfDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.",
        "label": "Cost Of Sales Exclusive Of Depreciation",
        "terseLabel": "Cost of sales excluding depreciation"
       }
      }
     },
     "localname": "CostOfSalesExclusiveOfDepreciation",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CoughAndColdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cough and Cold [Member]",
        "label": "Cough and Cold [Member]",
        "terseLabel": "Cough &amp; Cold"
       }
      }
     },
     "localname": "CoughAndColdMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_DebtInstrumentVariableRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate, Minimum",
        "label": "Debt Instrument, Variable Rate, Minimum",
        "terseLabel": "Debt instrument, variable rate, minimum"
       }
      }
     },
     "localname": "DebtInstrumentVariableRateMinimum",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DermatologicalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dermatologicals [Member]",
        "label": "Dermatologicals [Member]",
        "terseLabel": "Dermatologicals"
       }
      }
     },
     "localname": "DermatologicalsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "terseLabel": "Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EscrowReceipt": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow Receipt",
        "label": "Escrow Receipt",
        "terseLabel": "Escrow receipt"
       }
      }
     },
     "localname": "EscrowReceipt",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EyeAndEarCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eye and Ear Care [Member]",
        "label": "Eye and Ear Care [Member]",
        "terseLabel": "Eye &amp; Ear Care"
       }
      }
     },
     "localname": "EyeAndEarCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, Due after Year Four",
        "label": "Finance Lease, Liability, to be Paid, Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "negatedLabel": "Accumulated amortization, effects of foreign exchange rates"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedTradenamesandCustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Tradenames and Customer Relationships [Member]",
        "label": "Finite Lived Tradenames and Customer Relationships [Member]",
        "terseLabel": "Finite-Lived Trademarks and Customer Relationships"
       }
      }
     },
     "localname": "FiniteLivedTradenamesandCustomerRelationshipsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_GEODISLogisticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GEODIS Logistics LLC [Member]",
        "label": "GEODIS Logistics LLC [Member]",
        "terseLabel": "GEODIS"
       }
      }
     },
     "localname": "GEODISLogisticsLLCMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GastrointestinalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gastrointestinal [Member]",
        "label": "Gastrointestinal [Member]",
        "terseLabel": "Gastrointestinal"
       }
      }
     },
     "localname": "GastrointestinalMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative, and Depreciation and Amortization Expense",
        "label": "General and Administrative, and Depreciation and Amortization Expense",
        "verboseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeAndDepreciationAndAmortizationExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IncreaseDecreaseInOperatingLeasesLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Leases Liabilities",
        "label": "Increase (Decrease) In Operating Leases Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeasesLiabilities",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IndefinitelivedTradenamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Tradenames [Member]",
        "label": "Indefinite-lived Tradenames [Member]",
        "terseLabel": "Indefinite- Lived Trademarks"
       }
      }
     },
     "localname": "IndefinitelivedTradenamesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_IntangibleAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Gross [Abstract]",
        "label": "Intangible Assets, Gross [Abstract]",
        "terseLabel": "Intangible Assets, Gross [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsGrossAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_IntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Roll Forward]",
        "label": "Intangible Assets [Roll Forward]",
        "terseLabel": "Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "IntangibleAssetsRollForward",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "label": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "totalLabel": "Intangible Assets, Translation Adjustments Gain (Loss)"
       }
      }
     },
     "localname": "IntangibleAssetsTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_InternationalOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International OTC Healthcare [Member]",
        "label": "International OTC Healthcare [Member]",
        "terseLabel": "International OTC Healthcare"
       }
      }
     },
     "localname": "InternationalOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due after Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LoansPayableTermB4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-4 [Member]",
        "label": "Loans Payable, Term B-4 [Member]",
        "terseLabel": "2012 Term B-5 Loans"
       }
      }
     },
     "localname": "LoansPayableTermB4Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-5 [Member]",
        "label": "Loans Payable, Term B-5 [Member]",
        "terseLabel": "Term B-5 Loans"
       }
      }
     },
     "localname": "LoansPayableTermB5Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Four",
        "label": "Long-Term Debt, Maturity, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LongTermIncentivePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Incentive Plan, 2020",
        "label": "Long-term Incentive Plan, 2020 [Member]",
        "terseLabel": "Long-term Incentive Plan, 2020"
       }
      }
     },
     "localname": "LongTermIncentivePlan2020Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongtermEquityIncentivePlan2005Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Equity Incentive Plan, 2005 [Member]",
        "label": "Long-term Equity Incentive Plan, 2005 [Member]",
        "terseLabel": "Long-term Equity Incentive Plan, 2005"
       }
      }
     },
     "localname": "LongtermEquityIncentivePlan2005Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NorthAmericanOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North American OTC Healthcare [Member]",
        "label": "North American OTC Healthcare [Member]",
        "terseLabel": "North American OTC Healthcare"
       }
      }
     },
     "localname": "NorthAmericanOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NumberOfThirdPartyManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers",
        "label": "Number of Third-party Manufacturers",
        "terseLabel": "Number of third-party manufacturers"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturers",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_NumberOfThirdPartyManufacturersWithLongTermContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers with Long-term Contracts",
        "label": "Number of Third-party Manufacturers with Long-term Contracts",
        "terseLabel": "Number of third-party manufacturers with long-term contracts"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturersWithLongTermContracts",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease Liability",
        "label": "Operating And Finance Lease Liability",
        "totalLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiability",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment, Due",
        "label": "Operating And Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDue",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment Due",
        "label": "Operating And Finance Lease, Liability, Payment Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDueAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 6.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due after Year Four",
        "label": "Operating And Finance Lease, Liability, Payments, Due after Year Four",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 5.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 4.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 3.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year",
        "label": "Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year",
        "totalLabel": "2021 (Remaining three months ending March 31, 2021)"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Care [Member]",
        "label": "Oral Care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_OtherOtcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other OTC [Member]",
        "label": "Other OTC [Member]",
        "terseLabel": "Other OTC"
       }
      }
     },
     "localname": "OtherOtcMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted",
        "label": "Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted",
        "terseLabel": "Number of securities into which each RSU may be converted"
       }
      }
     },
     "localname": "RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_RestrictedStockUnitsRSUsStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) &amp; Stock Options",
        "label": "Restricted Stock Units (RSUs) &amp; Stock Options [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) &amp; Stock Options"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsStockOptionsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Accrued and Other Liabilities [Table Text Block]",
        "label": "Schedule Of Accrued And Other Liabilities [Table Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Line Items]",
        "label": "Schedule of Intangible Assets [Line Items]",
        "terseLabel": "Schedule of Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsLineItems",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table]",
        "label": "Schedule of Intangible Assets [Table]",
        "terseLabel": "Schedule of Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTable",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_SeniorNotes2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2012 [Member]",
        "label": "Senior Notes 2012 [Member]",
        "terseLabel": "2012 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SeniorNotes2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2016 [Member]",
        "label": "Senior Notes 2016 [Member]",
        "terseLabel": "2016 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2016Member",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "negatedTerseLabel": "Vested and issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and issued, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "terseLabel": "Vested, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, end of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "terseLabel": "Extension of plan term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "terseLabel": "Total fair value of options and RSUs vested during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_TopFiveBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top Five Brands [Member]",
        "label": "Top Five Brands [Member]",
        "terseLabel": "Top 5 brands"
       }
      }
     },
     "localname": "TopFiveBrandsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_TotalOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.",
        "label": "Total Other Income (Expense)",
        "negatedTotalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "TotalOtherIncomeExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_VotingRightsNumberOfVotesPerCommonShareOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting Rights, Number of Votes Per Common Share Owned",
        "label": "Voting Rights, Number of Votes Per Common Share Owned",
        "terseLabel": "Voting rights, number of votes per common share owned"
       }
      }
     },
     "localname": "VotingRightsNumberOfVotesPerCommonShareOwned",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "pbh_WalmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart [Member]",
        "label": "Walmart [Member]",
        "terseLabel": "Walmart"
       }
      }
     },
     "localname": "WalmartMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_WeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Discount Rate",
        "label": "Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "WeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Shares Outstanding [Abstract]",
        "label": "Weighted Average Shares Outstanding [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Women's Health [Member]",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.prestigebrandsinc.com/20201231",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r164",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r184",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r164",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r184",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r54",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r195",
      "r267",
      "r270",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r347",
      "r348",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r533",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r347",
      "r348",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r533",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r195",
      "r267",
      "r270",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r190",
      "r267",
      "r268",
      "r499",
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r190",
      "r267",
      "r268",
      "r499",
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r293",
      "r347",
      "r348",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r533",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r293",
      "r347",
      "r348",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r533",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r267",
      "r269",
      "r535",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r267",
      "r269",
      "r535",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r197",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r19",
      "r198",
      "r199"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $19,025 and $20,194, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r505",
      "r519"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Accrued marketing costs"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Accrued broker commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r58",
      "r63",
      "r66",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Unrecognized net gain (loss) on pension plans, net of tax of $(624) and $17, respectively"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r63",
      "r73",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Unrealized loss on interest rate swaps, net of tax of $752 and $1,453, respectively"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r22",
      "r61",
      "r62",
      "r63",
      "r521",
      "r542",
      "r543"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r63",
      "r66",
      "r114",
      "r115",
      "r116",
      "r417",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss, net of tax",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r56",
      "r63",
      "r66",
      "r417",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r20",
      "r386"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r350",
      "r352",
      "r389",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r352",
      "r379",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Pre-tax share-based compensation costs charged against income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r26",
      "r200",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts receivable, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r99",
      "r468"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt origination costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r99",
      "r217",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Accumulated amortization, additions"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r172",
      "r179",
      "r186",
      "r202",
      "r414",
      "r418",
      "r457",
      "r503",
      "r518"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r52",
      "r106",
      "r202",
      "r414",
      "r418",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r353",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r425",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r36",
      "r101"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r94",
      "r101",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r94",
      "r458"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(Decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r240",
      "r509",
      "r525"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies \u2014 Note 16"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r114",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r69",
      "r71",
      "r72",
      "r77",
      "r512",
      "r529"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive income, net of tax:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r76",
      "r86",
      "r511",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r195",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r195",
      "r454",
      "r455",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r195",
      "r454",
      "r455",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r153",
      "r154",
      "r195",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r150",
      "r153",
      "r154",
      "r155",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r195",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Services Sold [Abstract]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r79",
      "r231"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Cost of sales depreciation"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r81",
      "r106",
      "r202",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales",
        "totalLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r151",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r504",
      "r506",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r244",
      "r506",
      "r517"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total long-term debt (including current portion)",
        "totalLabel": "Total long-term debt (including current portion)"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r109",
      "r254",
      "r257",
      "r258",
      "r259",
      "r466",
      "r467",
      "r469",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r245",
      "r468"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r99",
      "r107",
      "r399",
      "r404",
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.",
        "label": "Defined Benefit Plan, Benefit Obligation, Payment for Settlement",
        "terseLabel": "Lump sum payout"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r286",
      "r294",
      "r296",
      "r340",
      "r342",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r340",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Expected employer contributions, remainder of fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r271",
      "r308",
      "r335",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r271",
      "r275",
      "r307",
      "r334",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r305",
      "r332",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit income"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r330",
      "r331",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r99",
      "r167"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r53",
      "r55",
      "r428",
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r426",
      "r429",
      "r434",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r424",
      "r426",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r432",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion",
        "terseLabel": "Gain Recognized in Other Comprehensive Loss (effective portion)"
       }
      }
     },
     "localname": "DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLossOnDerivative": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Loss on Derivative",
        "negatedTerseLabel": "Loss Recognized as Expense"
       }
      }
     },
     "localname": "DerivativeLossOnDerivative",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Derivative, number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r260",
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r78",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r127",
      "r129",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r513",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per Common Share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r78",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r129",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r513",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effects of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Additional Disclosure [Abstract]",
        "terseLabel": "Share-based Compensation, Aggregate Disclosures:"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation costs related to nonvested awards, weighted average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit recognized on compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r143",
      "r203",
      "r253",
      "r260",
      "r383",
      "r384",
      "r385",
      "r400",
      "r401",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Summary of Carry Amounts and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r442",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r342",
      "r443",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r442",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r442",
      "r443",
      "r445",
      "r446",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value, Disclosure Item Amounts [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Liabilities",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r294",
      "r296",
      "r301",
      "r342",
      "r443",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r342",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r447",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r425",
      "r431",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r472",
      "r475",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r471",
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total present value of lease payments",
        "verboseLabel": "Finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails",
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021 (Remaining three months ending March 31, 2021)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r473",
      "r480"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r472",
      "r475",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r482",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r481",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "periodEndLabel": "Accumulated amortization, ending balance",
        "periodStartLabel": "Accumulated amortization, beginning balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of the year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r218",
      "r220",
      "r223",
      "r227",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r223",
      "r501"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "periodEndLabel": "Finite-lived trademarks and customer relationships, ending balance",
        "periodStartLabel": "Finite-lived trademarks and customer relationships, beginning balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Gross [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r218",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r223",
      "r500"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived, net",
        "totalLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Finite-lived Intangible Assets [Roll Forward]",
        "terseLabel": "Finite-lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r99",
      "r247",
      "r248"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Areas, Revenues from External Customers [Abstract]",
        "terseLabel": "Geographic Areas, Revenues from External Customers [Abstract]"
       }
      }
     },
     "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r208",
      "r209",
      "r502"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net",
        "periodStartLabel": "Goodwill, net",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill",
        "periodStartLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedLabel": "Accumulated impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r80",
      "r106",
      "r172",
      "r178",
      "r182",
      "r185",
      "r188",
      "r202",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r424",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r99",
      "r228"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "negatedTotalLabel": "Impairment of intangible assets",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r99",
      "r228"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "negatedTerseLabel": "Finite-lived trademarks and customer relationships, impairment of intangible assets, finite-lived",
        "terseLabel": "Impairment of finite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r402",
      "r407",
      "r409",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r125",
      "r126",
      "r170",
      "r394",
      "r403",
      "r408",
      "r531"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "terseLabel": "Effective income tax rate reconciliation, tax credit, foreign, amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r96",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r136"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of nonvested restricted stock units and options issued to employees and directors (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "periodEndLabel": "Indefinite-lived trademarks, ending balance",
        "periodStartLabel": "Indefinite-lived trademarks, beginning balance",
        "terseLabel": "Indefinite-lived"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Indefinite lived trademarks, effects of foreign currency exchange rate"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Indefinite-lived Intangible Assets [Roll Forward]",
        "terseLabel": "Indefinite-lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "periodEndLabel": "Totals, gross, ending balance",
        "periodStartLabel": "Totals, gross, beginning balance"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r216",
      "r221"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net [Abstract]",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendsPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest and Dividends Payable, Current",
        "terseLabel": "Accrued interest payable"
       }
      }
     },
     "localname": "InterestAndDividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r514"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r93",
      "r95",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r164",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r184",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r206"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r51"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r29",
      "r30",
      "r206"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Packaging and raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r51",
      "r112",
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves related to obsolete and slow-moving inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r28",
      "r206"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r483",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021 (Remaining three months ending March 31, 2021)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r106",
      "r180",
      "r202",
      "r415",
      "r418",
      "r419",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r25",
      "r106",
      "r202",
      "r457",
      "r507",
      "r523"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r106",
      "r202",
      "r415",
      "r418",
      "r419",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.",
        "label": "Lines of Credit, Fair Value Disclosure",
        "terseLabel": "2012 ABL Revolver"
       }
      }
     },
     "localname": "LinesOfCreditFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loans"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r246",
      "r506",
      "r520"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate Future Principal Payments"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt, senior notes and term loans"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r111",
      "r242"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r111",
      "r242"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r111",
      "r242"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r111",
      "r242"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021 (remaining three months ending March 31, 2021)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Advertising and marketing"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r94",
      "r97",
      "r100"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r67",
      "r70",
      "r75",
      "r100",
      "r106",
      "r117",
      "r119",
      "r120",
      "r121",
      "r122",
      "r125",
      "r126",
      "r133",
      "r172",
      "r178",
      "r182",
      "r185",
      "r188",
      "r202",
      "r457",
      "r510",
      "r527"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "verboseLabel": "Rest of world"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (income) expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonqualifiedPlanMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r323",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Nonqualified Plan [Member]",
        "terseLabel": "Non-qualified Plan"
       }
      }
     },
     "localname": "NonqualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r172",
      "r178",
      "r182",
      "r185",
      "r188"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r476",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r482",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r481",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r2",
      "r113",
      "r159",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Business and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r59",
      "r61",
      "r412",
      "r416"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Unrecognized net gain on pension plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r412",
      "r413",
      "r416"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, reclassification tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Unrealized gain on interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Settlement gain (loss), before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r68",
      "r71",
      "r412",
      "r413",
      "r416"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r65",
      "r313"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Net gain on pension distribution reclassified to net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.",
        "label": "Other Comprehensive Income (Loss) [Member]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r83",
      "r99",
      "r231"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofFairValuesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Fair value of shares surrendered as payment of tax withholding"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r293",
      "r295",
      "r301",
      "r319",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r342",
      "r344",
      "r345",
      "r346",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Retirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r353",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of 5.125% Senior Notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r89",
      "r110"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under revolving credit agreement"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r88",
      "r382"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r232",
      "r524"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QualifiedPlanMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r323",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Qualified Plan [Member]",
        "terseLabel": "Qualified Plan"
       }
      }
     },
     "localname": "QualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r63",
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification from accumulated other comprehensive loss into earnings"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": {
     "auth_ref": [
      "r179",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r179",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Information about our Consolidated Goodwill and Intangible Assets Allocated to Reportable Segments"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r91",
      "r110"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments under revolving credit agreement"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayment of 5.375% Senior Notes",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Term loan repayments"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r21",
      "r260",
      "r386",
      "r522",
      "r541",
      "r543"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r203",
      "r383",
      "r384",
      "r385",
      "r400",
      "r401",
      "r538",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r323",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Axis]",
        "terseLabel": "Retirement Plan Tax Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r323",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Domain]",
        "terseLabel": "Retirement Plan Tax Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r163",
      "r164",
      "r177",
      "r183",
      "r184",
      "r190",
      "r191",
      "r195",
      "r266",
      "r267",
      "r499"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Information about our Segment Revenues by Geographic Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r508",
      "r526"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r63",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of Primary Components of Net Periodic Benefits"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r44",
      "r109",
      "r254",
      "r257",
      "r258",
      "r259",
      "r466",
      "r467",
      "r469",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r426",
      "r434",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r352",
      "r378",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Compensation Expense Information"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Information about our Revenues from Similar Product Groups"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r218",
      "r222",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r218",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Finite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r226",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Aggregate Future Principal Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r74",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r172",
      "r175",
      "r181",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r172",
      "r175",
      "r181",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Information about our Operating and Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r353",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r356",
      "r367",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Shares"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r47",
      "r104",
      "r144",
      "r145",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Class of Treasury Stock"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r160",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r195",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAssetReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Asset Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Asset Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingAssetReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r172",
      "r176",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r194",
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss):"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Share grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, end of period, weighted-average grant-date fair value (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per participant, 12 month period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the Plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Options, Additional Disclosures:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, end of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Forfeited or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited or expired, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value",
        "terseLabel": "Stock options granted, exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Stock options granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r358",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period, weighted-average exercise price (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r351",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r373",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r477",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r160",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r195",
      "r213",
      "r234",
      "r235",
      "r236",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r143",
      "r203",
      "r253",
      "r260",
      "r383",
      "r384",
      "r385",
      "r400",
      "r401",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r143",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Awards"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r17",
      "r18",
      "r253",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r253",
      "r260",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r253",
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r253",
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r23",
      "r24",
      "r106",
      "r201",
      "r202",
      "r457"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "totalLabel": "Total Stockholders' Equity",
        "verboseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r260",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r479",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r49",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r253",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury share repurchases (in shares)",
        "verboseLabel": "Number of share (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r261",
      "r264"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 4,033 shares at December 31, 2020 and 3,719 shares at March 31, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r253",
      "r260",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Treasury share repurchases",
        "terseLabel": "Total amount repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r156",
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r478",
      "r485"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r128",
      "r136"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Denominator for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r127",
      "r136"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Denominator for basic earnings per share \u2014 weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r556": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r557": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r558": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r559": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>95
<FILENAME>0001295947-21-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001295947-21-000009-xbrl.zip
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M2Q+DR9?W4VPXD_I^(<HP!_#'@XXZ>&; $[L#O!F)AL"N X0V^)7 \R4K^'L
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MGCY9KPL7]MP>V3"?C(Q_O4;+K3]]XL,Y#,>SLW RAE_*X5LW]]PVS(X@/)[
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MAY =!\M1>:,"62WI@MPO 33S&7.:%4R0.4:.WI=8$'+1*%5.PM01CH04PM+
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MM2I @2-.C"%FEG%C47B[?.#>VBS5O%8YFFPRE20]@$,3%*"O97^D],P!8/D
MO<59JOE :HRBXI/3*"UDJX*RB5(Q+C/ $9JPTFKAN,+\415)UQ5S.9#(D++S
M0C/1T"1LR,) $Y:3-X&TSQ]H%RVA4!&49&5E$JFS%=8+Y:**(M"402X!OK<W
MYC2[M'W->B>""D$ U (=F-G2RN)DB:R,2P/-?,:<9@53\H8XZM 1)(#F6*38
M!-%I2UH&5'YI8+K-,:>932$6:X2OR8O20(@<+D..TED!)F2GU=* ,_\QIUE!
M9D3R6-!3\@6<<RB<UD)PP,=QGXVP-)#=\IC3K/#Q:+1SQ4=P H1@5^0+PR$9
M*DKLI&X/GWGU "*%HDR=- W -B4HHZ76(67-#B"*VUM/MQR<:88+_;S/)K-D
M^I@):O9( >&$-CKGDE5>'FCFM)IL1C!)DLCH@-7*@H" (::0$Q@V+8&T7AJ8
M;G4UV8S H>!).LPY)@7.>@PR.%UD8$ PDED:<.:?V3,KR% &R$DP<!FAF! Y
M6O0^"2M2C4/RTD!VVZO)9H1/9FLG 9.-R8,V(1A)3**H4%(NX#QJQBZ+?YI_
M-:.8/4A6.I%KB3'E@Y6H,6MCA 10<OG O<VU5', U$#,0A/I9 N@AVA$UK*$
M8HK*BO3R 7J[:ZGF 6G*GK0(*DL+%E-=&E^4BM*9NJZU+!^DM[Z6:@ZH^@ 0
M6"&-9::J?1TGEUYG $,4<['+A^K<9ZGF [1(+GB!QE@G(902*'(TPJKLHO,J
MN_,\I^;SVUO,C)Y5M$@);+$QH%<0:F6 NMXX2)T<.1W#TD SI\SH&<&D##$(
MBIS4&KS7T3 B(D<5B$).96E@NM7,Z%F!DQ@.1D&IS.#D6N0VH-)5M7*=4EP:
M<.8_2S4KR((,,1@=I8T6DJK]:4(1'"-$BQEP:2"[[<SHF8TP)ZL8')D, #/
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M3WSP(K]L[FQL/7LR..B.QMTT>O+D44-<A9>U1!$I6<LN)A=#T+&6=<LZ:39
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MVP#1_1E[V$_T[)!H_&20KGB,Z;;L[*KXKD^Z&.L 6[<Q-8EUIJQ%=$5Y7>M
M^)(MD:BQA=:0&E$R<9Y">DWYZ SZZ5M%9"$495'D%+-&Z[2-'*N ,>S[3='6
MQQ2E!PJP^#'+RI@VC ?,*MRV-M3MH20;5P4V1A^%X2@;(3E-7C8@D6\EN@O+
M V8VMS/9]UI:0EM :XNBD%+9^F I!7(K(5WQ@$604X*2G0@^:<P@(_E<O!,Y
M4\B^+L69%O&4H@%%/!?"KDVMUN#X9$B']5C5GC0XIK^R<9^?/7OA^:3:IQ2W
M7NU3&:"H.8@/1D+6D<-W4,E%$$PX2Q95TF0XES3^925IS9<T&:XM:?74&4E:
M5(D\.2$4%'"48Q4OI15%K^NF40TJ3+R2M(6N8,S.4SB$:M$BAR*(BK0+!2 +
MCX[,U*:=2]K*IBV%I+&ANJZDS="F&57(Q&B"<P2D+#HEE8E9RRQ1J- @GC8%
MZ=F8>Z)>>36V%W'%YML3OGYF,\H+1NGGS\J$)4#TMN:-@;76QU R)%F$\%$2
M-HB5K>1J@3@8U1T9D5PB$ "D(^00@T$03,>T5PWB8"NY6B#&Y0$3!I**@@5T
M*88@G R@I91U>X &,:Z57"T0ORJ9C96OA?RKQ9)U?W>!$<"@",YZ=T?G;><X
M7?D^&>SU8$Q7YH'5 Q<77SL%3( /V22?K09(V2.!19&8]X#+*?@&$>GU-SC,
M5ZU18OB[B77WV7B07BTC:]4A%Z6SLLX*("M]0"%,T2%D%#&'!K'610!Q/A11
M@8HY6^ET9E>NI4\"I%$F%RN"B-0@BK@((,Z'CRGGZA9-6GG2("7'CZY.'!7I
MK29GFS0"M@@@SH?\6)250"M'TD-"$WT (YW0Q@>!(C?()SX[Q"'MTLGI,!WB
MB)X.!P=#//YH?X$KCR^CCY2"]3)90U%(*%2\DQZ=$5X4857R#?*1BPCJ?'PF
MJV3=;<S;K#(8ISRHXHBD4,1(0VZ0SUQ$4.?C0PVD(+U#4Q35[7]\$9Z8#)&1
M*5E7&N1#%Q'4^?A4CC*+ 1-!NEIHN43M"\0@HXDE9F$6?T#A_<C4YG].^;GJ
M1-N@SQ\_61*XGM+I\6FOCA7M#;$_FB:;KN>CT]&X00G1,A5(,EIR04+PX)T3
M2L58@O7,CAJ0$-T,O&:5N.:]YL Q:*)"H'/!$H(6+DMK=? F-<D3?C-P%SG>
M'1I_G,--3W&XI./^T8*HC">BBH"8D*0Q5D<G$(J5E\?]ETU/YPGW-WC/3[7[
MGPPKZ$24=3":,34A!]+,=JT72(ZU?"F]YVVC?#/KBJ+#J)PU)1NPDH//D@II
M=JF4ZG+-972C<P5N5O[4H'?9^8)2$!AEO"A9HP]*Y<QZUX"-0;X=N TJW3[E
MGZG/OXR?]I@--8ZW:L&A1;(IH@ H%+W-EH"1-$D#N@;4JVP6;C/;04LHJ;67
M2:&$:!A$-,J)X!([.DUN#H2F$<Q  _L112 ,:JCI:MH!8888I;$Q-2D1<IU;
MR-W>:9VS?U:KLTQ6+VV^3;W33/GQ<'!<=>%T/ G0=LHF#OO=_L'H*0TGPR@_
MGUW=P"=;AM5)B]H.WWW24%6791SO9G228:*!D4,"SS$@JN H(@EAP,?4H/'N
M916,^8R9&V:A&;"0J.N%4XDF20!,@2FJL=(T:*1@605C/F,*5BLO,5JO++O@
M "'K6#!H"BI[G$ZF-&3<?5D%8SYC]T+G6&KR7W8 3#5\A@*&.5J1=3)UD@PH
MF8$LKCQ49#IX3!]O1S.M:STEV5O]5&_RFNJ);/S,3;)FR0B:V;!F(*VCLS9F
M$R$ZQZQ9FN*+J<MA'$[334#8J<KR+UJL(+J>IC%(]IJ:-CE5BQEH6G&ER(1,
MUY0 CS)*F60VP9@4V573.9ZL:>W;4KF_T6\?"_=7^LW,QD(Y:XB"5:B8[&HR
MWD8OC)(REU)T27/0@T;(6]:$RA:M%080"5&01)%"\A""2O%\M,0+:);9J!N,
M?6(PE+CID1#/OGD&-EU%B2%%(R+;= #I4TE" 3B+(-W[I4*&B<#%+XL*SA=2
M")EFE<'P>%K0A.G6#12Q^91-FX^P^<K S,>G_A/5DBDS:4*!5"O>H#=LGHQ+
M%+R7_OVJ^P;"6)7LDRS0Y_WN>+3[[/EH\FGG9%)?:QE1)>]3)!]R9"I<)]FS
MC<&)) U'TSG$YJ+ZOJ3U\4EO<$;T$9++"*1QK)*:A ?OP:H4BF2NI6(N==9'
MY^8#^045748PG9$Y:N-<XM"4(U]OA+1*N91<=J0ODE_\!9@+S&=F"N97[SH:
MCA_L=<<]VBE;_=Q]W<VG>%[&O1[:Z XIC0?#FY<9?WV9\;.1&0 M(*$.LLZ6
M2,LX@I7!D)2* X?)YI0R+/)$X;SU_J,1C3"S><"Z6YM6.@;O)' 0POXV:RPV
MU(%H!-6D0<@%LLMSJM+B$H@2/<DBP 7A6:\,6DU>8S;F7,=6&%Y3QV:6E"0*
ML<<DG8L%5!2SCC(78O>)D=%9_!R)Q8%EABD0S@GP(DNP14$=6T=V4;:02DQJ
M7!)-FIA;(-,WG\DT$328(LEIMH&U%)JO5?ADR>B,,2(N?O[8O#&\D?2P:+TO
M28=26*FD"U%'2\86S690BM*D6H@SB]^O%27L8O^ /D0&V]U^]_AT*9>?E6A(
MUQ44D 4$QWPE*N,H:8HR!%U6(G)-$<&WRRHBE<8Z#DETUAJ0Q<((1S:7;*W.
M*=GF!RE+9$7F$_J@M<YX)G"$!B0P<$ZIJ$U,)=4DO)6(+) 5F8^(D"(.MMC=
M6%F8[_O(9)^YOT-E'4JM[Z*C::0[$-$'B=:K4B244K</2* 3Z8#.Z="HQ+D%
M 7).1EM2\$&5!*+N<>Q#C*3KN&-4*60=&J21NS3N3G<ZK>D/>_BV+BLY_22#
ML3/H_^<4>_56>5FS6GUT*DJ*.G$@KGU"Z;*<YLLEBMB 0/Q:4/Y^LSC>2#">
MR'"4I0Q9_L?P[ZYDR#H!1>,*^"6!YN:U[$;0"4E+#5YP3..@D(OHG4]U6^]8
MB@=HT,JB1X-)+MAPDJ5=BX#^?/8S]=/A,0X_J0?Z#'O_?,.DREN?#@?Y-(UW
MAL]H^)HE_4/JS-[@Y''W-?T\Q'Z>V=Y,5[SA%7E7TV?Z[-RE7/ZD<E%85T"A
M@!S9K<OD/+%L:65\B0URY2OIG:_TSJ,$EA"QBI&QT0/_115#5C5S15JCK6[0
MXKV5],Y1>N>TV4%&;4T6TN8$"CFFLB*Y7+2(JDC3I*+T*^F=K_3.H_IK#$@2
MR 6R()4-$!1*$@1$SB;=;-[[.;:/3D?CP7'=.>K;P%UD'=K&H\'PXL5&'S3H
M!?;XKC=?$6P.A->J%(-B.4T<M>D2@D<I8\JRA!Q,:CCA78GM;8CM/(;GBO0
M63L'!JS#H!+8%'U628F,T&RFNQ+;&Q?;.16>%CX)TN#1"G ^QE"<DCI::Z.P
MU*0,@)78SDEL;X?;OM\WZ!C[IP73^'1(PROW#_KXA(O&KKV/$(F2ZM()6Y@P
M:U4SZXI6D*$()L_3E)AEHA_/3D^XG<8H1".Y@4(OM,C>%)] 9N6-@$"@"MJB
MDTG+9F3OEDS-)[I/Q4),0A4H&:2!J'U,*J$I9E(\KT'1_?M"D3^?CKI]&HV>
M39OXR)5U!L/QX3J[MV["_L[>HU\)>^/#A,-_O'-B=: L3J-!KYLGXK3%S_+)
MQ.<.X\+'^@<7#[:,<;?A&%ME"AJ#!2@!8XE*AA!+,>0N5H0OBT!-]DN<[I")
MO95 W81 D<TL410C)L8WF6@3L2 Y+YVQ(C=IWGWA+=1$G,_?:[/7/>Y.17L9
MQ<H(B9I#U"1E!BM-D$$YYE0VARB4:^0&$8LJ5K=OI^; SIW6,AICDD;'4I,#
M)J>DB#HX&S W:N^ME>-; (%2HM@292P*-21M4,B$I+4#!R::)LU@++R%FI?C
MFX-8:<E&29@L"QD(1<448JUT[#QS*G2Q03,,"R]6MVRGYC/V+T4 ,]EB*RO(
MW@5KO:<BG"FD7&S2;MLKQ[<( H76D]69I  #I, 'B%E:="B\CZDLET#=0<<W
MIPWEK4XF:JMT1$BI1(JUJJM*(4F7(C1H^'SAQ>KV[=0\RCE9$T-,)"T !.4X
MT$O> Y,UX"@P+YE W37'-P>!RBP\+K.!*NB!*7D4.KBD/;L]C+$T*8MBX2W4
MO!S?//:KR+(NP;;>V Q.)$_)R>3K7Z&-4JL1].N+U9>ST=?9+![0J)N6<A8&
M;&&Z5+*+Y"!'SWY/2R-S"K($14LF0S?KZ^ZJ#)$M;'&"2&Q^(#J(/@M=E!?*
M%!FB;( ,W67X CL0([UUUL6ZA!2%*-&&Z*1-((MM/'R/!J<'A^O]_&C0R[-*
M,;I)A]5(*2HZ.0Q@E,\! DN0\-%+BD5FQQ+5A/R0A92BO^VR&BE%J82<*62*
M0H$P4"=8C;).>7!0H ET9&92U$@ /?O^D%74UDJ HK 46;(B5TS0TC6!"S0@
M)GDQJ"=.[[:,4A2%#9"LM3XX4,G$((QQ.1B;L.;;+Y<4S2LJ678I(I>UXJA$
M@XGL213Z$C-F5$:%7( :($5W&T A*1@1O(V)X9+"8R82QD(-3>(JB7TV9N 7
M'(V'@R[W^VC<90NTC))4=!&";(U("K!!\$IZA3*X# BT<B@K2;IV$@,HYK7>
MYJ(MD*&8,BE;(U_2$E3SX]P[ :+3WGF)%BRC:3!DJ-L:LHDHPF)J H@-<"R;
M9\21[B8.'RWK:(5!;X32E- !LTM,5NE4)W5#\N3\<HG1O+S*THN1%\%"C,X6
M[]BE*"\UN*"54E"*!FR &-UQ!*&"DP(9[1$D90\6M!;2BIRDIB9,H33 GVS0
M\!C'@][@@&_<6\JY.%(^8G8Z.U7 6/+1!>^<L0&+1[GR*"M!NJ9/D77W-1>5
MC D*$3*O%;*DY$0!*4L#!&F%88Y2HI8V1@%&1\80,,0 2?AL:37\-1-CL#/$
MWK+RDCS9F$6")R/JUCO>DA6H9'"B[L'9I!J?"^Q.EEF"0.=D2_+,/]AOL 0Y
M*4HQP*&O8Y[;?#^RS. E<H),]%FRYXA&(=7LSL)_!3KOFU!BXRO@C0]IN#-.
MJZRNFW(@UKAH28H8)9B8 ^D8@D(3C(IF)4&KC*ZODUC&4CFT.1+HZ#Q2T5D#
M6J5"*OFN2% CP<M*)TTANH !<G ^9/Y@I$/%/VT3U']EVK^TO)^<QBRT\23!
M.8.*@H>0LW*R;O"X7-C>+:,+.0?!\$(=B([912.C RLU8D$%3=K;>X%'#FYQ
M6<@<ZLE 8,H7D\N@(E@?41;+<B63P(B$3=JV=X''#I9;AEA67,I>I&P0HHR8
M)11 (Y/#C!<9F LM0W<9OL ^@]$!]+H B()UJW=KE#9".)NQ\?#=O95A<Y B
MLMXK:Y(J9$'7V"$'HS%J*4VRUJRDJ'&4=AY5$]D6)1\$."%!*XQ6."7(VV38
M0KDF5$U<H)5A\]@!*01-RA@'Q8#R$$N,,7.\"=(Y59I@!AH0D]SJDI!Y[!B+
MY-&;X@Q'MN D&AVSB*A5YB#7-6G_E06.2I9=BE"GQ*8HU.*HX.M&F).\;V?K
M,J/WE7,66HKN-H#2Z8(<4(+1-4].> A%Y"1$7>RG<.5,FKF>9QZ2%&HU6Y1D
M!4&*%*6UJJ981<ID91.&*!K@4.Z")"4.3&),4K-? 1DEJFBB1H'.>F=S\YW*
M70#1>>=*"NB*4!!T"#9%:[,1E#066CF6!B[IF0?!--F %B4&2P ".6IA#Q-%
M,"JCBZLP925&UQ&CR/%(,@:RBHE_A,CR@S(:,(6="[@&B-$=1S 9CTE[EU0I
MX&7B<!.  0V"BC1FM1U5(Q?TS(.81)NM8,6/ *!0^6!2H&1#*-++59RR$J1K
ME_LT&<GY!!$A&UTS^HTHVGIA,MNI!@C2G<<P6A,T>91:$) NH>B4"Y@LG<G*
MK_*[FK6N9QX!2C(Z4RXQ4@:A!4H7)?/*H'1DSA*62X*6?F78/.9S#>K,,D2I
M)G59'3.H0)'-$7D.?9M 2.XN>#H(P>Q1I5*KZ3D7*&2E3&'U5^!2$Y([%VY=
MS]W*ZK+26C(Q%^\C"/0AJ.),$$Y&!MFO)&B5T?45">)H0PJJ>W)G R5[)!+@
M#444R:9&) 0MR,JP.8"7O=-!9>5$8M L!IT(B]2.6/=#R*N]')NT.F!.^X$6
M1U:HDDP. $ Q9TC>Z"1"-"*;Y9*A95]A,A\9LNB8>4 )B4+=/]UG[7.1(*Q6
M(MLFV*&[#)_01 :(PT>5V8T$'Q1_=I! *F]]$_:87LBU ?.*1>8C13%[\" X
MIBT.!&3/H2Q9IY&I"!2=5E+4K'AD/E($T10$&PH)"]Z96F\Q>26 DO,:U5V2
MHD8":+(G:5C]2XZ03$*M6?NC<$#!RFGQS 4'L $QR>VEEL]'BC0A<TJTLM8\
M,4Y&,JA)ZRACB$ZYY9*BY5]A,J?8UIF4/,M,+!ZL]C&B#Z2]]]H+/=TF8L&E
MZ&X#R&$D-Y=,)&<@4HXAHTG16Z= )2\: & #G,GMII3/1Y(""@.%C$@U]:^4
M2,&DS!XF(PER>KDDZ6ZL,)G3:(G3TF==I.8HEZE(K:@G^7\BBU)@\T=+[@*(
M,HE@;#0H- )B"MZ*K,E+0,>L<\G,P1U883(G@LG"(Y",L]H _Q*SLB6YNF^R
MK346EDN,[L *DSG1W)RT=*25MP6$R77[Y@!*D"@E)X(&B-%=1S!&CVACB*(N
M#9!12%F$RT:+$+W$!B#8 ']RJTGE<QK_%B"=+T4Q%0$=ZY1J9HXBE/:QR&*7
M2Y#NQ J3.4W':<T1+GDLGD#Y%.J.5A%1Q.!#3$W(Z[CS&()&"\X$;T"#DEAS
M+)@9\&]9LF%812D-6A\P'PE*;A*09)F+!HC&:XG>*93$@A3M*D!92=#70MPD
MM!):$&4":<DG=BI&:>< DH#FIW4L,WBV9)%-=#YG"]YC$'6C9*>U=L;*U/QL
MBCNTPF1.#D1&0^BMU87 "HI!&JD4HG8QJD:D<RR<!-VMC*ZDE57>&17(@P-$
M6Y><Y **&:S731@:6805)G.:)V'*R#A1L3& T0(%2F-!)\EQ9,Q-R.Q>F?8O
M%3/)!1G10J'6H! 8)>202Y!)>P^F"=DQ*Z/[Q<RG5((E5_=\ Z^5CTP$<\3B
MDU(4SN.^\V5]C<?V#JP,N^[JPEF.($K$X*7COY)E*'GT0M;9*65%P:*72X;N
MP,JP.<B0 R5LMDE2"5"\0>?0"<M^1Z$*2C9 ANXR?$!*02Q)%%6@A!BS!EU2
MT;8XI2\6AS88OKNW,FP.4I1%5%YFJ1,!)$RA!#)@,"OA;3!-(",+*45SI+1S
MD"(%%)UC.0F P+;' RJA@3 XKYS*=TF*&@E@C$+&POC%P'R2_4K6UL50IZ:Q
M@*8& -B F.16EX3,08JTU-*G(@V2 J,A1E2F>(N0LX?4!$;9@*ADV:6H).>M
M"T4)R!"]BLK5  4PVEA4L@V0HKL-H R9O$<RB2$4@J+WH*2T)6FD1*$! #;
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MYZ5&H58X-PKG&2<+YU3YX 6XQ"0(3BT8YR1X8U2D/$JFS=:VHEU-UZ#:WDJ
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M:Y7<+Y4![HD!IFJ-U=00@0FH%A2$H!R,XQ)B-JHM241ZIC(#D*Z4:]U!M#+
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MV3K57;%Z>D4%<(, GFH51DMEF>' @RAI!/D?GZT"B,@4M3P84AR.LFL$:Q&
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MA/ *!OY?[8&]J/KS?6+21O7'78*[I3+I8DSZ]6HW;(XN2DJ 6:) \)# F"
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MR<__YNN'SWL'K_+WO2@A>4>[7_]U].9@K[?W^(W</_B0G^F/L^-WDK=Y0H0
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MQ4Q:<-]@"N>8I8V<T+H6;Z\!G0Q.^^-[6X,WUVZNO>F&E:5XB1_'YP8^N<;
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MH4/;%L6=K#>$;Z<[5BFUA&COQ&=Z(Y:=*'>59!L@V9DT5ZU,C(*#3-& X"Z
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M+ H<,]9EJ4G6BX 2\0 <6#JDA;-(&I= 5I%S#ZR+MS$KL%%X5^%==]SG\N8
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M>SBL.FXTM*X;#_JO;15[PQ+46BBH]7ZXVS2QJH-:3B;JF=-(!F40%Y@A)ZU
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M3MVQK0Y!J<:H),^RR>EDUI ^0[#:C,!S=>W)(#Z;_/+K)*C0Z=5CJ3]TWF"
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M\A.&]3N>\8+93P>S;W*T?,'LU<7L&>VVG@609D)&V(2XT P9;RQRPNL0HB
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M==(P \4%G_XR_QW08(82,ZL,'^M4@ BP#C-P'YT>@M_>K(-!["94WP30:HQ
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MQ<4PYVQP$3$>,>*<6>18"/E7'[TP7&:_=$5PG0F^0NZL52Q_Q4"_9"!"/!9
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M ?2^ )U3U;&QC%N";.04<0I0-98:Q!P66 HI"0UK&_+>9K8*H*L+T*6?R5<
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M^'4PCF&*@W8<;O;"#C#U8.Y/68?H](?C0?Q[/!@ <[>@17]U^O[HB<'2;$_
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MQK@L46(B1<"^""8C]>5:WVX'DV=DEWNMN'^$G*,5[I>'^SDY%'O/&)-($2]
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M@TF* [>!B,B<3$0NPWVHM'BI6CQUZ&^%E=XY)(@QH,J>(Z/!IR"$$<JYLE*
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M<AQK'E/ &1J)&4$CO+@%&B]BMQ-LKU&AXHJAXJ22)"41."4!*>+RD57@R#%
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M?<U[XKQ'7.T]<9&..TN.P]XQ^R.K_5Y[\GNUMRVPM]7?3X53M7+,@C@A:TA
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M#?HW7S+#!/%,0( (1]>F=NIGXY+%]=0>1>1 <[XCFV"X[VSKS)[WUOYYY:G
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MNR?#4T&B"]RFB#6LG$].>,*Y]2;EI!$B;FLB4VG*TVE*C8"F!.RE@/]# **
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M=SYEUQD9>50DMTC!8-<)K)'6VB#A$^%:1I6"7-ND%&^\PB8I;U7Y;S:$'H@
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MBN>8/\_U/"7>-[?76(9XWXTDQ>=DX+YH$.%Q[/.+OJ'<:4%J*YA223NN8,/
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MU"?U]72*.A(=\\ISIKTE*A 7!!CN/CKK[F%MG$Y,1J>,G\Y.SWIQ)"77A&=
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MB#J9GD.V%*\6GJ?WZUR\.[*&5\*C:SQ/D7%C#:"0QDDAKI)!%GN+8G L6DX
ME')'5(7K6"TMZ4O1^7EQ2HK./UOGQRX)L]I+X3'"7FG$)5@C3GB*&/9)X^A(
MPF)EC>,ZXPL3X)SCPZ,"(W/GS!08>3:,3/2FHR)PBP/B(1-8&ZF0]I0A 'YP
M<H3$-#* $8+KG)3>='.DE(7G::[]FF4@?W@MO)KD>;*"V.@31D*!L<.]);EM
MF$7.&S!9.>%"@MEC2%U,GS,SQY'8I=?EU_17BB[/4I?'+HS1W%'K&-(B"C!
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M^F29V#*QB_7),K%E8A?KDW<S1HV^<2?SS4P=G5<ED[)21\E"))@+'BG7AKM
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M7PG0SM/1I)^;?CZ. WC&E_C#UWZ8'L\U<^7&V2#AY2W6P9"<3:^_Y;HN/B+
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M^ .6D(1DBM0:D9C@$+!(6A'2)J+A7:BQ_&0GT_&H#UHXF?:'=E!J+-=Z-#H
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M9KI%E*&+%+2K/X\7>\9/[5%$;ASM9V03=/>Y'7RUYY.]OU_DK.T/T:51O#P
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M$"4:JD20--7,=%A4E&XJ)](Y_HR" D]>3BDHL&D46%F.*[P-@.%(1&\1]RH
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MQQ'0=W([\P,6<#[GOL9J/GMFGYQ-+G\"B+CX*#][/EU')S!8YXO)-YY_\3^
M\]/^49Q_4W<O/W/^16UE\^$5O25'=0]BQOT:^C( 3\[<I!_Z=IPM2:_W:Q^&
MW<+;5,MWS0W:!G^?Q?VC_1IQR=^:"R;YV\91N!*F>XPT,PV,2_[N6TQMJ[]T
MM5?Y4QR"MS-H4T>OGMF_ ^2!L./P"(!JYBV!O8]?XF!TFL&LR@;^+!MR,(?#
MH_SG^'.<UK].[&!F'L$Z3<' UWB9!9E]*30& #H:0F="U7/C?%E.5/1&7W*@
M>AS!R)UE$PAV]-U[L*.]X^7D.QV/PIF?UM/F!/R:'DS.;(#A.3"9JEX8G\'S
MTV@$38=L(L=55L$O<=C/<[&J.P6>B(/Q'(UGG<Q//,D-@;I"6\,XJ/7S I5]
M[UGM >1%\J%!].;>E^"H!?NWN0/Q H0&\NW;YD$S/ZS&!_AZE?V]&:Z+[A<,
M^AF 2'X2- -C#\^?.=+U.,$+YM]!.0$]^Y/CF!UI>,+@XC@/X_3K:/P97K8'
MWAB\W&0Z][+!')V,0APL%#C^ 5_48Q.R0$'8M36;1GLR5TT8G%,0;(ZI>S9\
ML>"+'L7N*.*U\_O8P@L=C4=?A\L1[F4,!B^V/^J!WP&C/SZRP^R, $ W <5X
M='9TW+/^_\[Z3?8@X][O"]68#2J((X]U([5L"\ UC\UG_2R@K_.9W,M=F\SU
M $8'PIN%HPXR'<$=,.C9)9K4+O_9:>XB///%2A?R+ %=F3^O?K/:8W$QYGBB
MUS_)=X'HP/'(1J:95/GEX27SE)W&H_/F19J;<^/CN.P"].:2[LX?5@<#?FXH
M%@I:#^:Q'9]8'\]J?ZZ>2#":<7(AK#H=][_ XWL1GCB%V*(_/JF']!B<[R:(
MJ U !,58?;U![A984%#C[(O#-<T0KD#43"GSP#>(]16:B(,^7%%;%.C&M%:V
M*<RL_.7BK>'#$T"TK#A?P8K5K]<'_QN^FME.\)Q L<8+V]F8^WX>@/BE/SJ#
M'GT%J,]O\@(&8Q925;,763QH]D:A7\>GT+MA3/UI,Z8VP)#DD5G1RS2">*M^
MKP7<SJ=$+]1 7+]0UNE1R$,[J@UZT[6520MC<=P'\^HA0,N(-JJ;R/GI/)@Y
M=CJK,78<8?SZ1]E?C!>%4(_M"8B['LSZS>.XSD5GFW\*0X=6GI>'(>>4>HWO
M#P.2!V\FLAG.+%2O%M0DQL_Y&P@<<Q )KA5,JMJPS$U-;W*<3<(W9@84K-;=
MA1;6%@94;@'N<RU> TQG.)T5Y/1L/#F+C?LVTZ!Y@_/.@MZ<@A>3'Y[C^17]
MO5)T5=V]I=5<N:!1S5IG9J,-8K7^LSV:MY;'_&S09%"JV90?CK[4.= +VK!0
MD27*7!^B7@O4[0/XJSVMER, +ONE/X:)_.YL6N<U>VWJ]C=VB8AZ3U+OG^!7
MY=@R)R9JP.C]/AH/PLP'[[VK3=*?S?E?S_9^_^]W>]G]&([.:B-N>T>#D0.T
M;;PFT/!^3B.%LYDC7L\TF%7]VA_S*Z/T;._ENW^_>86(6<E=;'8,Z*W&H-=[
MF*??6@)-Z+$R_O_]#IQ&<#?[J=]8A]Y\J !#9G/+9IB'_H9XTO<[/'YU-G,^
M#CWXW:84_71NFKYUH6?S%1R+X>BD0;I%LM#;L\;M <V$P??9@_DRRF@WR,["
M+"RYT,+Y2H)YYF^MI"[!Z)YE-9D]S?=R^>U+;@N> X8KYNBU2='NL@A7)OA"
ME/.$.F &C.[IJ+%O1SEL&]8&IOET$E<=T)Q 7;'B.?D<3TX'H_.91U9[(;.+
M;".=N1%?^)1S6[K#$GD]GZZ+,LHDQ^?5S#&OPS@_;?(D(*/S7B[F]V:%UQKY
M'5Q\#"W"[)XI4+Q8#&@BUCKCOWI?HS#@2)S,G(W&5[O@YI_ELO/78<YZ9O]W
M,LE)])SDA,@Y3G98;#DN!-=^DA/(PQ57=CAW]IKX(^9@/*V8G471"@0 GND
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M;O9"PJ2I7S>.R0*>9@G'G.\ 4S6>_  SZ2N\_'@)ECG_M9J-M@NW/;<_/FO
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M])."?GJ9+Z*@G]0XAQ]'03]56-FL5;'KO+AC 4%1 % GO'@% '7"BU< 4 H
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MA E\#KP45FK@AZN!&'P^<KA%/P8S6+$&"M"V;.["_P-ZUN<(T@&KA%\MFM;
MQP++<XN%?.SY^-S0MV%UB$H VQ)$0%)MP"?LP?9\A9-3)76S$A=D>[B<O+;!
M>XA2X^4LD^L<; [>[&^I;9ISD'XK64&2 ]13IP4DFWD"<^J#SQU8P .7*!K"
MSLE^49JC]?0K; #&9Q2N_LHRR(]#<-U9PSC+;TCVOQ,_+3D:\[,!T./'&1O!
M=#\PYY$]!6_.\] FMGLVMXOS&[!:V917-%]V/B7GQ5;G4_:T674^*=C%7:!)
M_<9=[H.2PN.W/P161@P[$OPRS7VYK9J=.\O-/0%]RIX/C5HW=SZT:MVMCX>"
M%ER.GS>8]5+!B <)<!0$+(1GF< :7(8FR$(02OHX8\B1A86'B\\>N)-\$54]
M;H*G7=S\>7UY!A.OM"VUEN4O^<SGB.5(>X-\/P7WP/XW_:%,TU^N5!:FSS+3
MS[ 0!UOCK=%-,00+X2KCP/CM5O%O(]?/,_UPPTDOXWL+_ E&F&4!!VX=<&+Q
MR,$GXF%A%JL<DY$=6"!NZ)\<,5.3R<EAY5=B+W48N +V?S)M'D_;Y0)/^VV[
MD=KSA7&MI9I^V\DH_>V<;]"3/MHM-CPU #YS$6TP9Z6_-6IM;;#51(6FA@&Z
M6PVP,$G4Y\CS \_W!4Y@'H830Q!%M(! W457HHCT'Z^4?4%3%(AT]1//R\@.
M)N2$PHY? G.4:?XKSHZ".*J/Z*Y:>,$ &EMSY.KYPNI1-/#?MV8*4XT,]P@6
M")K\(VG5PU,9DT,P)4)7MFJ-3NL7?&E#N^.N#<SV%2S] .'[;6LBYC'D?"KT
M?#+3(V>W:Q?,/*[=LY\\*--L5P.4(M"U'<3F@BWF'^+\BVI&.@,:35"M,3_%
M.KT!"FE;G3[?TH&/1AB2?*!):F"&\VWF"98%*%8Y/[-5M!'#4C<A7#Z[(MI[
MI7O-9C/'ME@,=SZR,4Q%K^#CR&$B FL'003#X@M_N_YR?ZV3W49R#!:5SV$R
MZ,>'Z-RC?28="'P I)N6(6%B'Y@32<L/X6N9:W%4(S U&/N),Q]? ISDTAQ@
MZ*$=+H'KU>SA7][8W4ZGTVU;[:Y5'S1YVQQ8YH";W0YK]ZS&L-O\AU&OO_EU
M0Y#? YTB]K\B&];X1#MZP688]-5N>0"JT(+7% ,J/O :RJ^7;N" $6+PI(DM
M1L:T6#!!+QK>DX#OT]]&P*+R3\#90A@0@UJ(Y(P%(9V+$["YM" "2>)3PCZ&
MC^U@_@74*^ !!-"+ G'^C9B%L-8V'FZI<))'[[J<;C]DAP$+=EA$5O']_RM?
MB<+JH@N/$TYG**03K6@K)*<)ML5VA<C+K\Q]0_- 80E= I32PD?N/,0J18^;
M', &#6PWU121.PQD! .7/+=--(?$]@RDMM4D 5S+G@&?1^CHQ?N# 7'4,'*,
M#%RW+K8+:/Y@6^ 7!!,1/)_!_DX8/6!)R:&O "]&/I?[,+=WG\@ QB4@D2/?
M1[7E@/9R:"9S"V"P<SA57. 8EA).='B%Y41#NM/*#$V,,.".S5%%3UB8<M'Z
M/<+'^$_L!0$C"H6780S8?,>!<34VY.#(A@M$?/3\'_1-N0&$\KUD,V!.OA>-
M)RNH##MSQ[GVYL+S/9<]V#[PZ$T44L#[S=9!UO(95\O50C\0=KLX-06KI@XD
M2?A0,JDK?P!JV'"8"<1UL';;N993F4M2_+!AUCII\ 29X \&K)M_D3SXYW'=
M@VB*BN'?7%Q$ <.[8_YABW#R,\180&6'K[T2!GNWU=@&@QW[/[1? =&Z7FNV
MVSM'M 8[T-@,>_JH)]M9_?$6^-M5R'A<GOV5+,IH513&4"&!'P8)O!K<L2'
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M*W@3W)I6+S,9#)NEN$EI/;LHZZUGGI1<O_D6+!R[>61E+.Y.2]RI2MZ;PL#
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M>.Z>_?1<;XJ=F4/LS0H'^YTUX5.6,.$1T_ZB_T71/D?["^8@##X9>%]L]\<
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ML(@/G0I@PO'HJ@4#:#L2]S\\-/P$&8E2)/#7^Z;\^01,L/>X*DAD*YOI54L
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MYR;Z$H"%1/LKE]IPJ?:HC)B-8>BCZ/(DY)'^]<>-C7?"RET5N+\4&@9,O_0
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M[7G>$;G+2R,B_^?Y\J+W\%6)WPEW6:+-!9BJIII+!7RR#'PL/J/(VMXM./C
M\_%=9FV04DRVR\_3C_5.Z/;$/\P79!S-+IJ/IL\WZ+A>LI5>V, =6!/)UO!>
M@DL!P7#A1"F%UF9[V'\'43T&[[,SO#9D) \DY8;N1\9R$-DN)Q%R#&!$J8F)
M*D(H9 U[J7.TQEBG.Q5>.Y#R,?BY P-T6&FW ^G9AS!=7%0QO4OSRT^7-YM7
MEN9$8'$1C8#">:%]I$M- 9' &+.ZMA7PV,=;WH7*GBRY4$.G5<*3;'1M5\Q
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M3.QO3T@5U0XT7^C0BJGLK8.8@P9EM(7 6 "19"F\1(FVBRM[GY0QQ4?:B/U
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MS\YF6+:BOQYR!64JG'^I3_OI8$QG!&26+B(R^BE.*L%[Q+CIZ8=C_O8LEK'
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M8/(AI [ZVCK05K7 7YS!Y /2'[U;3-,_SZ;G-+/GO_SWQ7CQM2]-=GW=H)7
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MV;-$$IK16HY@P!=+6'C1-39!D8D::>X$(ZNK7D*;1.)[,#UM,O6EC 95;>Y
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MM!!M6-H%W..KW;(3339&^_2HKF;18-LQ7N=7=$#9\GRZ&\SC'%;WK^8=>72
MCH['*"C>JF(,<[GF>8@ #)3.S!?@AKPG5+G)U>TQF?3 "?:I$&D7U0Q(H.L:
M:<EJ2\LN*Z*60_%9,9^15(W6\9QL2K;)O>W]L(:W[5LHLR-?]M!$@X..2RSO
M%N2GUOW\SBQQ6EIE/&>A\-HX,M%\<=DS!:!L]H2L3<FZ>S!]7[9/7\IIX !N
M@79=U;$#N):6SKWHCF/@]*;+;APY0!%-\C;O ZG1JRBM9DX6 BD<S0[M!#-)
MR11D%KQ-5:(CL.0!X^4X)-E%_@V3>G_Y\HG$=+TO%F>+#3XP(\E.TRI)VFV%
M9S*:%'0H1N<F>54;T0QOF/2HL2TYO?N+>[BBN2X(5[*.S""91%IB8("ZL !"
MUJ:000GS]),BCF-\]*"2(7,>NN#Z[G,>=E)>UQ#W?20_9,Y#B8)\>N.9U8XF
M07&I%A4SS.0H4:F81&P24? 8<AZ:$&(7@1\IYX%\=A5#**2S4@NDU,@"$P)S
MAA>!"B3:1EV9'U/.PTZ*W"/G81<M#!S@]VXQ3?\\FY[3F^:__/=%+<BX>_#>
MAH?T&9CW$,:5H#NO8T+T0D>5M9>9YG<PTJ;BG#0!R^A^N+T)<N\^O%L?U5:H
M'3KPHA0HLZ2I0N:S3"ED3";E8+BJ4P@WB+:W]KOKC]X_VG3[L]J*N$O,J)7)
M2^&R1(DZ<A]Y<;%H[X/4F$7>(.,-X'L3\KMTAOGB'*?E+7ZZF*4SF&-^=P:S
M0VIG[_6:MJK9=9PK6LNT:T2NJ[:2=IH6?"PZ%BY\#I9KO4%K'=YX8&!_#=1Z
M799O?O4M@L(Z]-97CTRH<GD03SC)83+D/*D@:RY5D\#^36@.M8'>SQ#(#_RZ
M?.JE[)XEDNX,\PB30%>'YT0-JQ?*L>AC9-(+!5QYI(VBQ4#OP32\S7,X!U8-
MGKY$WN!TY0ZT:U#//N,,/N"+Z7SQ!F=+P".'VH6"GD7A:S9AULR+Y%CBX%&;
MG$R;0GI= 3XYGO2EC 9NU!V<R^S5:[ 5Y6^X.)L2L:T2.B@:.7? M*Y9T:X4
M)H,RG)P$V@AR<\)L ??DR-*'$AI<!5[OUU<#?_YU*8;+ T@GH'CR$EG!0AQV
MVC 0J3;QREX;,!!5DZN=>S -%<_9/QGZ$O2I1&(^^P-FN::W+X^B0LE<.5-8
MPEJ6"81B(=K,K*4OA3:6_-865+F#XEA'_+VI=MJ7B!OL*,MM[7FUYFLX#(GD
M\AQR1F[(AR6SYL^_WGSF#7RM/UN.X&88D_SF'":_P\?K\K9=QM3RW+_%H(YS
M9W  5U87JE-1]*,A,9ET+H&J75 3F7H(M"'0RB&D<=Q SL$W.8Y^/.1]X'KC
MU+F[@WX;</8MSA>S<5I@7NXN5Z?OF$M()5F6#<],&YW)%#&.V<1C$B)P@TUR
M'#:B&=Y8/[ZBIWUKJ<'1P5("-^=P;V;3#S/X>%GT0]BHH5@F0%=D"E@P5C$1
M7>3H0S"RC6V_%=)3L]YZ$GX+GV\CLNMKPP[8FIMD6\ =Q[3J2Y&=^'& %EK9
M2ULQ BI75+WV)4WJ(I %5\N\R%3OSDH*T.3X:'B&/&"_'(4@.PB_1V)\BF=;
M<%WM> *M=3)%EKQ9#IAP!2&8ME9+);WP<J42U]H]VD/O.)*UT8LFI@W$.'!P
MQ>W:"&O9,375?8^KTX>?V><]Z8XC6+D4%=4F-)$V?R.T*#;F7, YBUBBR5J.
M=AI,*R7L':?1]<F#*J1#%$=&[C$+7K05FB:,!X/*&R.]PQPB/*R6WH(Z'GS3
M_C$&G1\]J'HZ18#HD+/-Q6<06I+EXC1]EX.F?5!Q'Q[63S_Q _>^YCI_<'ZK
M.$-2.ODL'(LN0"UDA\P7'YFU(8#R#L W*?JS*]"#;;VU6(Y1L"+*&"-3/FJF
M8Q6"L)E\H,@=YSIX:%)P?%LLVY![?E.>K)EZA\F^52N4+6.^7? 1;THG72:Y
M_#J=U4R&Z60QGES4&LG/L4QG^!Z^C+B6X!6XFJ%2ZI"011H=4V"<-\+PC T[
MZ_0ZEB?.QV-KOV>/I8/L;GV$P%ZE5SW'"6EV,<K@/)#5S:35!%VA8YY$RY+6
MH$TI!>5#&W</,)XHYX964(,#M;594$O(3=/XJL_5&YR-I_EW7+PN!/W98C$;
MQXM%M3;?3]] _<2H"!=U!,Z*<88F1ZUNH5VF441)?I_2LLW]^<'(GR@ICZ/9
M!BEW':5U>=R=C)-!2<E$J&TL0HUOR=FQS(6/%D :;'*BMPO(H2* !J59,RV=
M2K30MUSH2^NVCF\Z66;"+A/9!/?.1,5*E/6T*QD2HI7,VV2%*#*FU"1=_%Y4
MQ[J/:L>%-:>C+YTTN'E8P72=K=H!5,O+J8VHCG0KU9_VIJU$/Q@OA(C.\8#,
M98Y,"T((@1 Z(WF6V1A:?1\Y'QZZ@QJ8#KM(O $-;GL#,YC,+QM:/,O_=3%?
MW,I1C38X'D$SC<[2GER >5HQ&5CA5#$6<VBRL72#-[SMW(,NMULN?2FBP6G6
M+937);_):+]SDG%IKG_+;;:2.ZV83*)BYIK%R($%VE1]*387UR259D><3XQ
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M'/CJ>.\SC,_KM3<-[V_TMXM1XDX:DSC+A7.FL=!2$#@R:\!")+,K0Y/)T6I
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MMN5*J^O:@OL,__N$OLS]MYD*7U+@O*9+(:)2CN8,*K((PF@&UFH',@LJ TJ
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MS^/NSS]O1_OA">H"L8Z M-;@FFDC^(!T!A:8LIJ@3=[F^I7#N)Z/?M0DH&(
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M*LJ.@3U4Z=A9E'! 1L]=(E9LHOOBA6_[E[M=!+IM0!/(<P5!E<*%K-!'R)D
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MX[(VH,[(/I?X2_>0:Q3T#(Q,S-P\O'QW^24DI:3OR\@J/E%25GFJJJ:KIV\
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MM61P; FL9RDILO)XFKU&KG#COA%81QR+XE92CS1?=]!X[9\6UM-RL[5CY\3
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MN<2S"^=OX'/YIPJTOG<,:3)XV2OZH2<.%D9A+T[$%(PRFPL(@%#]A5(LH(,
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MKYO8^-"QHX&&1/G+S\6A=\RHPMJAS ZD[G9QCYMK:+E\<8QK1Z7Y[:'/Z0"
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M$"N6\9+06_KH5+2SO40S]8CUJJR@ UUP@B2=@5+H?X,$_]^>@:O!G!-X'DQ
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M=V5?$QS5K7I1KC,JC;OJ<:8/I\;1H=DK;M<A5\RD>!^D#CY8?7WN#=8UW\O
MV"KOK[;$9V[L3T5:)D/67 K9M=:,*],<[<E>G/@@-==H%H?>SS'LXR>I<J=W
M(7CC64"'PL!H@XV2$L4;_K=O *UTE0;"FL853^)^\67"8D/_37X+D5^VN$4
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M/^/EL3"^TOM;_^IW[?_-6,$$W=L#]VJ$#FVW8&F*F.?00SAX_?Q%<!\!D&%
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M>GT)A\ZJ^YO)HYC"Y7IS>R&GQ0CU5)-P9:JN[F$KT/8;3:TF_^[4 -] !ML
M5J$@;Z1VW^H>A<W+-^E:I)+HBZ#P1>@9G2<<>Q!& #P$2F8P<K_,[^MK^,)3
MC [0'OX5!6GS.6F%WAHXP >X&8'WAY$M1R*#!,!;3@(@O-0JD7$MLD?"D4-:
MWS+&L3M8&"<^5NQI'ZCXM57(^LT[CTO4L>-?G$G+0(G\]O7NWG;Y'CF>/01
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M,)!*@-ANAE]Y72O=>^#KD986DQ(ZB6T$6L\-A3 3$RUJK0BG'HY@G^D:IZ<
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M"F_?C3ZYI/U*.!#37WM!\$W14\]FL31PS( 7QG65;)MPP7;7#>*@L1/"L<&
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M\^!.W]&BP0+S)3SQU",)WZ^P>]0 .J KD70.O+4-7AI?Y5ZA P3 _])-=71
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MS<A8'7SK7 KF7#OO;'^I>33?EN_)Q6!,.:5$H0F[_Z#WEK3Q4T]_X'T[8+>
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MD8,6:'G*L&-KYF&GQ8_S=CL@Y<%OP?'P=OMR'+3SM(<O*-3W\O@G4@T)W)T
M6619@]ZR3&K_..3[G-+OOQYDP65F5]#U[Z,T4O^ 0,2/+_(V+*>@47'>MGFY
M6R?3GTM^3J2\,+\B55()!XE\N01_JPV*C1K_$V1HO7S\=L^7F^9O2Q,@*^86
M?.YBQ0U<OF>^7M/A/P'ML;\^!&NWEQ]3JF%YK)#"">YDR,@E_>!@>PA^L$VV
MT.6%?]3 Z3M/6^R^,WT-F*>=H%4/Z\(K*M>?6*K&S%ML,)2%<K9GJ:N&5GRH
M+U_&-433AQY*XIJ]CG66X,0R;N?U9K6A8L/LW0Y$0%!B7Z,K)$-6: A>47\@
MRVUC@@Z_/^JQ4RJDI<H9PQF=S?VT*;?NGZ<?-W71 1W&113$<%7)RQGVCR<6
M\*,#_N]KEXXG_BR^[G7!3UNCR?@@JKK=.=VQ+DV1Z $>P]1@/E$\1]CS<:3M
MW-N]!3]3G%K:=VMI$1P+4/TIYP\EG4@5:!&<Z:-3?-D"'9"5YHZX#,3:V]@5
MM-D9NJ#/5[5M5<N=MBDG_%8#'D[(M.0T\?>SN(BM6S.LJ:SZMUDE<S.R:<@7
MOF(>A@XNIT4F^3]S)%,\7AR@A#8NG+?QG=X-3@#G/[I_6"L;5&AK!Y[-L'Q+
M-1K0%U!*EA:]^N,&X*7R1BEW DL)"$G4=I^8.[//"-6[DTWAJP\2U^PZGQ#=
MC 7DHWRVU,X(NOD8T %!0-6-C#&4M,FN^[:UC COD1[#IR&Z=$"9.4(9)8!Z
M0F4P@B6Q; 3F"CH#$P_-A1"=EXKPE>O(2/"N\;XG>6F.+ A]9(MH0Y(DR*I4
M+T_JV9)O*!#B@@;V7UO"C^S=\',THQ$$9A]!/@W-AV907C+\P@=)H )I8>/Y
M\O&<X$BD&G0( 0 OW1T#;S"0[0GWWG(P"XZ)IG]6[]^)B+K$5ROY>)%2?>X?
ME!N8;2W%!=6Q+3Z9SA>L[H7JNO-_4SG:,HUB18TRF<IZODX>P>X3A]\@+T['
M*7E]?N)9J+01,/)GXLJBNM%=#:2#XKU[_"L9<ZTPMO7&K)]7?'Z9!OGU,02W
M)-FA:<^6R%%FQ9P":0B_J].C=U1+]5?>5^:N<C/1-O19'(PCW &:#3^+KRE]
MHIR72WRBJ[BO_?=/!F"/-ZQY/BX*JV]6OU';_OSLI[KY>D$A:+'%D1@S_T'K
MPB*P4JRJQCS^8$3UGF;XMDQ9ZA-MD16MM;KUN#LL]F-:JB6=A6OF5>8& ?P+
MW;YB=<H$IPBXL<?BX)EIUQJT_'N5?I& ^.Y9V-YD+(FY&740-#87@LHOOZPE
MT9:H=VBZTKUL_CKLQ1_A*U:3!^O_3%=0'_IOT&X*>]*:&/)KR"U6,S=_$_[F
MG^1_B;!.!U0>'<.>U0_Z>!Y"/4!C[>,]%RJ3D5V)G_\>8L'^G4$WF/I:P(S5
M\?$1@^<R=-T-5])V2RCULX0^+BN3TS,3I<#R30\&AN9&$]EOH3GW7WY/)$DF
M(S";R%ZWD8T!T E$KU8*@TS1C.W3;2U"5'S:%_X>>O,$*.K?3X/$,WC6%X:!
M \;S,!+0!T:F))+&[!48W W[E_*MH?<5[Q%Y&7R,EX86H_FN4Q.3.@\&RQC&
M[28,_34.B5^AI,P@:*U[B%7F%@-4&3R  ;>',#K@&WR.? R55-)X%E>94;-*
M0/\ZI!G8F=.:T^D 750(ZA@5B5AZ,@[>^(78ESY<;T/C^4OE7S'<\?N03#<=
MX&Q* JP!";MT /ELT$E_.F#K%!T@*BQ&:V$\6Z?4F0[@Y#1?< J'CL"8P$N9
M\E1X+V7CSQ39>-Z)DI+/L/T#.--W$<3$!N9<)1A;U08U,].FKJ=G3!EBUN^'
M0EU8>RXU[142LV+'\:#W4ZJQU;+:H<=/IUOTT(2639=C^U"/-$NR@H8GCR1O
MU!]Y1NU/?TW;V[J4(K[TZ;,V0F"H3'">]JT!U?Z&2_:#^QL;M4$Q%\9BQN:%
M6/S&I$BX*+TL\'V>$RMM\.]C>+P&A)ODKVZ7=PNDO71\]=G+*.?48GWDD]I4
MB?@H"^S#OI"(NR=2^RFW&"[J\;>5&DW@'H/*XV5H1C4,869/!XQ9Z"WJ!@$E
MH:B00<3NM?4YPCJ:S(>ZB+*G9C&0XM$X>F,<L7_]?R^?($:0_:'Y?X[5+"A<
MKQ&XS>QQ:UOP 8.QB(7:6V ]XWCVUO9<9OG8MQ3>!=4*^H5CG F'A>_&7FI\
M(]Z:C+$^O3*T!^::A13Z-UHVAM;J*R]]C5]O3.!8MKIOQF &NM+7S>R.M^3@
M),9>9IT8D8@)/^9>^&(R@972"6^TFVN?BSE/A 3'4^YX?^F9?F6^ISO30V"I
MHP,V5F[=,TLK^)#QR.EU3KTJ9&C?\G+,XM:%CNM1(SN+28,/WF^]H ..:4W,
M^'W)ZNXR.1^^G%S) +4/%_^](Q3QZI0DP%<)4+V'Z QZUT",#W%<XS,<')-B
M;H[N8"@D)7GV:4.>-;F=&YJR"QZ_/+TTV$@8,S3R_EB9?-E''\QY?J&C%-OQ
MO(P*4,KE]OMQ,U8R,E;<1<,UO\R:^00\N'\$7R=0%/)P>>7"O9>BS-=9>PHP
M:7!-8N:7EGC/?#?,\8D_OTZ\&)"<28*8!)U30]VI;:AM?/.C.DO]+1W Y<X7
MDCK'?T5L[[>!R!>19XHW_YYY\//O,@APZI)G;LEV;A$=S9W1KMBJUQ=J\/,L
MI,%NX=F.CHUII#[G-VP]X8OB)H;CO@2Y+(_#%4^ES<0$>/#N& 2E"G?7NBZ7
MW)G[ #1.?<H99\&&&J9%OYN8B]2R0"S(/O)T9WWRJ,;Y :4"E7VXKUW"/9SK
M599O9<(J=N(>5,-ODGRE3?D25L)G\ M<%7]:!R]T>FDFO[H+Y!8P*<.T&2BP
M[H8=,E1G89E"Z92NI[7SD./'](8O/Z*Z94.#S?8(7FJU@5X5>Z!*<8"1&E.1
M\D^W%FW<0>@%P69=]2=,KQ]>G*39R?SY18B_M?SB!<);=#^ L<RLBV/$=XL-
M2L7CGG.=27;VG;O)M:M6$)@RVK-!<<&?OH=_US:AK#+E[SDS+2DQZ-!=?[!F
M7XMK;X.TBPCNR:5X$/#G[V05LLS VB7QRC_A*L2'$PK=I?X)\G-E K/CZ'#J
ME\-][@WE^_/3?Y*ZWSL4207;<.!**5V]M**6J!;#,<22#"/HV<TQ\$:9T/0O
MW;(4;TS3K440?C&HMI@YS,=GR69PF9PUAVM?Y++NC--0*;UFI\L]?:&>X76Y
M!933_VJ9[MD2C(Z/K?@4Q7("FN,?A)6KS;_YS76XK(0-)V+P2XH."'U),0A>
MC723,?3?S+F74J2',MW5/HC=XPM1=S;EVZLZ6IT3>L451_6VFNKN-J0D9["G
MT1X)&?M]/PG>1L%^6+9," ]*JS^3,_D=A>HJ?29H>KH[+\K\1="E<I/U6._&
M/4"([SS!^_ZXIV^I@?&6R<*VG#A8L9S*\OF@V+=?W?O6RL3\-[1%3M'L3B&T
M!<X_A+R#JVJ(V*BYH],NAZA3 XYAD/Y,"YTK,2BQIC''H. K['\<KHTB*M!8
MF*[>&3^<^#510^S=PMS/3)]+G5OG/F09O(A[D_@MG"% +A(ZX#:5;NCH='?T
M[LZE6Y :AF]60CTM?&58?>_(_6E;?2KX/D/RX(2CV&R#.(HG$9EM_LLB[DAQ
M*5":5I]KYRPPT/41'ODDM&]%2&VS?3(VVSZ +/0X[UW:CWWYB"RY6ARM4CLA
M5S1VY C8].PU]DMP@B$J!&+%:<>G\*WGH1<K*G%]R;HK_X3(;=7#ZYW4SM17
ME$KKMI+8<JRC5WY,T9:8#*A@).0R_N>;A2 _U5H9B9\@&^<$6R3"M*L>'9U1
MUKRXY;77H1'?44-VN!(U-2#(64X0:]$.7#IR:"IIG64?TW(J.6FWX1K_\<V7
M):E]EL8@Z)#LRVQ_58.H*;?W[J4>0])B=;\1['D9$PK>\,&; 0\RN+Z]/5"B
MKB<B));7O8!"DC=Q3_+$*;OV)5('K+]HCGLHEK+114A\>B>YROCQUQJ>5Z]K
MG]MFE2;,L"S;VCVZ=^M>@S:E)J+PT3NGE@7[0]RMY2<XVX-Y"F[FNF?NL<0E
MMU:9:J('-@*74'3U96M&V\;Q.[D2?#[N9B:V%8T\3W0M<#^OS7FO3IUU6K/>
M_E!Z0V)DYU']/7!H%V3,MY1MIR$(R"%5UZCLV :2)4KLEUH0!C04W,NF%:43
M"?=>4CA@96X#,AO]C0_D2Q_7-,8\C;+X6]D2BF+#U[8%445</'U.N/4?-P[0
M^W!1Y/VV]D9RODKF,$']V1-^?;/BS8G!^A7N531'BQ0X:L%.T0J*-!W<7K*W
M!WKZTBQ6W+_&68R5,(6QMG*EQCU>W$Y\VLSF_]KK/A0R1D;$:8&+=<6KQDL-
MNPP#CG,2!9X68#W9UZ[S-HZ75C#K=BU,THZWV'P^;L(B/C$[:ZGEN:EABUGQ
MTV;JGKM0IF427^#B>C#U+,0=MQ<<S%+]<,;?VHWC>&O9K(R8O>V)4-;N;9S)
M3G>U+Y"#QC/C>GAMW9HBRYP5H="&/0NNT93U!0N:.>+BPPRRS9[=L& "G"V(
M3>=7J^\9=I :+CTC!W1;]W_"968ELK#O^8_*NSI4!&+WC@\=</B'#AB.MRL-
M/$<T(]$4J7\*2B@_3'F(?D N_V<KMS^R;:OJ7:0#TKS8H\E ![<_PKIM*\9C
MERN:XSJUY"S&R!B,<CM%AQC@N3@-J[9RKQUW@*7I@JP@AS9D@;Y2D(?97)KC
MA(C]SX(V.H 9OF$:%N!1)I8U:Q#[8%)!0XA;+)OYZWJ#/NT-_" CLW+Z1\';
M=E2==J=YF=[FA7M0Z]P9."_>K]^L-G:P(Z&FMO@X-9<O >9-'24CI/??RUUL
M>&WL(7V'?Q7_[2&"$R8Z_B98=W>(#LB9N<-!]7Z+VBW%6I4.GN9,'OU47P2"
MR45C+)!%&PWVB8*@ L3);V;)PET(N>K=C0URQYMJ@G&7K2.S'QT@D"M><7LZ
MW\^/X)CQK'$U[F*2YM'>4=(&2)'8A;EF]&CAB?-X%Z;I153W$5/M&!U 6$]L
MDV<%E98BVG0*2Y2K<_\(,V32! P&]R4OEL,Y<!MW\79]@QK59>_S>#]$G3X2
MW0XFLY$%3;_5C&Q>K"R/<0CC9GN=FW\N[@LIST2A^HRP9'3[]N&3#*F<AL1/
M; G^CO6UR?S#]E>X2G+/1+&$2=^28EH>C+$'(%L;1HV>E5Y.?=XQW8]Q.CJ[
M#;9>=-L<@!E68)1ZORJK\00%I)\IJ*W;5]Y[F1C"ZQK"61?TT2)HYDK"/5]^
MY^[<A#G[U#F#BN2J6G57\YK"-= 9BIZ=.J;=^D>C1SY\ZG;WZTF"WF9@(IR,
M:89V?'^KPW+"!P4C!N$S]R<=1YHL[=U\VSK]U?T93\+.H2:^5//,*=TJ,,_5
M7H\M*G!-TVC.^;V6;F;;-B.BPER*X1SZKY.6#V.;/'+]#0;RQ[:A/[M[W:,5
MU,E^Y P7E<W(;RW*^#NU$7!E4.[SOB>M-OZ]?XPX=*ANK;3S,P,(?-C/[>7^
M =6L[0["917E<"Q,P%5$>2)^>6UW/E'&T[U@.091I#W@#N=G4,XBA@*H5Z7%
MNF[%@VX]._JT#1^U!&45'QZ8N5K[=J;V;4<M7H[I+O[62O-UB%W0,$UH,LK^
M[>_9H1IH-Z3Y^6VD XA\X-EA<=KF@_OV0GVM0XKNAKB[YC5UECWN?<_.Q.B"
MSD#G,9_"UG$/:*10P!IUKG"+!!W8[<#U#=^.2[XHW==^ JAGGZD1^T)MA9<G
M.&9AQI7C'#&PWZ):[,D/G;[P0\$&&LNEJHT59/C<.<<AN>F;X\O3C[Q(499:
MNC1:5TN$ 7OVVRA+_A-"83)A>4(2CE_._X$*_Q4YD0&'73#.LIAYJU(QN.VZ
MT^:J9L3ZRBZ6=D*F>MS76%O0)(T.,,M\6!OI];-[GXSI!X'Q$;.*>*7T#J[J
MN "_8>""SMQZ8,9LG%!^R.N?>?5F/Z"?X2*X$O_PKK>SIB+N52.27I SV&WY
ME<$AJ'".<^VLZ'CV:%6=@%N,"8 I4KA7^Q6JN(E_P1C&0O025IGFD)S-<G_8
MLU)$#H1:N'XJK_C=]DENVX?K;VN\U0+B'W6.A+DIM@-^N$Z^M=A3FZ"7+BR?
M':XSI&7&KO3_KH ,-L<5T(Q"XND VX]T@)[KIDP,4>?E64R[\#7=A8RS>$/%
MOF]>SQ''.;!VU0%[Q _CPF_-]+E/G@Q =2-(D@RA"ANF U9E[5/MH?A=LE03
MO\OCCH#*F9+"034+=2S^OQ.&Z_]WPG 6X30].:TW?K660T5]PJZY1XR?*E/+
M25',2N\(.OD<+(!>2I]#8!X@]A^6D>N \;!=XQWTQE<P^1J4&QPOK$BT K:B
M+Y0USA=^74Y1S?#<?FP^5H!37>X>@V9#>V;9\$\&PYN,V',]TUY3TCF=J(^=
M"FFYOZ'C&G+5CHMGI67UC#.?AIF]U5DVS=Y7]BVJZZ.R%L@]=OZ;3BJ$OJ4-
MO<C&T5(NFOTYG7:L$>MYB[!.&L0ZQ<YCM(S8/SZ22ILS/:%9U%<570;*E'$]
M59^KD3"LU=<<=  /'7RM[!8G_,:UT-0]G84LL'ONE.BQY$ VLO<"1\02KCL\
M(KVHXO#N(ZWBP!PL:P&NE\'^H'8!$J?Y[D%3?QY\:_(0-)[W>,);8M7#0MVS
MJ3X[TS#S:^ 9'>!W7\I[^[I]H-]+C<$W,FBB?(G<!_RE6?4'TC#=@U^@@C/H
M#W?! MCJ9CD/7MNFT3*NKVF[%>>"C\W3+"QG%VV,"\MD?W=?-1'F\[W'KH.R
M-,Y043-?3CHHY?[NS[N8E;+HQOIH[)ECQ3BW;J]0'/=C\*SY*/+6SKV;J4P&
M?>N!W.K,3?7ZG;\RB[Z41=^[$&K5@'Q=%2S DV(^YE':1N 0'5R>:'):Y.WR
M+IHVSO>'PBUWCU?,7FM7V^;R$Z&Z9IN8![+=,[-^#^.CV/'&:-VO25/PK!C5
MB;'U"3A%ZCF8YVB?;=IMD$&QSCP@\G!PPICC['Z_+L4^ZK]\2@[!V>E=O=HJ
M(2B6 'VV2=:<AU!2>L$;!Z9+U6N^RS  :N%C*Z;F8C?2T\\NI67"+)P4!F8C
M6.\54]PW_J8OK_"'%3U5 SQ.F:J\2F+I@NUJN2$(5%5:E"OL^-^SQ_ZK3[;8
M/V-=9H?'M=9RJ^$*2L+'TT+NN<LL=U.B*=XO]:7FB5C!NE^3= #;-C\X-1#]
M</$(,NES3X;YKDZ/]EG9 ,C?_/^QP?^9S9P G_=\](WXHM1($R!>[0S-^HIU
MIMZ!9]I->D9^&J^%E-(&T;L*ZTC")IK,'42 [^!X#C01@K;3A@MW!HI8.?#<
MHO,A_.#(8,X'4-K%?/F(O_L;8_\?^QN#6Z=?GBL?_GK(H=8KWNC=<Q<P^ =Q
M:R(1S\D-XO%_$BR!4Z09C3!^Z0_DSQ8/5$[+";M.U5")6H,?W^Q4"-N*81RD
M_;(FR/='D$5M4*P42FL=%$+<6:BIP',)+%TY^CAVZB)3WAN:& F:@L',RN+&
M:]]HJ7KGVPFW//QQS_&RJK @Y6  GEWJC&D!CJ^,5JO%0<_5L&ZVCXG,8[)U
MX</+FU[C\9D_5^;GXLS;6\2"-<@WTJP3>+U%SNL<FF[$DF\(Q1*1!;<..*+G
M^']^=.-)76S>T^$[?78QKD(^E_UOS,NIOCRG!#')L5:<=?XZH-@1""IGZ_^R
M;HEAFU'I423YEBH\5W!+=,R3^AH,[0SD>7,J_=ZX;#:35L"K<@J+\A)(C3@G
ML:3@0N.$UL97H *Q[)"_I&)OOR12_<[J[;S<^FS\Q^[BAYYLJQ4!*;=U9YK@
M\TZON^NU&?Q''D#T;9*?[Q?6L"4=P7M)JUN]P&C3MJ;H>4R8^(1O^>(=*_Y2
M#YB/B!/('3U[R(3"<.]SV]GH>UUZ]'+GVC]SGCEU.[&8<BNX\CA\ O C3%SD
MZP-$I!-'#*_LA]WFP,/-0SI C+V4(1]+Z(#LV%T!@N<KU;?MB]-'+D(ROZU#
M-B\<QGX3#[&E<:]:_BOU;TAF_T=*5(LQR?._K?-;D69XD6SOB^LCQ=46=$#D
MA2^(H:<[-&II8"EW>D6T8_-3M;RO!201QG=LDK<9<6%@CGID#5ZXN8;<YV^D
M ]!N]B7Z(EW"T=3\-S1$SRZ*:*;A1&5F(-'.U/ _QA"LI0ZN;0*G'J!7*(E7
M$^<](A18WM@T0\S;I:4N-;/HCN0/5[W?+$!G47,E+PP>OMZGR-R*+1R-LQN.
M=+=S71^7^+O1]?/?F5&GSJQSZ9V7E37&ER/8/EJS7J_^&9BQ5I@O522CL#:6
MJNX-\>ZC QA&%J1\G4EAA*V)%!J7R0<Z0.<C^NB@>KW*,J1+.&%NZRILCP9)
M1;3%C()7%1DB/F0B\3_LQQ0/0\JC'])&.ND \%( E"*5J4@+5T4<;KDN1[?N
MCTJ<=Z%)C)5^\KD.J%Y3,MO,GC2]WFED-;A[L2IR:W,ARBCC98*R02IM/^(,
M#VBE](X^=]%WPG]/@#J2$P[&T0$Q7H<3(1:M=$#Z&^]R.N [3123Z8HXCLIU
MF#(H/=';>\HKDB_H\6/@2'-9[,_[6+&&*#"GCO7YT<HQTH1IA(B\P47W[+>!
MI7T(\SNP"/MKDBRF,9"B^D2*VVJ?M':$R>#65],GA^ ]+4UCHF#QS[ZIFEQ/
MYXC'>3=ZL-/?J'<"H5$TX"J(MWURZL.S%P,_5H)HPM'S,@4Y94K8"PDMCUZ7
ME:J[_/K[]ZS.SU]CI;[[7FH:;4.S7<T]LEN)]3AQJ&CR1^WVA_NW/XEPB--2
MU][=[V,SV9Q-NY0OU7?-K[[=%<RJ=24$65^3P0A@:,\KM#M)9*AP(>54BZY)
M2DFK B->+2KRB_SB'URS']<WSF<96LU_OUBTI4E>AV_),UX*;^ZYM.>WM"T7
MF!$*5\(7>..,5DSB$-,_$%B8@9G9YB5?.L##(4B^G@[X,#^%: 6>L[VF>FCI
MYY(5XB@6 GA!Q@0L[$38 X?M+C?-%?U&X4T <<#'P+&,'>?B^SD)KK^RI(LK
M4]/3PLUXU,;%[A;G'KOQG6M=JM14[6^^Y@\<-N^AV,63_6SOY)CC(=0LKN*(
M\W<0--D5>))BZJ8R#:Z8@_P:N1N-/YNX ;LQ;-7W[O%V(!^\G3,Z\:HPYBE\
M%<FJ]7";Z4%;^-& UZ<0@X9!#@H[9U^E?S+U\5WO@R#;5R%EB+? ^$ JMW2<
M6?7M.6[EQR/[BHARCZVJ*TH#8C2)0L<K@M-Q?+VTBSNVW)A68YM?&6X#(;0
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M:FK;WH:CJ(@(2!.I0;H$L !2A$1$NH#T#@HH @+2I!.E"E($!!2$"$@-122
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M(@#"!,5>[/>1VJ?V/)"E#F]#;[W)E]'Z$JFFXN'STN55):,4NV>!<4A!AI!
MH5,C6*9'AET8X3T>QVT*%_,W5=@^)]JW"B(C,$$#(4NS6T3 J:3<>^IF7*;I
MY39I/>9>1  EJA:V@_$@ EYU*/UZ?X@-N&XIVK5[N4CFM_86-LL-/:]6RFC,
M78G8<+AV5:VPK[99-9%"R4V<9_^DQESL'[H+X: W TAAK,G]@4*WL<--_=F1
M-N7+I^]"C#.9A(-&35)J&)=@OSXAM&X+;8/'FQ$!TZ)ZI,?E)Z&G?'KUSJ\M
MC\::$2Z2J-);%/Z<G>RG(_+_VFQS8I#P5&8,=3'UQZRN%T.B]%]ESLK]Z#)>
M7V4S=7O"EUJKP*!]Y=\4^$W!N1B(>B_>CSS$.OAC2@Q/Q<7;31O=M(?^[N-Z
MDJ7?"S^<*$7]5O/Q6OZ8;ESWQ:3II]B!:2Q_[#41D?*F1I/+S3F2>1&F9?<<
MA+ON_MU3%=F &W::*Y;=#%)_M8C6[_U4 GOT1]?D"!7.(HL#-L?C&$@D7KEV
M5%%!TRCAMW'50&(6QO$LE3IA5-91):90+PDBPG5(QKRRQ_CZMVOJI_$5QHAH
MF93\6X=G_-I86 GLL>M_W;Z_NU*T#;BVBV/I[YV0H],O\ ]'J(!0^ZJB#\)+
M-=>/N6PGYQ[[JE!HO=XR>R*O?N=6G.:C]/!K%_]8L5(H88;-GH%1V]/;)GT:
MHG2EE@AZ]77>IL#F-P?+<[5;H>]@[-^5_KO0S%Y?&C;%;'JS,RYES'D$&KUB
M8O+B)_@E56&?&'U6T=EL20OQHWJ0(; 9KBX;VJ/@S()J+*)\EE33F0R5;1LW
M ;>>_J'<-1C,)/P:47['^^_NE/<?0$ :$NE/G: ;2?(B40"D)UJ'9-K')_XA
M=O*&7NG>K6OVMP+^]3'[R?8\ED<+$5N9+M NR@8 ES;:PR[CKZ67*.UOE3VH
MT1[PV%E)C5<5,:'XHT7-?%@BX$S<\SXQRK!CLI93D%?GLC0CI?-R$M9J$ULI
MFM@]K/8>"AY''-%WT0\]*Y+L14IX/L4]9MP>7RGJ.UAY!_[B5HAK/BGOE["D
M61&^>'D9<^.QED#;G?0X3<L.!GV.X-D-_@;CX./41*%HX: 0J?*K9)PQM5LM
MF4_/+3!H*?][A3?G26ELV)-IJZ>)M[=<A7L@/,]/Z;&;)*UNB%C6E(2L3@0V
MBMESW=@\WR(V;FS .+"N_N^!ZPSFP1;,;%VT%[7U6%PHG!E;%'*VIFJ[XKK+
ME7?3Y24I!#M'P[<KP&!/=]=O38>'ZWFBN'[A([EGC_"5ZH<<%9H8^+[.'[U1
MJN"YC?<OBT]N01^/O^+HI)+$^P3?>(+>F"WTX@WF:"+Y)G]1C[F>$^:H?OL&
MO>U!=[0V(RJF$*:,A<W(/I5C+X.S:4N<$CD5 >L*U_@TN&RGY2-:F)X4]8W3
M[5%;_=77+=R#*7_EV[KN*<9#]WHVQ67E/CH4)+H%,SF32:Y@>[XSY?Q=."%(
M'J3T7^/A3M>OH/.;7Y*NP_:GSY_@,^L_3AT8Q#HU)$'#$; -]JL3&_AZ#K/;
MGR)LHIOB@C+@\MJ:5L;A CD"OR]I^^\WP8+]CU:Y>2(9-F>[Y>/I%8%.?>)V
MX8!%<5@HDGG0[; @LV=]QD.;[MEC73?9-X]$L09ME<')MKCXCN1/"#J$-6YZ
M%ME3],[W:9JO SSX"M#>GWRPZD:O Z+3N]5X%BLJQ\&'B4KY<H<Q:M9BDG&5
M5NYI,_)44?8ZGG8FF=(]9.S>5UVM",2%G_[Y+IISYF1H,PE?K:^0B7!+R-88
MS9J%ANXLSV&^'D.%HYS-$X?'Y'%63HS5=Y>LE1E==QEE&0RN%6L<J/25\BGV
M/W?8##]]J>.27\5N2[ZPT\Q0B'O!;7N/7F'.^/XW2R&<49%1U$K;A5GA=NK/
M07R^1AZ.@XDE)JC)<$5Y+)M^<X#;68Q$!.)84/N^CLK'EWO#GTO\ ^">7\YB
M7N8!?C"Y3-,<1+I;G&4H;UB[!0EA#B,"D.<)I:LJI><ZQ6K6.(YLIV$7AW\4
MFSS3OY!W,^YT,41;47/.>+\L85]_[>PGVEJZW2CQ"QEH1G'&A8F:SFX2:/X1
M,_IF4R&(.X<\L0?*Q=^]J,TRR_6%_%H9<Q5D7QVBYJX'K,L(YX^8/4._]5';
M]?WQY5W4AT[1[DOUT05>I3Y%&Q=1&% /*SO?>YN^!6-TWFY.V72RY"I/9MJ>
M31!>(EUSADK0"/&6F<='5VC#\4M<5$6C/1%0!_H,[:;7)+FQ-2E'CJZ=^H=<
MU'9!WLZ7B<[2XC")0!GQ%YDVW6)#9ZR2=4D'3<LXH74>5'Z-W:I[D7RGI<F_
MH_K#PC[S/+"98V!-5R=B@<FM839UJ0U";>T F75\QZ^OJ 83[H^X]$(1(HVK
MK":?%8E(!6);,^U>%"4ZY9@JW/SQ@YJ-G!"*$=_Z/&^M7SHE_D5!W#[M67KX
MDOAO@WIF_NJ+Y5'AR0R7NU&C?.^6D.2J5>9&F&S]U-DQ=73JQQUSN]@0=_)T
MLM<P.'29KY!V,3XL[EO%]&A"KG.NO0'+IT[_'K$FRY%Y.E<+/4_Z!M"LT[GA
M54#@-3FV^IZA0 O^R5'UQWZRF6WK2>0W*W&7G,T+T$P-*.M!QVJ("Q%056TA
M/4[_(T;I)X1QB4!F5CKC:>8FM=+66R*[_<<73;\V]E($VEM?-_5R-Z^0=8_;
MP42[8YD\K+<T)_OE*S0DTOQ<G]B5_#V_RP,.W*GR##WW;[PN?G=W8^KUBKF"
MA9*OQ\,IZCE^K%,&-^'0^["IY@*=(\NG>+TO/M&U1:>>'1#8'5R-OH7O&V5:
M!_.;M837H#UY8 OF7V1 GZDAQ6)HR-H(I.ZK/VUZ=MT$9T[3PKORBITK4-4-
M4-27Y&1ISMAPUC\4-Y5I&0!Y&0 :57<&?87@7X@TQ]DC.2 V5PR%VW<ZOE"
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MYW/@# #&W-9\ZTB6DP6,.![U;)[/QMLC2^RH,A*2JJ-5-2FPWN*4'*'9.>R
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M60QK \O[7):5\@8$K_698N&JF'YW<03O,U4>5?"V35J/ F/8;]-6YG=F2X@
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MEO"DI(GKW$DVZ(3/R\!<E8V.@4]";5"'I]: >Q@@(<"^]B^_D2CT2+O:K&P
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MI##&41BEB!!*J->^:I>TN9%LHYOQ,(QVGCY9-ZZ.NV%#H37VOI8C4/Y[4"X
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MQYJ]AFWNIY=N(S;=$>41R+,XB=QK]?LX<#Q"<;!SQ>,G]^/SU]G*]J!^JXR
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M6[5(4:)P0%(8B-"VL;=-8>(@A2'%RBQQ,<$A7CRH/%O+3QN6;]Q(;PZF^3#
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MJ^ :M/9S/TVFK0]]%5I'-:2O>YI_G>GW.5N^,"NQNF!F2D6 6!I#)BR?Q3R
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MNWHFFBC#5>KI]LZI&M/OS-?[\V]J^57]M%YMOA0+$0=!$!(%I=!E"(V$G.K
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M8?JPLD/TGB.<;*?#+,/(#A'J&SYV]!Q_%[.[!E&L6!1%-(0R$10B3+EALB"
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M" 8JXDH2%8O8:=?X]./G-J]+#?^M )6.[BOK$\!=WG*X#HZ1Y_%3)'IL-IR
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M3@A42!M7#@D.*>8"$AJ) &&4!,(I0<]%V-QF<:DKV"L+:FU[GGYWXNQQ1#(
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M!G1DVU@F%-) 82A%R%*IXDBZ>9AG)<S-8ZR4!+66H%03&#W=$Y=/ ]G-.8/
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MJ^V W7BN 6O0-CV]%)FV?\\U6!TU]KGJ87U7:V)]KVR\^<DRM!&*0T02#8E
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MJS]4EWF6?;A^*!U]TBD':.Q/1@EY94R3D%>9T]3U.]$1I32J3-2S0]HR;.
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M_FPUL#2_[>;&S KWAKCG]<@EV-8V^2#07)KF=@),:J$/PN;84!_VD&&,I[8
M6\VL;T7]OQ_6'];?U<B;K:X?E(B$"9IB0*@NC)K%"-"0QR")4Y*E(B(B0P,<
M3[V#SM3!U)'0CK?Z$3;CJ?& 3=6AN)8O>-5*^IO:C00FV%G3D!$F+FFG?\!)
M:<9(]V-:,;O)?MO_5FP?U%RM-G<%(ZLV/(OG<2QC@@"/4UUYAH2 9# 'E"0,
MAI)&,C7RM%P<86X&T)&0YAN^\_A=WUB/1L4S&1S)-Z P_84WRWB;.QJAB;:P
MUDA9;4Q[4>C9=)Z_;[(-9:_8W<UB_X6NS*(;5FTWR\_DE^X>LLP@R5"2YVJA
M8!3 7$*U[T,<<)+%A(>2"VX5 WAUQ+GQ72N>/H34\HVUBHX!'FH9C8#M9:RC
M/9"?KP#IP$2Z (Y?,^EXT!<VE2Y@<-U<NG3CQ#EL;6L,M?][JEW.VK'S[9ZL
M;^N$A7T%E"^;U>K]9JMO6E($8Q;&*1 D47S%,@I0DDH0<4(CRM(L8G*2=+9!
MXL^-_"K5IDKG'C;A9OPYWVGT3,8.4MSV78+V& 2UEWRG4 ANVXRW/1#JGT_:
M-M'^N_H%"O[4X 0-.BX+J[[(M,XB'6Z8!G^-S+A1L^,L26Z<%*X,\FK0O:/H
M#7DL=F3U2>R6<8R0X"(&.A<'0,DIH"*!.BQ*((X1Q5ENUL'%?O !AY>>5ZI*
MTK&V^46LAQKIH_![46N]9OB.T[EJCU!Y83H5UA>Z=:M/0_X:@'XM^HNCO[!I
M?PV5ZS;^U2?8GX]J!\ZVH$^:&G\GV[MBO4SS/$1A&H(XQ3H,/==5\U$*)**(
MAI2A7,:FI?Y.'V]E+$\0NM25,'BH1#0_ SR#WO6CT7&8>'?>=N#X?3P<YN>A
MXV"9Z##4!AZK<]#+VO<<@IZY:;(3T,L"=X\_>ZX:U$[O--CFV^:U^$P*_O9)
MW$BUN][7;]3%N@7,.8 YU'TS(P&02 A +$OBD.4)3(T"8*Q'GMMQP#>U: BB
M);1J?V8!]77.\P:@9SJ\'+&WVP14!%K\N@YF!?"0XJ1V4%NUD?,#^70]XAQ#
M;]O_S1Z^_N9N%L^;LG.;O9I';=D&/&#8/ENG-1UV]E5WDPCF>2(Q!BQ+U7X:
M0P0(3"( PSR$E$"88"M/U^D0<Z-S+6'G6&]0OY@S0)IMEL?!X]VG;X6,]4;W
MLO(N-[1G1IETXWI9R^,-:L^5P[[O&\ZKZO9DI<GCP[K9X3:A%6FDS+=,I #G
M.%-6'4< LQ"#%,),9")"(K.J>=@[VMR^^H.PU<('BG70R&OWY?=#;$8"SH#S
MS >7,?-0W,H(%)<\T3_@I)1AI/LQ>YC=-/1 ODXRJW,(=8V\=2GTD3!BN6[R
MQ$!"$0(0"@00HKQ*2"8TQ"FB>%#,\/GQ!IRX3Q,N7(L;B%K21;#N.1"V0]CT
MT'T$8%,=L3<@-8G$KQHI?W-^?-X/A=O#\@MC37PTWJ_QZ4'XE>O]]<!1&YAE
MED&FMA$<(-UP ))<_8M'"<BYA!3)$ F>N&Y]H\:=VT%YW?GYJ9NH^#S/UWT_
M%HW^];,E3YAZIA?+;BO528<?A-TWNK%$>F:YN$:(>VEJT\'-02\;_;3Y9-B>
MJCBD<TWW]H%[S/6NX,7J:5=\%U\%:TKD?%+O35,B):*)8G04JFUF3@&D/ (D
MBD(0<1DR+K(X2:VZ$E\;<'8[S8Z\P4%@9?6HFP96I[D*NN'&TR&4OO>>XU"T
MWWX:0N-T!WIMS&DWH88(G.Q#3>\;6!^K9;:OXJXRD]K3+"8)1*G"5288Z'-J
M@&*D_I/S-*)11,(DM2J(=7Z<N;'+81%NY;2L<W4!3C,"<0#29&9A*Z*'LZHK
M,#BM5'5AJ&E+4_7K>U*+ZLKE \MWK$A9WLJONPW[U\=B+3[LQ$.YC DC29QC
MD L2Z>)2 F 4$ET<CU(12\J85<W/LZ/,C00J(:M <RUF\*<6-*@DM2V[<193
M,RX8C91G)A@"DGVYC#X0G);%.#O0M.4O^G0]*7/1>['#O,WMD^"=V-QE!G&6
M$Z@ I+K1,E6$0!F*@4RHS+,\296E,#IU\VC0N?%#(V&P.HCH(('S&&G3DVJW
M^'D_M;Z4QEDA^M$ 43>9G!<@\I[,>3SNR^=S7D#"**7STKW#".B;?O#3]E?%
M:G4G*?;?3\56)]F4N]_%[G[#ERR*.,HP DR(%, 0AP ED@,2TS#.,D%Q;IFA
M8C+L $^9[_/N1NJ@U'E&NHBE>O*]FAA++C("/24A57Q/ ,5Q6C?10!$F()-I
M*&.62D1C&]9W!OF4<:J5@Z&I(GJ V[(+EQ'<9M3O&D3/U+]_82MY%W4'GT70
MRKP(M-1!+;8[\K<!R27Y&XT[*?G;('%,_E;W#@VN^J^GLB[<]FWS16BEBI5V
MH[:%EDOU^S>DO/^\W>@^N/SUKS_4U_=A?3B;9[OB>[4.[2L90L+S5/ ,8!IR
M *.( 1)&*<AC)B,:8R%#J\1]'T+.C><Z.NI0YFVKI0["4+9:%6R@?J]_8DK3
MX+%152=\;_;'0V2OYW_81H!Y> \,S^]?>'9]G_D_G]B]@CI>9!]%HI7\3?]9
MZQE\[LSM*ZVK>@%^ZR9P[O7U4BW3YX2XC77S(.?$(7+^D#Z-K/,XUK#%I^O3
M;<-YFD">)2<Q$7&4@R3!%,!,[34H(PA@#F&<QCQ'662SAO2,-;>E8!]CMEDW
MP32#CSSZ$#9C9T>X>2;9H[B-/8*-I.ZXT0 .EQ37-]RD3&6@]S'AF-PR*-VS
MV(F/Q7=-33OU#A1T)>J*!C>,/3T\K?0IP,W#9KLK_EV7!]F;I51MG!,: II*
M32DP![H:,.!(2I211"2)40S'.#'FQC:U)F"E50D.NC15(O1.<:].T-7'NBKZ
MR-GKIZOIYL0_D_TEIL,JY72":9DN_]3;]-AFHHY$M3\M=>C#I\Q1'0G 4<+J
MV*<-[]^Q65<G/'6!M=NG7:D$X,K@7J:"PS F%)!4'P!GZE^4(J9^I!$1(<J2
M%"Z5>5YL^-<=V>X,HP%ZAK3YY(X']NCUKB0.ROH(DXJ[8KW6&V%*5I79]ZI8
MUP?RY6_V'3HNH@]I0C ,$Q!"D0!(,@Q0J+8@D9"8L5AG%+?HOUL;>CW<8M\.
M.Q7RHI+3,^R&@1J.@/0=KU'CUQR^UY(N@HZL;IN<7$/$=4^3B^--WL+DFN;G
M.I9<O6=P1,?F07PC/\\T^<%AAC"G"2!)K#@EA@@@B#%0C))D,J(DY;EE(,>E
ML>:VT6C..I6L+GHK]8%L',/A CK_H1O#4!L2L'$-#\=Q&A>'FSH\XYK>9Z(R
MKMXR\$B4%-O*T_=_!+\3G2"/F]W^3\LT)5 JVP\PG$D (QT>FD2Y^@]6-$(H
M)WEB=39J,.C\V*0YXMLJPSPH?Y!'VZ-1$Z0-ST@=X^?[B$')5,<!!)7 ?N*_
M;$!Q>F1J,NZT9Z<62)P<HMK<.XQR_D&VA6X.4!W4ZL"")8Y(GH<B!YF45=R1
MVG%2EH),<,4O:<RCV,KW<C+"W,BD%;!QM["-:2?BRQB:,<<H9#S3Q!Z4QJGR
MI@\5:WJXJ+E++C@=9-(/_Z*.QU_YY0OM'23#:Z3_W.D>ZYOUK7SW\['85O=]
MKLX9EIG (LKR!"#$E,6!40X(U)Z47&UF\I1)QHPB$7T).#="V8NJ4S4>U9\"
M->J#^<&\ETF\[D%YZ:GQS&A&#31>]S?0Z$[L0=6@UO6%)]C<)_/2$SV1M^;E
M)MS*E^-S-GJ\/%Z&G<S_XQ.TKF?(ZSC#+/8OXOMF]5T7^]\*7JB- *NJ831)
MST00D4I,0898#&#(*$ Y%B""*8X833.$J8WUWCO:W!;>O;!!+6W0BFMGS_<C
M;&;;.\/-\ZIX$3(/.>9&F+C< ?0/..ENP$CWXYV!V4T#V_FQ>\&?5N)6_GVS
MX3^*U>I;U<82HRRA,90@RE-E[$.. <Y2I*@D36&:AB1)[?KNG1]G;M31BJD7
M^E;0X,]*5$O?Q"5@S7C# 5R^[>@A2-DWA.O'P6GGM@M#3=MBK5_?DUYH5RZ?
MN,5GTT>MXT7]IRCN[G70S'>Q)7?BW4^Q944I/F\+)I9ADL<QS!.0B2P$,"<1
MP)1E@ M$:"ISFL:9?63+1-+/,TBF(WPW1D8?0%0R+((?C4Z U$H%HM$J>-1J
M5?$<?WQ]JZ^OXSHLPSJF>GFR4%FV1"8@$KD D @)<(ASM4#!D.0XC6.>V@;F
MS/;5\1_C\^S%$6O^_\=7QG#IG=]+,(<CL?Z>LONNL<_>HU;_H $@:!$(*@AF
MT#=VV)S-HF&LI>A_C4ZQP^;#68O8@<,/::ZXCSQKJMO7 6A?1"FVWP5_O]F^
M?]H];<6'LGS2<99_K OU+\'KRY8P1DD4IQ1PF1  TX0!G/ 4B C3-($\P82;
M^F)&RC*W+=RA6?53(V<3GQIL&X4"N=D&^G,,/F[6=^";V#[H)%SU$NB2G)_5
MTTK[L%87LWK=.3/A7'E>=)X'Q;;=-YK^XE^Z,U4K%+0:+8)6I\"FG;V+^;%I
M63G9/$W6W]+[?%FVQ72"<&\/S7$C3-APTPD4S[MSNGFDHWR8FZ?=_69;_%OP
M)8:(Y[' @,DD S#*.*!Q+D',HA G:D<8IU:]GGK&FMO*]CP/HUG4R%Y<AZD8
M';S--DV.4)QTS6FXZR"IQS2,4SB\9F%TAGO9)(Q3O:_F8)RY92B+5#9=[7/]
M4I3_>OWKFWI2U=.0)QG/F(A!RJ $4,H0$ 8SD)!02H9SR;$EBUP<:WXLTA$U
MT+(&6M1!W2+[(#8E#B? >2>.09@-X(VK:+CEC<O#3<P;5_4^Y8WKMPR.K!#K
M)_%>2:G#-[9KLGKSI!;=!_5QOO[U=[&YVY+'^X+=Z,ILE;_EF_BY>ZWT^9?B
M%1D3%"6 RAP#2-(8(!8IFLGC3-DMD'$.+>,NALHR-][YL%:;@X?Z"R)T\[0+
MU*/;6O9!HVBISQD/:@5:+^NHC<&S9QS3,<6<^(_XT%H$^F,,6CV"O2)GYJ%L
MW+N!5B>H]'$;%3(65<<Q(X/%F3JB9"QN9^)-1C]R1!WTZC!CU=B%M4FXVVT+
M^K2KAMJ<'MT>#G;+I> ()DF8 4IY F 6QX!&RKS+.,(QQU&:QK;)M2-%FAL1
MOVV;#PDI!=OID]+U9OU=E-I3H]/IM@73_ZSVF?H0=:=VF=HC6!^.!\UASFX3
MB(?'U>:7$/7?>;%5C]ML!QR>.IQ_,PZ?=E8]4WE'F:#=XC9[VXX^>L+V4_]N
M/_5GG7H=/1T7@W>"N?-2\>.DFKZ0O!,4SY:9=_/D8>S_>;MA0O!2+SS5@4#C
MCFN=;GPID80\B2C@.5?FM4@E("FF0/ PYAF52<J,W%[&(\Z-NUN!:[-M'X>A
MON.:K1N.MF/=Z[C'&24T$1E .8P S%,.,$D0@#S-0A%F HIL^5ULZ>9%D.^.
M[/$00)?E54N<J.I^51.PNQ?338+9RN846,\+U_.WN>YFU(B[#Q5Q>"IK#(W+
M]>7ZH),N'\88'*\.YC<.2%?=A[$>UUUK@M%)&,8)# &25-&^#"&@,&$@)AE#
M+ N3E)MGGO:/-3?"[X99GY0:M(M,-T'Z>@2"0_P\L\O$T%DD7KJ#<*H<RE%0
MVN5!FH'3E])XY0G392>:J?(LT=#PEK')/LVQZQ?QJ(M9KN\ZA[.O?S5_[)QJ
MQR*)9!X!G"1"1UBK#2-/- DSGDB2IYE9M-E(.>;&S>=/M \M&O2A2*U9M?\>
MUM9VZ)R968L3S,2$+']P)C1*!!TM%E4(<W.%SY/LD9CZR6FR$^6%<IX&X74Y
M)VK8XX91Z[MR5ZA'JU'W)9GV_S@4B&MRAVD4P9S&$*0P@P"B2 "$1 A$@@@7
MJ4Q"AFSXU&;PN9'HH1"9'2]: 6Y&AKY@],R K=B: 3MEW7ZO^H;5R1OND[B'
M8.62V:S&GY3.AB!SS&&#GC&F4.U7M8.H7I5]_53!\SC*TA"0*(L!C%@.2)B'
MROI+6$IH1$64VA>I/1EG;G34E%K=RSFR-NTIKL;^J;%H^7<Z60,UL!SM11C<
MEZ(]'>H%RM!>U/=\"=K+EP]L!WGH=7"[NQ=;G4.U%?>ZCLUW40_9+*LY86DD
ML@1@"!5'8"( %HHR>!J*'(8A$03:N06,QYZ?>Z#;]:.2/7@F_/,V?Y:-&8UG
M1*11)N.0 \QS!* D'""&* BS+,20,Y3G5CMU+_,Q4:/X_6QLJME@SV9#K:#E
MHNJDJ:RF'?GI:T+,Z-X+S)X7@)O;-Q]. @P^DZT?>],:(:=-)HT'G[9SI"TF
M)^T@K1\P;$79'XE5M4W; L:_/BDUG[;ZA5GF*<4QIA3P6"K>(HD$5) 49"05
M.)99%D.K>/RK(\Z-KZI,5%T?M-/(]Z3OXYZP&B6"ZF!CL[8CK^NS849:3C'V
M3%:'0]FFD/%>W$5P$-@=71ECXY*FK@\Z*3T98W!,2^8W#FXY>['/5Z>Y5].G
M\C\%V;Y7+^)2Y (F:0)UD2+%4<K24CMB"H'@+$L)BT@66^V(AXDQ-^)2[V)J
MW8]V"/QFI.0?5,],U307_'BVN>"B:F;+CAL++@*M2* U<=KE=@22CAO@#I%D
MZMZX(] ZTS9WS--&!-\KPGTKZO_]L/Z\%8^DX&^%%(IW>3/<S;JV%FMYEJE$
M')(P!0GE5&TY4P$022F0&,5)QD7(8KA<BSMM97ZSC+NWEL;H0\;UAWPBD\]
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MN;JN]TE3*X-;1E)'W1GP=T%T1@*_72O.VNISD:WBK->D+,I#7I&N9I@+R8'
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M(.5Q#A,!1:P>815K,1K2::(B:E O+ ON<39; T9CYYGI3T.T%T$EHSLR[X7
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M_:-N8X_M$O5"Y(07U._^OF6+GWM8?U/;C\NF>LDN&'.69@BEA"=0Y()#+*F
MC!0(%CSA/*,HH6GITP+'95 O.AJA^<V-'<.W"K$#MH[A)H$1BQUK<AQ=8GO<
M_+27&>R$_CEDH6)WC,*6+'88=^3BQ>Y(')<Q]KC7OSJ ;;/P<;G9KJLC[7^R
M]=SZSKZRK?IUOIS?/][/$--4<68,GJ2PC52(ADRG)62<H;PD)2JE4P$1I]&F
M9O14S3;G>XFOP/=&9K V0E^!^UIL]Z3TRWAW$U!P%&.'I%3=2EL [L0%7RL
M?PT/H'LJ?U @1\K?'PJH5\:^,T =:?J7GS%:;KZS.NV$?/>;>G:I>?;\&_OP
M6:K25)6IA$+9,BQ9F4+&"+7!QXKJI*#&YO-J4G,\QM28]INX4_)QH8X[,;7>
M]@WXHQ+>,Z_E%,1N=MY X&([XL-@YM_$YCPJ07O8G!AFW!8VY_4\ZF#3<>F
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MX?)^U& C;^U9@PT!_<W(76<KSQ*$,T+3$A:JI!"7:0H)XZEEAB(3!2T9<6K
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MSH59+$JA85YPPI@4*?(KJ']AO*F9AY]6R]NZ8H!N%V8"BW9#YJ6QGU8:-"J
M!WLRY>MPN#0/SF>_H="-?\9[AID.XL:IQM2!2ZSR2Z>&?+5Z2QWZ=Q58ZKJM
M;U:T6-?^U?K/C\L]_;UE#W-C^5US6^5?;&>8$BU$R6"IJ+!;4L-"M+14A!@5
MA4:,>R9$NPX]-4)Z>V=]:ANS9P6K_5+/ZNQ<&[W5(J;_\$V'=IX.-S** W)D
M7MH)#7[:B?VSQ?I@5C6B@S]VP@=-A_9%+&PFM//H(R=!^Z)RG/_L_80A9\//
M^[\=V6YU;3KST,_ZPWPCV,):<K.4%H1DVEA66!);U#>#C!N3"PF4EAH7E&*O
M;HW]19D:Y9G7%8&?#N4:MS;&!]ROEMN[#5!+:7_WJ^W-"S)T!>S5GLU !LR:
MSTET[+D8Z:#ZJ)EDRW;;K@!79F\YEU=@KX^UC6N-JGUFZ./L(;"&/^WN)<TK
M'(8/0>WT6?F@)_:DV]52KI8?EX:%.%O^^5EKM5;R*]NJ3Q_??/[:5)[,$&$9
M2W+([5DY+I2$3",*<\JDIHRF)??*EW8:=6HD6HGF28M.Z#HR8&C,8I-=)2_8
M"PP:B8$5&?Q4"1VCI[873D'9RVG@<8G*!XLC3O*ZN>\&]KMAMM7ZZ7#@?8@
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MLR/%99%!PC()59&)/",2D5P,+HXU-9:N@YH>ZA!3\)TM'I7]ANNZ6 ^-)R!
M\:M9FI)4"81AD2D,,2[,IC\1#+*TS/(\TS)/V>R[6O/5:/BV1XN'\(>3I<:>
M0F#JMBX-QBGR(G.N>%CD@F$Q6/_T0*]?'.P<'W=?W-/0%N+Q_K&J#?Y.:</8
M\HU:FA^VMOG=YEK^G\?-UK)*4W% ED2GC!60"2$,+[ 4$F4/E(H,I:4J2E)X
ML:[?\%.CX]^7:R56M\OYOXUQ92L1WK+Y$ORTJ.HX&_/*A@18,\NVQCS4*MRR
M'_:/__I3D>*?JWR7_XK**V $L[W5S%J[\*0;SSETM(^CS4QL*_@@.&@D!XWH
M5:?-#3@(?Z;8=H3B$OW@#&KC^DDPKB7;"YTC>[7?4WH&[VWOU-K:OVMU9S_S
M[^I05/PMV]Q]6*S^^H>2M^JK$@NVV>P;87U8K6TLP,JF^CQ:/G^C]&JM;MB/
M699J(3DO8<)%!C%C&M)$2YB7!<<)H5+DQ"OL+[R,4Z/@2D4@VCHV/04:'KX"
MPF@*M%$5W%E=+=,^U]8RLF>8883)=Z/E5Y[2R-Q=S^8S]9YW1[@"5DE@M03_
MJ&?SI:+ J 6>JWH%>*6L;0D8,$ RWE0$#:V,(.:X09GQ<#X*YXPX5/P&$S=_
MK6RU7IF2TFS7*=<0IQA!6IIU),M*PD2*<DJS6 TFS/A>R\,X#2:R>$T.+."7
MS_LCPQB;DOLW-3"*Q,4^7H,)SSF8?H.)KKF(VF"BA63 !A/VJ9-M,-%2>4B#
MB?9C^NU1OFU7XL^[U<+<L7G_?Q_-$/M(@))@FHB$PAPG9JLA4P1)HB1,&2XY
MI;)$&OEL-<X/-;4=0UO2_PYJ6?VL_PY8W8SX,&!%)OY3.)WUET2(O;@,4D@K
MN6.T48W=RUJ_M%D=[ACL&NZRBP\'[S3/,<:E-O#F!&+%&"2T5+#@K$R+,A6R
M8#V=PTX"3(UIVI[(BSO;(9$3OA/E[0$.#O^(/N! R _Q^'K!%\GGZR;#:WE]
MO1#J\/OZ/:>G5;5OG]MNL-OJN/SFZ:C#[O5?;"T_5WW,-Y\?MYLMJWHG?%TM
M%A]6:_N/,ZU4AG-!8%[:Y"R5"DB1R&!B&T0RF2:L\(IVC2/FU#BV4L$SY"'2
M!#K:?J\^+;'MQE8[\K:*SWJ2\R=PLFVYU<7F*U6JFA\.RH(_K+J@T3>DG1EU
M0H+:J'$D'=>^C8KVD6T<=S3_*C_O&D=174KDBUK/5_*#^=UFAAE/$+,E/W*;
M9L6Q^3:D2,UJD&G!59Y@G+J6^3D[RM38>R?HKHA-+2JH9'6O\W,>U&Y*#@95
M9$;MA9)7I9^+* PH]7/^V:/5^KFH7KO8S^6+PP<,O#Q..L0JV"C;Z\]O/WZI
M0XFNE[6)^V5EMOAJ.U_7+-8*<S <]9O:_L+F2_M@\^-G;4^7F4!9PG35B,<&
M;J4I9*B04,K,V)P)*I N9TMU:XWHFS 1!M&5<OI$:?V)'JD6[W/];1<(UHH
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MO$ SK3@JF<9F,ZHXQ$E&S<+$$LASQK5&.!/,:V%R'7AJ:])1@4Q>>8@VE>S
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M;-R]67-;29(F^MZ_(F_-Z_7*V)>R[AY32LH:V56F-)*J:V9>8+%X2.@B 5T
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MD>C(D'AYMJB2^G6Z3.'D?V-87+I!B2EM-.>@R:R!LO1=R(Y^M$4HDP)S3@V
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MJL2&"'5OOG,[&/2<*=U7@",KOM;[G;S_,I]='@QZ&U3VT= &J RY1JQ \*A
M&ZXD.=4\.C. \N^^=SL =)P0/4B0(X/@(Z:S!0&8B_AINCK!B7&68529-">)
M]N0]."$EB) R*E%$',0"W'WO=O59'><]#Q+DR"#XM BUNOKCC],X/YEPJWE@
MF8-#^J),$. #^<$*)>/"2)&2'@ !MUZZG?H[3G?N+\).#,#K[^E+F'W&=4E
MLM$G3U1G8349L, @)E7 UHP;Q4(NIB$.R#:]>SLD=)S0/%B@780,%\>_YV5C
M%=BD@[/E)(843%82G.'$1]84]7A3+T@DHY-'VMB&"QHVT[ =0+K/7PX@X"Z
M\F9&3R-Q3+_AJ[ *%VQ-@LR:,RT@*6;)#[8,O&$:C)*6O"!E8AC"@CQ&PW9
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MLKA\-WO]O<KL;+K\4E=A/>^)JXD@%RY@*I4;5[EQ$*,RX$K(EO/ !=]P[72
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MD2#]PZ9<KPI9VA R"*P.<@H:0O (& S7B1G&6;NSOF-Q.?8%T8$QNNGPL$O
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MG.L.=*RW[>N.<,:W%^?#'_@]<D@M0O QF 0H56TH2\%$S(5#X3'RJ*S/HO6
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MWFG)FEQ<V$S.N*>(P^-I *%W8+"NHH^WQ,L;^G8YB5)P5"Q#2I+7@)5X$5Z
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MG9L^"38HZRF@+C:)6HI0KZ&Y",IHDQE*&WBCYDVWZ!AYA%$+7=^[L+J_X+O
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M+%',0?&PJ_..LB,WDN)A$YAEDJD<6?,["0/!LLF)Z'%@V5!I(U>#W.'FU45
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MW0N2D YS+)HU:4ZRB9AQ]Z-C%?PL7@Z0=@>(N0[[:B.5!\RL;:615@IM5@=
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M<H+DE.118HZ\B9':F<)Q7= !T?-D"FP3'77?VO<IVP=/F]_ZJ-:&JN&<^1<
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MI6K94P$74Y0%)>.R26"PD9J^L#2$VF=#ZZ W(%T8QK-%[L$Q2^X([7@02W&
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M5C@OF3RS%@PM"C;[R]L>>6&.BL/S3]=L-17NF5><."WS#&; F:!89%Q#D;&
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M30(GF061I5=*IZAB7P6)#<+2<[B8.(<%V@)S/]Y5QO.BX8FONB=[)1F)IHY
M*1A B!R#+-%9T>4M^X[\_3#7'N>P'%M@[@?8&5_E/*E?A,N[<_F[PW8O0K&\
M7A-Y0;;)& G.)0Z):\^Y28K)=H7$K;@:-\@\X^N/X;#2R\*)+PLC[FW^/F)M
M2$7?_VDV78GF*ES6:FMQ(8UT&E.&K%054<T/%9R#9AZY%#X:VZZ/S&EY/>\;
MD &1/E0M_XE@]P.LS.T[_381\0O4,ML@,Q27)2@>R#.)-H.,.>I$-C?H=IG^
MI^7UO*] ^EV9K6'7R\H<)F3XE20QF2XFZ6;B960E! U\E<]'[%%D$#ADK]!Z
MCU[RWI-O'G)TWC<9C5?9Z!#J92T-8VX>"H)?I"!21*X@1*GKY$A&,4)M0,\U
MR<8;ETM?[9]>9.F\;Q;.8L\Z!D3=]\/X=4I?XJ?P)Q[2ZN+^7P_;Q6(K70,U
MJ+A]_AWP;G'GG!.6JP+6"%*K"1:\XA)*BCIH(9C!)E>4S]!TK$W=\.A/),G7
M]#O_NBB2!:MMI+"'F%;6E=K*F38)@X6)'$KAYD3\WA(U;I0\%#H>6Z7!U'!.
M=N7P3CH;'M+,RK3LAO,<G!(R7CA3(%TA.$GM@3:1 K'$(GR,QN8F_GU#8_.F
M%*P]AO#V';417 WQ)M,K<D_??\/UC?Q%L2QRQ2R@\0F4R!J<D '0!:\E_5?:
MU$SO3F*_AF@?Y#SIZ]]&11U$#W<,89I-T^1RLN*#OO$3$3-9UO00G'R>7EB+
MR.K<Z%"\ Y4LB2]FXDMQ;KVP3(JV"^\% L<]C6H%O";JZ7XWO!FC\1&7D_DJ
M_*@S.@[9$K<]:=A]<2=Z^V@5IV7.@14&9)A83;[4$!)]58)$Z22+I.P6RWC<
M5G$?Z'75$DSSJKOC!WK;_%97KW&*A9;21B=3)Z^C3)"]R>1D9D-.9B*?,P?G
M"\/(39,3D$,)/NMV;_M@\[&A/(F&S]5PKL;!#&@^U\\[B1'=1'L?IC3*;&GK
MMJ"Y$W50E".X)@U26V]*+LSR'['KYNUXHM6+WI=-^KI;7BPJ<DQ* )X$"2D%
M X%;!AYEH;4==?!MRDWV(O.LS>8^.-P^RGQP;9ZKL;R9:T#?OII/9]/ZS5>+
M!2Z/.)DY^%4G,;%[<MR']65&ARR,@LQ2H*A*>7!(.[C(:"QY$1A<DU/G<:WO
MS^3'3#&O'9JJJ)OA ?7%%UXF[SQ+X#2N9A<J"-G4?R@BI(5+7E03=_5YLL[:
MNNZ#L\?6=4!M=7!4])2;AX;C_3W#<>%=R+$P!Z84#TI8XK*0;QUCK+.4I';N
M1$C<3N19MR\9%I<#:;*?KG)/67R'R^MZMDE:?W>U"$NVQ6J2HS=U1+O(#B):
M 4);83RS:#P_#5 W$WC62>;#@G0 #1YN1F?+<#F>4_HNS.L%PQ\XN _ZY,DG
M<3F?YZ<3#S,*%B4&<#)$4-$J<-Q;$*&4F$U&PM=?P<-</'NHMOJ->^E(UZ.'
M#5-H3*F5_9&#RA0H.A%(=MH)*X0@/Z?)1>4@U)^WO[H':E\VN:UUWX%;^] R
M?0I__DZZOEJ\^G.RN) F6&Y8;::KB141. 2;$6A/B^B+L-(TZ2[V#$TC@_/T
M")FU45>_R/MY5K/\+X)!GKA%<-$I4(P<G.B\ (PE"W)Y.&?LA-B[IFI<] VF
M^]TP=8 B.D#5N]GT?Z_"Y:1,:'<@=G[#5=_6K$L463I QFE?X(C@ Y.5%::5
M2,;%)H5)F\GI$D>'Z'LVN/ [@-#_V\!"XM+DX@1(;R7Y%87D(Y$X*CJ:Y(/.
MIDE'DPVTC'MNTPX\QXJ] ^0<Y!\\O&1Z>SL/5*$J7GH-)5$XK[*3$$S)P+-D
M#IT4F/L)(K8P,?(9X^CNVFB Z'(QK.HV)_%JE2KZ^OOZ<&1^P8K)HAZ,%5_/
MR92.X$+,H+V(4N<DO6]2S[\SA6<8=0P"HA?1/(1&NX3JS8W +U>U-=P-7P_8
MO2Y')M6_+[^0S0B7_XV!=BQ4W@84D&1,Q#DCNT'.-V!V/#'.4M$GOOG9EX4S
MM-FG ?M),-'E:EA_^3Y>3CZOD+ ^=_ME-O\=E\O+E4(NG';2&60D;:Y!^1 A
M"*\ T>K )2K!\#30WXG>D:^6^L7Y\-KN -0KR=8#Y3E^J<FR-\4L;V>+Q2^3
M*84>_[?B]7VYRZ6E<';]X:%*JI!J>>_J#UYCF<UKC<*%C\&8%!)$SD@B@GF2
M" 6\J)-&%QFB;)+LUYZU<>O&NUDJG6&H^Q1#$M77R7)U04,_NZX7^XS3-#DH
M&_NYIPU[:[LSW0/=U-Y[WZM'[]M04%44.0_,"$ I%2CT$7PP 3BYVDQ3C!JP
MB8>Y%Y7'FNN=7G:7F6N$#SG7J:I.%E %.;C"240\),Z$=*'-\=Q^9(X;1K9#
MV6,[V5!Y9V#SI@EK>ZI5/# K'R>+?QUD[#8\9F@K]Q*E YFW^N *A+_3^^9+
MBH^6DWM]6Y*TN6#.P$JF':^P#%Z+#!0S.9M8BDXWR4![EJKCS=<]V=8W;<*]
M$BF4B)F8SG42A*Q9"]Z#43D+GI2.I@GGNQ W\@W58(AY:IH&5LQ9&J3#T^B>
M>UI[\]0R7>YYS''F4W;604I<U0/-!)ZQ"-9*S8M,VI0F1]2GM5+7%QY"*]K@
M7029Z[!Z1UNQBTE",LPHSI@2;8:N;":G9TNT#RI>M$3["W_$8Y7%?'GQ83[+
M5VGY?OX[SO^8)%PEHG#NK0^E ,?L2236UI-_#LDIQHTM'L,N%?;T_'O H4^/
M0;.-@+%][..5.AM0PGT@I"Z@-0<WB0*&<Q<LR4$R05NLIT43K6$@N%4L!)11
M[!*P[0.3IU2,@Y5A%/L4)4=*>42HD)=Q\6GV[9?)'_AZY0BLLS]<"+1@T$+T
M2.3K+&J1@P:'F2>392XQO>"O;'GTZ)H_5EFSX237P>'\$[/Y^OMKG*8O7\/\
M7ZNEX91A0C-)+CC]HVP=NUY8@IQU*LF)PIP[B4ORB+!Q[TH'W&V::*)+9-UP
M<Y.Q9FWBV2,D7VOZBU<0,U-@C8R.<31"-''L7R*L,S_F*!B\B+$C=-(!QGX/
MEWAC>'/B22>MP3@=B/3DR.9R^H@ZQ1*9]*%-PX\[&GI#SC'*?=ROXT!)=P"2
M#2OJ$_WI:C&AU+IPA1#J%"^%+D,0VD%1VCJO3+0NGFAWNZ%IW.2(TVQL!\F_
M1RA51M:KBUQ(I[GTM0<..7XN&0@*.;!BR.ESCG[>I&KS&9IZLT<'ZOW%XYO#
ME- !GM8AR1..UH86E8K2<PE"U^$J,A%?.EO(R0;.,TK;I@KP>;(Z0]6AVG_<
MQV\X570 K)^N%LO9UU6*Y$9VF,S*<\?!VLQ !5-J!Q@+WDK40J<059-NG"_0
MU5M0-PRTAE1&!]CZ_>K;M\O)=G84#XGYP$#[VA$8?8:8" I))&&\9>2"-O&I
M7J"K-[]J&&P-J8R1CZQ_"_\SF]^LE>O:VEAG'@6BGFM.;D(=$QJE-,"R$.1Q
MYI1V:CN_TUGUT]>/FWLY\(7&D=(=&1OOPE=\7Q[PL%X\V7&,*T]26PI&=72U
MC9D +2P*)T50;)><O)T@LI6*\0ZUCU7K;&@9CWR9\<]P^37,ES<[J_$)@_9@
M3#9UUK"!R(4 BC>B<XB&IT?WZ1NO,1X\=#Q=#Z2@V1#2ZL />6(@W]ZEFC/:
M0!62M^Y4!%4M92A900Q&FL!C$FV&H6XG:2?4Z#/82P:6?H\X^H#S^HWP&?D%
M6NZB91Y**>2;VR@A!.Z!W">II-=6M>G2]QQ1G07@!RK^)3P=JH61-Z!W5]66
MOB^?ODSF^0,9U^^_A>E5J3-SY_0""O:"2TYF$(+LJZ)E!KXN/"-UT)+8R4SO
ML"6]\)K. NGC(#*T6/M&R#\GRR]O9]//=;[RS;CEQ47-0A'&UBES]<#4Z% +
M66.=9L<SJV-W'MNA0V"S\=V=!<[-L72\ KK/3'Y]19]QL?@=/Z]J10Y(1W[R
MB&%SD)^G<*#$X_7#/^*WV;P6RMP-A/'>%U\"H$BUPC:2-6&%_"3%R#?R!4UJ
M4D^]C:"CC^P>/7=3ZCU&'4QB&;3RM9D9+[3'!N(Y<"="U":))HD^.] VKL,S
M"$J>G-L-K)&S,SD'CP;:\J"VYJ?A,*"M\'*V9K0[!5S6*R<6Z@%QK#%^42&[
MC,PUR8]J9H1N1[X\?L.OTS*;?[VNQ_Z^_N'=,K!%Z50,[;Q<D1QTO2M&VGE5
M<,@=!A]=XTD^>]';J;':!TW;A_6TTUP'!P%W;+Z9+B?+[_^<9+S'X$?\ Z=7
M^ O)_ TM_?DT7-X>O+[^OB&[^$X0@86LZT$+ZHR@4O$0F>,@/":5%+-,-YG<
MW8RC<>/+QB ?4_L=+(/G.?T;SC[/P[<OD_1JCN')G"X3E1;$(,NA%E*@ EKE
M'H12GBG%7!)-'.<C:!XWO&T"Y5-IL NPWA]/_+Y<SXZIG-_L1K.?:A'KY21?
MSWFY';_I0Q%UWB9GGH$2R,'K5;OZK*)0T6??)%WO4(+'O8QN!-,3Z.[L J-[
M>PX)Y7J^^_0S_=FU\.MJO?G5PXO)!WAIVX#K6"FT#LYX)NQQ0V:2<U^K,$H]
M=D3:V#76<<)&8)-*[4Z"L]7U8;%%BX01+-;S#VTX!),2&"%$<HYVBS89SP?0
MVFE0M@^*C@S*]M;8R!D_=Y:?V%B=]U]7/R5NT- &D[@7H+@+X(I)( H3 I-D
M.@]6Y+Z9A)&AU%KKLT%5T!V(;DJA5$E:*0U)&P/*) E.6P&9*R:"U%G;7>*4
M V$T=M+8$(I]%B<'2+F#6.+6S;CQ+-9Y49&IY*4V4+3*H(AP<C>5@QK3ERB(
MI=RD[=\6>GK"S2&*?MS:<P"I=P">U8#=Q34+;RXG7R?3E91NIFF4[*2MV=VT
MJ]>K' 7.* %%.":RU(SI)O46SU(USB%>,R -IX$.X%1GNUQWUGT4&*TL==;<
M:,%I,3A/S*RF[MF0H*02<R8.!3;);WR6JI'/A$_D& VOH![0=DW[33L4%UT.
M1@+&>FU31.U>P@S(@MH+YE3T+6/;'FI7!]3NYHO_ T0]=MH:K:8OK[[B?)+"
M]/VGG_X+P^7R2R)QKBUL2#XPXSED59LH2446-@L+0L:@>=3,ET=NTN84M1?>
MTT4H?XCZ9HUD.3(N5MON]58;+C?QXERP.9"!32;0]FL#@F>*3"U7F39>[6,*
M.^#BI?=T<25Y)"X&E64_^\JFK?CM;1JGR:X$@PA"U7[7B4GPECYJ*X-(PEKE
MVAPC[D#<R)>#I_9IAE97WQ#\,)^5R;*.D+CKO2XE1EE4K<*F?TPMQ69(Z-&T
MB+D)0K09'[X7E5WL@ ."9'<4'JFQ#N!X[VK^)K>\YIO?7,^_^3-=7N5Z1;!8
MD->)N4XFT2ED*RAJ%4R+Z@PD\!@="*%\EER4XIID#QU :[?0/!8YVS,LFJBQ
M Z3^-%LLWY<UHQ?<"]I*LH!"2QLJP>1XA!H!:48+767FFPP%?T!%%R[>"=!U
MN.@[P,W?YB2&:X%<A**YLDE <(7"F%@3-6(AR"OK>-*LD$/< C7W:.@KO:L=
M9@X5^^&(F2W#Y2"(^2W,_X6K>_%I?I7_0)+4@C[5H8_3!5Z@DB'6!N_6<PM*
M)0-.*0$\I^RY3 Y3DQ+<Y\GJ*Q^K':X&5,[(!Q7WQX425Y]7UPW6BA@%B&!K
M.&W)M"*YJ3*[H&1T&,NC76WCT<33)X];[M\>'0/(<T3#4ZG_&TYQ'BY7J/XZ
MF4X6JQ+3/Y"^\3,20>DZ*['^_&N5XO5\P1O85\%@CAY"\=7"!DDRLQE2DLG(
MDI$]SA[=")RCB-@)8^:\,78Z+1T,1S*)<39T!L+==,O:;=<KX108X<C".E3@
M'?F 9%R#E)$V=M'D-F8#+3LASIXOXH92PV"F[50YQ^M08[A\XD</;)LK_!SU
MS?. 40G.BB5P*5-[:M..ET2 F"SY1<RHTB:QHWT>\$!54->'TLY;$VG))*-4
M/90VX(-$B-XD9-9:BF_;9@H/R$U?9UP'(;%Y[=O>6N_@X.+Y._^"R&T(B<*;
M>B.;C8>H*<0N/&N,VJ90VE0A'YUR<X)<Y-%0LU=2SCXJ[ &/#ZZ4LS:EIIV
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M)V2S;HKPR,U6BOQC4QSM=R4:<(%)8,$6U#*@]+LTO][\]'$R,MIH?P#YC8R
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M,2YH=&U02P$"% ,4    " "T,D120HJ\1A((  "#*P  &
M@ %("   97AH:6)I=#,Q,C(P,C M,3)X,S$N:'1M4$L! A0#%     @ M#)$
M4JVM5^B=!   MQ0  !@              ( !D!   &5X:&EB:70S,C$R,#(P
M+3$R>#,Q+FAT;5!+ 0(4 Q0    ( +0R1%(Y>CDJC00   @5   8
M      "  6,5  !E>&AI8FET,S(R,C R,"TQ,G@S,2YH=&U02P$"% ,4
M" "T,D12&2);.'M3 @"O9"  $               @ $F&@  <&)H+3(P,C Q
M,C,Q+FAT;5!+ 0(4 Q0    ( +0R1%+'I7</F!(  (/9   0
M  "  <]M @!P8F@M,C R,#$R,S$N>'-D4$L! A0#%     @ M#)$4O+U2=H3
M,@  '!P" !0              ( !E8 " '!B:"TR,#(P,3(S,5]C86PN>&UL
M4$L! A0#%     @ M#)$4I+'=KX\9P  IH $ !0              ( !VK("
M '!B:"TR,#(P,3(S,5]D968N>&UL4$L! A0#%     @ M#)$4DLW9-;ER0
M60(! !,              ( !2!H# '!B:"TR,#(P,3(S,5]G,2YJ<&=02P$"
M% ,4    " "T,D12&\+A_^<3 0 CD L %               @ %>Y , <&)H
M+3(P,C Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "T,D12CF@SW="A  "XI <
M%               @ %W^ 0 <&)H+3(P,C Q,C,Q7W!R92YX;6Q02P4&
/  L "P#= @  >9H%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
